data_2jmd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jmd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 54.0 t -88.7 110.13 34.89 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.47 -17.86 53.92 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.848 2.365 . . . . 0.0 111.952 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.442 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -65.8 -43.99 93.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.754 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -115.0 -8.24 12.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.542 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.5 mt 56.68 34.82 25.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.845 0.858 . . . . 0.0 110.914 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -118.16 164.06 15.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.714 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.57 32.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.917 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.48 119.58 13.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.031 0.443 . . . . 0.0 111.008 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.478 ' C ' ' H ' ' A' ' 19' ' ' ALA . 28.2 tpt180 -91.37 115.61 28.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.252 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 69.23 -16.23 0.25 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.553 1.141 . . . . 0.0 113.026 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 47.72 91.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.026 1.33 . . . . 0.0 113.569 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -101.83 116.73 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.319 0.58 . . . . 0.0 110.735 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.41 134.22 35.52 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.082 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -87.92 160.71 46.07 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.781 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.87 -17.96 62.31 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 122.39 2.06 . . . . 0.0 111.014 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.82 -21.43 63.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.411 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.91 2.08 58.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.417 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -97.54 136.39 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -102.54 135.34 44.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.98 166.61 22.31 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.9 m -65.74 150.11 49.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.06 -10.61 51.71 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.502 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.12 -38.13 3.68 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.559 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 36.6 m -61.77 -45.12 95.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.692 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -66.94 -39.34 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.57 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -62.97 -42.87 98.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.063 0.459 . . . . 0.0 110.509 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -78.61 -1.48 34.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.479 0.657 . . . . 0.0 110.374 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -105.84 -19.69 13.67 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.997 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -102.98 -26.16 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.0 ptm180 -103.02 8.55 38.87 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.795 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -115.28 -53.84 2.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.95 -66.68 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.22 0.533 . . . . 0.0 110.2 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.82 161.71 35.04 Favored Glycine 0 CA--C 1.497 -1.032 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -80.86 81.08 7.21 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 117.206 0.503 . . . . 0.0 112.197 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.2 ptpt -151.3 154.8 37.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.479 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.4 p -83.36 125.67 73.61 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.94 -27.33 84.63 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.636 2.224 . . . . 0.0 114.313 -170.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.15 -49.49 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.941 0.4 . . . . 0.0 111.864 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.91 6.39 4.29 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.85 37.85 21.58 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.46 147.04 28.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.77 121.33 15.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -125.63 127.14 45.84 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.838 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.35 151.93 29.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.13 -39.44 86.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.535 0.334 . . . . 0.0 111.148 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -75.38 -15.21 60.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.772 0.32 . . . . 0.0 111.6 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -83.08 -14.87 52.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.8 mt . . . . . 0 C--O 1.24 0.557 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.02 177.913 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.2 t -86.49 107.59 14.31 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.41 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -63.16 -20.76 71.7 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.644 2.229 . . . . 0.0 113.251 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.0 -43.69 92.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.861 0.363 . . . . 0.0 111.018 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.0 p -101.15 -21.23 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.791 0.329 . . . . 0.0 111.488 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 60.27 22.35 11.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.977 0.911 . . . . 0.0 111.94 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -99.14 -71.65 0.69 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.808 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.13 -169.87 0.58 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.2 mt -97.0 107.98 20.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.764 0.316 . . . . 0.0 110.375 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -64.99 -49.66 69.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.695 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -116.11 -16.09 11.05 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.643 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.84 76.07 0.21 Allowed 'General case' 0 N--CA 1.462 0.139 0 O-C-N 123.862 0.726 . . . . 0.0 111.959 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.05 116.98 49.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.266 0.555 . . . . 0.0 110.919 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -71.8 125.89 28.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.933 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 p -89.66 158.76 44.88 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.44 -22.53 65.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.223 1.949 . . . . 0.0 113.56 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.57 -46.29 26.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.018 0.437 . . . . 0.0 110.966 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.68 48.94 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.346 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -139.92 163.17 33.37 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -124.86 137.6 54.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.08 0.467 . . . . 0.0 110.293 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.41 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.5 168.98 18.23 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.064 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 48.4 m -79.96 147.04 31.76 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -74.72 -3.58 32.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.256 0.55 . . . . 0.0 111.409 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.51 -18.57 12.38 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.957 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 43.9 m -85.07 -48.03 9.6 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.285 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.535 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.73 -42.27 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.406 ' HA ' HG12 ' A' ' 37' ' ' ILE . 84.8 mt -63.48 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 111.633 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -77.25 -2.04 32.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 m -106.68 -24.21 12.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.8 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 33' ' ' ILE . 47.8 pt -105.1 -21.77 5.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -79.04 -15.45 58.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.887 -174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.16 -53.74 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.771 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.21 -65.34 0.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.562 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.43 139.65 5.49 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.866 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 71.3 m80 -79.55 67.05 5.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.698 0.761 . . . . 0.0 111.706 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -150.85 155.8 39.93 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.197 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 51' ' ' LEU . 35.3 m -64.54 129.61 94.32 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.91 -21.81 56.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.989 1.793 . . . . 0.0 111.001 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.35 -74.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.553 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.14 4.52 53.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 54.61 32.99 18.21 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -88.39 155.26 19.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.73 117.39 6.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.495 HD12 ' SG ' ' A' ' 44' ' ' CYS . 7.8 tt -124.28 121.43 35.01 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.423 HD13 ' NE2' ' A' ' 55' ' ' GLN . 79.3 mt -111.36 145.22 39.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.255 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.39 -36.38 83.96 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.915 0.886 . . . . 0.0 110.466 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -64.79 -32.02 73.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.57 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.423 ' NE2' HD13 ' A' ' 52' ' ' LEU . 82.0 mt-30 -89.09 -8.64 53.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.759 174.714 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.431 -1.4 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.5 t -84.21 107.69 11.68 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.71 -18.46 47.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.423 2.082 . . . . 0.0 112.52 -174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.18 -43.58 91.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.292 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -100.53 -27.31 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.26 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.4 mt 63.89 23.09 13.25 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.778 0.831 . . . . 0.0 111.608 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.2 mtm -96.08 -71.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.497 0.665 . . . . 0.0 109.371 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.77 -158.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -98.95 104.76 16.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -68.63 -43.85 75.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.983 0.421 . . . . 0.0 110.747 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 63.2 mm-40 -119.21 -15.99 9.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.641 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.76 81.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.795 0.684 . . . . 0.0 112.278 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.42 115.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.806 0.812 . . . . 0.0 110.787 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.61 129.05 34.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.375 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -101.05 154.47 37.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -22.11 70.24 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.639 2.226 . . . . 0.0 112.094 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.06 -14.65 60.61 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.647 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.96 25.67 16.64 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.032 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -113.01 152.9 28.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -131.1 122.28 26.42 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.82 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -130.12 -169.54 2.15 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.96 0.409 . . . . 0.0 110.861 -172.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.602 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -99.54 155.38 17.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.8 172.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.0 tttt -68.13 -12.57 61.13 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.239 0.616 . . . . 0.0 111.641 -176.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.96 -24.26 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.308 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 45.5 m -76.88 -51.37 11.37 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.322 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.59 -41.28 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.851 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 30' ' ' LYS . 82.5 mt -63.08 -43.31 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -79.86 -1.98 41.48 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.484 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -106.45 -8.94 16.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.691 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 33' ' ' ILE . 41.3 pt -117.43 -8.18 11.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -93.96 -15.3 25.04 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.702 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -116.61 -46.71 2.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.134 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.48 -65.98 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 110.308 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.43 160.01 23.45 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.433 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 65.1 m80 -86.21 77.48 9.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.377 0.608 . . . . 0.0 111.333 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -150.39 148.95 29.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.228 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -79.52 123.7 84.17 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.61 -27.5 76.34 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 123.136 2.558 . . . . 0.0 115.097 -166.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -67.56 -46.14 83.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -119.31 4.3 11.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.286 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 56.42 33.94 23.34 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 113.211 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -87.82 150.13 23.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.29 120.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.271 0.557 . . . . 0.0 110.558 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -125.56 121.81 34.72 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.361 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.62 148.66 23.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.662 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.24 -41.57 96.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.235 0.541 . . . . 0.0 110.007 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -65.11 -29.55 70.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.562 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -73.95 -7.64 53.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.448 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.428 -1.569 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.9 t -59.91 115.64 13.77 Favored Pre-proline 0 C--N 1.317 -0.818 0 C-N-CA 123.699 0.799 . . . . 0.0 111.25 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -62.42 -20.16 69.57 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.85 2.367 . . . . 0.0 112.739 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.432 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.7 mt -67.32 -44.39 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 111.599 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -110.9 -27.54 8.77 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 62.09 23.39 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.856 0.863 . . . . 0.0 112.159 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -95.64 -65.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.875 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.96 -172.12 1.49 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.643 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 97.1 mt -108.5 122.61 47.42 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -68.67 -44.18 74.57 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.55 -11.9 2.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.14 81.71 0.18 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.129 0.49 . . . . 0.0 111.906 -175.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 116.21 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.656 0.741 . . . . 0.0 111.19 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -81.64 134.8 35.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.343 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.76 162.24 33.88 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.73 -33.11 96.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.021 2.48 . . . . 0.0 112.1 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -72.55 -15.07 61.77 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.205 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.95 34.74 5.82 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.648 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -116.47 152.93 33.05 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -124.74 121.8 35.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.21 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.42 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 81.1 m-85 -131.04 173.55 10.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.943 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 16' ' ' LEU . 62.2 m -84.12 147.95 27.06 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.06 7.69 5.8 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.0 0.905 . . . . 0.0 110.523 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.92 -32.14 5.87 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.38 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 48.5 m -78.3 -46.07 21.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.203 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -66.01 -41.52 89.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.249 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.553 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.0 mt -63.54 -42.51 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.365 . . . . 0.0 110.859 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.61 -1.54 34.66 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.336 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -105.64 -21.29 13.23 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.942 -0.474 . . . . 0.0 110.037 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.4 pt -103.53 -20.36 5.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.9 ptm180 -105.74 3.19 28.63 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.665 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -118.75 -55.5 2.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.15 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.8 -79.08 0.4 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -140.06 138.19 8.93 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 9.3 t-80 -80.48 53.73 1.9 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.888 0.851 . . . . 0.0 110.879 -174.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.41 157.73 43.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.109 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.67 123.65 83.96 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.46 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.85 -25.34 74.48 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.022 2.482 . . . . 0.0 114.601 -171.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.95 -49.1 77.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.62 5.81 11.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.4 34.25 24.41 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -101.08 151.05 22.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.678 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.72 121.91 16.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 121.214 0.53 . . . . 0.0 110.79 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.88 124.75 53.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.241 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HB2' ' CG ' ' A' ' 55' ' ' GLN . 2.7 mm? -105.35 140.25 38.76 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.44 -38.16 83.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 111.155 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -72.91 -15.45 61.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.29 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.437 ' CG ' ' HB2' ' A' ' 52' ' ' LEU . 15.5 mm100 -84.31 -7.53 59.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.32 -0.691 0 CA-C-O 120.719 0.295 . . . . 0.0 110.383 178.704 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.491 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.0 tt0 . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 50.9 t -89.79 107.98 22.52 Favored Pre-proline 0 N--CA 1.438 -1.063 0 O-C-N 123.798 0.686 . . . . 0.0 109.376 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 31.8 Cg_exo -63.43 -18.44 64.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.479 2.786 . . . . 0.0 111.951 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.435 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.22 -43.78 91.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.049 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 p -107.9 -22.76 12.31 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 64.02 21.22 12.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.213 0.605 . . . . 0.0 112.299 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.478 ' HA ' ' HE2' ' A' ' 14' ' ' MET . 9.4 mmt -95.81 -68.36 0.8 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.421 0.629 . . . . 0.0 109.739 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.47 -159.11 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.1 128.94 55.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -76.35 -73.29 0.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.304 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.51 -15.21 25.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.42 84.3 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.951 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.85 117.63 49.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.455 0.645 . . . . 0.0 111.033 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.68 133.53 36.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.099 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 71.9 p -88.9 162.33 38.54 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 27.7 Cg_endo -60.16 -28.82 87.74 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.478 2.118 . . . . 0.0 112.937 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.6 p -72.09 -30.57 65.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 111.152 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.1 29.74 2.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.812 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -117.75 157.56 26.32 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -125.51 139.24 53.79 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.295 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.447 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.86 171.53 14.33 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.187 0.995 . . . . 0.0 108.605 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.536 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -78.32 150.55 33.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -70.81 -8.06 49.74 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.464 0.705 . . . . 0.0 111.609 -172.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.67 -34.13 5.29 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.507 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 61.5 m -65.66 -46.48 78.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.796 0.331 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.508 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.29 -41.26 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.553 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.405 ' HA ' HG12 ' A' ' 37' ' ' ILE . 94.0 mt -63.19 -41.95 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.427 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -78.12 -3.18 41.11 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.539 0.685 . . . . 0.0 109.673 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 m -106.95 -20.4 13.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.201 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 33' ' ' ILE . 38.5 pt -104.31 -8.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.52 -3.36 46.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -116.46 -56.02 2.33 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.341 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.09 -67.26 0.75 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.28 166.93 37.8 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 72.2 m80 -91.13 76.9 6.06 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.917 0.865 . . . . 0.0 111.651 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.75 157.53 42.12 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.83 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.5 p -77.83 132.74 67.23 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.741 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.02 -25.49 73.75 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.665 2.244 . . . . 0.0 113.749 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.36 -59.96 2.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.56 3.86 27.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.9 m120 55.26 34.03 21.91 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -78.75 151.45 32.04 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.347 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.98 121.03 15.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 7.8 tt -110.02 125.73 53.22 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.357 0.599 . . . . 0.0 110.593 -170.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.97 135.52 45.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.623 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -64.97 -38.7 91.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.924 0.392 . . . . 0.0 110.657 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -65.06 -31.5 72.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.231 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -81.53 -9.08 59.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 CA--C 1.508 -0.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.409 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 120.664 0.269 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.1 t -79.33 113.17 34.29 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.08 -19.91 70.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.951 2.434 . . . . 0.0 113.182 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.03 -44.62 88.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 14' ' ' MET . 14.4 p -104.13 -19.95 13.99 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 64.28 20.57 12.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.791 0.836 . . . . 0.0 111.219 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.417 ' HE2' ' HB2' ' A' ' 12' ' ' CYS . 78.1 mtm -102.5 -73.78 0.65 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.107 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.34 -173.24 1.42 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.6 mt -97.55 107.32 19.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -68.36 -45.13 73.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.159 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 70.5 mm-40 -113.02 -16.01 12.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.299 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.75 81.79 0.14 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.998 0.811 . . . . 0.0 113.06 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -120.08 111.99 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.781 0.8 . . . . 0.0 111.616 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -81.55 132.95 35.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.807 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 p -94.23 159.35 34.25 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.605 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.0 -39.46 90.82 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.446 2.764 . . . . 0.0 113.003 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.676 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.6 p -71.96 -15.43 62.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 35.95 3.67 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.728 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.676 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 72.3 m-70 -119.34 148.18 43.48 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.0 129.07 56.62 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.002 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -134.38 169.87 16.58 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.9 m -87.4 147.69 25.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.474 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 23.8 ttpp -78.5 -2.28 37.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.143 0.497 . . . . 0.0 111.716 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.64 -10.95 13.05 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.029 -0.419 . . . . 0.0 110.012 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.9 m -89.03 -48.21 7.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.525 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.6 -41.78 83.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.09 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.658 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.2 mt -63.5 -42.53 96.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.547 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.23 -1.5 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.45 0.643 . . . . 0.0 109.997 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.1 t -105.8 -22.78 12.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 33' ' ' ILE . 43.7 pt -102.9 -12.14 8.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 40.5 ptt85 -99.68 3.43 45.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.702 0.763 . . . . 0.0 109.306 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -116.68 -46.65 2.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.648 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.59 -66.9 0.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.256 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -175.52 167.32 39.19 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 63.0 m80 -84.33 67.18 9.74 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.895 0.855 . . . . 0.0 111.906 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -151.09 150.32 30.55 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.584 -1.189 . . . . 0.0 107.888 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.9 p -71.54 123.41 89.35 Favored Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.73 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.64 -25.21 75.19 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.644 2.229 . . . . 0.0 113.27 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.443 HG21 ' OD1' ' A' ' 47' ' ' ASP . 27.1 m -73.09 -33.0 41.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.443 ' OD1' HG21 ' A' ' 46' ' ' VAL . 15.0 p-10 -141.74 6.48 1.83 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 58.15 35.42 25.05 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.6 mm-40 -92.7 142.67 27.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -65.95 121.47 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 111.142 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.3 tp -122.68 131.78 53.96 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.513 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.484 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -106.68 150.97 25.71 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.68 -34.88 78.84 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.43 0.34 55.64 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.3 mm100 -77.72 -16.27 58.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.824 0.821 . . . . 0.0 109.344 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--N 1.314 -0.956 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.459 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB2' HD21 ' A' ' 16' ' ' LEU . 49.7 t -70.56 111.02 8.12 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.79 -19.73 52.84 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.195 1.93 . . . . 0.0 113.049 -172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.15 -44.68 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.031 0.443 . . . . 0.0 111.808 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.0 p -108.14 -20.16 13.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.773 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt 69.51 22.83 6.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.279 1.032 . . . . 0.0 110.885 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -112.38 169.56 8.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.944 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 154.72 27.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 9' ' ' CYS . 88.8 mt -71.08 119.17 14.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -176.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -75.46 -47.65 26.27 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.843 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -113.85 -16.34 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.775 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.3 58.93 4.98 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.89 0.876 . . . . 0.0 112.981 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.34 115.68 27.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.442 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 27' ' ' ARG . 60.4 tt0 -81.61 135.35 35.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.897 -177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -96.86 158.25 33.77 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.61 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.9 -23.19 74.22 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.862 2.375 . . . . 0.0 112.894 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.0 p -72.44 -28.13 62.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.91 40.72 1.05 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.491 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 59.9 m80 -127.07 160.74 30.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.674 0.273 . . . . 0.0 110.773 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 21' ' ' GLN . 31.5 mmt180 -125.6 136.59 53.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.4 m-85 -137.72 164.57 28.53 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.406 0.441 . . . . 0.0 110.012 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.66 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -85.45 157.52 20.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -68.47 -15.2 63.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -1.3 14.19 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.194 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 42.7 m -94.98 -54.2 3.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.893 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.425 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.44 -41.14 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.988 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.4 mt -63.23 -42.59 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.682 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -77.68 -1.28 30.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.385 0.612 . . . . 0.0 109.87 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -105.86 -19.98 13.58 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 122.018 -0.426 . . . . 0.0 109.958 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -103.79 -15.16 8.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.47 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -104.88 0.81 28.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.348 0.594 . . . . 0.0 110.498 173.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -116.97 -49.81 2.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.512 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.56 -66.23 0.94 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.518 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -177.86 162.16 29.68 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.33 81.68 3.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 111.176 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -173.71 155.63 2.72 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 4.9 p -76.47 126.06 86.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.275 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.96 -29.42 81.96 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.787 2.325 . . . . 0.0 114.726 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -77.16 -57.54 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -102.56 5.3 39.24 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 49.71 43.2 24.39 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 71.6 mm-40 -90.73 142.82 27.36 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.66 120.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.198 0.523 . . . . 0.0 109.876 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -124.36 130.72 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.158 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -107.64 152.51 24.21 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.87 -36.4 83.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.918 0.39 . . . . 0.0 111.551 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -69.58 -17.78 63.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.902 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.1 mm100 -68.32 -25.51 65.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.896 0.379 . . . . 0.0 111.463 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--N 1.317 -0.827 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.896 -178.644 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.563 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.4 t -72.95 114.86 34.62 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.64 -19.22 54.17 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.221 1.948 . . . . 0.0 113.875 -170.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.12 -44.78 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.245 0.545 . . . . 0.0 112.057 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 6.7 p -108.46 -17.38 14.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 63.18 46.25 4.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.696 0.76 . . . . 0.0 111.076 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.493 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 23.9 ptp -144.4 176.44 9.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.709 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.19 46.78 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.179 0.299 . . . . 0.0 111.005 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.581 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 65.8 mt -70.31 129.42 39.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.713 -174.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -71.27 -46.46 60.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -113.96 -15.2 12.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.254 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.26 87.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.903 0.752 . . . . 0.0 112.727 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.22 118.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.074 0.464 . . . . 0.0 111.295 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -79.76 139.31 37.32 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.12 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -97.69 159.41 31.08 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.73 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.56 -25.16 80.12 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.157 2.571 . . . . 0.0 114.101 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.8 p -87.53 -14.76 39.42 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.495 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.44 36.3 2.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.119 -1.039 . . . . 0.0 114.483 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.422 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 79.9 m-70 -117.97 152.93 34.51 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -108.57 132.98 53.32 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.29 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.5 165.2 26.06 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.156 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 35.3 m -79.13 154.27 29.47 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 167.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.27 -11.29 60.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.473 0.654 . . . . 0.0 110.707 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 2.73 15.74 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.225 0.536 . . . . 0.0 109.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 74.2 m -98.08 -56.87 2.36 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.255 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.466 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -67.95 -41.25 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.482 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.5 mt -62.61 -42.21 95.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 111.011 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -78.32 -1.39 32.98 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.526 0.679 . . . . 0.0 110.741 -177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 m -106.04 -21.76 13.05 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.965 -0.459 . . . . 0.0 111.135 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 33' ' ' ILE . 33.3 pt -104.26 -9.62 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptp180 -101.5 2.85 39.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.209 0.528 . . . . 0.0 111.101 172.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -115.91 -47.22 2.8 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.573 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -75.07 0.35 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.719 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.3 169.6 42.19 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.458 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 65.4 m80 -83.97 69.03 10.24 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.65 0.725 . . . . 0.0 112.38 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -152.04 151.23 30.87 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.0 p -83.51 146.14 49.59 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.703 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.71 -18.52 58.69 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.703 2.269 . . . . 0.0 112.526 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.74 -74.31 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -106.73 4.57 27.84 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.901 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 57.59 29.06 16.57 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -78.17 147.25 34.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.31 121.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.317 0.58 . . . . 0.0 109.846 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 6.8 tt -117.05 120.5 38.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.735 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.44 143.14 32.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.248 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.99 -40.57 91.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.103 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.36 -29.96 67.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.995 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -73.22 -8.61 56.56 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.836 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 99.7 mt-10 . . . . . 0 CA--C 1.492 -1.286 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.7 t -82.62 107.31 8.74 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.674 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 41.9 Cg_exo -60.32 -21.06 65.63 Favored 'Trans proline' 0 N--CA 1.475 0.391 0 C-N-CA 122.965 2.443 . . . . 0.0 113.185 -172.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.28 -44.16 91.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HB2' ' HE2' ' A' ' 14' ' ' MET . 8.2 p -112.74 -9.11 13.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 55.56 37.05 28.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.696 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.42 ' HE2' ' HB2' ' A' ' 12' ' ' CYS . 76.3 mtm -121.34 168.54 11.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.625 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.5 154.79 19.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.29 123.95 22.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.614 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -69.63 -44.18 71.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.846 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -126.44 -17.14 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.962 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.81 81.7 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 m -105.83 117.51 51.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.862 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -81.59 131.78 35.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -90.16 152.43 45.97 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.11 -22.49 73.22 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.433 2.088 . . . . 0.0 112.376 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.747 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 30.9 p -79.82 -17.29 53.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.702 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.43 40.67 1.59 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.361 -0.924 . . . . 0.0 113.907 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.747 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 95.0 m-70 -133.28 161.37 34.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -128.32 137.74 52.08 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.4 m-85 -137.78 170.43 16.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.078 0.466 . . . . 0.0 111.357 -173.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 21.0 m -76.74 160.18 29.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' O ' HD12 ' A' ' 34' ' ' ILE . 23.1 tptm -71.16 -15.35 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.707 0.289 . . . . 0.0 111.291 -171.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.33 -1.47 12.31 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.519 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 75.1 m -88.26 -65.06 1.06 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.491 ' HB ' ' CG ' ' A' ' 28' ' ' PHE . 11.1 tp -67.78 -38.89 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.2 mt -62.54 -42.84 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.96 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -78.82 -2.02 37.68 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.464 0.65 . . . . 0.0 110.5 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -105.4 -23.24 12.87 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.72 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.7 pt -102.92 -14.14 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.932 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.8 ptm180 -102.32 1.61 35.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.746 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.57 -56.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.0 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.04 -68.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.276 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -151.59 147.39 17.21 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -84.63 34.09 0.53 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.783 0.801 . . . . 0.0 111.121 -171.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -144.14 154.94 43.69 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.44 ' HB3' HD13 ' A' ' 51' ' ' LEU . 25.8 p -64.29 130.06 94.41 Favored Pre-proline 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.078 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.2 -18.94 62.4 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.442 2.094 . . . . 0.0 111.379 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.79 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.104 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -117.37 15.93 14.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 63.69 35.09 11.69 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.628 ' OE1' ' HB2' ' A' ' 24' ' ' CYS . 57.9 mt-10 -89.86 139.56 30.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 mm -66.56 122.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.099 0.476 . . . . 0.0 111.313 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.639 HD23 ' SG ' ' A' ' 24' ' ' CYS . 77.1 mt -112.69 128.98 56.55 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.058 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.2 133.37 50.08 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -61.42 -38.04 85.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -74.72 -13.33 60.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.507 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.62 -9.07 55.32 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.507 -0.694 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.224 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 t -76.43 112.1 19.49 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.6 Cg_exo -61.02 -19.4 62.9 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.027 2.484 . . . . 0.0 113.222 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.91 -43.98 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.45 -25.55 10.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp 66.22 23.68 10.84 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.886 0.874 . . . . 0.0 112.087 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -93.54 -67.41 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.587 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.96 -167.72 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.6 mt -98.69 106.27 18.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -68.92 -43.83 74.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 0.0 110.377 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 66.8 mm-40 -124.01 -15.16 6.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.101 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.43 83.16 0.05 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.853 0.861 . . . . 0.0 113.301 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.36 118.88 59.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 0.0 111.06 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 52.3 tt0 -80.65 128.42 33.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 51.2 p -80.93 164.69 49.54 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 25.3 Cg_endo -59.94 -28.03 86.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.551 2.168 . . . . 0.0 112.331 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.486 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.5 p -79.9 -15.69 56.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.804 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.59 45.78 2.44 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.392 -0.909 . . . . 0.0 114.325 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.486 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 89.0 m-70 -120.58 154.25 35.66 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -105.1 124.76 50.09 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 123.315 0.384 . . . . 0.0 110.325 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.462 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 92.4 m-85 -134.66 170.39 15.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.088 0.555 . . . . 0.0 110.105 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 40.0 m -85.32 150.15 24.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.416 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 62.5 tttp -68.39 -11.55 59.79 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.871 0.469 . . . . 0.0 111.136 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.18 -14.28 13.4 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.881 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.8 m -87.12 -46.57 9.66 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.896 174.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -68.17 -42.01 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.734 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.628 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.8 mt -63.5 -42.54 96.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 0.0 110.468 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.8 7.67 6.67 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.805 0.812 . . . . 0.0 110.342 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.9 t -106.83 -27.35 10.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.941 -0.475 . . . . 0.0 109.936 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 37.5 pt -104.37 -16.83 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.628 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -98.59 4.78 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -115.59 -56.56 2.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.728 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.9 -68.36 0.8 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.88 169.09 41.89 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.564 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 53.9 m80 -83.41 74.39 10.08 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.656 0.741 . . . . 0.0 111.978 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -150.88 155.28 38.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.812 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.7 t -67.72 129.04 93.51 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.94 -23.77 61.37 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.906 2.404 . . . . 0.0 114.156 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.58 -52.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -105.81 4.03 29.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.107 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 m120 56.87 31.76 20.23 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -78.71 145.79 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -66.12 122.52 17.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.272 0.558 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 60.4 tp -121.06 128.5 52.69 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.239 -171.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.29 146.5 34.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.791 0.329 . . . . 0.0 110.329 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.01 -37.37 87.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.871 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -19.49 63.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.97 0.414 . . . . 0.0 111.514 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.19 -8.0 58.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.844 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.5 mt . . . . . 0 C--N 1.322 -0.592 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.074 178.581 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -64.17 111.65 5.92 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.84 -19.45 58.75 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.061 . . . . 0.0 113.429 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.62 -44.52 89.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.014 0.435 . . . . 0.0 110.945 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -101.52 -23.65 14.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.2 mt 64.48 22.77 12.79 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 111.118 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.6 mtm -96.16 -68.33 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.933 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.33 -161.35 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.92 107.32 18.1 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.454 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 6.0 tpm_? -68.05 -44.67 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.828 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -114.92 -16.34 11.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.22 74.5 0.39 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.077 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.93 113.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.425 0.631 . . . . 0.0 110.47 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.62 142.08 32.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -101.14 159.48 29.35 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.22 -19.95 66.43 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.419 2.079 . . . . 0.0 110.979 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.1 t -75.18 -14.29 60.53 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.972 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 18.99 48.47 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.29 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -106.32 141.42 37.67 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -104.38 133.88 48.52 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -139.43 172.27 13.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.487 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 36.0 m -89.25 154.16 20.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.03 -12.91 61.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 122.922 0.489 . . . . 0.0 111.963 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.38 -13.9 12.24 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.41 -176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 44.0 m -84.64 -54.77 4.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.985 0.421 . . . . 0.0 110.689 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.437 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.16 -41.85 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -172.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.48 -43.66 98.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.789 0.328 . . . . 0.0 111.163 -175.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -81.73 1.99 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.204 0.526 . . . . 0.0 111.09 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.1 t -105.06 -22.21 13.14 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.8 pt -103.26 -25.68 3.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.648 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -98.61 3.83 47.97 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.312 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.08 -56.52 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.745 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -71.09 0.55 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.556 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.691 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -142.33 132.04 4.97 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.3 30.12 0.48 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.971 0.891 . . . . 0.0 111.39 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -142.54 153.88 43.96 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 16.8 p -63.0 124.51 83.99 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 120.859 0.362 . . . . 0.0 110.065 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.31 -22.11 73.63 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.909 2.406 . . . . 0.0 114.169 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.416 HG21 ' OD1' ' A' ' 47' ' ' ASP . 28.6 m -79.21 -51.89 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' OD1' HG21 ' A' ' 46' ' ' VAL . 11.5 p-10 -117.47 7.15 12.67 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 62.02 37.02 15.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.5 mm-40 -93.94 139.5 30.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.673 0.273 . . . . 0.0 111.303 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.78 121.91 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.631 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.3 tp -117.66 131.65 56.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.672 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.41 139.89 41.19 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.81 -38.62 82.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.418 0.449 . . . . 0.0 111.401 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -63.25 -30.15 71.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.464 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -73.81 -8.75 57.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.784 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 N--CA 1.434 -1.227 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.9 t -59.19 107.88 1.14 Allowed Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.753 0.658 . . . . 0.0 109.972 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.2 Cg_exo -65.51 -20.24 60.69 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.839 2.359 . . . . 0.0 112.405 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.03 -44.01 92.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.775 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -98.95 -26.78 14.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.136 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 65.5 21.17 11.79 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.192 0.997 . . . . 0.0 111.426 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.9 mtm -98.3 -67.23 0.86 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.518 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.51 -172.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.5 mt -100.86 108.47 20.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -73.67 -45.29 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.042 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 48.8 mm-40 -104.93 -19.0 13.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.701 -175.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.43 71.58 0.27 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.224 -173.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -99.77 113.21 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.663 0.744 . . . . 0.0 109.72 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.08 135.43 35.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.815 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 p -89.7 162.37 36.29 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.01 -27.81 85.72 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.361 2.041 . . . . 0.0 112.819 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.703 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.4 p -75.8 -14.97 60.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.98 36.1 5.1 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.703 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 86.0 m-70 -117.05 151.89 35.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -117.15 135.94 53.39 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.278 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.443 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.3 m-85 -137.87 172.6 12.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.468 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.8 m -83.94 149.06 26.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 62.0 tttp -67.64 -12.82 61.31 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 120.942 0.401 . . . . 0.0 111.427 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.29 -16.79 12.89 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.435 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 47.2 m -81.59 -46.78 13.92 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.9 tp -68.95 -42.21 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.5 mt -63.25 -42.74 97.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.893 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.62 2.95 20.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.524 0.678 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -107.01 -22.77 12.55 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.05 -0.406 . . . . 0.0 111.104 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.0 pt -103.41 -19.0 6.41 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -105.22 7.97 33.8 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.656 0.741 . . . . 0.0 109.908 172.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -116.48 -56.02 2.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.373 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.63 -66.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.75 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.56 160.16 33.56 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -79.47 73.51 6.13 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.807 0.804 . . . . 0.0 111.616 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -153.36 150.73 29.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.46 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.0 129.41 86.47 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.87 -20.84 68.88 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.031 2.488 . . . . 0.0 113.649 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.15 -59.81 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -107.42 4.81 26.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.84 32.32 21.17 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -88.47 147.79 24.49 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.103 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mp -66.45 119.98 12.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.302 0.573 . . . . 0.0 110.297 -175.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.27 128.88 54.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.058 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.93 144.67 30.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.9 -41.55 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.752 0.821 . . . . 0.0 110.896 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -66.51 -31.28 71.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -77.22 -8.86 58.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -170.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.476 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.0 t -75.58 111.58 15.04 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 123.401 0.681 . . . . 0.0 109.621 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.5 Cg_exo -63.67 -20.44 69.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 112.903 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.93 -44.39 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.64 -23.38 13.85 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.371 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.04 22.23 7.13 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.829 0.851 . . . . 0.0 111.601 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.66 -49.77 5.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.201 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 172.7 -165.63 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.2 mt -103.56 125.65 50.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -80.08 -76.55 0.22 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.686 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -90.21 -15.32 31.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.4 84.24 0.14 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.622 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.49 116.89 50.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.291 0.567 . . . . 0.0 111.077 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -80.88 134.99 35.84 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.36 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -101.49 156.2 35.46 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.69 -22.86 74.34 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.679 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.8 p -77.23 -14.02 59.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.01 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.17 29.52 6.03 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.096 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.679 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 88.3 m-70 -112.92 148.22 35.43 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -107.59 128.59 54.67 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 88.7 m-85 -131.89 -174.74 3.51 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.65 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.4 m -99.54 159.15 15.24 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.84 0.352 . . . . 0.0 110.134 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.9 tttt -77.06 -9.94 59.05 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.566 0.747 . . . . 0.0 110.731 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.22 -6.98 13.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.165 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 85.7 m -91.26 -61.54 1.63 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.795 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.411 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -67.44 -40.91 85.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.944 -174.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.0 mt -62.89 -42.39 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 110.454 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 38.5 ttpt -79.57 1.07 27.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.721 0.772 . . . . 0.0 110.865 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -104.48 -24.77 12.99 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.5 pt -102.62 -7.05 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.7 ptm180 -99.55 2.81 45.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.033 0.444 . . . . 0.0 110.147 172.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -122.37 -56.13 1.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.072 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.35 -66.37 0.91 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.186 0.517 . . . . 0.0 110.785 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -170.65 163.96 37.15 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -85.1 73.56 10.63 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.712 0.768 . . . . 0.0 110.846 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -149.28 151.38 34.09 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.967 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.78 123.84 90.04 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.17 -24.96 65.5 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 113.138 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.12 -57.39 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -108.13 5.7 26.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 56.74 31.77 19.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.309 1.044 . . . . 0.0 113.638 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -83.99 147.46 27.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mm -66.56 120.77 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.25 0.548 . . . . 0.0 109.615 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.1 tp -122.46 126.27 47.55 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.965 -174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.82 156.03 19.6 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -66.13 -35.66 81.08 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.21 0.528 . . . . 0.0 110.124 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.26 -20.76 63.93 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.019 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -82.38 -11.43 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.104 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.318 -0.762 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.279 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 45.1 tt0 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.69 0.281 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 t -83.89 111.5 33.21 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.06 -18.52 56.88 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.735 2.29 . . . . 0.0 113.708 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.45 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.789 0.328 . . . . 0.0 111.088 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.47 -20.79 14.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.921 0.391 . . . . 0.0 111.212 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.3 mt 64.03 21.34 12.56 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.294 1.037 . . . . 0.0 112.177 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.9 mtm -95.74 -66.88 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.221 0.534 . . . . 0.0 111.165 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -174.93 -173.43 0.69 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.98 125.68 36.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -79.39 -75.26 0.25 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -91.29 -16.79 26.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.91 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.24 84.74 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.038 0.935 . . . . 0.0 112.445 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -115.31 117.69 56.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.184 0.516 . . . . 0.0 110.431 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 22' ' ' THR . 52.8 tt0 -82.82 146.45 28.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.498 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 70.8 p -92.3 159.31 37.44 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -56.47 -38.43 95.36 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.74 2.294 . . . . 0.0 112.323 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -67.53 -36.71 81.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.696 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.04 48.51 0.21 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.883 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 36.0 m-70 -124.65 145.01 49.88 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.3 mtm-85 -114.25 132.4 56.15 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.205 0.526 . . . . 0.0 111.874 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.89 171.66 14.17 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.868 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.512 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.1 m -79.63 150.7 30.91 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -72.73 -9.23 58.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.347 0.594 . . . . 0.0 110.97 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.57 -14.92 12.62 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.975 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.6 m -84.69 -46.64 11.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.417 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.4 tp -68.6 -42.09 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.943 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.1 mt -63.14 -42.35 96.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.629 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -77.43 -1.92 32.66 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.402 0.62 . . . . 0.0 109.939 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -104.99 -23.69 12.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.205 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.614 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.49 -7.3 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -97.85 0.05 45.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.546 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -139.55 -56.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.83 -65.86 0.94 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.271 0.558 . . . . 0.0 111.132 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.38 136.57 5.27 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -83.31 52.73 2.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.527 0.68 . . . . 0.0 109.542 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -147.24 156.17 42.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.266 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.32 123.35 75.1 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.62 -24.15 69.83 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.955 2.437 . . . . 0.0 114.428 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.59 -48.66 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -118.78 5.79 11.51 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.979 -0.451 . . . . 0.0 111.653 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 57.47 33.08 22.79 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.437 0.695 . . . . 0.0 112.807 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -87.27 145.18 26.47 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.491 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.21 121.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.59 130.27 56.29 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.105 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.439 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -109.38 146.87 33.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.18 -33.51 73.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.489 0.716 . . . . 0.0 109.651 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.517 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.8 mm100 -77.67 -14.7 59.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.847 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--O 1.246 0.92 0 CA-C-O 120.744 0.306 . . . . 0.0 110.41 -177.096 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 t -92.78 113.65 60.26 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.79 -18.92 63.9 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.599 2.199 . . . . 0.0 113.575 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.2 -43.91 91.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.839 0.352 . . . . 0.0 111.181 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.9 p -101.7 -21.22 14.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.798 0.332 . . . . 0.0 111.325 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt 59.51 23.03 11.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.001 0.92 . . . . 0.0 111.907 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.8 mtm -95.32 -68.54 0.8 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.672 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.74 -165.59 0.32 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.06 124.08 47.05 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.35 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 8.8 tpt180 -78.4 -61.13 2.1 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.169 174.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 69.9 mm-40 -108.42 -15.05 14.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.338 -176.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.91 73.87 0.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.959 0.787 . . . . 0.0 112.335 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.32 116.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 110.684 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -81.2 139.95 35.22 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.004 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 p -98.46 158.67 32.19 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.7 -34.63 91.27 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.092 2.528 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -15.34 61.93 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.47 42.18 3.01 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.715 -0.755 . . . . 0.0 114.006 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -127.47 141.13 51.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.12 136.86 42.96 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.119 0.485 . . . . 0.0 111.6 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -133.68 173.3 11.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.651 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -86.03 149.63 25.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -68.51 -12.2 60.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.37 0.668 . . . . 0.0 111.606 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.25 -5.62 12.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.992 0.425 . . . . 0.0 110.143 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 79.5 m -92.59 -58.68 2.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.625 175.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -65.93 -42.43 91.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.836 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.613 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.51 -43.19 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.674 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -80.34 -1.5 41.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.599 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -105.54 -20.09 13.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.9 pt -102.1 -19.83 5.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.953 -175.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.8 ptm180 -100.87 2.79 41.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.614 0.721 . . . . 0.0 110.254 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -115.96 -46.57 2.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.78 -70.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 0.0 110.466 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.54 155.27 26.35 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.434 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 62.3 m80 -80.1 68.58 6.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.963 0.887 . . . . 0.0 112.358 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.27 153.89 34.64 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.02 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.5 p -79.35 123.42 84.53 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.786 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.18 -21.41 67.6 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.142 2.562 . . . . 0.0 113.942 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.2 m -78.54 -52.55 15.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -112.03 4.85 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 57.73 35.26 25.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 62.3 mm-40 -94.51 148.26 22.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.41 121.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.35 127.43 49.77 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.013 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.28 150.34 26.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.475 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.69 -37.97 89.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.3 -27.41 67.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.818 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -73.75 -8.47 56.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.7 mt . . . . . 0 C--N 1.319 -0.75 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.171 179.393 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.434 -1.257 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.2 t -69.01 113.83 19.1 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.43 -18.19 54.51 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.192 2.595 . . . . 0.0 112.271 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.8 mt -66.62 -44.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.106 0.479 . . . . 0.0 111.134 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 p -105.24 -20.84 13.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.09 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 62.94 22.94 13.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 111.516 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -103.93 -68.12 0.86 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.67 -167.27 1.08 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.3 mt -113.98 132.29 56.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -69.09 -77.42 0.08 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.1 5.6 20.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 171.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.54 80.78 0.14 Allowed 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.612 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.1 m -90.9 116.24 31.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.783 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.08 130.12 34.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.643 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.3 p -89.56 155.96 48.09 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.88 -23.14 75.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.735 2.29 . . . . 0.0 112.754 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.505 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 5.0 p -77.94 -20.14 53.31 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.4 39.93 2.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.151 -1.024 . . . . 0.0 114.142 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.505 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 88.3 m-70 -122.51 155.37 36.36 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -124.38 131.09 53.5 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -134.16 172.85 12.28 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.871 0.469 . . . . 0.0 110.891 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.413 ' O ' HG22 ' A' ' 33' ' ' ILE . 63.6 m -72.09 160.08 33.08 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.732 169.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' O ' HD12 ' A' ' 34' ' ' ILE . 89.2 tttt -82.63 -1.07 49.94 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.99 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.4 -40.07 3.48 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.319 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.7 m -62.26 -50.07 73.18 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -69.34 -42.36 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.556 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.8 mt -63.53 -43.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 111.575 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -78.0 -0.37 27.57 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.578 0.704 . . . . 0.0 109.553 -174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 t -105.25 -26.16 12.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.748 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.9 pt -104.24 -14.01 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -93.39 -6.96 45.98 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.5 174.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -115.74 -56.8 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.71 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.27 -66.1 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.986 0.422 . . . . 0.0 110.048 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.02 165.54 38.7 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -87.6 69.2 9.7 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.497 0.665 . . . . 0.0 111.759 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -147.17 154.61 41.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.228 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 29.7 m -62.14 131.74 93.59 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.75 -24.37 61.97 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.235 1.957 . . . . 0.0 111.505 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.53 -70.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.234 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -97.46 6.17 48.58 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -172.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 p30 54.33 16.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 174.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.54 151.33 45.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.3 120.47 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -120.93 122.03 39.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.514 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.67 138.91 34.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.65 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.4 -41.13 96.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.835 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -74.99 -12.7 60.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.205 0.526 . . . . 0.0 111.317 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -82.19 -10.17 59.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.246 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 C--O 1.236 0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.191 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HB2' HD21 ' A' ' 16' ' ' LEU . 41.3 t -83.44 112.35 38.67 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.13 -20.01 65.96 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 122.42 2.08 . . . . 0.0 112.513 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.26 -44.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.532 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -119.15 -2.42 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.8 mt 53.8 27.3 6.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.093 0.957 . . . . 0.0 112.053 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.3 mtm -111.67 174.16 6.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.724 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.16 149.95 49.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.359 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 9' ' ' CYS . 89.3 mt -70.28 109.86 4.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -65.56 -46.22 80.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -116.49 -15.51 10.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.079 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 47.81 72.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.053 0.941 . . . . 0.0 113.164 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.79 116.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.363 0.602 . . . . 0.0 110.674 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -82.13 136.61 35.13 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.965 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -84.29 163.62 46.9 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.81 -36.47 95.37 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.694 2.262 . . . . 0.0 112.508 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.508 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 5.0 p -65.68 -21.74 66.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.812 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.5 38.07 3.83 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.102 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -115.54 143.06 45.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.01 130.28 53.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.746 0.307 . . . . 0.0 111.267 -173.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -139.65 162.83 34.15 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.641 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.631 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 47.1 m -78.39 147.8 33.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.83 -10.25 55.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 -13.29 13.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.5 m -85.64 -45.16 11.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.694 173.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -65.58 -39.98 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.75 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.86 -41.38 92.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.164 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.08 -2.25 33.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.355 0.598 . . . . 0.0 109.944 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 m -105.68 -21.3 13.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.0 pt -103.12 -8.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.559 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.54 -2.27 45.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.085 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -116.78 -55.51 2.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.073 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.63 -64.79 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.42 -175.08 41.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -80.42 80.77 6.8 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.546 0.689 . . . . 0.0 111.596 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.0 ptpt -148.53 153.29 38.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.556 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.439 ' SG ' ' HG2' ' A' ' 49' ' ' GLU . 4.6 p -76.78 136.01 67.36 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 165.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.98 -20.3 69.05 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 122.848 2.365 . . . . 0.0 114.167 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.428 HG21 ' OD1' ' A' ' 47' ' ' ASP . 3.8 m -92.89 -71.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.428 ' OD1' HG21 ' A' ' 46' ' ' VAL . 12.8 p-10 -96.14 5.27 51.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.827 0.451 . . . . 0.0 112.052 -174.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.33 0.3 OUTLIER 44.19 56.67 4.71 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.098 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 17.5 pt-20 -94.58 163.52 13.35 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.54 115.33 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 109.504 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.1 tp -115.63 130.08 56.73 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.182 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.97 149.4 35.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.307 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.97 -35.84 75.87 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.529 0.518 . . . . 0.0 110.193 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -63.8 -31.28 72.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.776 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -78.43 -7.59 57.55 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.318 -0.777 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.21 176.774 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.95 108.01 11.2 Favored Pre-proline 0 N--CA 1.436 -1.136 0 O-C-N 123.657 0.598 . . . . 0.0 109.764 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.64 -17.86 37.87 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.948 2.432 . . . . 0.0 111.789 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.77 -43.77 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.1 p -99.72 -20.19 16.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.99 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 61.87 21.76 12.52 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.729 0.811 . . . . 0.0 111.883 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.68 -71.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.704 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.22 -166.49 0.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.16 105.04 17.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -70.47 -57.01 5.25 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 63.8 mm-40 -103.42 -16.41 15.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.006 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.55 61.51 3.16 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -93.04 118.23 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.188 0.518 . . . . 0.0 111.374 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.401 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 65.3 tt0 -75.51 134.44 40.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.947 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -99.96 159.17 30.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.766 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.89 -23.77 68.24 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.749 2.299 . . . . 0.0 113.113 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -73.11 -28.61 62.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.379 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.64 38.75 1.16 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -133.28 162.02 32.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 80.2 mtp180 -127.98 140.12 52.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -136.13 173.9 11.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.571 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.1 m -84.91 148.23 26.35 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 87.9 tttt -79.33 -3.58 46.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 110.324 -174.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.61 -12.55 13.41 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.6 m -94.09 -54.22 3.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.777 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.1 tp -66.03 -38.57 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.556 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.9 mt -62.8 -42.99 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.663 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.95 -2.52 40.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.611 0.719 . . . . 0.0 110.48 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -105.43 -16.47 14.72 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.965 -0.459 . . . . 0.0 110.618 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.659 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -104.09 -24.18 4.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.559 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -97.42 1.04 48.77 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.813 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -116.4 -56.02 2.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.564 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.26 -66.71 0.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.467 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.1 159.1 32.0 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 64.0 m80 -85.45 75.64 10.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.285 0.543 . . . . 0.0 110.871 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -153.76 155.19 35.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.498 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.1 p -80.71 130.91 62.35 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -31.55 85.61 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.782 2.321 . . . . 0.0 114.775 -172.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.0 m -78.87 -53.28 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -174.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -106.05 3.5 28.26 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 m120 52.82 40.18 30.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.15 146.22 24.02 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 mm -66.65 120.58 14.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.373 0.606 . . . . 0.0 109.909 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.507 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.6 tp -124.42 118.05 25.81 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.801 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -96.05 161.42 13.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.91 -37.39 87.48 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.806 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.89 -24.02 64.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 111.247 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.7 mm100 -76.38 -10.78 59.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.665 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.32 -0.689 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.168 177.882 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.432 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 42.5 tt0 . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 51.3 t -87.63 108.74 21.8 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 37.3 Cg_exo -61.54 -20.61 69.32 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.478 2.119 . . . . 0.0 111.677 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.24 -43.47 91.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.034 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.0 m -88.89 -27.49 20.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.182 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 56.78 35.21 25.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.073 0.939 . . . . 0.0 108.693 -165.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -139.48 171.28 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.309 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.66 152.48 22.36 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.546 0.529 . . . . 0.0 111.608 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.85 139.51 50.87 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.997 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -79.12 -72.3 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.289 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.47 -15.96 20.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.649 0.261 . . . . 0.0 110.911 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.71 102.47 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.957 0.903 . . . . 0.0 113.274 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.8 m -117.15 118.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -80.41 135.31 36.14 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.768 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -95.77 152.57 39.16 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -26.52 83.27 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.902 2.401 . . . . 0.0 113.823 -173.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -79.72 -19.36 49.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.72 48.48 0.68 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.649 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -133.33 152.11 51.91 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -121.44 136.3 54.97 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.982 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.67 170.0 16.48 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 39.0 m -78.92 153.29 30.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.96 -12.68 61.2 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.77 -31.56 6.1 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.224 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 28.0 m -62.98 -44.61 95.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -64.73 -41.12 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.0 mt -63.48 -43.51 98.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.836 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.77 -2.8 44.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.872 0.368 . . . . 0.0 110.539 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.0 t -106.92 -22.8 12.57 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.797 0.332 . . . . 0.0 110.635 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 33' ' ' ILE . 45.7 pt -101.78 -7.91 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.061 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -101.98 6.66 41.32 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.586 167.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.52 -54.89 2.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.186 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -66.11 0.94 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.137 0.494 . . . . 0.0 109.809 176.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.65 166.83 38.84 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.45 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 49.9 m80 -79.73 77.4 6.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.164 0.982 . . . . 0.0 110.83 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.1 ptpt -152.25 149.79 29.09 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.625 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.568 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 2.2 m -68.01 130.54 92.63 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.6 -34.02 94.5 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.262 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.76 -54.95 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.568 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 31.4 p-10 -104.19 4.29 33.81 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.719 -0.613 . . . . 0.0 112.07 -174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 54.96 32.23 17.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.799 0.84 . . . . 0.0 112.739 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 73.7 mm-40 -92.91 142.82 26.88 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.83 120.38 11.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 CA-C-O 121.597 0.713 . . . . 0.0 110.373 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.8 tp -117.14 129.25 55.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.316 -175.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.8 mm? -98.21 148.74 23.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.59 -37.24 86.07 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.328 0.393 . . . . 0.0 111.882 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -68.37 -19.74 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.437 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 14.1 mm-40 -77.24 -6.62 53.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.199 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 39.8 t -78.25 113.83 37.19 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.98 -20.96 64.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.481 2.121 . . . . 0.0 112.895 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.86 -44.34 85.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.094 0.473 . . . . 0.0 111.874 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 20.7 p -101.85 -13.22 17.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.166 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mp 54.09 23.37 4.07 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.996 0.918 . . . . 0.0 111.742 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.7 mtm -100.03 -70.98 0.72 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.687 0.279 . . . . 0.0 111.676 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.89 165.25 5.16 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.6 109.92 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -70.42 -46.12 64.54 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.895 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -115.35 -17.9 11.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.06 81.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.798 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.71 117.37 42.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.601 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -80.83 140.96 35.13 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.195 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -96.9 156.77 36.07 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.418 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 74.9 Cg_exo -54.53 -37.59 90.27 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.966 2.444 . . . . 0.0 112.594 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -64.9 -18.33 65.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.903 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.87 4.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.471 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -120.35 152.32 38.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -123.07 138.27 54.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.349 0.595 . . . . 0.0 112.439 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -137.3 169.26 18.08 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.329 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.558 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.3 m -76.47 151.4 36.47 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.228 171.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.52 -5.78 31.38 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.04 0.447 . . . . 0.0 112.107 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.85 -34.13 5.55 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.93 -0.481 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.5 m -64.29 -44.8 90.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.015 0.436 . . . . 0.0 110.608 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.514 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.1 tp -65.53 -39.91 86.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.169 -176.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -63.02 -42.35 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.039 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -78.12 -2.3 36.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.785 0.326 . . . . 0.0 110.422 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -105.35 -25.62 12.32 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.003 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.8 pt -103.81 -10.29 9.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.71 -174.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.5 ptm180 -93.47 -14.04 27.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.487 176.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -131.72 -56.33 1.0 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.138 -172.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.02 -66.2 0.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.87 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.06 137.32 5.11 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -85.23 43.44 1.01 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.854 0.835 . . . . 0.0 110.244 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -148.05 155.11 41.11 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 12.0 p -75.04 127.03 87.46 Favored Pre-proline 0 C--N 1.318 -0.778 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.192 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.7 -25.27 68.76 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.917 2.411 . . . . 0.0 113.557 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.52 -49.33 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -131.87 12.21 4.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.99 35.32 21.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.487 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 73.3 mm-40 -85.03 143.5 28.87 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.322 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.81 120.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.7 tp -121.03 126.6 50.3 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.489 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -110.43 148.01 32.88 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.02 -28.82 69.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.689 0.757 . . . . 0.0 109.835 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.96 -30.65 71.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.438 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.489 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.4 mm100 -80.16 -16.37 55.02 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.363 -175.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.239 0.506 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.35 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.241 0.636 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 19.6 p -91.55 134.15 29.88 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.573 175.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.55 -17.52 58.71 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.929 2.419 . . . . 0.0 113.131 -174.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.8 -45.03 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -106.89 -20.08 13.44 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.53 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.25 23.0 6.68 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.843 0.857 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -97.45 -66.61 0.89 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.202 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.72 -172.62 0.9 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -105.12 105.36 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.22 174.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -69.91 -44.15 70.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.709 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -125.41 -15.16 6.24 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.633 -175.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 49.6 56.24 8.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 30.3 m -77.48 118.22 23.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -75.9 133.32 40.56 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.643 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -106.1 162.58 19.26 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.264 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.23 -36.64 99.07 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.294 2.663 . . . . 0.0 112.46 178.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.0 -25.94 64.76 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.932 0.396 . . . . 0.0 111.602 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.31 29.01 4.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.038 177.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -112.58 157.65 20.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 94.8 mtt-85 -124.74 140.48 52.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 110.238 174.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.414 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 88.3 m-85 -134.49 165.56 24.9 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.015 -176.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.5 m -73.84 152.66 40.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 171.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -68.87 -13.23 62.3 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 121.296 0.569 . . . . 0.0 110.778 -174.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.86 -1.22 13.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.218 0.533 . . . . 0.0 110.387 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 89.3 m -90.72 -64.02 1.19 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.421 176.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.414 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.28 -40.94 83.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.428 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.8 mt -63.09 -42.15 95.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 110.336 -178.072 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.9 tptp -78.7 -1.64 35.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.673 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.1 m -106.9 -19.77 13.53 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.381 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.1 pt -102.99 -31.63 2.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.488 -174.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.6 ptm180 -99.13 4.31 46.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.232 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -115.72 -55.08 2.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.842 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.27 -71.77 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.433 . . . . 0.0 110.184 178.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.24 152.75 23.6 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -79.23 71.58 5.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.434 0.635 . . . . 0.0 112.105 -175.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.3 ptpt -153.36 152.29 30.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.609 178.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 m -64.76 124.77 87.29 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 170.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.51 -27.32 70.04 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 121.702 1.601 . . . . 0.0 112.067 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.72 -54.79 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.11 4.97 29.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 54.43 33.91 19.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.3 mm-40 -96.75 141.41 30.0 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.02 121.18 13.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 -176.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.53 132.82 44.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.818 -173.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -116.43 157.67 24.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.59 -37.41 78.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 109.774 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -65.12 -29.55 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.147 -177.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.795 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.6 tt0 . . . . . 0 N--CA 1.442 -0.85 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 t -75.44 108.07 5.13 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 53.6 Cg_endo -68.23 -17.79 44.96 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.922 2.415 . . . . 0.0 111.983 -177.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.16 -43.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.232 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.92 -13.81 15.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 0.0 111.339 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.65 21.44 5.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 112.011 -177.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -99.83 -69.81 0.75 Allowed 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.45 -167.36 0.2 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.9 mt -94.41 107.07 19.05 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -69.74 -43.83 71.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 64.9 mm-40 -122.61 -14.66 7.71 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.617 -175.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.87 56.44 6.66 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.517 0.727 . . . . 0.0 112.424 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.2 m -83.51 116.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.461 0.648 . . . . 0.0 110.708 178.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -78.78 134.25 37.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.873 -176.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 157.53 36.89 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.76 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.38 -40.28 83.65 Favored 'Trans proline' 0 C--N 1.364 1.342 0 C-N-CA 122.587 2.191 . . . . 0.0 113.323 -177.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 -14.88 61.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.43 36.87 2.97 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.144 173.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -117.26 157.74 25.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.3 mtt180 -123.22 140.38 53.08 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.283 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.421 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 98.2 m-85 -132.13 173.07 11.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.263 -177.09 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.7 m -85.05 148.74 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 38.9 ttpt -73.69 -10.94 60.2 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.351 0.596 . . . . 0.0 111.346 -172.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.49 -4.53 12.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.019 0.438 . . . . 0.0 109.958 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 88.2 m -90.02 -60.78 1.84 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 174.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.421 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -67.1 -40.68 85.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.591 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.4 mt -62.71 -43.03 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.917 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -79.99 1.46 27.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.802 0.811 . . . . 0.0 110.169 -177.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 t -105.44 -24.8 12.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.876 175.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.71 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 49.2 pt -103.23 -22.67 4.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -99.26 4.56 46.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.456 174.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -119.37 -57.23 2.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.466 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.95 -68.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.892 0.377 . . . . 0.0 111.598 -177.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -146.03 140.12 8.65 Favored Glycine 0 CA--C 1.502 -0.756 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.437 ' HE2' ' CD ' ' A' ' 53' ' ' GLU . 3.7 t-160 -83.32 52.25 2.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.458 0.647 . . . . 0.0 110.488 -172.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -155.32 160.96 41.15 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.672 -174.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.428 ' HB3' HD12 ' A' ' 51' ' ' LEU . 2.6 p -79.16 130.47 69.26 Favored Pre-proline 0 C--N 1.318 -0.764 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.441 173.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.08 -21.05 72.68 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.209 2.606 . . . . 0.0 113.666 -173.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.401 HG21 ' H ' ' A' ' 47' ' ' ASP . 4.0 m -72.58 -70.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.401 ' H ' HG21 ' A' ' 46' ' ' VAL . 46.4 p-10 -103.13 5.56 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.16 33.0 21.1 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 113.179 173.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -83.48 139.99 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.13 121.36 16.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.493 . . . . 0.0 110.476 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 44' ' ' CYS . 83.0 mt -109.58 132.37 54.2 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.314 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 71.4 mt -108.68 143.41 37.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.437 ' CD ' ' HE2' ' A' ' 42' ' ' HIS . 52.7 mp0 -61.17 -36.13 79.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.17 0.509 . . . . 0.0 110.266 -179.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -65.05 -31.71 73.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.089 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -86.14 -13.21 47.81 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.041 -176.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 85.4 mt . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.87 109.75 4.38 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.8 -19.91 69.8 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.9 2.4 . . . . 0.0 113.407 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.03 -43.97 92.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 121.139 0.495 . . . . 0.0 110.989 179.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.2 p -104.49 -21.4 13.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.791 -177.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.1 mt 59.03 29.37 18.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.703 0.801 . . . . 0.0 111.719 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.8 mtm -98.68 -66.87 0.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.174 0.512 . . . . 0.0 110.528 176.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.52 -172.03 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -91.09 105.81 18.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -69.28 -45.2 70.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.928 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -116.3 -15.82 10.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -178.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 88.66 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -117.24 117.59 55.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.243 0.544 . . . . 0.0 110.353 171.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -80.56 139.32 36.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.114 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 p -109.39 158.95 33.15 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.75 -27.0 82.25 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.907 2.405 . . . . 0.0 111.576 176.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.36 -24.96 67.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.262 178.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.89 8.17 57.13 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.892 -174.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -92.87 154.0 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -124.36 139.42 53.92 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.197 173.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.52 168.87 18.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.625 -174.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 49.9 m -79.12 151.72 31.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 169.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.497 ' O ' HD12 ' A' ' 34' ' ' ILE . 86.9 tttt -78.36 8.6 4.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.721 0.772 . . . . 0.0 111.289 -173.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.64 -38.91 3.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 38.7 m -66.39 -50.06 64.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.069 -178.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -69.12 -40.24 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.071 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.633 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.9 mt -62.94 -42.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.718 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HZ2' ' HB3' ' A' ' 35' ' ' LYS . 3.1 mmmp? -78.92 0.59 26.77 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.097 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -105.37 -23.85 12.77 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.789 176.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.4 pt -103.92 -22.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.174 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -104.13 6.17 35.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.798 175.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.47 -53.0 2.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 178.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.73 -71.15 0.52 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.917 0.389 . . . . 0.0 110.362 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.57 161.61 35.33 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -80.32 75.55 7.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.721 0.772 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -151.95 148.85 28.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.729 177.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.0 p -72.37 126.09 91.12 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.99 -22.73 73.96 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 122.326 2.018 . . . . 0.0 112.585 -175.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.18 -50.71 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -135.9 11.79 3.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.44 35.51 9.5 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 173.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 53.6 mt-10 -83.85 145.47 28.62 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -66.5 113.7 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.241 0.543 . . . . 0.0 110.25 -176.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.9 tp -126.23 123.18 37.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.987 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.1 mm? -97.61 160.39 14.35 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.11 -38.61 91.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -176.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.01 -17.65 63.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 178.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.2 mm100 -76.3 -8.99 58.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.895 -178.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.919 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.433 -1.295 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.28 109.61 22.62 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.31 -17.66 54.37 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.805 2.337 . . . . 0.0 112.657 -175.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -65.92 -43.83 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.866 0.365 . . . . 0.0 110.987 177.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.7 p -105.39 -15.63 14.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mp 57.87 22.67 8.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.889 0.876 . . . . 0.0 111.433 -176.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.473 ' HA ' ' HE2' ' A' ' 14' ' ' MET . 8.1 mmt -95.03 -66.51 0.91 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.501 -178.256 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.59 -166.61 0.06 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.69 117.58 34.35 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -67.63 -44.85 77.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 179.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -134.96 -15.03 2.04 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 67.59 88.86 0.11 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.353 1.061 . . . . 0.0 112.847 179.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 m -106.24 117.1 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.174 0.511 . . . . 0.0 111.033 175.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -80.37 132.12 35.72 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.93 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 p -95.86 156.15 37.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.31 -29.63 86.36 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.569 2.18 . . . . 0.0 112.767 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.26 -22.91 51.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.659 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.7 51.56 0.65 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.213 -0.994 . . . . 0.0 114.013 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -131.47 161.39 32.63 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -127.74 136.38 51.45 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 171.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.09 -179.1 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.188 -176.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.5 m -86.7 152.94 22.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 170.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' O ' HD12 ' A' ' 34' ' ' ILE . 35.9 ttpt -78.65 -1.97 36.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.617 0.723 . . . . 0.0 111.021 -174.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.41 -19.26 10.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 177.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.3 m -82.86 -57.8 3.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.331 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -67.76 -41.08 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.911 -175.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 81.5 mt -62.9 -42.85 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 111.544 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -78.61 -2.72 40.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.23 0.538 . . . . 0.0 109.647 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -105.97 -21.99 13.01 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 176.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.3 pt -103.25 -15.56 7.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.175 -177.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.4 ptm180 -99.87 2.27 43.68 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.03 175.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -116.28 -55.76 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.994 -178.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.55 -67.03 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.287 0.565 . . . . 0.0 109.773 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.48 159.68 31.43 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -81.72 72.41 8.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -156.38 148.15 22.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.124 173.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.82 124.47 89.62 Favored Pre-proline 0 N--CA 1.436 -1.14 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.831 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.1 -24.52 76.57 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.092 2.528 . . . . 0.0 113.739 -170.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.7 m -68.87 -47.47 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -119.79 5.58 10.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 m120 58.71 33.56 23.16 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.451 0.701 . . . . 0.0 112.642 177.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -95.78 144.36 26.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.6 mm -66.11 120.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.122 0.487 . . . . 0.0 110.343 -173.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.9 tp -131.18 132.56 44.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -174.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 3.8 mm? -116.58 150.16 38.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.56 -37.03 82.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.066 0.546 . . . . 0.0 110.131 -177.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -64.32 -31.73 73.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.414 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 12.0 mm100 -76.43 -17.64 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.862 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.316 -0.876 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.257 178.138 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.541 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 41.8 t -75.85 114.66 38.99 Favored Pre-proline 0 N--CA 1.438 -1.035 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.1 -19.4 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.121 1.881 . . . . 0.0 113.224 -177.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -67.96 -44.33 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.541 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 14.4 p -100.28 -24.62 14.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 65.1 21.9 12.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.348 0.659 . . . . 0.0 110.866 -176.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.3 mmt -96.4 -70.14 0.73 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.706 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.68 -168.67 0.24 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -176.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.35 122.16 44.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -84.57 -66.38 0.9 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.685 177.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -88.29 -15.64 35.25 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.555 176.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.44 56.3 7.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.659 1.184 . . . . 0.0 112.297 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.4 m -80.88 116.56 25.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.251 0.548 . . . . 0.0 111.636 -175.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 22' ' ' THR . 26.7 tt0 -81.4 131.52 35.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.206 176.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 82.3 p -83.82 159.18 61.04 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.299 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.17 -24.26 78.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.072 1.848 . . . . 0.0 111.978 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -76.48 -15.92 59.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.857 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 33.93 5.63 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.472 178.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -119.96 150.77 39.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -122.13 139.79 53.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.414 ' O ' HG22 ' A' ' 20' ' ' VAL . 85.5 m-85 -142.88 172.06 13.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.673 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.6 m -84.05 153.62 23.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.51 -14.07 62.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.143 0.497 . . . . 0.0 112.054 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.18 1.4 15.24 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.804 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 57.9 m -95.81 -56.44 2.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.669 172.099 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -66.81 -41.88 88.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.747 -177.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.461 ' HA ' HG12 ' A' ' 37' ' ' ILE . 76.5 mt -63.39 -41.58 93.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 111.915 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -77.46 -2.73 36.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.484 0.659 . . . . 0.0 109.395 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.94 -17.72 14.11 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.408 177.093 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 42' ' ' HIS . 38.2 pt -106.49 -11.73 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -175.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -95.21 -10.91 29.05 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.222 -178.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.7 -45.88 2.87 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.927 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.88 -76.65 0.16 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.32 158.6 31.6 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 177.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.481 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 55.1 m80 -83.56 67.48 9.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.628 0.727 . . . . 0.0 111.61 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -143.18 150.77 39.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.436 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.1 p -83.22 124.33 76.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -28.18 81.45 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.728 2.285 . . . . 0.0 113.449 -171.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -69.58 -45.45 78.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -120.17 5.56 10.78 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 57.98 33.15 22.88 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 175.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -95.57 146.21 24.63 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 177.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.94 120.74 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -121.76 126.75 49.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.11 -172.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.52 148.75 31.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.543 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.05 -41.04 95.52 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.639 1.176 . . . . 0.0 112.983 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -87.12 -0.61 56.95 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.363 -176.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -87.31 -7.86 57.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.691 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 96.0 mt . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.224 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.096 0 CA-C-O 120.937 0.399 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.493 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 45.8 t -118.92 108.9 40.13 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.46 -21.52 72.13 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 122.589 2.193 . . . . 0.0 112.653 -171.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.49 -44.14 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.791 177.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 19.5 p -106.67 -17.9 14.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 57.08 33.52 23.46 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.112 0.965 . . . . 0.0 111.885 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -121.35 -77.02 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.328 177.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.6 158.47 2.75 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.774 0.43 . . . . 0.0 110.014 -179.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 9' ' ' CYS . 96.0 mt -71.82 105.22 3.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.692 0.282 . . . . 0.0 110.853 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -70.65 -44.8 66.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 178.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -112.86 -16.87 12.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.644 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.0 80.72 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.97 116.47 47.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 110.326 174.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -81.01 136.11 35.94 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.411 -177.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -103.13 154.34 37.7 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.77 -29.35 85.56 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.051 2.501 . . . . 0.0 112.839 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.7 p -69.1 -15.59 63.47 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.51 11.41 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.172 177.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -114.22 155.78 25.5 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 122.571 -0.37 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -126.49 136.54 52.74 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.48 167.92 20.18 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.206 0.316 . . . . 0.0 110.814 -176.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 58.2 m -80.63 156.19 26.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.256 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.8 tttt -69.48 -12.65 61.82 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.966 -173.473 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.07 -20.56 10.94 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.156 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 98.1 m -72.1 -54.1 10.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.845 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -67.97 -39.85 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.247 -175.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 88.0 mt -62.73 -42.8 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.663 0.268 . . . . 0.0 111.131 -178.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -78.87 -0.83 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.464 0.649 . . . . 0.0 110.372 -177.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -103.61 -25.45 13.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -103.05 -7.32 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.452 -177.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -100.94 -2.84 30.82 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.7 -52.74 2.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.707 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.97 -69.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.079 0.466 . . . . 0.0 110.241 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -176.82 167.29 38.59 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 177.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -81.5 67.16 7.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.809 0.814 . . . . 0.0 111.616 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -148.08 157.66 43.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.339 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 50.4 t -64.9 127.22 92.48 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.44 -26.53 70.58 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.388 2.058 . . . . 0.0 112.449 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.77 -71.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -98.28 5.63 48.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -174.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 12.6 m120 57.31 33.47 23.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.875 0.87 . . . . 0.0 113.151 173.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -86.44 148.58 25.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mp -66.19 122.56 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 110.322 -173.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.24 125.74 46.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -174.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.47 152.43 18.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 177.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.68 -36.82 84.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.909 -173.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -71.16 -11.96 61.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.861 0.363 . . . . 0.0 111.483 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.44 -8.23 59.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.452 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt . . . . . 0 C--O 1.238 0.45 0 O-C-N 123.12 0.262 . . . . 0.0 110.911 -177.669 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB2' HD22 ' A' ' 16' ' ' LEU . 40.9 t -89.78 108.05 22.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.7 Cg_exo -63.37 -20.47 70.29 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.743 2.296 . . . . 0.0 112.839 -177.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -66.57 -44.45 90.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.609 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.07 -20.26 14.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.7 mt 59.1 22.02 10.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.096 0.959 . . . . 0.0 112.848 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.6 mtm -98.19 -65.69 0.95 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.485 176.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.51 -169.82 0.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 9' ' ' CYS . 96.5 mt -100.44 108.47 20.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.43 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 3.3 tpm_? -69.83 -42.34 73.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.29 -15.52 9.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 -177.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.93 82.17 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 28' ' ' PHE . 19.6 m -115.97 114.88 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.299 0.571 . . . . 0.0 110.661 176.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.56 129.49 34.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.307 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.4 p -77.96 168.21 29.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.125 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.4 -28.77 81.81 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.556 2.17 . . . . 0.0 111.731 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.454 ' HB2' ' OE1' ' A' ' 49' ' ' GLU . 27.6 p -84.5 -21.53 30.55 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.675 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.42 4.22 22.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.792 177.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -88.65 149.68 23.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.209 0.504 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -116.77 136.32 53.05 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.673 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.471 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.7 m-85 -139.86 170.01 16.66 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 28.3 m -83.26 147.65 27.85 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -69.36 -7.76 40.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -173.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.88 -16.62 12.68 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.708 -178.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 46.0 m -82.52 -46.28 13.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.58 -41.66 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.438 ' HA ' HG12 ' A' ' 37' ' ' ILE . 91.3 mt -63.06 -41.83 94.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 111.707 -178.205 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.66 -1.81 32.85 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.869 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 m -106.15 -20.84 13.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 34' ' ' ILE . 37.7 pt -102.99 -9.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.967 -176.143 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -99.04 7.81 45.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.12 0.962 . . . . 0.0 108.533 167.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -114.94 -56.03 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.361 -179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.3 -70.07 0.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.163 176.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.04 172.88 40.36 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 74.4 m80 -80.4 69.12 6.8 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.707 0.765 . . . . 0.0 111.525 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 9.6 ptpp? -148.05 152.75 37.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.0 177.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.5 p -77.13 128.34 81.21 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.84 -22.24 69.07 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.148 1.899 . . . . 0.0 112.684 -176.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.97 -50.49 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -138.84 17.23 2.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.79 33.97 17.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.344 1.058 . . . . 0.0 113.654 170.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 56.6 mt-10 -89.12 153.06 21.26 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.712 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.4 121.82 15.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 111.302 -175.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 6.5 tt -120.6 126.27 49.85 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.131 -176.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.62 139.61 45.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.429 178.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.46 -42.8 91.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.426 -174.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -69.33 -23.43 63.78 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.8 mm-40 -74.92 -14.87 60.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.482 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.67 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 N--CA 1.445 -0.707 0 CA-C-O 120.764 0.316 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.52 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.3 t -93.62 111.34 52.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.13 -19.54 50.93 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.435 2.09 . . . . 0.0 113.678 -174.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.27 -44.84 83.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.8 p -103.73 -21.49 13.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.021 -174.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp 65.41 21.29 11.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.349 1.06 . . . . 0.0 110.617 -175.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.4 mmt -95.52 -75.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -179.31 162.58 1.18 Allowed 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 9' ' ' CYS . 92.5 mt -79.75 103.37 9.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.052 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -71.18 -44.94 64.48 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.656 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -112.4 -17.17 12.76 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.94 -177.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.13 73.31 0.16 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -93.59 117.57 37.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.953 175.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.28 142.0 34.98 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.04 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -108.96 168.21 8.06 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 177.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.85 -33.32 94.44 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 123.042 2.494 . . . . 0.0 113.031 -176.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 p -74.68 -14.55 60.76 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.961 0.41 . . . . 0.0 111.852 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.46 1.0 50.27 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.372 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -79.26 146.72 32.85 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.54 -0.388 . . . . 0.0 110.603 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -122.59 138.44 54.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.466 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 91.1 m-85 -140.91 170.13 16.32 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.186 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.533 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -81.1 159.24 24.77 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' O ' HD12 ' A' ' 34' ' ' ILE . 7.1 ttpm? -68.94 -11.37 60.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.438 0.637 . . . . 0.0 111.169 -176.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.94 -16.75 12.14 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.823 -179.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.9 m -83.91 -51.7 6.95 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.466 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 10.9 tp -69.26 -39.29 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.771 -178.082 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.598 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.1 mt -62.85 -42.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.459 ' HZ2' ' HB3' ' A' ' 35' ' ' LYS . 3.8 mmmp? -79.53 9.51 4.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 178.011 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 m -109.6 -25.99 10.15 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.723 170.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.1 pt -103.96 -27.67 3.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -173.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -100.1 2.89 43.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.705 0.764 . . . . 0.0 108.957 175.097 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -116.05 -56.54 2.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.765 -171.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.88 -69.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.085 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.43 159.89 33.31 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.848 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -79.03 67.52 4.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.7 pttm -152.72 150.26 29.24 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.949 173.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.4 p -79.73 124.48 83.49 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.91 -28.68 75.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.929 2.42 . . . . 0.0 114.69 -168.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.72 -48.19 83.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -119.06 6.4 11.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 51.74 40.02 26.66 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.551 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 66.5 mm-40 -89.87 138.37 31.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.38 121.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.79 128.92 52.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.457 -173.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.03 150.47 27.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -59.59 -37.0 77.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.896 0.379 . . . . 0.0 111.114 -174.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -65.39 -28.73 69.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 179.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -66.79 -21.64 66.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.848 179.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.441 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.44 -0.961 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.7 t -66.32 110.19 4.41 Favored Pre-proline 0 N--CA 1.444 -0.747 0 O-C-N 123.73 0.643 . . . . 0.0 109.632 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.54 -18.14 53.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 112.339 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.03 -43.6 92.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.841 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.3 p -106.06 -17.88 14.2 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.15 26.77 12.54 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.714 0.806 . . . . 0.0 112.223 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.3 mtm -98.48 -64.99 0.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.51 175.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.66 -169.14 0.07 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -94.99 104.51 16.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -70.82 -45.89 63.77 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.38 -176.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -110.17 -15.92 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.013 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.39 86.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.271 0.982 . . . . 0.0 112.174 -177.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.12 119.81 62.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.37 0.605 . . . . 0.0 111.638 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -80.33 136.0 36.32 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.75 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.42 ' HB ' HD23 ' A' ' 51' ' ' LEU . 31.2 p -98.24 159.34 30.9 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.138 176.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.93 -27.88 85.48 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.373 2.049 . . . . 0.0 112.771 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.631 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 6.6 p -77.61 -26.14 50.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.906 0.384 . . . . 0.0 111.41 178.683 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.52 43.11 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.436 175.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.631 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 57.1 m-70 -130.77 133.58 46.12 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -104.99 134.35 48.24 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 120.998 0.427 . . . . 0.0 112.062 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -135.31 -172.52 3.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.725 -176.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.5 m -89.84 151.89 21.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.91 -12.12 61.38 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 121.028 0.442 . . . . 0.0 111.853 -173.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.85 -18.44 12.27 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.653 -0.654 . . . . 0.0 110.713 -178.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.4 m -79.2 -45.94 18.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.071 0.463 . . . . 0.0 110.333 176.43 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.17 -40.49 82.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 C-N-CA 120.439 -0.505 . . . . 0.0 111.605 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.5 mt -63.15 -43.66 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -80.07 -1.64 40.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.299 0.571 . . . . 0.0 111.058 -174.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.2 p -106.5 -18.42 13.98 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 121.831 -0.543 . . . . 0.0 111.242 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.56 -18.47 6.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.127 -177.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -106.33 7.89 31.5 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.018 174.429 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -114.71 -54.3 2.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.291 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -69.47 0.61 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 0.0 109.805 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.13 159.43 32.8 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 176.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -77.64 67.92 3.63 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.887 0.851 . . . . 0.0 112.036 -179.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -147.52 150.97 35.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.219 177.573 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -76.05 129.77 79.87 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.968 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -22.54 74.39 Favored 'Trans proline' 0 N--CA 1.478 0.575 0 C-N-CA 122.97 2.447 . . . . 0.0 113.379 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.56 -72.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.208 0.528 . . . . 0.0 111.511 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -104.83 4.26 31.96 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.28 36.18 25.46 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -87.13 151.78 22.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -66.07 119.82 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -119.43 122.37 41.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.137 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -105.1 141.19 37.09 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.61 -39.36 94.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.261 0.553 . . . . 0.0 111.002 -175.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.01 -30.06 71.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.518 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -76.51 -8.01 56.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.08 -176.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.674 0.274 . . . . 0.0 110.836 179.175 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -66.73 112.02 8.47 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 34.7 Cg_exo -61.82 -20.4 69.07 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.726 2.284 . . . . 0.0 112.432 -176.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.6 -43.93 90.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.69 178.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.1 p -105.55 -19.09 13.88 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.959 -176.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 57.16 23.12 8.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.921 0.888 . . . . 0.0 112.255 -179.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.5 mtm -96.0 -64.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.393 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.89 -165.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -174.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -103.93 125.97 50.71 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -80.18 -73.19 0.37 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.35 178.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -96.33 -16.59 21.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.05 90.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.121 0.968 . . . . 0.0 113.046 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m -110.44 115.4 49.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.498 0.666 . . . . 0.0 111.136 175.015 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -82.56 133.49 35.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.662 176.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.1 p -93.11 164.99 19.48 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.168 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.78 -26.36 79.5 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.169 1.912 . . . . 0.0 112.144 176.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.451 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 35.7 m -70.45 -28.33 64.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.092 0.473 . . . . 0.0 110.488 176.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.78 9.86 29.7 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.916 -177.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.451 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 24.3 m-70 -88.1 144.35 26.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -111.68 130.79 55.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.94 176.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.46 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 99.2 m-85 -132.07 172.72 12.02 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.559 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.454 ' O ' HG22 ' A' ' 33' ' ' ILE . 59.7 m -82.99 150.27 26.48 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.12 -8.63 55.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.424 0.63 . . . . 0.0 110.496 -175.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.67 -29.96 7.26 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 69.1 m -70.08 -46.06 65.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.03 175.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -68.42 -41.6 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.601 -178.406 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.7 mt -63.61 -42.33 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -77.23 -1.94 32.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.416 0.627 . . . . 0.0 110.225 -177.018 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 m -105.88 -25.41 12.15 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.772 174.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 33' ' ' ILE . 46.0 pt -103.49 -9.18 9.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.859 -176.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.6 ptm180 -94.18 2.13 55.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.628 0.728 . . . . 0.0 109.213 174.075 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.35 -55.08 2.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.56 -71.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.396 178.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -178.22 -179.26 48.14 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.404 ' HE2' ' CD ' ' A' ' 53' ' ' GLU . 14.5 m170 -89.55 81.22 6.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.24 0.543 . . . . 0.0 112.194 -177.245 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -170.55 144.27 2.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.734 175.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 p -72.02 123.8 89.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.83 -25.28 74.52 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.031 2.487 . . . . 0.0 113.554 -170.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.61 -46.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -175.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.63 6.69 8.2 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.16 34.21 19.0 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 177.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 69.5 mm-40 -91.17 141.23 29.03 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.908 175.064 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.1 mp -66.57 121.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.123 0.487 . . . . 0.0 110.234 -174.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.0 tp -126.85 128.75 47.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.735 -175.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.416 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -112.27 154.59 25.39 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.43 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.404 ' CD ' ' HE2' ' A' ' 42' ' ' HIS . 55.7 mp0 -61.62 -37.08 82.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.117 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.93 -30.84 71.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.391 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 17.0 mm-40 -77.79 -9.16 58.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.239 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.669 -178.985 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 33.8 t -77.55 116.17 55.75 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.835 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -60.97 -20.86 69.24 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.037 1.825 . . . . 0.0 112.605 -177.225 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.89 -45.05 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.618 0.247 . . . . 0.0 111.376 178.324 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 12.0 p -109.06 -22.26 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.405 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 59.23 22.9 11.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.245 1.018 . . . . 0.0 112.121 -177.386 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -95.57 -66.46 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.34 176.393 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.08 -172.46 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 9' ' ' CYS . 96.4 mt -107.44 124.98 50.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.684 0.278 . . . . 0.0 110.31 175.199 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 19' ' ' ALA . 22.9 tpt180 -92.76 114.71 27.34 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.253 168.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 68.75 -16.21 0.22 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.594 1.158 . . . . 0.0 112.811 -179.445 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 50.31 82.78 0.05 OUTLIER 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 113.329 177.161 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.2 m -97.01 116.56 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.626 0.727 . . . . 0.0 110.474 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.65 142.6 32.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.844 -179.296 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -93.17 163.65 24.35 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.628 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.91 -34.17 96.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.701 2.268 . . . . 0.0 111.935 176.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.06 -14.47 62.69 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.122 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.82 23.26 18.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.283 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -106.93 129.9 54.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.359 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -106.24 132.95 51.69 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.588 -173.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.23 167.84 19.63 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.455 -176.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.1 m -71.62 147.82 47.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.753 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -67.88 -4.89 14.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.728 -179.33 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.97 -38.86 3.79 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.167 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.77 -46.1 80.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.1 tp -66.36 -41.63 89.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.953 -173.96 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.576 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.3 mt -63.61 -43.43 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.411 . . . . 0.0 110.128 -178.534 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -79.4 -2.08 40.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.855 -176.086 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 m -106.77 -20.24 13.4 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.649 177.016 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -103.15 -24.03 4.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.226 -174.588 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.2 ptm180 -99.95 7.4 44.84 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.115 176.124 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.26 -56.69 2.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.539 -178.336 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.08 -67.64 0.8 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.527 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.05 159.12 32.3 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.093 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 75.9 m80 -86.29 64.89 8.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.584 0.707 . . . . 0.0 111.916 -176.611 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.44 150.31 27.73 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.34 176.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -70.33 135.41 86.66 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.886 0.374 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.18 -23.94 75.86 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.101 2.534 . . . . 0.0 114.305 -171.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 m -91.39 -55.46 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.354 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -103.68 4.89 35.93 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.105 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 50.97 33.95 9.78 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.599 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -86.36 147.0 26.23 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.721 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.59 120.4 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 109.718 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.6 tp -120.2 130.59 54.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.223 -174.099 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.12 153.47 28.17 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.43 -36.34 83.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.43 -31.02 72.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.681 176.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -77.97 -8.61 58.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--N 1.322 -0.625 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.614 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 p -92.67 134.31 27.98 Favored Pre-proline 0 C--N 1.313 -0.996 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.607 -177.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.9 -19.85 56.94 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.869 2.379 . . . . 0.0 112.19 -178.115 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.02 -44.94 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.092 -177.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -120.31 -20.21 7.37 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.253 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt 60.52 27.96 17.62 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.873 0.869 . . . . 0.0 111.908 -173.499 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.1 mtm -103.16 175.34 5.51 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.092 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.22 148.37 49.94 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.505 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.1 mt -78.76 130.43 35.75 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -68.1 -60.28 2.6 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -107.52 -15.05 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -178.263 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.01 90.23 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.792 -177.494 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 116.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.684 0.754 . . . . 0.0 111.368 179.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -81.15 136.86 35.94 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.709 177.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.2 p -94.59 160.37 31.66 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -54.71 -37.52 91.6 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 112.525 178.107 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.587 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.0 OUTLIER -70.37 -20.56 62.95 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 178.386 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.8 4.29 24.64 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.442 174.067 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.587 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 77.8 m-70 -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.241 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -101.56 132.58 47.13 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.322 177.084 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.71 165.39 24.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.479 179.432 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.618 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -80.97 159.52 24.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.037 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.411 ' O ' HD11 ' A' ' 34' ' ' ILE . 88.3 tttt -76.8 -12.93 60.05 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.326 -172.043 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.91 -10.95 12.88 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 -179.383 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.5 m -85.45 -57.87 2.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.334 177.787 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -66.77 -41.04 87.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -175.909 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.624 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.9 mt -63.24 -43.49 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 111.078 -177.099 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 35' ' ' LYS . 4.2 tppp? -79.33 -1.47 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -176.751 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -104.61 -17.82 14.55 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.32 177.33 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -104.34 -30.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.923 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.1 ptm180 -96.72 2.39 51.98 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.442 178.113 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -115.9 -54.63 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.302 179.5 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.81 -69.17 0.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 0.0 110.524 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -164.8 155.14 26.37 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 176.893 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -80.04 70.41 6.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.528 0.664 . . . . 0.0 111.686 -177.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.494 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -144.94 152.21 39.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.919 178.571 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.3 t -74.65 122.95 88.64 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.48 -34.25 97.7 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.241 2.627 . . . . 0.0 114.278 -172.066 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 m -83.19 -50.72 15.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -172.472 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -104.68 5.19 33.33 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.66 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.1 32.68 20.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.721 0.808 . . . . 0.0 112.29 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -87.75 149.0 24.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.198 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.84 121.32 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.29 119.68 32.91 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.389 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.488 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -102.54 153.7 19.82 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.08 -178.671 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.41 -40.09 96.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.465 0.706 . . . . 0.0 111.532 -174.005 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -68.37 -20.8 64.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.488 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.3 mm100 -75.11 -9.95 59.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.444 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 C--N 1.324 -0.502 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.377 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 . . . . . 0 N--CA 1.438 -1.035 0 CA-C-O 120.997 0.427 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.0 t -79.82 109.22 11.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.84 -19.42 65.54 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.863 2.375 . . . . 0.0 112.722 -175.265 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.93 -43.82 92.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.006 0.431 . . . . 0.0 111.26 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.38 -21.05 15.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.789 -177.018 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 65.94 20.33 11.32 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 111.633 -177.699 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -99.64 -71.03 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.088 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.33 -162.6 0.13 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -174.311 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.2 mt -106.57 125.82 51.48 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -84.47 -71.35 0.52 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.896 175.31 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -89.76 -16.23 30.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.82 178.707 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.89 77.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.252 0.621 . . . . 0.0 111.592 -176.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 21.1 m -92.3 116.8 34.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.042 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.31 129.89 34.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.732 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -92.27 164.9 21.25 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.338 177.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.58 -36.44 94.54 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 112.32 178.265 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.7 -20.49 62.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.071 -178.135 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.0 6.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.98 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -113.33 154.35 27.0 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.459 -0.436 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 81.9 mtm180 -123.47 137.56 54.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.048 0.452 . . . . 0.0 111.522 -176.321 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.424 ' O ' HG21 ' A' ' 20' ' ' VAL . 95.7 m-85 -138.91 172.93 12.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.75 -177.104 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.0 m -84.74 153.85 22.79 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.725 0.298 . . . . 0.0 110.33 175.647 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.15 -14.78 63.24 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.837 0.855 . . . . 0.0 111.886 -176.466 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.78 -13.81 12.01 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.048 -176.766 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 52.5 m -87.84 -47.91 8.24 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.078 177.772 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.36 -38.51 79.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.8 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.8 mt -62.67 -42.43 96.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.425 . . . . 0.0 110.561 -177.769 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -77.64 -1.66 32.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.806 0.813 . . . . 0.0 109.962 -178.542 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 16.2 t -105.3 -21.82 13.17 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.88 -0.513 . . . . 0.0 109.982 177.009 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.64 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.5 pt -104.97 -28.06 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.391 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -96.01 -7.55 36.05 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.708 177.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -115.11 -40.95 3.39 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.308 -175.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 36' ' ' SER . . . -91.66 -72.94 0.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.969 0.414 . . . . 0.0 110.012 176.587 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.17 157.61 30.14 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.927 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -82.82 69.67 9.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.493 0.663 . . . . 0.0 111.979 -176.3 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -150.91 153.11 34.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.796 -179.781 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 p -77.34 133.56 67.81 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.039 171.793 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.07 -23.8 75.99 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 123.015 2.477 . . . . 0.0 114.244 -170.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -90.5 -61.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.206 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -100.91 4.22 42.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.637 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.33 35.23 25.49 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.046 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 71.2 mm-40 -83.5 150.67 25.85 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.782 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -66.71 121.18 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.109 0.48 . . . . 0.0 109.903 -177.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -126.7 129.86 49.25 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.325 -175.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.87 156.49 23.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.622 178.478 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.6 mp0 -61.23 -39.05 88.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.612 0.365 . . . . 0.0 110.66 -178.894 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -74.96 -10.2 59.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 0.0 111.407 179.563 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -91.48 -7.76 49.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.026 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.774 179.059 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 44.2 mt-10 . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 t -56.27 112.95 5.01 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.494 177.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.1 -20.95 71.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.7 2.267 . . . . 0.0 112.461 -173.569 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.49 -44.07 90.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.464 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -108.09 -21.25 12.87 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.647 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 56.53 30.23 16.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.824 0.849 . . . . 0.0 111.754 -175.265 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -96.29 -66.91 0.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 173.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -179.53 -172.65 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -176.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.5 mt -93.93 103.61 15.7 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.273 174.13 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -66.51 -43.97 83.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.904 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -123.0 -15.02 7.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.797 179.587 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.93 56.54 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.203 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 28' ' ' PHE . 27.3 m -76.84 116.09 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.36 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -80.6 121.32 25.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.527 -176.438 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -88.8 160.83 43.16 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.55 -30.75 89.56 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 178.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -14.72 62.89 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.319 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.02 5.07 44.46 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.375 -0.916 . . . . 0.0 114.251 174.518 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.79 168.33 10.56 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.434 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.6 mtt180 -127.3 142.22 51.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 112.016 -169.784 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.474 ' O ' HG21 ' A' ' 20' ' ' VAL . 99.2 m-85 -131.42 170.23 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.769 178.583 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 53.3 m -80.19 148.19 30.98 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.555 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -68.62 -13.16 62.17 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -174.414 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.21 -17.8 12.69 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.8 m -79.59 -45.51 19.03 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.665 173.107 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -66.47 -40.95 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.832 -176.641 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.84 -42.63 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 111.006 -179.15 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -78.72 -1.9 36.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.352 0.596 . . . . 0.0 110.149 -174.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 m -105.32 -23.08 12.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.299 177.296 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.9 pt -104.76 -5.36 9.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.256 -177.784 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -96.82 -15.73 21.15 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.618 176.968 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -116.52 -56.09 2.32 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.145 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.28 -65.79 0.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 110.692 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.86 155.36 26.6 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -84.65 54.62 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 122.073 0.94 . . . . 0.0 109.111 -176.204 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -147.44 154.17 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.301 -175.357 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 45.3 t -61.65 123.02 75.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.112 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.05 -35.82 99.06 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.166 2.577 . . . . 0.0 114.123 -172.042 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -82.67 -45.96 19.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.12 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -114.95 5.57 15.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 56.58 33.45 22.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.337 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -92.2 149.71 21.32 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.209 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.4 121.66 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.074 0.464 . . . . 0.0 110.589 -176.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 tp -126.13 127.81 46.34 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.224 -179.746 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.48 143.91 30.9 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.656 176.78 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.53 -36.59 84.27 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.303 1.041 . . . . 0.0 110.203 -175.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.4 -30.25 71.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.973 177.846 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -64.89 -29.11 70.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.146 0.498 . . . . 0.0 110.884 179.54 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.556 -176.7 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 41.8 t -83.75 110.81 27.68 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -177.769 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.43 -18.81 49.65 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.069 1.846 . . . . 0.0 112.301 -176.663 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.52 -43.51 90.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 178.874 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 25.4 p -109.83 -6.41 15.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.526 -176.687 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.89 33.19 22.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.902 0.881 . . . . 0.0 111.1 -175.593 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -127.52 167.44 16.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.379 178.893 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 151.12 37.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.421 HD22 ' HB2' ' A' ' 9' ' ' CYS . 93.7 mt -69.89 118.35 12.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.867 0.365 . . . . 0.0 110.393 -173.416 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -69.39 -45.62 68.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.323 179.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -116.92 -16.54 10.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.04 87.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.135 0.897 . . . . 0.0 112.737 -178.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -105.39 117.23 50.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.51 0.672 . . . . 0.0 111.476 176.204 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -73.16 132.54 43.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.137 175.155 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 p -106.29 159.04 31.16 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 178.759 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.8 -24.41 74.52 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.88 2.386 . . . . 0.0 113.01 -179.807 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.1 p -79.48 -14.66 58.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 111.203 178.483 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.61 8.36 37.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.566 175.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -99.23 162.05 13.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.696 0.248 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -124.1 137.61 54.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.916 0.389 . . . . 0.0 110.214 177.824 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.23 167.49 21.73 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.869 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.0 m -76.28 156.7 33.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.083 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.73 -3.97 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.139 0.495 . . . . 0.0 111.382 -170.669 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.74 -26.59 7.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.761 0.315 . . . . 0.0 110.381 178.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -71.86 -45.9 59.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.318 179.377 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -65.96 -38.24 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.238 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.53 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.2 mt -62.25 -42.31 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 110.386 177.987 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.84 -0.5 30.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.656 0.741 . . . . 0.0 110.452 -177.332 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -104.75 -25.33 12.71 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.915 -0.49 . . . . 0.0 109.793 177.325 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.1 pt -103.81 -15.17 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.001 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -106.78 -2.34 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.286 175.244 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.67 -50.79 2.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.733 -175.562 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.69 -68.8 0.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 -179.784 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.25 154.76 25.83 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 178.512 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -81.01 45.4 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.65 0.738 . . . . 0.0 110.927 -173.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -144.25 154.42 43.07 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.956 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.0 p -64.1 135.41 96.31 Favored Pre-proline 0 N--CA 1.445 -0.688 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.257 177.499 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.23 -29.61 80.58 Favored 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 122.839 2.359 . . . . 0.0 113.593 -172.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.86 -71.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.18 0.514 . . . . 0.0 111.697 -174.028 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -95.65 4.56 52.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.549 -173.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.93 34.17 24.43 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 169.39 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -87.45 141.96 28.23 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.624 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mp -65.24 119.5 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tt -110.51 127.67 55.28 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -168.49 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.44 ' HB2' HE21 ' A' ' 55' ' ' GLN . 3.8 mm? -96.88 132.87 42.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.913 178.54 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.26 -35.43 80.4 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -173.994 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -63.56 -29.72 70.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 178.108 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 52' ' ' LEU . 50.2 mt-30 -80.34 -7.86 59.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.503 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 C--O 1.237 0.426 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.956 177.205 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.92 112.52 9.95 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.712 0.632 . . . . 0.0 109.689 175.864 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -63.12 -20.37 70.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.248 1.966 . . . . 0.0 112.87 -178.343 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -66.08 -44.43 91.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.2 p -105.24 -19.19 13.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.635 -177.791 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 57.0 26.7 12.22 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.791 0.836 . . . . 0.0 111.797 -176.658 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.88 -65.73 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.023 0.44 . . . . 0.0 110.469 176.689 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.3 -164.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -177.326 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.9 mt -103.3 113.76 27.5 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 172.512 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -63.91 -44.98 91.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 178.018 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -132.52 -7.18 3.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 178.608 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.15 92.47 0.07 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 175.623 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -117.19 111.63 35.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 110.289 171.594 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -80.94 143.43 32.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.385 178.638 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -108.82 154.68 41.66 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.272 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 55' ' ' GLN . 40.6 Cg_endo -65.37 -20.01 61.6 Favored 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 122.742 2.295 . . . . 0.0 111.463 177.448 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.4 t -73.99 -15.06 61.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.077 179.01 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.07 22.2 18.23 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.234 178.4 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -113.03 152.12 29.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.587 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -120.01 136.04 54.7 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.696 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.408 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 94.8 m-85 -136.67 172.99 12.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.092 0.472 . . . . 0.0 110.502 -177.024 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -82.01 152.0 26.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 171.05 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.87 -10.7 58.44 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -177.489 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 -12.32 12.82 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.711 -0.618 . . . . 0.0 110.205 179.325 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 70.9 m -85.92 -62.94 1.41 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.982 177.573 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -67.79 -39.9 82.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.062 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.722 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.5 mt -63.04 -43.38 98.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 0.0 110.523 -178.504 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -79.53 0.79 28.34 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.714 0.768 . . . . 0.0 109.729 -178.561 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 t -106.38 -23.76 12.44 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.992 -0.442 . . . . 0.0 110.83 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.0 pt -103.96 -26.09 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.384 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -97.41 3.43 50.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.423 0.63 . . . . 0.0 109.773 176.553 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -116.66 -55.88 2.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.76 -72.93 0.52 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.108 179.809 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -158.46 160.46 30.98 Favored Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 178.55 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -85.42 71.08 10.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.373 0.606 . . . . 0.0 111.162 -176.242 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -152.22 150.61 30.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.764 178.023 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 9.2 p -79.9 122.03 82.84 Favored Pre-proline 0 N--CA 1.429 -1.519 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.689 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.98 -18.43 62.16 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.652 2.235 . . . . 0.0 113.274 -170.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.0 -48.44 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -133.53 13.77 4.1 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.621 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER 63.04 21.44 12.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 174.214 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 72.2 mm-40 -72.66 142.52 48.28 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.564 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.5 mm -66.4 121.05 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.973 0.416 . . . . 0.0 110.605 -176.39 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.1 tp -128.16 134.4 49.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.056 -177.456 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -116.89 155.27 29.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' OE2' ' HD2' ' A' ' 38' ' ' ARG . 48.8 mt-10 -62.85 -36.48 83.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.16 0.505 . . . . 0.0 110.299 179.273 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.13 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.931 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.459 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.6 mm100 -79.8 -7.69 58.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.489 -174.082 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 120.966 0.413 . . . . 0.0 110.844 179.839 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.445 -0.693 0 CA-C-O 120.956 0.408 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.515 ' HB2' HD21 ' A' ' 16' ' ' LEU . 46.9 t -96.19 109.41 47.05 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.39 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.22 -19.47 62.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.038 1.825 . . . . 0.0 112.736 -174.438 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.61 -43.92 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.832 0.349 . . . . 0.0 111.288 178.284 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.6 p -106.51 -4.38 19.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.696 -177.131 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt 55.16 34.35 22.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.349 0.66 . . . . 0.0 111.135 -177.518 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -133.12 -174.76 3.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.368 179.286 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.17 157.38 37.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 9' ' ' CYS . 95.1 mt -70.62 134.33 47.49 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -86.05 -73.45 0.45 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.783 177.64 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -93.1 -16.35 25.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 178.125 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.32 66.46 1.23 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.183 -179.29 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.5 m -85.36 117.7 30.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.135 0.493 . . . . 0.0 111.114 -179.367 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.55 133.38 36.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.318 -177.095 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -101.34 157.67 33.23 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.472 -178.617 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -56.84 -33.51 94.83 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.713 2.276 . . . . 0.0 112.509 178.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 p -69.49 -26.08 64.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.98 -178.4 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.56 51.1 0.72 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.135 -178.225 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -138.51 159.68 41.46 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 122.732 0.413 . . . . 0.0 110.909 177.582 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -126.27 135.73 51.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.169 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.6 m-85 -139.7 169.76 17.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.522 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 24.5 m -79.2 152.09 30.87 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 173.099 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.23 -13.57 62.48 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -173.877 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.08 -3.49 13.97 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.632 -178.771 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.7 m -91.55 -59.62 2.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.401 174.663 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.1 tp -68.46 -39.75 81.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.435 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.502 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.3 mt -63.13 -41.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.057 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.07 -0.97 30.08 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.555 0.693 . . . . 0.0 109.628 -178.265 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.25 -18.68 13.93 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.075 -0.391 . . . . 0.0 111.323 175.418 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -105.06 -30.08 2.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -177.118 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptm180 -98.4 4.19 48.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.554 178.999 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.56 -56.15 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.641 -179.023 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 -74.38 0.36 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 178.634 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.51 155.7 26.88 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -79.23 66.06 4.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.078 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.2 ptpp? -152.54 149.81 28.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.223 174.435 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.8 p -74.4 127.12 88.13 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.263 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.24 -23.81 77.76 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.282 2.655 . . . . 0.0 113.806 -171.197 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.422 HG11 ' OD1' ' A' ' 47' ' ' ASP . 4.4 p -77.1 -51.11 19.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.112 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.422 ' OD1' HG11 ' A' ' 46' ' ' VAL . 13.0 p-10 -117.59 6.4 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.1 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 59.66 35.01 22.32 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.6 mm-40 -95.41 140.13 30.72 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.978 -0.451 . . . . 0.0 110.677 176.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.65 121.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.087 0.47 . . . . 0.0 110.131 -176.544 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -122.73 134.59 54.45 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.62 -176.327 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.9 mt -114.36 147.65 38.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.933 178.752 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.435 ' OE2' ' HB3' ' A' ' 38' ' ' ARG . 53.8 mp0 -62.75 -35.89 81.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 0.0 109.464 179.179 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -65.52 -29.77 70.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.239 -179.639 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -71.18 -27.79 63.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.166 0.508 . . . . 0.0 111.353 177.713 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.99 -179.236 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.3 t -54.93 112.49 4.13 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.083 0.553 . . . . 0.0 110.684 179.432 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -62.21 -20.53 70.31 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.926 2.417 . . . . 0.0 113.35 -175.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -67.71 -44.74 85.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.336 176.229 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.45 -25.95 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.161 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 63.98 23.58 13.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.175 0.59 . . . . 0.0 111.787 -178.17 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -95.34 -66.3 0.92 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 109.64 178.913 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.69 -163.44 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -176.91 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.23 124.81 50.16 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.812 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -79.06 -60.37 2.4 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.19 174.299 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -105.97 -14.98 15.03 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.252 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.45 90.83 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.2 117.4 52.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.035 0.445 . . . . 0.0 110.475 175.373 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -80.74 133.69 35.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.204 178.726 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.3 p -88.02 161.14 44.75 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 179.507 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.2 -29.82 88.71 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.097 2.531 . . . . 0.0 112.1 177.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.16 -21.2 63.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 179.52 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.84 36.67 2.34 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.813 173.825 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -149.74 167.22 27.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.352 0.576 . . . . 0.0 111.944 176.433 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -109.52 140.76 42.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.149 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.5 m-85 -132.49 167.19 20.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.962 173.249 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.574 ' O ' HG22 ' A' ' 33' ' ' ILE . 38.2 m -84.81 150.15 25.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.507 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.02 -8.83 56.11 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -172.573 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.73 -28.35 7.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.022 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -65.31 -52.96 50.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.362 0.601 . . . . 0.0 110.208 176.522 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -70.35 -40.5 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.947 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.586 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.48 -43.21 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.516 -176.749 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -78.88 -2.01 37.81 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.567 0.699 . . . . 0.0 110.359 -176.698 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 48.4 m -105.74 -18.56 14.03 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 175.683 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.7 pt -104.29 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.115 -178.267 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -95.08 -4.33 46.52 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.889 177.59 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.51 -47.49 2.73 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.398 -177.085 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 36' ' ' SER . . . -87.59 -69.69 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.03 157.71 30.3 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.534 179.047 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -87.91 18.59 4.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -176.41 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -95.92 140.83 30.12 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.005 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 53.0 t -60.79 130.85 91.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.36 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.51 -29.18 88.08 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -172.091 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.96 -55.63 5.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -103.2 4.38 36.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -173.137 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.6 29.5 15.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 173.898 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -79.81 145.54 32.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.36 119.5 13.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 179.012 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -125.45 131.78 52.82 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.437 -172.581 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.77 156.86 27.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -38.45 85.49 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.855 0.36 . . . . 0.0 110.952 -176.878 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -65.2 -30.51 71.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.826 178.723 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -80.15 -12.03 59.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.898 -176.068 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--O 1.245 0.853 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.024 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.8 t -61.92 112.66 6.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.192 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -62.06 -21.32 72.21 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.569 2.18 . . . . 0.0 112.793 -174.254 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.39 -44.17 90.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.085 0.469 . . . . 0.0 111.777 179.53 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.5 p -106.06 -19.37 13.74 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.598 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.2 mt 53.47 28.47 7.65 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -175.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -95.61 -65.5 0.97 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.259 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.66 -171.47 0.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.58 109.06 21.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.28 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -70.28 -44.68 67.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.806 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 54.7 mm-40 -111.9 -16.48 13.12 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.098 -177.14 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.41 82.19 0.09 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 177.407 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.95 116.68 51.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 110.972 175.963 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.22 125.42 30.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.285 176.553 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -75.76 157.29 84.09 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.97 -23.69 76.08 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.375 2.05 . . . . 0.0 112.34 177.77 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.552 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 7.8 p -77.85 -20.76 52.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.617 176.876 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.76 43.53 1.42 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.024 -1.084 . . . . 0.0 114.232 174.537 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.552 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 87.3 m-70 -130.86 152.55 50.07 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.175 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -113.02 132.78 55.25 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.534 178.187 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.424 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.0 m-85 -138.25 167.64 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.123 -178.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 42.4 m -78.31 151.86 32.73 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.204 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.446 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 88.0 tttt -68.49 -13.45 62.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -171.062 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.92 -27.09 7.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.885 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.8 m -64.59 -46.79 81.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.299 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -69.43 -41.37 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.145 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.606 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 80.8 mt -63.57 -42.67 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.153 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -79.42 -0.54 33.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -177.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -105.29 -21.72 13.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.051 176.793 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.64 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.6 pt -104.89 -13.68 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.33 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -108.18 -1.7 20.05 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.557 175.873 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -122.23 -57.58 1.76 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.033 -179.867 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.84 -65.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.647 -178.553 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -157.09 159.2 29.48 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.546 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -79.88 -8.84 59.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.474 0.637 . . . . 0.0 110.992 -176.611 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 20.2 ptpt -81.29 149.33 29.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.121 176.591 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 51.0 t -58.8 125.97 79.0 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.92 -22.01 73.44 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.018 2.478 . . . . 0.0 113.514 -167.993 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -97.79 -48.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.443 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -108.98 5.86 24.65 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 58.63 32.73 22.47 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 176.22 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -97.54 137.39 36.55 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.205 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 43' ' ' LYS . 46.6 mm -65.81 120.92 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.599 -177.458 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 37' ' ' ILE . 49.7 tp -109.7 130.22 55.53 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.99 -172.467 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.59 135.55 40.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 -176.486 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.53 -36.76 84.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.401 -179.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -63.58 -31.83 73.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.883 -177.342 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.7 mm-40 -71.65 -25.05 61.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 111.481 179.641 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 C--N 1.317 -0.808 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 -175.732 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.477 ' HB2' HD21 ' A' ' 16' ' ' LEU . 37.1 t -71.8 114.12 25.93 Favored Pre-proline 0 C--O 1.221 -0.428 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.313 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.69 -21.27 71.73 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.583 2.189 . . . . 0.0 112.951 -176.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.63 -45.01 89.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.898 0.38 . . . . 0.0 111.664 179.203 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 9.6 p -105.3 -23.85 12.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.422 . . . . 0.0 111.53 -177.201 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.23 22.53 13.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.15 0.98 . . . . 0.0 111.844 -177.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtm -94.69 -64.69 1.04 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.043 0.449 . . . . 0.0 109.911 176.348 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.96 -175.33 0.86 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.116 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 9' ' ' CYS . 93.9 mt -96.58 116.77 29.64 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 170.442 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 20.7 tpt180 -66.18 -44.73 83.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.778 177.906 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 17' ' ' ARG . 47.4 mt-10 -132.66 -15.15 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -177.052 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.54 84.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.132 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.36 118.41 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.224 0.535 . . . . 0.0 111.009 175.208 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -78.63 133.12 37.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.211 179.512 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -87.57 160.17 48.22 Favored Pre-proline 0 C--N 1.311 -1.1 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.483 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.53 -23.65 74.94 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.373 2.048 . . . . 0.0 112.507 179.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.523 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -80.67 -15.8 55.62 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.994 0.426 . . . . 0.0 111.551 176.191 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.59 52.3 1.32 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.162 175.218 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.523 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 38.9 m-70 -135.06 141.08 46.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.727 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -105.63 133.47 50.32 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.686 176.242 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -135.02 169.25 17.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.744 177.184 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 61.3 m -69.36 148.81 49.15 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 171.435 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.41 -6.72 45.47 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.288 0.566 . . . . 0.0 111.356 -173.414 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.13 -34.01 5.5 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.026 -0.421 . . . . 0.0 110.263 179.332 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.1 m -65.84 -46.96 76.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.932 179.109 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.0 tp -68.89 -40.65 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.014 -177.506 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.2 mt -63.28 -43.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.961 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -80.96 4.42 19.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.008 0.433 . . . . 0.0 111.351 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -105.46 -24.67 12.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.715 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.39 -20.52 5.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.47 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.8 ptm180 -99.92 4.08 44.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.497 176.107 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -128.03 -54.51 1.29 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.018 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.15 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -179.04 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.44 144.6 11.36 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.923 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -84.19 40.62 0.78 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.736 0.779 . . . . 0.0 111.165 -171.092 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -142.63 152.86 42.92 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.119 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.23 123.58 89.14 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.731 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.59 -24.18 75.03 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.077 2.518 . . . . 0.0 114.078 -170.259 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.1 m -72.34 -49.82 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.973 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -115.49 5.74 14.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.005 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 58.76 33.68 23.23 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 175.502 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -100.23 144.5 29.17 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.351 -0.218 . . . . 0.0 110.495 179.345 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.59 121.72 15.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 -176.371 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.8 tp -115.33 127.78 55.66 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.275 -174.61 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.5 138.88 38.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.338 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.85 -36.85 77.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.747 0.419 . . . . 0.0 111.959 -175.133 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -71.78 -17.8 62.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.833 0.349 . . . . 0.0 111.571 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -81.26 -9.06 59.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.865 -177.136 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.983 178.6 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.429 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 5.1 t -89.92 118.13 68.67 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.28 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.76 -18.73 63.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 113.218 -176.349 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.4 mt -65.84 -44.33 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.692 0.282 . . . . 0.0 110.856 177.806 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.6 p -106.44 -26.47 11.43 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.716 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 66.3 22.93 10.82 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.142 0.977 . . . . 0.0 111.895 179.569 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -97.64 -66.85 0.88 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.316 0.579 . . . . 0.0 110.631 176.651 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.99 -161.65 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 9' ' ' CYS . 90.4 mt -109.77 122.75 48.22 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.539 172.389 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 27.4 tpt180 -86.85 108.92 18.97 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.944 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 71.49 -10.39 0.82 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.155 1.382 . . . . 0.0 113.173 -179.544 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 50.86 83.63 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.144 0.978 . . . . 0.0 113.329 175.467 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.42 115.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.086 177.907 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -80.7 128.32 33.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.145 177.474 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -79.77 161.91 64.65 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.204 177.579 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.24 -18.95 67.3 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.5 2.133 . . . . 0.0 111.438 175.884 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.2 m -65.85 -35.43 80.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.785 174.357 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 -28.23 5.44 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.902 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -82.6 154.48 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.746 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -109.5 140.67 42.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.136 -174.946 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.43 167.81 18.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.428 176.546 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.551 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 88.3 m -73.4 146.42 45.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.28 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -69.72 -12.79 61.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.361 179.236 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.42 2.98 15.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 -177.533 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 83.5 m -105.77 -56.97 2.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.734 173.067 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -68.8 -41.85 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.28 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.0 mt -63.42 -41.68 93.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.515 0.674 . . . . 0.0 110.254 179.24 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -77.97 -0.2 26.77 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.64 -177.159 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -105.85 -22.8 12.84 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.129 -0.357 . . . . 0.0 110.71 175.93 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.4 pt -102.23 -23.4 4.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.208 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -102.81 6.15 39.09 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.754 174.345 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -114.84 -51.15 2.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.607 -178.842 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.05 -69.62 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.525 177.298 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -162.85 159.49 31.89 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.433 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -82.08 65.0 7.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -173.439 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 10.4 ptpp? -153.11 147.64 26.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.932 175.248 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.77 124.18 86.41 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.086 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.54 -26.9 81.28 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.993 2.462 . . . . 0.0 114.886 -168.488 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.14 -44.07 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.714 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -121.44 6.43 10.11 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.502 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 52.31 34.54 15.04 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.131 1.372 . . . . 0.0 113.622 177.834 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 77.0 mm-40 -88.89 142.87 27.28 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.085 178.828 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.21 120.07 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.305 0.574 . . . . 0.0 110.216 -175.3 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.8 tp -128.89 132.68 47.72 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 -177.46 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.94 152.69 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.855 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.49 -31.02 71.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.268 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -63.53 -32.81 74.38 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.051 178.167 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -68.32 -34.31 75.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.409 0.623 . . . . 0.0 109.996 178.719 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.437 -1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.583 178.555 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.433 -1.297 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.583 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.5 t -84.37 114.23 53.55 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.059 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.91 -21.68 73.31 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.36 2.04 . . . . 0.0 112.806 -175.323 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.79 -44.17 85.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.619 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 18.5 p -106.24 -22.15 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.54 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp 63.85 21.18 12.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 111.108 -174.907 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.438 ' HA ' ' HE3' ' A' ' 14' ' ' MET . 30.1 mmt -95.44 -73.49 0.59 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.124 0.488 . . . . 0.0 109.792 178.778 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.09 166.88 2.96 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 9' ' ' CYS . 91.6 mt -84.19 103.65 13.57 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.232 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -83.52 -53.91 5.34 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 118.879 -1.129 . . . . 0.0 112.037 -177.348 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 29' ' ' CYS . 9.3 mp0 -87.7 -16.56 33.96 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.595 177.318 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 43.34 73.14 0.15 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.189 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -99.65 116.31 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.369 0.604 . . . . 0.0 110.187 177.781 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -80.08 136.53 36.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.92 179.795 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -89.95 159.46 42.77 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.092 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.15 -25.97 81.29 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 174.28 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.55 -17.62 64.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.898 177.931 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 13.84 57.46 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.804 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -109.13 143.28 38.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.844 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -109.98 139.99 44.49 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.075 0.464 . . . . 0.0 111.857 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.476 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.5 m-85 -141.0 169.68 17.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.104 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.8 m -82.81 154.05 24.9 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.352 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.86 -14.37 62.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.298 0.571 . . . . 0.0 110.566 -176.59 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.97 2.62 15.86 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.186 0.517 . . . . 0.0 109.921 -178.535 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.4 m -103.06 -55.96 2.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.44 174.007 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.581 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -66.69 -43.28 90.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.641 -175.707 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.39 -41.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.229 0.538 . . . . 0.0 110.675 179.817 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -76.97 -3.83 40.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.812 -175.916 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.0 m -110.88 -23.72 10.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 176.133 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 33' ' ' ILE . 44.6 pt -103.64 -7.3 9.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.099 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -95.32 -10.11 31.11 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.252 177.451 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -116.8 -43.01 2.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.056 -177.668 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.96 -72.81 0.43 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.119 176.819 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.46 152.36 21.7 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 177.649 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.451 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 24.1 m80 -82.46 68.88 9.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.855 0.836 . . . . 0.0 111.996 -179.299 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -151.71 150.7 30.51 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.462 177.582 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.2 p -70.97 123.58 89.55 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.407 177.207 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.93 -28.07 80.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.918 2.412 . . . . 0.0 113.651 -171.615 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.49 -49.23 81.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.766 -177.758 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -127.05 6.65 6.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.417 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 60.31 35.35 20.74 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -94.53 143.18 26.63 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 174.14 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 122.18 14.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.313 0.577 . . . . 0.0 110.815 -174.003 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.1 tp -120.97 130.24 53.75 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.143 -174.436 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.57 139.18 40.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -65.35 -37.84 88.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.883 -174.058 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -68.58 -19.02 64.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 177.959 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.6 mm-40 -81.36 -8.53 59.75 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.132 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.242 0.702 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.859 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 N--CA 1.432 -1.364 0 CA-C-O 120.74 0.305 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.56 108.83 4.84 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.498 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.08 -19.14 51.66 Favored 'Trans proline' 0 C--O 1.226 -0.113 0 C-N-CA 122.881 2.387 . . . . 0.0 113.463 -171.113 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.21 -43.61 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.0 111.144 178.635 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 p -99.17 -25.29 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.973 0.416 . . . . 0.0 111.042 178.692 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.1 mt 60.5 29.86 19.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 111.249 -176.349 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.6 mtm -99.09 -68.19 0.81 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 175.136 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.65 -163.24 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -176.253 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.74 124.35 46.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.026 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -88.29 -72.28 0.54 Allowed 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.954 176.846 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -81.13 -15.97 54.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.223 177.004 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.4 77.59 0.17 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.646 -178.281 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.12 114.03 40.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.552 0.691 . . . . 0.0 110.015 177.889 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -80.8 135.78 36.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.928 -178.4 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -99.63 154.2 37.39 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.62 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.14 -24.69 72.91 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 122.722 2.281 . . . . 0.0 113.153 -176.229 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.684 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.5 p -76.21 -15.31 60.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 178.692 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.35 23.46 6.94 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.704 175.795 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.684 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 81.4 m-70 -112.61 155.65 24.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.634 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -126.07 137.35 53.62 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.53 176.69 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.587 -175.761 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 8.7 m -91.61 160.43 15.4 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 170.702 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.482 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 61.2 pttt -75.88 -7.11 53.74 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.175 0.512 . . . . 0.0 110.353 -174.682 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.37 -0.85 15.24 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.152 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 49.2 m -101.94 -64.16 1.09 Allowed 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.393 175.879 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -67.32 -41.72 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.992 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 30' ' ' LYS . 82.8 mt -63.18 -42.89 98.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 110.97 -178.341 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -79.9 -3.22 47.15 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.246 0.546 . . . . 0.0 110.478 -176.933 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -106.15 -18.22 14.08 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.809 -0.557 . . . . 0.0 111.4 178.156 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 36.5 pt -102.23 -13.28 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.453 -175.051 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -104.87 0.94 28.48 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.06 174.342 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.32 -51.72 2.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 -176.032 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.79 -69.78 0.59 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.42 0.629 . . . . 0.0 109.451 174.796 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.76 163.94 35.26 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 177.682 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -80.31 72.26 7.15 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.87 0.835 . . . . 0.0 112.124 -176.709 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.0 ptpp? -144.61 150.05 36.79 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.784 176.075 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 p -83.75 123.23 76.37 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.36 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.96 -25.71 74.07 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.842 2.361 . . . . 0.0 114.109 -168.962 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.5 m -72.08 -42.96 67.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.874 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -120.27 6.43 10.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 50.93 36.55 15.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 176.303 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.6 mm-40 -96.94 153.29 17.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.345 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.53 122.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.145 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.6 118.35 35.44 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -176.368 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.545 ' HB2' HE21 ' A' ' 55' ' ' GLN . 2.9 mm? -98.36 134.82 40.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.484 179.736 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -64.89 -35.6 81.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.339 0.399 . . . . 0.0 111.74 -173.426 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -65.86 -30.65 71.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.287 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.545 HE21 ' HB2' ' A' ' 52' ' ' LEU . 48.7 mt-30 -68.1 -20.25 64.92 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.188 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 178.341 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 . . . . . 0 N--CA 1.442 -0.83 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 38.7 t -70.34 114.21 24.08 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.944 0.778 . . . . 0.0 109.426 179.023 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.7 -21.61 73.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.346 2.03 . . . . 0.0 112.553 -177.666 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.8 -44.02 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.764 0.316 . . . . 0.0 111.582 178.317 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -104.01 -22.92 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.891 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt 56.75 25.48 10.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 111.939 -176.421 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -96.4 -63.13 1.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.324 174.291 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.37 -172.72 0.31 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.786 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.4 mt -98.93 106.82 19.12 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.961 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -69.61 -43.96 71.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.138 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -115.38 -16.24 11.46 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 177.876 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.95 70.48 0.58 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.661 0.601 . . . . 0.0 112.329 -178.544 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 28' ' ' PHE . 26.8 m -93.27 116.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.141 0.496 . . . . 0.0 110.777 179.236 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -80.0 135.81 36.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 175.116 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -111.01 151.74 43.2 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.498 -179.791 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.435 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 50.2 Cg_exo -56.63 -37.38 97.76 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.791 2.327 . . . . 0.0 111.154 179.737 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.8 t -59.69 -31.14 69.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.907 -178.793 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.89 36.33 2.04 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.418 179.812 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.56 156.85 40.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.162 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.72 131.35 53.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.012 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 20' ' ' VAL . 94.5 m-85 -139.6 179.72 6.4 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.252 0.345 . . . . 0.0 110.208 -177.109 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 61.8 m -90.61 151.22 21.39 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 169.972 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.55 -6.8 43.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.34 0.59 . . . . 0.0 111.449 -176.121 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.48 -16.14 12.47 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.081 0.467 . . . . 0.0 109.952 -179.437 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 76.3 m -83.82 -59.28 2.47 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 175.351 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.436 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.2 tp -67.87 -41.05 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.243 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 67.0 mt -62.72 -42.97 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.658 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -78.83 -1.66 35.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.546 0.689 . . . . 0.0 109.61 -175.568 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 m -105.38 -21.08 13.3 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.651 176.158 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.7 pt -104.07 -24.34 4.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.077 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -98.9 0.49 44.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.764 177.371 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.87 -46.52 2.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.749 -177.395 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 -68.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.115 0.483 . . . . 0.0 110.794 177.202 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.49 161.98 35.66 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.31 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 66.0 m80 -86.21 76.17 9.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 117.444 0.622 . . . . 0.0 111.555 -173.886 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 22.4 pttp -154.25 144.68 22.22 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 -179.214 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.3 p -77.32 123.79 86.98 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 170.351 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.25 -24.77 76.32 Favored 'Trans proline' 0 N--CA 1.481 0.751 0 C-N-CA 123.321 2.681 . . . . 0.0 114.019 -167.251 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -66.79 -46.19 86.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.056 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.55 7.45 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.943 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.321 0.2 OUTLIER 53.77 38.12 27.83 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 178.886 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 69.1 mm-40 -86.28 142.01 28.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.382 173.336 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 48.5 mm -66.45 121.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.575 -176.941 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.68 132.39 43.9 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.402 -177.629 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.404 ' HB2' ' HG3' ' A' ' 55' ' ' GLN . 2.7 mm? -110.58 157.99 19.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.354 177.748 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.65 -38.15 89.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.655 0.74 . . . . 0.0 109.917 -179.473 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -76.72 -6.04 50.55 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.15 -174.006 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HB3' ' CG ' ' A' ' 23' ' ' PRO . 61.7 mt-30 -89.38 -8.07 53.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 0.0 111.413 178.723 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.484 -175.742 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.416 -2.127 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -72.79 108.55 4.58 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.889 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.19 -17.5 45.16 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.528 2.152 . . . . 0.0 112.002 -174.31 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.4 mt -66.13 -43.6 92.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.61 177.527 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -104.81 -16.51 14.89 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -177.706 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 mp 57.87 22.72 8.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.928 0.891 . . . . 0.0 111.569 -176.326 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.452 ' HA ' ' CE ' ' A' ' 14' ' ' MET . 1.8 mmt -94.88 -66.89 0.88 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.529 -178.865 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.78 -169.43 0.12 Allowed 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.975 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.3 mt -97.49 109.36 22.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.898 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -65.48 -45.13 84.87 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.311 -178.823 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -132.72 -14.08 2.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.764 176.344 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.24 92.21 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.602 0.761 . . . . 0.0 112.9 178.167 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.91 117.62 49.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.163 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.31 128.22 33.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.331 -177.584 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -89.32 155.16 49.11 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.872 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.37 -29.55 89.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.504 2.136 . . . . 0.0 113.07 -173.663 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.605 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -76.27 -15.4 60.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.944 0.402 . . . . 0.0 111.923 178.985 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.21 42.45 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.951 174.346 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.605 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 75.3 m-70 -125.62 143.29 51.09 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.524 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 7.5 mpt_? -109.97 135.62 50.53 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.402 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.0 m-85 -133.81 168.08 19.39 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.8 m -75.88 156.65 34.13 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.775 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.1 tttt -68.82 -11.23 60.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.508 -174.697 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.32 -37.56 4.33 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.973 -179.101 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -62.8 -47.28 84.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.813 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -70.11 -41.61 79.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.896 -178.681 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.7 mt -63.55 -42.78 97.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.696 -178.592 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -78.01 -0.94 29.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.482 0.658 . . . . 0.0 110.02 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -105.86 -20.36 13.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.701 174.164 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.64 -21.73 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -176.577 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 12.2 ptp180 -97.57 8.01 45.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.464 171.605 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -116.2 -55.82 2.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.746 -177.94 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.87 -72.64 0.5 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.88 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.46 163.56 37.02 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.987 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.488 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 70.5 m80 -87.93 76.65 8.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.598 0.713 . . . . 0.0 111.909 -176.706 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -159.91 155.32 25.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.848 175.708 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 p -79.07 124.05 84.75 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.702 175.988 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.8 -27.21 75.15 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 122.82 2.347 . . . . 0.0 113.614 -172.851 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.91 -45.34 73.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.444 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -122.47 4.87 9.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.77 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 57.71 34.74 24.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.477 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 148.76 22.78 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.448 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.99 120.67 14.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.952 0.406 . . . . 0.0 110.594 -175.486 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 61.7 tp -121.45 127.98 51.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.154 -176.646 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.17 148.92 29.21 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.529 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.08 -37.33 87.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -175.893 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.0 -29.81 70.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.471 177.381 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.72 -15.11 62.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.076 -179.581 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.742 0.306 . . . . 0.0 110.729 178.65 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.407 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 38.8 t -79.79 109.84 13.55 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.712 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.79 -20.57 71.55 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.525 2.15 . . . . 0.0 112.576 -174.467 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -67.32 -44.7 87.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.684 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.3 p -103.92 -19.3 14.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.462 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp 58.42 23.19 10.34 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.693 0.797 . . . . 0.0 111.563 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.4 mtm -95.28 -64.62 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.158 178.273 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.51 -173.97 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.757 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.22 102.66 14.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 173.184 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.29 -45.06 63.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.053 -179.555 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 18.5 mm-40 -106.43 -17.45 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.815 -175.176 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 44.52 89.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.596 1.159 . . . . 0.0 114.034 -176.716 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.89 121.26 65.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 175.939 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.348 -178.811 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -110.66 151.1 42.6 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.349 174.638 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.9 -24.82 77.51 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.87 2.38 . . . . 0.0 113.634 -178.802 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.7 p -79.32 -15.47 57.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.978 177.77 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 44.8 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.304 173.621 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.453 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 23.8 m-70 -133.33 149.46 51.9 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.708 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -111.45 134.85 52.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.495 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.405 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 96.9 m-85 -136.18 173.15 12.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.718 -178.725 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.7 m -86.89 151.21 23.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.124 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 65.2 tttp -68.42 -11.21 59.35 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 122.999 0.52 . . . . 0.0 111.348 -178.966 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.55 2.64 15.4 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.171 -178.994 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -105.41 -53.8 2.59 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.399 175.25 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -68.17 -38.54 79.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.923 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.559 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.09 -41.61 91.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.069 0.462 . . . . 0.0 110.126 178.326 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 32.1 mmmt -79.18 2.75 19.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -106.37 -25.46 11.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.742 173.669 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.3 pt -104.63 -5.87 9.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.387 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.0 ptm180 -124.61 3.15 8.29 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.546 171.097 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 3.9 m-20 -127.11 -42.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.149 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.41 -65.91 0.97 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.437 0.637 . . . . 0.0 110.755 -178.597 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.52 -148.52 5.42 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.579 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -139.02 31.96 2.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 171.517 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -132.5 161.03 34.79 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.086 -175.065 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.1 t -74.94 122.04 86.6 Favored Pre-proline 0 N--CA 1.43 -1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.13 -31.16 54.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.386 2.057 . . . . 0.0 113.327 -175.167 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.38 -48.57 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.007 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -114.33 6.49 16.1 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.573 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 58.91 31.97 21.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.489 0.716 . . . . 0.0 112.439 177.106 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.76 147.17 26.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.636 178.943 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.0 122.42 16.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.129 0.49 . . . . 0.0 109.974 -178.022 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.5 tp -111.34 131.0 55.5 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.133 -175.114 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -97.76 138.62 34.85 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.075 -178.903 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.77 -38.64 89.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.414 -174.563 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.13 -30.13 70.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.015 0.436 . . . . 0.0 111.189 178.37 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -74.58 -7.14 52.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.57 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.013 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.41 ' HB2' HD21 ' A' ' 16' ' ' LEU . 39.4 t -94.88 108.37 37.43 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 173.853 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.7 -19.48 68.34 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.841 2.361 . . . . 0.0 112.862 -174.599 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.58 -44.13 90.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 178.61 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.5 p -102.79 -13.37 17.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.794 -178.351 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 mp 69.37 23.97 5.98 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.625 0.77 . . . . 0.0 110.425 -179.04 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -128.18 170.07 13.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.38 157.7 13.31 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.428 0.455 . . . . 0.0 110.899 177.853 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 9' ' ' CYS . 86.1 mt -70.09 133.1 46.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.719 -174.859 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 12.8 tpt180 -77.98 -62.86 1.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.087 172.716 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.8 mm-40 -99.18 -18.43 17.66 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.062 -177.545 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 86.98 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.629 -175.539 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -108.8 118.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.508 0.67 . . . . 0.0 111.126 175.133 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.22 139.41 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.18 179.867 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -110.51 155.32 42.27 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.803 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.02 -20.24 63.83 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.703 2.269 . . . . 0.0 111.72 178.769 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.9 t -74.42 -19.47 60.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.876 178.253 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.72 25.98 11.17 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.979 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -113.69 154.04 27.95 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.028 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -117.99 138.43 52.19 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.665 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.7 168.29 20.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.775 0.321 . . . . 0.0 110.581 -178.689 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.611 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.8 m -86.21 148.36 25.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 169.977 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.78 -12.85 61.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.958 -171.514 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -7.92 13.41 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.352 -178.587 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.611 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -85.94 -46.39 10.6 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 170.149 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.601 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -67.78 -43.14 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.859 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.592 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.9 mt -63.46 -42.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 111.221 -177.958 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -78.76 -2.09 37.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 -175.607 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 t -106.16 -25.54 11.96 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.832 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.8 pt -103.77 -15.59 8.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.479 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.3 ptm180 -98.35 2.99 48.57 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.262 173.89 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -115.18 -52.09 2.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.068 -172.123 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.3 -68.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.223 175.671 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.74 165.73 39.1 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.099 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.442 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 62.4 m80 -87.94 80.48 7.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.837 0.827 . . . . 0.0 111.473 -177.776 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -152.7 159.51 43.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.439 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 9.7 m -67.21 127.4 93.47 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.861 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.49 -20.77 70.37 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.736 2.291 . . . . 0.0 112.516 -179.31 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.73 -61.0 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.276 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 43.2 p-10 -103.92 5.29 35.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.033 -0.417 . . . . 0.0 111.128 -174.378 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 56.28 34.55 24.25 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.542 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -90.04 145.65 24.92 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.098 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -65.86 121.58 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 0.0 110.426 -174.252 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 64.9 tp -126.89 129.12 47.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.929 -175.983 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -112.14 152.26 28.52 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -175.539 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.58 -36.15 82.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.302 0.573 . . . . 0.0 111.171 -177.971 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.99 -31.09 72.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.459 176.27 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -78.93 -8.64 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.384 -175.735 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.238 0.456 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.667 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 44.2 tt0 . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.4 t -78.28 108.49 7.8 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.756 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 35.7 Cg_exo -64.48 -19.8 65.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.926 2.417 . . . . 0.0 112.06 -177.123 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.1 -43.86 92.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 -179.352 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.3 p -99.76 -26.0 14.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.272 179.841 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt 64.22 21.65 12.6 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.153 0.981 . . . . 0.0 111.92 179.797 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -100.52 -64.47 1.04 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.936 0.398 . . . . 0.0 111.004 177.884 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.7 -170.07 0.38 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.544 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.03 108.01 20.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.533 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.12 -45.84 75.94 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.019 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -112.45 -16.81 12.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.342 176.425 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.37 62.53 2.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.256 -175.046 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 28' ' ' PHE . 29.1 m -83.18 118.12 30.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.39 -178.492 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -74.51 126.22 30.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.688 178.794 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.1 p -94.68 165.54 17.03 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.085 -177.27 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.83 -34.2 96.22 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.801 2.334 . . . . 0.0 112.062 177.442 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 p -76.62 -15.15 59.9 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.187 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.17 44.0 Favored Glycine 0 CA--C 1.516 0.152 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.936 179.0 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -90.97 167.15 12.62 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.054 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 92.4 mtt180 -130.55 140.24 50.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.001 179.293 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 20' ' ' VAL . 96.9 m-85 -138.7 -177.23 4.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.51 ' O ' HG22 ' A' ' 33' ' ' ILE . 45.6 m -91.12 152.3 20.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.371 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.77 -11.88 61.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.049 0.452 . . . . 0.0 111.131 -176.269 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.45 -10.08 13.25 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.041 -177.448 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -92.66 -56.09 3.14 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.709 177.189 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.576 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -69.03 -40.3 80.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.667 -177.167 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.583 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.0 mt -62.91 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.381 . . . . 0.0 111.851 -178.934 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.14 -3.29 41.71 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.884 0.373 . . . . 0.0 110.49 -175.44 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.9 p -108.18 -19.71 13.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 175.157 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 33' ' ' ILE . 36.4 pt -102.64 -13.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.906 -0.496 . . . . 0.0 112.183 -174.55 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.3 ptp180 -98.0 7.99 45.46 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 167.852 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.09 -54.88 2.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.685 -175.286 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.96 -72.9 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.346 0.593 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.22 167.17 39.69 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.86 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 59.8 m80 -83.38 74.27 10.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.449 0.642 . . . . 0.0 111.992 -176.338 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.7 ptpt -151.7 152.03 32.23 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.267 177.746 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 1.5 p -77.46 135.69 64.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.829 173.982 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.62 -21.88 65.09 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.502 2.134 . . . . 0.0 112.259 -179.09 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -76.43 -74.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.02 4.47 47.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -175.08 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 11.8 m120 56.08 34.55 24.01 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 172.053 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 75.5 mm-40 -93.64 154.07 18.03 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.725 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.57 120.59 14.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.565 0.698 . . . . 0.0 109.988 -175.805 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.46 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 7.8 tt -124.05 121.25 34.7 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.297 -172.341 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.51 141.35 35.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.768 0.318 . . . . 0.0 111.378 -176.453 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.51 -43.02 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.957 -175.066 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -67.29 -30.91 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.261 -177.373 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -78.85 -8.18 58.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.439 -176.953 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 C--N 1.315 -0.915 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.684 179.407 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 120.703 0.287 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.1 t -88.17 108.16 20.21 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.851 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.456 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.8 Cg_exo -62.73 -20.72 71.82 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.684 2.256 . . . . 0.0 113.3 -174.755 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.67 -43.74 90.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.686 178.958 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.59 -7.96 14.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.113 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt 61.73 26.46 16.09 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.503 0.721 . . . . 0.0 110.785 -177.062 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -120.08 169.16 10.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 152.9 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.744 175.481 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.9 mt -69.44 114.25 7.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.937 0.399 . . . . 0.0 110.003 -172.226 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -71.65 -46.56 58.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.779 -177.564 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -114.18 -17.18 11.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.464 178.485 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.45 82.68 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.872 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.43 116.72 53.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.327 0.584 . . . . 0.0 110.994 174.209 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -82.84 133.84 35.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.891 -178.5 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -86.54 160.39 50.82 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.147 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -55.64 -37.76 94.96 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.612 2.208 . . . . 0.0 112.074 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.553 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -67.99 -17.23 64.37 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.649 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.41 41.44 2.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.015 174.069 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.553 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 76.7 m-70 -122.49 143.76 49.5 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.193 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -111.28 137.52 48.91 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.64 175.239 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.5 m-85 -131.65 166.36 21.62 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.428 -178.425 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.626 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.3 m -79.38 149.65 31.61 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.122 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -76.22 -2.95 33.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.788 0.804 . . . . 0.0 111.455 -173.155 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.92 -24.0 9.77 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.113 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.7 m -73.35 -51.11 18.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.276 174.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.499 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -67.23 -39.55 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.926 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.1 mt -62.78 -41.7 93.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.625 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -78.18 -1.78 34.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.94 -176.762 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.5 m -105.86 -21.58 13.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.653 0.263 . . . . 0.0 111.178 173.828 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -102.87 -16.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.343 -175.196 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 ptm180 -99.73 1.13 43.03 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.002 175.467 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -115.49 -54.15 2.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.224 -178.0 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 -66.55 0.89 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.048 0.452 . . . . 0.0 110.48 179.013 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -172.09 161.99 33.99 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 177.218 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.606 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 47.2 m80 -83.18 83.25 7.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.776 0.798 . . . . 0.0 110.473 179.769 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -151.38 157.09 41.98 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.397 -176.987 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 46.3 t -80.9 122.49 82.0 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.915 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.83 -28.86 76.06 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.958 2.439 . . . . 0.0 115.055 -170.548 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.0 m -85.78 -49.93 14.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -173.095 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -106.98 6.61 29.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.801 0.334 . . . . 0.0 111.322 -176.397 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.255 4.5 p-10 50.82 40.19 24.09 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.227 . . . . 0.0 113.736 177.826 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -80.51 149.84 29.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.799 175.064 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.09 120.84 16.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.109 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.606 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.8 tp -124.29 129.33 50.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.709 0.29 . . . . 0.0 111.138 -176.176 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.02 152.51 24.38 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -65.2 -24.19 67.29 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -174.381 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -89.57 5.48 45.4 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.75 179.162 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -84.8 -11.27 56.08 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.017 0.437 . . . . 0.0 110.168 174.063 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.397 -175.989 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 N--CA 1.428 -1.533 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 34.7 t -68.12 115.99 34.47 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.351 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.5 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 35.8 Cg_exo -62.04 -22.49 74.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.171 1.914 . . . . 0.0 113.171 -174.653 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.78 -44.28 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.475 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 8.1 p -97.96 -16.41 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.646 -177.413 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt 54.92 27.08 8.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 109.81 -174.031 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.9 ttm -108.35 -73.96 0.67 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.699 -173.488 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.65 162.75 2.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.015 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.05 104.5 7.57 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.328 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -70.65 -45.65 64.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 177.294 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -114.59 -16.47 11.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.948 -178.027 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.58 82.67 0.08 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.949 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -111.85 117.81 56.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.244 0.545 . . . . 0.0 110.59 175.001 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.34 138.33 35.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.357 -177.914 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.9 p -113.73 156.54 43.51 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.584 -179.011 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.98 -22.0 73.54 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.027 2.485 . . . . 0.0 113.409 -176.17 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.482 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 56.5 m -73.99 -19.25 60.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.643 177.509 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 30.56 7.18 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.169 -175.885 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.482 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 16.5 m-70 -114.0 152.13 31.38 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.078 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -122.64 134.34 54.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.309 171.656 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.5 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 93.0 m-85 -129.97 -177.82 4.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.289 -176.151 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.6 m -99.61 157.89 16.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.999 173.443 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -68.64 -13.39 62.33 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.046 0.451 . . . . 0.0 111.631 -178.209 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 1.93 16.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.863 0.84 . . . . 0.0 109.198 -178.138 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 84.0 m -103.12 -63.32 1.18 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.713 175.935 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.1 -40.63 85.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.528 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.634 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.6 mt -63.47 -42.46 96.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.953 0.406 . . . . 0.0 110.273 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.84 4.95 12.58 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.627 0.727 . . . . 0.0 110.247 -179.289 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.7 t -106.46 -26.44 11.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.738 173.418 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.9 pt -103.77 -19.47 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.968 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -101.01 8.63 42.91 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.771 0.796 . . . . 0.0 109.36 173.8 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.41 -56.61 2.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.871 -174.66 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.33 -68.93 0.77 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.947 177.322 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.1 176.09 45.9 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 178.895 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -79.11 92.66 5.05 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 117.824 0.812 . . . . 0.0 111.478 -179.806 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 18.8 ptpt -169.08 147.46 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.328 0.651 . . . . 0.0 109.526 177.733 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 125.32 71.06 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 170.197 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.01 -25.59 81.77 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.965 2.444 . . . . 0.0 114.661 -167.909 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.98 -44.74 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.099 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -121.48 5.72 10.12 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.193 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 51.21 31.07 6.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.051 1.341 . . . . 0.0 114.24 179.691 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.1 140.11 32.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.509 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.36 120.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.278 0.561 . . . . 0.0 110.198 -176.448 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.9 tt -121.78 131.99 54.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.255 -173.46 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.429 HD11 ' NE2' ' A' ' 55' ' ' GLN . 8.3 mp -111.41 153.1 26.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.445 -178.01 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -61.69 -34.43 75.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.265 0.626 . . . . 0.0 111.461 -177.671 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -74.59 -11.47 60.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.11 0.481 . . . . 0.0 111.29 -178.018 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 52' ' ' LEU . 80.8 mt-30 -87.61 -10.63 50.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.841 177.9 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 177.52 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.188 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -60.44 143.76 99.48 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.389 2.059 . . . . 0.0 111.129 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.52 123.89 46.3 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.84 81.75 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.275 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.7 m -76.25 141.45 41.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.848 0.356 . . . . 0.0 111.457 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.35 102.34 5.92 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 48.7 76.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.56 0.695 . . . . 0.0 110.88 -170.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -134.46 149.7 50.76 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.741 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 54.0 t -88.7 110.13 34.89 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.47 -17.86 53.92 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.848 2.365 . . . . 0.0 111.952 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.442 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -65.8 -43.99 93.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.754 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -115.0 -8.24 12.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.542 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.5 mt 56.68 34.82 25.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.845 0.858 . . . . 0.0 110.914 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -118.16 164.06 15.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.714 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.57 32.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.917 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.48 119.58 13.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.031 0.443 . . . . 0.0 111.008 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.478 ' C ' ' H ' ' A' ' 19' ' ' ALA . 28.2 tpt180 -91.37 115.61 28.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.252 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 69.23 -16.23 0.25 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.553 1.141 . . . . 0.0 113.026 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 47.72 91.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.026 1.33 . . . . 0.0 113.569 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -101.83 116.73 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.319 0.58 . . . . 0.0 110.735 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.41 134.22 35.52 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.082 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -87.92 160.71 46.07 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.781 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.87 -17.96 62.31 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 122.39 2.06 . . . . 0.0 111.014 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.82 -21.43 63.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.411 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.91 2.08 58.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.417 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -97.54 136.39 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -102.54 135.34 44.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.98 166.61 22.31 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.9 m -65.74 150.11 49.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.06 -10.61 51.71 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.502 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.12 -38.13 3.68 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.559 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 36.6 m -61.77 -45.12 95.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.692 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -66.94 -39.34 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.57 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -62.97 -42.87 98.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.063 0.459 . . . . 0.0 110.509 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -78.61 -1.48 34.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.479 0.657 . . . . 0.0 110.374 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -105.84 -19.69 13.67 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.997 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -102.98 -26.16 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.0 ptm180 -103.02 8.55 38.87 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.795 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -115.28 -53.84 2.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.95 -66.68 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.22 0.533 . . . . 0.0 110.2 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.82 161.71 35.04 Favored Glycine 0 CA--C 1.497 -1.032 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -80.86 81.08 7.21 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 117.206 0.503 . . . . 0.0 112.197 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.2 ptpt -151.3 154.8 37.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.479 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.4 p -83.36 125.67 73.61 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.94 -27.33 84.63 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.636 2.224 . . . . 0.0 114.313 -170.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.15 -49.49 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.941 0.4 . . . . 0.0 111.864 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.91 6.39 4.29 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.85 37.85 21.58 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.46 147.04 28.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.77 121.33 15.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -125.63 127.14 45.84 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.838 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.35 151.93 29.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.13 -39.44 86.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.535 0.334 . . . . 0.0 111.148 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -75.38 -15.21 60.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.772 0.32 . . . . 0.0 111.6 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -83.08 -14.87 52.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.8 mt -76.06 133.85 40.22 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.02 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -130.97 124.89 20.92 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.325 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.59 136.53 74.68 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 121.928 1.752 . . . . 0.0 110.367 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.73 136.67 41.77 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.305 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.24 104.08 16.69 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.675 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -97.51 8.59 44.35 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.566 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.44 2.62 47.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.395 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.595 ' O ' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.3 150.56 42.03 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.71 2.273 . . . . 0.0 111.855 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.67 -47.1 85.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.668 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 53.47 -127.84 37.66 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.22 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -136.36 120.69 18.0 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -126.52 174.24 8.8 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.917 0.389 . . . . 0.0 111.319 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.619 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 98.4 m-85 -106.54 29.48 6.86 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.938 0.875 . . . . 0.0 110.211 -174.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -96.48 136.7 36.62 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.897 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.2 t -86.49 107.59 14.31 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.41 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -63.16 -20.76 71.7 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.644 2.229 . . . . 0.0 113.251 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.0 -43.69 92.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.861 0.363 . . . . 0.0 111.018 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.0 p -101.15 -21.23 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.791 0.329 . . . . 0.0 111.488 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 60.27 22.35 11.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.977 0.911 . . . . 0.0 111.94 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -99.14 -71.65 0.69 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.808 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.13 -169.87 0.58 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 98.2 mt -97.0 107.98 20.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.764 0.316 . . . . 0.0 110.375 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -64.99 -49.66 69.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.695 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -116.11 -16.09 11.05 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.643 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.84 76.07 0.21 Allowed 'General case' 0 N--CA 1.462 0.139 0 O-C-N 123.862 0.726 . . . . 0.0 111.959 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.05 116.98 49.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.266 0.555 . . . . 0.0 110.919 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -71.8 125.89 28.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.933 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 p -89.66 158.76 44.88 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.44 -22.53 65.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.223 1.949 . . . . 0.0 113.56 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.57 -46.29 26.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.018 0.437 . . . . 0.0 110.966 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.68 48.94 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.346 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -139.92 163.17 33.37 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -124.86 137.6 54.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.08 0.467 . . . . 0.0 110.293 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.41 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.5 168.98 18.23 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.064 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 48.4 m -79.96 147.04 31.76 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HD3' ' HB3' ' A' ' 59' ' ' ASP . 63.6 tttm -74.72 -3.58 32.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.256 0.55 . . . . 0.0 111.409 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.51 -18.57 12.38 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.957 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 43.9 m -85.07 -48.03 9.6 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.285 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.535 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.73 -42.27 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.406 ' HA ' HG12 ' A' ' 37' ' ' ILE . 84.8 mt -63.48 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 111.633 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -77.25 -2.04 32.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 m -106.68 -24.21 12.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.8 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 33' ' ' ILE . 47.8 pt -105.1 -21.77 5.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -79.04 -15.45 58.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.887 -174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.16 -53.74 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.771 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.21 -65.34 0.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.562 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.43 139.65 5.49 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.866 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 71.3 m80 -79.55 67.05 5.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.698 0.761 . . . . 0.0 111.706 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -150.85 155.8 39.93 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.197 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 51' ' ' LEU . 35.3 m -64.54 129.61 94.32 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.91 -21.81 56.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.989 1.793 . . . . 0.0 111.001 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.35 -74.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.553 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.14 4.52 53.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 54.61 32.99 18.21 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -88.39 155.26 19.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.73 117.39 6.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.495 HD12 ' SG ' ' A' ' 44' ' ' CYS . 7.8 tt -124.28 121.43 35.01 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.423 HD13 ' NE2' ' A' ' 55' ' ' GLN . 79.3 mt -111.36 145.22 39.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.255 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.39 -36.38 83.96 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.915 0.886 . . . . 0.0 110.466 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -64.79 -32.02 73.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.57 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.423 ' NE2' HD13 ' A' ' 52' ' ' LEU . 82.0 mt-30 -89.09 -8.64 53.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.41 141.16 41.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.759 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -72.71 144.85 86.37 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.639 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -60.21 146.04 97.22 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 122.767 2.311 . . . . 0.0 111.392 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' HB3' ' HD3' ' A' ' 30' ' ' LYS . 2.6 p30 -86.09 -176.12 5.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.282 0.563 . . . . 0.0 112.153 -175.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -102.3 14.35 32.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.791 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -140.73 150.2 43.13 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.937 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.72 -33.91 21.37 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HZ1' ' HB3' ' A' ' 63' ' ' LYS . 5.0 ttpm? . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.527 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -63.05 148.02 93.81 Favored 'Trans proline' 0 CA--C 1.515 -0.457 0 C-N-CA 123.211 2.607 . . . . 0.0 111.512 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -84.35 128.58 34.66 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.7 -154.72 32.81 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.941 -175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.7 m -72.95 146.65 45.89 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.698 0.285 . . . . 0.0 110.83 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 8' ' ' GLU . 62.5 tttp -86.69 125.51 33.92 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.44 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 97.0 m-85 -109.11 12.76 24.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.894 0.854 . . . . 0.0 110.253 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.499 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 42.1 tt0 -105.39 124.23 49.19 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.829 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.5 t -84.21 107.69 11.68 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.71 -18.46 47.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.423 2.082 . . . . 0.0 112.52 -174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.18 -43.58 91.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.292 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -100.53 -27.31 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.26 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.4 mt 63.89 23.09 13.25 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.778 0.831 . . . . 0.0 111.608 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.2 mtm -96.08 -71.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.497 0.665 . . . . 0.0 109.371 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.77 -158.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 91.7 mt -98.95 104.76 16.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -68.63 -43.85 75.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.983 0.421 . . . . 0.0 110.747 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 63.2 mm-40 -119.21 -15.99 9.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.641 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.76 81.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.795 0.684 . . . . 0.0 112.278 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.42 115.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.806 0.812 . . . . 0.0 110.787 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.61 129.05 34.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.375 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -101.05 154.47 37.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -22.11 70.24 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.639 2.226 . . . . 0.0 112.094 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.06 -14.65 60.61 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.647 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.96 25.67 16.64 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.032 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -113.01 152.9 28.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -131.1 122.28 26.42 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.82 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -130.12 -169.54 2.15 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.96 0.409 . . . . 0.0 110.861 -172.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.602 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -99.54 155.38 17.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.8 172.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.0 tttt -68.13 -12.57 61.13 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.239 0.616 . . . . 0.0 111.641 -176.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.96 -24.26 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.308 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 45.5 m -76.88 -51.37 11.37 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.322 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.59 -41.28 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.851 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 30' ' ' LYS . 82.5 mt -63.08 -43.31 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -79.86 -1.98 41.48 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.484 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -106.45 -8.94 16.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.691 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 33' ' ' ILE . 41.3 pt -117.43 -8.18 11.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -93.96 -15.3 25.04 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.702 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -116.61 -46.71 2.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.134 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.48 -65.98 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 110.308 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.43 160.01 23.45 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.433 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 65.1 m80 -86.21 77.48 9.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.377 0.608 . . . . 0.0 111.333 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -150.39 148.95 29.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.228 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -79.52 123.7 84.17 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.61 -27.5 76.34 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 123.136 2.558 . . . . 0.0 115.097 -166.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -67.56 -46.14 83.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -119.31 4.3 11.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.286 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 56.42 33.94 23.34 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 113.211 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -87.82 150.13 23.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.29 120.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.271 0.557 . . . . 0.0 110.558 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -125.56 121.81 34.72 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.361 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.62 148.66 23.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.662 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.24 -41.57 96.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.235 0.541 . . . . 0.0 110.007 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -65.11 -29.55 70.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.562 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -73.95 -7.64 53.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.48 136.04 52.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -119.15 148.39 44.92 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.53 150.36 87.86 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.251 1.967 . . . . 0.0 109.538 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.13 122.23 11.24 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -95.58 5.3 51.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -62.1 -46.42 89.14 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 119.896 -0.721 . . . . 0.0 109.226 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.61 129.08 50.62 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 tptm . . . . . 0 C--N 1.305 -1.363 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.739 -172.154 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.12 143.34 99.55 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.581 2.188 . . . . 0.0 110.548 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp 71.55 -48.92 0.68 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.302 1.041 . . . . 0.0 111.15 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.33 -168.08 41.2 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.2 m -100.38 87.1 3.32 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.277 0.561 . . . . 0.0 110.559 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HG2' ' CD2' ' A' ' 7' ' ' TYR . 8.2 ttpm? -111.16 130.68 55.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CD2' ' HG2' ' A' ' 6' ' ' LYS . 75.1 m-85 60.2 24.22 13.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.219 1.009 . . . . 0.0 110.327 -171.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -138.26 124.96 20.91 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 113.852 -1.522 . . . . 0.0 106.947 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.9 t -59.91 115.64 13.77 Favored Pre-proline 0 C--N 1.317 -0.818 0 C-N-CA 123.699 0.799 . . . . 0.0 111.25 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -62.42 -20.16 69.57 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.85 2.367 . . . . 0.0 112.739 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.432 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.7 mt -67.32 -44.39 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 111.599 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -110.9 -27.54 8.77 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 62.09 23.39 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.856 0.863 . . . . 0.0 112.159 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -95.64 -65.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.875 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.96 -172.12 1.49 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.643 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 97.1 mt -108.5 122.61 47.42 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -68.67 -44.18 74.57 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.55 -11.9 2.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.14 81.71 0.18 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.129 0.49 . . . . 0.0 111.906 -175.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 116.21 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.656 0.741 . . . . 0.0 111.19 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -81.64 134.8 35.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.343 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.76 162.24 33.88 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.73 -33.11 96.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.021 2.48 . . . . 0.0 112.1 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -72.55 -15.07 61.77 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.205 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.95 34.74 5.82 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.648 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -116.47 152.93 33.05 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -124.74 121.8 35.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.21 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.42 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 81.1 m-85 -131.04 173.55 10.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.943 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 16' ' ' LEU . 62.2 m -84.12 147.95 27.06 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.06 7.69 5.8 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.0 0.905 . . . . 0.0 110.523 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.92 -32.14 5.87 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.38 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 48.5 m -78.3 -46.07 21.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.203 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -66.01 -41.52 89.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.249 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.553 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.0 mt -63.54 -42.51 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.365 . . . . 0.0 110.859 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.61 -1.54 34.66 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.336 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -105.64 -21.29 13.23 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.942 -0.474 . . . . 0.0 110.037 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.4 pt -103.53 -20.36 5.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.9 ptm180 -105.74 3.19 28.63 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.665 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -118.75 -55.5 2.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.15 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.8 -79.08 0.4 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -140.06 138.19 8.93 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 9.3 t-80 -80.48 53.73 1.9 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.888 0.851 . . . . 0.0 110.879 -174.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.41 157.73 43.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.109 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.67 123.65 83.96 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.46 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.85 -25.34 74.48 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.022 2.482 . . . . 0.0 114.601 -171.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.95 -49.1 77.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.62 5.81 11.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.4 34.25 24.41 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -101.08 151.05 22.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.678 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.72 121.91 16.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 121.214 0.53 . . . . 0.0 110.79 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.88 124.75 53.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.241 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HB2' ' CG ' ' A' ' 55' ' ' GLN . 2.7 mm? -105.35 140.25 38.76 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.44 -38.16 83.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 111.155 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -72.91 -15.45 61.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.29 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.437 ' CG ' ' HB2' ' A' ' 52' ' ' LEU . 15.5 mm100 -84.31 -7.53 59.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.86 137.99 55.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.719 0.295 . . . . 0.0 110.383 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -118.98 104.21 46.9 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.982 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.39 143.36 99.47 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.562 2.175 . . . . 0.0 111.302 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -113.72 144.74 42.44 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.962 0.411 . . . . 0.0 110.22 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.4 p30 -95.54 5.85 50.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.849 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.17 -47.29 86.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.692 0.282 . . . . 0.0 110.877 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.6 152.47 34.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 111.824 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm . . . . . 0 C--O 1.244 0.791 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.609 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.45 -28.81 71.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.942 2.428 . . . . 0.0 113.349 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.8 mt -113.08 134.43 54.54 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.7 106.69 1.88 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -93.6 115.41 27.89 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -170.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -66.74 -38.21 86.2 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 167.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -88.59 88.13 7.5 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.491 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.0 tt0 -150.97 142.92 23.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 50.9 t -89.79 107.98 22.52 Favored Pre-proline 0 N--CA 1.438 -1.063 0 O-C-N 123.798 0.686 . . . . 0.0 109.376 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 31.8 Cg_exo -63.43 -18.44 64.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.479 2.786 . . . . 0.0 111.951 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.435 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.22 -43.78 91.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.049 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 p -107.9 -22.76 12.31 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 64.02 21.22 12.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.213 0.605 . . . . 0.0 112.299 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.478 ' HA ' ' HE2' ' A' ' 14' ' ' MET . 9.4 mmt -95.81 -68.36 0.8 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.421 0.629 . . . . 0.0 109.739 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.47 -159.11 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.1 128.94 55.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -76.35 -73.29 0.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.304 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.51 -15.21 25.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.42 84.3 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.951 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.85 117.63 49.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.455 0.645 . . . . 0.0 111.033 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.68 133.53 36.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.099 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 71.9 p -88.9 162.33 38.54 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 27.7 Cg_endo -60.16 -28.82 87.74 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.478 2.118 . . . . 0.0 112.937 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.6 p -72.09 -30.57 65.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 111.152 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.1 29.74 2.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.812 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -117.75 157.56 26.32 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -125.51 139.24 53.79 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.295 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.447 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.86 171.53 14.33 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.187 0.995 . . . . 0.0 108.605 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.536 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -78.32 150.55 33.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -70.81 -8.06 49.74 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.464 0.705 . . . . 0.0 111.609 -172.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.67 -34.13 5.29 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.507 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 61.5 m -65.66 -46.48 78.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.796 0.331 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.508 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.29 -41.26 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.553 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.405 ' HA ' HG12 ' A' ' 37' ' ' ILE . 94.0 mt -63.19 -41.95 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.427 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -78.12 -3.18 41.11 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.539 0.685 . . . . 0.0 109.673 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 m -106.95 -20.4 13.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.201 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 33' ' ' ILE . 38.5 pt -104.31 -8.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.52 -3.36 46.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -116.46 -56.02 2.33 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.341 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.09 -67.26 0.75 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.28 166.93 37.8 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 72.2 m80 -91.13 76.9 6.06 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.917 0.865 . . . . 0.0 111.651 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.75 157.53 42.12 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.83 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.5 p -77.83 132.74 67.23 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.741 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.02 -25.49 73.75 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.665 2.244 . . . . 0.0 113.749 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.36 -59.96 2.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.56 3.86 27.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.9 m120 55.26 34.03 21.91 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -78.75 151.45 32.04 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.347 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.98 121.03 15.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 7.8 tt -110.02 125.73 53.22 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.357 0.599 . . . . 0.0 110.593 -170.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.97 135.52 45.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.623 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -64.97 -38.7 91.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.924 0.392 . . . . 0.0 110.657 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -65.06 -31.5 72.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.231 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -81.53 -9.08 59.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.88 116.62 10.46 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.5 t80 68.35 121.18 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.361 0 O-C-N 124.163 0.914 . . . . 0.0 109.449 -172.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.04 133.26 56.99 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 121.982 1.788 . . . . 0.0 110.971 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.43 112.86 22.6 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.829 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -98.06 140.82 31.82 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -60.24 -45.36 93.49 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 123.466 0.479 . . . . 0.0 111.16 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.46 111.88 23.62 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.967 0.413 . . . . 0.0 110.509 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.2 tptp . . . . . 0 C--N 1.308 -1.231 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.38 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.05 141.27 88.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.607 2.204 . . . . 0.0 110.992 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.5 tp -64.18 -45.27 89.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.001 0.429 . . . . 0.0 110.684 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.84 -159.37 46.24 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.7 m -79.79 153.49 29.13 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -80.61 83.24 6.44 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.31 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.748 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 92.5 m-85 -122.47 28.47 7.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.295 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -104.81 125.81 51.25 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.863 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.1 t -79.33 113.17 34.29 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.08 -19.91 70.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.951 2.434 . . . . 0.0 113.182 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.03 -44.62 88.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 14' ' ' MET . 14.4 p -104.13 -19.95 13.99 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 64.28 20.57 12.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.791 0.836 . . . . 0.0 111.219 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.417 ' HE2' ' HB2' ' A' ' 12' ' ' CYS . 78.1 mtm -102.5 -73.78 0.65 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.107 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.34 -173.24 1.42 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 93.6 mt -97.55 107.32 19.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -68.36 -45.13 73.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.159 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 70.5 mm-40 -113.02 -16.01 12.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.299 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.75 81.79 0.14 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.998 0.811 . . . . 0.0 113.06 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -120.08 111.99 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.781 0.8 . . . . 0.0 111.616 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -81.55 132.95 35.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.807 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 p -94.23 159.35 34.25 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.605 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.0 -39.46 90.82 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.446 2.764 . . . . 0.0 113.003 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.676 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.6 p -71.96 -15.43 62.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 35.95 3.67 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.728 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.676 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 72.3 m-70 -119.34 148.18 43.48 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.0 129.07 56.62 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.002 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -134.38 169.87 16.58 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.9 m -87.4 147.69 25.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.474 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 23.8 ttpp -78.5 -2.28 37.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.143 0.497 . . . . 0.0 111.716 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.64 -10.95 13.05 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.029 -0.419 . . . . 0.0 110.012 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.9 m -89.03 -48.21 7.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.525 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.6 -41.78 83.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.09 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.658 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.2 mt -63.5 -42.53 96.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.547 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.23 -1.5 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.45 0.643 . . . . 0.0 109.997 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.1 t -105.8 -22.78 12.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 33' ' ' ILE . 43.7 pt -102.9 -12.14 8.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 40.5 ptt85 -99.68 3.43 45.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.702 0.763 . . . . 0.0 109.306 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -116.68 -46.65 2.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.648 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.59 -66.9 0.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.256 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -175.52 167.32 39.19 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 63.0 m80 -84.33 67.18 9.74 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.895 0.855 . . . . 0.0 111.906 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -151.09 150.32 30.55 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.584 -1.189 . . . . 0.0 107.888 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.9 p -71.54 123.41 89.35 Favored Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.73 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.64 -25.21 75.19 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.644 2.229 . . . . 0.0 113.27 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG21 ' OD1' ' A' ' 47' ' ' ASP . 27.1 m -73.09 -33.0 41.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.443 ' OD1' HG21 ' A' ' 46' ' ' VAL . 15.0 p-10 -141.74 6.48 1.83 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 58.15 35.42 25.05 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.6 mm-40 -92.7 142.67 27.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -65.95 121.47 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 111.142 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.3 tp -122.68 131.78 53.96 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.513 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.484 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -106.68 150.97 25.71 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.68 -34.88 78.84 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.43 0.34 55.64 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.3 mm100 -77.72 -16.27 58.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.824 0.821 . . . . 0.0 109.344 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.31 161.02 29.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.459 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.254 19.4 p90 66.01 135.43 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 125.908 1.683 . . . . 0.0 115.069 172.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.39 141.16 80.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.098 1.865 . . . . 0.0 109.628 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 61' ' ' PHE . 4.3 p-10 -78.68 153.89 30.59 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 75.33 -22.29 0.27 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.49 0.716 . . . . 0.0 111.043 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 59' ' ' ASP . 91.5 t80 -61.07 -47.52 85.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.58 0.752 . . . . 0.0 111.666 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.88 78.46 1.12 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.715 0.769 . . . . 0.0 109.564 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? . . . . . 0 C--N 1.301 -1.537 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -177.199 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.841 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.61 147.31 76.06 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.388 2.059 . . . . 0.0 111.962 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 tt -112.41 123.22 49.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.89 -46.5 0.02 OUTLIER Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.371 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.3 m -95.74 37.34 1.22 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.184 0.516 . . . . 0.0 109.863 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -79.45 111.15 15.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.05 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 93.8 m-85 -113.87 10.31 17.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.641 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -101.3 120.3 40.05 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.504 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB2' HD21 ' A' ' 16' ' ' LEU . 49.7 t -70.56 111.02 8.12 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.79 -19.73 52.84 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.195 1.93 . . . . 0.0 113.049 -172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.15 -44.68 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.031 0.443 . . . . 0.0 111.808 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.0 p -108.14 -20.16 13.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.773 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt 69.51 22.83 6.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.279 1.032 . . . . 0.0 110.885 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -112.38 169.56 8.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.944 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 154.72 27.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 88.8 mt -71.08 119.17 14.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -176.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -75.46 -47.65 26.27 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.843 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -113.85 -16.34 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.775 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.3 58.93 4.98 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.89 0.876 . . . . 0.0 112.981 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.34 115.68 27.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.442 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 27' ' ' ARG . 60.4 tt0 -81.61 135.35 35.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.897 -177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -96.86 158.25 33.77 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.61 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.9 -23.19 74.22 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.862 2.375 . . . . 0.0 112.894 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.0 p -72.44 -28.13 62.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.91 40.72 1.05 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.491 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 59.9 m80 -127.07 160.74 30.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.674 0.273 . . . . 0.0 110.773 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 21' ' ' GLN . 31.5 mmt180 -125.6 136.59 53.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.4 m-85 -137.72 164.57 28.53 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.406 0.441 . . . . 0.0 110.012 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.66 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -85.45 157.52 20.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.512 ' HZ1' ' CG ' ' A' ' 59' ' ' ASP . 87.2 tttt -68.47 -15.2 63.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -1.3 14.19 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.194 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 42.7 m -94.98 -54.2 3.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.893 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.425 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.44 -41.14 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.988 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.4 mt -63.23 -42.59 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.682 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -77.68 -1.28 30.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.385 0.612 . . . . 0.0 109.87 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -105.86 -19.98 13.58 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 122.018 -0.426 . . . . 0.0 109.958 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -103.79 -15.16 8.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.47 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -104.88 0.81 28.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.348 0.594 . . . . 0.0 110.498 173.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -116.97 -49.81 2.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.512 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.56 -66.23 0.94 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.518 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -177.86 162.16 29.68 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.33 81.68 3.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 111.176 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -173.71 155.63 2.72 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 4.9 p -76.47 126.06 86.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.275 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.96 -29.42 81.96 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.787 2.325 . . . . 0.0 114.726 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -77.16 -57.54 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -102.56 5.3 39.24 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 49.71 43.2 24.39 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 71.6 mm-40 -90.73 142.82 27.36 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.66 120.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.198 0.523 . . . . 0.0 109.876 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -124.36 130.72 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.158 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -107.64 152.51 24.21 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.87 -36.4 83.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.918 0.39 . . . . 0.0 111.551 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -69.58 -17.78 63.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.902 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.1 mm100 -68.32 -25.51 65.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.896 0.379 . . . . 0.0 111.463 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.67 148.68 47.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.896 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -60.83 158.98 29.28 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -60.02 146.92 94.89 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.796 2.331 . . . . 0.0 110.873 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.512 ' CG ' ' HZ1' ' A' ' 30' ' ' LYS . 24.6 t0 -78.1 112.07 14.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.728 -170.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -65.41 -41.12 93.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.502 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -111.76 106.95 15.87 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.115 0.483 . . . . 0.0 111.162 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.12 102.96 8.66 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.584 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 tttm . . . . . 0 C--N 1.312 -1.03 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.295 -177.477 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.89 144.49 99.58 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.661 2.241 . . . . 0.0 111.867 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.6 tp -111.47 112.94 25.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.22 -55.01 3.59 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.2 m -153.03 165.45 35.56 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -111.56 152.86 27.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.236 0.541 . . . . 0.0 111.222 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.472 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 97.3 m-85 -108.23 19.85 19.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.861 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -101.36 127.13 48.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.46 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.556 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.4 t -72.95 114.86 34.62 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.64 -19.22 54.17 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.221 1.948 . . . . 0.0 113.875 -170.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.12 -44.78 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.245 0.545 . . . . 0.0 112.057 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 6.7 p -108.46 -17.38 14.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 63.18 46.25 4.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.696 0.76 . . . . 0.0 111.076 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.493 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 23.9 ptp -144.4 176.44 9.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.709 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.19 46.78 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.179 0.299 . . . . 0.0 111.005 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.581 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 65.8 mt -70.31 129.42 39.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.713 -174.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -71.27 -46.46 60.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -113.96 -15.2 12.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.254 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.26 87.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.903 0.752 . . . . 0.0 112.727 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.22 118.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.074 0.464 . . . . 0.0 111.295 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.42 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 37.1 tt0 -79.76 139.31 37.32 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.12 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -97.69 159.41 31.08 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.73 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.56 -25.16 80.12 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.157 2.571 . . . . 0.0 114.101 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.8 p -87.53 -14.76 39.42 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.495 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.44 36.3 2.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.119 -1.039 . . . . 0.0 114.483 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.422 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 79.9 m-70 -117.97 152.93 34.51 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -108.57 132.98 53.32 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.29 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.5 165.2 26.06 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.156 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.6 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 35.3 m -79.13 154.27 29.47 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 167.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.27 -11.29 60.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.473 0.654 . . . . 0.0 110.707 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 2.73 15.74 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.225 0.536 . . . . 0.0 109.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 74.2 m -98.08 -56.87 2.36 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.255 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.466 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -67.95 -41.25 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.482 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.5 mt -62.61 -42.21 95.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 111.011 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -78.32 -1.39 32.98 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.526 0.679 . . . . 0.0 110.741 -177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 m -106.04 -21.76 13.05 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.965 -0.459 . . . . 0.0 111.135 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 33' ' ' ILE . 33.3 pt -104.26 -9.62 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptp180 -101.5 2.85 39.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.209 0.528 . . . . 0.0 111.101 172.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -115.91 -47.22 2.8 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.573 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -75.07 0.35 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.719 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.3 169.6 42.19 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.458 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 65.4 m80 -83.97 69.03 10.24 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.65 0.725 . . . . 0.0 112.38 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -152.04 151.23 30.87 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.0 p -83.51 146.14 49.59 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.703 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.71 -18.52 58.69 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.703 2.269 . . . . 0.0 112.526 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.74 -74.31 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -106.73 4.57 27.84 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.901 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 57.59 29.06 16.57 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -78.17 147.25 34.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.31 121.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.317 0.58 . . . . 0.0 109.846 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 6.8 tt -117.05 120.5 38.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.735 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.44 143.14 32.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.248 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.99 -40.57 91.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.103 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.36 -29.96 67.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.995 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -73.22 -8.61 56.56 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.17 137.87 57.9 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' HD1' ' O ' ' A' ' 21' ' ' GLN . 50.8 m-85 -62.94 134.61 95.76 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -61.11 142.2 96.25 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 C-N-CA 122.686 2.257 . . . . 0.0 114.376 -160.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -119.8 109.87 16.1 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.135 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -103.49 134.31 47.06 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.095 0.474 . . . . 0.0 110.789 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -151.78 160.62 43.51 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.32 110.81 9.72 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 120.963 0.411 . . . . 0.0 110.432 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.106 -178.516 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.113 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.41 150.8 64.78 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 123.003 2.469 . . . . 0.0 112.536 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.8 tt -109.26 125.26 52.09 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.0 -143.45 7.69 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.805 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 p -65.23 -33.77 76.77 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.507 0.723 . . . . 0.0 112.546 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -70.28 133.44 47.01 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -92.2 126.64 37.37 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.23 0.538 . . . . 0.0 111.29 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 99.7 mt-10 -131.74 157.13 44.62 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.7 t -82.62 107.31 8.74 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.674 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 41.9 Cg_exo -60.32 -21.06 65.63 Favored 'Trans proline' 0 N--CA 1.475 0.391 0 C-N-CA 122.965 2.443 . . . . 0.0 113.185 -172.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.28 -44.16 91.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HB2' ' HE2' ' A' ' 14' ' ' MET . 8.2 p -112.74 -9.11 13.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 55.56 37.05 28.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.696 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.42 ' HE2' ' HB2' ' A' ' 12' ' ' CYS . 76.3 mtm -121.34 168.54 11.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.625 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.5 154.79 19.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.29 123.95 22.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.614 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -69.63 -44.18 71.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.846 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -126.44 -17.14 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.962 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.81 81.7 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 m -105.83 117.51 51.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.862 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -81.59 131.78 35.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -90.16 152.43 45.97 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.11 -22.49 73.22 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.433 2.088 . . . . 0.0 112.376 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.747 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 30.9 p -79.82 -17.29 53.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.702 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.43 40.67 1.59 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.361 -0.924 . . . . 0.0 113.907 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.747 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 95.0 m-70 -133.28 161.37 34.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -128.32 137.74 52.08 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.4 m-85 -137.78 170.43 16.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.078 0.466 . . . . 0.0 111.357 -173.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 21.0 m -76.74 160.18 29.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' O ' HD12 ' A' ' 34' ' ' ILE . 23.1 tptm -71.16 -15.35 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.707 0.289 . . . . 0.0 111.291 -171.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.33 -1.47 12.31 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.519 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 75.1 m -88.26 -65.06 1.06 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.491 ' HB ' ' CG ' ' A' ' 28' ' ' PHE . 11.1 tp -67.78 -38.89 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.2 mt -62.54 -42.84 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.96 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -78.82 -2.02 37.68 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.464 0.65 . . . . 0.0 110.5 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -105.4 -23.24 12.87 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.72 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.7 pt -102.92 -14.14 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.932 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.8 ptm180 -102.32 1.61 35.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.746 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.57 -56.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.0 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.04 -68.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.276 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -151.59 147.39 17.21 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -84.63 34.09 0.53 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.783 0.801 . . . . 0.0 111.121 -171.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -144.14 154.94 43.69 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.44 ' HB3' HD13 ' A' ' 51' ' ' LEU . 25.8 p -64.29 130.06 94.41 Favored Pre-proline 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.078 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.2 -18.94 62.4 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.442 2.094 . . . . 0.0 111.379 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.79 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.104 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -117.37 15.93 14.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 63.69 35.09 11.69 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.628 ' OE1' ' HB2' ' A' ' 24' ' ' CYS . 57.9 mt-10 -89.86 139.56 30.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 mm -66.56 122.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.099 0.476 . . . . 0.0 111.313 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.639 HD23 ' SG ' ' A' ' 24' ' ' CYS . 77.1 mt -112.69 128.98 56.55 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.058 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.2 133.37 50.08 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -61.42 -38.04 85.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -74.72 -13.33 60.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.507 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.62 -9.07 55.32 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -73.32 136.13 44.44 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -80.78 121.54 81.15 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.85 155.55 68.74 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.347 2.032 . . . . 0.0 111.705 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -47.54 104.46 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.226 0.954 . . . . 0.0 111.78 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -101.32 -17.6 16.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.183 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -86.29 131.03 34.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.273 0.558 . . . . 0.0 111.222 -172.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.82 138.77 35.48 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.994 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.6 pttt . . . . . 0 C--N 1.298 -1.656 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.76 -176.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.719 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.51 158.78 43.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.847 2.365 . . . . 0.0 111.373 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.53 127.25 45.6 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.35 -123.07 2.54 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -132.48 145.78 51.43 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -92.74 -7.51 46.42 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 171.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.403 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 95.1 m-85 -83.69 38.22 0.62 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.692 170.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -122.98 128.15 49.82 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.244 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 t -76.43 112.1 19.49 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.6 Cg_exo -61.02 -19.4 62.9 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.027 2.484 . . . . 0.0 113.222 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.91 -43.98 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.45 -25.55 10.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp 66.22 23.68 10.84 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.886 0.874 . . . . 0.0 112.087 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -93.54 -67.41 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.587 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.96 -167.72 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 93.6 mt -98.69 106.27 18.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -68.92 -43.83 74.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 0.0 110.377 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 66.8 mm-40 -124.01 -15.16 6.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.101 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.43 83.16 0.05 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.853 0.861 . . . . 0.0 113.301 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.36 118.88 59.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 0.0 111.06 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 52.3 tt0 -80.65 128.42 33.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 51.2 p -80.93 164.69 49.54 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 25.3 Cg_endo -59.94 -28.03 86.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.551 2.168 . . . . 0.0 112.331 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.486 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.5 p -79.9 -15.69 56.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.804 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.59 45.78 2.44 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.392 -0.909 . . . . 0.0 114.325 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.486 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 89.0 m-70 -120.58 154.25 35.66 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -105.1 124.76 50.09 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 123.315 0.384 . . . . 0.0 110.325 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.462 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 92.4 m-85 -134.66 170.39 15.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.088 0.555 . . . . 0.0 110.105 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 40.0 m -85.32 150.15 24.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.416 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 62.5 tttp -68.39 -11.55 59.79 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.871 0.469 . . . . 0.0 111.136 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.18 -14.28 13.4 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.881 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.8 m -87.12 -46.57 9.66 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.896 174.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -68.17 -42.01 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.734 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.628 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.8 mt -63.5 -42.54 96.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 0.0 110.468 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.8 7.67 6.67 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.805 0.812 . . . . 0.0 110.342 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.9 t -106.83 -27.35 10.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.941 -0.475 . . . . 0.0 109.936 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 37.5 pt -104.37 -16.83 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.628 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -98.59 4.78 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -115.59 -56.56 2.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.728 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.9 -68.36 0.8 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.88 169.09 41.89 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.564 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 53.9 m80 -83.41 74.39 10.08 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.656 0.741 . . . . 0.0 111.978 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -150.88 155.28 38.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.812 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.7 t -67.72 129.04 93.51 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.94 -23.77 61.37 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.906 2.404 . . . . 0.0 114.156 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.58 -52.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -105.81 4.03 29.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.107 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 m120 56.87 31.76 20.23 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -78.71 145.79 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -66.12 122.52 17.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.272 0.558 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 60.4 tp -121.06 128.5 52.69 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.239 -171.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.29 146.5 34.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.791 0.329 . . . . 0.0 110.329 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.01 -37.37 87.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.871 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -19.49 63.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.97 0.414 . . . . 0.0 111.514 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.19 -8.0 58.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.844 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.5 mt -76.3 124.32 27.32 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.074 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.4 160.97 64.76 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.56 150.28 86.08 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 122.66 2.24 . . . . 0.0 110.636 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -51.81 134.87 30.57 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -75.69 94.43 3.24 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -166.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.17 -2.87 20.44 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 164.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.42 136.35 47.66 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.167 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? . . . . . 0 C--N 1.298 -1.664 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.405 179.578 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.904 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.85 144.44 96.76 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 122.675 2.25 . . . . 0.0 110.911 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.85 125.84 29.66 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.897 0.38 . . . . 0.0 110.393 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.45 -17.47 59.22 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.963 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.8 m -102.85 108.84 20.2 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.882 0.372 . . . . 0.0 110.179 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -146.81 150.64 35.69 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.774 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.697 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 95.6 m-85 -110.49 15.26 22.24 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.031 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.96 112.15 20.93 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.764 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -64.17 111.65 5.92 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.84 -19.45 58.75 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.061 . . . . 0.0 113.429 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.62 -44.52 89.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.014 0.435 . . . . 0.0 110.945 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -101.52 -23.65 14.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.2 mt 64.48 22.77 12.79 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 111.118 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.6 mtm -96.16 -68.33 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.933 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.33 -161.35 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 95.3 mt -102.92 107.32 18.1 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.454 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 6.0 tpm_? -68.05 -44.67 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.828 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -114.92 -16.34 11.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.22 74.5 0.39 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.077 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.93 113.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.425 0.631 . . . . 0.0 110.47 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.62 142.08 32.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -101.14 159.48 29.35 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.22 -19.95 66.43 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.419 2.079 . . . . 0.0 110.979 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.1 t -75.18 -14.29 60.53 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.972 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 18.99 48.47 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.29 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -106.32 141.42 37.67 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -104.38 133.88 48.52 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -139.43 172.27 13.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.487 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 36.0 m -89.25 154.16 20.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.03 -12.91 61.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 122.922 0.489 . . . . 0.0 111.963 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.38 -13.9 12.24 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.41 -176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 44.0 m -84.64 -54.77 4.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.985 0.421 . . . . 0.0 110.689 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.16 -41.85 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -172.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.48 -43.66 98.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.789 0.328 . . . . 0.0 111.163 -175.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -81.73 1.99 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.204 0.526 . . . . 0.0 111.09 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.1 t -105.06 -22.21 13.14 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.8 pt -103.26 -25.68 3.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.648 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -98.61 3.83 47.97 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.312 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.08 -56.52 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.745 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -71.09 0.55 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.556 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.691 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -142.33 132.04 4.97 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.3 30.12 0.48 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.971 0.891 . . . . 0.0 111.39 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -142.54 153.88 43.96 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 16.8 p -63.0 124.51 83.99 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 120.859 0.362 . . . . 0.0 110.065 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.31 -22.11 73.63 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.909 2.406 . . . . 0.0 114.169 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.416 HG21 ' OD1' ' A' ' 47' ' ' ASP . 28.6 m -79.21 -51.89 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' OD1' HG21 ' A' ' 46' ' ' VAL . 11.5 p-10 -117.47 7.15 12.67 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 62.02 37.02 15.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.5 mm-40 -93.94 139.5 30.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.673 0.273 . . . . 0.0 111.303 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.78 121.91 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.631 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.3 tp -117.66 131.65 56.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.672 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.41 139.89 41.19 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.81 -38.62 82.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.418 0.449 . . . . 0.0 111.401 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -63.25 -30.15 71.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.464 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -73.81 -8.75 57.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.42 124.56 25.41 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -131.43 122.44 18.93 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -60.14 126.25 19.7 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 121.754 1.636 . . . . 0.0 111.844 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.01 -34.32 61.92 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -73.94 112.79 10.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.232 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -79.18 152.24 30.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.684 0.278 . . . . 0.0 111.368 -172.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.16 99.09 3.29 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.796 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 C--N 1.308 -1.2 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.6 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.42 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -60.81 145.4 99.04 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.663 2.242 . . . . 0.0 111.719 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.94 127.57 32.17 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.834 0.35 . . . . 0.0 110.336 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.65 -157.66 53.57 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.949 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.7 p -79.63 151.19 30.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.792 0.33 . . . . 0.0 110.553 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -107.57 130.76 54.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.876 0.369 . . . . 0.0 110.292 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.428 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.3 m-85 -108.69 14.58 24.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.654 0.74 . . . . 0.0 111.057 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -123.28 119.44 30.16 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.901 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.9 t -59.19 107.88 1.14 Allowed Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.753 0.658 . . . . 0.0 109.972 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.2 Cg_exo -65.51 -20.24 60.69 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.839 2.359 . . . . 0.0 112.405 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.03 -44.01 92.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.775 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -98.95 -26.78 14.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.136 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 65.5 21.17 11.79 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.192 0.997 . . . . 0.0 111.426 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.9 mtm -98.3 -67.23 0.86 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.518 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.51 -172.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 88.5 mt -100.86 108.47 20.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -73.67 -45.29 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.042 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.455 ' CD ' ' HZ3' ' A' ' 63' ' ' LYS . 48.8 mm-40 -104.93 -19.0 13.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.701 -175.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.43 71.58 0.27 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.224 -173.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -99.77 113.21 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.663 0.744 . . . . 0.0 109.72 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.08 135.43 35.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.815 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 p -89.7 162.37 36.29 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.01 -27.81 85.72 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.361 2.041 . . . . 0.0 112.819 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.703 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.4 p -75.8 -14.97 60.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.98 36.1 5.1 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.703 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 86.0 m-70 -117.05 151.89 35.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -117.15 135.94 53.39 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.278 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.443 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.3 m-85 -137.87 172.6 12.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.468 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.8 m -83.94 149.06 26.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 62.0 tttp -67.64 -12.82 61.31 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 120.942 0.401 . . . . 0.0 111.427 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.29 -16.79 12.89 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.435 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 47.2 m -81.59 -46.78 13.92 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.9 tp -68.95 -42.21 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.5 mt -63.25 -42.74 97.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.893 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.62 2.95 20.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.524 0.678 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -107.01 -22.77 12.55 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.05 -0.406 . . . . 0.0 111.104 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.0 pt -103.41 -19.0 6.41 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -105.22 7.97 33.8 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.656 0.741 . . . . 0.0 109.908 172.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -116.48 -56.02 2.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.373 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.63 -66.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.75 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.56 160.16 33.56 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -79.47 73.51 6.13 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.807 0.804 . . . . 0.0 111.616 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -153.36 150.73 29.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.46 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.0 129.41 86.47 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.87 -20.84 68.88 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.031 2.488 . . . . 0.0 113.649 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.15 -59.81 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -107.42 4.81 26.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.84 32.32 21.17 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -88.47 147.79 24.49 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.103 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mp -66.45 119.98 12.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.302 0.573 . . . . 0.0 110.297 -175.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.27 128.88 54.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.058 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.93 144.67 30.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.9 -41.55 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.752 0.821 . . . . 0.0 110.896 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -66.51 -31.28 71.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -77.22 -8.86 58.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -170.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.47 135.0 52.4 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -76.04 155.38 84.57 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.9 148.76 87.33 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 123.15 2.567 . . . . 0.0 112.227 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -58.33 106.91 0.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.947 0.879 . . . . 0.0 112.131 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -69.36 -40.29 77.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.24 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -77.68 137.58 38.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.327 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.82 139.86 56.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HZ3' ' CD ' ' A' ' 18' ' ' GLU . 5.0 ttmm . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.597 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.012 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.63 -30.96 93.67 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.145 2.563 . . . . 0.0 112.404 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.5 tp -110.73 131.93 54.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.776 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.45 -111.6 1.71 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.9 p -77.41 139.92 39.79 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -126.97 144.5 50.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 111.92 -174.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.4 m-85 -109.74 18.19 20.47 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 172.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -126.46 144.5 50.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.902 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.0 t -75.58 111.58 15.04 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 123.401 0.681 . . . . 0.0 109.621 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.5 Cg_exo -63.67 -20.44 69.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 112.903 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.93 -44.39 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.64 -23.38 13.85 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.371 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.04 22.23 7.13 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.829 0.851 . . . . 0.0 111.601 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.66 -49.77 5.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.201 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 172.7 -165.63 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.2 mt -103.56 125.65 50.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -80.08 -76.55 0.22 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.686 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -90.21 -15.32 31.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.4 84.24 0.14 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.622 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.564 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 32.8 m -105.49 116.89 50.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.291 0.567 . . . . 0.0 111.077 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -80.88 134.99 35.84 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.36 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -101.49 156.2 35.46 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.69 -22.86 74.34 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.679 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.8 p -77.23 -14.02 59.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.01 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.17 29.52 6.03 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.096 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.679 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 88.3 m-70 -112.92 148.22 35.43 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -107.59 128.59 54.67 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 88.7 m-85 -131.89 -174.74 3.51 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.65 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.4 m -99.54 159.15 15.24 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.84 0.352 . . . . 0.0 110.134 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.9 tttt -77.06 -9.94 59.05 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.566 0.747 . . . . 0.0 110.731 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.22 -6.98 13.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.165 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 85.7 m -91.26 -61.54 1.63 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.795 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.411 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -67.44 -40.91 85.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.944 -174.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.0 mt -62.89 -42.39 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 110.454 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 38.5 ttpt -79.57 1.07 27.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.721 0.772 . . . . 0.0 110.865 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -104.48 -24.77 12.99 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.5 pt -102.62 -7.05 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.7 ptm180 -99.55 2.81 45.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.033 0.444 . . . . 0.0 110.147 172.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -122.37 -56.13 1.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.072 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.35 -66.37 0.91 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.186 0.517 . . . . 0.0 110.785 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -170.65 163.96 37.15 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -85.1 73.56 10.63 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.712 0.768 . . . . 0.0 110.846 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -149.28 151.38 34.09 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.967 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.78 123.84 90.04 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.17 -24.96 65.5 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 113.138 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.12 -57.39 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -108.13 5.7 26.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 56.74 31.77 19.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.309 1.044 . . . . 0.0 113.638 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -83.99 147.46 27.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mm -66.56 120.77 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.25 0.548 . . . . 0.0 109.615 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.1 tp -122.46 126.27 47.55 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.965 -174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.82 156.03 19.6 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -66.13 -35.66 81.08 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.21 0.528 . . . . 0.0 110.124 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.26 -20.76 63.93 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.019 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -82.38 -11.43 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.104 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.59 143.59 44.33 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.564 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 93.1 m-85 72.54 156.34 0.16 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 123.938 0.895 . . . . 0.0 109.119 -173.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.56 138.15 81.94 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.36 1.373 . . . . 0.0 110.016 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -86.77 1.73 51.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.164 0.507 . . . . 0.0 111.735 -171.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -79.26 -12.66 59.95 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.7 t80 55.17 79.49 0.15 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.971 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.468 ' C ' ' HD2' ' A' ' 63' ' ' LYS . . . -139.55 131.54 27.82 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 62' ' ' ALA . 3.7 mptp? . . . . . 0 C--N 1.305 -1.328 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.019 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.88 118.64 5.53 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 121.931 1.754 . . . . 0.0 110.689 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.9 tt 46.89 85.53 0.02 OUTLIER 'General case' 0 C--O 1.246 0.9 0 O-C-N 124.358 1.036 . . . . 0.0 109.61 -170.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.1 67.58 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.926 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 m -131.75 156.04 46.64 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -66.28 125.24 24.97 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.25 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 50.27 78.27 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.652 0.781 . . . . 0.0 112.139 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 45.1 tt0 -129.72 131.12 46.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.202 -174.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 t -83.89 111.5 33.21 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.06 -18.52 56.88 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.735 2.29 . . . . 0.0 113.708 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.45 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.789 0.328 . . . . 0.0 111.088 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.47 -20.79 14.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.921 0.391 . . . . 0.0 111.212 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.3 mt 64.03 21.34 12.56 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.294 1.037 . . . . 0.0 112.177 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.9 mtm -95.74 -66.88 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.221 0.534 . . . . 0.0 111.165 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -174.93 -173.43 0.69 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.98 125.68 36.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -79.39 -75.26 0.25 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -91.29 -16.79 26.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.91 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.24 84.74 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.038 0.935 . . . . 0.0 112.445 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -115.31 117.69 56.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.184 0.516 . . . . 0.0 110.431 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 22' ' ' THR . 52.8 tt0 -82.82 146.45 28.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.498 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 70.8 p -92.3 159.31 37.44 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -56.47 -38.43 95.36 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.74 2.294 . . . . 0.0 112.323 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -67.53 -36.71 81.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.696 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.04 48.51 0.21 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.883 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 36.0 m-70 -124.65 145.01 49.88 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.3 mtm-85 -114.25 132.4 56.15 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.205 0.526 . . . . 0.0 111.874 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.89 171.66 14.17 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.868 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.512 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.1 m -79.63 150.7 30.91 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -72.73 -9.23 58.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.347 0.594 . . . . 0.0 110.97 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.57 -14.92 12.62 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.975 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.6 m -84.69 -46.64 11.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.417 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.4 tp -68.6 -42.09 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.943 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.1 mt -63.14 -42.35 96.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.629 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -77.43 -1.92 32.66 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.402 0.62 . . . . 0.0 109.939 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -104.99 -23.69 12.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.205 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.614 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.49 -7.3 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -97.85 0.05 45.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.546 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -139.55 -56.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.83 -65.86 0.94 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.271 0.558 . . . . 0.0 111.132 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.38 136.57 5.27 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -83.31 52.73 2.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.527 0.68 . . . . 0.0 109.542 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -147.24 156.17 42.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.266 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.32 123.35 75.1 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.62 -24.15 69.83 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.955 2.437 . . . . 0.0 114.428 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.59 -48.66 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -118.78 5.79 11.51 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.979 -0.451 . . . . 0.0 111.653 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 57.47 33.08 22.79 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.437 0.695 . . . . 0.0 112.807 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -87.27 145.18 26.47 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.491 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.21 121.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.59 130.27 56.29 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.105 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.439 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -109.38 146.87 33.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.18 -33.51 73.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.489 0.716 . . . . 0.0 109.651 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.517 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.8 mm100 -77.67 -14.7 59.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.847 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.55 137.56 48.16 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 120.744 0.306 . . . . 0.0 110.41 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -71.9 163.13 69.27 Favored Pre-proline 0 C--O 1.246 0.918 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.285 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -60.55 145.67 98.37 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.441 2.094 . . . . 0.0 111.552 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -70.38 148.62 48.2 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.962 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -91.86 -8.52 46.25 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.097 0.475 . . . . 0.0 110.778 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -64.85 -47.15 78.95 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.129 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.09 100.18 12.46 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.961 0.41 . . . . 0.0 111.348 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 N--CA 1.44 -0.945 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.868 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.67 151.03 63.6 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.585 2.19 . . . . 0.0 111.721 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.69 115.16 27.42 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.54 -51.15 0.58 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.8 m -133.35 149.41 51.88 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -88.62 -4.43 58.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.663 177.421 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -75.84 78.76 2.76 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 166.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.04 128.5 22.78 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.941 -170.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 t -92.78 113.65 60.26 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.79 -18.92 63.9 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.599 2.199 . . . . 0.0 113.575 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.2 -43.91 91.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.839 0.352 . . . . 0.0 111.181 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.9 p -101.7 -21.22 14.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.798 0.332 . . . . 0.0 111.325 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt 59.51 23.03 11.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.001 0.92 . . . . 0.0 111.907 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.8 mtm -95.32 -68.54 0.8 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.672 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.74 -165.59 0.32 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.06 124.08 47.05 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.35 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 8.8 tpt180 -78.4 -61.13 2.1 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.169 174.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 69.9 mm-40 -108.42 -15.05 14.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.338 -176.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.91 73.87 0.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.959 0.787 . . . . 0.0 112.335 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.32 116.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 110.684 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -81.2 139.95 35.22 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.004 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 p -98.46 158.67 32.19 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.7 -34.63 91.27 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.092 2.528 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -15.34 61.93 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.47 42.18 3.01 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.715 -0.755 . . . . 0.0 114.006 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -127.47 141.13 51.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.12 136.86 42.96 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.119 0.485 . . . . 0.0 111.6 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -133.68 173.3 11.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.651 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -86.03 149.63 25.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -68.51 -12.2 60.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.37 0.668 . . . . 0.0 111.606 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.25 -5.62 12.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.992 0.425 . . . . 0.0 110.143 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 79.5 m -92.59 -58.68 2.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.625 175.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -65.93 -42.43 91.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.836 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.613 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.51 -43.19 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.674 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -80.34 -1.5 41.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.599 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -105.54 -20.09 13.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.9 pt -102.1 -19.83 5.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.953 -175.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.8 ptm180 -100.87 2.79 41.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.614 0.721 . . . . 0.0 110.254 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -115.96 -46.57 2.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.78 -70.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 0.0 110.466 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.54 155.27 26.35 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.434 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 62.3 m80 -80.1 68.58 6.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.963 0.887 . . . . 0.0 112.358 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.27 153.89 34.64 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.02 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.5 p -79.35 123.42 84.53 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.786 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.18 -21.41 67.6 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.142 2.562 . . . . 0.0 113.942 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.2 m -78.54 -52.55 15.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -112.03 4.85 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 57.73 35.26 25.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 62.3 mm-40 -94.51 148.26 22.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.41 121.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.35 127.43 49.77 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.013 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.28 150.34 26.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.475 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.69 -37.97 89.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.3 -27.41 67.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.818 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -73.75 -8.47 56.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.7 mt -70.01 137.69 51.57 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.171 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.74 120.18 42.94 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.166 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 60' ' ' ASN . 64.8 Cg_endo -70.01 158.02 58.01 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.434 2.089 . . . . 0.0 111.663 177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.418 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 5.8 p-10 -79.71 12.14 2.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.922 0.391 . . . . 0.0 110.412 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.428 ' H ' ' C ' ' A' ' 58' ' ' PRO . 5.7 m-20 -65.99 -0.86 2.59 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.681 1.192 . . . . 0.0 112.945 -175.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.418 ' CE2' ' HA ' ' A' ' 59' ' ' ASP . 43.5 p90 -63.09 -26.76 68.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.665 0.745 . . . . 0.0 109.47 170.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.79 135.86 48.16 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 CA-C-O 117.995 -1.002 . . . . 0.0 108.524 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.566 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.29 145.44 43.46 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 121.857 1.705 . . . . 0.0 111.917 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.52 -44.06 92.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.0 -163.49 54.6 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.919 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.6 m -126.87 154.64 44.13 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 65.5 2.65 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -175.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.496 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.8 m-85 -111.58 17.63 19.82 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 170.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -116.9 131.66 56.9 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 113.481 -1.691 . . . . 0.0 108.882 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.2 t -69.01 113.83 19.1 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.43 -18.19 54.51 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.192 2.595 . . . . 0.0 112.271 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.8 mt -66.62 -44.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.106 0.479 . . . . 0.0 111.134 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 p -105.24 -20.84 13.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.09 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 62.94 22.94 13.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 111.516 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -103.93 -68.12 0.86 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.67 -167.27 1.08 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 98.3 mt -113.98 132.29 56.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -69.09 -77.42 0.08 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.1 5.6 20.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 171.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 56.54 80.78 0.14 Allowed 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.612 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.1 m -90.9 116.24 31.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.783 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.08 130.12 34.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.643 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.3 p -89.56 155.96 48.09 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.88 -23.14 75.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.735 2.29 . . . . 0.0 112.754 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.505 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 5.0 p -77.94 -20.14 53.31 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.4 39.93 2.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.151 -1.024 . . . . 0.0 114.142 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.505 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 88.3 m-70 -122.51 155.37 36.36 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -124.38 131.09 53.5 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -134.16 172.85 12.28 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.871 0.469 . . . . 0.0 110.891 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.413 ' O ' HG22 ' A' ' 33' ' ' ILE . 63.6 m -72.09 160.08 33.08 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.732 169.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' O ' HD12 ' A' ' 34' ' ' ILE . 89.2 tttt -82.63 -1.07 49.94 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.99 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.4 -40.07 3.48 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.319 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.7 m -62.26 -50.07 73.18 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -69.34 -42.36 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.556 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.8 mt -63.53 -43.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 111.575 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -78.0 -0.37 27.57 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.578 0.704 . . . . 0.0 109.553 -174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 t -105.25 -26.16 12.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.748 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.9 pt -104.24 -14.01 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -93.39 -6.96 45.98 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.5 174.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -115.74 -56.8 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.71 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.27 -66.1 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.986 0.422 . . . . 0.0 110.048 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.02 165.54 38.7 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -87.6 69.2 9.7 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.497 0.665 . . . . 0.0 111.759 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -147.17 154.61 41.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.228 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 29.7 m -62.14 131.74 93.59 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.75 -24.37 61.97 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.235 1.957 . . . . 0.0 111.505 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.53 -70.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.234 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -97.46 6.17 48.58 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -172.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 p30 54.33 16.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 174.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.54 151.33 45.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.3 120.47 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -120.93 122.03 39.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.514 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.67 138.91 34.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.65 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.4 -41.13 96.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.835 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -74.99 -12.7 60.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.205 0.526 . . . . 0.0 111.317 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -82.19 -10.17 59.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.246 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.35 130.98 38.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -137.86 135.02 18.41 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 32.0 Cg_exo -61.74 141.04 89.19 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.205 1.936 . . . . 0.0 112.441 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.59 -38.78 87.75 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.53 0.732 . . . . 0.0 110.027 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -103.99 -176.7 3.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.087 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -142.61 157.13 45.01 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.983 0.42 . . . . 0.0 111.177 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.87 146.24 37.24 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.164 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -56.14 -39.87 88.49 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.051 2.5 . . . . 0.0 111.776 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.4 tp -103.88 129.21 51.36 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.89 101.72 0.57 Allowed Glycine 0 N--CA 1.445 -0.763 0 O-C-N 123.618 0.574 . . . . 0.0 112.319 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -150.79 153.69 35.93 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -113.63 86.57 2.42 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.936 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -110.1 13.85 23.09 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.469 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -94.9 126.67 40.38 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.364 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HB2' HD21 ' A' ' 16' ' ' LEU . 41.3 t -83.44 112.35 38.67 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.13 -20.01 65.96 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 122.42 2.08 . . . . 0.0 112.513 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.26 -44.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.532 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -119.15 -2.42 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.8 mt 53.8 27.3 6.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.093 0.957 . . . . 0.0 112.053 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.3 mtm -111.67 174.16 6.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.724 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.16 149.95 49.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.359 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 9' ' ' CYS . 89.3 mt -70.28 109.86 4.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -65.56 -46.22 80.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -116.49 -15.51 10.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.079 -176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 47.81 72.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.053 0.941 . . . . 0.0 113.164 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.79 116.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.363 0.602 . . . . 0.0 110.674 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -82.13 136.61 35.13 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.965 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -84.29 163.62 46.9 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.81 -36.47 95.37 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.694 2.262 . . . . 0.0 112.508 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.508 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 5.0 p -65.68 -21.74 66.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.812 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.5 38.07 3.83 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.102 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -115.54 143.06 45.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.01 130.28 53.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.746 0.307 . . . . 0.0 111.267 -173.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -139.65 162.83 34.15 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.641 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.631 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 47.1 m -78.39 147.8 33.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.83 -10.25 55.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 -13.29 13.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.5 m -85.64 -45.16 11.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.694 173.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -65.58 -39.98 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.75 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.86 -41.38 92.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.164 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.08 -2.25 33.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.355 0.598 . . . . 0.0 109.944 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 m -105.68 -21.3 13.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.0 pt -103.12 -8.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.559 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.54 -2.27 45.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.085 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -116.78 -55.51 2.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.073 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.63 -64.79 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.42 -175.08 41.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -80.42 80.77 6.8 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.546 0.689 . . . . 0.0 111.596 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.0 ptpt -148.53 153.29 38.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.556 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.439 ' SG ' ' HG2' ' A' ' 49' ' ' GLU . 4.6 p -76.78 136.01 67.36 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 165.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.98 -20.3 69.05 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 122.848 2.365 . . . . 0.0 114.167 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.428 HG21 ' OD1' ' A' ' 47' ' ' ASP . 3.8 m -92.89 -71.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' OD1' HG21 ' A' ' 46' ' ' VAL . 12.8 p-10 -96.14 5.27 51.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.827 0.451 . . . . 0.0 112.052 -174.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.33 0.3 OUTLIER 44.19 56.67 4.71 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.098 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 17.5 pt-20 -94.58 163.52 13.35 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.54 115.33 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 109.504 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.1 tp -115.63 130.08 56.73 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.182 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.97 149.4 35.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.307 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.97 -35.84 75.87 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.529 0.518 . . . . 0.0 110.193 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -63.8 -31.28 72.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.776 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -78.43 -7.59 57.55 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.45 128.73 36.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.21 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -144.72 124.02 7.03 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 120.963 0.411 . . . . 0.0 111.396 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.09 145.58 44.77 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.839 1.693 . . . . 0.0 111.133 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.76 -35.36 79.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.089 0.471 . . . . 0.0 109.732 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -96.03 103.11 14.98 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 172.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.92 120.28 17.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.051 0.453 . . . . 0.0 110.894 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.51 154.05 36.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.226 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.828 175.336 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.002 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.96 147.7 94.64 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.462 2.775 . . . . 0.0 112.812 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 57.77 91.28 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.431 1.092 . . . . 0.0 112.896 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.05 106.59 0.27 Allowed Glycine 0 N--CA 1.431 -1.645 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.512 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.9 m -79.61 -7.16 58.35 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.186 0.517 . . . . 0.0 110.727 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -66.86 149.63 50.32 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -97.05 120.04 36.66 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -139.94 135.68 33.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.95 108.01 11.2 Favored Pre-proline 0 N--CA 1.436 -1.136 0 O-C-N 123.657 0.598 . . . . 0.0 109.764 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.64 -17.86 37.87 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.948 2.432 . . . . 0.0 111.789 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.77 -43.77 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.1 p -99.72 -20.19 16.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.99 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 61.87 21.76 12.52 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.729 0.811 . . . . 0.0 111.883 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.68 -71.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.704 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.22 -166.49 0.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.16 105.04 17.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -70.47 -57.01 5.25 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 63.8 mm-40 -103.42 -16.41 15.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.006 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.55 61.51 3.16 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -93.04 118.23 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.188 0.518 . . . . 0.0 111.374 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.401 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 65.3 tt0 -75.51 134.44 40.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.947 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -99.96 159.17 30.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.766 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.89 -23.77 68.24 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.749 2.299 . . . . 0.0 113.113 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -73.11 -28.61 62.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.379 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.64 38.75 1.16 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -133.28 162.02 32.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 80.2 mtp180 -127.98 140.12 52.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -136.13 173.9 11.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.571 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.1 m -84.91 148.23 26.35 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 87.9 tttt -79.33 -3.58 46.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 110.324 -174.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.61 -12.55 13.41 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.6 m -94.09 -54.22 3.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.777 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.1 tp -66.03 -38.57 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.556 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.9 mt -62.8 -42.99 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.663 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.95 -2.52 40.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.611 0.719 . . . . 0.0 110.48 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -105.43 -16.47 14.72 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.965 -0.459 . . . . 0.0 110.618 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.659 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -104.09 -24.18 4.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.559 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -97.42 1.04 48.77 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.813 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -116.4 -56.02 2.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.564 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.26 -66.71 0.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.467 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.1 159.1 32.0 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 64.0 m80 -85.45 75.64 10.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.285 0.543 . . . . 0.0 110.871 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -153.76 155.19 35.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.498 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.1 p -80.71 130.91 62.35 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -31.55 85.61 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.782 2.321 . . . . 0.0 114.775 -172.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.0 m -78.87 -53.28 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -174.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -106.05 3.5 28.26 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 m120 52.82 40.18 30.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.15 146.22 24.02 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 mm -66.65 120.58 14.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.373 0.606 . . . . 0.0 109.909 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.507 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.6 tp -124.42 118.05 25.81 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.801 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -96.05 161.42 13.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.91 -37.39 87.48 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.806 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.89 -24.02 64.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 111.247 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.7 mm100 -76.38 -10.78 59.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.665 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.37 147.47 46.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.168 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -55.13 115.23 8.6 Favored Pre-proline 0 C--O 1.237 0.438 0 O-C-N 123.775 0.672 . . . . 0.0 110.332 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.81 143.68 46.42 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.111 1.874 . . . . 0.0 111.759 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -97.81 115.21 27.59 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -62.85 -44.33 96.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -157.13 129.23 7.25 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.5 103.09 4.71 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.246 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.952 -176.401 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.938 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.99 -30.63 83.51 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.669 2.246 . . . . 0.0 112.114 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.1 tp -133.89 91.97 2.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.935 0.398 . . . . 0.0 109.985 173.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.7 -163.39 36.58 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.5 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 72.0 m -130.72 78.94 1.87 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -113.83 129.86 56.54 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.401 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 53.4 m-85 60.97 20.57 10.93 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.45 0.469 . . . . 0.0 111.066 -169.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.432 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 42.5 tt0 -124.78 140.89 52.51 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 51.3 t -87.63 108.74 21.8 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 37.3 Cg_exo -61.54 -20.61 69.32 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.478 2.119 . . . . 0.0 111.677 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.24 -43.47 91.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.034 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.0 m -88.89 -27.49 20.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.182 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 56.78 35.21 25.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.073 0.939 . . . . 0.0 108.693 -165.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -139.48 171.28 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.309 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.66 152.48 22.36 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.546 0.529 . . . . 0.0 111.608 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 96.0 mt -70.85 139.51 50.87 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.997 -177.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -79.12 -72.3 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.289 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.47 -15.96 20.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.649 0.261 . . . . 0.0 110.911 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.71 102.47 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.957 0.903 . . . . 0.0 113.274 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.8 m -117.15 118.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -80.41 135.31 36.14 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.768 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -95.77 152.57 39.16 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -26.52 83.27 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.902 2.401 . . . . 0.0 113.823 -173.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -79.72 -19.36 49.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.72 48.48 0.68 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.649 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -133.33 152.11 51.91 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -121.44 136.3 54.97 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.982 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.67 170.0 16.48 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 39.0 m -78.92 153.29 30.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.96 -12.68 61.2 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.77 -31.56 6.1 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.224 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 28.0 m -62.98 -44.61 95.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -64.73 -41.12 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.0 mt -63.48 -43.51 98.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.836 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.77 -2.8 44.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.872 0.368 . . . . 0.0 110.539 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.0 t -106.92 -22.8 12.57 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.797 0.332 . . . . 0.0 110.635 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 33' ' ' ILE . 45.7 pt -101.78 -7.91 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.061 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -101.98 6.66 41.32 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.586 167.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.52 -54.89 2.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.186 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -66.11 0.94 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.137 0.494 . . . . 0.0 109.809 176.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.65 166.83 38.84 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.45 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 49.9 m80 -79.73 77.4 6.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.164 0.982 . . . . 0.0 110.83 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.1 ptpt -152.25 149.79 29.09 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.625 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.568 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 2.2 m -68.01 130.54 92.63 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.6 -34.02 94.5 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.262 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.76 -54.95 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.568 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 31.4 p-10 -104.19 4.29 33.81 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.719 -0.613 . . . . 0.0 112.07 -174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 54.96 32.23 17.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.799 0.84 . . . . 0.0 112.739 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 73.7 mm-40 -92.91 142.82 26.88 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.83 120.38 11.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 CA-C-O 121.597 0.713 . . . . 0.0 110.373 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.8 tp -117.14 129.25 55.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.316 -175.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.8 mm? -98.21 148.74 23.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.59 -37.24 86.07 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.328 0.393 . . . . 0.0 111.882 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -68.37 -19.74 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.437 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 14.1 mm-40 -77.24 -6.62 53.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.23 131.66 45.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -128.61 129.02 23.53 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.501 ' HD2' ' CE1' ' A' ' 61' ' ' PHE . 72.4 Cg_endo -74.35 165.71 31.18 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 122.517 2.145 . . . . 0.0 110.298 165.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.31 -42.25 95.19 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.573 0.702 . . . . 0.0 110.323 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -128.35 137.97 52.16 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.501 ' CE1' ' HD2' ' A' ' 58' ' ' PRO . 94.0 m-85 -88.15 104.02 16.3 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.884 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.98 119.02 25.83 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.572 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.253 1.256 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.18 -176.171 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.027 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.3 139.93 85.67 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.652 2.234 . . . . 0.0 111.578 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.61 -43.53 89.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.635 0.731 . . . . 0.0 110.465 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.21 -89.27 0.15 Allowed Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.5 t -129.66 136.27 49.51 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.135 0.493 . . . . 0.0 110.309 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -145.58 153.59 41.23 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -79.61 81.84 5.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.869 0.842 . . . . 0.0 109.793 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -158.59 139.07 12.55 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.151 -174.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 39.8 t -78.25 113.83 37.19 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.98 -20.96 64.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.481 2.121 . . . . 0.0 112.895 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.86 -44.34 85.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.094 0.473 . . . . 0.0 111.874 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 20.7 p -101.85 -13.22 17.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.166 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mp 54.09 23.37 4.07 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.996 0.918 . . . . 0.0 111.742 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.7 mtm -100.03 -70.98 0.72 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.687 0.279 . . . . 0.0 111.676 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.89 165.25 5.16 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.6 109.92 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -70.42 -46.12 64.54 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.895 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -115.35 -17.9 11.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.4 ' HB2' ' H ' ' A' ' 61' ' ' PHE . . . 56.06 81.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.798 -174.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.71 117.37 42.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.601 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.422 ' O ' ' HD2' ' A' ' 57' ' ' PHE . 53.0 tt0 -80.83 140.96 35.13 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.195 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -96.9 156.77 36.07 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.418 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 74.9 Cg_exo -54.53 -37.59 90.27 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.966 2.444 . . . . 0.0 112.594 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -64.9 -18.33 65.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.903 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.87 4.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.471 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -120.35 152.32 38.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -123.07 138.27 54.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.349 0.595 . . . . 0.0 112.439 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -137.3 169.26 18.08 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.329 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.558 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.3 m -76.47 151.4 36.47 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.228 171.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.52 -5.78 31.38 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.04 0.447 . . . . 0.0 112.107 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.85 -34.13 5.55 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.93 -0.481 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.5 m -64.29 -44.8 90.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.015 0.436 . . . . 0.0 110.608 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.514 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.1 tp -65.53 -39.91 86.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.169 -176.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -63.02 -42.35 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.039 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -78.12 -2.3 36.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.785 0.326 . . . . 0.0 110.422 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -105.35 -25.62 12.32 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.003 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.8 pt -103.81 -10.29 9.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.71 -174.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.5 ptm180 -93.47 -14.04 27.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.487 176.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -131.72 -56.33 1.0 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.138 -172.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.02 -66.2 0.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.87 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.06 137.32 5.11 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -85.23 43.44 1.01 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.854 0.835 . . . . 0.0 110.244 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -148.05 155.11 41.11 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 12.0 p -75.04 127.03 87.46 Favored Pre-proline 0 C--N 1.318 -0.778 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.192 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.7 -25.27 68.76 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.917 2.411 . . . . 0.0 113.557 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.52 -49.33 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -131.87 12.21 4.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.99 35.32 21.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.487 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 73.3 mm-40 -85.03 143.5 28.87 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.322 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.81 120.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.7 tp -121.03 126.6 50.3 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.489 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -110.43 148.01 32.88 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.02 -28.82 69.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.689 0.757 . . . . 0.0 109.835 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.96 -30.65 71.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.438 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.4 mm100 -80.16 -16.37 55.02 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.363 -175.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.4 mt -69.28 131.99 45.75 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.422 ' HD2' ' O ' ' A' ' 21' ' ' GLN . 97.0 m-85 -85.19 153.3 59.45 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.48 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.26 153.48 77.89 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.005 2.47 . . . . 0.0 111.953 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -36.19 102.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.031 1.332 . . . . 0.0 113.738 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' OD1' ' HB2' ' A' ' 21' ' ' GLN . 8.5 m120 -67.22 -45.38 76.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.986 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.4 ' H ' ' HB2' ' A' ' 19' ' ' ALA . 98.6 m-85 -141.49 100.47 3.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.955 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.94 125.61 41.83 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.345 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--N 1.303 -1.421 0 CA-C-O 118.404 -0.808 . . . . 0.0 109.172 -177.476 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.854 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -60.82 144.48 99.56 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 122.869 2.38 . . . . 0.0 112.023 178.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.43 133.69 49.04 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.1 123.28 31.96 Favored Glycine 0 N--CA 1.444 -0.812 0 O-C-N 123.784 0.678 . . . . 0.0 111.726 -178.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 m -127.97 157.5 40.43 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -177.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -65.26 -32.8 74.65 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.437 -177.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.423 ' C ' ' HG ' ' A' ' 16' ' ' LEU . 91.9 m-85 -80.67 61.16 4.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.245 0.545 . . . . 0.0 110.413 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -146.9 122.58 10.51 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.142 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 19.6 p -91.55 134.15 29.88 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.573 175.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.55 -17.52 58.71 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.929 2.419 . . . . 0.0 113.131 -174.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.8 -45.03 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -106.89 -20.08 13.44 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.53 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.25 23.0 6.68 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.843 0.857 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -97.45 -66.61 0.89 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.202 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.72 -172.62 0.9 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HG ' ' C ' ' A' ' 7' ' ' TYR . 91.7 mt -105.12 105.36 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.22 174.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -69.91 -44.15 70.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.709 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -125.41 -15.16 6.24 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.633 -175.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 49.6 56.24 8.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 30.3 m -77.48 118.22 23.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -75.9 133.32 40.56 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.643 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -106.1 162.58 19.26 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.264 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.23 -36.64 99.07 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.294 2.663 . . . . 0.0 112.46 178.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.0 -25.94 64.76 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.932 0.396 . . . . 0.0 111.602 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.31 29.01 4.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.038 177.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -112.58 157.65 20.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 94.8 mtt-85 -124.74 140.48 52.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 110.238 174.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.414 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 88.3 m-85 -134.49 165.56 24.9 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.015 -176.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.5 m -73.84 152.66 40.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 171.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -68.87 -13.23 62.3 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 121.296 0.569 . . . . 0.0 110.778 -174.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.86 -1.22 13.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.218 0.533 . . . . 0.0 110.387 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 89.3 m -90.72 -64.02 1.19 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.421 176.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.414 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.28 -40.94 83.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.428 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.8 mt -63.09 -42.15 95.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 110.336 -178.072 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.9 tptp -78.7 -1.64 35.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.673 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.1 m -106.9 -19.77 13.53 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.381 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.1 pt -102.99 -31.63 2.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.488 -174.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.6 ptm180 -99.13 4.31 46.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.232 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -115.72 -55.08 2.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.842 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.27 -71.77 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.433 . . . . 0.0 110.184 178.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.24 152.75 23.6 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -79.23 71.58 5.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.434 0.635 . . . . 0.0 112.105 -175.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.3 ptpt -153.36 152.29 30.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.609 178.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 m -64.76 124.77 87.29 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 170.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.51 -27.32 70.04 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 121.702 1.601 . . . . 0.0 112.067 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.72 -54.79 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.11 4.97 29.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 54.43 33.91 19.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.3 mm-40 -96.75 141.41 30.0 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.02 121.18 13.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 -176.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.53 132.82 44.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.818 -173.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -116.43 157.67 24.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.59 -37.41 78.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 109.774 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -65.12 -29.55 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.147 -177.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.9 mt -76.14 136.32 39.81 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -73.04 148.01 88.75 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.08 145.78 96.39 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 C-N-CA 122.256 1.97 . . . . 0.0 112.08 -172.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -77.24 90.27 3.72 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 122.002 0.906 . . . . 0.0 109.947 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -143.9 138.22 28.41 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.456 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.06 101.13 8.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.21 0.529 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.81 131.25 42.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.805 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' HZ1' ' HB3' ' A' ' 63' ' ' LYS . 6.7 ttpm? . . . . . 0 C--N 1.311 -1.096 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.277 178.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.13 140.58 78.94 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.312 2.008 . . . . 0.0 111.342 178.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 44.3 64.63 1.25 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 112.673 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.69 117.41 1.79 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.327 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -83.7 96.93 8.86 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.708 0.766 . . . . 0.0 110.69 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -113.1 115.84 28.94 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 55.2 30.57 14.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.037 0.922 . . . . 0.0 109.993 -171.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.6 tt0 -127.09 130.72 50.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.217 -1.356 . . . . 0.0 107.382 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 t -75.44 108.07 5.13 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 53.6 Cg_endo -68.23 -17.79 44.96 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.922 2.415 . . . . 0.0 111.983 -177.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.16 -43.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.232 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.92 -13.81 15.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 0.0 111.339 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.65 21.44 5.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 112.011 -177.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -99.83 -69.81 0.75 Allowed 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.45 -167.36 0.2 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.9 mt -94.41 107.07 19.05 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -69.74 -43.83 71.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 64.9 mm-40 -122.61 -14.66 7.71 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.617 -175.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.87 56.44 6.66 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.517 0.727 . . . . 0.0 112.424 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.2 m -83.51 116.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.461 0.648 . . . . 0.0 110.708 178.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -78.78 134.25 37.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.873 -176.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 157.53 36.89 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.76 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.38 -40.28 83.65 Favored 'Trans proline' 0 C--N 1.364 1.342 0 C-N-CA 122.587 2.191 . . . . 0.0 113.323 -177.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 -14.88 61.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.43 36.87 2.97 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.144 173.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -117.26 157.74 25.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.3 mtt180 -123.22 140.38 53.08 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.283 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.421 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 98.2 m-85 -132.13 173.07 11.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.263 -177.09 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.7 m -85.05 148.74 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 38.9 ttpt -73.69 -10.94 60.2 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.351 0.596 . . . . 0.0 111.346 -172.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.49 -4.53 12.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.019 0.438 . . . . 0.0 109.958 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 88.2 m -90.02 -60.78 1.84 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 174.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.421 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -67.1 -40.68 85.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.591 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.4 mt -62.71 -43.03 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.917 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -79.99 1.46 27.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.802 0.811 . . . . 0.0 110.169 -177.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 t -105.44 -24.8 12.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.876 175.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.71 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 49.2 pt -103.23 -22.67 4.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -99.26 4.56 46.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.456 174.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -119.37 -57.23 2.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.466 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.95 -68.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.892 0.377 . . . . 0.0 111.598 -177.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -146.03 140.12 8.65 Favored Glycine 0 CA--C 1.502 -0.756 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.437 ' HE2' ' CD ' ' A' ' 53' ' ' GLU . 3.7 t-160 -83.32 52.25 2.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.458 0.647 . . . . 0.0 110.488 -172.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -155.32 160.96 41.15 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.672 -174.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.428 ' HB3' HD12 ' A' ' 51' ' ' LEU . 2.6 p -79.16 130.47 69.26 Favored Pre-proline 0 C--N 1.318 -0.764 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.441 173.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.08 -21.05 72.68 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.209 2.606 . . . . 0.0 113.666 -173.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.401 HG21 ' H ' ' A' ' 47' ' ' ASP . 4.0 m -72.58 -70.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' H ' HG21 ' A' ' 46' ' ' VAL . 46.4 p-10 -103.13 5.56 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.16 33.0 21.1 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 113.179 173.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -83.48 139.99 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.13 121.36 16.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.493 . . . . 0.0 110.476 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 44' ' ' CYS . 83.0 mt -109.58 132.37 54.2 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.314 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 71.4 mt -108.68 143.41 37.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.437 ' CD ' ' HE2' ' A' ' 42' ' ' HIS . 52.7 mp0 -61.17 -36.13 79.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.17 0.509 . . . . 0.0 110.266 -179.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -65.05 -31.71 73.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.089 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -86.14 -13.21 47.81 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.041 -176.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 85.4 mt -76.63 124.98 28.45 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 55.3 t80 68.58 141.12 0.07 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 O-C-N 124.187 0.929 . . . . 0.0 110.815 177.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.63 146.41 91.73 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.168 1.912 . . . . 0.0 111.893 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.11 113.52 9.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.593 -176.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -107.47 0.76 23.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.369 178.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -114.53 83.65 1.92 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.093 -176.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.68 -21.58 19.92 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 170.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.78 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.22 177.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -56.08 -41.45 76.78 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.871 2.381 . . . . 0.0 112.72 -178.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.9 tp -129.02 121.64 28.34 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.686 0.279 . . . . 0.0 110.803 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.39 86.04 0.97 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 175.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -137.98 149.34 46.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.031 0.443 . . . . 0.0 111.521 -172.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -85.37 7.17 23.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.161 176.168 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.627 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 97.2 m-85 -91.83 10.95 26.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.965 0.888 . . . . 0.0 109.196 171.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -110.1 122.7 48.21 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.607 173.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.87 109.75 4.38 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.8 -19.91 69.8 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.9 2.4 . . . . 0.0 113.407 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.03 -43.97 92.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 121.139 0.495 . . . . 0.0 110.989 179.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.2 p -104.49 -21.4 13.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.791 -177.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.1 mt 59.03 29.37 18.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.703 0.801 . . . . 0.0 111.719 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.8 mtm -98.68 -66.87 0.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.174 0.512 . . . . 0.0 110.528 176.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.52 -172.03 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 91.7 mt -91.09 105.81 18.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -69.28 -45.2 70.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.928 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -116.3 -15.82 10.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -178.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 88.66 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -117.24 117.59 55.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.243 0.544 . . . . 0.0 110.353 171.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -80.56 139.32 36.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.114 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 p -109.39 158.95 33.15 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.75 -27.0 82.25 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.907 2.405 . . . . 0.0 111.576 176.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.36 -24.96 67.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.262 178.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.89 8.17 57.13 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.892 -174.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -92.87 154.0 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -124.36 139.42 53.92 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.197 173.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.52 168.87 18.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.625 -174.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 49.9 m -79.12 151.72 31.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 169.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.497 ' O ' HD12 ' A' ' 34' ' ' ILE . 86.9 tttt -78.36 8.6 4.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.721 0.772 . . . . 0.0 111.289 -173.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.64 -38.91 3.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 38.7 m -66.39 -50.06 64.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.069 -178.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -69.12 -40.24 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.071 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.633 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.9 mt -62.94 -42.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.718 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HZ2' ' HB3' ' A' ' 35' ' ' LYS . 3.1 mmmp? -78.92 0.59 26.77 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.097 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -105.37 -23.85 12.77 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.789 176.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.4 pt -103.92 -22.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.174 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -104.13 6.17 35.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.798 175.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.47 -53.0 2.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 178.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.73 -71.15 0.52 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.917 0.389 . . . . 0.0 110.362 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.57 161.61 35.33 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -80.32 75.55 7.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.721 0.772 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -151.95 148.85 28.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.729 177.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.0 p -72.37 126.09 91.12 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.99 -22.73 73.96 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 122.326 2.018 . . . . 0.0 112.585 -175.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.18 -50.71 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -135.9 11.79 3.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.44 35.51 9.5 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 173.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 53.6 mt-10 -83.85 145.47 28.62 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -66.5 113.7 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.241 0.543 . . . . 0.0 110.25 -176.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.9 tp -126.23 123.18 37.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.987 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.1 mm? -97.61 160.39 14.35 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.11 -38.61 91.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -176.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.01 -17.65 63.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 178.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.2 mm100 -76.3 -8.99 58.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.895 -178.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.7 mt -75.15 126.96 32.1 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -100.2 132.92 21.91 Favored Pre-proline 0 C--N 1.311 -1.098 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.55 153.11 65.52 Favored 'Trans proline' 0 C--N 1.327 -0.595 0 C-N-CA 122.429 2.086 . . . . 0.0 111.088 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -56.01 137.54 50.81 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.243 0.339 . . . . 0.0 110.405 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -99.26 -17.1 18.26 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.419 -175.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -62.21 -47.17 85.63 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 120.938 0.399 . . . . 0.0 110.592 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.12 134.86 40.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.232 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? . . . . . 0 C--N 1.311 -1.103 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.106 -177.589 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.329 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -56.93 -40.81 81.43 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.574 2.183 . . . . 0.0 110.612 177.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.1 tp -143.9 139.8 29.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.82 106.65 0.93 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 172.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.7 m -93.51 119.47 32.62 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 120.901 0.382 . . . . 0.0 111.447 -168.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -67.46 -33.7 75.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.95 176.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -79.51 65.61 4.73 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.867 0.841 . . . . 0.0 110.059 177.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -137.09 146.13 44.75 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.217 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.28 109.61 22.62 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.31 -17.66 54.37 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.805 2.337 . . . . 0.0 112.657 -175.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -65.92 -43.83 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.866 0.365 . . . . 0.0 110.987 177.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.7 p -105.39 -15.63 14.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mp 57.87 22.67 8.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.889 0.876 . . . . 0.0 111.433 -176.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.473 ' HA ' ' HE2' ' A' ' 14' ' ' MET . 8.1 mmt -95.03 -66.51 0.91 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.501 -178.256 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.59 -166.61 0.06 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.69 117.58 34.35 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -67.63 -44.85 77.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 179.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -134.96 -15.03 2.04 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 67.59 88.86 0.11 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.353 1.061 . . . . 0.0 112.847 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 m -106.24 117.1 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.174 0.511 . . . . 0.0 111.033 175.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -80.37 132.12 35.72 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.93 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 p -95.86 156.15 37.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.31 -29.63 86.36 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.569 2.18 . . . . 0.0 112.767 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.26 -22.91 51.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.659 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.7 51.56 0.65 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.213 -0.994 . . . . 0.0 114.013 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -131.47 161.39 32.63 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -127.74 136.38 51.45 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 171.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.09 -179.1 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.188 -176.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.5 m -86.7 152.94 22.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 170.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' O ' HD12 ' A' ' 34' ' ' ILE . 35.9 ttpt -78.65 -1.97 36.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.617 0.723 . . . . 0.0 111.021 -174.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.41 -19.26 10.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 177.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.3 m -82.86 -57.8 3.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.331 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -67.76 -41.08 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.911 -175.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 81.5 mt -62.9 -42.85 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 111.544 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -78.61 -2.72 40.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.23 0.538 . . . . 0.0 109.647 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -105.97 -21.99 13.01 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 176.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.3 pt -103.25 -15.56 7.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.175 -177.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.4 ptm180 -99.87 2.27 43.68 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.03 175.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -116.28 -55.76 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.994 -178.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.55 -67.03 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.287 0.565 . . . . 0.0 109.773 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.48 159.68 31.43 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -81.72 72.41 8.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -156.38 148.15 22.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.124 173.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.82 124.47 89.62 Favored Pre-proline 0 N--CA 1.436 -1.14 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.831 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.1 -24.52 76.57 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.092 2.528 . . . . 0.0 113.739 -170.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.7 m -68.87 -47.47 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -119.79 5.58 10.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 m120 58.71 33.56 23.16 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.451 0.701 . . . . 0.0 112.642 177.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -95.78 144.36 26.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.6 mm -66.11 120.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.122 0.487 . . . . 0.0 110.343 -173.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.9 tp -131.18 132.56 44.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -174.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 3.8 mm? -116.58 150.16 38.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.56 -37.03 82.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.066 0.546 . . . . 0.0 110.131 -177.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -64.32 -31.73 73.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.414 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 12.0 mm100 -76.43 -17.64 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.862 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.1 137.25 40.01 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.257 178.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -159.09 150.94 17.07 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 176.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 83.2 Cg_endo -79.56 -166.4 0.41 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.304 2.669 . . . . 0.0 111.563 175.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -74.12 91.71 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.249 0.547 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -99.09 12.86 34.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.691 178.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.38 -39.44 90.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.832 -177.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.18 136.23 46.92 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? . . . . . 0 C--N 1.309 -1.161 0 CA-C-O 118.371 -0.823 . . . . 0.0 109.617 -179.164 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -60.12 146.98 94.97 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.305 2.67 . . . . 0.0 112.802 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.9 tp 55.11 68.03 0.93 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.964 0.906 . . . . 0.0 111.536 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.93 -86.68 0.14 Allowed Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.025 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t -62.74 -41.9 99.41 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.133 0.573 . . . . 0.0 110.606 -178.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -86.03 122.75 30.5 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -79.7 100.84 8.07 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -164.72 136.38 4.37 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.569 -170.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.541 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 41.8 t -75.85 114.66 38.99 Favored Pre-proline 0 N--CA 1.438 -1.035 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.1 -19.4 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.121 1.881 . . . . 0.0 113.224 -177.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -67.96 -44.33 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.541 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 14.4 p -100.28 -24.62 14.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 65.1 21.9 12.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.348 0.659 . . . . 0.0 110.866 -176.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.3 mmt -96.4 -70.14 0.73 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.706 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.68 -168.67 0.24 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -176.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.35 122.16 44.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -84.57 -66.38 0.9 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.685 177.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -88.29 -15.64 35.25 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.555 176.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.44 56.3 7.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.659 1.184 . . . . 0.0 112.297 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.4 m -80.88 116.56 25.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.251 0.548 . . . . 0.0 111.636 -175.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 22' ' ' THR . 26.7 tt0 -81.4 131.52 35.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.206 176.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 82.3 p -83.82 159.18 61.04 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.299 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.17 -24.26 78.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.072 1.848 . . . . 0.0 111.978 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -76.48 -15.92 59.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.857 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 33.93 5.63 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.472 178.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -119.96 150.77 39.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -122.13 139.79 53.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.414 ' O ' HG22 ' A' ' 20' ' ' VAL . 85.5 m-85 -142.88 172.06 13.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.673 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.6 m -84.05 153.62 23.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.51 -14.07 62.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.143 0.497 . . . . 0.0 112.054 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.18 1.4 15.24 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.804 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 57.9 m -95.81 -56.44 2.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.669 172.099 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -66.81 -41.88 88.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.747 -177.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.461 ' HA ' HG12 ' A' ' 37' ' ' ILE . 76.5 mt -63.39 -41.58 93.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 111.915 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -77.46 -2.73 36.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.484 0.659 . . . . 0.0 109.395 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.94 -17.72 14.11 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.408 177.093 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 42' ' ' HIS . 38.2 pt -106.49 -11.73 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -175.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -95.21 -10.91 29.05 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.222 -178.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.7 -45.88 2.87 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.927 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.88 -76.65 0.16 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.32 158.6 31.6 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 177.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.481 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 55.1 m80 -83.56 67.48 9.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.628 0.727 . . . . 0.0 111.61 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -143.18 150.77 39.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.436 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.1 p -83.22 124.33 76.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -28.18 81.45 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.728 2.285 . . . . 0.0 113.449 -171.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -69.58 -45.45 78.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -120.17 5.56 10.78 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 57.98 33.15 22.88 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 175.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -95.57 146.21 24.63 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 177.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.94 120.74 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -121.76 126.75 49.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.11 -172.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.52 148.75 31.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.543 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.05 -41.04 95.52 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.639 1.176 . . . . 0.0 112.983 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -87.12 -0.61 56.95 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.363 -176.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -87.31 -7.86 57.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.691 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 96.0 mt -73.44 140.9 46.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.224 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -113.18 94.5 30.92 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.24 -41.96 67.93 Favored 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 122.533 2.155 . . . . 0.0 112.218 175.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -140.45 96.87 3.1 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.103 -178.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -111.59 3.39 17.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.386 0.612 . . . . 0.0 111.203 176.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.98 105.27 12.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 176.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -164.44 169.83 16.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.608 -176.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? . . . . . 0 N--CA 1.443 -0.817 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.854 177.161 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -55.73 -41.13 80.62 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.003 2.469 . . . . 0.0 112.451 -177.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.11 128.34 35.92 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.073 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.44 -49.15 66.97 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.047 -178.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -78.33 151.95 32.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -86.55 79.92 8.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.391 0.615 . . . . 0.0 111.513 -175.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.516 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 92.0 m-85 -111.86 15.28 20.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.554 171.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.99 147.84 28.98 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.336 -178.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.492 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 45.8 t -118.92 108.9 40.13 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.46 -21.52 72.13 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 122.589 2.193 . . . . 0.0 112.653 -171.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.49 -44.14 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.791 177.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 19.5 p -106.67 -17.9 14.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 57.08 33.52 23.46 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.112 0.965 . . . . 0.0 111.885 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -121.35 -77.02 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.328 177.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.6 158.47 2.75 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.774 0.43 . . . . 0.0 110.014 -179.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 96.0 mt -71.82 105.22 3.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.692 0.282 . . . . 0.0 110.853 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -70.65 -44.8 66.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 178.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -112.86 -16.87 12.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.644 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.0 80.72 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.97 116.47 47.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 110.326 174.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -81.01 136.11 35.94 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.411 -177.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -103.13 154.34 37.7 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.77 -29.35 85.56 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.051 2.501 . . . . 0.0 112.839 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.7 p -69.1 -15.59 63.47 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.51 11.41 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.172 177.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -114.22 155.78 25.5 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 122.571 -0.37 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -126.49 136.54 52.74 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.48 167.92 20.18 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.206 0.316 . . . . 0.0 110.814 -176.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 58.2 m -80.63 156.19 26.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.256 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.8 tttt -69.48 -12.65 61.82 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.966 -173.473 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.07 -20.56 10.94 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.156 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 98.1 m -72.1 -54.1 10.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.845 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -67.97 -39.85 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.247 -175.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 88.0 mt -62.73 -42.8 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.663 0.268 . . . . 0.0 111.131 -178.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -78.87 -0.83 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.464 0.649 . . . . 0.0 110.372 -177.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -103.61 -25.45 13.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -103.05 -7.32 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.452 -177.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -100.94 -2.84 30.82 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.7 -52.74 2.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.707 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.97 -69.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.079 0.466 . . . . 0.0 110.241 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -176.82 167.29 38.59 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 177.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -81.5 67.16 7.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.809 0.814 . . . . 0.0 111.616 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -148.08 157.66 43.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.339 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 50.4 t -64.9 127.22 92.48 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.44 -26.53 70.58 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.388 2.058 . . . . 0.0 112.449 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.77 -71.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -98.28 5.63 48.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -174.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 12.6 m120 57.31 33.47 23.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.875 0.87 . . . . 0.0 113.151 173.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -86.44 148.58 25.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mp -66.19 122.56 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 110.322 -173.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.24 125.74 46.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -174.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.47 152.43 18.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 177.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.68 -36.82 84.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.909 -173.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -71.16 -11.96 61.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.861 0.363 . . . . 0.0 111.483 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.44 -8.23 59.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.452 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 88.0 mt -76.59 79.22 3.26 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.12 0.262 . . . . 0.0 110.911 -177.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 26.1 t80 168.5 142.87 0.06 OUTLIER Pre-proline 0 C--O 1.234 0.288 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.58 162.03 40.93 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.518 2.146 . . . . 0.0 111.286 175.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.09 114.67 2.47 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.174 0.511 . . . . 0.0 111.264 -176.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -95.65 0.98 53.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.36 -178.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -61.92 -46.43 89.39 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.4 143.94 51.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.255 175.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.126 177.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -56.24 -45.93 34.35 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.365 2.043 . . . . 0.0 111.361 177.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 mp -138.26 -61.61 0.6 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.83 115.23 0.61 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 175.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.4 t -158.15 155.79 29.74 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 117.136 0.468 . . . . 0.0 110.543 -176.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -76.72 -7.62 55.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.554 0.693 . . . . 0.0 110.043 176.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -81.98 49.94 1.47 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.512 178.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -139.23 146.46 40.49 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.581 -176.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB2' HD22 ' A' ' 16' ' ' LEU . 40.9 t -89.78 108.05 22.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.7 Cg_exo -63.37 -20.47 70.29 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.743 2.296 . . . . 0.0 112.839 -177.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -66.57 -44.45 90.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.609 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.07 -20.26 14.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.7 mt 59.1 22.02 10.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.096 0.959 . . . . 0.0 112.848 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.6 mtm -98.19 -65.69 0.95 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.485 176.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.51 -169.82 0.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 9' ' ' CYS . 96.5 mt -100.44 108.47 20.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.43 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 3.3 tpm_? -69.83 -42.34 73.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.29 -15.52 9.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 -177.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.93 82.17 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 57' ' ' PHE . 19.6 m -115.97 114.88 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.299 0.571 . . . . 0.0 110.661 176.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.56 129.49 34.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.307 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.4 p -77.96 168.21 29.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.125 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.4 -28.77 81.81 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.556 2.17 . . . . 0.0 111.731 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.454 ' HB2' ' OE1' ' A' ' 49' ' ' GLU . 27.6 p -84.5 -21.53 30.55 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.675 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.42 4.22 22.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.792 177.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -88.65 149.68 23.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.209 0.504 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -116.77 136.32 53.05 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.673 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.471 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.7 m-85 -139.86 170.01 16.66 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 28.3 m -83.26 147.65 27.85 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -69.36 -7.76 40.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -173.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.88 -16.62 12.68 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.708 -178.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 46.0 m -82.52 -46.28 13.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.58 -41.66 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.438 ' HA ' HG12 ' A' ' 37' ' ' ILE . 91.3 mt -63.06 -41.83 94.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 111.707 -178.205 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.66 -1.81 32.85 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.869 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 m -106.15 -20.84 13.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 34' ' ' ILE . 37.7 pt -102.99 -9.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.967 -176.143 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -99.04 7.81 45.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.12 0.962 . . . . 0.0 108.533 167.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -114.94 -56.03 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.361 -179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.3 -70.07 0.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.163 176.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.04 172.88 40.36 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 74.4 m80 -80.4 69.12 6.8 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.707 0.765 . . . . 0.0 111.525 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 9.6 ptpp? -148.05 152.75 37.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.0 177.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.5 p -77.13 128.34 81.21 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.84 -22.24 69.07 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.148 1.899 . . . . 0.0 112.684 -176.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.97 -50.49 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -138.84 17.23 2.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.79 33.97 17.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.344 1.058 . . . . 0.0 113.654 170.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 56.6 mt-10 -89.12 153.06 21.26 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.712 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.4 121.82 15.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 111.302 -175.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 6.5 tt -120.6 126.27 49.85 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.131 -176.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.62 139.61 45.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.429 178.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.46 -42.8 91.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.426 -174.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -69.33 -23.43 63.78 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.8 mm-40 -74.92 -14.87 60.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.482 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.05 145.65 44.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.452 ' O ' HG12 ' A' ' 20' ' ' VAL . 90.9 m-85 -83.31 127.29 69.28 Favored Pre-proline 0 C--N 1.313 -0.981 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -55.55 -40.57 84.66 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 122.541 2.161 . . . . 0.0 112.825 -178.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.71 -67.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.296 1.439 . . . . 0.0 111.418 -175.072 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -87.96 104.86 17.02 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.78 0.8 . . . . 0.0 109.632 174.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -98.15 129.8 44.93 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.12 140.82 58.91 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.29 0.567 . . . . 0.0 111.921 -174.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.494 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.874 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.962 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.378 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.52 148.32 78.52 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.344 2.029 . . . . 0.0 110.866 178.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.87 127.08 41.58 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.371 0.605 . . . . 0.0 110.925 -173.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.92 47.82 0.38 Allowed Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 177.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.9 m -82.01 158.45 23.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.353 -0.423 . . . . 0.0 110.993 -175.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HZ1' ' HB3' ' A' ' 6' ' ' LYS . 1.2 ptpm? -82.27 14.21 3.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.22 0.533 . . . . 0.0 111.826 -178.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -97.82 25.68 5.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.081 178.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -93.98 138.84 31.65 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.836 -179.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.515 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.3 t -93.62 111.34 52.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.13 -19.54 50.93 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.435 2.09 . . . . 0.0 113.678 -174.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.27 -44.84 83.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.8 p -103.73 -21.49 13.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.021 -174.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp 65.41 21.29 11.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.349 1.06 . . . . 0.0 110.617 -175.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.4 mmt -95.52 -75.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -179.31 162.58 1.18 Allowed 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 9' ' ' CYS . 92.5 mt -79.75 103.37 9.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.052 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -71.18 -44.94 64.48 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.656 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -112.4 -17.17 12.76 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.94 -177.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.13 73.31 0.16 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -93.59 117.57 37.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.953 175.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.28 142.0 34.98 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.04 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -108.96 168.21 8.06 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 177.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.85 -33.32 94.44 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 123.042 2.494 . . . . 0.0 113.031 -176.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 p -74.68 -14.55 60.76 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.961 0.41 . . . . 0.0 111.852 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.46 1.0 50.27 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.372 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -79.26 146.72 32.85 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.54 -0.388 . . . . 0.0 110.603 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -122.59 138.44 54.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.466 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 91.1 m-85 -140.91 170.13 16.32 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.186 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -81.1 159.24 24.77 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' O ' HD12 ' A' ' 34' ' ' ILE . 7.1 ttpm? -68.94 -11.37 60.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.438 0.637 . . . . 0.0 111.169 -176.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.94 -16.75 12.14 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.823 -179.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.9 m -83.91 -51.7 6.95 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.466 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 10.9 tp -69.26 -39.29 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.771 -178.082 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.598 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.1 mt -62.85 -42.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.459 ' HZ2' ' HB3' ' A' ' 35' ' ' LYS . 3.8 mmmp? -79.53 9.51 4.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 178.011 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 m -109.6 -25.99 10.15 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.723 170.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.1 pt -103.96 -27.67 3.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -173.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -100.1 2.89 43.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.705 0.764 . . . . 0.0 108.957 175.097 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -116.05 -56.54 2.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.765 -171.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.88 -69.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.085 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.43 159.89 33.31 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.848 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -79.03 67.52 4.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.7 pttm -152.72 150.26 29.24 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.949 173.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.4 p -79.73 124.48 83.49 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.91 -28.68 75.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.929 2.42 . . . . 0.0 114.69 -168.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.72 -48.19 83.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -119.06 6.4 11.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 51.74 40.02 26.66 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.551 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 66.5 mm-40 -89.87 138.37 31.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.38 121.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.79 128.92 52.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.457 -173.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.03 150.47 27.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -59.59 -37.0 77.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.896 0.379 . . . . 0.0 111.114 -174.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -65.39 -28.73 69.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 179.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -66.79 -21.64 66.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.848 179.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.59 126.69 30.48 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -89.2 163.62 33.46 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.463 -176.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.17 151.69 77.08 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.893 2.395 . . . . 0.0 110.546 176.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.83 138.55 47.97 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.317 0.58 . . . . 0.0 111.107 -173.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.04 -10.25 59.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.329 -175.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -75.03 140.93 43.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.101 0.477 . . . . 0.0 110.502 179.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.51 146.57 26.91 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--N 1.31 -1.147 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.069 -178.543 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.456 ' H3 ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 CA--C 1.504 -0.619 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.08 -42.37 23.78 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 113.177 -178.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.2 tp -66.74 -43.25 84.67 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.068 0.461 . . . . 0.0 110.937 177.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.6 -179.57 48.68 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 p -113.2 1.5 15.26 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 117.217 0.508 . . . . 0.0 111.689 178.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -78.59 138.51 38.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.56 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 95.3 m-85 73.35 12.51 4.77 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.338 1.055 . . . . 0.0 110.49 -172.004 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' CD ' ' H3 ' ' A' ' 1' ' ' GLY . 42.9 tt0 -120.4 127.33 52.19 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.214 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.7 t -66.32 110.19 4.41 Favored Pre-proline 0 N--CA 1.444 -0.747 0 O-C-N 123.73 0.643 . . . . 0.0 109.632 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.54 -18.14 53.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 112.339 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.03 -43.6 92.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.841 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.3 p -106.06 -17.88 14.2 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.15 26.77 12.54 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.714 0.806 . . . . 0.0 112.223 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.3 mtm -98.48 -64.99 0.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.51 175.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.66 -169.14 0.07 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 85.5 mt -94.99 104.51 16.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -70.82 -45.89 63.77 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.38 -176.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -110.17 -15.92 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.013 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.39 86.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.271 0.982 . . . . 0.0 112.174 -177.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.12 119.81 62.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.37 0.605 . . . . 0.0 111.638 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -80.33 136.0 36.32 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.75 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.42 ' HB ' HD23 ' A' ' 51' ' ' LEU . 31.2 p -98.24 159.34 30.9 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.138 176.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.93 -27.88 85.48 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.373 2.049 . . . . 0.0 112.771 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.631 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 6.6 p -77.61 -26.14 50.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.906 0.384 . . . . 0.0 111.41 178.683 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.52 43.11 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.436 175.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.631 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 57.1 m-70 -130.77 133.58 46.12 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -104.99 134.35 48.24 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 120.998 0.427 . . . . 0.0 112.062 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -135.31 -172.52 3.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.725 -176.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.5 m -89.84 151.89 21.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.91 -12.12 61.38 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 121.028 0.442 . . . . 0.0 111.853 -173.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.85 -18.44 12.27 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.653 -0.654 . . . . 0.0 110.713 -178.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.4 m -79.2 -45.94 18.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.071 0.463 . . . . 0.0 110.333 176.43 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.17 -40.49 82.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 C-N-CA 120.439 -0.505 . . . . 0.0 111.605 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.5 mt -63.15 -43.66 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -80.07 -1.64 40.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.299 0.571 . . . . 0.0 111.058 -174.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.2 p -106.5 -18.42 13.98 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 121.831 -0.543 . . . . 0.0 111.242 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.56 -18.47 6.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.127 -177.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -106.33 7.89 31.5 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.018 174.429 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -114.71 -54.3 2.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.291 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -69.47 0.61 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 0.0 109.805 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.13 159.43 32.8 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 176.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -77.64 67.92 3.63 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.887 0.851 . . . . 0.0 112.036 -179.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -147.52 150.97 35.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.219 177.573 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -76.05 129.77 79.87 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.968 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -22.54 74.39 Favored 'Trans proline' 0 N--CA 1.478 0.575 0 C-N-CA 122.97 2.447 . . . . 0.0 113.379 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.56 -72.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.208 0.528 . . . . 0.0 111.511 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -104.83 4.26 31.96 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.28 36.18 25.46 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -87.13 151.78 22.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -66.07 119.82 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -119.43 122.37 41.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.137 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -105.1 141.19 37.09 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.61 -39.36 94.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.261 0.553 . . . . 0.0 111.002 -175.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.01 -30.06 71.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.518 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -76.51 -8.01 56.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.08 -176.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.81 141.32 46.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.674 0.274 . . . . 0.0 110.836 179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -151.93 148.12 21.06 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.699 178.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.34 146.1 97.62 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.779 2.319 . . . . 0.0 112.194 178.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.59 -42.88 98.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.657 177.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.01 -41.18 91.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.621 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -86.24 118.08 25.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.423 0.63 . . . . 0.0 111.912 -174.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.01 150.58 39.05 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.196 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--N 1.302 -1.499 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 178.699 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.681 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.99 146.78 66.09 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.597 2.198 . . . . 0.0 112.784 -177.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -100.28 117.4 34.4 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.06 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.05 -166.79 52.16 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -174.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.8 m -84.06 109.88 18.02 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 174.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -86.46 104.6 16.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.045 0.45 . . . . 0.0 110.635 -176.091 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -102.34 69.11 1.11 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.64 1.21 . . . . 0.0 110.379 175.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -143.42 129.16 19.32 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.525 -1.671 . . . . 0.0 107.546 -175.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -66.73 112.02 8.47 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 34.7 Cg_exo -61.82 -20.4 69.07 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.726 2.284 . . . . 0.0 112.432 -176.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.6 -43.93 90.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.69 178.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.1 p -105.55 -19.09 13.88 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.959 -176.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 57.16 23.12 8.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.921 0.888 . . . . 0.0 112.255 -179.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.5 mtm -96.0 -64.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.393 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.89 -165.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -174.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -103.93 125.97 50.71 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -80.18 -73.19 0.37 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.35 178.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -96.33 -16.59 21.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.05 90.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.121 0.968 . . . . 0.0 113.046 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 17.5 m -110.44 115.4 49.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.498 0.666 . . . . 0.0 111.136 175.015 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -82.56 133.49 35.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.662 176.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.1 p -93.11 164.99 19.48 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.168 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.78 -26.36 79.5 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.169 1.912 . . . . 0.0 112.144 176.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.451 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 35.7 m -70.45 -28.33 64.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.092 0.473 . . . . 0.0 110.488 176.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.78 9.86 29.7 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.916 -177.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.451 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 24.3 m-70 -88.1 144.35 26.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -111.68 130.79 55.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.94 176.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.46 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 99.2 m-85 -132.07 172.72 12.02 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.559 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' O ' HG22 ' A' ' 33' ' ' ILE . 59.7 m -82.99 150.27 26.48 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.12 -8.63 55.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.424 0.63 . . . . 0.0 110.496 -175.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.67 -29.96 7.26 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 69.1 m -70.08 -46.06 65.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.03 175.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -68.42 -41.6 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.601 -178.406 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.7 mt -63.61 -42.33 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -77.23 -1.94 32.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.416 0.627 . . . . 0.0 110.225 -177.018 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 m -105.88 -25.41 12.15 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.772 174.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 33' ' ' ILE . 46.0 pt -103.49 -9.18 9.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.859 -176.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.6 ptm180 -94.18 2.13 55.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.628 0.728 . . . . 0.0 109.213 174.075 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.35 -55.08 2.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.56 -71.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.396 178.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -178.22 -179.26 48.14 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.404 ' HE2' ' CD ' ' A' ' 53' ' ' GLU . 14.5 m170 -89.55 81.22 6.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.24 0.543 . . . . 0.0 112.194 -177.245 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -170.55 144.27 2.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.734 175.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 p -72.02 123.8 89.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.83 -25.28 74.52 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.031 2.487 . . . . 0.0 113.554 -170.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.61 -46.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -175.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.63 6.69 8.2 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.16 34.21 19.0 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 177.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 69.5 mm-40 -91.17 141.23 29.03 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.908 175.064 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.1 mp -66.57 121.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.123 0.487 . . . . 0.0 110.234 -174.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.0 tp -126.85 128.75 47.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.735 -175.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.416 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -112.27 154.59 25.39 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.43 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.404 ' CD ' ' HE2' ' A' ' 42' ' ' HIS . 55.7 mp0 -61.62 -37.08 82.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.117 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.93 -30.84 71.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.391 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 17.0 mm-40 -77.79 -9.16 58.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.239 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.62 139.5 45.52 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.669 -178.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -119.6 89.97 42.09 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 58.0 Cg_endo -69.24 141.84 48.51 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 121.917 1.744 . . . . 0.0 112.192 178.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -101.24 117.94 35.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.56 86.97 6.27 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.658 0.742 . . . . 0.0 112.867 -171.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -69.27 -38.04 78.2 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.46 151.85 26.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.167 175.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.8 pttt . . . . . 0 C--N 1.307 -1.241 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.663 179.238 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.193 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.87 141.0 97.65 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.57 2.18 . . . . 0.0 112.109 -175.677 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.8 tt 51.29 84.85 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.23 1.012 . . . . 0.0 110.252 -175.58 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.52 -55.58 0.6 Allowed Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.309 -179.126 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.0 p -138.76 73.95 1.45 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.667 -0.413 . . . . 0.0 112.112 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -75.87 -33.64 59.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.551 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -85.59 67.79 10.2 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.359 1.076 . . . . 0.0 110.147 173.535 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.56 120.9 35.16 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.098 -175.357 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 33.8 t -77.55 116.17 55.75 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.835 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -60.97 -20.86 69.24 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.037 1.825 . . . . 0.0 112.605 -177.225 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.89 -45.05 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.618 0.247 . . . . 0.0 111.376 178.324 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 12.0 p -109.06 -22.26 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.405 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 59.23 22.9 11.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.245 1.018 . . . . 0.0 112.121 -177.386 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -95.57 -66.46 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.34 176.393 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.08 -172.46 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 9' ' ' CYS . 96.4 mt -107.44 124.98 50.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.684 0.278 . . . . 0.0 110.31 175.199 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 19' ' ' ALA . 22.9 tpt180 -92.76 114.71 27.34 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.253 168.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 68.75 -16.21 0.22 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.594 1.158 . . . . 0.0 112.811 -179.445 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 50.31 82.78 0.05 OUTLIER 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 113.329 177.161 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.2 m -97.01 116.56 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.626 0.727 . . . . 0.0 110.474 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.65 142.6 32.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.844 -179.296 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -93.17 163.65 24.35 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.628 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.91 -34.17 96.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.701 2.268 . . . . 0.0 111.935 176.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.06 -14.47 62.69 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.122 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.82 23.26 18.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.283 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -106.93 129.9 54.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.359 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -106.24 132.95 51.69 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.588 -173.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.23 167.84 19.63 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.455 -176.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.1 m -71.62 147.82 47.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.753 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -67.88 -4.89 14.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.728 -179.33 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.97 -38.86 3.79 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.167 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.77 -46.1 80.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.1 tp -66.36 -41.63 89.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.953 -173.96 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.576 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.3 mt -63.61 -43.43 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.411 . . . . 0.0 110.128 -178.534 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -79.4 -2.08 40.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.855 -176.086 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 m -106.77 -20.24 13.4 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.649 177.016 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -103.15 -24.03 4.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.226 -174.588 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.2 ptm180 -99.95 7.4 44.84 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.115 176.124 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.26 -56.69 2.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.539 -178.336 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.08 -67.64 0.8 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.527 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.05 159.12 32.3 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.093 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 75.9 m80 -86.29 64.89 8.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.584 0.707 . . . . 0.0 111.916 -176.611 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.44 150.31 27.73 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.34 176.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -70.33 135.41 86.66 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.886 0.374 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.18 -23.94 75.86 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.101 2.534 . . . . 0.0 114.305 -171.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 m -91.39 -55.46 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.354 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -103.68 4.89 35.93 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.105 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 50.97 33.95 9.78 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.599 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -86.36 147.0 26.23 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.721 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.59 120.4 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 109.718 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.6 tp -120.2 130.59 54.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.223 -174.099 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.12 153.47 28.17 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.43 -36.34 83.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.43 -31.02 72.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.681 176.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -77.97 -8.61 58.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.81 131.05 41.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -75.2 157.58 84.89 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.181 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.68 165.02 21.95 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.126 2.551 . . . . 0.0 111.999 177.55 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -54.26 148.77 10.87 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.661 -174.664 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 29.5 t30 -60.33 -76.42 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.981 -178.467 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -160.23 133.6 6.86 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.493 -175.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.89 98.3 0.73 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.113 0.482 . . . . 0.0 110.134 177.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 tptt . . . . . 0 C--N 1.308 -1.196 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.036 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.37 -36.16 86.51 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.584 2.856 . . . . 0.0 113.092 -178.974 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.7 mt -106.45 122.7 46.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 120.942 0.401 . . . . 0.0 110.55 175.819 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.65 -7.38 42.28 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 174.087 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.9 p -85.35 -6.04 59.26 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.438 0.695 . . . . 0.0 111.067 -178.45 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -80.3 178.47 8.26 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.877 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -90.47 85.26 6.1 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.65 0.738 . . . . 0.0 111.314 -171.695 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -169.71 127.46 0.91 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.317 179.318 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 p -92.67 134.31 27.98 Favored Pre-proline 0 C--N 1.313 -0.996 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.607 -177.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.9 -19.85 56.94 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.869 2.379 . . . . 0.0 112.19 -178.115 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.02 -44.94 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.092 -177.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -120.31 -20.21 7.37 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.253 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt 60.52 27.96 17.62 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.873 0.869 . . . . 0.0 111.908 -173.499 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.1 mtm -103.16 175.34 5.51 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.092 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.22 148.37 49.94 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.505 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.1 mt -78.76 130.43 35.75 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -68.1 -60.28 2.6 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -107.52 -15.05 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -178.263 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.01 90.23 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.792 -177.494 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 116.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.684 0.754 . . . . 0.0 111.368 179.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -81.15 136.86 35.94 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.709 177.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.2 p -94.59 160.37 31.66 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -54.71 -37.52 91.6 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 112.525 178.107 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.587 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.0 OUTLIER -70.37 -20.56 62.95 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 178.386 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.8 4.29 24.64 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.442 174.067 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.587 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 77.8 m-70 -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.241 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -101.56 132.58 47.13 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.322 177.084 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.71 165.39 24.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.479 179.432 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.612 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -80.97 159.52 24.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.037 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' O ' HD11 ' A' ' 34' ' ' ILE . 88.3 tttt -76.8 -12.93 60.05 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.326 -172.043 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.91 -10.95 12.88 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 -179.383 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.5 m -85.45 -57.87 2.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.334 177.787 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -66.77 -41.04 87.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -175.909 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.624 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.9 mt -63.24 -43.49 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 111.078 -177.099 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 35' ' ' LYS . 4.2 tppp? -79.33 -1.47 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -176.751 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -104.61 -17.82 14.55 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.32 177.33 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -104.34 -30.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.923 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.1 ptm180 -96.72 2.39 51.98 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.442 178.113 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -115.9 -54.63 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.302 179.5 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.81 -69.17 0.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 0.0 110.524 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -164.8 155.14 26.37 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 176.893 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -80.04 70.41 6.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.528 0.664 . . . . 0.0 111.686 -177.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.494 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -144.94 152.21 39.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.919 178.571 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.3 t -74.65 122.95 88.64 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.48 -34.25 97.7 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.241 2.627 . . . . 0.0 114.278 -172.066 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 m -83.19 -50.72 15.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -172.472 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -104.68 5.19 33.33 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.66 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.1 32.68 20.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.721 0.808 . . . . 0.0 112.29 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -87.75 149.0 24.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.198 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.84 121.32 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.29 119.68 32.91 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.389 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.488 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -102.54 153.7 19.82 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.08 -178.671 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.41 -40.09 96.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.465 0.706 . . . . 0.0 111.532 -174.005 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -68.37 -20.8 64.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.488 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.3 mm100 -75.11 -9.95 59.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.444 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.56 138.58 46.97 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.377 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -113.31 106.87 54.23 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.993 177.433 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.89 155.95 57.16 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.64 2.227 . . . . 0.0 111.676 176.857 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -60.96 134.49 57.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.929 -179.312 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -63.21 -46.2 88.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 -175.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -66.11 -46.06 78.92 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.022 0.439 . . . . 0.0 111.643 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.88 87.51 4.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.387 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp . . . . . 0 C--N 1.315 -0.914 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.907 -173.654 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.245 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.07 152.43 62.46 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.815 2.344 . . . . 0.0 111.606 177.52 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.65 119.39 31.49 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.708 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.73 172.23 48.68 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -176.092 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -109.41 118.88 37.8 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.533 178.616 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -145.9 172.66 13.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.221 -179.457 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.524 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 91.0 m-85 60.67 37.64 19.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -173.984 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -121.69 133.17 54.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.9 -175.443 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.0 t -79.82 109.22 11.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.84 -19.42 65.54 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.863 2.375 . . . . 0.0 112.722 -175.265 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.93 -43.82 92.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.006 0.431 . . . . 0.0 111.26 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.38 -21.05 15.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.789 -177.018 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 65.94 20.33 11.32 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 111.633 -177.699 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -99.64 -71.03 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.088 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.33 -162.6 0.13 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -174.311 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.2 mt -106.57 125.82 51.48 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.182 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -84.47 -71.35 0.52 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.896 175.31 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -89.76 -16.23 30.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.82 178.707 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.89 77.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.252 0.621 . . . . 0.0 111.592 -176.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 21.1 m -92.3 116.8 34.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.042 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.31 129.89 34.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.732 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -92.27 164.9 21.25 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.338 177.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.58 -36.44 94.54 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 112.32 178.265 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.7 -20.49 62.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.071 -178.135 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.0 6.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.98 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -113.33 154.35 27.0 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.459 -0.436 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 81.9 mtm180 -123.47 137.56 54.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.048 0.452 . . . . 0.0 111.522 -176.321 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.424 ' O ' HG21 ' A' ' 20' ' ' VAL . 95.7 m-85 -138.91 172.93 12.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.75 -177.104 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.0 m -84.74 153.85 22.79 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.725 0.298 . . . . 0.0 110.33 175.647 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.15 -14.78 63.24 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.837 0.855 . . . . 0.0 111.886 -176.466 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.78 -13.81 12.01 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.048 -176.766 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 52.5 m -87.84 -47.91 8.24 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.078 177.772 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.36 -38.51 79.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.8 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.8 mt -62.67 -42.43 96.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.425 . . . . 0.0 110.561 -177.769 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -77.64 -1.66 32.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.806 0.813 . . . . 0.0 109.962 -178.542 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 16.2 t -105.3 -21.82 13.17 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.88 -0.513 . . . . 0.0 109.982 177.009 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.64 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.5 pt -104.97 -28.06 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.391 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -96.01 -7.55 36.05 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.708 177.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -115.11 -40.95 3.39 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.308 -175.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 36' ' ' SER . . . -91.66 -72.94 0.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.969 0.414 . . . . 0.0 110.012 176.587 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.17 157.61 30.14 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.927 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -82.82 69.67 9.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.493 0.663 . . . . 0.0 111.979 -176.3 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -150.91 153.11 34.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.796 -179.781 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 p -77.34 133.56 67.81 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.039 171.793 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.07 -23.8 75.99 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 123.015 2.477 . . . . 0.0 114.244 -170.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -90.5 -61.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.206 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -100.91 4.22 42.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.637 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.33 35.23 25.49 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.046 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 71.2 mm-40 -83.5 150.67 25.85 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.782 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -66.71 121.18 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.109 0.48 . . . . 0.0 109.903 -177.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -126.7 129.86 49.25 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.325 -175.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.87 156.49 23.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.622 178.478 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.6 mp0 -61.23 -39.05 88.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.612 0.365 . . . . 0.0 110.66 -178.894 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -74.96 -10.2 59.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 0.0 111.407 179.563 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -91.48 -7.76 49.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.026 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 96.5 mt -73.84 155.42 38.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.774 179.059 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 97.2 m-85 80.29 149.4 0.12 Allowed Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.451 1.101 . . . . 0.0 111.728 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.56 148.01 94.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.363 2.042 . . . . 0.0 109.58 173.6 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -57.89 108.67 0.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.0 0.429 . . . . 0.0 111.064 -176.454 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -149.2 133.4 17.34 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.339 176.511 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -122.39 104.58 9.5 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.738 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.09 165.7 30.03 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.128 -174.7 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? . . . . . 0 C--N 1.312 -1.062 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.268 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.851 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -60.88 139.33 84.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.424 2.082 . . . . 0.0 112.44 -177.626 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.93 -43.02 89.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.496 0.665 . . . . 0.0 110.683 177.596 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.85 74.4 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -178.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.9 p -74.56 101.25 4.14 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -168.248 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -86.16 -5.93 59.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.832 172.644 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.77 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 88.6 t80 -63.91 -16.18 60.82 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.556 170.247 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 44.2 mt-10 -100.3 115.85 30.91 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.466 174.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 t -56.27 112.95 5.01 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.494 177.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.1 -20.95 71.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.7 2.267 . . . . 0.0 112.461 -173.569 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.49 -44.07 90.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.464 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -108.09 -21.25 12.87 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.647 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 56.53 30.23 16.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.824 0.849 . . . . 0.0 111.754 -175.265 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -96.29 -66.91 0.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 173.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -179.53 -172.65 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -176.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.77 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 95.5 mt -93.93 103.61 15.7 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.273 174.13 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -66.51 -43.97 83.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.904 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.688 ' HA ' ' ND2' ' A' ' 60' ' ' ASN . 76.3 mm-40 -123.0 -15.02 7.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.797 179.587 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.93 56.54 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.203 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 28' ' ' PHE . 27.3 m -76.84 116.09 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.36 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -80.6 121.32 25.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.527 -176.438 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -88.8 160.83 43.16 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.55 -30.75 89.56 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 178.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -14.72 62.89 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.319 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.02 5.07 44.46 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.375 -0.916 . . . . 0.0 114.251 174.518 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.79 168.33 10.56 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.434 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.6 mtt180 -127.3 142.22 51.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 112.016 -169.784 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.474 ' O ' HG21 ' A' ' 20' ' ' VAL . 99.2 m-85 -131.42 170.23 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.769 178.583 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.571 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 53.3 m -80.19 148.19 30.98 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.555 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -68.62 -13.16 62.17 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -174.414 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.21 -17.8 12.69 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.8 m -79.59 -45.51 19.03 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.665 173.107 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -66.47 -40.95 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.832 -176.641 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.84 -42.63 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 111.006 -179.15 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -78.72 -1.9 36.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.352 0.596 . . . . 0.0 110.149 -174.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 m -105.32 -23.08 12.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.299 177.296 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.9 pt -104.76 -5.36 9.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.256 -177.784 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -96.82 -15.73 21.15 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.618 176.968 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -116.52 -56.09 2.32 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.145 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.28 -65.79 0.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 110.692 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.86 155.36 26.6 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -84.65 54.62 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 122.073 0.94 . . . . 0.0 109.111 -176.204 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -147.44 154.17 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.301 -175.357 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 45.3 t -61.65 123.02 75.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.112 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.05 -35.82 99.06 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.166 2.577 . . . . 0.0 114.123 -172.042 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -82.67 -45.96 19.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.12 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -114.95 5.57 15.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 56.58 33.45 22.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.337 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -92.2 149.71 21.32 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.209 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.4 121.66 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.074 0.464 . . . . 0.0 110.589 -176.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 tp -126.13 127.81 46.34 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.224 -179.746 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.48 143.91 30.9 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.656 176.78 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.53 -36.59 84.27 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.303 1.041 . . . . 0.0 110.203 -175.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.4 -30.25 71.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.973 177.846 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -64.89 -29.11 70.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.146 0.498 . . . . 0.0 110.884 179.54 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.84 142.11 53.14 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.556 -176.7 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -65.12 143.7 98.9 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.842 -177.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.42 -43.48 51.32 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.956 2.437 . . . . 0.0 112.772 177.173 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -178.93 154.28 0.69 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.782 0.325 . . . . 0.0 111.049 -176.152 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.688 ' ND2' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -116.94 -1.42 11.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.707 0.765 . . . . 0.0 109.19 168.807 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -113.28 122.63 48.01 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.623 -176.764 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.16 128.17 35.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.141 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 tttp . . . . . 0 C--O 1.25 1.113 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -176.291 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.069 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.46 150.72 75.78 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.819 2.346 . . . . 0.0 111.54 179.054 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.7 tp -67.18 104.65 1.5 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.083 0.468 . . . . 0.0 111.671 -177.221 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.86 -7.48 23.55 Favored Glycine 0 N--CA 1.44 -1.033 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 175.548 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -72.65 150.36 43.06 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.665 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 27' ' ' ARG 0.273 21.3 pttm -74.05 67.59 1.31 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.747 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.653 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 94.8 m-85 -119.57 13.77 12.59 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.688 167.095 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -119.25 137.08 53.9 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.975 -179.552 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 41.8 t -83.75 110.81 27.68 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -177.769 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.43 -18.81 49.65 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.069 1.846 . . . . 0.0 112.301 -176.663 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.52 -43.51 90.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 178.874 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 25.4 p -109.83 -6.41 15.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.526 -176.687 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.89 33.19 22.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.902 0.881 . . . . 0.0 111.1 -175.593 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -127.52 167.44 16.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.379 178.893 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 151.12 37.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 93.7 mt -69.89 118.35 12.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.867 0.365 . . . . 0.0 110.393 -173.416 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -69.39 -45.62 68.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.323 179.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -116.92 -16.54 10.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.04 87.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.135 0.897 . . . . 0.0 112.737 -178.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -105.39 117.23 50.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.51 0.672 . . . . 0.0 111.476 176.204 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -73.16 132.54 43.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.137 175.155 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 p -106.29 159.04 31.16 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 178.759 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.8 -24.41 74.52 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.88 2.386 . . . . 0.0 113.01 -179.807 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.1 p -79.48 -14.66 58.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 111.203 178.483 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.61 8.36 37.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.566 175.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -99.23 162.05 13.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.696 0.248 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 77.5 mtt85 -124.1 137.61 54.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.916 0.389 . . . . 0.0 110.214 177.824 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.23 167.49 21.73 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.869 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.0 m -76.28 156.7 33.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.083 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.73 -3.97 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.139 0.495 . . . . 0.0 111.382 -170.669 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.74 -26.59 7.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.761 0.315 . . . . 0.0 110.381 178.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -71.86 -45.9 59.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.318 179.377 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -65.96 -38.24 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.238 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.53 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.2 mt -62.25 -42.31 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 110.386 177.987 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.84 -0.5 30.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.656 0.741 . . . . 0.0 110.452 -177.332 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -104.75 -25.33 12.71 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.915 -0.49 . . . . 0.0 109.793 177.325 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.1 pt -103.81 -15.17 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.001 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -106.78 -2.34 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.286 175.244 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.67 -50.79 2.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.733 -175.562 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.69 -68.8 0.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 -179.784 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.25 154.76 25.83 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 178.512 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -81.01 45.4 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.65 0.738 . . . . 0.0 110.927 -173.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -144.25 154.42 43.07 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.956 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.0 p -64.1 135.41 96.31 Favored Pre-proline 0 N--CA 1.445 -0.688 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.257 177.499 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.23 -29.61 80.58 Favored 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 122.839 2.359 . . . . 0.0 113.593 -172.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.86 -71.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.18 0.514 . . . . 0.0 111.697 -174.028 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -95.65 4.56 52.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.549 -173.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.93 34.17 24.43 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 169.39 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -87.45 141.96 28.23 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.624 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mp -65.24 119.5 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tt -110.51 127.67 55.28 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -168.49 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' HB2' HE21 ' A' ' 55' ' ' GLN . 3.8 mm? -96.88 132.87 42.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.913 178.54 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.26 -35.43 80.4 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -173.994 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -63.56 -29.72 70.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 178.108 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 52' ' ' LEU . 50.2 mt-30 -80.34 -7.86 59.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.503 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.23 125.97 28.32 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.956 177.205 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.49 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 30.2 t80 69.8 145.19 0.11 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.967 0.907 . . . . 0.0 109.789 -179.342 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 57' ' ' PHE . 33.5 Cg_endo -61.51 148.82 92.05 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.928 1.752 . . . . 0.0 111.877 178.05 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -61.36 122.28 14.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.473 -173.843 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -99.2 145.7 26.96 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.706 -179.411 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -111.57 126.57 55.14 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.797 174.73 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.13 89.99 6.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.16 0.505 . . . . 0.0 111.16 -176.063 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm . . . . . 0 C--N 1.31 -1.109 0 CA-C-O 118.503 -0.76 . . . . 0.0 108.983 175.589 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.97 144.96 96.95 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.805 2.336 . . . . 0.0 111.149 176.603 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.0 tt -75.25 127.72 33.81 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.162 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.36 -3.46 58.02 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.724 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.3 m -130.63 150.86 51.63 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.791 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.42 146.49 32.52 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.339 179.524 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.563 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 92.7 m-85 -101.11 41.65 1.17 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.487 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -123.18 124.41 42.97 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.871 -172.579 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.92 112.52 9.95 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.712 0.632 . . . . 0.0 109.689 175.864 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -63.12 -20.37 70.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.248 1.966 . . . . 0.0 112.87 -178.343 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -66.08 -44.43 91.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.2 p -105.24 -19.19 13.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.635 -177.791 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 57.0 26.7 12.22 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.791 0.836 . . . . 0.0 111.797 -176.658 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.88 -65.73 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.023 0.44 . . . . 0.0 110.469 176.689 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.3 -164.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -177.326 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 92.9 mt -103.3 113.76 27.5 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 172.512 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -63.91 -44.98 91.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 178.018 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -132.52 -7.18 3.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 178.608 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.15 92.47 0.07 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 175.623 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -117.19 111.63 35.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 110.289 171.594 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -80.94 143.43 32.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.385 178.638 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -108.82 154.68 41.66 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.272 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 55' ' ' GLN . 40.6 Cg_endo -65.37 -20.01 61.6 Favored 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 122.742 2.295 . . . . 0.0 111.463 177.448 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.4 t -73.99 -15.06 61.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.077 179.01 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.07 22.2 18.23 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.234 178.4 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -113.03 152.12 29.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.587 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -120.01 136.04 54.7 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.696 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.408 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 94.8 m-85 -136.67 172.99 12.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.092 0.472 . . . . 0.0 110.502 -177.024 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -82.01 152.0 26.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 171.05 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.87 -10.7 58.44 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -177.489 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 -12.32 12.82 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.711 -0.618 . . . . 0.0 110.205 179.325 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 70.9 m -85.92 -62.94 1.41 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.982 177.573 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -67.79 -39.9 82.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.062 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.722 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.5 mt -63.04 -43.38 98.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 0.0 110.523 -178.504 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -79.53 0.79 28.34 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.714 0.768 . . . . 0.0 109.729 -178.561 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 t -106.38 -23.76 12.44 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.992 -0.442 . . . . 0.0 110.83 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.0 pt -103.96 -26.09 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.384 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -97.41 3.43 50.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.423 0.63 . . . . 0.0 109.773 176.553 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -116.66 -55.88 2.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.76 -72.93 0.52 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.108 179.809 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -158.46 160.46 30.98 Favored Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 178.55 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -85.42 71.08 10.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.373 0.606 . . . . 0.0 111.162 -176.242 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -152.22 150.61 30.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.764 178.023 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 9.2 p -79.9 122.03 82.84 Favored Pre-proline 0 N--CA 1.429 -1.519 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.689 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.98 -18.43 62.16 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.652 2.235 . . . . 0.0 113.274 -170.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.0 -48.44 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -133.53 13.77 4.1 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.621 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER 63.04 21.44 12.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 174.214 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 72.2 mm-40 -72.66 142.52 48.28 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.564 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.5 mm -66.4 121.05 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.973 0.416 . . . . 0.0 110.605 -176.39 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.1 tp -128.16 134.4 49.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.056 -177.456 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -116.89 155.27 29.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' OE2' ' HD2' ' A' ' 38' ' ' ARG . 48.8 mt-10 -62.85 -36.48 83.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.16 0.505 . . . . 0.0 110.299 179.273 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.13 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.931 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.459 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.6 mm100 -79.8 -7.69 58.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.489 -174.082 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.01 140.99 50.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.966 0.413 . . . . 0.0 110.844 179.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -77.17 147.26 76.21 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.116 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -55.99 139.6 84.99 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.399 2.066 . . . . 0.0 113.476 -174.481 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -83.39 147.48 27.87 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.929 -179.23 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -143.28 100.24 3.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.206 0.527 . . . . 0.0 111.697 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -151.01 106.72 3.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 173.154 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' O ' ' HD2' ' A' ' 63' ' ' LYS . . . -99.75 111.72 24.02 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -169.051 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 31.7 mmmt . . . . . 0 C--O 1.243 0.728 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.364 176.067 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.069 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.95 148.73 51.94 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.467 2.111 . . . . 0.0 111.641 177.226 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.22 97.25 7.79 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.822 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.84 -23.1 24.04 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.7 179.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.7 t -146.92 145.18 29.71 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.612 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.75 79.45 8.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.745 0.783 . . . . 0.0 109.272 -176.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.477 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 60.7 t80 -115.83 16.24 16.29 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.481 -176.018 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -102.93 135.06 45.31 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.93 -176.836 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.515 ' HB2' HD21 ' A' ' 16' ' ' LEU . 46.9 t -96.19 109.41 47.05 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.39 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.22 -19.47 62.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.038 1.825 . . . . 0.0 112.736 -174.438 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.61 -43.92 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.832 0.349 . . . . 0.0 111.288 178.284 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.6 p -106.51 -4.38 19.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.696 -177.131 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt 55.16 34.35 22.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.349 0.66 . . . . 0.0 111.135 -177.518 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -133.12 -174.76 3.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.368 179.286 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.17 157.38 37.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 9' ' ' CYS . 95.1 mt -70.62 134.33 47.49 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -86.05 -73.45 0.45 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.783 177.64 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -93.1 -16.35 25.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 178.125 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.32 66.46 1.23 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.183 -179.29 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.5 m -85.36 117.7 30.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.135 0.493 . . . . 0.0 111.114 -179.367 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.55 133.38 36.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.318 -177.095 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -101.34 157.67 33.23 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.472 -178.617 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -56.84 -33.51 94.83 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.713 2.276 . . . . 0.0 112.509 178.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 p -69.49 -26.08 64.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.98 -178.4 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.56 51.1 0.72 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.135 -178.225 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -138.51 159.68 41.46 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 122.732 0.413 . . . . 0.0 110.909 177.582 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -126.27 135.73 51.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.169 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.6 m-85 -139.7 169.76 17.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.522 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 24.5 m -79.2 152.09 30.87 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 173.099 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.23 -13.57 62.48 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -173.877 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.08 -3.49 13.97 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.632 -178.771 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.7 m -91.55 -59.62 2.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.401 174.663 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.1 tp -68.46 -39.75 81.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.435 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.502 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.3 mt -63.13 -41.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.057 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.07 -0.97 30.08 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.555 0.693 . . . . 0.0 109.628 -178.265 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.25 -18.68 13.93 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.075 -0.391 . . . . 0.0 111.323 175.418 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -105.06 -30.08 2.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -177.118 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptm180 -98.4 4.19 48.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.554 178.999 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.56 -56.15 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.641 -179.023 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 -74.38 0.36 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 178.634 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.51 155.7 26.88 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -79.23 66.06 4.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.078 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.2 ptpp? -152.54 149.81 28.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.223 174.435 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.8 p -74.4 127.12 88.13 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.263 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.24 -23.81 77.76 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.282 2.655 . . . . 0.0 113.806 -171.197 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.422 HG11 ' OD1' ' A' ' 47' ' ' ASP . 4.4 p -77.1 -51.11 19.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.112 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.422 ' OD1' HG11 ' A' ' 46' ' ' VAL . 13.0 p-10 -117.59 6.4 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.1 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 59.66 35.01 22.32 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.6 mm-40 -95.41 140.13 30.72 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.978 -0.451 . . . . 0.0 110.677 176.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.65 121.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.087 0.47 . . . . 0.0 110.131 -176.544 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -122.73 134.59 54.45 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.62 -176.327 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.9 mt -114.36 147.65 38.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.933 178.752 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.435 ' OE2' ' HB3' ' A' ' 38' ' ' ARG . 53.8 mp0 -62.75 -35.89 81.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 0.0 109.464 179.179 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -65.52 -29.77 70.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.239 -179.639 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -71.18 -27.79 63.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.166 0.508 . . . . 0.0 111.353 177.713 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.05 149.51 39.16 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.99 -179.236 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -61.16 133.88 92.91 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.806 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.53 -49.77 13.87 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.384 2.056 . . . . 0.0 112.752 -174.513 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.44 36.08 6.75 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.422 0.629 . . . . 0.0 112.099 -179.82 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -112.69 -70.27 0.82 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.04 -174.332 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -62.33 -46.11 90.19 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -175.085 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.17 13.21 9.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.799 -175.413 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm . . . . . 0 C--O 1.252 1.211 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.217 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -55.91 -39.51 90.7 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.281 2.654 . . . . 0.0 112.882 -179.392 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 tt -123.98 125.3 44.35 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.415 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.81 86.81 0.44 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.805 -178.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p -79.2 -2.23 40.03 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -175.071 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -71.17 -9.33 57.91 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.558 0.694 . . . . 0.0 110.414 173.343 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.607 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 98.0 m-85 -102.36 12.1 37.08 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.56 174.943 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -102.59 119.14 38.31 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.068 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.3 t -54.93 112.49 4.13 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.083 0.553 . . . . 0.0 110.684 179.432 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -62.21 -20.53 70.31 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.926 2.417 . . . . 0.0 113.35 -175.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -67.71 -44.74 85.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.336 176.229 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.45 -25.95 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.161 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 63.98 23.58 13.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.175 0.59 . . . . 0.0 111.787 -178.17 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -95.34 -66.3 0.92 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 109.64 178.913 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.69 -163.44 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -176.91 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 95.4 mt -106.23 124.81 50.16 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.812 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -79.06 -60.37 2.4 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.19 174.299 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -105.97 -14.98 15.03 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.252 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.45 90.83 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.2 117.4 52.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.035 0.445 . . . . 0.0 110.475 175.373 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -80.74 133.69 35.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.204 178.726 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.3 p -88.02 161.14 44.75 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 179.507 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.2 -29.82 88.71 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.097 2.531 . . . . 0.0 112.1 177.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.16 -21.2 63.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 179.52 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.84 36.67 2.34 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.813 173.825 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -149.74 167.22 27.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.352 0.576 . . . . 0.0 111.944 176.433 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -109.52 140.76 42.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.149 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.5 m-85 -132.49 167.19 20.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.962 173.249 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.574 ' O ' HG22 ' A' ' 33' ' ' ILE . 38.2 m -84.81 150.15 25.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.507 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.02 -8.83 56.11 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -172.573 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.73 -28.35 7.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.022 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -65.31 -52.96 50.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.362 0.601 . . . . 0.0 110.208 176.522 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -70.35 -40.5 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.947 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.586 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.48 -43.21 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.516 -176.749 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -78.88 -2.01 37.81 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.567 0.699 . . . . 0.0 110.359 -176.698 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 48.4 m -105.74 -18.56 14.03 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 175.683 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.7 pt -104.29 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.115 -178.267 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -95.08 -4.33 46.52 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.889 177.59 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.51 -47.49 2.73 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.398 -177.085 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 36' ' ' SER . . . -87.59 -69.69 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.03 157.71 30.3 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.534 179.047 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -87.91 18.59 4.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -176.41 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -95.92 140.83 30.12 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.005 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 53.0 t -60.79 130.85 91.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.36 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.51 -29.18 88.08 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -172.091 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.96 -55.63 5.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -103.2 4.38 36.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -173.137 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.6 29.5 15.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 173.898 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -79.81 145.54 32.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.36 119.5 13.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 179.012 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -125.45 131.78 52.82 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.437 -172.581 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.77 156.86 27.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -38.45 85.49 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.855 0.36 . . . . 0.0 110.952 -176.878 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -65.2 -30.51 71.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.826 178.723 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -80.15 -12.03 59.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.898 -176.068 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.65 100.39 5.35 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.024 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 84.5 t80 64.67 113.02 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -167.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.15 143.38 74.86 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.183 1.922 . . . . 0.0 111.849 -170.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -70.33 80.49 0.54 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.309 1.052 . . . . 0.0 112.988 -169.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -106.21 63.83 0.66 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.475 177.23 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -136.66 142.42 43.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.266 -178.288 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.54 144.73 41.77 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.145 177.594 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.31 -1.148 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.509 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.599 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.28 -29.58 80.22 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.936 2.424 . . . . 0.0 113.891 -176.802 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.6 tp -122.35 112.75 18.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.217 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.25 23.63 64.49 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.435 -0.802 . . . . 0.0 114.521 169.684 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -154.52 86.2 1.14 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.157 0.503 . . . . 0.0 110.695 -179.852 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -101.37 68.93 1.23 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.609 1.195 . . . . 0.0 111.731 179.109 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.592 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 98.3 m-85 -102.76 12.37 36.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.346 174.924 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -117.64 122.17 42.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.989 175.572 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.8 t -61.92 112.66 6.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.192 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -62.06 -21.32 72.21 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.569 2.18 . . . . 0.0 112.793 -174.254 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.39 -44.17 90.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.085 0.469 . . . . 0.0 111.777 179.53 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.5 p -106.06 -19.37 13.74 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.598 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.2 mt 53.47 28.47 7.65 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -175.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -95.61 -65.5 0.97 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.259 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.66 -171.47 0.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.2 mt -97.58 109.06 21.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.28 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -70.28 -44.68 67.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.806 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 54.7 mm-40 -111.9 -16.48 13.12 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.098 -177.14 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.41 82.19 0.09 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 177.407 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.95 116.68 51.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 110.972 175.963 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.22 125.42 30.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.285 176.553 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -75.76 157.29 84.09 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.97 -23.69 76.08 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.375 2.05 . . . . 0.0 112.34 177.77 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.552 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 7.8 p -77.85 -20.76 52.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.617 176.876 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.76 43.53 1.42 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.024 -1.084 . . . . 0.0 114.232 174.537 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.552 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 87.3 m-70 -130.86 152.55 50.07 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.175 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -113.02 132.78 55.25 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.534 178.187 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.424 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.0 m-85 -138.25 167.64 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.123 -178.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 42.4 m -78.31 151.86 32.73 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.204 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.446 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 88.0 tttt -68.49 -13.45 62.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -171.062 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.92 -27.09 7.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.885 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.8 m -64.59 -46.79 81.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.299 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -69.43 -41.37 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.145 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.606 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 80.8 mt -63.57 -42.67 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.153 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -79.42 -0.54 33.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -177.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -105.29 -21.72 13.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.051 176.793 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.64 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.6 pt -104.89 -13.68 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.33 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -108.18 -1.7 20.05 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.557 175.873 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -122.23 -57.58 1.76 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.033 -179.867 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.84 -65.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.647 -178.553 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -157.09 159.2 29.48 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.546 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -79.88 -8.84 59.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.474 0.637 . . . . 0.0 110.992 -176.611 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 20.2 ptpt -81.29 149.33 29.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.121 176.591 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 51.0 t -58.8 125.97 79.0 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.92 -22.01 73.44 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.018 2.478 . . . . 0.0 113.514 -167.993 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -97.79 -48.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.443 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -108.98 5.86 24.65 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 58.63 32.73 22.47 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 176.22 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -97.54 137.39 36.55 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.205 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 43' ' ' LYS . 46.6 mm -65.81 120.92 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.599 -177.458 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 37' ' ' ILE . 49.7 tp -109.7 130.22 55.53 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.99 -172.467 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.59 135.55 40.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 -176.486 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.53 -36.76 84.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.401 -179.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -63.58 -31.83 73.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.883 -177.342 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.7 mm-40 -71.65 -25.05 61.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 111.481 179.641 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.69 131.15 38.64 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 -175.732 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 80.7 t80 65.03 108.59 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 124.47 1.108 . . . . 0.0 112.646 176.453 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -60.58 144.96 99.58 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.556 2.171 . . . . 0.0 109.868 173.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -59.78 126.81 29.04 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.587 0.708 . . . . 0.0 112.199 -172.38 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -169.54 124.52 0.82 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.727 178.513 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -148.23 154.36 39.97 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.375 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.64 101.36 12.85 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.795 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 tptp . . . . . 0 C--N 1.306 -1.3 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.851 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.988 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.13 148.32 85.05 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.009 2.472 . . . . 0.0 113.514 -178.321 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.12 -45.41 92.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.536 -177.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.2 93.58 1.7 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.067 -176.779 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.8 m -143.17 -74.87 0.27 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 177.242 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 179.8 26.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.834 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.46 ' C ' ' HG ' ' A' ' 16' ' ' LEU . 93.2 m-85 -114.24 15.69 18.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.041 -173.374 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -107.16 119.96 40.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.222 174.141 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.477 ' HB2' HD21 ' A' ' 16' ' ' LEU . 37.1 t -71.8 114.12 25.93 Favored Pre-proline 0 C--O 1.221 -0.428 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.313 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.69 -21.27 71.73 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.583 2.189 . . . . 0.0 112.951 -176.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.63 -45.01 89.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.898 0.38 . . . . 0.0 111.664 179.203 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 9.6 p -105.3 -23.85 12.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.422 . . . . 0.0 111.53 -177.201 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.23 22.53 13.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.15 0.98 . . . . 0.0 111.844 -177.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtm -94.69 -64.69 1.04 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.043 0.449 . . . . 0.0 109.911 176.348 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.96 -175.33 0.86 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.116 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 9' ' ' CYS . 93.9 mt -96.58 116.77 29.64 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 170.442 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 20.7 tpt180 -66.18 -44.73 83.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.778 177.906 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 17' ' ' ARG . 47.4 mt-10 -132.66 -15.15 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -177.052 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.54 84.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.132 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.36 118.41 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.224 0.535 . . . . 0.0 111.009 175.208 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -78.63 133.12 37.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.211 179.512 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -87.57 160.17 48.22 Favored Pre-proline 0 C--N 1.311 -1.1 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.483 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.53 -23.65 74.94 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.373 2.048 . . . . 0.0 112.507 179.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.523 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -80.67 -15.8 55.62 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.994 0.426 . . . . 0.0 111.551 176.191 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.59 52.3 1.32 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.162 175.218 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.523 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 38.9 m-70 -135.06 141.08 46.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.727 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -105.63 133.47 50.32 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.686 176.242 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -135.02 169.25 17.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.744 177.184 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 61.3 m -69.36 148.81 49.15 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 171.435 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.41 -6.72 45.47 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.288 0.566 . . . . 0.0 111.356 -173.414 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.13 -34.01 5.5 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.026 -0.421 . . . . 0.0 110.263 179.332 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.1 m -65.84 -46.96 76.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.932 179.109 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.0 tp -68.89 -40.65 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.014 -177.506 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.2 mt -63.28 -43.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.961 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -80.96 4.42 19.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.008 0.433 . . . . 0.0 111.351 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -105.46 -24.67 12.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.715 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.39 -20.52 5.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.47 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.8 ptm180 -99.92 4.08 44.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.497 176.107 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -128.03 -54.51 1.29 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.018 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.15 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -179.04 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.44 144.6 11.36 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.923 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -84.19 40.62 0.78 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.736 0.779 . . . . 0.0 111.165 -171.092 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -142.63 152.86 42.92 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.119 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.23 123.58 89.14 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.731 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.59 -24.18 75.03 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.077 2.518 . . . . 0.0 114.078 -170.259 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.1 m -72.34 -49.82 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.973 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -115.49 5.74 14.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.005 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 58.76 33.68 23.23 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 175.502 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -100.23 144.5 29.17 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.351 -0.218 . . . . 0.0 110.495 179.345 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.59 121.72 15.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 -176.371 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.8 tp -115.33 127.78 55.66 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.275 -174.61 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.5 138.88 38.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.338 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.85 -36.85 77.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.747 0.419 . . . . 0.0 111.959 -175.133 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -71.78 -17.8 62.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.833 0.349 . . . . 0.0 111.571 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -81.26 -9.06 59.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.865 -177.136 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.43 132.9 39.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.983 178.6 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -141.72 127.17 10.78 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-O 121.122 0.486 . . . . 0.0 111.805 179.321 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.14 171.19 17.31 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.106 2.537 . . . . 0.0 111.37 177.71 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.2 117.38 16.96 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.165 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -86.38 97.05 10.22 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.506 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -67.11 -38.4 85.56 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.114 -177.456 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -178.88 -51.31 0.01 OUTLIER 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.907 0.883 . . . . 0.0 109.399 176.807 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.122 -177.759 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.996 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.41 142.65 96.19 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.759 2.306 . . . . 0.0 112.425 -178.411 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tt -134.82 123.21 23.17 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.178 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.58 -144.06 3.84 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 178.951 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.5 m -69.06 132.05 46.01 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.769 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -145.92 157.11 43.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.864 0.364 . . . . 0.0 110.601 -174.488 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CD2' HD12 ' A' ' 16' ' ' LEU . 92.9 m-85 -93.36 68.22 4.15 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.626 0.726 . . . . 0.0 111.244 178.686 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -145.47 123.79 12.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.337 177.547 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 5.1 t -89.92 118.13 68.67 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.28 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.76 -18.73 63.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 113.218 -176.349 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.4 mt -65.84 -44.33 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.692 0.282 . . . . 0.0 110.856 177.806 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.6 p -106.44 -26.47 11.43 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.716 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 66.3 22.93 10.82 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.142 0.977 . . . . 0.0 111.895 179.569 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -97.64 -66.85 0.88 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.316 0.579 . . . . 0.0 110.631 176.651 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.99 -161.65 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.42 HD12 ' CD2' ' A' ' 7' ' ' TYR . 90.4 mt -109.77 122.75 48.22 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.539 172.389 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 27.4 tpt180 -86.85 108.92 18.97 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.944 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 71.49 -10.39 0.82 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.155 1.382 . . . . 0.0 113.173 -179.544 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 50.86 83.63 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.144 0.978 . . . . 0.0 113.329 175.467 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.42 115.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.086 177.907 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -80.7 128.32 33.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.145 177.474 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -79.77 161.91 64.65 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.204 177.579 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.24 -18.95 67.3 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.5 2.133 . . . . 0.0 111.438 175.884 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.2 m -65.85 -35.43 80.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.785 174.357 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 -28.23 5.44 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.902 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -82.6 154.48 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.746 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -109.5 140.67 42.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.136 -174.946 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.43 167.81 18.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.428 176.546 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.551 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 88.3 m -73.4 146.42 45.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.28 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -69.72 -12.79 61.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.361 179.236 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.42 2.98 15.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 -177.533 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 83.5 m -105.77 -56.97 2.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.734 173.067 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -68.8 -41.85 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.28 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.0 mt -63.42 -41.68 93.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.515 0.674 . . . . 0.0 110.254 179.24 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -77.97 -0.2 26.77 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.64 -177.159 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -105.85 -22.8 12.84 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.129 -0.357 . . . . 0.0 110.71 175.93 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.4 pt -102.23 -23.4 4.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.208 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -102.81 6.15 39.09 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.754 174.345 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -114.84 -51.15 2.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.607 -178.842 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.05 -69.62 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.525 177.298 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -162.85 159.49 31.89 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.433 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -82.08 65.0 7.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -173.439 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 10.4 ptpp? -153.11 147.64 26.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.932 175.248 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.77 124.18 86.41 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.086 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.54 -26.9 81.28 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.993 2.462 . . . . 0.0 114.886 -168.488 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.14 -44.07 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.714 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -121.44 6.43 10.11 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.502 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 52.31 34.54 15.04 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.131 1.372 . . . . 0.0 113.622 177.834 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 77.0 mm-40 -88.89 142.87 27.28 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.085 178.828 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.21 120.07 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.305 0.574 . . . . 0.0 110.216 -175.3 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.8 tp -128.89 132.68 47.72 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 -177.46 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.94 152.69 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.855 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.49 -31.02 71.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.268 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -63.53 -32.81 74.38 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.051 178.167 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -68.32 -34.31 75.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.409 0.623 . . . . 0.0 109.996 178.719 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.0 mt -76.13 153.86 35.92 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.583 178.555 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -62.26 151.69 81.14 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.263 -178.36 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.16 154.64 65.96 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 122.958 2.439 . . . . 0.0 112.975 -178.443 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.65 117.19 21.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.854 -179.185 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -125.93 69.68 1.2 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.276 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.25 -45.72 92.05 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.435 179.949 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.91 159.49 42.47 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.433 -174.999 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.741 -179.947 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.35 -40.54 66.96 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.694 2.263 . . . . 0.0 112.838 -178.685 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 tt -80.7 -45.01 17.81 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 172.489 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.28 -96.8 0.17 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -177.105 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.7 m -123.14 115.68 22.2 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 173.544 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -87.68 -16.72 33.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.457 0.646 . . . . 0.0 109.882 175.356 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.06 43.24 1.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.999 0.904 . . . . 0.0 108.94 175.658 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -100.13 134.55 42.88 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.363 -179.393 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.583 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.5 t -84.37 114.23 53.55 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.059 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.91 -21.68 73.31 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.36 2.04 . . . . 0.0 112.806 -175.323 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.79 -44.17 85.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.619 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 18.5 p -106.24 -22.15 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.54 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp 63.85 21.18 12.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 111.108 -174.907 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.438 ' HA ' ' HE3' ' A' ' 14' ' ' MET . 30.1 mmt -95.44 -73.49 0.59 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.124 0.488 . . . . 0.0 109.792 178.778 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.09 166.88 2.96 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 9' ' ' CYS . 91.6 mt -84.19 103.65 13.57 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.232 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -83.52 -53.91 5.34 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 118.879 -1.129 . . . . 0.0 112.037 -177.348 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.443 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 9.3 mp0 -87.7 -16.56 33.96 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.595 177.318 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 43.34 73.14 0.15 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.189 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -99.65 116.31 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.369 0.604 . . . . 0.0 110.187 177.781 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.433 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 63.1 tt0 -80.08 136.53 36.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.92 179.795 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -89.95 159.46 42.77 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.092 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.15 -25.97 81.29 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 174.28 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.55 -17.62 64.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.898 177.931 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 13.84 57.46 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.804 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -109.13 143.28 38.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.844 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -109.98 139.99 44.49 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.075 0.464 . . . . 0.0 111.857 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.5 m-85 -141.0 169.68 17.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.104 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.8 m -82.81 154.05 24.9 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.352 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.86 -14.37 62.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.298 0.571 . . . . 0.0 110.566 -176.59 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.97 2.62 15.86 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.186 0.517 . . . . 0.0 109.921 -178.535 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.4 m -103.06 -55.96 2.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.44 174.007 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.581 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -66.69 -43.28 90.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.641 -175.707 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.39 -41.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.229 0.538 . . . . 0.0 110.675 179.817 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -76.97 -3.83 40.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.812 -175.916 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.0 m -110.88 -23.72 10.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 176.133 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 33' ' ' ILE . 44.6 pt -103.64 -7.3 9.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.099 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -95.32 -10.11 31.11 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.252 177.451 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -116.8 -43.01 2.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.056 -177.668 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.96 -72.81 0.43 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.119 176.819 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.46 152.36 21.7 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 177.649 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.451 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 24.1 m80 -82.46 68.88 9.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.855 0.836 . . . . 0.0 111.996 -179.299 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -151.71 150.7 30.51 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.462 177.582 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.2 p -70.97 123.58 89.55 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.407 177.207 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.93 -28.07 80.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.918 2.412 . . . . 0.0 113.651 -171.615 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.49 -49.23 81.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.766 -177.758 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -127.05 6.65 6.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.417 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 60.31 35.35 20.74 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -94.53 143.18 26.63 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 174.14 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 122.18 14.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.313 0.577 . . . . 0.0 110.815 -174.003 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.1 tp -120.97 130.24 53.75 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.143 -174.436 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.57 139.18 40.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -65.35 -37.84 88.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.883 -174.058 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -68.58 -19.02 64.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 177.959 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.6 mm-40 -81.36 -8.53 59.75 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.132 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt -69.3 137.88 53.38 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.859 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.433 ' HD1' ' O ' ' A' ' 21' ' ' GLN . 63.3 m-85 -66.45 133.74 94.41 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.951 179.046 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.88 144.01 99.52 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.019 2.479 . . . . 0.0 113.126 -176.781 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -91.36 -179.03 5.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.412 178.001 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -135.56 73.61 1.48 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.185 0.517 . . . . 0.0 110.743 174.101 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 18' ' ' GLU . 70.1 m-85 -120.1 -53.42 2.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.373 174.802 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.55 155.26 23.93 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.581 -179.123 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HZ2' ' HB2' ' A' ' 63' ' ' LYS . 5.0 ttmp? . . . . . 0 C--N 1.308 -1.202 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.654 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.08 -40.21 87.02 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.226 2.618 . . . . 0.0 112.424 -177.374 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.1 mt -121.22 144.92 48.35 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.048 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.9 57.09 4.83 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 172.085 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 p -73.69 157.81 35.85 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.583 0.753 . . . . 0.0 112.04 -173.003 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -86.69 63.83 8.18 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.759 0.79 . . . . 0.0 111.032 -173.413 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.558 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.5 m-85 -114.09 13.23 18.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.525 173.509 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -105.86 116.74 32.46 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.512 -179.088 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.56 108.83 4.84 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.498 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.08 -19.14 51.66 Favored 'Trans proline' 0 C--O 1.226 -0.113 0 C-N-CA 122.881 2.387 . . . . 0.0 113.463 -171.113 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.21 -43.61 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.0 111.144 178.635 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 p -99.17 -25.29 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.973 0.416 . . . . 0.0 111.042 178.692 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.1 mt 60.5 29.86 19.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 111.249 -176.349 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.6 mtm -99.09 -68.19 0.81 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 175.136 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.65 -163.24 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -176.253 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 76.6 mt -100.74 124.35 46.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.026 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -88.29 -72.28 0.54 Allowed 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.954 176.846 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -81.13 -15.97 54.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.223 177.004 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.4 77.59 0.17 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.646 -178.281 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.12 114.03 40.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.552 0.691 . . . . 0.0 110.015 177.889 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 30.3 tt0 -80.8 135.78 36.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.928 -178.4 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -99.63 154.2 37.39 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.62 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.14 -24.69 72.91 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 122.722 2.281 . . . . 0.0 113.153 -176.229 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.684 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.5 p -76.21 -15.31 60.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 178.692 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.35 23.46 6.94 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.704 175.795 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.684 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 81.4 m-70 -112.61 155.65 24.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.634 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -126.07 137.35 53.62 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.53 176.69 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.587 -175.761 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 8.7 m -91.61 160.43 15.4 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 170.702 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.482 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 61.2 pttt -75.88 -7.11 53.74 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.175 0.512 . . . . 0.0 110.353 -174.682 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.37 -0.85 15.24 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.152 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 49.2 m -101.94 -64.16 1.09 Allowed 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.393 175.879 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -67.32 -41.72 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.992 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 30' ' ' LYS . 82.8 mt -63.18 -42.89 98.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 110.97 -178.341 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -79.9 -3.22 47.15 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.246 0.546 . . . . 0.0 110.478 -176.933 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -106.15 -18.22 14.08 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.809 -0.557 . . . . 0.0 111.4 178.156 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 36.5 pt -102.23 -13.28 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.453 -175.051 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -104.87 0.94 28.48 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.06 174.342 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.32 -51.72 2.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 -176.032 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.79 -69.78 0.59 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.42 0.629 . . . . 0.0 109.451 174.796 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.76 163.94 35.26 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 177.682 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -80.31 72.26 7.15 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.87 0.835 . . . . 0.0 112.124 -176.709 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.0 ptpp? -144.61 150.05 36.79 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.784 176.075 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 p -83.75 123.23 76.37 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.36 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.96 -25.71 74.07 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.842 2.361 . . . . 0.0 114.109 -168.962 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.5 m -72.08 -42.96 67.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.874 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -120.27 6.43 10.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 50.93 36.55 15.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 176.303 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.6 mm-40 -96.94 153.29 17.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.345 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.53 122.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.145 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.6 118.35 35.44 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -176.368 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.545 ' HB2' HE21 ' A' ' 55' ' ' GLN . 2.9 mm? -98.36 134.82 40.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.484 179.736 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -64.89 -35.6 81.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.339 0.399 . . . . 0.0 111.74 -173.426 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -65.86 -30.65 71.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.287 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.545 HE21 ' HB2' ' A' ' 52' ' ' LEU . 48.7 mt-30 -68.1 -20.25 64.92 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.188 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.65 141.38 55.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 178.341 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 21' ' ' GLN . 22.3 m-85 -63.86 139.44 97.64 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.28 177.247 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.89 150.27 73.21 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.346 2.03 . . . . 0.0 112.276 -179.139 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -77.85 121.19 23.77 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.995 178.87 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -86.21 110.34 19.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.118 0.485 . . . . 0.0 110.861 -176.515 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -79.09 147.21 32.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.195 -179.263 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.5 158.2 41.52 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.342 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--N 1.306 -1.284 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.839 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.942 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.46 150.65 70.33 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.743 2.295 . . . . 0.0 112.319 177.859 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.8 tp -73.97 126.71 31.07 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.051 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.41 68.72 1.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.237 -0.982 . . . . 0.0 111.042 -175.485 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 p -69.31 151.16 46.55 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 111.489 -177.699 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HZ2' ' HB2' ' A' ' 6' ' ' LYS . 4.8 ttmp? -92.12 122.79 34.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.973 -176.198 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 52.2 69.33 0.69 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.656 0.783 . . . . 0.0 112.154 -176.875 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -146.39 128.75 15.85 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.251 179.204 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 38.7 t -70.34 114.21 24.08 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.944 0.778 . . . . 0.0 109.426 179.023 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.7 -21.61 73.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.346 2.03 . . . . 0.0 112.553 -177.666 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.8 -44.02 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.764 0.316 . . . . 0.0 111.582 178.317 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -104.01 -22.92 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.891 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt 56.75 25.48 10.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 111.939 -176.421 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -96.4 -63.13 1.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.324 174.291 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.37 -172.72 0.31 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.786 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.4 mt -98.93 106.82 19.12 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.961 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -69.61 -43.96 71.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.138 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -115.38 -16.24 11.46 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 177.876 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.95 70.48 0.58 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.661 0.601 . . . . 0.0 112.329 -178.544 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 58' ' ' PRO . 26.8 m -93.27 116.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.141 0.496 . . . . 0.0 110.777 179.236 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -80.0 135.81 36.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 175.116 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -111.01 151.74 43.2 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.498 -179.791 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.435 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 50.2 Cg_exo -56.63 -37.38 97.76 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.791 2.327 . . . . 0.0 111.154 179.737 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.8 t -59.69 -31.14 69.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.907 -178.793 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.89 36.33 2.04 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.418 179.812 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.56 156.85 40.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.162 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.72 131.35 53.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.012 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 20' ' ' VAL . 94.5 m-85 -139.6 179.72 6.4 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.252 0.345 . . . . 0.0 110.208 -177.109 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 61.8 m -90.61 151.22 21.39 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 169.972 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.55 -6.8 43.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.34 0.59 . . . . 0.0 111.449 -176.121 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.48 -16.14 12.47 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.081 0.467 . . . . 0.0 109.952 -179.437 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 76.3 m -83.82 -59.28 2.47 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 175.351 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.436 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.2 tp -67.87 -41.05 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.243 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 67.0 mt -62.72 -42.97 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.658 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -78.83 -1.66 35.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.546 0.689 . . . . 0.0 109.61 -175.568 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 m -105.38 -21.08 13.3 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.651 176.158 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.7 pt -104.07 -24.34 4.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.077 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -98.9 0.49 44.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.764 177.371 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.87 -46.52 2.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.749 -177.395 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 -68.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.115 0.483 . . . . 0.0 110.794 177.202 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.49 161.98 35.66 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.31 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 66.0 m80 -86.21 76.17 9.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 117.444 0.622 . . . . 0.0 111.555 -173.886 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 22.4 pttp -154.25 144.68 22.22 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 -179.214 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.3 p -77.32 123.79 86.98 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 170.351 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.25 -24.77 76.32 Favored 'Trans proline' 0 N--CA 1.481 0.751 0 C-N-CA 123.321 2.681 . . . . 0.0 114.019 -167.251 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -66.79 -46.19 86.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.056 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.55 7.45 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.943 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.321 0.2 OUTLIER 53.77 38.12 27.83 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 178.886 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 69.1 mm-40 -86.28 142.01 28.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.382 173.336 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 48.5 mm -66.45 121.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.575 -176.941 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.68 132.39 43.9 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.402 -177.629 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.404 ' HB2' ' HG3' ' A' ' 55' ' ' GLN . 2.7 mm? -110.58 157.99 19.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.354 177.748 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.65 -38.15 89.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.655 0.74 . . . . 0.0 109.917 -179.473 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -76.72 -6.04 50.55 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.15 -174.006 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HB3' ' CG ' ' A' ' 23' ' ' PRO . 61.7 mt-30 -89.38 -8.07 53.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 0.0 111.413 178.723 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.9 mt -73.1 146.63 45.6 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.484 -175.742 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.19 79.98 9.13 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 171.467 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.436 ' HA ' HG12 ' A' ' 20' ' ' VAL . 32.0 Cg_exo -63.71 -41.57 24.1 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.606 2.871 . . . . 0.0 115.38 -175.867 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -116.32 85.68 2.35 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.875 -169.157 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -155.84 11.47 0.3 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.092 171.43 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.06 142.82 51.25 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.958 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 50.91 40.79 25.9 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.957 0.786 . . . . 0.0 112.154 173.979 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.232 -174.177 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.802 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.36 -30.85 81.23 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 123.259 2.639 . . . . 0.0 113.322 178.579 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.7 tp -118.91 130.6 55.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.505 -178.514 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.12 -150.06 18.73 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.936 177.22 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 p -114.53 104.98 12.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.407 0.622 . . . . 0.0 111.253 179.157 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' C ' ' H ' ' A' ' 8' ' ' GLU . 63.1 tttm -97.89 163.5 12.76 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.141 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -79.3 47.92 0.84 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.785 1.278 . . . . 0.0 109.947 175.728 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 6' ' ' LYS . 35.1 tt0 -141.46 137.89 32.48 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -179.533 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -72.79 108.55 4.58 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.889 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.19 -17.5 45.16 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.528 2.152 . . . . 0.0 112.002 -174.31 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.4 mt -66.13 -43.6 92.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.61 177.527 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -104.81 -16.51 14.89 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -177.706 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 mp 57.87 22.72 8.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.928 0.891 . . . . 0.0 111.569 -176.326 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.452 ' HA ' ' CE ' ' A' ' 14' ' ' MET . 1.8 mmt -94.88 -66.89 0.88 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.529 -178.865 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.78 -169.43 0.12 Allowed 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.975 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.3 mt -97.49 109.36 22.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.898 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -65.48 -45.13 84.87 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.311 -178.823 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -132.72 -14.08 2.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.764 176.344 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.24 92.21 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.602 0.761 . . . . 0.0 112.9 178.167 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.91 117.62 49.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.163 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.31 128.22 33.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.331 -177.584 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -89.32 155.16 49.11 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.872 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.37 -29.55 89.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.504 2.136 . . . . 0.0 113.07 -173.663 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.605 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -76.27 -15.4 60.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.944 0.402 . . . . 0.0 111.923 178.985 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.21 42.45 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.951 174.346 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.605 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 75.3 m-70 -125.62 143.29 51.09 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.524 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 7.5 mpt_? -109.97 135.62 50.53 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.402 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.0 m-85 -133.81 168.08 19.39 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.8 m -75.88 156.65 34.13 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.775 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.1 tttt -68.82 -11.23 60.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.508 -174.697 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.32 -37.56 4.33 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.973 -179.101 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -62.8 -47.28 84.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.813 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -70.11 -41.61 79.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.896 -178.681 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.7 mt -63.55 -42.78 97.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.696 -178.592 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -78.01 -0.94 29.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.482 0.658 . . . . 0.0 110.02 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -105.86 -20.36 13.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.701 174.164 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.64 -21.73 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -176.577 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 12.2 ptp180 -97.57 8.01 45.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.464 171.605 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -116.2 -55.82 2.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.746 -177.94 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.87 -72.64 0.5 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.88 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.46 163.56 37.02 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.987 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.488 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 70.5 m80 -87.93 76.65 8.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.598 0.713 . . . . 0.0 111.909 -176.706 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -159.91 155.32 25.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.848 175.708 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 p -79.07 124.05 84.75 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.702 175.988 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.8 -27.21 75.15 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 122.82 2.347 . . . . 0.0 113.614 -172.851 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.91 -45.34 73.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.444 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -122.47 4.87 9.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.77 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 57.71 34.74 24.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.477 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 148.76 22.78 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.448 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.99 120.67 14.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.952 0.406 . . . . 0.0 110.594 -175.486 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 61.7 tp -121.45 127.98 51.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.154 -176.646 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.17 148.92 29.21 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.529 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.08 -37.33 87.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -175.893 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.0 -29.81 70.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.471 177.381 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.72 -15.11 62.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.076 -179.581 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.43 136.08 39.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.742 0.306 . . . . 0.0 110.729 178.65 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -151.15 144.08 16.78 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.401 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.24 142.89 68.69 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 121.865 1.71 . . . . 0.0 110.839 176.853 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -149.77 129.55 13.29 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 179.938 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -120.38 29.58 7.39 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 173.753 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 62.2 36.33 14.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.549 0.69 . . . . 0.0 109.435 -172.099 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.66 133.27 28.7 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.298 -178.289 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -179.468 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.066 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.0 147.42 95.18 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.507 2.804 . . . . 0.0 113.33 -178.82 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.38 -43.66 98.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 174.992 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.48 -134.0 52.49 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.122 -0.944 . . . . 0.0 113.33 173.674 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m -130.7 147.0 52.32 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.345 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.11 160.64 42.68 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.707 0.289 . . . . 0.0 110.43 -176.632 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.37 87.39 3.86 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 171.296 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -146.14 150.76 36.5 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.215 -173.578 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.407 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 38.8 t -79.79 109.84 13.55 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.712 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.79 -20.57 71.55 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.525 2.15 . . . . 0.0 112.576 -174.467 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -67.32 -44.7 87.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.684 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.3 p -103.92 -19.3 14.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.462 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp 58.42 23.19 10.34 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.693 0.797 . . . . 0.0 111.563 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.4 mtm -95.28 -64.62 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.158 178.273 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.51 -173.97 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.757 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.22 102.66 14.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 173.184 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.29 -45.06 63.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.053 -179.555 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 18.5 mm-40 -106.43 -17.45 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.815 -175.176 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 44.52 89.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.596 1.159 . . . . 0.0 114.034 -176.716 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.89 121.26 65.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 175.939 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.348 -178.811 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -110.66 151.1 42.6 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.349 174.638 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.9 -24.82 77.51 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.87 2.38 . . . . 0.0 113.634 -178.802 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.7 p -79.32 -15.47 57.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.978 177.77 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 44.8 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.304 173.621 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.453 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 23.8 m-70 -133.33 149.46 51.9 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.708 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -111.45 134.85 52.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.495 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.405 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 96.9 m-85 -136.18 173.15 12.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.718 -178.725 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.7 m -86.89 151.21 23.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.124 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 65.2 tttp -68.42 -11.21 59.35 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 122.999 0.52 . . . . 0.0 111.348 -178.966 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.55 2.64 15.4 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.171 -178.994 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -105.41 -53.8 2.59 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.399 175.25 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -68.17 -38.54 79.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.923 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.559 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.09 -41.61 91.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.069 0.462 . . . . 0.0 110.126 178.326 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 32.1 mmmt -79.18 2.75 19.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -106.37 -25.46 11.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.742 173.669 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.3 pt -104.63 -5.87 9.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.387 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.0 ptm180 -124.61 3.15 8.29 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.546 171.097 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 3.9 m-20 -127.11 -42.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.149 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.41 -65.91 0.97 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.437 0.637 . . . . 0.0 110.755 -178.597 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.52 -148.52 5.42 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.579 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -139.02 31.96 2.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 171.517 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -132.5 161.03 34.79 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.086 -175.065 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.1 t -74.94 122.04 86.6 Favored Pre-proline 0 N--CA 1.43 -1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.13 -31.16 54.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.386 2.057 . . . . 0.0 113.327 -175.167 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.38 -48.57 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.007 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -114.33 6.49 16.1 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.573 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 58.91 31.97 21.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.489 0.716 . . . . 0.0 112.439 177.106 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.76 147.17 26.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.636 178.943 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.0 122.42 16.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.129 0.49 . . . . 0.0 109.974 -178.022 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.5 tp -111.34 131.0 55.5 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.133 -175.114 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -97.76 138.62 34.85 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.075 -178.903 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.77 -38.64 89.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.414 -174.563 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.13 -30.13 70.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.015 0.436 . . . . 0.0 111.189 178.37 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -74.58 -7.14 52.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.57 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.6 132.02 42.33 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.013 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -134.47 137.57 28.09 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.893 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.99 139.83 89.76 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 121.8 1.667 . . . . 0.0 110.965 178.379 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.3 -45.23 81.09 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.222 0.534 . . . . 0.0 109.704 179.935 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -111.3 105.18 13.76 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.12 173.307 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -116.83 102.98 9.85 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.007 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.84 111.11 18.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.508 -174.565 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.768 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.13 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.33 42.21 1.14 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.405 2.737 . . . . 0.0 111.887 -179.521 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 7' ' ' TYR . 53.6 tp 69.87 15.13 7.93 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.971 0.908 . . . . 0.0 110.313 -179.089 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 8' ' ' GLU . . . -99.82 36.29 4.2 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.258 -177.536 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.3 m -97.73 -70.04 0.74 Allowed 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.386 -0.479 . . . . 0.0 110.422 178.122 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -92.13 -16.11 26.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.365 0.603 . . . . 0.0 110.23 175.762 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.678 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 94.6 m-85 -105.3 45.21 0.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.679 174.549 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 43.8 tt0 -102.32 141.05 35.78 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.101 177.652 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.41 ' HB2' HD21 ' A' ' 16' ' ' LEU . 39.4 t -94.88 108.37 37.43 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 173.853 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.7 -19.48 68.34 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.841 2.361 . . . . 0.0 112.862 -174.599 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.58 -44.13 90.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 178.61 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.5 p -102.79 -13.37 17.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.794 -178.351 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 mp 69.37 23.97 5.98 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.625 0.77 . . . . 0.0 110.425 -179.04 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -128.18 170.07 13.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.38 157.7 13.31 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.428 0.455 . . . . 0.0 110.899 177.853 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 86.1 mt -70.09 133.1 46.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.719 -174.859 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 12.8 tpt180 -77.98 -62.86 1.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.087 172.716 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.8 mm-40 -99.18 -18.43 17.66 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.062 -177.545 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 86.98 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.629 -175.539 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -108.8 118.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.508 0.67 . . . . 0.0 111.126 175.133 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.22 139.41 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.18 179.867 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -110.51 155.32 42.27 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.803 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.02 -20.24 63.83 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.703 2.269 . . . . 0.0 111.72 178.769 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.9 t -74.42 -19.47 60.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.876 178.253 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.72 25.98 11.17 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.979 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -113.69 154.04 27.95 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.028 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -117.99 138.43 52.19 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.665 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.7 168.29 20.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.775 0.321 . . . . 0.0 110.581 -178.689 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.8 m -86.21 148.36 25.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 169.977 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.78 -12.85 61.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.958 -171.514 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -7.92 13.41 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.352 -178.587 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -85.94 -46.39 10.6 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 170.149 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.601 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -67.78 -43.14 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.859 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.592 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.9 mt -63.46 -42.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 111.221 -177.958 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -78.76 -2.09 37.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 -175.607 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 t -106.16 -25.54 11.96 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.832 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.8 pt -103.77 -15.59 8.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.479 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.3 ptm180 -98.35 2.99 48.57 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.262 173.89 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -115.18 -52.09 2.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.068 -172.123 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.3 -68.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.223 175.671 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.74 165.73 39.1 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.099 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.442 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 62.4 m80 -87.94 80.48 7.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.837 0.827 . . . . 0.0 111.473 -177.776 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -152.7 159.51 43.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.439 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 9.7 m -67.21 127.4 93.47 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.861 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.49 -20.77 70.37 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.736 2.291 . . . . 0.0 112.516 -179.31 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.73 -61.0 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.276 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 43.2 p-10 -103.92 5.29 35.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.033 -0.417 . . . . 0.0 111.128 -174.378 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 56.28 34.55 24.25 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.542 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -90.04 145.65 24.92 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.098 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -65.86 121.58 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 0.0 110.426 -174.252 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 64.9 tp -126.89 129.12 47.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.929 -175.983 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -112.14 152.26 28.52 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -175.539 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.58 -36.15 82.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.302 0.573 . . . . 0.0 111.171 -177.971 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.99 -31.09 72.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.459 176.27 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -78.93 -8.64 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.384 -175.735 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.84 131.75 42.67 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.667 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.73 107.43 36.76 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.866 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.88 -42.31 68.33 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.051 2.501 . . . . 0.0 113.241 -173.246 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.2 t70 68.05 -48.21 0.53 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.967 1.307 . . . . 0.0 111.413 -175.688 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -104.51 167.16 9.91 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.456 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -97.31 118.33 33.54 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.925 174.088 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.09 155.76 21.16 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.742 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.301 -1.521 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.774 178.76 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.12 156.37 62.57 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 123.372 2.715 . . . . 0.0 111.353 179.41 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.98 102.39 1.99 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.457 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.28 63.32 0.3 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 178.694 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -82.62 95.72 7.88 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.117 -0.541 . . . . 0.0 112.035 -170.723 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -67.43 -45.2 76.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.485 174.691 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -121.14 93.74 4.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.409 0.623 . . . . 0.0 111.158 176.451 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 44.2 tt0 -154.72 143.81 21.06 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.791 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.4 t -78.28 108.49 7.8 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.756 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 35.7 Cg_exo -64.48 -19.8 65.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.926 2.417 . . . . 0.0 112.06 -177.123 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.1 -43.86 92.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 -179.352 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.3 p -99.76 -26.0 14.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.272 179.841 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt 64.22 21.65 12.6 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.153 0.981 . . . . 0.0 111.92 179.797 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -100.52 -64.47 1.04 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.936 0.398 . . . . 0.0 111.004 177.884 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.7 -170.07 0.38 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.544 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.03 108.01 20.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.533 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.12 -45.84 75.94 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.019 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -112.45 -16.81 12.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.342 176.425 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.37 62.53 2.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.256 -175.046 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 28' ' ' PHE . 29.1 m -83.18 118.12 30.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.39 -178.492 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -74.51 126.22 30.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.688 178.794 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.1 p -94.68 165.54 17.03 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.085 -177.27 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.83 -34.2 96.22 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.801 2.334 . . . . 0.0 112.062 177.442 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 p -76.62 -15.15 59.9 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.187 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.17 44.0 Favored Glycine 0 CA--C 1.516 0.152 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.936 179.0 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -90.97 167.15 12.62 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.054 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 92.4 mtt180 -130.55 140.24 50.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.001 179.293 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 20' ' ' VAL . 96.9 m-85 -138.7 -177.23 4.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.51 ' O ' HG22 ' A' ' 33' ' ' ILE . 45.6 m -91.12 152.3 20.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.371 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.77 -11.88 61.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.049 0.452 . . . . 0.0 111.131 -176.269 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.45 -10.08 13.25 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.041 -177.448 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -92.66 -56.09 3.14 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.709 177.189 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.576 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -69.03 -40.3 80.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.667 -177.167 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.583 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.0 mt -62.91 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.381 . . . . 0.0 111.851 -178.934 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.14 -3.29 41.71 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.884 0.373 . . . . 0.0 110.49 -175.44 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.9 p -108.18 -19.71 13.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 175.157 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 33' ' ' ILE . 36.4 pt -102.64 -13.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.906 -0.496 . . . . 0.0 112.183 -174.55 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.3 ptp180 -98.0 7.99 45.46 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 167.852 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.09 -54.88 2.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.685 -175.286 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.96 -72.9 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.346 0.593 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.22 167.17 39.69 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.86 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 59.8 m80 -83.38 74.27 10.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.449 0.642 . . . . 0.0 111.992 -176.338 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.7 ptpt -151.7 152.03 32.23 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.267 177.746 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 1.5 p -77.46 135.69 64.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.829 173.982 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.62 -21.88 65.09 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.502 2.134 . . . . 0.0 112.259 -179.09 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -76.43 -74.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.02 4.47 47.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -175.08 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 11.8 m120 56.08 34.55 24.01 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 172.053 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 75.5 mm-40 -93.64 154.07 18.03 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.725 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.57 120.59 14.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.565 0.698 . . . . 0.0 109.988 -175.805 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.46 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 7.8 tt -124.05 121.25 34.7 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.297 -172.341 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.51 141.35 35.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.768 0.318 . . . . 0.0 111.378 -176.453 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.51 -43.02 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.957 -175.066 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -67.29 -30.91 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.261 -177.373 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -78.85 -8.18 58.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.439 -176.953 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.82 127.31 32.52 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.684 179.407 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -135.87 127.56 17.33 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -62.43 139.52 77.12 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.437 2.091 . . . . 0.0 111.741 176.144 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -107.84 118.48 36.86 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 172.95 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 63.69 78.66 0.28 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.729 0.643 . . . . 0.0 110.302 -175.894 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -111.02 139.09 46.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.565 -174.145 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.9 139.4 46.82 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.248 179.585 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.168 0 CA-C-O 118.804 -0.617 . . . . 0.0 109.445 177.678 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.01 118.18 5.36 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.265 1.977 . . . . 0.0 112.386 -177.427 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 tm? 65.3 -52.96 0.35 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.731 1.612 . . . . 0.0 112.503 179.842 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.76 -126.25 10.61 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.689 -176.576 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -125.34 96.55 4.87 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.015 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -90.81 77.28 6.26 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.24 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.433 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 29.9 t80 -145.5 29.02 1.16 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.996 0.903 . . . . 0.0 108.73 -176.662 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -106.97 129.7 54.74 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.088 -176.242 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.1 t -88.17 108.16 20.21 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.851 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.456 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.8 Cg_exo -62.73 -20.72 71.82 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.684 2.256 . . . . 0.0 113.3 -174.755 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.67 -43.74 90.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.686 178.958 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.59 -7.96 14.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.113 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt 61.73 26.46 16.09 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.503 0.721 . . . . 0.0 110.785 -177.062 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -120.08 169.16 10.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 152.9 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.744 175.481 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 77.9 mt -69.44 114.25 7.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.937 0.399 . . . . 0.0 110.003 -172.226 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -71.65 -46.56 58.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.779 -177.564 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -114.18 -17.18 11.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.464 178.485 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.45 82.68 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.872 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.43 116.72 53.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.327 0.584 . . . . 0.0 110.994 174.209 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -82.84 133.84 35.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.891 -178.5 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -86.54 160.39 50.82 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.147 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -55.64 -37.76 94.96 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.612 2.208 . . . . 0.0 112.074 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.553 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -67.99 -17.23 64.37 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.649 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.41 41.44 2.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.015 174.069 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.553 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 76.7 m-70 -122.49 143.76 49.5 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.193 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -111.28 137.52 48.91 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.64 175.239 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.5 m-85 -131.65 166.36 21.62 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.428 -178.425 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.611 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.3 m -79.38 149.65 31.61 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.122 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -76.22 -2.95 33.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.788 0.804 . . . . 0.0 111.455 -173.155 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.92 -24.0 9.77 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.113 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.611 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.7 m -73.35 -51.11 18.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.276 174.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.499 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -67.23 -39.55 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.926 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.1 mt -62.78 -41.7 93.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.625 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -78.18 -1.78 34.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.94 -176.762 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.5 m -105.86 -21.58 13.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.653 0.263 . . . . 0.0 111.178 173.828 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -102.87 -16.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.343 -175.196 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 ptm180 -99.73 1.13 43.03 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.002 175.467 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -115.49 -54.15 2.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.224 -178.0 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 -66.55 0.89 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.048 0.452 . . . . 0.0 110.48 179.013 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -172.09 161.99 33.99 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 177.218 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.606 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 47.2 m80 -83.18 83.25 7.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.776 0.798 . . . . 0.0 110.473 179.769 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -151.38 157.09 41.98 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.397 -176.987 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 46.3 t -80.9 122.49 82.0 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.915 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.83 -28.86 76.06 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.958 2.439 . . . . 0.0 115.055 -170.548 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.0 m -85.78 -49.93 14.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -173.095 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -106.98 6.61 29.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.801 0.334 . . . . 0.0 111.322 -176.397 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.255 4.5 p-10 50.82 40.19 24.09 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.227 . . . . 0.0 113.736 177.826 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -80.51 149.84 29.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.799 175.064 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.09 120.84 16.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.109 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.606 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.8 tp -124.29 129.33 50.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.709 0.29 . . . . 0.0 111.138 -176.176 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.02 152.51 24.38 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -65.2 -24.19 67.29 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -174.381 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -89.57 5.48 45.4 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.75 179.162 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -84.8 -11.27 56.08 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.017 0.437 . . . . 0.0 110.168 174.063 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.43 106.62 8.16 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.397 -175.989 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -136.3 150.04 69.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.872 179.042 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.61 151.52 64.3 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.726 1.617 . . . . 0.0 108.849 167.743 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.93 123.12 16.65 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.254 0.549 . . . . 0.0 112.11 -172.425 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -72.51 142.93 48.52 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -172.247 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -158.88 -171.29 3.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 178.751 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.36 83.96 1.07 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 119.476 1.034 . . . . 0.0 109.296 171.43 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? . . . . . 0 C--O 1.257 1.459 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.683 -174.65 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.197 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.67 142.06 92.98 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.368 2.045 . . . . 0.0 110.291 175.69 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -114.73 114.58 25.81 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.346 0.593 . . . . 0.0 110.123 -178.122 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.89 -53.42 0.03 OUTLIER Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 173.995 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.3 p -87.48 99.33 11.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.623 -0.788 . . . . 0.0 108.888 169.785 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -84.68 120.77 26.77 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -177.122 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.532 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.0 m-85 -106.46 10.64 31.34 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.643 0.735 . . . . 0.0 109.553 177.267 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -96.02 122.37 38.78 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.411 177.717 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.622 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 34.7 t -68.12 115.99 34.47 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.351 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.5 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 35.8 Cg_exo -62.04 -22.49 74.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.171 1.914 . . . . 0.0 113.171 -174.653 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.78 -44.28 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.475 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 8.1 p -97.96 -16.41 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.646 -177.413 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt 54.92 27.08 8.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 109.81 -174.031 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.9 ttm -108.35 -73.96 0.67 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.699 -173.488 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.65 162.75 2.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.015 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.5 mt -77.05 104.5 7.57 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.328 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -70.65 -45.65 64.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 177.294 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -114.59 -16.47 11.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.948 -178.027 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.58 82.67 0.08 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.949 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -111.85 117.81 56.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.244 0.545 . . . . 0.0 110.59 175.001 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.34 138.33 35.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.357 -177.914 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.9 p -113.73 156.54 43.51 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.584 -179.011 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.98 -22.0 73.54 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.027 2.485 . . . . 0.0 113.409 -176.17 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.482 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 56.5 m -73.99 -19.25 60.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.643 177.509 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 30.56 7.18 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.169 -175.885 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.482 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 16.5 m-70 -114.0 152.13 31.38 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.078 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -122.64 134.34 54.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.309 171.656 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.5 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 93.0 m-85 -129.97 -177.82 4.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.289 -176.151 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.6 m -99.61 157.89 16.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.999 173.443 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -68.64 -13.39 62.33 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.046 0.451 . . . . 0.0 111.631 -178.209 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 1.93 16.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.863 0.84 . . . . 0.0 109.198 -178.138 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 84.0 m -103.12 -63.32 1.18 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.713 175.935 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.1 -40.63 85.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.528 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.634 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.6 mt -63.47 -42.46 96.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.953 0.406 . . . . 0.0 110.273 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.84 4.95 12.58 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.627 0.727 . . . . 0.0 110.247 -179.289 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.7 t -106.46 -26.44 11.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.738 173.418 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.9 pt -103.77 -19.47 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.968 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -101.01 8.63 42.91 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.771 0.796 . . . . 0.0 109.36 173.8 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.41 -56.61 2.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.871 -174.66 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.33 -68.93 0.77 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.947 177.322 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.1 176.09 45.9 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 178.895 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -79.11 92.66 5.05 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 117.824 0.812 . . . . 0.0 111.478 -179.806 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 18.8 ptpt -169.08 147.46 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.328 0.651 . . . . 0.0 109.526 177.733 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 125.32 71.06 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 170.197 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.01 -25.59 81.77 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.965 2.444 . . . . 0.0 114.661 -167.909 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.98 -44.74 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.099 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -121.48 5.72 10.12 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.193 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 51.21 31.07 6.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.051 1.341 . . . . 0.0 114.24 179.691 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.1 140.11 32.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.509 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.36 120.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.278 0.561 . . . . 0.0 110.198 -176.448 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.9 tt -121.78 131.99 54.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.255 -173.46 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.429 HD11 ' NE2' ' A' ' 55' ' ' GLN . 8.3 mp -111.41 153.1 26.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.445 -178.01 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -61.69 -34.43 75.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.265 0.626 . . . . 0.0 111.461 -177.671 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -74.59 -11.47 60.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.11 0.481 . . . . 0.0 111.29 -178.018 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 52' ' ' LEU . 80.8 mt-30 -87.61 -10.63 50.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.841 177.9 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt -77.98 130.82 36.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 177.52 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -136.06 138.97 28.88 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.139 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -65.93 142.84 70.54 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 121.806 1.671 . . . . 0.0 111.508 -179.557 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.423 ' OD2' ' HB2' ' A' ' 61' ' ' PHE . 29.5 t70 -73.81 138.97 44.81 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.877 -177.117 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.41 -35.5 81.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -175.321 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.423 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 94.8 m-85 -66.85 -37.66 84.88 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.067 0.46 . . . . 0.0 110.012 -178.235 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.77 76.25 6.44 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.399 178.943 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 tptm . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.095 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 54.0 t -88.7 110.13 34.89 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.47 -17.86 53.92 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.848 2.365 . . . . 0.0 111.952 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.445 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -65.8 -43.99 93.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.754 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -115.0 -8.24 12.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.542 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.5 mt 56.68 34.82 25.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.845 0.858 . . . . 0.0 110.914 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -118.16 164.06 15.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.714 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.57 32.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.917 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.48 119.58 13.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.031 0.443 . . . . 0.0 111.008 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 19' ' ' ALA . 28.2 tpt180 -91.37 115.61 28.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.252 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 69.23 -16.23 0.25 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.553 1.141 . . . . 0.0 113.026 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 47.72 91.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.026 1.33 . . . . 0.0 113.569 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -101.83 116.73 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.319 0.58 . . . . 0.0 110.735 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.41 134.22 35.52 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.082 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -87.92 160.71 46.07 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.781 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.87 -17.96 62.31 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 122.39 2.06 . . . . 0.0 111.014 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.82 -21.43 63.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.411 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.91 2.08 58.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.417 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -97.54 136.39 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -102.54 135.34 44.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.98 166.61 22.31 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.9 m -65.74 150.11 49.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.06 -10.61 51.71 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.502 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.12 -38.13 3.68 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.559 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 36.6 m -61.77 -45.12 95.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.692 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -66.94 -39.34 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.577 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -62.97 -42.87 98.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.063 0.459 . . . . 0.0 110.509 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -78.61 -1.48 34.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.479 0.657 . . . . 0.0 110.374 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -105.84 -19.69 13.67 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.997 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -102.98 -26.16 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.0 ptm180 -103.02 8.55 38.87 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.795 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -115.28 -53.84 2.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.95 -66.68 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.22 0.533 . . . . 0.0 110.2 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.82 161.71 35.04 Favored Glycine 0 CA--C 1.497 -1.032 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -80.86 81.08 7.21 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 117.206 0.503 . . . . 0.0 112.197 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.2 ptpt -151.3 154.8 37.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.479 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.4 p -83.36 125.67 73.61 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.94 -27.33 84.63 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.636 2.224 . . . . 0.0 114.313 -170.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.15 -49.49 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.941 0.4 . . . . 0.0 111.864 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.91 6.39 4.29 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' HD22 ' A' ' 48' ' ' ASN . 1.0 OUTLIER 59.85 37.85 21.58 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.047 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.46 147.04 28.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.77 121.33 15.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.438 HD12 HG21 ' A' ' 37' ' ' ILE . 3.0 tm? -125.63 127.14 45.84 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.838 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.5 mm? -112.35 151.93 29.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HG3' HD11 ' A' ' 37' ' ' ILE . 2.7 mp0 -60.13 -39.44 86.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.535 0.334 . . . . 0.0 111.148 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -75.38 -15.21 60.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.772 0.32 . . . . 0.0 111.6 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.8 mm100 -83.08 -14.87 52.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 51' ' ' LEU . 93.8 mt . . . . . 0 C--O 1.24 0.557 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.02 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.2 t -86.49 107.59 14.31 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -63.16 -20.76 71.7 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.644 2.229 . . . . 0.0 113.251 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.0 -43.69 92.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.861 0.363 . . . . 0.0 111.018 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.0 p -101.15 -21.23 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.791 0.329 . . . . 0.0 111.488 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 60.27 22.35 11.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.977 0.911 . . . . 0.0 111.94 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -99.14 -71.65 0.69 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.808 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.13 -169.87 0.58 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.2 mt -97.0 107.98 20.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.764 0.316 . . . . 0.0 110.375 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 7.4 tpm_? -64.99 -49.66 69.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.695 174.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -116.11 -16.09 11.05 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.643 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.84 76.07 0.21 Allowed 'General case' 0 N--CA 1.462 0.139 0 O-C-N 123.862 0.726 . . . . 0.0 111.959 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.05 116.98 49.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.266 0.555 . . . . 0.0 110.919 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -71.8 125.89 28.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.933 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 p -89.66 158.76 44.88 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.44 -22.53 65.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.223 1.949 . . . . 0.0 113.56 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.57 -46.29 26.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.018 0.437 . . . . 0.0 110.966 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.68 48.94 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.346 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -139.92 163.17 33.37 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -124.86 137.6 54.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.08 0.467 . . . . 0.0 110.293 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.42 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.5 168.98 18.23 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.064 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 48.4 m -79.96 147.04 31.76 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -74.72 -3.58 32.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.256 0.55 . . . . 0.0 111.409 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.51 -18.57 12.38 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.957 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 43.9 m -85.07 -48.03 9.6 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.285 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.52 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.73 -42.27 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HA ' HG12 ' A' ' 37' ' ' ILE . 84.8 mt -63.48 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 111.633 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -77.25 -2.04 32.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 m -106.68 -24.21 12.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.8 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 42' ' ' HIS . 47.8 pt -105.1 -21.77 5.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -79.04 -15.45 58.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.887 -174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.16 -53.74 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.771 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.21 -65.34 0.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.562 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.43 139.65 5.49 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.866 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.545 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 71.3 m80 -79.55 67.05 5.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.698 0.761 . . . . 0.0 111.706 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -150.85 155.8 39.93 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.197 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.505 ' SG ' HD12 ' A' ' 51' ' ' LEU . 35.3 m -64.54 129.61 94.32 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.91 -21.81 56.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.989 1.793 . . . . 0.0 111.001 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.35 -74.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.553 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.14 4.52 53.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 62.5 m-80 54.61 32.99 18.21 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -88.39 155.26 19.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 50' ' ' ILE . 2.1 mp -65.73 117.39 6.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' SG ' ' A' ' 44' ' ' CYS . 7.8 tt -124.28 121.43 35.01 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.445 HD12 ' NE2' ' A' ' 55' ' ' GLN . 79.3 mt -111.36 145.22 39.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.255 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.39 -36.38 83.96 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.915 0.886 . . . . 0.0 110.466 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -64.79 -32.02 73.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.57 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.445 ' NE2' HD12 ' A' ' 52' ' ' LEU . 82.0 mt-30 -89.09 -8.64 53.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.759 174.714 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.431 -1.4 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.5 t -84.21 107.69 11.68 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.71 -18.46 47.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.423 2.082 . . . . 0.0 112.52 -174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.18 -43.58 91.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.292 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -100.53 -27.31 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.26 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.4 mt 63.89 23.09 13.25 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.778 0.831 . . . . 0.0 111.608 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.2 mtm -96.08 -71.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.497 0.665 . . . . 0.0 109.371 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.77 -158.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -98.95 104.76 16.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -68.63 -43.85 75.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.983 0.421 . . . . 0.0 110.747 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 63.2 mm-40 -119.21 -15.99 9.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.641 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.76 81.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.795 0.684 . . . . 0.0 112.278 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.42 115.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.806 0.812 . . . . 0.0 110.787 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.61 129.05 34.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.375 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -101.05 154.47 37.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -22.11 70.24 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.639 2.226 . . . . 0.0 112.094 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.06 -14.65 60.61 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.647 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.96 25.67 16.64 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.032 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -113.01 152.9 28.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -131.1 122.28 26.42 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.82 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -130.12 -169.54 2.15 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.96 0.409 . . . . 0.0 110.861 -172.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.6 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -99.54 155.38 17.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.8 172.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.0 tttt -68.13 -12.57 61.13 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.239 0.616 . . . . 0.0 111.641 -176.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.96 -24.26 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.308 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 45.5 m -76.88 -51.37 11.37 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.322 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -68.59 -41.28 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.851 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 30' ' ' LYS . 82.5 mt -63.08 -43.31 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -79.86 -1.98 41.48 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.484 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -106.45 -8.94 16.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.691 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 33' ' ' ILE . 41.3 pt -117.43 -8.18 11.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -93.96 -15.3 25.04 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.702 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -116.61 -46.71 2.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.134 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.48 -65.98 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 110.308 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.43 160.01 23.45 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.461 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 65.1 m80 -86.21 77.48 9.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.377 0.608 . . . . 0.0 111.333 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -150.39 148.95 29.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.228 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -79.52 123.7 84.17 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.61 -27.5 76.34 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 123.136 2.558 . . . . 0.0 115.097 -166.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -67.56 -46.14 83.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -119.31 4.3 11.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.286 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 56.42 33.94 23.34 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 113.211 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -87.82 150.13 23.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.29 120.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.271 0.557 . . . . 0.0 110.558 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -125.56 121.81 34.72 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.361 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.62 148.66 23.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.662 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.24 -41.57 96.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.235 0.541 . . . . 0.0 110.007 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -65.11 -29.55 70.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.562 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -73.95 -7.64 53.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.448 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.428 -1.569 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.9 t -59.91 115.64 13.77 Favored Pre-proline 0 C--N 1.317 -0.818 0 C-N-CA 123.699 0.799 . . . . 0.0 111.25 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.427 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -62.42 -20.16 69.57 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.85 2.367 . . . . 0.0 112.739 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.438 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.7 mt -67.32 -44.39 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 111.599 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -110.9 -27.54 8.77 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 62.09 23.39 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.856 0.863 . . . . 0.0 112.159 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -95.64 -65.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.875 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.96 -172.12 1.49 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.647 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 97.1 mt -108.5 122.61 47.42 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -68.67 -44.18 74.57 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.55 -11.9 2.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.14 81.71 0.18 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.129 0.49 . . . . 0.0 111.906 -175.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 116.21 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.656 0.741 . . . . 0.0 111.19 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -81.64 134.8 35.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.343 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.76 162.24 33.88 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.73 -33.11 96.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.021 2.48 . . . . 0.0 112.1 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -72.55 -15.07 61.77 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.205 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.95 34.74 5.82 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.648 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -116.47 152.93 33.05 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -124.74 121.8 35.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.21 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 81.1 m-85 -131.04 173.55 10.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.943 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.647 ' SG ' ' HA ' ' A' ' 16' ' ' LEU . 62.2 m -84.12 147.95 27.06 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.5 tttt -78.06 7.69 5.8 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.0 0.905 . . . . 0.0 110.523 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.92 -32.14 5.87 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.38 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 48.5 m -78.3 -46.07 21.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.203 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.9 tp -66.01 -41.52 89.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.249 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.551 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.0 mt -63.54 -42.51 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.365 . . . . 0.0 110.859 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.61 -1.54 34.66 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.336 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -105.64 -21.29 13.23 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.942 -0.474 . . . . 0.0 110.037 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.662 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.4 pt -103.53 -20.36 5.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.9 ptm180 -105.74 3.19 28.63 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.665 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -118.75 -55.5 2.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.15 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.8 -79.08 0.4 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -140.06 138.19 8.93 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.454 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 9.3 t-80 -80.48 53.73 1.9 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.888 0.851 . . . . 0.0 110.879 -174.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.41 157.73 43.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.109 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.67 123.65 83.96 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.46 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.85 -25.34 74.48 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.022 2.482 . . . . 0.0 114.601 -171.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.95 -49.1 77.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.62 5.81 11.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.4 34.25 24.41 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -101.08 151.05 22.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.678 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.72 121.91 16.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 121.214 0.53 . . . . 0.0 110.79 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.408 HD12 HD13 ' A' ' 37' ' ' ILE . 2.9 tm? -112.88 124.75 53.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.241 -177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -105.35 140.25 38.76 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.44 -38.16 83.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 111.155 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -72.91 -15.45 61.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.29 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.5 mm100 -84.31 -7.53 59.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.32 -0.691 0 CA-C-O 120.719 0.295 . . . . 0.0 110.383 178.704 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.0 tt0 . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 50.9 t -89.79 107.98 22.52 Favored Pre-proline 0 N--CA 1.438 -1.063 0 O-C-N 123.798 0.686 . . . . 0.0 109.376 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 31.8 Cg_exo -63.43 -18.44 64.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.479 2.786 . . . . 0.0 111.951 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.22 -43.78 91.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.049 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 p -107.9 -22.76 12.31 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 64.02 21.22 12.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.213 0.605 . . . . 0.0 112.299 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 9.4 mmt -95.81 -68.36 0.8 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.421 0.629 . . . . 0.0 109.739 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.47 -159.11 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.1 128.94 55.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -76.35 -73.29 0.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.304 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.51 -15.21 25.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.42 84.3 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.951 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.85 117.63 49.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.455 0.645 . . . . 0.0 111.033 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.68 133.53 36.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.099 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 71.9 p -88.9 162.33 38.54 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 27.7 Cg_endo -60.16 -28.82 87.74 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.478 2.118 . . . . 0.0 112.937 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.6 p -72.09 -30.57 65.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 111.152 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.1 29.74 2.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.812 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -117.75 157.56 26.32 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -125.51 139.24 53.79 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.295 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.86 171.53 14.33 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.187 0.995 . . . . 0.0 108.605 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -78.32 150.55 33.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -70.81 -8.06 49.74 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.464 0.705 . . . . 0.0 111.609 -172.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.67 -34.13 5.29 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.507 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 61.5 m -65.66 -46.48 78.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.796 0.331 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.29 -41.26 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.553 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.19 -41.95 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.427 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -78.12 -3.18 41.11 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.539 0.685 . . . . 0.0 109.673 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 m -106.95 -20.4 13.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.201 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 33' ' ' ILE . 38.5 pt -104.31 -8.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.52 -3.36 46.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -116.46 -56.02 2.33 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.341 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.09 -67.26 0.75 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.28 166.93 37.8 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 72.2 m80 -91.13 76.9 6.06 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.917 0.865 . . . . 0.0 111.651 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.75 157.53 42.12 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.83 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.5 p -77.83 132.74 67.23 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.741 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.02 -25.49 73.75 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.665 2.244 . . . . 0.0 113.749 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.36 -59.96 2.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.56 3.86 27.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 55.26 34.03 21.91 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -78.75 151.45 32.04 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.347 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.98 121.03 15.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 7.8 tt -110.02 125.73 53.22 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.357 0.599 . . . . 0.0 110.593 -170.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.97 135.52 45.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.623 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -64.97 -38.7 91.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.924 0.392 . . . . 0.0 110.657 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -65.06 -31.5 72.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.231 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -81.53 -9.08 59.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD21 HD21 ' A' ' 51' ' ' LEU . 89.3 mt . . . . . 0 CA--C 1.508 -0.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 120.664 0.269 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.1 t -79.33 113.17 34.29 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.08 -19.91 70.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.951 2.434 . . . . 0.0 113.182 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.03 -44.62 88.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.4 p -104.13 -19.95 13.99 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 64.28 20.57 12.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.791 0.836 . . . . 0.0 111.219 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.1 mtm -102.5 -73.78 0.65 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.107 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.34 -173.24 1.42 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . 93.6 mt -97.55 107.32 19.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -68.36 -45.13 73.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.159 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.544 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 70.5 mm-40 -113.02 -16.01 12.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.299 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . . . 57.75 81.79 0.14 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.998 0.811 . . . . 0.0 113.06 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -120.08 111.99 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.781 0.8 . . . . 0.0 111.616 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -81.55 132.95 35.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.807 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 p -94.23 159.35 34.25 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.605 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.0 -39.46 90.82 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.446 2.764 . . . . 0.0 113.003 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.6 p -71.96 -15.43 62.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 35.95 3.67 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.728 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -119.34 148.18 43.48 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.0 129.07 56.62 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.002 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -134.38 169.87 16.58 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.9 m -87.4 147.69 25.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 23.8 ttpp -78.5 -2.28 37.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.143 0.497 . . . . 0.0 111.716 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.64 -10.95 13.05 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.029 -0.419 . . . . 0.0 110.012 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.9 m -89.03 -48.21 7.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.505 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.6 -41.78 83.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.09 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.662 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.2 mt -63.5 -42.53 96.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.547 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.23 -1.5 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.45 0.643 . . . . 0.0 109.997 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.1 t -105.8 -22.78 12.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 33' ' ' ILE . 43.7 pt -102.9 -12.14 8.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 40.5 ptt85 -99.68 3.43 45.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.702 0.763 . . . . 0.0 109.306 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -116.68 -46.65 2.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.648 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.59 -66.9 0.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.256 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -175.52 167.32 39.19 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 63.0 m80 -84.33 67.18 9.74 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.895 0.855 . . . . 0.0 111.906 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -151.09 150.32 30.55 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.584 -1.189 . . . . 0.0 107.888 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.9 p -71.54 123.41 89.35 Favored Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.73 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.64 -25.21 75.19 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.644 2.229 . . . . 0.0 113.27 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.456 HG23 ' OD1' ' A' ' 47' ' ' ASP . 27.1 m -73.09 -33.0 41.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.456 ' OD1' HG23 ' A' ' 46' ' ' VAL . 15.0 p-10 -141.74 6.48 1.83 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 58.15 35.42 25.05 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.6 mm-40 -92.7 142.67 27.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -65.95 121.47 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 111.142 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.3 tp -122.68 131.78 53.96 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.513 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.629 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -106.68 150.97 25.71 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.68 -34.88 78.84 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.43 0.34 55.64 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.629 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.3 mm100 -77.72 -16.27 58.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.824 0.821 . . . . 0.0 109.344 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--N 1.314 -0.956 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.459 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.497 ' HB2' HD23 ' A' ' 16' ' ' LEU . 49.7 t -70.56 111.02 8.12 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.79 -19.73 52.84 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.195 1.93 . . . . 0.0 113.049 -172.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.15 -44.68 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.031 0.443 . . . . 0.0 111.808 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.0 p -108.14 -20.16 13.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.773 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt 69.51 22.83 6.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.279 1.032 . . . . 0.0 110.885 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -112.38 169.56 8.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.944 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 154.72 27.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.497 HD23 ' HB2' ' A' ' 9' ' ' CYS . 88.8 mt -71.08 119.17 14.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -176.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -75.46 -47.65 26.27 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.843 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 30' ' ' LYS . 50.9 mm-40 -113.85 -16.34 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.775 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.3 58.93 4.98 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.89 0.876 . . . . 0.0 112.981 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.34 115.68 27.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.442 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 27' ' ' ARG . 60.4 tt0 -81.61 135.35 35.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.897 -177.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -96.86 158.25 33.77 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.61 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.9 -23.19 74.22 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.862 2.375 . . . . 0.0 112.894 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.0 p -72.44 -28.13 62.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.91 40.72 1.05 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.491 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 59.9 m80 -127.07 160.74 30.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.674 0.273 . . . . 0.0 110.773 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 21' ' ' GLN . 31.5 mmt180 -125.6 136.59 53.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.435 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.4 m-85 -137.72 164.57 28.53 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.406 0.441 . . . . 0.0 110.012 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -85.45 157.52 20.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 87.2 tttt -68.47 -15.2 63.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -1.3 14.19 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.194 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 42.7 m -94.98 -54.2 3.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.893 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.44 -41.14 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.988 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.4 mt -63.23 -42.59 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.682 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -77.68 -1.28 30.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.385 0.612 . . . . 0.0 109.87 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -105.86 -19.98 13.58 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 122.018 -0.426 . . . . 0.0 109.958 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -103.79 -15.16 8.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.47 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -104.88 0.81 28.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.348 0.594 . . . . 0.0 110.498 173.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -116.97 -49.81 2.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.512 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.56 -66.23 0.94 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.518 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -177.86 162.16 29.68 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.33 81.68 3.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 111.176 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -173.71 155.63 2.72 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 4.9 p -76.47 126.06 86.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.275 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.96 -29.42 81.96 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.787 2.325 . . . . 0.0 114.726 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -77.16 -57.54 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -102.56 5.3 39.24 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 49.71 43.2 24.39 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 71.6 mm-40 -90.73 142.82 27.36 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.66 120.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.198 0.523 . . . . 0.0 109.876 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -124.36 130.72 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.158 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -107.64 152.51 24.21 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.87 -36.4 83.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.918 0.39 . . . . 0.0 111.551 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -69.58 -17.78 63.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.902 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.1 mm100 -68.32 -25.51 65.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.896 0.379 . . . . 0.0 111.463 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--N 1.317 -0.827 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.896 -178.644 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.56 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.4 t -72.95 114.86 34.62 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.64 -19.22 54.17 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.221 1.948 . . . . 0.0 113.875 -170.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.12 -44.78 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.245 0.545 . . . . 0.0 112.057 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 6.7 p -108.46 -17.38 14.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 63.18 46.25 4.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.696 0.76 . . . . 0.0 111.076 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.51 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 23.9 ptp -144.4 176.44 9.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.709 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.19 46.78 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.179 0.299 . . . . 0.0 111.005 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.605 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 65.8 mt -70.31 129.42 39.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.713 -174.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -71.27 -46.46 60.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -113.96 -15.2 12.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.254 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.413 ' HA ' HD13 ' A' ' 16' ' ' LEU . . . 58.26 87.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.903 0.752 . . . . 0.0 112.727 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.22 118.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.074 0.464 . . . . 0.0 111.295 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -79.76 139.31 37.32 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.12 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.471 HG21 HD11 ' A' ' 51' ' ' LEU . 41.5 p -97.69 159.41 31.08 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.73 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 29.1 Cg_endo -60.56 -25.16 80.12 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.157 2.571 . . . . 0.0 114.101 -177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -87.53 -14.76 39.42 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.495 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.44 36.3 2.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.119 -1.039 . . . . 0.0 114.483 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -117.97 152.93 34.51 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HB3' HD11 ' A' ' 16' ' ' LEU . 84.7 mtt85 -108.57 132.98 53.32 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.29 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.5 165.2 26.06 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.156 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 35.3 m -79.13 154.27 29.47 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 167.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.27 -11.29 60.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.473 0.654 . . . . 0.0 110.707 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 2.73 15.74 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.225 0.536 . . . . 0.0 109.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 74.2 m -98.08 -56.87 2.36 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.255 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -67.95 -41.25 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.5 mt -62.61 -42.21 95.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 111.011 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -78.32 -1.39 32.98 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.526 0.679 . . . . 0.0 110.741 -177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 m -106.04 -21.76 13.05 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.965 -0.459 . . . . 0.0 111.135 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 33' ' ' ILE . 33.3 pt -104.26 -9.62 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptp180 -101.5 2.85 39.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.209 0.528 . . . . 0.0 111.101 172.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -115.91 -47.22 2.8 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.573 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -75.07 0.35 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.719 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.3 169.6 42.19 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 65.4 m80 -83.97 69.03 10.24 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.65 0.725 . . . . 0.0 112.38 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -152.04 151.23 30.87 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.431 ' HB3' HD12 ' A' ' 51' ' ' LEU . 32.0 p -83.51 146.14 49.59 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.703 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.71 -18.52 58.69 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.703 2.269 . . . . 0.0 112.526 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.74 -74.31 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -106.73 4.57 27.84 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.901 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 57.59 29.06 16.57 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -78.17 147.25 34.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.31 121.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.317 0.58 . . . . 0.0 109.846 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 22' ' ' THR . 6.8 tt -117.05 120.5 38.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.735 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.44 143.14 32.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.248 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.99 -40.57 91.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.103 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.36 -29.96 67.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.995 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -73.22 -8.61 56.56 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.432 HD21 HD21 ' A' ' 51' ' ' LEU . 96.5 mt . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 99.7 mt-10 . . . . . 0 CA--C 1.492 -1.286 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.7 t -82.62 107.31 8.74 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.677 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 41.9 Cg_exo -60.32 -21.06 65.63 Favored 'Trans proline' 0 N--CA 1.475 0.391 0 C-N-CA 122.965 2.443 . . . . 0.0 113.185 -172.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.28 -44.16 91.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.2 p -112.74 -9.11 13.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 55.56 37.05 28.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.696 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.3 mtm -121.34 168.54 11.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.625 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.5 154.79 19.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.29 123.95 22.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.614 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -69.63 -44.18 71.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.846 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -126.44 -17.14 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.962 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.81 81.7 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 m -105.83 117.51 51.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.862 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -81.59 131.78 35.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -90.16 152.43 45.97 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.11 -22.49 73.22 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.433 2.088 . . . . 0.0 112.376 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.668 ' SG ' HD21 ' A' ' 51' ' ' LEU . 30.9 p -79.82 -17.29 53.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.702 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.43 40.67 1.59 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.361 -0.924 . . . . 0.0 113.907 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.472 ' HE1' ' OD1' ' A' ' 47' ' ' ASP . 65.6 m80 -133.28 161.37 34.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -128.32 137.74 52.08 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.677 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.4 m-85 -137.78 170.43 16.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.078 0.466 . . . . 0.0 111.357 -173.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 21.0 m -76.74 160.18 29.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' HD12 ' A' ' 34' ' ' ILE . 23.1 tptm -71.16 -15.35 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.707 0.289 . . . . 0.0 111.291 -171.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.33 -1.47 12.31 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.519 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 75.1 m -88.26 -65.06 1.06 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.501 ' HB ' ' CG ' ' A' ' 28' ' ' PHE . 11.1 tp -67.78 -38.89 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.2 mt -62.54 -42.84 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.96 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -78.82 -2.02 37.68 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.464 0.65 . . . . 0.0 110.5 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -105.4 -23.24 12.87 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.72 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.7 pt -102.92 -14.14 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.932 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.8 ptm180 -102.32 1.61 35.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.746 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.57 -56.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.0 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.04 -68.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.276 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -151.59 147.39 17.21 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -84.63 34.09 0.53 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.783 0.801 . . . . 0.0 111.121 -171.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -144.14 154.94 43.69 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.636 ' HB3' HD11 ' A' ' 51' ' ' LEU . 25.8 p -64.29 130.06 94.41 Favored Pre-proline 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.078 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.2 -18.94 62.4 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.442 2.094 . . . . 0.0 111.379 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.79 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.104 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.472 ' OD1' ' HE1' ' A' ' 26' ' ' HIS . 51.1 p-10 -117.37 15.93 14.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 63.69 35.09 11.69 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.612 ' OE1' ' HB2' ' A' ' 24' ' ' CYS . 57.9 mt-10 -89.86 139.56 30.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 mm -66.56 122.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.099 0.476 . . . . 0.0 111.313 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 ' SG ' ' A' ' 24' ' ' CYS . 77.1 mt -112.69 128.98 56.55 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.058 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.2 133.37 50.08 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -61.42 -38.04 85.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -74.72 -13.33 60.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.507 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.62 -9.07 55.32 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.507 -0.694 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.224 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 t -76.43 112.1 19.49 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.6 Cg_exo -61.02 -19.4 62.9 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.027 2.484 . . . . 0.0 113.222 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.91 -43.98 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.45 -25.55 10.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp 66.22 23.68 10.84 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.886 0.874 . . . . 0.0 112.087 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -93.54 -67.41 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.587 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.96 -167.72 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.6 mt -98.69 106.27 18.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -68.92 -43.83 74.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 0.0 110.377 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 66.8 mm-40 -124.01 -15.16 6.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.101 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.43 83.16 0.05 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.853 0.861 . . . . 0.0 113.301 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.36 118.88 59.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 0.0 111.06 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 52.3 tt0 -80.65 128.42 33.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 51.2 p -80.93 164.69 49.54 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 25.3 Cg_endo -59.94 -28.03 86.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.551 2.168 . . . . 0.0 112.331 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 p -79.9 -15.69 56.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.804 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.59 45.78 2.44 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.392 -0.909 . . . . 0.0 114.325 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.665 ' HE1' ' OD2' ' A' ' 47' ' ' ASP . 47.0 m80 -120.58 154.25 35.66 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -105.1 124.76 50.09 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 123.315 0.384 . . . . 0.0 110.325 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 92.4 m-85 -134.66 170.39 15.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.088 0.555 . . . . 0.0 110.105 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 40.0 m -85.32 150.15 24.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.474 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 62.5 tttp -68.39 -11.55 59.79 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.871 0.469 . . . . 0.0 111.136 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.18 -14.28 13.4 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.881 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.8 m -87.12 -46.57 9.66 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.896 174.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -68.17 -42.01 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.734 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.638 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.8 mt -63.5 -42.54 96.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 0.0 110.468 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.8 7.67 6.67 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.805 0.812 . . . . 0.0 110.342 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.9 t -106.83 -27.35 10.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.941 -0.475 . . . . 0.0 109.936 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 37.5 pt -104.37 -16.83 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.638 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -98.59 4.78 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -115.59 -56.56 2.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.728 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.9 -68.36 0.8 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.88 169.09 41.89 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.573 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 53.9 m80 -83.41 74.39 10.08 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.656 0.741 . . . . 0.0 111.978 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -150.88 155.28 38.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.812 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.7 t -67.72 129.04 93.51 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.94 -23.77 61.37 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.906 2.404 . . . . 0.0 114.156 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.58 -52.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.665 ' OD2' ' HE1' ' A' ' 26' ' ' HIS . 36.0 p30 -105.81 4.03 29.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.107 -176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 56.87 31.76 20.23 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -78.71 145.79 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -66.12 122.52 17.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.272 0.558 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 60.4 tp -121.06 128.5 52.69 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.239 -171.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.29 146.5 34.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.791 0.329 . . . . 0.0 110.329 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.01 -37.37 87.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.871 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -19.49 63.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.97 0.414 . . . . 0.0 111.514 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.19 -8.0 58.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.844 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.5 mt . . . . . 0 C--N 1.322 -0.592 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.074 178.581 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -64.17 111.65 5.92 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.84 -19.45 58.75 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.061 . . . . 0.0 113.429 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.62 -44.52 89.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.014 0.435 . . . . 0.0 110.945 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -101.52 -23.65 14.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.2 mt 64.48 22.77 12.79 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 111.118 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.6 mtm -96.16 -68.33 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.933 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.33 -161.35 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.92 107.32 18.1 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 6.0 tpm_? -68.05 -44.67 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.828 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -114.92 -16.34 11.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.22 74.5 0.39 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.077 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.93 113.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.425 0.631 . . . . 0.0 110.47 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.62 142.08 32.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -101.14 159.48 29.35 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.22 -19.95 66.43 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.419 2.079 . . . . 0.0 110.979 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.1 t -75.18 -14.29 60.53 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.972 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 18.99 48.47 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.29 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -106.32 141.42 37.67 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -104.38 133.88 48.52 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -139.43 172.27 13.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.487 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 36.0 m -89.25 154.16 20.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.03 -12.91 61.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 122.922 0.489 . . . . 0.0 111.963 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.38 -13.9 12.24 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.41 -176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 44.0 m -84.64 -54.77 4.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.985 0.421 . . . . 0.0 110.689 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.16 -41.85 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -172.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.656 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.48 -43.66 98.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.789 0.328 . . . . 0.0 111.163 -175.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -81.73 1.99 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.204 0.526 . . . . 0.0 111.09 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.1 t -105.06 -22.21 13.14 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.8 pt -103.26 -25.68 3.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.656 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -98.61 3.83 47.97 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.312 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.08 -56.52 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.745 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -71.09 0.55 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.556 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.692 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -142.33 132.04 4.97 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.3 30.12 0.48 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.971 0.891 . . . . 0.0 111.39 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -142.54 153.88 43.96 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 16.8 p -63.0 124.51 83.99 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 120.859 0.362 . . . . 0.0 110.065 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.31 -22.11 73.63 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.909 2.406 . . . . 0.0 114.169 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.427 HG23 ' OD1' ' A' ' 47' ' ' ASP . 28.6 m -79.21 -51.89 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.427 ' OD1' HG23 ' A' ' 46' ' ' VAL . 11.5 p-10 -117.47 7.15 12.67 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 62.02 37.02 15.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.5 mm-40 -93.94 139.5 30.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.673 0.273 . . . . 0.0 111.303 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.78 121.91 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.631 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.3 tp -117.66 131.65 56.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.672 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.41 139.89 41.19 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.81 -38.62 82.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.418 0.449 . . . . 0.0 111.401 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -63.25 -30.15 71.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.464 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -73.81 -8.75 57.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.784 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 N--CA 1.434 -1.227 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB2' HD23 ' A' ' 16' ' ' LEU . 42.9 t -59.19 107.88 1.14 Allowed Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.753 0.658 . . . . 0.0 109.972 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.454 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.2 Cg_exo -65.51 -20.24 60.69 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.839 2.359 . . . . 0.0 112.405 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.03 -44.01 92.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.775 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -98.95 -26.78 14.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.136 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 65.5 21.17 11.79 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.192 0.997 . . . . 0.0 111.426 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.9 mtm -98.3 -67.23 0.86 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.518 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.51 -172.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 9' ' ' CYS . 88.5 mt -100.86 108.47 20.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -73.67 -45.29 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.042 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 48.8 mm-40 -104.93 -19.0 13.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.701 -175.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.43 71.58 0.27 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.224 -173.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -99.77 113.21 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.663 0.744 . . . . 0.0 109.72 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.08 135.43 35.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.815 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 p -89.7 162.37 36.29 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.01 -27.81 85.72 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.361 2.041 . . . . 0.0 112.819 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -75.8 -14.97 60.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.98 36.1 5.1 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -117.05 151.89 35.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -117.15 135.94 53.39 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.278 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.454 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.3 m-85 -137.87 172.6 12.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.468 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.8 m -83.94 149.06 26.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 62.0 tttp -67.64 -12.82 61.31 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 120.942 0.401 . . . . 0.0 111.427 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.29 -16.79 12.89 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.435 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 47.2 m -81.59 -46.78 13.92 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.9 tp -68.95 -42.21 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.5 mt -63.25 -42.74 97.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.893 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.62 2.95 20.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.524 0.678 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -107.01 -22.77 12.55 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.05 -0.406 . . . . 0.0 111.104 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.0 pt -103.41 -19.0 6.41 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -105.22 7.97 33.8 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.656 0.741 . . . . 0.0 109.908 172.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -116.48 -56.02 2.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.373 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.63 -66.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.75 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.56 160.16 33.56 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -79.47 73.51 6.13 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.807 0.804 . . . . 0.0 111.616 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -153.36 150.73 29.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.46 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.0 129.41 86.47 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.87 -20.84 68.88 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.031 2.488 . . . . 0.0 113.649 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.414 HG23 ' OD1' ' A' ' 47' ' ' ASP . 14.9 m -82.15 -59.81 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 46' ' ' VAL . 16.2 p-10 -107.42 4.81 26.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 56.84 32.32 21.17 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -88.47 147.79 24.49 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.103 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 50' ' ' ILE . 3.2 mp -66.45 119.98 12.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.302 0.573 . . . . 0.0 110.297 -175.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.27 128.88 54.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.058 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.93 144.67 30.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.9 -41.55 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.752 0.821 . . . . 0.0 110.896 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -66.51 -31.28 71.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -77.22 -8.86 58.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -170.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.476 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.0 t -75.58 111.58 15.04 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 123.401 0.681 . . . . 0.0 109.621 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.5 Cg_exo -63.67 -20.44 69.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 112.903 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.93 -44.39 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.64 -23.38 13.85 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.371 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.04 22.23 7.13 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.829 0.851 . . . . 0.0 111.601 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.66 -49.77 5.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.201 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 172.7 -165.63 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.2 mt -103.56 125.65 50.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -80.08 -76.55 0.22 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.686 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -90.21 -15.32 31.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.4 84.24 0.14 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.622 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.49 116.89 50.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.291 0.567 . . . . 0.0 111.077 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -80.88 134.99 35.84 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.36 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -101.49 156.2 35.46 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.69 -22.86 74.34 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -77.23 -14.02 59.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.01 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.17 29.52 6.03 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.096 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -112.92 148.22 35.43 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -107.59 128.59 54.67 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 88.7 m-85 -131.89 -174.74 3.51 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.4 m -99.54 159.15 15.24 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.84 0.352 . . . . 0.0 110.134 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.42 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.9 tttt -77.06 -9.94 59.05 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.566 0.747 . . . . 0.0 110.731 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.22 -6.98 13.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.165 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 85.7 m -91.26 -61.54 1.63 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.795 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -67.44 -40.91 85.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.944 -174.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.0 mt -62.89 -42.39 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 110.454 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 38.5 ttpt -79.57 1.07 27.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.721 0.772 . . . . 0.0 110.865 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -104.48 -24.77 12.99 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.5 pt -102.62 -7.05 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.7 ptm180 -99.55 2.81 45.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.033 0.444 . . . . 0.0 110.147 172.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -122.37 -56.13 1.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.072 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.35 -66.37 0.91 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.186 0.517 . . . . 0.0 110.785 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -170.65 163.96 37.15 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -85.1 73.56 10.63 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.712 0.768 . . . . 0.0 110.846 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.422 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 19.4 ptpt -149.28 151.38 34.09 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.967 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.78 123.84 90.04 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.17 -24.96 65.5 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 113.138 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.12 -57.39 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -108.13 5.7 26.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 56.74 31.77 19.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.309 1.044 . . . . 0.0 113.638 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -83.99 147.46 27.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mm -66.56 120.77 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.25 0.548 . . . . 0.0 109.615 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 43' ' ' LYS . 67.1 tp -122.46 126.27 47.55 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.965 -174.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.82 156.03 19.6 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -66.13 -35.66 81.08 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.21 0.528 . . . . 0.0 110.124 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.26 -20.76 63.93 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.019 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -82.38 -11.43 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.104 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.318 -0.762 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.279 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 45.1 tt0 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.69 0.281 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 t -83.89 111.5 33.21 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.06 -18.52 56.88 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.735 2.29 . . . . 0.0 113.708 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.45 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.789 0.328 . . . . 0.0 111.088 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.47 -20.79 14.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.921 0.391 . . . . 0.0 111.212 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.3 mt 64.03 21.34 12.56 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.294 1.037 . . . . 0.0 112.177 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.9 mtm -95.74 -66.88 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.221 0.534 . . . . 0.0 111.165 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -174.93 -173.43 0.69 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.98 125.68 36.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -79.39 -75.26 0.25 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -91.29 -16.79 26.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.91 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.24 84.74 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.038 0.935 . . . . 0.0 112.445 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -115.31 117.69 56.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.184 0.516 . . . . 0.0 110.431 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 22' ' ' THR . 52.8 tt0 -82.82 146.45 28.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.498 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 70.8 p -92.3 159.31 37.44 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -56.47 -38.43 95.36 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.74 2.294 . . . . 0.0 112.323 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -67.53 -36.71 81.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.696 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.04 48.51 0.21 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.883 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 36.0 m-70 -124.65 145.01 49.88 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.3 mtm-85 -114.25 132.4 56.15 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.205 0.526 . . . . 0.0 111.874 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.89 171.66 14.17 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.868 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.529 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.1 m -79.63 150.7 30.91 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -72.73 -9.23 58.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.347 0.594 . . . . 0.0 110.97 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.57 -14.92 12.62 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.975 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.6 m -84.69 -46.64 11.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.417 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.6 -42.09 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.943 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.1 mt -63.14 -42.35 96.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.629 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -77.43 -1.92 32.66 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.402 0.62 . . . . 0.0 109.939 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -104.99 -23.69 12.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.205 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.49 -7.3 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -97.85 0.05 45.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.546 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -139.55 -56.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.83 -65.86 0.94 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.271 0.558 . . . . 0.0 111.132 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.38 136.57 5.27 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.406 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 6.0 t-80 -83.31 52.73 2.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.527 0.68 . . . . 0.0 109.542 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -147.24 156.17 42.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.266 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.32 123.35 75.1 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.62 -24.15 69.83 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.955 2.437 . . . . 0.0 114.428 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.59 -48.66 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -118.78 5.79 11.51 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.979 -0.451 . . . . 0.0 111.653 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 57.47 33.08 22.79 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.437 0.695 . . . . 0.0 112.807 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -87.27 145.18 26.47 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.491 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.21 121.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.59 130.27 56.29 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.105 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.54 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -109.38 146.87 33.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.18 -33.51 73.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.489 0.716 . . . . 0.0 109.651 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.517 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.8 mm100 -77.67 -14.7 59.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.847 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--O 1.246 0.92 0 CA-C-O 120.744 0.306 . . . . 0.0 110.41 -177.096 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 t -92.78 113.65 60.26 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.79 -18.92 63.9 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.599 2.199 . . . . 0.0 113.575 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.2 -43.91 91.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.839 0.352 . . . . 0.0 111.181 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.9 p -101.7 -21.22 14.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.798 0.332 . . . . 0.0 111.325 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt 59.51 23.03 11.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.001 0.92 . . . . 0.0 111.907 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.8 mtm -95.32 -68.54 0.8 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.672 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.74 -165.59 0.32 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.06 124.08 47.05 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.35 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 8.8 tpt180 -78.4 -61.13 2.1 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.169 174.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 69.9 mm-40 -108.42 -15.05 14.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.338 -176.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.91 73.87 0.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.959 0.787 . . . . 0.0 112.335 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.32 116.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 110.684 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -81.2 139.95 35.22 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.004 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 p -98.46 158.67 32.19 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.7 -34.63 91.27 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.092 2.528 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -15.34 61.93 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.47 42.18 3.01 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.715 -0.755 . . . . 0.0 114.006 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -127.47 141.13 51.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.12 136.86 42.96 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.119 0.485 . . . . 0.0 111.6 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -133.68 173.3 11.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.651 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.589 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -86.03 149.63 25.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 66.0 tttm -68.51 -12.2 60.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.37 0.668 . . . . 0.0 111.606 -176.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.25 -5.62 12.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.992 0.425 . . . . 0.0 110.143 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 79.5 m -92.59 -58.68 2.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.625 175.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -65.93 -42.43 91.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.836 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.616 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.51 -43.19 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.674 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -80.34 -1.5 41.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.599 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -105.54 -20.09 13.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.9 pt -102.1 -19.83 5.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.953 -175.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.8 ptm180 -100.87 2.79 41.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.614 0.721 . . . . 0.0 110.254 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -115.96 -46.57 2.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.78 -70.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 0.0 110.466 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.54 155.27 26.35 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 62.3 m80 -80.1 68.58 6.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.963 0.887 . . . . 0.0 112.358 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.27 153.89 34.64 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.02 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.5 p -79.35 123.42 84.53 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.786 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.18 -21.41 67.6 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.142 2.562 . . . . 0.0 113.942 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.2 m -78.54 -52.55 15.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -112.03 4.85 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 57.73 35.26 25.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.456 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 62.3 mm-40 -94.51 148.26 22.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.41 121.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.35 127.43 49.77 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.013 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.6 mm? -106.28 150.34 26.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.475 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.69 -37.97 89.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.3 -27.41 67.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.818 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.6 mm100 -73.75 -8.47 56.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 -174.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.7 mt . . . . . 0 C--N 1.319 -0.75 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.171 179.393 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.434 -1.257 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.2 t -69.01 113.83 19.1 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.43 -18.19 54.51 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.192 2.595 . . . . 0.0 112.271 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.8 mt -66.62 -44.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.106 0.479 . . . . 0.0 111.134 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 p -105.24 -20.84 13.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.09 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 62.94 22.94 13.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 111.516 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -103.93 -68.12 0.86 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.67 -167.27 1.08 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.3 mt -113.98 132.29 56.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB3' ' H ' ' A' ' 30' ' ' LYS . 27.9 tpt180 -69.09 -77.42 0.08 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.1 5.6 20.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 171.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.54 80.78 0.14 Allowed 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.612 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.1 m -90.9 116.24 31.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.783 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.08 130.12 34.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.643 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.3 p -89.56 155.96 48.09 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.88 -23.14 75.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.735 2.29 . . . . 0.0 112.754 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.0 p -77.94 -20.14 53.31 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.4 39.93 2.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.151 -1.024 . . . . 0.0 114.142 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.421 ' HE1' ' CG ' ' A' ' 47' ' ' ASP . 38.5 m80 -122.51 155.37 36.36 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -124.38 131.09 53.5 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -134.16 172.85 12.28 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.871 0.469 . . . . 0.0 110.891 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.433 ' O ' HG22 ' A' ' 33' ' ' ILE . 63.6 m -72.09 160.08 33.08 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.732 169.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' O ' HD12 ' A' ' 34' ' ' ILE . 89.2 tttt -82.63 -1.07 49.94 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.99 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.4 -40.07 3.48 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.319 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.7 m -62.26 -50.07 73.18 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -69.34 -42.36 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.556 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.8 mt -63.53 -43.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 111.575 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -78.0 -0.37 27.57 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.578 0.704 . . . . 0.0 109.553 -174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 t -105.25 -26.16 12.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.748 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.9 pt -104.24 -14.01 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -93.39 -6.96 45.98 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.5 174.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -115.74 -56.8 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.71 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.27 -66.1 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.986 0.422 . . . . 0.0 110.048 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.02 165.54 38.7 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -87.6 69.2 9.7 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.497 0.665 . . . . 0.0 111.759 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -147.17 154.61 41.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.228 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 29.7 m -62.14 131.74 93.59 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.75 -24.37 61.97 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.235 1.957 . . . . 0.0 111.505 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.53 -70.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.234 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' CG ' ' HE1' ' A' ' 26' ' ' HIS . 14.6 p-10 -97.46 6.17 48.58 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -172.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 9.2 p30 54.33 16.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 174.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.54 151.33 45.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.3 120.47 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -120.93 122.03 39.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.514 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.67 138.91 34.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.65 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.4 -41.13 96.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.835 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -74.99 -12.7 60.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.205 0.526 . . . . 0.0 111.317 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -82.19 -10.17 59.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.246 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 C--O 1.236 0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.191 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' HD23 ' A' ' 16' ' ' LEU . 41.3 t -83.44 112.35 38.67 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.13 -20.01 65.96 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 122.42 2.08 . . . . 0.0 112.513 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.26 -44.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.532 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -119.15 -2.42 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.8 mt 53.8 27.3 6.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.093 0.957 . . . . 0.0 112.053 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.3 mtm -111.67 174.16 6.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.724 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.16 149.95 49.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.359 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 9' ' ' CYS . 89.3 mt -70.28 109.86 4.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -65.56 -46.22 80.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 57.6 mm-40 -116.49 -15.51 10.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.079 -176.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 47.81 72.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.053 0.941 . . . . 0.0 113.164 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.79 116.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.363 0.602 . . . . 0.0 110.674 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 22' ' ' THR . 9.6 tt0 -82.13 136.61 35.13 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.965 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 32.3 p -84.29 163.62 46.9 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.81 -36.47 95.37 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.694 2.262 . . . . 0.0 112.508 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.511 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 5.0 p -65.68 -21.74 66.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.812 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.5 38.07 3.83 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.102 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -115.54 143.06 45.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.01 130.28 53.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.746 0.307 . . . . 0.0 111.267 -173.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -139.65 162.83 34.15 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.641 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.63 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 47.1 m -78.39 147.8 33.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.3 tttt -68.83 -10.25 55.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -174.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 -13.29 13.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.63 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.5 m -85.64 -45.16 11.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.694 173.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -65.58 -39.98 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.75 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.86 -41.38 92.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.164 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.08 -2.25 33.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.355 0.598 . . . . 0.0 109.944 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 m -105.68 -21.3 13.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.0 pt -103.12 -8.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.559 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.54 -2.27 45.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.085 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -116.78 -55.51 2.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.073 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.63 -64.79 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.42 -175.08 41.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -80.42 80.77 6.8 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.546 0.689 . . . . 0.0 111.596 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.0 ptpt -148.53 153.29 38.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.556 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 49' ' ' GLU . 4.6 p -76.78 136.01 67.36 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 165.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.98 -20.3 69.05 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 122.848 2.365 . . . . 0.0 114.167 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 47' ' ' ASP . 3.8 m -92.89 -71.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.481 ' H ' HG23 ' A' ' 46' ' ' VAL . 12.8 p-10 -96.14 5.27 51.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.827 0.451 . . . . 0.0 112.052 -174.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.33 0.3 OUTLIER 44.19 56.67 4.71 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.098 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 17.5 pt-20 -94.58 163.52 13.35 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.54 115.33 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 109.504 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.1 tp -115.63 130.08 56.73 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.182 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.97 149.4 35.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.307 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.97 -35.84 75.87 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.529 0.518 . . . . 0.0 110.193 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -63.8 -31.28 72.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.776 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -78.43 -7.59 57.55 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.318 -0.777 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.21 176.774 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.95 108.01 11.2 Favored Pre-proline 0 N--CA 1.436 -1.136 0 O-C-N 123.657 0.598 . . . . 0.0 109.764 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HG3' HG13 ' A' ' 46' ' ' VAL . 58.5 Cg_endo -69.64 -17.86 37.87 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.948 2.432 . . . . 0.0 111.789 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.77 -43.77 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.1 p -99.72 -20.19 16.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.99 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 61.87 21.76 12.52 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.729 0.811 . . . . 0.0 111.883 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.68 -71.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.704 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.22 -166.49 0.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.16 105.04 17.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -70.47 -57.01 5.25 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 63.8 mm-40 -103.42 -16.41 15.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.006 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.55 61.51 3.16 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -93.04 118.23 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.188 0.518 . . . . 0.0 111.374 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 65.3 tt0 -75.51 134.44 40.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.947 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -99.96 159.17 30.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.766 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.89 -23.77 68.24 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.749 2.299 . . . . 0.0 113.113 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -73.11 -28.61 62.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.379 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.64 38.75 1.16 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -133.28 162.02 32.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 80.2 mtp180 -127.98 140.12 52.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -136.13 173.9 11.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.1 m -84.91 148.23 26.35 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 87.9 tttt -79.33 -3.58 46.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 110.324 -174.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.61 -12.55 13.41 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.6 m -94.09 -54.22 3.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.777 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -66.03 -38.57 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.9 mt -62.8 -42.99 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.663 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.95 -2.52 40.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.611 0.719 . . . . 0.0 110.48 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -105.43 -16.47 14.72 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.965 -0.459 . . . . 0.0 110.618 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.661 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -104.09 -24.18 4.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.559 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -97.42 1.04 48.77 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.813 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -116.4 -56.02 2.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.564 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.26 -66.71 0.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.467 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.1 159.1 32.0 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 64.0 m80 -85.45 75.64 10.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.285 0.543 . . . . 0.0 110.871 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -153.76 155.19 35.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.498 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.1 p -80.71 130.91 62.35 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -31.55 85.61 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.782 2.321 . . . . 0.0 114.775 -172.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 10' ' ' PRO . 16.0 m -78.87 -53.28 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -106.05 3.5 28.26 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 52.82 40.18 30.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.15 146.22 24.02 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 mm -66.65 120.58 14.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.373 0.606 . . . . 0.0 109.909 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.6 tp -124.42 118.05 25.81 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.801 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.565 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -96.05 161.42 13.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.91 -37.39 87.48 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.806 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.89 -24.02 64.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 111.247 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.565 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.7 mm100 -76.38 -10.78 59.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.665 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.32 -0.689 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.168 177.882 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 42.5 tt0 . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 51.3 t -87.63 108.74 21.8 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 37.3 Cg_exo -61.54 -20.61 69.32 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.478 2.119 . . . . 0.0 111.677 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.462 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.24 -43.47 91.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.034 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.0 m -88.89 -27.49 20.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.182 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 56.78 35.21 25.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.073 0.939 . . . . 0.0 108.693 -165.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -139.48 171.28 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.309 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.66 152.48 22.36 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.546 0.529 . . . . 0.0 111.608 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.0 mt -70.85 139.51 50.87 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.997 -177.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -79.12 -72.3 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.289 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.47 -15.96 20.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.649 0.261 . . . . 0.0 110.911 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.71 102.47 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.957 0.903 . . . . 0.0 113.274 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.8 m -117.15 118.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.411 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 60.6 tt0 -80.41 135.31 36.14 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.768 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -95.77 152.57 39.16 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -26.52 83.27 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.902 2.401 . . . . 0.0 113.823 -173.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -79.72 -19.36 49.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.72 48.48 0.68 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.649 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -133.33 152.11 51.91 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 65.2 mtt180 -121.44 136.3 54.97 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.982 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.67 170.0 16.48 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 39.0 m -78.92 153.29 30.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.96 -12.68 61.2 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.77 -31.56 6.1 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.224 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 28.0 m -62.98 -44.61 95.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.543 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -64.73 -41.12 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.0 mt -63.48 -43.51 98.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.836 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.77 -2.8 44.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.872 0.368 . . . . 0.0 110.539 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.0 t -106.92 -22.8 12.57 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.797 0.332 . . . . 0.0 110.635 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 33' ' ' ILE . 45.7 pt -101.78 -7.91 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.061 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -101.98 6.66 41.32 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.586 167.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.52 -54.89 2.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.186 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -66.11 0.94 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.137 0.494 . . . . 0.0 109.809 176.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.65 166.83 38.84 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 49.9 m80 -79.73 77.4 6.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.164 0.982 . . . . 0.0 110.83 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.1 ptpt -152.25 149.79 29.09 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.625 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.573 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 2.2 m -68.01 130.54 92.63 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.6 -34.02 94.5 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.262 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.76 -54.95 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.573 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 31.4 p-10 -104.19 4.29 33.81 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.719 -0.613 . . . . 0.0 112.07 -174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 54.96 32.23 17.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.799 0.84 . . . . 0.0 112.739 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 73.7 mm-40 -92.91 142.82 26.88 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.83 120.38 11.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 CA-C-O 121.597 0.713 . . . . 0.0 110.373 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.8 tp -117.14 129.25 55.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.316 -175.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.8 mm? -98.21 148.74 23.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.59 -37.24 86.07 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.328 0.393 . . . . 0.0 111.882 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -68.37 -19.74 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.534 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 14.1 mm-40 -77.24 -6.62 53.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.199 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.434 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 39.8 t -78.25 113.83 37.19 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.98 -20.96 64.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.481 2.121 . . . . 0.0 112.895 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.86 -44.34 85.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.094 0.473 . . . . 0.0 111.874 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 20.7 p -101.85 -13.22 17.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.166 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mp 54.09 23.37 4.07 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.996 0.918 . . . . 0.0 111.742 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.7 mtm -100.03 -70.98 0.72 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.687 0.279 . . . . 0.0 111.676 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.89 165.25 5.16 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.6 109.92 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -70.42 -46.12 64.54 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.895 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -115.35 -17.9 11.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.06 81.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.798 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.71 117.37 42.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.601 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -80.83 140.96 35.13 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.195 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -96.9 156.77 36.07 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 74.9 Cg_exo -54.53 -37.59 90.27 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.966 2.444 . . . . 0.0 112.594 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -64.9 -18.33 65.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.903 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.87 4.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.471 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -120.35 152.32 38.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -123.07 138.27 54.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.349 0.595 . . . . 0.0 112.439 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -137.3 169.26 18.08 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.329 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HB2' ' HG ' ' A' ' 32' ' ' CYS . 82.3 m -76.47 151.4 36.47 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.228 171.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.52 -5.78 31.38 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.04 0.447 . . . . 0.0 112.107 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.85 -34.13 5.55 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.93 -0.481 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.59 ' HG ' ' HB2' ' A' ' 29' ' ' CYS . 58.5 m -64.29 -44.8 90.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.015 0.436 . . . . 0.0 110.608 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.515 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.1 tp -65.53 -39.91 86.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.169 -176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -63.02 -42.35 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.039 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -78.12 -2.3 36.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.785 0.326 . . . . 0.0 110.422 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -105.35 -25.62 12.32 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.003 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.8 pt -103.81 -10.29 9.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.71 -174.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.5 ptm180 -93.47 -14.04 27.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.487 176.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -131.72 -56.33 1.0 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.138 -172.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.02 -66.2 0.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.87 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.06 137.32 5.11 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -85.23 43.44 1.01 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.854 0.835 . . . . 0.0 110.244 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -148.05 155.11 41.11 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 12.0 p -75.04 127.03 87.46 Favored Pre-proline 0 C--N 1.318 -0.778 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.192 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.7 -25.27 68.76 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.917 2.411 . . . . 0.0 113.557 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.52 -49.33 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -131.87 12.21 4.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.99 35.32 21.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 73.3 mm-40 -85.03 143.5 28.87 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.322 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.81 120.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.7 tp -121.03 126.6 50.3 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.555 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -110.43 148.01 32.88 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.02 -28.82 69.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.689 0.757 . . . . 0.0 109.835 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.96 -30.65 71.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.438 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.555 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.4 mm100 -80.16 -16.37 55.02 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.363 -175.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.239 0.506 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.35 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.241 0.636 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 19.6 p -91.55 134.15 29.88 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.573 175.629 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.55 -17.52 58.71 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.929 2.419 . . . . 0.0 113.131 -174.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.8 -45.03 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -106.89 -20.08 13.44 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.53 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.25 23.0 6.68 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.843 0.857 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -97.45 -66.61 0.89 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.202 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.72 -172.62 0.9 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -105.12 105.36 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.22 174.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -69.91 -44.15 70.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.709 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -125.41 -15.16 6.24 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.633 -175.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HB1' ' HD3' ' A' ' 27' ' ' ARG . . . 49.6 56.24 8.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 30.3 m -77.48 118.22 23.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -75.9 133.32 40.56 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.643 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -106.1 162.58 19.26 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.264 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.23 -36.64 99.07 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.294 2.663 . . . . 0.0 112.46 178.526 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.0 -25.94 64.76 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.932 0.396 . . . . 0.0 111.602 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.31 29.01 4.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.038 177.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -112.58 157.65 20.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 94.8 mtt-85 -124.74 140.48 52.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 110.238 174.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.45 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 88.3 m-85 -134.49 165.56 24.9 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.015 -176.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.5 m -73.84 152.66 40.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 171.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' O ' HD12 ' A' ' 34' ' ' ILE . 57.7 tttp -68.87 -13.23 62.3 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 121.296 0.569 . . . . 0.0 110.778 -174.312 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.86 -1.22 13.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.218 0.533 . . . . 0.0 110.387 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 89.3 m -90.72 -64.02 1.19 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.421 176.234 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.28 -40.94 83.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.8 mt -63.09 -42.15 95.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 110.336 -178.072 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.9 tptp -78.7 -1.64 35.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.673 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.1 m -106.9 -19.77 13.53 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.381 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.1 pt -102.99 -31.63 2.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.488 -174.286 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.6 ptm180 -99.13 4.31 46.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.232 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -115.72 -55.08 2.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.842 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.27 -71.77 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.433 . . . . 0.0 110.184 178.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.24 152.75 23.6 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -79.23 71.58 5.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.434 0.635 . . . . 0.0 112.105 -175.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.3 ptpt -153.36 152.29 30.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.609 178.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 m -64.76 124.77 87.29 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 170.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.51 -27.32 70.04 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 121.702 1.601 . . . . 0.0 112.067 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.72 -54.79 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.11 4.97 29.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 54.43 33.91 19.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.3 mm-40 -96.75 141.41 30.0 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.02 121.18 13.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 -176.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.53 132.82 44.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.818 -173.008 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.455 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -116.43 157.67 24.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.59 -37.41 78.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 109.774 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -65.12 -29.55 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.7 mm100 -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.147 -177.323 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.795 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.6 tt0 . . . . . 0 N--CA 1.442 -0.85 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 t -75.44 108.07 5.13 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 53.6 Cg_endo -68.23 -17.79 44.96 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.922 2.415 . . . . 0.0 111.983 -177.3 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.16 -43.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.232 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.92 -13.81 15.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 0.0 111.339 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.65 21.44 5.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 112.011 -177.385 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -99.83 -69.81 0.75 Allowed 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.45 -167.36 0.2 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.9 mt -94.41 107.07 19.05 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -69.74 -43.83 71.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 64.9 mm-40 -122.61 -14.66 7.71 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.617 -175.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.87 56.44 6.66 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.517 0.727 . . . . 0.0 112.424 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.2 m -83.51 116.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.461 0.648 . . . . 0.0 110.708 178.099 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -78.78 134.25 37.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.873 -176.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 157.53 36.89 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.76 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.38 -40.28 83.65 Favored 'Trans proline' 0 C--N 1.364 1.342 0 C-N-CA 122.587 2.191 . . . . 0.0 113.323 -177.134 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 -14.88 61.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.43 36.87 2.97 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.144 173.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -117.26 157.74 25.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.3 mtt180 -123.22 140.38 53.08 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.283 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.423 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 98.2 m-85 -132.13 173.07 11.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.263 -177.09 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.7 m -85.05 148.74 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.504 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 38.9 ttpt -73.69 -10.94 60.2 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.351 0.596 . . . . 0.0 111.346 -172.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.49 -4.53 12.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.019 0.438 . . . . 0.0 109.958 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 88.2 m -90.02 -60.78 1.84 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 174.666 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -67.1 -40.68 85.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.385 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.599 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.4 mt -62.71 -43.03 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.917 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -79.99 1.46 27.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.802 0.811 . . . . 0.0 110.169 -177.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 t -105.44 -24.8 12.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.876 175.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 49.2 pt -103.23 -22.67 4.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -99.26 4.56 46.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.456 174.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -119.37 -57.23 2.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.466 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.95 -68.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.892 0.377 . . . . 0.0 111.598 -177.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -146.03 140.12 8.65 Favored Glycine 0 CA--C 1.502 -0.756 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.483 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 3.7 t-160 -83.32 52.25 2.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.458 0.647 . . . . 0.0 110.488 -172.041 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -155.32 160.96 41.15 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.672 -174.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.615 ' HB3' HD11 ' A' ' 51' ' ' LEU . 2.6 p -79.16 130.47 69.26 Favored Pre-proline 0 C--N 1.318 -0.764 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.441 173.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.08 -21.05 72.68 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.209 2.606 . . . . 0.0 113.666 -173.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 47' ' ' ASP . 4.0 m -72.58 -70.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 46' ' ' VAL . 46.4 p-10 -103.13 5.56 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.16 33.0 21.1 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 113.179 173.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -83.48 139.99 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.416 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.13 121.36 16.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.493 . . . . 0.0 110.476 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 44' ' ' CYS . 83.0 mt -109.58 132.37 54.2 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.314 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 71.4 mt -108.68 143.41 37.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -61.17 -36.13 79.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.17 0.509 . . . . 0.0 110.266 -179.062 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -65.05 -31.71 73.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.089 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -86.14 -13.21 47.81 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.041 -176.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 85.4 mt . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.87 109.75 4.38 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.8 -19.91 69.8 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.9 2.4 . . . . 0.0 113.407 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.03 -43.97 92.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 121.139 0.495 . . . . 0.0 110.989 179.059 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.2 p -104.49 -21.4 13.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.791 -177.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.1 mt 59.03 29.37 18.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.703 0.801 . . . . 0.0 111.719 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.8 mtm -98.68 -66.87 0.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.174 0.512 . . . . 0.0 110.528 176.318 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.52 -172.03 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -91.09 105.81 18.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -69.28 -45.2 70.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.928 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.442 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 71.1 mm-40 -116.3 -15.82 10.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -178.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 88.66 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -117.24 117.59 55.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.243 0.544 . . . . 0.0 110.353 171.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -80.56 139.32 36.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.114 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 p -109.39 158.95 33.15 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.75 -27.0 82.25 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.907 2.405 . . . . 0.0 111.576 176.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.36 -24.96 67.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.262 178.15 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.89 8.17 57.13 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.892 -174.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -92.87 154.0 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -124.36 139.42 53.92 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.197 173.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.52 168.87 18.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.625 -174.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 49.9 m -79.12 151.72 31.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 169.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 34' ' ' ILE . 86.9 tttt -78.36 8.6 4.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.721 0.772 . . . . 0.0 111.289 -173.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.64 -38.91 3.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 38.7 m -66.39 -50.06 64.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.069 -178.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -69.12 -40.24 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.071 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.636 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.9 mt -62.94 -42.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.718 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -78.92 0.59 26.77 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.097 -177.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -105.37 -23.85 12.77 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.789 176.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.4 pt -103.92 -22.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.174 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -104.13 6.17 35.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.798 175.439 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.47 -53.0 2.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 178.09 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.73 -71.15 0.52 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.917 0.389 . . . . 0.0 110.362 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.57 161.61 35.33 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -80.32 75.55 7.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.721 0.772 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.8 ptpt -151.95 148.85 28.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.729 177.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.0 p -72.37 126.09 91.12 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.99 -22.73 73.96 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 122.326 2.018 . . . . 0.0 112.585 -175.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.18 -50.71 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.246 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -135.9 11.79 3.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 64.44 35.51 9.5 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 173.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 53.6 mt-10 -83.85 145.47 28.62 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -66.5 113.7 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.241 0.543 . . . . 0.0 110.25 -176.206 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.9 tp -126.23 123.18 37.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.987 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.568 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.1 mm? -97.61 160.39 14.35 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.11 -38.61 91.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -176.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.01 -17.65 63.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 178.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.568 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.2 mm100 -76.3 -8.99 58.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.895 -178.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.919 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.433 -1.295 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.28 109.61 22.62 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.31 -17.66 54.37 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.805 2.337 . . . . 0.0 112.657 -175.208 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -65.92 -43.83 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.866 0.365 . . . . 0.0 110.987 177.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.7 p -105.39 -15.63 14.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.05 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mp 57.87 22.67 8.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.889 0.876 . . . . 0.0 111.433 -176.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 8.1 mmt -95.03 -66.51 0.91 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.501 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.59 -166.61 0.06 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.69 117.58 34.35 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -67.63 -44.85 77.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 179.18 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -134.96 -15.03 2.04 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 67.59 88.86 0.11 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.353 1.061 . . . . 0.0 112.847 179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.0 m -106.24 117.1 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.174 0.511 . . . . 0.0 111.033 175.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -80.37 132.12 35.72 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.93 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 p -95.86 156.15 37.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.31 -29.63 86.36 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.569 2.18 . . . . 0.0 112.767 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.26 -22.91 51.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.659 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.7 51.56 0.65 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.213 -0.994 . . . . 0.0 114.013 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -131.47 161.39 32.63 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 68.9 mtt180 -127.74 136.38 51.45 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 171.155 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.09 -179.1 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.188 -176.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.561 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.5 m -86.7 152.94 22.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 170.181 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 34' ' ' ILE . 35.9 ttpt -78.65 -1.97 36.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.617 0.723 . . . . 0.0 111.021 -174.533 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.41 -19.26 10.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 177.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.3 m -82.86 -57.8 3.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.331 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -67.76 -41.08 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.911 -175.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 81.5 mt -62.9 -42.85 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 111.544 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -78.61 -2.72 40.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.23 0.538 . . . . 0.0 109.647 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -105.97 -21.99 13.01 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 176.245 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 33' ' ' ILE . 46.3 pt -103.25 -15.56 7.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.175 -177.144 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.4 ptm180 -99.87 2.27 43.68 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.03 175.432 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -116.28 -55.76 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.994 -178.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.55 -67.03 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.287 0.565 . . . . 0.0 109.773 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.48 159.68 31.43 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -81.72 72.41 8.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -156.38 148.15 22.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.124 173.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.82 124.47 89.62 Favored Pre-proline 0 N--CA 1.436 -1.14 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.831 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.1 -24.52 76.57 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.092 2.528 . . . . 0.0 113.739 -170.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.7 m -68.87 -47.47 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.049 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -119.79 5.58 10.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 m120 58.71 33.56 23.16 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.451 0.701 . . . . 0.0 112.642 177.068 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -95.78 144.36 26.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.6 mm -66.11 120.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.122 0.487 . . . . 0.0 110.343 -173.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.9 tp -131.18 132.56 44.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -174.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 3.8 mm? -116.58 150.16 38.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.14 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.56 -37.03 82.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.066 0.546 . . . . 0.0 110.131 -177.621 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -64.32 -31.73 73.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 12.0 mm100 -76.43 -17.64 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.862 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 95.8 mt . . . . . 0 C--N 1.316 -0.876 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.257 178.138 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 41.8 t -75.85 114.66 38.99 Favored Pre-proline 0 N--CA 1.438 -1.035 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.397 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.1 -19.4 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.121 1.881 . . . . 0.0 113.224 -177.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -67.96 -44.33 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 14.4 p -100.28 -24.62 14.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.079 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 65.1 21.9 12.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.348 0.659 . . . . 0.0 110.866 -176.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.3 mmt -96.4 -70.14 0.73 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.706 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.68 -168.67 0.24 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -176.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.35 122.16 44.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -84.57 -66.38 0.9 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.685 177.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -88.29 -15.64 35.25 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.555 176.451 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.44 56.3 7.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.659 1.184 . . . . 0.0 112.297 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.4 m -80.88 116.56 25.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.251 0.548 . . . . 0.0 111.636 -175.45 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 22' ' ' THR . 26.7 tt0 -81.4 131.52 35.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.206 176.361 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 82.3 p -83.82 159.18 61.04 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.299 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD2' ' CD2' ' A' ' 51' ' ' LEU . 31.7 Cg_endo -61.17 -24.26 78.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.072 1.848 . . . . 0.0 111.978 178.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -76.48 -15.92 59.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.857 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 33.93 5.63 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.472 178.497 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -119.96 150.77 39.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -122.13 139.79 53.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' O ' HG22 ' A' ' 20' ' ' VAL . 85.5 m-85 -142.88 172.06 13.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.401 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.677 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.6 m -84.05 153.62 23.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.51 -14.07 62.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.143 0.497 . . . . 0.0 112.054 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.18 1.4 15.24 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.804 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 57.9 m -95.81 -56.44 2.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.669 172.099 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -66.81 -41.88 88.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.747 -177.47 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.435 ' HA ' HG12 ' A' ' 37' ' ' ILE . 76.5 mt -63.39 -41.58 93.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 111.915 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -77.46 -2.73 36.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.484 0.659 . . . . 0.0 109.395 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.94 -17.72 14.11 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.408 177.093 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 42' ' ' HIS . 38.2 pt -106.49 -11.73 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -175.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -95.21 -10.91 29.05 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.222 -178.144 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.7 -45.88 2.87 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.927 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.88 -76.65 0.16 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.32 158.6 31.6 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 177.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.513 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 55.1 m80 -83.56 67.48 9.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.628 0.727 . . . . 0.0 111.61 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -143.18 150.77 39.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.436 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.1 p -83.22 124.33 76.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -28.18 81.45 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.728 2.285 . . . . 0.0 113.449 -171.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -69.58 -45.45 78.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -120.17 5.56 10.78 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.052 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 57.98 33.15 22.88 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 175.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -95.57 146.21 24.63 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 177.094 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.94 120.74 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD12 HD13 ' A' ' 37' ' ' ILE . 3.3 tm? -121.76 126.75 49.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.11 -172.657 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.52 148.75 31.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.543 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.05 -41.04 95.52 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.639 1.176 . . . . 0.0 112.983 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -87.12 -0.61 56.95 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.363 -176.236 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -87.31 -7.86 57.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.691 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 96.0 mt . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.224 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.096 0 CA-C-O 120.937 0.399 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.496 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 45.8 t -118.92 108.9 40.13 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.804 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.46 -21.52 72.13 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 122.589 2.193 . . . . 0.0 112.653 -171.6 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.49 -44.14 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.791 177.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 19.5 p -106.67 -17.9 14.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 57.08 33.52 23.46 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.112 0.965 . . . . 0.0 111.885 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -121.35 -77.02 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.328 177.339 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.6 158.47 2.75 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.774 0.43 . . . . 0.0 110.014 -179.739 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.0 mt -71.82 105.22 3.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.692 0.282 . . . . 0.0 110.853 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -70.65 -44.8 66.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 178.549 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -112.86 -16.87 12.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.644 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.0 80.72 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.97 116.47 47.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 110.326 174.407 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -81.01 136.11 35.94 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.411 -177.252 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -103.13 154.34 37.7 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.77 -29.35 85.56 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.051 2.501 . . . . 0.0 112.839 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.7 p -69.1 -15.59 63.47 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.51 11.41 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.172 177.821 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -114.22 155.78 25.5 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 122.571 -0.37 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -126.49 136.54 52.74 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.223 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.48 167.92 20.18 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.206 0.316 . . . . 0.0 110.814 -176.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 58.2 m -80.63 156.19 26.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.256 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.8 tttt -69.48 -12.65 61.82 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.966 -173.473 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.07 -20.56 10.94 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.156 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 98.1 m -72.1 -54.1 10.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.845 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -67.97 -39.85 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.247 -175.873 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 88.0 mt -62.73 -42.8 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.663 0.268 . . . . 0.0 111.131 -178.935 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -78.87 -0.83 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.464 0.649 . . . . 0.0 110.372 -177.123 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -103.61 -25.45 13.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.323 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -103.05 -7.32 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.452 -177.275 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -100.94 -2.84 30.82 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.625 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.7 -52.74 2.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.707 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.97 -69.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.079 0.466 . . . . 0.0 110.241 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -176.82 167.29 38.59 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 177.611 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -81.5 67.16 7.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.809 0.814 . . . . 0.0 111.616 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -148.08 157.66 43.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.339 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 50.4 t -64.9 127.22 92.48 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.44 -26.53 70.58 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.388 2.058 . . . . 0.0 112.449 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.77 -71.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.321 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -98.28 5.63 48.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -174.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 91.2 m-20 57.31 33.47 23.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.875 0.87 . . . . 0.0 113.151 173.166 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -86.44 148.58 25.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.3 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.5 mp -66.19 122.56 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 110.322 -173.716 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.24 125.74 46.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -174.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.47 152.43 18.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 177.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.68 -36.82 84.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.909 -173.253 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -71.16 -11.96 61.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.861 0.363 . . . . 0.0 111.483 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.44 -8.23 59.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.452 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt . . . . . 0 C--O 1.238 0.45 0 O-C-N 123.12 0.262 . . . . 0.0 110.911 -177.669 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB2' HD23 ' A' ' 16' ' ' LEU . 40.9 t -89.78 108.05 22.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.7 Cg_exo -63.37 -20.47 70.29 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.743 2.296 . . . . 0.0 112.839 -177.527 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -66.57 -44.45 90.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.609 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.07 -20.26 14.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.7 mt 59.1 22.02 10.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.096 0.959 . . . . 0.0 112.848 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.6 mtm -98.19 -65.69 0.95 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.485 176.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.51 -169.82 0.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.254 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.472 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.5 mt -100.44 108.47 20.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.43 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 3.3 tpm_? -69.83 -42.34 73.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 43.6 mt-10 -118.29 -15.52 9.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 -177.906 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.93 82.17 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 28' ' ' PHE . 19.6 m -115.97 114.88 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.299 0.571 . . . . 0.0 110.661 176.496 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.56 129.49 34.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.307 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.4 p -77.96 168.21 29.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.125 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.4 -28.77 81.81 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.556 2.17 . . . . 0.0 111.731 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB2' ' OE1' ' A' ' 49' ' ' GLU . 27.6 p -84.5 -21.53 30.55 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.675 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.42 4.22 22.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.792 177.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -88.65 149.68 23.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.209 0.504 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -116.77 136.32 53.05 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.673 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.7 m-85 -139.86 170.01 16.66 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 28.3 m -83.26 147.65 27.85 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 3.5 ttpm? -69.36 -7.76 40.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -173.02 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.88 -16.62 12.68 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.708 -178.645 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 46.0 m -82.52 -46.28 13.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.58 -41.66 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.64 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.3 mt -63.06 -41.83 94.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 111.707 -178.205 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.66 -1.81 32.85 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.869 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 m -106.15 -20.84 13.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.433 HD11 ' HG2' ' A' ' 53' ' ' GLU . 37.7 pt -102.99 -9.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.967 -176.143 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -99.04 7.81 45.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.12 0.962 . . . . 0.0 108.533 167.58 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -114.94 -56.03 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.361 -179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.3 -70.07 0.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.163 176.488 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.04 172.88 40.36 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.487 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 74.4 m80 -80.4 69.12 6.8 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.707 0.765 . . . . 0.0 111.525 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 9.6 ptpp? -148.05 152.75 37.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.0 177.789 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.5 p -77.13 128.34 81.21 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.84 -22.24 69.07 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.148 1.899 . . . . 0.0 112.684 -176.562 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.97 -50.49 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.262 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -138.84 17.23 2.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.551 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.79 33.97 17.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.344 1.058 . . . . 0.0 113.654 170.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 56.6 mt-10 -89.12 153.06 21.26 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.712 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.4 121.82 15.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 111.302 -175.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 6.5 tt -120.6 126.27 49.85 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.131 -176.491 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.62 139.61 45.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.429 178.191 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HG2' HD11 ' A' ' 37' ' ' ILE . 77.8 mt-10 -65.46 -42.8 91.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.426 -174.018 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -69.33 -23.43 63.78 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.8 mm-40 -74.92 -14.87 60.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.482 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.67 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 N--CA 1.445 -0.707 0 CA-C-O 120.764 0.316 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.3 t -93.62 111.34 52.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.13 -19.54 50.93 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.435 2.09 . . . . 0.0 113.678 -174.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.27 -44.84 83.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.8 p -103.73 -21.49 13.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.021 -174.532 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp 65.41 21.29 11.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.349 1.06 . . . . 0.0 110.617 -175.144 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.4 mmt -95.52 -75.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -179.31 162.58 1.18 Allowed 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 9' ' ' CYS . 92.5 mt -79.75 103.37 9.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.052 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -71.18 -44.94 64.48 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.656 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -112.4 -17.17 12.76 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.94 -177.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.13 73.31 0.16 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.094 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -93.59 117.57 37.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.953 175.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.28 142.0 34.98 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.04 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -108.96 168.21 8.06 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 177.307 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.85 -33.32 94.44 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 123.042 2.494 . . . . 0.0 113.031 -176.369 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 p -74.68 -14.55 60.76 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.961 0.41 . . . . 0.0 111.852 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.46 1.0 50.27 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.372 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -79.26 146.72 32.85 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.54 -0.388 . . . . 0.0 110.603 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -122.59 138.44 54.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.481 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 91.1 m-85 -140.91 170.13 16.32 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.186 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -81.1 159.24 24.77 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.694 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 34' ' ' ILE . 7.1 ttpm? -68.94 -11.37 60.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.438 0.637 . . . . 0.0 111.169 -176.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.94 -16.75 12.14 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.823 -179.009 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.9 m -83.91 -51.7 6.95 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.481 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 10.9 tp -69.26 -39.29 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.771 -178.082 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.1 mt -62.85 -42.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -79.53 9.51 4.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 178.011 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 m -109.6 -25.99 10.15 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.723 170.311 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.1 pt -103.96 -27.67 3.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -173.278 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -100.1 2.89 43.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.705 0.764 . . . . 0.0 108.957 175.097 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -116.05 -56.54 2.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.765 -171.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.88 -69.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.085 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.43 159.89 33.31 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.848 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -79.03 67.52 4.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.7 pttm -152.72 150.26 29.24 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.949 173.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.4 p -79.73 124.48 83.49 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.549 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.91 -28.68 75.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.929 2.42 . . . . 0.0 114.69 -168.303 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.72 -48.19 83.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.477 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -119.06 6.4 11.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 51.74 40.02 26.66 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.564 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 66.5 mm-40 -89.87 138.37 31.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.712 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.38 121.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.79 128.92 52.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.457 -173.149 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.03 150.47 27.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.487 ' HA ' HD13 ' A' ' 56' ' ' LEU . 55.0 mp0 -59.59 -37.0 77.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.896 0.379 . . . . 0.0 111.114 -174.88 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -65.39 -28.73 69.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 179.417 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -66.79 -21.64 66.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.848 179.539 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 53' ' ' GLU . 8.8 mp . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.44 -0.961 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.7 t -66.32 110.19 4.41 Favored Pre-proline 0 N--CA 1.444 -0.747 0 O-C-N 123.73 0.643 . . . . 0.0 109.632 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.54 -18.14 53.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 112.339 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.03 -43.6 92.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.841 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.3 p -106.06 -17.88 14.2 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.15 26.77 12.54 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.714 0.806 . . . . 0.0 112.223 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.3 mtm -98.48 -64.99 0.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.51 175.591 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.66 -169.14 0.07 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.281 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -94.99 104.51 16.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.529 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -70.82 -45.89 63.77 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.38 -176.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -110.17 -15.92 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.013 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.39 86.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.271 0.982 . . . . 0.0 112.174 -177.073 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 29.8 m -115.12 119.81 62.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.37 0.605 . . . . 0.0 111.638 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -80.33 136.0 36.32 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.75 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.479 ' HB ' HD21 ' A' ' 51' ' ' LEU . 31.2 p -98.24 159.34 30.9 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.138 176.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.93 -27.88 85.48 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.373 2.049 . . . . 0.0 112.771 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.6 p -77.61 -26.14 50.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.906 0.384 . . . . 0.0 111.41 178.683 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.52 43.11 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.436 175.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -130.77 133.58 46.12 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 88.2 mtm180 -104.99 134.35 48.24 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 120.998 0.427 . . . . 0.0 112.062 -178.234 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -135.31 -172.52 3.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.725 -176.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.5 m -89.84 151.89 21.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.143 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.91 -12.12 61.38 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 121.028 0.442 . . . . 0.0 111.853 -173.489 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.85 -18.44 12.27 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.653 -0.654 . . . . 0.0 110.713 -178.572 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.4 m -79.2 -45.94 18.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.071 0.463 . . . . 0.0 110.333 176.43 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.55 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.17 -40.49 82.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 C-N-CA 120.439 -0.505 . . . . 0.0 111.605 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.5 mt -63.15 -43.66 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -80.07 -1.64 40.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.299 0.571 . . . . 0.0 111.058 -174.036 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.2 p -106.5 -18.42 13.98 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 121.831 -0.543 . . . . 0.0 111.242 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.56 -18.47 6.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.127 -177.17 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -106.33 7.89 31.5 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.018 174.429 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -114.71 -54.3 2.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.291 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -69.47 0.61 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 0.0 109.805 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.13 159.43 32.8 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 176.518 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -77.64 67.92 3.63 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.887 0.851 . . . . 0.0 112.036 -179.143 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.52 150.97 35.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.219 177.573 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -76.05 129.77 79.87 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.968 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -22.54 74.39 Favored 'Trans proline' 0 N--CA 1.478 0.575 0 C-N-CA 122.97 2.447 . . . . 0.0 113.379 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.56 -72.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.208 0.528 . . . . 0.0 111.511 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -104.83 4.26 31.96 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.259 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.28 36.18 25.46 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.062 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -87.13 151.78 22.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.4 mp -66.07 119.82 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.479 HD21 ' HB ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -119.43 122.37 41.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.137 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -105.1 141.19 37.09 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.396 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.61 -39.36 94.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.261 0.553 . . . . 0.0 111.002 -175.08 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.01 -30.06 71.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.518 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -76.51 -8.01 56.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.08 -176.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 51' ' ' LEU . 96.5 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.674 0.274 . . . . 0.0 110.836 179.175 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -66.73 112.02 8.47 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 34.7 Cg_exo -61.82 -20.4 69.07 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.726 2.284 . . . . 0.0 112.432 -176.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.6 -43.93 90.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.69 178.348 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.1 p -105.55 -19.09 13.88 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.959 -176.416 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 57.16 23.12 8.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.921 0.888 . . . . 0.0 112.255 -179.327 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.5 mtm -96.0 -64.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.393 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.89 -165.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -174.594 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -103.93 125.97 50.71 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.078 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -80.18 -73.19 0.37 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.35 178.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -96.33 -16.59 21.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.659 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.05 90.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.121 0.968 . . . . 0.0 113.046 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m -110.44 115.4 49.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.498 0.666 . . . . 0.0 111.136 175.015 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -82.56 133.49 35.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.662 176.833 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 39.1 p -93.11 164.99 19.48 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 30.7 Cg_endo -61.78 -26.36 79.5 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.169 1.912 . . . . 0.0 112.144 176.884 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 35.7 m -70.45 -28.33 64.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.092 0.473 . . . . 0.0 110.488 176.369 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.78 9.86 29.7 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.916 -177.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 24.3 m-70 -88.1 144.35 26.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.551 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -111.68 130.79 55.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.94 176.17 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.47 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 99.2 m-85 -132.07 172.72 12.02 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.559 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.471 ' O ' HG22 ' A' ' 33' ' ' ILE . 59.7 m -82.99 150.27 26.48 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.771 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.12 -8.63 55.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.424 0.63 . . . . 0.0 110.496 -175.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.67 -29.96 7.26 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 69.1 m -70.08 -46.06 65.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.03 175.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.482 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -68.42 -41.6 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.601 -178.406 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.7 mt -63.61 -42.33 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -77.23 -1.94 32.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.416 0.627 . . . . 0.0 110.225 -177.018 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 m -105.88 -25.41 12.15 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.772 174.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 33' ' ' ILE . 46.0 pt -103.49 -9.18 9.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.859 -176.507 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.6 ptm180 -94.18 2.13 55.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.628 0.728 . . . . 0.0 109.213 174.075 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.35 -55.08 2.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.56 -71.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.396 178.822 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -178.22 -179.26 48.14 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -89.55 81.22 6.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.24 0.543 . . . . 0.0 112.194 -177.245 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 9.5 ptpp? -170.55 144.27 2.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.734 175.216 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 p -72.02 123.8 89.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.83 -25.28 74.52 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.031 2.487 . . . . 0.0 113.554 -170.029 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.61 -46.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -175.788 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.63 6.69 8.2 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 61.16 34.21 19.0 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 177.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.431 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 69.5 mm-40 -91.17 141.23 29.03 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.908 175.064 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 50' ' ' ILE . 3.1 mp -66.57 121.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.123 0.487 . . . . 0.0 110.234 -174.153 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.406 ' H ' ' HA ' ' A' ' 43' ' ' LYS . 64.0 tp -126.85 128.75 47.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.735 -175.623 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -112.27 154.59 25.39 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.43 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -61.62 -37.08 82.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.117 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.93 -30.84 71.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.391 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 17.0 mm-40 -77.79 -9.16 58.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.239 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.669 -178.985 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.539 ' HB2' HD23 ' A' ' 16' ' ' LEU . 33.8 t -77.55 116.17 55.75 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.835 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -60.97 -20.86 69.24 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.037 1.825 . . . . 0.0 112.605 -177.225 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.89 -45.05 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.618 0.247 . . . . 0.0 111.376 178.324 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 12.0 p -109.06 -22.26 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.405 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 59.23 22.9 11.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.245 1.018 . . . . 0.0 112.121 -177.386 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -95.57 -66.46 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.34 176.393 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.08 -172.46 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.883 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.4 mt -107.44 124.98 50.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.684 0.278 . . . . 0.0 110.31 175.199 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 19' ' ' ALA . 22.9 tpt180 -92.76 114.71 27.34 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.253 168.936 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 68.75 -16.21 0.22 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.594 1.158 . . . . 0.0 112.811 -179.445 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 50.31 82.78 0.05 OUTLIER 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 113.329 177.161 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.2 m -97.01 116.56 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.626 0.727 . . . . 0.0 110.474 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.65 142.6 32.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.844 -179.296 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -93.17 163.65 24.35 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.628 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.91 -34.17 96.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.701 2.268 . . . . 0.0 111.935 176.6 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.06 -14.47 62.69 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.122 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.82 23.26 18.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.283 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -106.93 129.9 54.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.359 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -106.24 132.95 51.69 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.588 -173.776 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.23 167.84 19.63 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.455 -176.656 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.426 ' O ' HG22 ' A' ' 33' ' ' ILE . 85.1 m -71.62 147.82 47.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.753 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -67.88 -4.89 14.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.728 -179.33 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.97 -38.86 3.79 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.167 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.77 -46.1 80.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -66.36 -41.63 89.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.953 -173.96 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.581 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.3 mt -63.61 -43.43 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.411 . . . . 0.0 110.128 -178.534 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -79.4 -2.08 40.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.855 -176.086 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 m -106.77 -20.24 13.4 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.649 177.016 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -103.15 -24.03 4.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.226 -174.588 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.2 ptm180 -99.95 7.4 44.84 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.115 176.124 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.26 -56.69 2.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.539 -178.336 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.08 -67.64 0.8 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.527 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.05 159.12 32.3 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.093 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.406 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 75.9 m80 -86.29 64.89 8.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.584 0.707 . . . . 0.0 111.916 -176.611 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.1 ptpt -154.44 150.31 27.73 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.34 176.834 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -70.33 135.41 86.66 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.886 0.374 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.18 -23.94 75.86 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.101 2.534 . . . . 0.0 114.305 -171.698 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 m -91.39 -55.46 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.354 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -103.68 4.89 35.93 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.105 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 50.97 33.95 9.78 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.599 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 80.8 mm-40 -86.36 147.0 26.23 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.721 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.59 120.4 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 109.718 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.6 tp -120.2 130.59 54.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.223 -174.099 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.12 153.47 28.17 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.43 -36.34 83.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.43 -31.02 72.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.681 176.295 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -77.97 -8.61 58.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.683 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--N 1.322 -0.625 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.614 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 1.4 p -92.67 134.31 27.98 Favored Pre-proline 0 C--N 1.313 -0.996 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.607 -177.305 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 9' ' ' CYS . 32.3 Cg_exo -59.9 -19.85 56.94 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.869 2.379 . . . . 0.0 112.19 -178.115 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.02 -44.94 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.092 -177.173 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -120.31 -20.21 7.37 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.253 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt 60.52 27.96 17.62 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.873 0.869 . . . . 0.0 111.908 -173.499 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.1 mtm -103.16 175.34 5.51 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.092 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.22 148.37 49.94 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.505 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.1 mt -78.76 130.43 35.75 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.794 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -68.1 -60.28 2.6 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -107.52 -15.05 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -178.263 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.01 90.23 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.792 -177.494 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 116.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.684 0.754 . . . . 0.0 111.368 179.762 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -81.15 136.86 35.94 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.709 177.289 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.2 p -94.59 160.37 31.66 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.777 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -54.71 -37.52 91.6 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 112.525 178.107 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.37 -20.56 62.95 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 178.386 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.8 4.29 24.64 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.442 174.067 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.529 ' HE1' ' OD2' ' A' ' 47' ' ' ASP . 43.2 m80 -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.241 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -101.56 132.58 47.13 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.322 177.084 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 97.5 m-85 -132.71 165.39 24.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.479 179.432 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.612 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -80.97 159.52 24.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.037 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.3 tttt -76.8 -12.93 60.05 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.326 -172.043 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.91 -10.95 12.88 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 -179.383 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.5 m -85.45 -57.87 2.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.334 177.787 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -66.77 -41.04 87.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -175.909 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.634 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.9 mt -63.24 -43.49 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 111.078 -177.099 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -79.33 -1.47 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -176.751 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -104.61 -17.82 14.55 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.32 177.33 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -104.34 -30.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.923 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.1 ptm180 -96.72 2.39 51.98 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.442 178.113 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -115.9 -54.63 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.302 179.5 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.81 -69.17 0.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 0.0 110.524 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -164.8 155.14 26.37 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 176.893 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -80.04 70.41 6.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.528 0.664 . . . . 0.0 111.686 -177.296 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.94 152.21 39.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.919 178.571 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 52.3 t -74.65 122.95 88.64 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.706 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 51.7 Cg_exo -57.48 -34.25 97.7 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.241 2.627 . . . . 0.0 114.278 -172.066 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 m -83.19 -50.72 15.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -172.472 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.529 ' OD2' ' HE1' ' A' ' 26' ' ' HIS . 48.3 p-10 -104.68 5.19 33.33 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.66 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.1 32.68 20.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.721 0.808 . . . . 0.0 112.29 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -87.75 149.0 24.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.198 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.84 121.32 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.29 119.68 32.91 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.389 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.632 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -102.54 153.7 19.82 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.08 -178.671 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.41 -40.09 96.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.465 0.706 . . . . 0.0 111.532 -174.005 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -68.37 -20.8 64.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.705 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.632 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.3 mm100 -75.11 -9.95 59.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.444 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 C--N 1.324 -0.502 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.377 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 . . . . . 0 N--CA 1.438 -1.035 0 CA-C-O 120.997 0.427 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.0 t -79.82 109.22 11.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.678 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.84 -19.42 65.54 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.863 2.375 . . . . 0.0 112.722 -175.265 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.93 -43.82 92.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.006 0.431 . . . . 0.0 111.26 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.38 -21.05 15.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.789 -177.018 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 65.94 20.33 11.32 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 111.633 -177.699 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -99.64 -71.03 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.088 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.33 -162.6 0.13 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -174.311 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.2 mt -106.57 125.82 51.48 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.182 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -84.47 -71.35 0.52 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.896 175.31 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -89.76 -16.23 30.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.82 178.707 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.89 77.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.252 0.621 . . . . 0.0 111.592 -176.953 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 21.1 m -92.3 116.8 34.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.042 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.31 129.89 34.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.732 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -92.27 164.9 21.25 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.338 177.631 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.58 -36.44 94.54 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 112.32 178.265 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.7 -20.49 62.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.071 -178.135 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.0 6.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.98 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -113.33 154.35 27.0 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.459 -0.436 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 81.9 mtm180 -123.47 137.56 54.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.048 0.452 . . . . 0.0 111.522 -176.321 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' O ' HG22 ' A' ' 20' ' ' VAL . 95.7 m-85 -138.91 172.93 12.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.75 -177.104 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.0 m -84.74 153.85 22.79 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.725 0.298 . . . . 0.0 110.33 175.647 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.15 -14.78 63.24 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.837 0.855 . . . . 0.0 111.886 -176.466 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.78 -13.81 12.01 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.048 -176.766 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 52.5 m -87.84 -47.91 8.24 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.078 177.772 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -68.36 -38.51 79.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.8 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.8 mt -62.67 -42.43 96.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.425 . . . . 0.0 110.561 -177.769 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 39' ' ' ASP . 29.2 tptp -77.64 -1.66 32.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.806 0.813 . . . . 0.0 109.962 -178.542 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.2 t -105.3 -21.82 13.17 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.88 -0.513 . . . . 0.0 109.982 177.009 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.5 pt -104.97 -28.06 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.391 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -96.01 -7.55 36.05 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.708 177.902 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 38.7 t70 -115.11 -40.95 3.39 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.308 -175.298 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 36' ' ' SER . . . -91.66 -72.94 0.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.969 0.414 . . . . 0.0 110.012 176.587 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.17 157.61 30.14 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.927 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -82.82 69.67 9.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.493 0.663 . . . . 0.0 111.979 -176.3 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -150.91 153.11 34.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.796 -179.781 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 p -77.34 133.56 67.81 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.039 171.793 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.07 -23.8 75.99 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 123.015 2.477 . . . . 0.0 114.244 -170.654 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -90.5 -61.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.206 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -100.91 4.22 42.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.637 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 56.33 35.23 25.49 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.046 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 71.2 mm-40 -83.5 150.67 25.85 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.782 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -66.71 121.18 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.109 0.48 . . . . 0.0 109.903 -177.719 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -126.7 129.86 49.25 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.325 -175.883 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.87 156.49 23.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.622 178.478 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 38' ' ' ARG . 54.6 mp0 -61.23 -39.05 88.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.612 0.365 . . . . 0.0 110.66 -178.894 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -74.96 -10.2 59.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 0.0 111.407 179.563 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -91.48 -7.76 49.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.026 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.774 179.059 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 44.2 mt-10 . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 16.6 t -56.27 112.95 5.01 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.494 177.697 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' CYS . 32.4 Cg_exo -62.1 -20.95 71.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.7 2.267 . . . . 0.0 112.461 -173.569 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.49 -44.07 90.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.464 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -108.09 -21.25 12.87 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.647 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 56.53 30.23 16.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.824 0.849 . . . . 0.0 111.754 -175.265 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -96.29 -66.91 0.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 173.838 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -179.53 -172.65 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -176.988 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.5 mt -93.93 103.61 15.7 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.273 174.13 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -66.51 -43.97 83.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.904 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -123.0 -15.02 7.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.797 179.587 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.93 56.54 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.203 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 28' ' ' PHE . 27.3 m -76.84 116.09 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.36 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.401 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 61.0 tt0 -80.6 121.32 25.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.527 -176.438 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -88.8 160.83 43.16 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.55 -30.75 89.56 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 178.67 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -14.72 62.89 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.319 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.02 5.07 44.46 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.375 -0.916 . . . . 0.0 114.251 174.518 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.79 168.33 10.56 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.434 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.6 mtt180 -127.3 142.22 51.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 112.016 -169.784 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.471 ' O ' HG22 ' A' ' 20' ' ' VAL . 99.2 m-85 -131.42 170.23 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.769 178.583 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 53.3 m -80.19 148.19 30.98 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.555 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -68.62 -13.16 62.17 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -174.414 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.21 -17.8 12.69 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.8 m -79.59 -45.51 19.03 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.665 173.107 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -66.47 -40.95 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.832 -176.641 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.84 -42.63 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 111.006 -179.15 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -78.72 -1.9 36.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.352 0.596 . . . . 0.0 110.149 -174.737 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 m -105.32 -23.08 12.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.299 177.296 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.9 pt -104.76 -5.36 9.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.256 -177.784 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -96.82 -15.73 21.15 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.618 176.968 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -116.52 -56.09 2.32 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.145 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.28 -65.79 0.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 110.692 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.86 155.36 26.6 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -84.65 54.62 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 122.073 0.94 . . . . 0.0 109.111 -176.204 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -147.44 154.17 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.301 -175.357 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 45.3 t -61.65 123.02 75.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.112 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 50.7 Cg_exo -57.05 -35.82 99.06 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.166 2.577 . . . . 0.0 114.123 -172.042 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -82.67 -45.96 19.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.12 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -114.95 5.57 15.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 56.58 33.45 22.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.337 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -92.2 149.71 21.32 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.209 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.4 121.66 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.074 0.464 . . . . 0.0 110.589 -176.698 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 tp -126.13 127.81 46.34 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.224 -179.746 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.48 143.91 30.9 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.656 176.78 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.53 -36.59 84.27 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.303 1.041 . . . . 0.0 110.203 -175.604 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.4 -30.25 71.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.973 177.846 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -64.89 -29.11 70.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.146 0.498 . . . . 0.0 110.884 179.54 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.556 -176.7 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.488 ' HB2' HD23 ' A' ' 16' ' ' LEU . 41.8 t -83.75 110.81 27.68 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -177.769 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.43 -18.81 49.65 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.069 1.846 . . . . 0.0 112.301 -176.663 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.52 -43.51 90.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 178.874 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 25.4 p -109.83 -6.41 15.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.526 -176.687 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.89 33.19 22.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.902 0.881 . . . . 0.0 111.1 -175.593 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -127.52 167.44 16.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.379 178.893 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 151.12 37.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 9' ' ' CYS . 93.7 mt -69.89 118.35 12.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.867 0.365 . . . . 0.0 110.393 -173.416 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -69.39 -45.62 68.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.323 179.446 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -116.92 -16.54 10.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.04 87.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.135 0.897 . . . . 0.0 112.737 -178.242 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 28' ' ' PHE . 35.2 m -105.39 117.23 50.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.51 0.672 . . . . 0.0 111.476 176.204 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -73.16 132.54 43.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.137 175.155 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 61.8 p -106.29 159.04 31.16 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 178.759 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 35.9 Cg_endo -62.8 -24.41 74.52 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.88 2.386 . . . . 0.0 113.01 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.1 p -79.48 -14.66 58.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 111.203 178.483 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.61 8.36 37.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.566 175.959 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -99.23 162.05 13.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.696 0.248 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -124.1 137.61 54.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.916 0.389 . . . . 0.0 110.214 177.824 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 20' ' ' VAL . 90.8 m-85 -138.23 167.49 21.73 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.546 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.0 m -76.28 156.7 33.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.083 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.73 -3.97 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.139 0.495 . . . . 0.0 111.382 -170.669 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.74 -26.59 7.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.761 0.315 . . . . 0.0 110.381 178.737 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -71.86 -45.9 59.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.318 179.377 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -65.96 -38.24 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.238 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.2 mt -62.25 -42.31 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 110.386 177.987 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.84 -0.5 30.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.656 0.741 . . . . 0.0 110.452 -177.332 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -104.75 -25.33 12.71 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.915 -0.49 . . . . 0.0 109.793 177.325 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.1 pt -103.81 -15.17 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.001 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -106.78 -2.34 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.286 175.244 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.67 -50.79 2.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.733 -175.562 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.69 -68.8 0.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 -179.784 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.25 154.76 25.83 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 178.512 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -81.01 45.4 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.65 0.738 . . . . 0.0 110.927 -173.432 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -144.25 154.42 43.07 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.956 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.0 p -64.1 135.41 96.31 Favored Pre-proline 0 N--CA 1.445 -0.688 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.257 177.499 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.23 -29.61 80.58 Favored 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 122.839 2.359 . . . . 0.0 113.593 -172.599 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.86 -71.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.18 0.514 . . . . 0.0 111.697 -174.028 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -95.65 4.56 52.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.549 -173.829 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 56.93 34.17 24.43 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 169.39 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -87.45 141.96 28.23 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.624 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.5 mp -65.24 119.5 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.895 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 56' ' ' LEU . 10.2 tt -110.51 127.67 55.28 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -168.49 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.88 132.87 42.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.913 178.54 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.26 -35.43 80.4 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -173.994 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -63.56 -29.72 70.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 178.108 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -80.34 -7.86 59.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.503 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 51' ' ' LEU . 95.6 mt . . . . . 0 C--O 1.237 0.426 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.956 177.205 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.92 112.52 9.95 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.712 0.632 . . . . 0.0 109.689 175.864 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -63.12 -20.37 70.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.248 1.966 . . . . 0.0 112.87 -178.343 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -66.08 -44.43 91.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.2 p -105.24 -19.19 13.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.635 -177.791 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 57.0 26.7 12.22 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.791 0.836 . . . . 0.0 111.797 -176.658 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.88 -65.73 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.023 0.44 . . . . 0.0 110.469 176.689 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.3 -164.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -177.326 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.9 mt -103.3 113.76 27.5 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 172.512 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -63.91 -44.98 91.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 178.018 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -132.52 -7.18 3.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 178.608 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.15 92.47 0.07 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 175.623 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -117.19 111.63 35.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 110.289 171.594 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -80.94 143.43 32.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.385 178.638 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -108.82 154.68 41.66 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.272 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 55' ' ' GLN . 40.6 Cg_endo -65.37 -20.01 61.6 Favored 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 122.742 2.295 . . . . 0.0 111.463 177.448 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.4 t -73.99 -15.06 61.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.077 179.01 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.07 22.2 18.23 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.234 178.4 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -113.03 152.12 29.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.587 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -120.01 136.04 54.7 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.696 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 94.8 m-85 -136.67 172.99 12.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.092 0.472 . . . . 0.0 110.502 -177.024 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -82.01 152.0 26.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 171.05 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.0 tttt -68.87 -10.7 58.44 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -177.489 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 -12.32 12.82 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.711 -0.618 . . . . 0.0 110.205 179.325 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 70.9 m -85.92 -62.94 1.41 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.982 177.573 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.4 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.1 tp -67.79 -39.9 82.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.062 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.737 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.5 mt -63.04 -43.38 98.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 0.0 110.523 -178.504 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -79.53 0.79 28.34 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.714 0.768 . . . . 0.0 109.729 -178.561 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 t -106.38 -23.76 12.44 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.992 -0.442 . . . . 0.0 110.83 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.0 pt -103.96 -26.09 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.384 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -97.41 3.43 50.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.423 0.63 . . . . 0.0 109.773 176.553 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -116.66 -55.88 2.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.76 -72.93 0.52 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.108 179.809 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -158.46 160.46 30.98 Favored Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 178.55 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -85.42 71.08 10.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.373 0.606 . . . . 0.0 111.162 -176.242 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -152.22 150.61 30.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.764 178.023 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 9.2 p -79.9 122.03 82.84 Favored Pre-proline 0 N--CA 1.429 -1.519 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.689 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.98 -18.43 62.16 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.652 2.235 . . . . 0.0 113.274 -170.712 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.0 -48.44 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -133.53 13.77 4.1 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.621 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER 63.04 21.44 12.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 174.214 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 72.2 mm-40 -72.66 142.52 48.28 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.564 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.5 mm -66.4 121.05 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.973 0.416 . . . . 0.0 110.605 -176.39 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.1 tp -128.16 134.4 49.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.056 -177.456 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -116.89 155.27 29.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.534 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' A' ' 38' ' ' ARG . 48.8 mt-10 -62.85 -36.48 83.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.16 0.505 . . . . 0.0 110.299 179.273 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.13 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.931 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.477 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.6 mm100 -79.8 -7.69 58.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.489 -174.082 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 120.966 0.413 . . . . 0.0 110.844 179.839 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.445 -0.693 0 CA-C-O 120.956 0.408 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB2' HD23 ' A' ' 16' ' ' LEU . 46.9 t -96.19 109.41 47.05 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.39 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.22 -19.47 62.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.038 1.825 . . . . 0.0 112.736 -174.438 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.61 -43.92 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.832 0.349 . . . . 0.0 111.288 178.284 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.6 p -106.51 -4.38 19.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.696 -177.131 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt 55.16 34.35 22.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.349 0.66 . . . . 0.0 111.135 -177.518 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -133.12 -174.76 3.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.368 179.286 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.17 157.38 37.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.578 HD23 ' HB2' ' A' ' 9' ' ' CYS . 95.1 mt -70.62 134.33 47.49 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -86.05 -73.45 0.45 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.783 177.64 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -93.1 -16.35 25.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 178.125 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.32 66.46 1.23 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.183 -179.29 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.5 m -85.36 117.7 30.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.135 0.493 . . . . 0.0 111.114 -179.367 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -79.55 133.38 36.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.318 -177.095 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -101.34 157.67 33.23 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.472 -178.617 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -56.84 -33.51 94.83 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.713 2.276 . . . . 0.0 112.509 178.992 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 p -69.49 -26.08 64.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.98 -178.4 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.56 51.1 0.72 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.135 -178.225 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 38.7 m80 -138.51 159.68 41.46 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 122.732 0.413 . . . . 0.0 110.909 177.582 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -126.27 135.73 51.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.169 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.436 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.6 m-85 -139.7 169.76 17.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.522 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 24.5 m -79.2 152.09 30.87 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 173.099 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.23 -13.57 62.48 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -173.877 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.08 -3.49 13.97 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.632 -178.771 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.7 m -91.55 -59.62 2.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.401 174.663 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.1 tp -68.46 -39.75 81.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.435 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.3 mt -63.13 -41.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.057 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.07 -0.97 30.08 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.555 0.693 . . . . 0.0 109.628 -178.265 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.25 -18.68 13.93 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.075 -0.391 . . . . 0.0 111.323 175.418 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -105.06 -30.08 2.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -177.118 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptm180 -98.4 4.19 48.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.554 178.999 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.56 -56.15 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.641 -179.023 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 -74.38 0.36 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 178.634 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.51 155.7 26.88 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 33.5 m80 -79.23 66.06 4.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.078 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.2 ptpp? -152.54 149.81 28.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.223 174.435 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 2.8 p -74.4 127.12 88.13 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.263 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.24 -23.81 77.76 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.282 2.655 . . . . 0.0 113.806 -171.197 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.437 HG13 ' OD1' ' A' ' 47' ' ' ASP . 4.4 p -77.1 -51.11 19.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.112 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' OD1' HG13 ' A' ' 46' ' ' VAL . 13.0 p-10 -117.59 6.4 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.1 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 59.66 35.01 22.32 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.6 mm-40 -95.41 140.13 30.72 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.978 -0.451 . . . . 0.0 110.677 176.8 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 2.4 mp -65.65 121.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.087 0.47 . . . . 0.0 110.131 -176.544 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -122.73 134.59 54.45 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.62 -176.327 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.432 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 88.9 mt -114.36 147.65 38.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.933 178.752 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.45 ' OE2' ' HB3' ' A' ' 38' ' ' ARG . 53.8 mp0 -62.75 -35.89 81.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 0.0 109.464 179.179 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -65.52 -29.77 70.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.239 -179.639 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 18.5 mm-40 -71.18 -27.79 63.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.166 0.508 . . . . 0.0 111.353 177.713 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.99 -179.236 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.3 t -54.93 112.49 4.13 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.083 0.553 . . . . 0.0 110.684 179.432 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -62.21 -20.53 70.31 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.926 2.417 . . . . 0.0 113.35 -175.926 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -67.71 -44.74 85.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.336 176.229 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.45 -25.95 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.161 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 63.98 23.58 13.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.175 0.59 . . . . 0.0 111.787 -178.17 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -95.34 -66.3 0.92 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 109.64 178.913 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.69 -163.44 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -176.91 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.23 124.81 50.16 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.812 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -79.06 -60.37 2.4 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.19 174.299 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -105.97 -14.98 15.03 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.252 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.45 90.83 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.978 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.2 117.4 52.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.035 0.445 . . . . 0.0 110.475 175.373 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -80.74 133.69 35.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.204 178.726 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.3 p -88.02 161.14 44.75 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 179.507 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.2 -29.82 88.71 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.097 2.531 . . . . 0.0 112.1 177.437 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.16 -21.2 63.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 179.52 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.84 36.67 2.34 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.813 173.825 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -149.74 167.22 27.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.352 0.576 . . . . 0.0 111.944 176.433 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -109.52 140.76 42.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.149 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.5 m-85 -132.49 167.19 20.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.962 173.249 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.577 ' O ' HG22 ' A' ' 33' ' ' ILE . 38.2 m -84.81 150.15 25.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.507 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.02 -8.83 56.11 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -172.573 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.73 -28.35 7.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.022 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -65.31 -52.96 50.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.362 0.601 . . . . 0.0 110.208 176.522 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -70.35 -40.5 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.947 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.48 -43.21 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.516 -176.749 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -78.88 -2.01 37.81 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.567 0.699 . . . . 0.0 110.359 -176.698 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 48.4 m -105.74 -18.56 14.03 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 175.683 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.7 pt -104.29 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.115 -178.267 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -95.08 -4.33 46.52 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.889 177.59 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.51 -47.49 2.73 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.398 -177.085 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 36' ' ' SER . . . -87.59 -69.69 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.03 157.71 30.3 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.534 179.047 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -87.91 18.59 4.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -176.41 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -95.92 140.83 30.12 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.005 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 53.0 t -60.79 130.85 91.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.36 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.51 -29.18 88.08 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -172.091 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.96 -55.63 5.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -103.2 4.38 36.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -173.137 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 56.6 29.5 15.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 173.898 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -79.81 145.54 32.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.462 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.36 119.5 13.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 179.012 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -125.45 131.78 52.82 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.437 -172.581 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.77 156.86 27.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -38.45 85.49 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.855 0.36 . . . . 0.0 110.952 -176.878 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -65.2 -30.51 71.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.826 178.723 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -80.15 -12.03 59.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.898 -176.068 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 33' ' ' ILE . 82.0 mt . . . . . 0 C--O 1.245 0.853 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.024 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 44.8 t -61.92 112.66 6.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.192 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -62.06 -21.32 72.21 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.569 2.18 . . . . 0.0 112.793 -174.254 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.39 -44.17 90.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.085 0.469 . . . . 0.0 111.777 179.53 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.5 p -106.06 -19.37 13.74 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.598 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 10' ' ' PRO . 98.2 mt 53.47 28.47 7.65 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -175.958 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -95.61 -65.5 0.97 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.259 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.66 -171.47 0.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.58 109.06 21.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.28 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -70.28 -44.68 67.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.806 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 54.7 mm-40 -111.9 -16.48 13.12 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.098 -177.14 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.41 82.19 0.09 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 177.407 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.95 116.68 51.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 110.972 175.963 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -81.22 125.42 30.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.285 176.553 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -75.76 157.29 84.09 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.97 -23.69 76.08 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.375 2.05 . . . . 0.0 112.34 177.77 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.8 p -77.85 -20.76 52.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.617 176.876 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.76 43.53 1.42 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.024 -1.084 . . . . 0.0 114.232 174.537 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.603 ' HE1' ' OD2' ' A' ' 47' ' ' ASP . 49.8 m80 -130.86 152.55 50.07 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.175 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -113.02 132.78 55.25 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.534 178.187 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 97.0 m-85 -138.25 167.64 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.123 -178.988 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 42.4 m -78.31 151.86 32.73 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.204 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.526 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 88.0 tttt -68.49 -13.45 62.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -171.062 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.92 -27.09 7.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.885 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.8 m -64.59 -46.79 81.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.299 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -69.43 -41.37 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.145 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 80.8 mt -63.57 -42.67 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.153 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -79.42 -0.54 33.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -177.958 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -105.29 -21.72 13.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.051 176.793 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.6 pt -104.89 -13.68 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.33 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -108.18 -1.7 20.05 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.557 175.873 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -122.23 -57.58 1.76 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.033 -179.867 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.84 -65.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.647 -178.553 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -157.09 159.2 29.48 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.546 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -79.88 -8.84 59.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.474 0.637 . . . . 0.0 110.992 -176.611 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 20.2 ptpt -81.29 149.33 29.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.121 176.591 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 51.0 t -58.8 125.97 79.0 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.751 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.92 -22.01 73.44 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.018 2.478 . . . . 0.0 113.514 -167.993 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -97.79 -48.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.443 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.603 ' OD2' ' HE1' ' A' ' 26' ' ' HIS . 53.9 p-10 -108.98 5.86 24.65 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.921 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 58.63 32.73 22.47 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 176.22 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -97.54 137.39 36.55 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.205 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' LYS . 46.6 mm -65.81 120.92 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.599 -177.458 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 37' ' ' ILE . 49.7 tp -109.7 130.22 55.53 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.99 -172.467 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.59 135.55 40.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 -176.486 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.53 -36.76 84.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.401 -179.562 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -63.58 -31.83 73.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.883 -177.342 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.7 mm-40 -71.65 -25.05 61.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 111.481 179.641 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 C--N 1.317 -0.808 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 -175.732 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.55 ' HB2' HD23 ' A' ' 16' ' ' LEU . 37.1 t -71.8 114.12 25.93 Favored Pre-proline 0 C--O 1.221 -0.428 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.313 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.69 -21.27 71.73 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.583 2.189 . . . . 0.0 112.951 -176.619 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.63 -45.01 89.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.898 0.38 . . . . 0.0 111.664 179.203 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 9.6 p -105.3 -23.85 12.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.422 . . . . 0.0 111.53 -177.201 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.23 22.53 13.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.15 0.98 . . . . 0.0 111.844 -177.945 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtm -94.69 -64.69 1.04 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.043 0.449 . . . . 0.0 109.911 176.348 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.96 -175.33 0.86 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.116 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 9' ' ' CYS . 93.9 mt -96.58 116.77 29.64 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 170.442 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 20.7 tpt180 -66.18 -44.73 83.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.778 177.906 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 17' ' ' ARG . 47.4 mt-10 -132.66 -15.15 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -177.052 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.54 84.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.132 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.36 118.41 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.224 0.535 . . . . 0.0 111.009 175.208 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.406 ' OE1' ' HG3' ' A' ' 27' ' ' ARG . 7.6 tp60 -78.63 133.12 37.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.211 179.512 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -87.57 160.17 48.22 Favored Pre-proline 0 C--N 1.311 -1.1 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.483 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.53 -23.65 74.94 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.373 2.048 . . . . 0.0 112.507 179.079 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 p -80.67 -15.8 55.62 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.994 0.426 . . . . 0.0 111.551 176.191 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.59 52.3 1.32 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.162 175.218 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -135.06 141.08 46.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.727 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.406 ' HG3' ' OE1' ' A' ' 21' ' ' GLN . 90.3 mtt180 -105.63 133.47 50.32 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.686 176.242 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -135.02 169.25 17.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.744 177.184 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 61.3 m -69.36 148.81 49.15 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 171.435 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.41 -6.72 45.47 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.288 0.566 . . . . 0.0 111.356 -173.414 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.13 -34.01 5.5 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.026 -0.421 . . . . 0.0 110.263 179.332 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.1 m -65.84 -46.96 76.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.932 179.109 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.0 tp -68.89 -40.65 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.014 -177.506 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.2 mt -63.28 -43.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.961 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -80.96 4.42 19.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.008 0.433 . . . . 0.0 111.351 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -105.46 -24.67 12.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.715 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.39 -20.52 5.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.47 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.8 ptm180 -99.92 4.08 44.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.497 176.107 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -128.03 -54.51 1.29 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.018 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.15 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -179.04 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.44 144.6 11.36 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.923 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -84.19 40.62 0.78 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.736 0.779 . . . . 0.0 111.165 -171.092 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -142.63 152.86 42.92 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.119 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.23 123.58 89.14 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.731 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.59 -24.18 75.03 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.077 2.518 . . . . 0.0 114.078 -170.259 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.1 m -72.34 -49.82 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.973 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -115.49 5.74 14.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.005 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 58.76 33.68 23.23 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 175.502 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -100.23 144.5 29.17 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.351 -0.218 . . . . 0.0 110.495 179.345 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.59 121.72 15.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 -176.371 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.466 HD21 HD21 ' A' ' 56' ' ' LEU . 43.8 tp -115.33 127.78 55.66 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.275 -174.61 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.5 138.88 38.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.338 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.85 -36.85 77.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.747 0.419 . . . . 0.0 111.959 -175.133 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.78 -17.8 62.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.833 0.349 . . . . 0.0 111.571 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -81.26 -9.06 59.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.865 -177.136 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.466 HD21 HD21 ' A' ' 51' ' ' LEU . 92.4 mt . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.983 178.6 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.469 ' HB2' HD23 ' A' ' 16' ' ' LEU . 5.1 t -89.92 118.13 68.67 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.28 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.76 -18.73 63.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 113.218 -176.349 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.432 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.4 mt -65.84 -44.33 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.692 0.282 . . . . 0.0 110.856 177.806 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.6 p -106.44 -26.47 11.43 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.716 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 66.3 22.93 10.82 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.142 0.977 . . . . 0.0 111.895 179.569 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -97.64 -66.85 0.88 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.316 0.579 . . . . 0.0 110.631 176.651 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.99 -161.65 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD23 ' HB2' ' A' ' 9' ' ' CYS . 90.4 mt -109.77 122.75 48.22 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.539 172.389 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 27.4 tpt180 -86.85 108.92 18.97 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.944 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 71.49 -10.39 0.82 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.155 1.382 . . . . 0.0 113.173 -179.544 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.86 83.63 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.144 0.978 . . . . 0.0 113.329 175.467 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.42 115.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.086 177.907 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -80.7 128.32 33.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.145 177.474 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -79.77 161.91 64.65 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.204 177.579 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.24 -18.95 67.3 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.5 2.133 . . . . 0.0 111.438 175.884 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.2 m -65.85 -35.43 80.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.785 174.357 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 -28.23 5.44 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.902 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -82.6 154.48 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.746 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -109.5 140.67 42.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.136 -174.946 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.43 167.81 18.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.428 176.546 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 88.3 m -73.4 146.42 45.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.28 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -69.72 -12.79 61.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.361 179.236 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.42 2.98 15.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 -177.533 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 83.5 m -105.77 -56.97 2.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.734 173.067 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -68.8 -41.85 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.28 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.0 mt -63.42 -41.68 93.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.515 0.674 . . . . 0.0 110.254 179.24 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -77.97 -0.2 26.77 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.64 -177.159 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -105.85 -22.8 12.84 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.129 -0.357 . . . . 0.0 110.71 175.93 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.4 pt -102.23 -23.4 4.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.208 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -102.81 6.15 39.09 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.754 174.345 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -114.84 -51.15 2.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.607 -178.842 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.05 -69.62 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.525 177.298 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -162.85 159.49 31.89 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.433 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -82.08 65.0 7.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -173.439 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 10.4 ptpp? -153.11 147.64 26.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.932 175.248 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.77 124.18 86.41 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.086 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.54 -26.9 81.28 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.993 2.462 . . . . 0.0 114.886 -168.488 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.14 -44.07 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.714 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -121.44 6.43 10.11 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.502 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 52.31 34.54 15.04 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.131 1.372 . . . . 0.0 113.622 177.834 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 77.0 mm-40 -88.89 142.87 27.28 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.085 178.828 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.21 120.07 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.305 0.574 . . . . 0.0 110.216 -175.3 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.8 tp -128.89 132.68 47.72 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 -177.46 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.94 152.69 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.855 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.49 -31.02 71.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.268 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -63.53 -32.81 74.38 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.051 178.167 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -68.32 -34.31 75.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.409 0.623 . . . . 0.0 109.996 178.719 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.437 -1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.583 178.555 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.433 -1.297 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.5 t -84.37 114.23 53.55 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.059 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.91 -21.68 73.31 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.36 2.04 . . . . 0.0 112.806 -175.323 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.79 -44.17 85.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.619 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 18.5 p -106.24 -22.15 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.54 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp 63.85 21.18 12.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 111.108 -174.907 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 30.1 mmt -95.44 -73.49 0.59 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.124 0.488 . . . . 0.0 109.792 178.778 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.09 166.88 2.96 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 9' ' ' CYS . 91.6 mt -84.19 103.65 13.57 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.232 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -83.52 -53.91 5.34 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 118.879 -1.129 . . . . 0.0 112.037 -177.348 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 9.3 mp0 -87.7 -16.56 33.96 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.595 177.318 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 43.34 73.14 0.15 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.189 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -99.65 116.31 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.369 0.604 . . . . 0.0 110.187 177.781 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -80.08 136.53 36.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.92 179.795 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -89.95 159.46 42.77 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.092 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.15 -25.97 81.29 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 174.28 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.55 -17.62 64.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.898 177.931 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 13.84 57.46 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.804 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -109.13 143.28 38.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.844 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -109.98 139.99 44.49 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.075 0.464 . . . . 0.0 111.857 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.487 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.5 m-85 -141.0 169.68 17.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.104 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.638 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.8 m -82.81 154.05 24.9 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.352 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 41.0 ttmt -70.86 -14.37 62.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.298 0.571 . . . . 0.0 110.566 -176.59 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.97 2.62 15.86 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.186 0.517 . . . . 0.0 109.921 -178.535 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.4 m -103.06 -55.96 2.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.44 174.007 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.585 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -66.69 -43.28 90.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.641 -175.707 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.39 -41.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.229 0.538 . . . . 0.0 110.675 179.817 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -76.97 -3.83 40.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.812 -175.916 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.0 m -110.88 -23.72 10.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 176.133 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 33' ' ' ILE . 44.6 pt -103.64 -7.3 9.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.099 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -95.32 -10.11 31.11 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.252 177.451 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -116.8 -43.01 2.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.056 -177.668 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.96 -72.81 0.43 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.119 176.819 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.46 152.36 21.7 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 177.649 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 24.1 m80 -82.46 68.88 9.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.855 0.836 . . . . 0.0 111.996 -179.299 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -151.71 150.7 30.51 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.462 177.582 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.2 p -70.97 123.58 89.55 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.407 177.207 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.93 -28.07 80.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.918 2.412 . . . . 0.0 113.651 -171.615 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.49 -49.23 81.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.766 -177.758 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -127.05 6.65 6.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.417 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 60.31 35.35 20.74 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -94.53 143.18 26.63 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 174.14 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 122.18 14.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.313 0.577 . . . . 0.0 110.815 -174.003 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.1 tp -120.97 130.24 53.75 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.143 -174.436 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.57 139.18 40.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -65.35 -37.84 88.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.883 -174.058 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -68.58 -19.02 64.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 177.959 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.6 mm-40 -81.36 -8.53 59.75 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.132 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.242 0.702 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.859 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 N--CA 1.432 -1.364 0 CA-C-O 120.74 0.305 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.56 108.83 4.84 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.498 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.08 -19.14 51.66 Favored 'Trans proline' 0 C--O 1.226 -0.113 0 C-N-CA 122.881 2.387 . . . . 0.0 113.463 -171.113 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 95.5 mt -66.21 -43.61 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.0 111.144 178.635 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 p -99.17 -25.29 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.973 0.416 . . . . 0.0 111.042 178.692 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.1 mt 60.5 29.86 19.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 111.249 -176.349 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.6 mtm -99.09 -68.19 0.81 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 175.136 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.65 -163.24 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -176.253 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.74 124.35 46.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.026 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -88.29 -72.28 0.54 Allowed 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.954 176.846 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.424 ' CD ' ' HG2' ' A' ' 30' ' ' LYS . 58.2 mp0 -81.13 -15.97 54.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.223 177.004 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.4 77.59 0.17 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.646 -178.281 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.12 114.03 40.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.552 0.691 . . . . 0.0 110.015 177.889 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -80.8 135.78 36.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.928 -178.4 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -99.63 154.2 37.39 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.62 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.14 -24.69 72.91 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 122.722 2.281 . . . . 0.0 113.153 -176.229 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 p -76.21 -15.31 60.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 178.692 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.35 23.46 6.94 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.704 175.795 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -112.61 155.65 24.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.634 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -126.07 137.35 53.62 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.53 176.69 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.587 -175.761 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 8.7 m -91.61 160.43 15.4 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 170.702 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 61.2 pttt -75.88 -7.11 53.74 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.175 0.512 . . . . 0.0 110.353 -174.682 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.37 -0.85 15.24 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.152 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 49.2 m -101.94 -64.16 1.09 Allowed 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.393 175.879 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -67.32 -41.72 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.992 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 30' ' ' LYS . 82.8 mt -63.18 -42.89 98.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 110.97 -178.341 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -79.9 -3.22 47.15 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.246 0.546 . . . . 0.0 110.478 -176.933 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -106.15 -18.22 14.08 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.809 -0.557 . . . . 0.0 111.4 178.156 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 36.5 pt -102.23 -13.28 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.453 -175.051 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -104.87 0.94 28.48 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.06 174.342 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.32 -51.72 2.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 -176.032 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.79 -69.78 0.59 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.42 0.629 . . . . 0.0 109.451 174.796 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.76 163.94 35.26 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 177.682 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -80.31 72.26 7.15 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.87 0.835 . . . . 0.0 112.124 -176.709 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.0 ptpp? -144.61 150.05 36.79 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.784 176.075 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 p -83.75 123.23 76.37 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.36 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.96 -25.71 74.07 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.842 2.361 . . . . 0.0 114.109 -168.962 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.5 m -72.08 -42.96 67.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.874 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -120.27 6.43 10.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 50.93 36.55 15.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 176.303 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.6 mm-40 -96.94 153.29 17.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.345 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.53 122.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.145 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.6 118.35 35.44 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -176.368 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.36 134.82 40.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.484 179.736 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -64.89 -35.6 81.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.339 0.399 . . . . 0.0 111.74 -173.426 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -65.86 -30.65 71.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.287 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -68.1 -20.25 64.92 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.188 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 178.341 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 . . . . . 0 N--CA 1.442 -0.83 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 38.7 t -70.34 114.21 24.08 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.944 0.778 . . . . 0.0 109.426 179.023 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 32.1 Cg_exo -62.7 -21.61 73.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.346 2.03 . . . . 0.0 112.553 -177.666 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.8 -44.02 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.764 0.316 . . . . 0.0 111.582 178.317 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -104.01 -22.92 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.891 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt 56.75 25.48 10.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 111.939 -176.421 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -96.4 -63.13 1.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.324 174.291 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.37 -172.72 0.31 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.786 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.4 mt -98.93 106.82 19.12 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.961 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -69.61 -43.96 71.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.138 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 67.1 mm-40 -115.38 -16.24 11.46 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 177.876 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.95 70.48 0.58 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.661 0.601 . . . . 0.0 112.329 -178.544 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 28' ' ' PHE . 26.8 m -93.27 116.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.141 0.496 . . . . 0.0 110.777 179.236 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -80.0 135.81 36.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 175.116 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -111.01 151.74 43.2 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.498 -179.791 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.449 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 50.2 Cg_exo -56.63 -37.38 97.76 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.791 2.327 . . . . 0.0 111.154 179.737 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.8 t -59.69 -31.14 69.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.907 -178.793 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.89 36.33 2.04 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.418 179.812 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.56 156.85 40.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.162 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.72 131.35 53.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.012 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.43 ' O ' HG22 ' A' ' 20' ' ' VAL . 94.5 m-85 -139.6 179.72 6.4 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.252 0.345 . . . . 0.0 110.208 -177.109 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.519 ' HB2' ' HG ' ' A' ' 32' ' ' CYS . 61.8 m -90.61 151.22 21.39 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 169.972 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 88.0 tttt -71.55 -6.8 43.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.34 0.59 . . . . 0.0 111.449 -176.121 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.48 -16.14 12.47 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.081 0.467 . . . . 0.0 109.952 -179.437 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.519 ' HG ' ' HB2' ' A' ' 29' ' ' CYS . 76.3 m -83.82 -59.28 2.47 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 175.351 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.2 tp -67.87 -41.05 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.243 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 67.0 mt -62.72 -42.97 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.658 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -78.83 -1.66 35.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.546 0.689 . . . . 0.0 109.61 -175.568 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 m -105.38 -21.08 13.3 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.651 176.158 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.7 pt -104.07 -24.34 4.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.077 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -98.9 0.49 44.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.764 177.371 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.87 -46.52 2.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.749 -177.395 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 -68.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.115 0.483 . . . . 0.0 110.794 177.202 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.49 161.98 35.66 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.31 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 66.0 m80 -86.21 76.17 9.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 117.444 0.622 . . . . 0.0 111.555 -173.886 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 22.4 pttp -154.25 144.68 22.22 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 -179.214 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.3 p -77.32 123.79 86.98 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 170.351 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.25 -24.77 76.32 Favored 'Trans proline' 0 N--CA 1.481 0.751 0 C-N-CA 123.321 2.681 . . . . 0.0 114.019 -167.251 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -66.79 -46.19 86.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.056 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.55 7.45 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.943 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.321 25.4 p30 53.77 38.12 27.83 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 178.886 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 69.1 mm-40 -86.28 142.01 28.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.382 173.336 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 48.5 mm -66.45 121.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.575 -176.941 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.68 132.39 43.9 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.402 -177.629 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HG3' ' A' ' 55' ' ' GLN . 2.7 mm? -110.58 157.99 19.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.354 177.748 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.65 -38.15 89.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.655 0.74 . . . . 0.0 109.917 -179.473 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -76.72 -6.04 50.55 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.15 -174.006 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 23' ' ' PRO . 61.7 mt-30 -89.38 -8.07 53.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 0.0 111.413 178.723 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.484 -175.742 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.416 -2.127 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -72.79 108.55 4.58 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.889 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.19 -17.5 45.16 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.528 2.152 . . . . 0.0 112.002 -174.31 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.4 mt -66.13 -43.6 92.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.61 177.527 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -104.81 -16.51 14.89 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -177.706 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 mp 57.87 22.72 8.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.928 0.891 . . . . 0.0 111.569 -176.326 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.465 ' HA ' ' CE ' ' A' ' 14' ' ' MET . 1.8 mmt -94.88 -66.89 0.88 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.529 -178.865 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.78 -169.43 0.12 Allowed 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.975 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.3 mt -97.49 109.36 22.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.898 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -65.48 -45.13 84.87 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.311 -178.823 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -132.72 -14.08 2.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.764 176.344 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.24 92.21 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.602 0.761 . . . . 0.0 112.9 178.167 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.91 117.62 49.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.163 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.31 128.22 33.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.331 -177.584 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -89.32 155.16 49.11 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.872 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.37 -29.55 89.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.504 2.136 . . . . 0.0 113.07 -173.663 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 p -76.27 -15.4 60.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.944 0.402 . . . . 0.0 111.923 178.985 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.21 42.45 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.951 174.346 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -125.62 143.29 51.09 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.524 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 7.5 mpt_? -109.97 135.62 50.53 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.409 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.0 m-85 -133.81 168.08 19.39 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.8 m -75.88 156.65 34.13 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.775 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.1 tttt -68.82 -11.23 60.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.508 -174.697 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.32 -37.56 4.33 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.973 -179.101 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -62.8 -47.28 84.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.813 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -70.11 -41.61 79.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.896 -178.681 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.556 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.7 mt -63.55 -42.78 97.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.696 -178.592 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -78.01 -0.94 29.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.482 0.658 . . . . 0.0 110.02 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -105.86 -20.36 13.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.701 174.164 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.64 -21.73 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -176.577 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 12.2 ptp180 -97.57 8.01 45.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.464 171.605 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -116.2 -55.82 2.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.746 -177.94 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.87 -72.64 0.5 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.88 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.46 163.56 37.02 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.987 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.493 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 70.5 m80 -87.93 76.65 8.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.598 0.713 . . . . 0.0 111.909 -176.706 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -159.91 155.32 25.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.848 175.708 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 p -79.07 124.05 84.75 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.702 175.988 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.8 -27.21 75.15 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 122.82 2.347 . . . . 0.0 113.614 -172.851 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.91 -45.34 73.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.444 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -122.47 4.87 9.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.77 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 57.71 34.74 24.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.477 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 148.76 22.78 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.448 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.99 120.67 14.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.952 0.406 . . . . 0.0 110.594 -175.486 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 61.7 tp -121.45 127.98 51.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.154 -176.646 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.17 148.92 29.21 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.529 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.08 -37.33 87.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -175.893 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.0 -29.81 70.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.471 177.381 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.72 -15.11 62.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.076 -179.581 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.742 0.306 . . . . 0.0 110.729 178.65 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.408 ' HB2' HD23 ' A' ' 16' ' ' LEU . 38.8 t -79.79 109.84 13.55 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.712 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.79 -20.57 71.55 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.525 2.15 . . . . 0.0 112.576 -174.467 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -67.32 -44.7 87.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.684 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.3 p -103.92 -19.3 14.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.462 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp 58.42 23.19 10.34 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.693 0.797 . . . . 0.0 111.563 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.4 mtm -95.28 -64.62 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.158 178.273 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.51 -173.97 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.757 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 9' ' ' CYS . 84.8 mt -95.22 102.66 14.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 173.184 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.29 -45.06 63.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.053 -179.555 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 18.5 mm-40 -106.43 -17.45 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.815 -175.176 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 44.52 89.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.596 1.159 . . . . 0.0 114.034 -176.716 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.89 121.26 65.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 175.939 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.348 -178.811 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -110.66 151.1 42.6 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.349 174.638 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.9 -24.82 77.51 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.87 2.38 . . . . 0.0 113.634 -178.802 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.7 p -79.32 -15.47 57.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.978 177.77 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 44.8 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.304 173.621 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.47 ' HE1' ' OD2' ' A' ' 47' ' ' ASP . 16.6 m80 -133.33 149.46 51.9 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.708 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -111.45 134.85 52.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.495 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 96.9 m-85 -136.18 173.15 12.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.718 -178.725 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.7 m -86.89 151.21 23.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.124 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.525 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 65.2 tttp -68.42 -11.21 59.35 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 122.999 0.52 . . . . 0.0 111.348 -178.966 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.55 2.64 15.4 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.171 -178.994 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -105.41 -53.8 2.59 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.399 175.25 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -68.17 -38.54 79.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.923 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.09 -41.61 91.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.069 0.462 . . . . 0.0 110.126 178.326 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 32.1 mmmt -79.18 2.75 19.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -106.37 -25.46 11.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.742 173.669 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.3 pt -104.63 -5.87 9.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.387 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.0 ptm180 -124.61 3.15 8.29 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.546 171.097 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 3.9 m-20 -127.11 -42.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.149 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.41 -65.91 0.97 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.437 0.637 . . . . 0.0 110.755 -178.597 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.52 -148.52 5.42 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.579 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -139.02 31.96 2.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 171.517 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -132.5 161.03 34.79 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.086 -175.065 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.1 t -74.94 122.04 86.6 Favored Pre-proline 0 N--CA 1.43 -1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.13 -31.16 54.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.386 2.057 . . . . 0.0 113.327 -175.167 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.38 -48.57 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.007 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' OD2' ' HE1' ' A' ' 26' ' ' HIS . 48.7 p-10 -114.33 6.49 16.1 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.573 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 58.91 31.97 21.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.489 0.716 . . . . 0.0 112.439 177.106 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.76 147.17 26.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.636 178.943 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.0 122.42 16.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.129 0.49 . . . . 0.0 109.974 -178.022 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.401 HD23 HG21 ' A' ' 37' ' ' ILE . 54.5 tp -111.34 131.0 55.5 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.133 -175.114 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -97.76 138.62 34.85 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.075 -178.903 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.77 -38.64 89.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.414 -174.563 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.13 -30.13 70.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.015 0.436 . . . . 0.0 111.189 178.37 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -74.58 -7.14 52.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.57 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.013 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.516 ' HB2' HD23 ' A' ' 16' ' ' LEU . 39.4 t -94.88 108.37 37.43 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 173.853 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.7 -19.48 68.34 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.841 2.361 . . . . 0.0 112.862 -174.599 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.58 -44.13 90.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 178.61 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.5 p -102.79 -13.37 17.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.794 -178.351 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 mp 69.37 23.97 5.98 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.625 0.77 . . . . 0.0 110.425 -179.04 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -128.18 170.07 13.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.38 157.7 13.31 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.428 0.455 . . . . 0.0 110.899 177.853 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 9' ' ' CYS . 86.1 mt -70.09 133.1 46.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.719 -174.859 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 12.8 tpt180 -77.98 -62.86 1.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.087 172.716 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.507 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.8 mm-40 -99.18 -18.43 17.66 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.062 -177.545 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 86.98 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.629 -175.539 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -108.8 118.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.508 0.67 . . . . 0.0 111.126 175.133 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.22 139.41 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.18 179.867 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -110.51 155.32 42.27 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.803 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.02 -20.24 63.83 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.703 2.269 . . . . 0.0 111.72 178.769 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.9 t -74.42 -19.47 60.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.876 178.253 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.72 25.98 11.17 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.979 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -113.69 154.04 27.95 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.028 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.41 ' HB3' HD11 ' A' ' 16' ' ' LEU . 77.8 mtt85 -117.99 138.43 52.19 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.665 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.7 168.29 20.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.775 0.321 . . . . 0.0 110.581 -178.689 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.612 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.8 m -86.21 148.36 25.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 169.977 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.78 -12.85 61.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.958 -171.514 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -7.92 13.41 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.352 -178.587 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -85.94 -46.39 10.6 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 170.149 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.608 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -67.78 -43.14 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.859 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.587 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.9 mt -63.46 -42.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 111.221 -177.958 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -78.76 -2.09 37.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 -175.607 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 t -106.16 -25.54 11.96 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.832 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.8 pt -103.77 -15.59 8.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.479 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.3 ptm180 -98.35 2.99 48.57 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.262 173.89 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -115.18 -52.09 2.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.068 -172.123 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.3 -68.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.223 175.671 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.74 165.73 39.1 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.099 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 62.4 m80 -87.94 80.48 7.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.837 0.827 . . . . 0.0 111.473 -177.776 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -152.7 159.51 43.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 9.7 m -67.21 127.4 93.47 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.861 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.49 -20.77 70.37 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.736 2.291 . . . . 0.0 112.516 -179.31 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.73 -61.0 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.276 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 43.2 p-10 -103.92 5.29 35.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.033 -0.417 . . . . 0.0 111.128 -174.378 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 56.28 34.55 24.25 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.542 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -90.04 145.65 24.92 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.098 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -65.86 121.58 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 0.0 110.426 -174.252 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 64.9 tp -126.89 129.12 47.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.929 -175.983 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.2 mm? -112.14 152.26 28.52 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -175.539 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.58 -36.15 82.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.302 0.573 . . . . 0.0 111.171 -177.971 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.99 -31.09 72.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.459 176.27 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.4 mm100 -78.93 -8.64 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.384 -175.735 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.238 0.456 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.667 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 44.2 tt0 . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.4 t -78.28 108.49 7.8 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.756 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 35.7 Cg_exo -64.48 -19.8 65.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.926 2.417 . . . . 0.0 112.06 -177.123 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.1 -43.86 92.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 -179.352 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.3 p -99.76 -26.0 14.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.272 179.841 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt 64.22 21.65 12.6 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.153 0.981 . . . . 0.0 111.92 179.797 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -100.52 -64.47 1.04 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.936 0.398 . . . . 0.0 111.004 177.884 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.7 -170.07 0.38 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.544 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.03 108.01 20.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.533 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.12 -45.84 75.94 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.019 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -112.45 -16.81 12.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.342 176.425 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.37 62.53 2.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.256 -175.046 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 29.1 m -83.18 118.12 30.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.39 -178.492 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -74.51 126.22 30.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.688 178.794 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.1 p -94.68 165.54 17.03 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.085 -177.27 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.83 -34.2 96.22 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.801 2.334 . . . . 0.0 112.062 177.442 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 p -76.62 -15.15 59.9 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.187 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.17 44.0 Favored Glycine 0 CA--C 1.516 0.152 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.936 179.0 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -90.97 167.15 12.62 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.054 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 92.4 mtt180 -130.55 140.24 50.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.001 179.293 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.421 ' O ' HG22 ' A' ' 20' ' ' VAL . 96.9 m-85 -138.7 -177.23 4.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.521 ' O ' HG22 ' A' ' 33' ' ' ILE . 45.6 m -91.12 152.3 20.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.371 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.77 -11.88 61.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.049 0.452 . . . . 0.0 111.131 -176.269 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.45 -10.08 13.25 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.041 -177.448 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -92.66 -56.09 3.14 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.709 177.189 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.558 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -69.03 -40.3 80.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.667 -177.167 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.594 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.0 mt -62.91 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.381 . . . . 0.0 111.851 -178.934 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.14 -3.29 41.71 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.884 0.373 . . . . 0.0 110.49 -175.44 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.9 p -108.18 -19.71 13.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 175.157 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 33' ' ' ILE . 36.4 pt -102.64 -13.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.906 -0.496 . . . . 0.0 112.183 -174.55 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.3 ptp180 -98.0 7.99 45.46 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 167.852 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.09 -54.88 2.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.685 -175.286 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.96 -72.9 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.346 0.593 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.22 167.17 39.69 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.86 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 59.8 m80 -83.38 74.27 10.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.449 0.642 . . . . 0.0 111.992 -176.338 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.7 ptpt -151.7 152.03 32.23 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.267 177.746 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 1.5 p -77.46 135.69 64.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.829 173.982 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.62 -21.88 65.09 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.502 2.134 . . . . 0.0 112.259 -179.09 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -76.43 -74.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.02 4.47 47.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -175.08 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 95.8 m-20 56.08 34.55 24.01 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 172.053 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 75.5 mm-40 -93.64 154.07 18.03 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.725 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.57 120.59 14.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.565 0.698 . . . . 0.0 109.988 -175.805 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 56' ' ' LEU . 7.8 tt -124.05 121.25 34.7 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.297 -172.341 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.51 141.35 35.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.768 0.318 . . . . 0.0 111.378 -176.453 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.51 -43.02 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.957 -175.066 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -67.29 -30.91 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.261 -177.373 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -78.85 -8.18 58.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.439 -176.953 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 51' ' ' LEU . 97.5 mt . . . . . 0 C--N 1.315 -0.915 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.684 179.407 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 120.703 0.287 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HB2' HD23 ' A' ' 16' ' ' LEU . 42.1 t -88.17 108.16 20.21 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.851 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.8 Cg_exo -62.73 -20.72 71.82 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.684 2.256 . . . . 0.0 113.3 -174.755 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.67 -43.74 90.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.686 178.958 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.59 -7.96 14.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.113 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt 61.73 26.46 16.09 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.503 0.721 . . . . 0.0 110.785 -177.062 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -120.08 169.16 10.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 152.9 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.744 175.481 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 9' ' ' CYS . 77.9 mt -69.44 114.25 7.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.937 0.399 . . . . 0.0 110.003 -172.226 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -71.65 -46.56 58.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.779 -177.564 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -114.18 -17.18 11.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.464 178.485 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.45 82.68 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.872 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.43 116.72 53.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.327 0.584 . . . . 0.0 110.994 174.209 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 51.6 tt0 -82.84 133.84 35.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.891 -178.5 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -86.54 160.39 50.82 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.147 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -55.64 -37.76 94.96 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.612 2.208 . . . . 0.0 112.074 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 p -67.99 -17.23 64.37 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.649 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.41 41.44 2.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.015 174.069 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.486 ' HE1' ' OD2' ' A' ' 47' ' ' ASP . 49.7 m80 -122.49 143.76 49.5 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.193 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 21' ' ' GLN . 89.1 mtm180 -111.28 137.52 48.91 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.64 175.239 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.5 m-85 -131.65 166.36 21.62 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.428 -178.425 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.626 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.3 m -79.38 149.65 31.61 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.122 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' HD12 ' A' ' 34' ' ' ILE . 40.5 ttmt -76.22 -2.95 33.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.788 0.804 . . . . 0.0 111.455 -173.155 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.92 -24.0 9.77 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.113 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.7 m -73.35 -51.11 18.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.276 174.967 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.486 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -67.23 -39.55 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.926 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.1 mt -62.78 -41.7 93.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.625 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -78.18 -1.78 34.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.94 -176.762 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.5 m -105.86 -21.58 13.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.653 0.263 . . . . 0.0 111.178 173.828 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -102.87 -16.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.343 -175.196 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 ptm180 -99.73 1.13 43.03 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.002 175.467 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -115.49 -54.15 2.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.224 -178.0 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 -66.55 0.89 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.048 0.452 . . . . 0.0 110.48 179.013 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -172.09 161.99 33.99 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 177.218 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.615 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 47.2 m80 -83.18 83.25 7.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.776 0.798 . . . . 0.0 110.473 179.769 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.38 157.09 41.98 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.397 -176.987 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 46.3 t -80.9 122.49 82.0 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.915 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.83 -28.86 76.06 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.958 2.439 . . . . 0.0 115.055 -170.548 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.0 m -85.78 -49.93 14.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -173.095 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.486 ' OD2' ' HE1' ' A' ' 26' ' ' HIS . 42.6 p-10 -106.98 6.61 29.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.801 0.334 . . . . 0.0 111.322 -176.397 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.255 4.5 p-10 50.82 40.19 24.09 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.227 . . . . 0.0 113.736 177.826 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -80.51 149.84 29.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.799 175.064 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.09 120.84 16.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.109 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.8 tp -124.29 129.33 50.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.709 0.29 . . . . 0.0 111.138 -176.176 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.02 152.51 24.38 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -65.2 -24.19 67.29 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -174.381 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -89.57 5.48 45.4 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.75 179.162 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -84.8 -11.27 56.08 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.017 0.437 . . . . 0.0 110.168 174.063 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.397 -175.989 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 N--CA 1.428 -1.533 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 34.7 t -68.12 115.99 34.47 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.351 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 35.8 Cg_exo -62.04 -22.49 74.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.171 1.914 . . . . 0.0 113.171 -174.653 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.78 -44.28 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.475 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 8.1 p -97.96 -16.41 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.646 -177.413 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt 54.92 27.08 8.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 109.81 -174.031 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.9 ttm -108.35 -73.96 0.67 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.699 -173.488 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.65 162.75 2.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.015 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.05 104.5 7.57 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.328 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -70.65 -45.65 64.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 177.294 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 63.8 mm-40 -114.59 -16.47 11.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.948 -178.027 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.58 82.67 0.08 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.949 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -111.85 117.81 56.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.244 0.545 . . . . 0.0 110.59 175.001 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 53.5 tt0 -81.34 138.33 35.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.357 -177.914 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.448 ' CG2' HD11 ' A' ' 51' ' ' LEU . 67.9 p -113.73 156.54 43.51 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.584 -179.011 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HG3' ' OE1' ' A' ' 55' ' ' GLN . 38.3 Cg_endo -62.98 -22.0 73.54 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.027 2.485 . . . . 0.0 113.409 -176.17 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 56.5 m -73.99 -19.25 60.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.643 177.509 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 30.56 7.18 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.169 -175.885 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.498 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 16.5 m-70 -114.0 152.13 31.38 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.078 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 88.7 mtm180 -122.64 134.34 54.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.309 171.656 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 93.0 m-85 -129.97 -177.82 4.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.289 -176.151 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.6 m -99.61 157.89 16.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.999 173.443 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.4 tttt -68.64 -13.39 62.33 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.046 0.451 . . . . 0.0 111.631 -178.209 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 1.93 16.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.863 0.84 . . . . 0.0 109.198 -178.138 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 84.0 m -103.12 -63.32 1.18 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.713 175.935 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.1 -40.63 85.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.528 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.644 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.6 mt -63.47 -42.46 96.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.953 0.406 . . . . 0.0 110.273 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.84 4.95 12.58 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.627 0.727 . . . . 0.0 110.247 -179.289 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.7 t -106.46 -26.44 11.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.738 173.418 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.9 pt -103.77 -19.47 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.968 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -101.01 8.63 42.91 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.771 0.796 . . . . 0.0 109.36 173.8 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.41 -56.61 2.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.871 -174.66 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.33 -68.93 0.77 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.947 177.322 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.1 176.09 45.9 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 178.895 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 33.5 m80 -79.11 92.66 5.05 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 117.824 0.812 . . . . 0.0 111.478 -179.806 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 18.8 ptpt -169.08 147.46 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.328 0.651 . . . . 0.0 109.526 177.733 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 125.32 71.06 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 170.197 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.01 -25.59 81.77 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.965 2.444 . . . . 0.0 114.661 -167.909 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.98 -44.74 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.099 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -121.48 5.72 10.12 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.193 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 51.21 31.07 6.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.051 1.341 . . . . 0.0 114.24 179.691 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.1 140.11 32.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.509 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 2.0 mp -66.36 120.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.278 0.561 . . . . 0.0 110.198 -176.448 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.448 HD11 ' CG2' ' A' ' 22' ' ' THR . 8.9 tt -121.78 131.99 54.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.255 -173.46 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.43 HD13 ' NE2' ' A' ' 55' ' ' GLN . 8.3 mp -111.41 153.1 26.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.445 -178.01 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -61.69 -34.43 75.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.265 0.626 . . . . 0.0 111.461 -177.671 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -74.59 -11.47 60.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.11 0.481 . . . . 0.0 111.29 -178.018 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.43 ' NE2' HD13 ' A' ' 52' ' ' LEU . 80.8 mt-30 -87.61 -10.63 50.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.841 177.9 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 177.52 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.188 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -60.44 143.76 99.48 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.389 2.059 . . . . 0.0 111.129 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.52 123.89 46.3 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.84 81.75 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.275 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.7 m -76.25 141.45 41.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.848 0.356 . . . . 0.0 111.457 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.35 102.34 5.92 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 48.7 76.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.56 0.695 . . . . 0.0 110.88 -170.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -134.46 149.7 50.76 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.741 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 54.0 t -88.7 110.13 34.89 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.47 -17.86 53.92 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.848 2.365 . . . . 0.0 111.952 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.445 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -65.8 -43.99 93.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.754 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -115.0 -8.24 12.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.542 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.5 mt 56.68 34.82 25.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.845 0.858 . . . . 0.0 110.914 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -118.16 164.06 15.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.714 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.57 32.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.917 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.48 119.58 13.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.031 0.443 . . . . 0.0 111.008 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 19' ' ' ALA . 28.2 tpt180 -91.37 115.61 28.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.252 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 69.23 -16.23 0.25 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.553 1.141 . . . . 0.0 113.026 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 47.72 91.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.026 1.33 . . . . 0.0 113.569 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -101.83 116.73 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.319 0.58 . . . . 0.0 110.735 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.41 134.22 35.52 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.082 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -87.92 160.71 46.07 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.781 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.87 -17.96 62.31 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 122.39 2.06 . . . . 0.0 111.014 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.82 -21.43 63.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.411 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.91 2.08 58.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.417 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -97.54 136.39 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -102.54 135.34 44.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.98 166.61 22.31 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.9 m -65.74 150.11 49.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.06 -10.61 51.71 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.502 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.12 -38.13 3.68 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.559 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 36.6 m -61.77 -45.12 95.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.692 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -66.94 -39.34 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.577 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -62.97 -42.87 98.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.063 0.459 . . . . 0.0 110.509 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -78.61 -1.48 34.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.479 0.657 . . . . 0.0 110.374 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -105.84 -19.69 13.67 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.997 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -102.98 -26.16 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.0 ptm180 -103.02 8.55 38.87 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.795 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -115.28 -53.84 2.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.95 -66.68 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.22 0.533 . . . . 0.0 110.2 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.82 161.71 35.04 Favored Glycine 0 CA--C 1.497 -1.032 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -80.86 81.08 7.21 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 117.206 0.503 . . . . 0.0 112.197 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.2 ptpt -151.3 154.8 37.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.479 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.4 p -83.36 125.67 73.61 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.94 -27.33 84.63 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.636 2.224 . . . . 0.0 114.313 -170.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.15 -49.49 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.941 0.4 . . . . 0.0 111.864 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.91 6.39 4.29 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' HD22 ' A' ' 48' ' ' ASN . 1.0 OUTLIER 59.85 37.85 21.58 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.047 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.46 147.04 28.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.77 121.33 15.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.438 HD12 HG21 ' A' ' 37' ' ' ILE . 3.0 tm? -125.63 127.14 45.84 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.838 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.5 mm? -112.35 151.93 29.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HG3' HD11 ' A' ' 37' ' ' ILE . 2.7 mp0 -60.13 -39.44 86.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.535 0.334 . . . . 0.0 111.148 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -75.38 -15.21 60.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.772 0.32 . . . . 0.0 111.6 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.8 mm100 -83.08 -14.87 52.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 51' ' ' LEU . 93.8 mt -76.06 133.85 40.22 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.02 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -130.97 124.89 20.92 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.325 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.59 136.53 74.68 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 121.928 1.752 . . . . 0.0 110.367 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.73 136.67 41.77 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.305 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.24 104.08 16.69 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.675 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -97.51 8.59 44.35 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.566 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.44 2.62 47.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.395 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.607 ' O ' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.3 150.56 42.03 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.71 2.273 . . . . 0.0 111.855 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.67 -47.1 85.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.668 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 53.47 -127.84 37.66 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.22 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -136.36 120.69 18.0 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -126.52 174.24 8.8 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.917 0.389 . . . . 0.0 111.319 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.626 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 98.4 m-85 -106.54 29.48 6.86 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.938 0.875 . . . . 0.0 110.211 -174.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -96.48 136.7 36.62 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.897 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.2 t -86.49 107.59 14.31 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -63.16 -20.76 71.7 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.644 2.229 . . . . 0.0 113.251 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.0 -43.69 92.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.861 0.363 . . . . 0.0 111.018 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.0 p -101.15 -21.23 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.791 0.329 . . . . 0.0 111.488 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 60.27 22.35 11.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.977 0.911 . . . . 0.0 111.94 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -99.14 -71.65 0.69 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.808 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.13 -169.87 0.58 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 98.2 mt -97.0 107.98 20.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.764 0.316 . . . . 0.0 110.375 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 7.4 tpm_? -64.99 -49.66 69.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.695 174.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -116.11 -16.09 11.05 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.643 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.84 76.07 0.21 Allowed 'General case' 0 N--CA 1.462 0.139 0 O-C-N 123.862 0.726 . . . . 0.0 111.959 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.05 116.98 49.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.266 0.555 . . . . 0.0 110.919 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -71.8 125.89 28.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.933 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 p -89.66 158.76 44.88 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.44 -22.53 65.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.223 1.949 . . . . 0.0 113.56 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.57 -46.29 26.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.018 0.437 . . . . 0.0 110.966 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.68 48.94 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.346 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -139.92 163.17 33.37 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -124.86 137.6 54.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.08 0.467 . . . . 0.0 110.293 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.42 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.5 168.98 18.23 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.064 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 48.4 m -79.96 147.04 31.76 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' HD3' ' HB3' ' A' ' 59' ' ' ASP . 63.6 tttm -74.72 -3.58 32.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.256 0.55 . . . . 0.0 111.409 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.51 -18.57 12.38 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.957 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 43.9 m -85.07 -48.03 9.6 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.285 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.52 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.73 -42.27 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HA ' HG12 ' A' ' 37' ' ' ILE . 84.8 mt -63.48 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 111.633 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -77.25 -2.04 32.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 m -106.68 -24.21 12.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.8 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 42' ' ' HIS . 47.8 pt -105.1 -21.77 5.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -79.04 -15.45 58.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.887 -174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.16 -53.74 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.771 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.21 -65.34 0.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.562 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.43 139.65 5.49 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.866 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.545 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 71.3 m80 -79.55 67.05 5.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.698 0.761 . . . . 0.0 111.706 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -150.85 155.8 39.93 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.197 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.505 ' SG ' HD12 ' A' ' 51' ' ' LEU . 35.3 m -64.54 129.61 94.32 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.91 -21.81 56.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.989 1.793 . . . . 0.0 111.001 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.35 -74.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.553 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.14 4.52 53.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 62.5 m-80 54.61 32.99 18.21 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -88.39 155.26 19.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 50' ' ' ILE . 2.1 mp -65.73 117.39 6.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' SG ' ' A' ' 44' ' ' CYS . 7.8 tt -124.28 121.43 35.01 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.445 HD12 ' NE2' ' A' ' 55' ' ' GLN . 79.3 mt -111.36 145.22 39.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.255 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.39 -36.38 83.96 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.915 0.886 . . . . 0.0 110.466 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -64.79 -32.02 73.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.57 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' NE2' HD12 ' A' ' 52' ' ' LEU . 82.0 mt-30 -89.09 -8.64 53.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.41 141.16 41.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.759 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 98.4 m-85 -72.71 144.85 86.37 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.639 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 48.8 Cg_exo -60.21 146.04 97.22 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 122.767 2.311 . . . . 0.0 111.392 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.486 ' HB3' ' HD3' ' A' ' 30' ' ' LYS . 2.6 p30 -86.09 -176.12 5.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.282 0.563 . . . . 0.0 112.153 -175.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -102.3 14.35 32.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.791 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -140.73 150.2 43.13 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.937 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.72 -33.91 21.37 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.447 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 5.0 ttpm? . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.527 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -63.05 148.02 93.81 Favored 'Trans proline' 0 CA--C 1.515 -0.457 0 C-N-CA 123.211 2.607 . . . . 0.0 111.512 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -84.35 128.58 34.66 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.7 -154.72 32.81 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.941 -175.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.7 m -72.95 146.65 45.89 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.698 0.285 . . . . 0.0 110.83 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' A' ' 8' ' ' GLU . 62.5 tttp -86.69 125.51 33.92 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.441 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 97.0 m-85 -109.11 12.76 24.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.894 0.854 . . . . 0.0 110.253 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.5 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 42.1 tt0 -105.39 124.23 49.19 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.829 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.5 t -84.21 107.69 11.68 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.71 -18.46 47.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.423 2.082 . . . . 0.0 112.52 -174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.18 -43.58 91.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.292 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -100.53 -27.31 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.26 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.4 mt 63.89 23.09 13.25 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.778 0.831 . . . . 0.0 111.608 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.2 mtm -96.08 -71.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.497 0.665 . . . . 0.0 109.371 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.77 -158.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 91.7 mt -98.95 104.76 16.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -68.63 -43.85 75.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.983 0.421 . . . . 0.0 110.747 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 63.2 mm-40 -119.21 -15.99 9.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.641 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.76 81.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.795 0.684 . . . . 0.0 112.278 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.42 115.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.806 0.812 . . . . 0.0 110.787 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.61 129.05 34.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.375 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -101.05 154.47 37.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -22.11 70.24 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.639 2.226 . . . . 0.0 112.094 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.06 -14.65 60.61 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.647 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.96 25.67 16.64 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.032 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -113.01 152.9 28.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -131.1 122.28 26.42 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.82 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -130.12 -169.54 2.15 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.96 0.409 . . . . 0.0 110.861 -172.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.6 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -99.54 155.38 17.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.8 172.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.0 tttt -68.13 -12.57 61.13 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.239 0.616 . . . . 0.0 111.641 -176.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.96 -24.26 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.308 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 45.5 m -76.88 -51.37 11.37 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.322 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -68.59 -41.28 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.851 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 30' ' ' LYS . 82.5 mt -63.08 -43.31 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -79.86 -1.98 41.48 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.484 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -106.45 -8.94 16.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.691 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 33' ' ' ILE . 41.3 pt -117.43 -8.18 11.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -93.96 -15.3 25.04 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.702 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -116.61 -46.71 2.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.134 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.48 -65.98 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 110.308 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.43 160.01 23.45 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.461 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 65.1 m80 -86.21 77.48 9.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.377 0.608 . . . . 0.0 111.333 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -150.39 148.95 29.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.228 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -79.52 123.7 84.17 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.61 -27.5 76.34 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 123.136 2.558 . . . . 0.0 115.097 -166.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -67.56 -46.14 83.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -119.31 4.3 11.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.286 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 56.42 33.94 23.34 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 113.211 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -87.82 150.13 23.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.29 120.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.271 0.557 . . . . 0.0 110.558 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -125.56 121.81 34.72 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.361 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.62 148.66 23.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.662 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.24 -41.57 96.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.235 0.541 . . . . 0.0 110.007 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -65.11 -29.55 70.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.562 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -73.95 -7.64 53.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.48 136.04 52.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -119.15 148.39 44.92 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.53 150.36 87.86 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.251 1.967 . . . . 0.0 109.538 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.13 122.23 11.24 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -95.58 5.3 51.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -62.1 -46.42 89.14 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 119.896 -0.721 . . . . 0.0 109.226 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.61 129.08 50.62 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 tptm . . . . . 0 C--N 1.305 -1.363 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.739 -172.154 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.12 143.34 99.55 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.581 2.188 . . . . 0.0 110.548 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp 71.55 -48.92 0.68 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.302 1.041 . . . . 0.0 111.15 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.33 -168.08 41.2 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.2 m -100.38 87.1 3.32 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.277 0.561 . . . . 0.0 110.559 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' HG2' ' CD2' ' A' ' 7' ' ' TYR . 8.2 ttpm? -111.16 130.68 55.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.431 ' CD2' ' HG2' ' A' ' 6' ' ' LYS . 75.1 m-85 60.2 24.22 13.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.219 1.009 . . . . 0.0 110.327 -171.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -138.26 124.96 20.91 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 113.852 -1.522 . . . . 0.0 106.947 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.9 t -59.91 115.64 13.77 Favored Pre-proline 0 C--N 1.317 -0.818 0 C-N-CA 123.699 0.799 . . . . 0.0 111.25 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.427 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -62.42 -20.16 69.57 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.85 2.367 . . . . 0.0 112.739 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.438 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.7 mt -67.32 -44.39 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 111.599 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -110.9 -27.54 8.77 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 62.09 23.39 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.856 0.863 . . . . 0.0 112.159 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -95.64 -65.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.875 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.96 -172.12 1.49 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.647 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 97.1 mt -108.5 122.61 47.42 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -68.67 -44.18 74.57 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.55 -11.9 2.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.14 81.71 0.18 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.129 0.49 . . . . 0.0 111.906 -175.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 116.21 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.656 0.741 . . . . 0.0 111.19 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -81.64 134.8 35.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.343 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.76 162.24 33.88 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.73 -33.11 96.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.021 2.48 . . . . 0.0 112.1 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -72.55 -15.07 61.77 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.205 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.95 34.74 5.82 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.648 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -116.47 152.93 33.05 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -124.74 121.8 35.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.21 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 81.1 m-85 -131.04 173.55 10.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.943 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.647 ' SG ' ' HA ' ' A' ' 16' ' ' LEU . 62.2 m -84.12 147.95 27.06 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.5 tttt -78.06 7.69 5.8 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.0 0.905 . . . . 0.0 110.523 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.92 -32.14 5.87 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.38 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 48.5 m -78.3 -46.07 21.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.203 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.9 tp -66.01 -41.52 89.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.249 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.551 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.0 mt -63.54 -42.51 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.365 . . . . 0.0 110.859 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.61 -1.54 34.66 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.336 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -105.64 -21.29 13.23 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.942 -0.474 . . . . 0.0 110.037 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.662 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.4 pt -103.53 -20.36 5.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.9 ptm180 -105.74 3.19 28.63 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.665 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -118.75 -55.5 2.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.15 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.8 -79.08 0.4 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -140.06 138.19 8.93 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.454 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 9.3 t-80 -80.48 53.73 1.9 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.888 0.851 . . . . 0.0 110.879 -174.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.41 157.73 43.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.109 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.67 123.65 83.96 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.46 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.85 -25.34 74.48 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.022 2.482 . . . . 0.0 114.601 -171.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.95 -49.1 77.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.62 5.81 11.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.4 34.25 24.41 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -101.08 151.05 22.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.678 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.72 121.91 16.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 121.214 0.53 . . . . 0.0 110.79 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD12 HD13 ' A' ' 37' ' ' ILE . 2.9 tm? -112.88 124.75 53.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.241 -177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -105.35 140.25 38.76 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.44 -38.16 83.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 111.155 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -72.91 -15.45 61.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.29 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.5 mm100 -84.31 -7.53 59.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.86 137.99 55.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.719 0.295 . . . . 0.0 110.383 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -118.98 104.21 46.9 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.982 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.39 143.36 99.47 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.562 2.175 . . . . 0.0 111.302 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -113.72 144.74 42.44 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.962 0.411 . . . . 0.0 110.22 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.4 p30 -95.54 5.85 50.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.849 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.17 -47.29 86.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.692 0.282 . . . . 0.0 110.877 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.6 152.47 34.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 111.824 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm . . . . . 0 C--O 1.244 0.791 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.609 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.45 -28.81 71.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.942 2.428 . . . . 0.0 113.349 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.8 mt -113.08 134.43 54.54 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.7 106.69 1.88 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -93.6 115.41 27.89 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -170.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -66.74 -38.21 86.2 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 167.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -88.59 88.13 7.5 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.0 tt0 -150.97 142.92 23.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 50.9 t -89.79 107.98 22.52 Favored Pre-proline 0 N--CA 1.438 -1.063 0 O-C-N 123.798 0.686 . . . . 0.0 109.376 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 31.8 Cg_exo -63.43 -18.44 64.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.479 2.786 . . . . 0.0 111.951 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.22 -43.78 91.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.049 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 p -107.9 -22.76 12.31 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 64.02 21.22 12.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.213 0.605 . . . . 0.0 112.299 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 9.4 mmt -95.81 -68.36 0.8 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.421 0.629 . . . . 0.0 109.739 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.47 -159.11 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.1 128.94 55.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -76.35 -73.29 0.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.304 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.51 -15.21 25.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.42 84.3 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.951 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.85 117.63 49.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.455 0.645 . . . . 0.0 111.033 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.68 133.53 36.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.099 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 71.9 p -88.9 162.33 38.54 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 27.7 Cg_endo -60.16 -28.82 87.74 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.478 2.118 . . . . 0.0 112.937 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.6 p -72.09 -30.57 65.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 111.152 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.1 29.74 2.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.812 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -117.75 157.56 26.32 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -125.51 139.24 53.79 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.295 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.86 171.53 14.33 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.187 0.995 . . . . 0.0 108.605 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -78.32 150.55 33.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -70.81 -8.06 49.74 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.464 0.705 . . . . 0.0 111.609 -172.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.67 -34.13 5.29 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.507 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 61.5 m -65.66 -46.48 78.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.796 0.331 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.29 -41.26 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.553 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.19 -41.95 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.427 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -78.12 -3.18 41.11 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.539 0.685 . . . . 0.0 109.673 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 m -106.95 -20.4 13.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.201 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 33' ' ' ILE . 38.5 pt -104.31 -8.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.52 -3.36 46.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -116.46 -56.02 2.33 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.341 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.09 -67.26 0.75 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.28 166.93 37.8 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 72.2 m80 -91.13 76.9 6.06 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.917 0.865 . . . . 0.0 111.651 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.75 157.53 42.12 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.83 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.5 p -77.83 132.74 67.23 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.741 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.02 -25.49 73.75 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.665 2.244 . . . . 0.0 113.749 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.36 -59.96 2.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.56 3.86 27.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 55.26 34.03 21.91 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -78.75 151.45 32.04 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.347 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.98 121.03 15.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 7.8 tt -110.02 125.73 53.22 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.357 0.599 . . . . 0.0 110.593 -170.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.97 135.52 45.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.623 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -64.97 -38.7 91.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.924 0.392 . . . . 0.0 110.657 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -65.06 -31.5 72.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.231 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -81.53 -9.08 59.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD21 HD21 ' A' ' 51' ' ' LEU . 89.3 mt -69.88 116.62 10.46 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.5 t80 68.35 121.18 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.361 0 O-C-N 124.163 0.914 . . . . 0.0 109.449 -172.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.04 133.26 56.99 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 121.982 1.788 . . . . 0.0 110.971 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.43 112.86 22.6 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.829 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -98.06 140.82 31.82 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -60.24 -45.36 93.49 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 123.466 0.479 . . . . 0.0 111.16 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.46 111.88 23.62 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.967 0.413 . . . . 0.0 110.509 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.2 tptp . . . . . 0 C--N 1.308 -1.231 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.38 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.05 141.27 88.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.607 2.204 . . . . 0.0 110.992 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.5 tp -64.18 -45.27 89.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.001 0.429 . . . . 0.0 110.684 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.84 -159.37 46.24 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.7 m -79.79 153.49 29.13 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -80.61 83.24 6.44 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.31 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.757 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 92.5 m-85 -122.47 28.47 7.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.295 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -104.81 125.81 51.25 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.863 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.1 t -79.33 113.17 34.29 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.08 -19.91 70.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.951 2.434 . . . . 0.0 113.182 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.03 -44.62 88.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.4 p -104.13 -19.95 13.99 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 64.28 20.57 12.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.791 0.836 . . . . 0.0 111.219 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.1 mtm -102.5 -73.78 0.65 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.107 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.34 -173.24 1.42 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 93.6 mt -97.55 107.32 19.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -68.36 -45.13 73.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.159 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.544 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 70.5 mm-40 -113.02 -16.01 12.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.299 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . . . 57.75 81.79 0.14 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.998 0.811 . . . . 0.0 113.06 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -120.08 111.99 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.781 0.8 . . . . 0.0 111.616 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -81.55 132.95 35.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.807 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 p -94.23 159.35 34.25 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.605 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.0 -39.46 90.82 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.446 2.764 . . . . 0.0 113.003 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.6 p -71.96 -15.43 62.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 35.95 3.67 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.728 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -119.34 148.18 43.48 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.0 129.07 56.62 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.002 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -134.38 169.87 16.58 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.9 m -87.4 147.69 25.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 23.8 ttpp -78.5 -2.28 37.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.143 0.497 . . . . 0.0 111.716 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.64 -10.95 13.05 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.029 -0.419 . . . . 0.0 110.012 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.9 m -89.03 -48.21 7.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.505 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.6 -41.78 83.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.09 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.662 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.2 mt -63.5 -42.53 96.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.547 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.23 -1.5 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.45 0.643 . . . . 0.0 109.997 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.1 t -105.8 -22.78 12.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 33' ' ' ILE . 43.7 pt -102.9 -12.14 8.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 40.5 ptt85 -99.68 3.43 45.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.702 0.763 . . . . 0.0 109.306 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -116.68 -46.65 2.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.648 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.59 -66.9 0.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.256 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -175.52 167.32 39.19 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 63.0 m80 -84.33 67.18 9.74 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.895 0.855 . . . . 0.0 111.906 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -151.09 150.32 30.55 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.584 -1.189 . . . . 0.0 107.888 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.9 p -71.54 123.41 89.35 Favored Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.73 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.64 -25.21 75.19 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.644 2.229 . . . . 0.0 113.27 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.456 HG23 ' OD1' ' A' ' 47' ' ' ASP . 27.1 m -73.09 -33.0 41.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.456 ' OD1' HG23 ' A' ' 46' ' ' VAL . 15.0 p-10 -141.74 6.48 1.83 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 58.15 35.42 25.05 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.6 mm-40 -92.7 142.67 27.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -65.95 121.47 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 111.142 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.3 tp -122.68 131.78 53.96 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.513 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.629 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -106.68 150.97 25.71 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.68 -34.88 78.84 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.43 0.34 55.64 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.629 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.3 mm100 -77.72 -16.27 58.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.824 0.821 . . . . 0.0 109.344 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.31 161.02 29.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.459 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 58' ' ' PRO 0.254 19.4 p90 66.01 135.43 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 125.908 1.683 . . . . 0.0 115.069 172.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 57' ' ' PHE . 34.1 Cg_exo -63.39 141.16 80.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.098 1.865 . . . . 0.0 109.628 170.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 61' ' ' PHE . 4.3 p-10 -78.68 153.89 30.59 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 75.33 -22.29 0.27 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.49 0.716 . . . . 0.0 111.043 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.422 ' H ' ' C ' ' A' ' 59' ' ' ASP . 91.5 t80 -61.07 -47.52 85.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.58 0.752 . . . . 0.0 111.666 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.88 78.46 1.12 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.715 0.769 . . . . 0.0 109.564 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? . . . . . 0 C--N 1.301 -1.537 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -177.199 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.841 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.61 147.31 76.06 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.388 2.059 . . . . 0.0 111.962 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 tt -112.41 123.22 49.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.89 -46.5 0.02 OUTLIER Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.371 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.3 m -95.74 37.34 1.22 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.184 0.516 . . . . 0.0 109.863 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -79.45 111.15 15.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.05 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 93.8 m-85 -113.87 10.31 17.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.641 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -101.3 120.3 40.05 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.504 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.497 ' HB2' HD23 ' A' ' 16' ' ' LEU . 49.7 t -70.56 111.02 8.12 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.79 -19.73 52.84 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.195 1.93 . . . . 0.0 113.049 -172.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.15 -44.68 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.031 0.443 . . . . 0.0 111.808 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.0 p -108.14 -20.16 13.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.773 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt 69.51 22.83 6.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.279 1.032 . . . . 0.0 110.885 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -112.38 169.56 8.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.944 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 154.72 27.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 88.8 mt -71.08 119.17 14.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -176.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -75.46 -47.65 26.27 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.843 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 30' ' ' LYS . 50.9 mm-40 -113.85 -16.34 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.775 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.3 58.93 4.98 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.89 0.876 . . . . 0.0 112.981 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.34 115.68 27.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.442 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 27' ' ' ARG . 60.4 tt0 -81.61 135.35 35.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.897 -177.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -96.86 158.25 33.77 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.61 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.9 -23.19 74.22 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.862 2.375 . . . . 0.0 112.894 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.0 p -72.44 -28.13 62.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.91 40.72 1.05 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.491 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 59.9 m80 -127.07 160.74 30.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.674 0.273 . . . . 0.0 110.773 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 21' ' ' GLN . 31.5 mmt180 -125.6 136.59 53.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.435 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.4 m-85 -137.72 164.57 28.53 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.406 0.441 . . . . 0.0 110.012 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -85.45 157.52 20.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 87.2 tttt -68.47 -15.2 63.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -1.3 14.19 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.194 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 42.7 m -94.98 -54.2 3.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.893 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.44 -41.14 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.988 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.4 mt -63.23 -42.59 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.682 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -77.68 -1.28 30.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.385 0.612 . . . . 0.0 109.87 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -105.86 -19.98 13.58 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 122.018 -0.426 . . . . 0.0 109.958 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -103.79 -15.16 8.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.47 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -104.88 0.81 28.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.348 0.594 . . . . 0.0 110.498 173.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -116.97 -49.81 2.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.512 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.56 -66.23 0.94 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.518 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -177.86 162.16 29.68 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.33 81.68 3.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 111.176 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -173.71 155.63 2.72 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 4.9 p -76.47 126.06 86.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.275 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.96 -29.42 81.96 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.787 2.325 . . . . 0.0 114.726 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -77.16 -57.54 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -102.56 5.3 39.24 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 49.71 43.2 24.39 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 71.6 mm-40 -90.73 142.82 27.36 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.66 120.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.198 0.523 . . . . 0.0 109.876 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -124.36 130.72 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.158 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -107.64 152.51 24.21 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.87 -36.4 83.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.918 0.39 . . . . 0.0 111.551 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -69.58 -17.78 63.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.902 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.1 mm100 -68.32 -25.51 65.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.896 0.379 . . . . 0.0 111.463 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.67 148.68 47.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.896 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -60.83 158.98 29.28 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -60.02 146.92 94.89 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.796 2.331 . . . . 0.0 110.873 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -78.1 112.07 14.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.728 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -65.41 -41.12 93.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.502 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -111.76 106.95 15.87 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.115 0.483 . . . . 0.0 111.162 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.12 102.96 8.66 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.584 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 tttm . . . . . 0 C--N 1.312 -1.03 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.295 -177.477 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.89 144.49 99.58 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.661 2.241 . . . . 0.0 111.867 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.6 tp -111.47 112.94 25.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.22 -55.01 3.59 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.2 m -153.03 165.45 35.56 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -111.56 152.86 27.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.236 0.541 . . . . 0.0 111.222 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.478 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 97.3 m-85 -108.23 19.85 19.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.861 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -101.36 127.13 48.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.46 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.4 t -72.95 114.86 34.62 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.64 -19.22 54.17 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.221 1.948 . . . . 0.0 113.875 -170.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.12 -44.78 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.245 0.545 . . . . 0.0 112.057 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 6.7 p -108.46 -17.38 14.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 63.18 46.25 4.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.696 0.76 . . . . 0.0 111.076 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.51 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 23.9 ptp -144.4 176.44 9.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.709 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.19 46.78 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.179 0.299 . . . . 0.0 111.005 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.605 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 65.8 mt -70.31 129.42 39.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.713 -174.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -71.27 -46.46 60.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -113.96 -15.2 12.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.254 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.413 ' HA ' HD13 ' A' ' 16' ' ' LEU . . . 58.26 87.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.903 0.752 . . . . 0.0 112.727 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.22 118.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.074 0.464 . . . . 0.0 111.295 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.421 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 29.5 tt0 -79.76 139.31 37.32 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.12 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.471 HG21 HD11 ' A' ' 51' ' ' LEU . 41.5 p -97.69 159.41 31.08 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.73 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 29.1 Cg_endo -60.56 -25.16 80.12 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.157 2.571 . . . . 0.0 114.101 -177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -87.53 -14.76 39.42 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.495 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.44 36.3 2.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.119 -1.039 . . . . 0.0 114.483 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -117.97 152.93 34.51 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HB3' HD11 ' A' ' 16' ' ' LEU . 84.7 mtt85 -108.57 132.98 53.32 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.29 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.5 165.2 26.06 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.156 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 35.3 m -79.13 154.27 29.47 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 167.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.27 -11.29 60.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.473 0.654 . . . . 0.0 110.707 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 2.73 15.74 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.225 0.536 . . . . 0.0 109.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 74.2 m -98.08 -56.87 2.36 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.255 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -67.95 -41.25 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.5 mt -62.61 -42.21 95.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 111.011 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -78.32 -1.39 32.98 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.526 0.679 . . . . 0.0 110.741 -177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 m -106.04 -21.76 13.05 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.965 -0.459 . . . . 0.0 111.135 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 33' ' ' ILE . 33.3 pt -104.26 -9.62 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptp180 -101.5 2.85 39.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.209 0.528 . . . . 0.0 111.101 172.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -115.91 -47.22 2.8 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.573 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -75.07 0.35 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.719 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.3 169.6 42.19 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 65.4 m80 -83.97 69.03 10.24 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.65 0.725 . . . . 0.0 112.38 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -152.04 151.23 30.87 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.431 ' HB3' HD12 ' A' ' 51' ' ' LEU . 32.0 p -83.51 146.14 49.59 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.703 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.71 -18.52 58.69 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.703 2.269 . . . . 0.0 112.526 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.74 -74.31 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -106.73 4.57 27.84 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.901 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 57.59 29.06 16.57 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -78.17 147.25 34.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.31 121.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.317 0.58 . . . . 0.0 109.846 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 22' ' ' THR . 6.8 tt -117.05 120.5 38.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.735 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.44 143.14 32.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.248 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.99 -40.57 91.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.103 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.36 -29.96 67.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.995 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -73.22 -8.61 56.56 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.432 HD21 HD21 ' A' ' 51' ' ' LEU . 96.5 mt -65.17 137.87 57.9 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.421 ' HD1' ' O ' ' A' ' 21' ' ' GLN . 50.8 m-85 -62.94 134.61 95.76 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -61.11 142.2 96.25 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 C-N-CA 122.686 2.257 . . . . 0.0 114.376 -160.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -119.8 109.87 16.1 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.135 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -103.49 134.31 47.06 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.095 0.474 . . . . 0.0 110.789 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -151.78 160.62 43.51 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.32 110.81 9.72 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 120.963 0.411 . . . . 0.0 110.432 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.106 -178.516 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.113 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.41 150.8 64.78 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 123.003 2.469 . . . . 0.0 112.536 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.8 tt -109.26 125.26 52.09 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.0 -143.45 7.69 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.805 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 p -65.23 -33.77 76.77 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.507 0.723 . . . . 0.0 112.546 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -70.28 133.44 47.01 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -92.2 126.64 37.37 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.23 0.538 . . . . 0.0 111.29 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 99.7 mt-10 -131.74 157.13 44.62 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.7 t -82.62 107.31 8.74 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.677 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 41.9 Cg_exo -60.32 -21.06 65.63 Favored 'Trans proline' 0 N--CA 1.475 0.391 0 C-N-CA 122.965 2.443 . . . . 0.0 113.185 -172.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.28 -44.16 91.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.2 p -112.74 -9.11 13.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 55.56 37.05 28.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.696 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.3 mtm -121.34 168.54 11.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.625 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.5 154.79 19.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.29 123.95 22.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.614 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -69.63 -44.18 71.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.846 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -126.44 -17.14 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.962 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.81 81.7 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 m -105.83 117.51 51.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.862 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -81.59 131.78 35.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -90.16 152.43 45.97 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.11 -22.49 73.22 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.433 2.088 . . . . 0.0 112.376 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.668 ' SG ' HD21 ' A' ' 51' ' ' LEU . 30.9 p -79.82 -17.29 53.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.702 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.43 40.67 1.59 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.361 -0.924 . . . . 0.0 113.907 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.472 ' HE1' ' OD1' ' A' ' 47' ' ' ASP . 65.6 m80 -133.28 161.37 34.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -128.32 137.74 52.08 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.677 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.4 m-85 -137.78 170.43 16.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.078 0.466 . . . . 0.0 111.357 -173.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 21.0 m -76.74 160.18 29.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' HD12 ' A' ' 34' ' ' ILE . 23.1 tptm -71.16 -15.35 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.707 0.289 . . . . 0.0 111.291 -171.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.33 -1.47 12.31 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.519 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 75.1 m -88.26 -65.06 1.06 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.501 ' HB ' ' CG ' ' A' ' 28' ' ' PHE . 11.1 tp -67.78 -38.89 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.2 mt -62.54 -42.84 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.96 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -78.82 -2.02 37.68 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.464 0.65 . . . . 0.0 110.5 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -105.4 -23.24 12.87 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.72 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.7 pt -102.92 -14.14 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.932 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.8 ptm180 -102.32 1.61 35.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.746 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.57 -56.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.0 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.04 -68.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.276 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -151.59 147.39 17.21 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -84.63 34.09 0.53 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.783 0.801 . . . . 0.0 111.121 -171.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -144.14 154.94 43.69 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.636 ' HB3' HD11 ' A' ' 51' ' ' LEU . 25.8 p -64.29 130.06 94.41 Favored Pre-proline 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.078 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.2 -18.94 62.4 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.442 2.094 . . . . 0.0 111.379 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.79 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.104 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.472 ' OD1' ' HE1' ' A' ' 26' ' ' HIS . 51.1 p-10 -117.37 15.93 14.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 63.69 35.09 11.69 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.612 ' OE1' ' HB2' ' A' ' 24' ' ' CYS . 57.9 mt-10 -89.86 139.56 30.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 mm -66.56 122.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.099 0.476 . . . . 0.0 111.313 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 ' SG ' ' A' ' 24' ' ' CYS . 77.1 mt -112.69 128.98 56.55 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.058 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.2 133.37 50.08 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -61.42 -38.04 85.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -74.72 -13.33 60.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.507 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.62 -9.07 55.32 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -73.32 136.13 44.44 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -80.78 121.54 81.15 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.85 155.55 68.74 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.347 2.032 . . . . 0.0 111.705 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -47.54 104.46 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.226 0.954 . . . . 0.0 111.78 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -101.32 -17.6 16.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.183 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -86.29 131.03 34.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.273 0.558 . . . . 0.0 111.222 -172.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.82 138.77 35.48 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.994 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.6 pttt . . . . . 0 C--N 1.298 -1.656 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.76 -176.962 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.719 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.51 158.78 43.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.847 2.365 . . . . 0.0 111.373 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.53 127.25 45.6 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.35 -123.07 2.54 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -132.48 145.78 51.43 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 6' ' ' LYS . 25.9 tptp -92.74 -7.51 46.42 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 171.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 95.1 m-85 -83.69 38.22 0.62 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.692 170.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -122.98 128.15 49.82 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.244 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 t -76.43 112.1 19.49 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.6 Cg_exo -61.02 -19.4 62.9 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.027 2.484 . . . . 0.0 113.222 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.91 -43.98 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.45 -25.55 10.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp 66.22 23.68 10.84 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.886 0.874 . . . . 0.0 112.087 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -93.54 -67.41 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.587 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.96 -167.72 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 93.6 mt -98.69 106.27 18.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -68.92 -43.83 74.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 0.0 110.377 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 66.8 mm-40 -124.01 -15.16 6.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.101 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.43 83.16 0.05 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.853 0.861 . . . . 0.0 113.301 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.36 118.88 59.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 0.0 111.06 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 52.3 tt0 -80.65 128.42 33.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 51.2 p -80.93 164.69 49.54 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 25.3 Cg_endo -59.94 -28.03 86.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.551 2.168 . . . . 0.0 112.331 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.484 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.5 p -79.9 -15.69 56.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.804 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.59 45.78 2.44 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.392 -0.909 . . . . 0.0 114.325 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 89.0 m-70 -120.58 154.25 35.66 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -105.1 124.76 50.09 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 123.315 0.384 . . . . 0.0 110.325 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 92.4 m-85 -134.66 170.39 15.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.088 0.555 . . . . 0.0 110.105 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 40.0 m -85.32 150.15 24.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.474 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 62.5 tttp -68.39 -11.55 59.79 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.871 0.469 . . . . 0.0 111.136 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.18 -14.28 13.4 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.881 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.8 m -87.12 -46.57 9.66 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.896 174.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -68.17 -42.01 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.734 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.638 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.8 mt -63.5 -42.54 96.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 0.0 110.468 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.8 7.67 6.67 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.805 0.812 . . . . 0.0 110.342 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.9 t -106.83 -27.35 10.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.941 -0.475 . . . . 0.0 109.936 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 37.5 pt -104.37 -16.83 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.638 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -98.59 4.78 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -115.59 -56.56 2.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.728 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.9 -68.36 0.8 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.88 169.09 41.89 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.573 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 53.9 m80 -83.41 74.39 10.08 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.656 0.741 . . . . 0.0 111.978 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -150.88 155.28 38.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.812 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.7 t -67.72 129.04 93.51 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.94 -23.77 61.37 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.906 2.404 . . . . 0.0 114.156 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.58 -52.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -105.81 4.03 29.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.107 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 56.87 31.76 20.23 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -78.71 145.79 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -66.12 122.52 17.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.272 0.558 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 60.4 tp -121.06 128.5 52.69 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.239 -171.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.29 146.5 34.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.791 0.329 . . . . 0.0 110.329 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.01 -37.37 87.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.871 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -19.49 63.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.97 0.414 . . . . 0.0 111.514 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.19 -8.0 58.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.844 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.5 mt -76.3 124.32 27.32 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.074 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.4 160.97 64.76 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.56 150.28 86.08 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 122.66 2.24 . . . . 0.0 110.636 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -51.81 134.87 30.57 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -75.69 94.43 3.24 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -166.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.17 -2.87 20.44 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 164.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.42 136.35 47.66 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.167 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? . . . . . 0 C--N 1.298 -1.664 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.405 179.578 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.904 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.85 144.44 96.76 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 122.675 2.25 . . . . 0.0 110.911 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.85 125.84 29.66 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.897 0.38 . . . . 0.0 110.393 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.45 -17.47 59.22 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.963 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.8 m -102.85 108.84 20.2 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.882 0.372 . . . . 0.0 110.179 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -146.81 150.64 35.69 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.774 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.704 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 95.6 m-85 -110.49 15.26 22.24 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.031 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.96 112.15 20.93 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.764 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -64.17 111.65 5.92 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.84 -19.45 58.75 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.061 . . . . 0.0 113.429 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.62 -44.52 89.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.014 0.435 . . . . 0.0 110.945 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -101.52 -23.65 14.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.2 mt 64.48 22.77 12.79 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 111.118 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.6 mtm -96.16 -68.33 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.933 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.33 -161.35 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 95.3 mt -102.92 107.32 18.1 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 6.0 tpm_? -68.05 -44.67 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.828 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -114.92 -16.34 11.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.22 74.5 0.39 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.077 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 20.7 m -104.93 113.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.425 0.631 . . . . 0.0 110.47 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.62 142.08 32.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -101.14 159.48 29.35 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.22 -19.95 66.43 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.419 2.079 . . . . 0.0 110.979 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.1 t -75.18 -14.29 60.53 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.972 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 18.99 48.47 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.29 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -106.32 141.42 37.67 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -104.38 133.88 48.52 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -139.43 172.27 13.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.487 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 36.0 m -89.25 154.16 20.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.03 -12.91 61.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 122.922 0.489 . . . . 0.0 111.963 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.38 -13.9 12.24 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.41 -176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 44.0 m -84.64 -54.77 4.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.985 0.421 . . . . 0.0 110.689 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.16 -41.85 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -172.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.656 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.48 -43.66 98.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.789 0.328 . . . . 0.0 111.163 -175.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -81.73 1.99 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.204 0.526 . . . . 0.0 111.09 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.1 t -105.06 -22.21 13.14 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.8 pt -103.26 -25.68 3.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.656 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -98.61 3.83 47.97 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.312 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.08 -56.52 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.745 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -71.09 0.55 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.556 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.692 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -142.33 132.04 4.97 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.3 30.12 0.48 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.971 0.891 . . . . 0.0 111.39 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -142.54 153.88 43.96 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 16.8 p -63.0 124.51 83.99 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 120.859 0.362 . . . . 0.0 110.065 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.31 -22.11 73.63 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.909 2.406 . . . . 0.0 114.169 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.427 HG23 ' OD1' ' A' ' 47' ' ' ASP . 28.6 m -79.21 -51.89 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.427 ' OD1' HG23 ' A' ' 46' ' ' VAL . 11.5 p-10 -117.47 7.15 12.67 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 62.02 37.02 15.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.5 mm-40 -93.94 139.5 30.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.673 0.273 . . . . 0.0 111.303 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.78 121.91 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.631 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.3 tp -117.66 131.65 56.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.672 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.41 139.89 41.19 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.81 -38.62 82.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.418 0.449 . . . . 0.0 111.401 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -63.25 -30.15 71.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.464 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -73.81 -8.75 57.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.42 124.56 25.41 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -131.43 122.44 18.93 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 46.2 Cg_exo -60.14 126.25 19.7 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 121.754 1.636 . . . . 0.0 111.844 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.01 -34.32 61.92 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -73.94 112.79 10.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.232 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -79.18 152.24 30.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.684 0.278 . . . . 0.0 111.368 -172.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.16 99.09 3.29 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.796 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 C--N 1.308 -1.2 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.6 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.42 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -60.81 145.4 99.04 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.663 2.242 . . . . 0.0 111.719 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.94 127.57 32.17 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.834 0.35 . . . . 0.0 110.336 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.65 -157.66 53.57 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.949 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.7 p -79.63 151.19 30.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.792 0.33 . . . . 0.0 110.553 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HG3' ' H ' ' A' ' 8' ' ' GLU . 18.0 tppt? -107.57 130.76 54.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.876 0.369 . . . . 0.0 110.292 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.427 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.3 m-85 -108.69 14.58 24.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.654 0.74 . . . . 0.0 111.057 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 43.9 tt0 -123.28 119.44 30.16 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.901 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB2' HD23 ' A' ' 16' ' ' LEU . 42.9 t -59.19 107.88 1.14 Allowed Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.753 0.658 . . . . 0.0 109.972 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.454 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.2 Cg_exo -65.51 -20.24 60.69 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.839 2.359 . . . . 0.0 112.405 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.03 -44.01 92.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.775 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -98.95 -26.78 14.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.136 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 65.5 21.17 11.79 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.192 0.997 . . . . 0.0 111.426 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.9 mtm -98.3 -67.23 0.86 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.518 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.51 -172.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 9' ' ' CYS . 88.5 mt -100.86 108.47 20.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -73.67 -45.29 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.042 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 48.8 mm-40 -104.93 -19.0 13.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.701 -175.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.43 71.58 0.27 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.224 -173.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -99.77 113.21 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.663 0.744 . . . . 0.0 109.72 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.08 135.43 35.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.815 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 p -89.7 162.37 36.29 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.01 -27.81 85.72 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.361 2.041 . . . . 0.0 112.819 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -75.8 -14.97 60.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.98 36.1 5.1 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -117.05 151.89 35.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -117.15 135.94 53.39 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.278 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.454 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.3 m-85 -137.87 172.6 12.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.468 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.8 m -83.94 149.06 26.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 62.0 tttp -67.64 -12.82 61.31 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 120.942 0.401 . . . . 0.0 111.427 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.29 -16.79 12.89 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.435 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 47.2 m -81.59 -46.78 13.92 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.9 tp -68.95 -42.21 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.5 mt -63.25 -42.74 97.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.893 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.62 2.95 20.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.524 0.678 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -107.01 -22.77 12.55 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.05 -0.406 . . . . 0.0 111.104 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.0 pt -103.41 -19.0 6.41 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -105.22 7.97 33.8 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.656 0.741 . . . . 0.0 109.908 172.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -116.48 -56.02 2.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.373 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.63 -66.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.75 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.56 160.16 33.56 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -79.47 73.51 6.13 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.807 0.804 . . . . 0.0 111.616 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -153.36 150.73 29.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.46 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.0 129.41 86.47 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.87 -20.84 68.88 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.031 2.488 . . . . 0.0 113.649 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.414 HG23 ' OD1' ' A' ' 47' ' ' ASP . 14.9 m -82.15 -59.81 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 46' ' ' VAL . 16.2 p-10 -107.42 4.81 26.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 56.84 32.32 21.17 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -88.47 147.79 24.49 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.103 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 50' ' ' ILE . 3.2 mp -66.45 119.98 12.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.302 0.573 . . . . 0.0 110.297 -175.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.27 128.88 54.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.058 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.93 144.67 30.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.9 -41.55 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.752 0.821 . . . . 0.0 110.896 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -66.51 -31.28 71.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -77.22 -8.86 58.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -170.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.47 135.0 52.4 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -76.04 155.38 84.57 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.9 148.76 87.33 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 123.15 2.567 . . . . 0.0 112.227 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -58.33 106.91 0.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.947 0.879 . . . . 0.0 112.131 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -69.36 -40.29 77.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.24 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -77.68 137.58 38.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.327 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.82 139.86 56.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 ttmm . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.597 -174.082 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.012 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.63 -30.96 93.67 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.145 2.563 . . . . 0.0 112.404 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.5 tp -110.73 131.93 54.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.776 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.45 -111.6 1.71 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.9 p -77.41 139.92 39.79 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -126.97 144.5 50.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 111.92 -174.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.4 m-85 -109.74 18.19 20.47 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 172.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -126.46 144.5 50.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.902 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.0 t -75.58 111.58 15.04 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 123.401 0.681 . . . . 0.0 109.621 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.5 Cg_exo -63.67 -20.44 69.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 112.903 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.93 -44.39 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.64 -23.38 13.85 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.371 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.04 22.23 7.13 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.829 0.851 . . . . 0.0 111.601 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.66 -49.77 5.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.201 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 172.7 -165.63 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.2 mt -103.56 125.65 50.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -80.08 -76.55 0.22 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.686 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -90.21 -15.32 31.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.4 84.24 0.14 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.622 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.545 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 32.8 m -105.49 116.89 50.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.291 0.567 . . . . 0.0 111.077 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -80.88 134.99 35.84 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.36 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -101.49 156.2 35.46 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.69 -22.86 74.34 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -77.23 -14.02 59.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.01 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.17 29.52 6.03 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.096 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -112.92 148.22 35.43 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -107.59 128.59 54.67 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 88.7 m-85 -131.89 -174.74 3.51 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.4 m -99.54 159.15 15.24 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.84 0.352 . . . . 0.0 110.134 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.42 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.9 tttt -77.06 -9.94 59.05 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.566 0.747 . . . . 0.0 110.731 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.22 -6.98 13.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.165 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 85.7 m -91.26 -61.54 1.63 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.795 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -67.44 -40.91 85.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.944 -174.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.0 mt -62.89 -42.39 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 110.454 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 38.5 ttpt -79.57 1.07 27.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.721 0.772 . . . . 0.0 110.865 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -104.48 -24.77 12.99 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.5 pt -102.62 -7.05 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.7 ptm180 -99.55 2.81 45.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.033 0.444 . . . . 0.0 110.147 172.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -122.37 -56.13 1.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.072 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.35 -66.37 0.91 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.186 0.517 . . . . 0.0 110.785 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -170.65 163.96 37.15 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -85.1 73.56 10.63 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.712 0.768 . . . . 0.0 110.846 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 19.4 ptpt -149.28 151.38 34.09 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.967 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.78 123.84 90.04 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.17 -24.96 65.5 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 113.138 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.12 -57.39 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -108.13 5.7 26.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 56.74 31.77 19.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.309 1.044 . . . . 0.0 113.638 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -83.99 147.46 27.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mm -66.56 120.77 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.25 0.548 . . . . 0.0 109.615 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 43' ' ' LYS . 67.1 tp -122.46 126.27 47.55 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.965 -174.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.82 156.03 19.6 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -66.13 -35.66 81.08 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.21 0.528 . . . . 0.0 110.124 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.26 -20.76 63.93 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.019 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -82.38 -11.43 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.104 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.59 143.59 44.33 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.545 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 93.1 m-85 72.54 156.34 0.16 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 123.938 0.895 . . . . 0.0 109.119 -173.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.56 138.15 81.94 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.36 1.373 . . . . 0.0 110.016 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -86.77 1.73 51.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.164 0.507 . . . . 0.0 111.735 -171.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -79.26 -12.66 59.95 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.7 t80 55.17 79.49 0.15 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.971 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.479 ' C ' ' HD2' ' A' ' 63' ' ' LYS . . . -139.55 131.54 27.82 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' HD2' ' C ' ' A' ' 62' ' ' ALA . 3.7 mptp? . . . . . 0 C--N 1.305 -1.328 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.019 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.88 118.64 5.53 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 121.931 1.754 . . . . 0.0 110.689 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.9 tt 46.89 85.53 0.02 OUTLIER 'General case' 0 C--O 1.246 0.9 0 O-C-N 124.358 1.036 . . . . 0.0 109.61 -170.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.1 67.58 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.926 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 m -131.75 156.04 46.64 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -66.28 125.24 24.97 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.25 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 50.27 78.27 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.652 0.781 . . . . 0.0 112.139 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 45.1 tt0 -129.72 131.12 46.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.202 -174.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 t -83.89 111.5 33.21 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.06 -18.52 56.88 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.735 2.29 . . . . 0.0 113.708 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.45 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.789 0.328 . . . . 0.0 111.088 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.47 -20.79 14.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.921 0.391 . . . . 0.0 111.212 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.3 mt 64.03 21.34 12.56 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.294 1.037 . . . . 0.0 112.177 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.9 mtm -95.74 -66.88 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.221 0.534 . . . . 0.0 111.165 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -174.93 -173.43 0.69 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.98 125.68 36.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -79.39 -75.26 0.25 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 56.1 mp0 -91.29 -16.79 26.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.91 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.24 84.74 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.038 0.935 . . . . 0.0 112.445 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -115.31 117.69 56.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.184 0.516 . . . . 0.0 110.431 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 22' ' ' THR . 52.8 tt0 -82.82 146.45 28.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.498 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 70.8 p -92.3 159.31 37.44 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -56.47 -38.43 95.36 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.74 2.294 . . . . 0.0 112.323 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -67.53 -36.71 81.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.696 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.04 48.51 0.21 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.883 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 36.0 m-70 -124.65 145.01 49.88 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.3 mtm-85 -114.25 132.4 56.15 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.205 0.526 . . . . 0.0 111.874 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.89 171.66 14.17 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.868 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.525 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.1 m -79.63 150.7 30.91 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -72.73 -9.23 58.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.347 0.594 . . . . 0.0 110.97 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.57 -14.92 12.62 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.975 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.6 m -84.69 -46.64 11.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.417 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.6 -42.09 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.943 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.1 mt -63.14 -42.35 96.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.629 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -77.43 -1.92 32.66 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.402 0.62 . . . . 0.0 109.939 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -104.99 -23.69 12.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.205 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.49 -7.3 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -97.85 0.05 45.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.546 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -139.55 -56.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.83 -65.86 0.94 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.271 0.558 . . . . 0.0 111.132 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.38 136.57 5.27 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.406 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 6.0 t-80 -83.31 52.73 2.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.527 0.68 . . . . 0.0 109.542 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -147.24 156.17 42.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.266 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.32 123.35 75.1 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.62 -24.15 69.83 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.955 2.437 . . . . 0.0 114.428 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.59 -48.66 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -118.78 5.79 11.51 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.979 -0.451 . . . . 0.0 111.653 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 57.47 33.08 22.79 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.437 0.695 . . . . 0.0 112.807 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -87.27 145.18 26.47 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.491 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.21 121.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.59 130.27 56.29 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.105 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.54 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -109.38 146.87 33.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.18 -33.51 73.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.489 0.716 . . . . 0.0 109.651 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.517 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.8 mm100 -77.67 -14.7 59.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.847 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.55 137.56 48.16 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 120.744 0.306 . . . . 0.0 110.41 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -71.9 163.13 69.27 Favored Pre-proline 0 C--O 1.246 0.918 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.285 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -60.55 145.67 98.37 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.441 2.094 . . . . 0.0 111.552 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 18' ' ' GLU . 6.6 p-10 -70.38 148.62 48.2 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.962 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -91.86 -8.52 46.25 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.097 0.475 . . . . 0.0 110.778 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -64.85 -47.15 78.95 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.129 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.09 100.18 12.46 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.961 0.41 . . . . 0.0 111.348 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 N--CA 1.44 -0.945 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.868 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.67 151.03 63.6 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.585 2.19 . . . . 0.0 111.721 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.69 115.16 27.42 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.54 -51.15 0.58 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.8 m -133.35 149.41 51.88 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.707 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -88.62 -4.43 58.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.663 177.421 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -75.84 78.76 2.76 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 166.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.04 128.5 22.78 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.941 -170.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 t -92.78 113.65 60.26 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.79 -18.92 63.9 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.599 2.199 . . . . 0.0 113.575 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.2 -43.91 91.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.839 0.352 . . . . 0.0 111.181 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.9 p -101.7 -21.22 14.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.798 0.332 . . . . 0.0 111.325 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt 59.51 23.03 11.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.001 0.92 . . . . 0.0 111.907 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.8 mtm -95.32 -68.54 0.8 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.672 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.74 -165.59 0.32 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.06 124.08 47.05 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.35 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 8.8 tpt180 -78.4 -61.13 2.1 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.169 174.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 69.9 mm-40 -108.42 -15.05 14.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.338 -176.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.91 73.87 0.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.959 0.787 . . . . 0.0 112.335 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.32 116.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 110.684 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -81.2 139.95 35.22 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.004 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 p -98.46 158.67 32.19 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.7 -34.63 91.27 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.092 2.528 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -15.34 61.93 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.47 42.18 3.01 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.715 -0.755 . . . . 0.0 114.006 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -127.47 141.13 51.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.12 136.86 42.96 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.119 0.485 . . . . 0.0 111.6 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -133.68 173.3 11.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.651 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.589 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -86.03 149.63 25.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 66.0 tttm -68.51 -12.2 60.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.37 0.668 . . . . 0.0 111.606 -176.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.25 -5.62 12.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.992 0.425 . . . . 0.0 110.143 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 79.5 m -92.59 -58.68 2.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.625 175.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -65.93 -42.43 91.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.836 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.616 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.51 -43.19 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.674 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -80.34 -1.5 41.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.599 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -105.54 -20.09 13.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.9 pt -102.1 -19.83 5.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.953 -175.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.8 ptm180 -100.87 2.79 41.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.614 0.721 . . . . 0.0 110.254 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -115.96 -46.57 2.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.78 -70.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 0.0 110.466 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.54 155.27 26.35 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 62.3 m80 -80.1 68.58 6.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.963 0.887 . . . . 0.0 112.358 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.27 153.89 34.64 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.02 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.5 p -79.35 123.42 84.53 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.786 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.18 -21.41 67.6 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.142 2.562 . . . . 0.0 113.942 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.2 m -78.54 -52.55 15.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -112.03 4.85 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 57.73 35.26 25.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.456 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 62.3 mm-40 -94.51 148.26 22.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.41 121.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.35 127.43 49.77 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.013 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.6 mm? -106.28 150.34 26.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.475 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.69 -37.97 89.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.3 -27.41 67.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.818 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.6 mm100 -73.75 -8.47 56.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 -174.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.7 mt -70.01 137.69 51.57 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.171 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.74 120.18 42.94 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.166 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.01 158.02 58.01 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.434 2.089 . . . . 0.0 111.663 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.426 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 5.8 p-10 -79.71 12.14 2.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.922 0.391 . . . . 0.0 110.412 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -65.99 -0.86 2.59 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.681 1.192 . . . . 0.0 112.945 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.426 ' CE2' ' HA ' ' A' ' 59' ' ' ASP . 43.5 p90 -63.09 -26.76 68.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.665 0.745 . . . . 0.0 109.47 170.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.79 135.86 48.16 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 CA-C-O 117.995 -1.002 . . . . 0.0 108.524 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.566 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.29 145.44 43.46 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 121.857 1.705 . . . . 0.0 111.917 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.52 -44.06 92.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.0 -163.49 54.6 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.919 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.6 m -126.87 154.64 44.13 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 65.5 2.65 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -175.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.8 m-85 -111.58 17.63 19.82 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 170.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -116.9 131.66 56.9 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 113.481 -1.691 . . . . 0.0 108.882 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.2 t -69.01 113.83 19.1 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.43 -18.19 54.51 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.192 2.595 . . . . 0.0 112.271 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.8 mt -66.62 -44.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.106 0.479 . . . . 0.0 111.134 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 p -105.24 -20.84 13.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.09 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 62.94 22.94 13.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 111.516 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -103.93 -68.12 0.86 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.67 -167.27 1.08 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 98.3 mt -113.98 132.29 56.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB3' ' H ' ' A' ' 30' ' ' LYS . 27.9 tpt180 -69.09 -77.42 0.08 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.1 5.6 20.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 171.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 56.54 80.78 0.14 Allowed 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.612 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.1 m -90.9 116.24 31.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.783 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.08 130.12 34.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.643 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.3 p -89.56 155.96 48.09 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.88 -23.14 75.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.735 2.29 . . . . 0.0 112.754 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.0 p -77.94 -20.14 53.31 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.4 39.93 2.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.151 -1.024 . . . . 0.0 114.142 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.421 ' HE1' ' CG ' ' A' ' 47' ' ' ASP . 38.5 m80 -122.51 155.37 36.36 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -124.38 131.09 53.5 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -134.16 172.85 12.28 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.871 0.469 . . . . 0.0 110.891 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.433 ' O ' HG22 ' A' ' 33' ' ' ILE . 63.6 m -72.09 160.08 33.08 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.732 169.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' O ' HD12 ' A' ' 34' ' ' ILE . 89.2 tttt -82.63 -1.07 49.94 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.99 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.4 -40.07 3.48 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.319 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.7 m -62.26 -50.07 73.18 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -69.34 -42.36 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.556 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.8 mt -63.53 -43.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 111.575 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -78.0 -0.37 27.57 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.578 0.704 . . . . 0.0 109.553 -174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 t -105.25 -26.16 12.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.748 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.9 pt -104.24 -14.01 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -93.39 -6.96 45.98 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.5 174.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -115.74 -56.8 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.71 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.27 -66.1 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.986 0.422 . . . . 0.0 110.048 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.02 165.54 38.7 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -87.6 69.2 9.7 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.497 0.665 . . . . 0.0 111.759 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -147.17 154.61 41.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.228 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 29.7 m -62.14 131.74 93.59 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.75 -24.37 61.97 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.235 1.957 . . . . 0.0 111.505 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.53 -70.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.234 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' CG ' ' HE1' ' A' ' 26' ' ' HIS . 14.6 p-10 -97.46 6.17 48.58 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -172.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 9.2 p30 54.33 16.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 174.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.54 151.33 45.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.3 120.47 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -120.93 122.03 39.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.514 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.67 138.91 34.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.65 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.4 -41.13 96.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.835 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -74.99 -12.7 60.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.205 0.526 . . . . 0.0 111.317 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -82.19 -10.17 59.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.246 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.35 130.98 38.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -137.86 135.02 18.41 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 32.0 Cg_exo -61.74 141.04 89.19 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.205 1.936 . . . . 0.0 112.441 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.59 -38.78 87.75 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.53 0.732 . . . . 0.0 110.027 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -103.99 -176.7 3.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.087 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -142.61 157.13 45.01 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.983 0.42 . . . . 0.0 111.177 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.87 146.24 37.24 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.164 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -56.14 -39.87 88.49 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.051 2.5 . . . . 0.0 111.776 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.4 tp -103.88 129.21 51.36 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.89 101.72 0.57 Allowed Glycine 0 N--CA 1.445 -0.763 0 O-C-N 123.618 0.574 . . . . 0.0 112.319 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -150.79 153.69 35.93 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -113.63 86.57 2.42 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.936 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 86.3 m-85 -110.1 13.85 23.09 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.469 173.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -94.9 126.67 40.38 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.364 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' HD23 ' A' ' 16' ' ' LEU . 41.3 t -83.44 112.35 38.67 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.13 -20.01 65.96 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 122.42 2.08 . . . . 0.0 112.513 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.26 -44.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.532 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -119.15 -2.42 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.8 mt 53.8 27.3 6.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.093 0.957 . . . . 0.0 112.053 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.3 mtm -111.67 174.16 6.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.724 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 7' ' ' TYR . . . -67.16 149.95 49.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.359 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 9' ' ' CYS . 89.3 mt -70.28 109.86 4.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -65.56 -46.22 80.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 57.6 mm-40 -116.49 -15.51 10.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.079 -176.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 47.81 72.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.053 0.941 . . . . 0.0 113.164 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.79 116.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.363 0.602 . . . . 0.0 110.674 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 22' ' ' THR . 9.6 tt0 -82.13 136.61 35.13 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.965 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 32.3 p -84.29 163.62 46.9 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.81 -36.47 95.37 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.694 2.262 . . . . 0.0 112.508 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.511 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 5.0 p -65.68 -21.74 66.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.812 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.5 38.07 3.83 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.102 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -115.54 143.06 45.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.01 130.28 53.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.746 0.307 . . . . 0.0 111.267 -173.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -139.65 162.83 34.15 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.641 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.63 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 47.1 m -78.39 147.8 33.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.3 tttt -68.83 -10.25 55.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -174.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 -13.29 13.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.63 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.5 m -85.64 -45.16 11.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.694 173.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -65.58 -39.98 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.75 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.86 -41.38 92.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.164 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.08 -2.25 33.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.355 0.598 . . . . 0.0 109.944 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 m -105.68 -21.3 13.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.0 pt -103.12 -8.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.559 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.54 -2.27 45.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.085 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -116.78 -55.51 2.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.073 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.63 -64.79 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.42 -175.08 41.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -80.42 80.77 6.8 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.546 0.689 . . . . 0.0 111.596 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.0 ptpt -148.53 153.29 38.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.556 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 49' ' ' GLU . 4.6 p -76.78 136.01 67.36 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 165.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.98 -20.3 69.05 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 122.848 2.365 . . . . 0.0 114.167 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 47' ' ' ASP . 3.8 m -92.89 -71.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.481 ' H ' HG23 ' A' ' 46' ' ' VAL . 12.8 p-10 -96.14 5.27 51.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.827 0.451 . . . . 0.0 112.052 -174.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.33 0.3 OUTLIER 44.19 56.67 4.71 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.098 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 17.5 pt-20 -94.58 163.52 13.35 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.54 115.33 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 109.504 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.1 tp -115.63 130.08 56.73 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.182 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.97 149.4 35.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.307 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.97 -35.84 75.87 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.529 0.518 . . . . 0.0 110.193 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -63.8 -31.28 72.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.776 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -78.43 -7.59 57.55 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.45 128.73 36.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.21 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -144.72 124.02 7.03 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 120.963 0.411 . . . . 0.0 111.396 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.09 145.58 44.77 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.839 1.693 . . . . 0.0 111.133 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.76 -35.36 79.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.089 0.471 . . . . 0.0 109.732 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -96.03 103.11 14.98 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 172.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.92 120.28 17.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.051 0.453 . . . . 0.0 110.894 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.51 154.05 36.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.226 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.828 175.336 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.002 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.96 147.7 94.64 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.462 2.775 . . . . 0.0 112.812 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 57.77 91.28 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.431 1.092 . . . . 0.0 112.896 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.05 106.59 0.27 Allowed Glycine 0 N--CA 1.431 -1.645 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.512 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.9 m -79.61 -7.16 58.35 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.186 0.517 . . . . 0.0 110.727 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -66.86 149.63 50.32 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -97.05 120.04 36.66 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -139.94 135.68 33.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.95 108.01 11.2 Favored Pre-proline 0 N--CA 1.436 -1.136 0 O-C-N 123.657 0.598 . . . . 0.0 109.764 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HG3' HG13 ' A' ' 46' ' ' VAL . 58.5 Cg_endo -69.64 -17.86 37.87 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.948 2.432 . . . . 0.0 111.789 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.77 -43.77 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.1 p -99.72 -20.19 16.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.99 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 61.87 21.76 12.52 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.729 0.811 . . . . 0.0 111.883 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.68 -71.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.704 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.22 -166.49 0.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.16 105.04 17.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -70.47 -57.01 5.25 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 63.8 mm-40 -103.42 -16.41 15.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.006 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.55 61.51 3.16 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -93.04 118.23 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.188 0.518 . . . . 0.0 111.374 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 65.3 tt0 -75.51 134.44 40.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.947 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -99.96 159.17 30.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.766 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.89 -23.77 68.24 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.749 2.299 . . . . 0.0 113.113 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -73.11 -28.61 62.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.379 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.64 38.75 1.16 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -133.28 162.02 32.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 80.2 mtp180 -127.98 140.12 52.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -136.13 173.9 11.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.1 m -84.91 148.23 26.35 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 87.9 tttt -79.33 -3.58 46.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 110.324 -174.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.61 -12.55 13.41 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.6 m -94.09 -54.22 3.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.777 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -66.03 -38.57 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.9 mt -62.8 -42.99 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.663 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.95 -2.52 40.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.611 0.719 . . . . 0.0 110.48 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -105.43 -16.47 14.72 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.965 -0.459 . . . . 0.0 110.618 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.661 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -104.09 -24.18 4.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.559 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -97.42 1.04 48.77 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.813 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -116.4 -56.02 2.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.564 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.26 -66.71 0.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.467 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.1 159.1 32.0 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 64.0 m80 -85.45 75.64 10.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.285 0.543 . . . . 0.0 110.871 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -153.76 155.19 35.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.498 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.1 p -80.71 130.91 62.35 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -31.55 85.61 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.782 2.321 . . . . 0.0 114.775 -172.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 10' ' ' PRO . 16.0 m -78.87 -53.28 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -106.05 3.5 28.26 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 52.82 40.18 30.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.15 146.22 24.02 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 mm -66.65 120.58 14.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.373 0.606 . . . . 0.0 109.909 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.6 tp -124.42 118.05 25.81 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.801 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.565 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -96.05 161.42 13.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.91 -37.39 87.48 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.806 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.89 -24.02 64.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 111.247 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.565 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.7 mm100 -76.38 -10.78 59.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.665 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.37 147.47 46.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.168 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -55.13 115.23 8.6 Favored Pre-proline 0 C--O 1.237 0.438 0 O-C-N 123.775 0.672 . . . . 0.0 110.332 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.81 143.68 46.42 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.111 1.874 . . . . 0.0 111.759 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -97.81 115.21 27.59 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -62.85 -44.33 96.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -157.13 129.23 7.25 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.5 103.09 4.71 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.246 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.952 -176.401 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.938 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.99 -30.63 83.51 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.669 2.246 . . . . 0.0 112.114 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.1 tp -133.89 91.97 2.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.935 0.398 . . . . 0.0 109.985 173.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.7 -163.39 36.58 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.5 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 72.0 m -130.72 78.94 1.87 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -113.83 129.86 56.54 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.41 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 53.4 m-85 60.97 20.57 10.93 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.45 0.469 . . . . 0.0 111.066 -169.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 42.5 tt0 -124.78 140.89 52.51 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 51.3 t -87.63 108.74 21.8 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 37.3 Cg_exo -61.54 -20.61 69.32 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.478 2.119 . . . . 0.0 111.677 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.462 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.24 -43.47 91.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.034 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.0 m -88.89 -27.49 20.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.182 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 56.78 35.21 25.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.073 0.939 . . . . 0.0 108.693 -165.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -139.48 171.28 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.309 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.66 152.48 22.36 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.546 0.529 . . . . 0.0 111.608 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.0 mt -70.85 139.51 50.87 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.997 -177.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -79.12 -72.3 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.289 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.47 -15.96 20.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.649 0.261 . . . . 0.0 110.911 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.71 102.47 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.957 0.903 . . . . 0.0 113.274 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.8 m -117.15 118.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.411 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 60.6 tt0 -80.41 135.31 36.14 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.768 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -95.77 152.57 39.16 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -26.52 83.27 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.902 2.401 . . . . 0.0 113.823 -173.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -79.72 -19.36 49.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.72 48.48 0.68 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.649 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -133.33 152.11 51.91 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 65.2 mtt180 -121.44 136.3 54.97 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.982 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.67 170.0 16.48 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 39.0 m -78.92 153.29 30.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.96 -12.68 61.2 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.77 -31.56 6.1 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.224 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 28.0 m -62.98 -44.61 95.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.543 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -64.73 -41.12 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.0 mt -63.48 -43.51 98.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.836 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.77 -2.8 44.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.872 0.368 . . . . 0.0 110.539 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.0 t -106.92 -22.8 12.57 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.797 0.332 . . . . 0.0 110.635 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 33' ' ' ILE . 45.7 pt -101.78 -7.91 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.061 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -101.98 6.66 41.32 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.586 167.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.52 -54.89 2.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.186 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -66.11 0.94 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.137 0.494 . . . . 0.0 109.809 176.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.65 166.83 38.84 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 49.9 m80 -79.73 77.4 6.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.164 0.982 . . . . 0.0 110.83 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.1 ptpt -152.25 149.79 29.09 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.625 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.573 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 2.2 m -68.01 130.54 92.63 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.6 -34.02 94.5 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.262 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.76 -54.95 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.573 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 31.4 p-10 -104.19 4.29 33.81 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.719 -0.613 . . . . 0.0 112.07 -174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 54.96 32.23 17.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.799 0.84 . . . . 0.0 112.739 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 73.7 mm-40 -92.91 142.82 26.88 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.83 120.38 11.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 CA-C-O 121.597 0.713 . . . . 0.0 110.373 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.8 tp -117.14 129.25 55.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.316 -175.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.8 mm? -98.21 148.74 23.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.59 -37.24 86.07 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.328 0.393 . . . . 0.0 111.882 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -68.37 -19.74 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.534 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 14.1 mm-40 -77.24 -6.62 53.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.23 131.66 45.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -128.61 129.02 23.53 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.492 ' HD2' ' CE1' ' A' ' 61' ' ' PHE . 72.4 Cg_endo -74.35 165.71 31.18 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 122.517 2.145 . . . . 0.0 110.298 165.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.31 -42.25 95.19 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.573 0.702 . . . . 0.0 110.323 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -128.35 137.97 52.16 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.492 ' CE1' ' HD2' ' A' ' 58' ' ' PRO . 94.0 m-85 -88.15 104.02 16.3 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.884 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.98 119.02 25.83 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.572 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.253 1.256 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.18 -176.171 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.027 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.3 139.93 85.67 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.652 2.234 . . . . 0.0 111.578 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.61 -43.53 89.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.635 0.731 . . . . 0.0 110.465 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.21 -89.27 0.15 Allowed Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.5 t -129.66 136.27 49.51 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.135 0.493 . . . . 0.0 110.309 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -145.58 153.59 41.23 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -79.61 81.84 5.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.869 0.842 . . . . 0.0 109.793 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -158.59 139.07 12.55 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.151 -174.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.434 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 39.8 t -78.25 113.83 37.19 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.98 -20.96 64.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.481 2.121 . . . . 0.0 112.895 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.86 -44.34 85.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.094 0.473 . . . . 0.0 111.874 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 20.7 p -101.85 -13.22 17.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.166 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mp 54.09 23.37 4.07 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.996 0.918 . . . . 0.0 111.742 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.7 mtm -100.03 -70.98 0.72 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.687 0.279 . . . . 0.0 111.676 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.89 165.25 5.16 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.6 109.92 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -70.42 -46.12 64.54 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.895 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -115.35 -17.9 11.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.478 ' HB3' ' H ' ' A' ' 61' ' ' PHE . . . 56.06 81.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.798 -174.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.71 117.37 42.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.601 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.424 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 53.0 tt0 -80.83 140.96 35.13 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.195 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -96.9 156.77 36.07 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 74.9 Cg_exo -54.53 -37.59 90.27 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.966 2.444 . . . . 0.0 112.594 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -64.9 -18.33 65.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.903 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.87 4.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.471 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -120.35 152.32 38.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -123.07 138.27 54.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.349 0.595 . . . . 0.0 112.439 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -137.3 169.26 18.08 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.329 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.3 m -76.47 151.4 36.47 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.228 171.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.52 -5.78 31.38 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.04 0.447 . . . . 0.0 112.107 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.85 -34.13 5.55 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.93 -0.481 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.5 m -64.29 -44.8 90.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.015 0.436 . . . . 0.0 110.608 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.515 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.1 tp -65.53 -39.91 86.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.169 -176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -63.02 -42.35 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.039 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -78.12 -2.3 36.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.785 0.326 . . . . 0.0 110.422 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -105.35 -25.62 12.32 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.003 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.8 pt -103.81 -10.29 9.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.71 -174.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.5 ptm180 -93.47 -14.04 27.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.487 176.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -131.72 -56.33 1.0 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.138 -172.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.02 -66.2 0.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.87 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.06 137.32 5.11 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -85.23 43.44 1.01 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.854 0.835 . . . . 0.0 110.244 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -148.05 155.11 41.11 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 12.0 p -75.04 127.03 87.46 Favored Pre-proline 0 C--N 1.318 -0.778 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.192 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.7 -25.27 68.76 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.917 2.411 . . . . 0.0 113.557 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.52 -49.33 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -131.87 12.21 4.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.99 35.32 21.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 73.3 mm-40 -85.03 143.5 28.87 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.322 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.81 120.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.7 tp -121.03 126.6 50.3 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.555 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -110.43 148.01 32.88 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.02 -28.82 69.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.689 0.757 . . . . 0.0 109.835 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.96 -30.65 71.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.438 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.555 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.4 mm100 -80.16 -16.37 55.02 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.363 -175.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.4 mt -69.28 131.99 45.75 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' HD2' ' O ' ' A' ' 21' ' ' GLN . 97.0 m-85 -85.19 153.3 59.45 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.48 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.26 153.48 77.89 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.005 2.47 . . . . 0.0 111.953 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -36.19 102.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.031 1.332 . . . . 0.0 113.738 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 21' ' ' GLN . 8.5 m120 -67.22 -45.38 76.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.986 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.478 ' H ' ' HB3' ' A' ' 19' ' ' ALA . 98.6 m-85 -141.49 100.47 3.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.955 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.94 125.61 41.83 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.345 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--N 1.303 -1.421 0 CA-C-O 118.404 -0.808 . . . . 0.0 109.172 -177.476 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.854 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -60.82 144.48 99.56 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 122.869 2.38 . . . . 0.0 112.023 178.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.43 133.69 49.04 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.1 123.28 31.96 Favored Glycine 0 N--CA 1.444 -0.812 0 O-C-N 123.784 0.678 . . . . 0.0 111.726 -178.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 m -127.97 157.5 40.43 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -177.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -65.26 -32.8 74.65 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.437 -177.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.431 ' C ' ' HG ' ' A' ' 16' ' ' LEU . 91.9 m-85 -80.67 61.16 4.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.245 0.545 . . . . 0.0 110.413 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -146.9 122.58 10.51 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.142 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 19.6 p -91.55 134.15 29.88 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.573 175.629 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.55 -17.52 58.71 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.929 2.419 . . . . 0.0 113.131 -174.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.8 -45.03 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -106.89 -20.08 13.44 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.53 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.25 23.0 6.68 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.843 0.857 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -97.45 -66.61 0.89 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.202 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.72 -172.62 0.9 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.431 ' HG ' ' C ' ' A' ' 7' ' ' TYR . 91.7 mt -105.12 105.36 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.22 174.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -69.91 -44.15 70.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.709 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -125.41 -15.16 6.24 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.633 -175.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HB1' ' HD3' ' A' ' 27' ' ' ARG . . . 49.6 56.24 8.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 30.3 m -77.48 118.22 23.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -75.9 133.32 40.56 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.643 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -106.1 162.58 19.26 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.264 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.23 -36.64 99.07 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.294 2.663 . . . . 0.0 112.46 178.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.0 -25.94 64.76 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.932 0.396 . . . . 0.0 111.602 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.31 29.01 4.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.038 177.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -112.58 157.65 20.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 94.8 mtt-85 -124.74 140.48 52.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 110.238 174.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.45 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 88.3 m-85 -134.49 165.56 24.9 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.015 -176.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.5 m -73.84 152.66 40.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 171.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' O ' HD12 ' A' ' 34' ' ' ILE . 57.7 tttp -68.87 -13.23 62.3 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 121.296 0.569 . . . . 0.0 110.778 -174.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.86 -1.22 13.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.218 0.533 . . . . 0.0 110.387 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 89.3 m -90.72 -64.02 1.19 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.421 176.234 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.28 -40.94 83.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.8 mt -63.09 -42.15 95.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 110.336 -178.072 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.9 tptp -78.7 -1.64 35.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.673 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.1 m -106.9 -19.77 13.53 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.381 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.1 pt -102.99 -31.63 2.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.488 -174.286 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.6 ptm180 -99.13 4.31 46.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.232 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -115.72 -55.08 2.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.842 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.27 -71.77 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.433 . . . . 0.0 110.184 178.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.24 152.75 23.6 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -79.23 71.58 5.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.434 0.635 . . . . 0.0 112.105 -175.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.3 ptpt -153.36 152.29 30.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.609 178.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 m -64.76 124.77 87.29 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 170.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.51 -27.32 70.04 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 121.702 1.601 . . . . 0.0 112.067 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.72 -54.79 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.11 4.97 29.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 54.43 33.91 19.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.3 mm-40 -96.75 141.41 30.0 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.02 121.18 13.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 -176.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.53 132.82 44.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.818 -173.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.455 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -116.43 157.67 24.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.59 -37.41 78.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 109.774 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -65.12 -29.55 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.7 mm100 -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.147 -177.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.9 mt -76.14 136.32 39.81 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -73.04 148.01 88.75 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.08 145.78 96.39 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 C-N-CA 122.256 1.97 . . . . 0.0 112.08 -172.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -77.24 90.27 3.72 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 122.002 0.906 . . . . 0.0 109.947 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -143.9 138.22 28.41 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.456 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.06 101.13 8.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.21 0.529 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.81 131.25 42.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.805 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? . . . . . 0 C--N 1.311 -1.096 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.277 178.098 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.13 140.58 78.94 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.312 2.008 . . . . 0.0 111.342 178.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 44.3 64.63 1.25 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 112.673 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.69 117.41 1.79 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.327 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -83.7 96.93 8.86 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.708 0.766 . . . . 0.0 110.69 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -113.1 115.84 28.94 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 55.2 30.57 14.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.037 0.922 . . . . 0.0 109.993 -171.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.6 tt0 -127.09 130.72 50.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.217 -1.356 . . . . 0.0 107.382 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 t -75.44 108.07 5.13 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 53.6 Cg_endo -68.23 -17.79 44.96 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.922 2.415 . . . . 0.0 111.983 -177.3 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.16 -43.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.232 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.92 -13.81 15.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 0.0 111.339 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.65 21.44 5.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 112.011 -177.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -99.83 -69.81 0.75 Allowed 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.45 -167.36 0.2 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.9 mt -94.41 107.07 19.05 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -69.74 -43.83 71.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 64.9 mm-40 -122.61 -14.66 7.71 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.617 -175.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.87 56.44 6.66 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.517 0.727 . . . . 0.0 112.424 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.2 m -83.51 116.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.461 0.648 . . . . 0.0 110.708 178.099 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -78.78 134.25 37.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.873 -176.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 157.53 36.89 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.76 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.38 -40.28 83.65 Favored 'Trans proline' 0 C--N 1.364 1.342 0 C-N-CA 122.587 2.191 . . . . 0.0 113.323 -177.134 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 -14.88 61.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.43 36.87 2.97 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.144 173.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -117.26 157.74 25.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.3 mtt180 -123.22 140.38 53.08 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.283 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.423 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 98.2 m-85 -132.13 173.07 11.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.263 -177.09 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.7 m -85.05 148.74 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.504 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 38.9 ttpt -73.69 -10.94 60.2 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.351 0.596 . . . . 0.0 111.346 -172.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.49 -4.53 12.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.019 0.438 . . . . 0.0 109.958 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 88.2 m -90.02 -60.78 1.84 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 174.666 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -67.1 -40.68 85.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.599 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.4 mt -62.71 -43.03 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.917 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -79.99 1.46 27.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.802 0.811 . . . . 0.0 110.169 -177.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 t -105.44 -24.8 12.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.876 175.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 49.2 pt -103.23 -22.67 4.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -99.26 4.56 46.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.456 174.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -119.37 -57.23 2.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.466 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.95 -68.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.892 0.377 . . . . 0.0 111.598 -177.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -146.03 140.12 8.65 Favored Glycine 0 CA--C 1.502 -0.756 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.483 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 3.7 t-160 -83.32 52.25 2.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.458 0.647 . . . . 0.0 110.488 -172.041 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -155.32 160.96 41.15 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.672 -174.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.615 ' HB3' HD11 ' A' ' 51' ' ' LEU . 2.6 p -79.16 130.47 69.26 Favored Pre-proline 0 C--N 1.318 -0.764 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.441 173.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.08 -21.05 72.68 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.209 2.606 . . . . 0.0 113.666 -173.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 47' ' ' ASP . 4.0 m -72.58 -70.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 46' ' ' VAL . 46.4 p-10 -103.13 5.56 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.16 33.0 21.1 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 113.179 173.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -83.48 139.99 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.416 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.13 121.36 16.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.493 . . . . 0.0 110.476 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 44' ' ' CYS . 83.0 mt -109.58 132.37 54.2 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.314 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 71.4 mt -108.68 143.41 37.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -61.17 -36.13 79.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.17 0.509 . . . . 0.0 110.266 -179.062 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -65.05 -31.71 73.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.089 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -86.14 -13.21 47.81 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.041 -176.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 85.4 mt -76.63 124.98 28.45 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.249 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 55.3 t80 68.58 141.12 0.07 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 O-C-N 124.187 0.929 . . . . 0.0 110.815 177.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.63 146.41 91.73 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.168 1.912 . . . . 0.0 111.893 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.11 113.52 9.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.593 -176.079 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -107.47 0.76 23.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.369 178.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -114.53 83.65 1.92 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.093 -176.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.68 -21.58 19.92 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 170.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.78 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.22 177.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -56.08 -41.45 76.78 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.871 2.381 . . . . 0.0 112.72 -178.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.9 tp -129.02 121.64 28.34 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.686 0.279 . . . . 0.0 110.803 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.39 86.04 0.97 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 175.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -137.98 149.34 46.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.031 0.443 . . . . 0.0 111.521 -172.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.639 ' HD3' ' H ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -85.37 7.17 23.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.161 176.168 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.636 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 97.2 m-85 -91.83 10.95 26.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.965 0.888 . . . . 0.0 109.196 171.088 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -110.1 122.7 48.21 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.607 173.129 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.87 109.75 4.38 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.8 -19.91 69.8 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.9 2.4 . . . . 0.0 113.407 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.03 -43.97 92.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 121.139 0.495 . . . . 0.0 110.989 179.059 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.2 p -104.49 -21.4 13.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.791 -177.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.1 mt 59.03 29.37 18.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.703 0.801 . . . . 0.0 111.719 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.8 mtm -98.68 -66.87 0.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.174 0.512 . . . . 0.0 110.528 176.318 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.52 -172.03 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 91.7 mt -91.09 105.81 18.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -69.28 -45.2 70.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.928 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.442 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 71.1 mm-40 -116.3 -15.82 10.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -178.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 88.66 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -117.24 117.59 55.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.243 0.544 . . . . 0.0 110.353 171.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -80.56 139.32 36.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.114 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 p -109.39 158.95 33.15 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.75 -27.0 82.25 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.907 2.405 . . . . 0.0 111.576 176.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.36 -24.96 67.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.262 178.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.89 8.17 57.13 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.892 -174.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -92.87 154.0 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -124.36 139.42 53.92 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.197 173.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.52 168.87 18.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.625 -174.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 49.9 m -79.12 151.72 31.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 169.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 34' ' ' ILE . 86.9 tttt -78.36 8.6 4.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.721 0.772 . . . . 0.0 111.289 -173.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.64 -38.91 3.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 38.7 m -66.39 -50.06 64.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.069 -178.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -69.12 -40.24 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.071 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.636 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.9 mt -62.94 -42.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.718 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -78.92 0.59 26.77 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.097 -177.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -105.37 -23.85 12.77 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.789 176.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.4 pt -103.92 -22.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.174 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -104.13 6.17 35.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.798 175.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.47 -53.0 2.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 178.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.73 -71.15 0.52 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.917 0.389 . . . . 0.0 110.362 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.57 161.61 35.33 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -80.32 75.55 7.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.721 0.772 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.8 ptpt -151.95 148.85 28.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.729 177.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.0 p -72.37 126.09 91.12 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.99 -22.73 73.96 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 122.326 2.018 . . . . 0.0 112.585 -175.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.18 -50.71 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.246 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -135.9 11.79 3.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 64.44 35.51 9.5 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 173.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 53.6 mt-10 -83.85 145.47 28.62 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -66.5 113.7 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.241 0.543 . . . . 0.0 110.25 -176.206 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.9 tp -126.23 123.18 37.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.987 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.568 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.1 mm? -97.61 160.39 14.35 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.11 -38.61 91.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -176.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.01 -17.65 63.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 178.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.568 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.2 mm100 -76.3 -8.99 58.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.895 -178.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.7 mt -75.15 126.96 32.1 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -100.2 132.92 21.91 Favored Pre-proline 0 C--N 1.311 -1.098 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.493 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.55 153.11 65.52 Favored 'Trans proline' 0 C--N 1.327 -0.595 0 C-N-CA 122.429 2.086 . . . . 0.0 111.088 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -56.01 137.54 50.81 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.243 0.339 . . . . 0.0 110.405 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -99.26 -17.1 18.26 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.419 -175.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -62.21 -47.17 85.63 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 120.938 0.399 . . . . 0.0 110.592 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.12 134.86 40.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.232 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? . . . . . 0 C--N 1.311 -1.103 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.106 -177.589 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.329 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -56.93 -40.81 81.43 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.574 2.183 . . . . 0.0 110.612 177.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.1 tp -143.9 139.8 29.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.82 106.65 0.93 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 172.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.7 m -93.51 119.47 32.62 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 120.901 0.382 . . . . 0.0 111.447 -168.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -67.46 -33.7 75.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.95 176.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -79.51 65.61 4.73 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.867 0.841 . . . . 0.0 110.059 177.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -137.09 146.13 44.75 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.217 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.28 109.61 22.62 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.31 -17.66 54.37 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.805 2.337 . . . . 0.0 112.657 -175.208 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -65.92 -43.83 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.866 0.365 . . . . 0.0 110.987 177.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.7 p -105.39 -15.63 14.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.05 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mp 57.87 22.67 8.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.889 0.876 . . . . 0.0 111.433 -176.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 8.1 mmt -95.03 -66.51 0.91 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.501 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.59 -166.61 0.06 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.69 117.58 34.35 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -67.63 -44.85 77.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 179.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -134.96 -15.03 2.04 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 67.59 88.86 0.11 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.353 1.061 . . . . 0.0 112.847 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.0 m -106.24 117.1 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.174 0.511 . . . . 0.0 111.033 175.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -80.37 132.12 35.72 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.93 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 p -95.86 156.15 37.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.31 -29.63 86.36 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.569 2.18 . . . . 0.0 112.767 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.26 -22.91 51.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.659 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.7 51.56 0.65 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.213 -0.994 . . . . 0.0 114.013 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -131.47 161.39 32.63 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 68.9 mtt180 -127.74 136.38 51.45 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 171.155 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.09 -179.1 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.188 -176.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.5 m -86.7 152.94 22.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 170.181 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 34' ' ' ILE . 35.9 ttpt -78.65 -1.97 36.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.617 0.723 . . . . 0.0 111.021 -174.533 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.41 -19.26 10.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 177.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.3 m -82.86 -57.8 3.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.331 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -67.76 -41.08 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.911 -175.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 81.5 mt -62.9 -42.85 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 111.544 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -78.61 -2.72 40.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.23 0.538 . . . . 0.0 109.647 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -105.97 -21.99 13.01 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 176.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 33' ' ' ILE . 46.3 pt -103.25 -15.56 7.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.175 -177.144 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.4 ptm180 -99.87 2.27 43.68 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.03 175.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -116.28 -55.76 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.994 -178.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.55 -67.03 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.287 0.565 . . . . 0.0 109.773 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.48 159.68 31.43 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -81.72 72.41 8.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -156.38 148.15 22.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.124 173.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.82 124.47 89.62 Favored Pre-proline 0 N--CA 1.436 -1.14 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.831 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.1 -24.52 76.57 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.092 2.528 . . . . 0.0 113.739 -170.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.7 m -68.87 -47.47 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.049 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -119.79 5.58 10.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 m120 58.71 33.56 23.16 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.451 0.701 . . . . 0.0 112.642 177.068 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -95.78 144.36 26.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.6 mm -66.11 120.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.122 0.487 . . . . 0.0 110.343 -173.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.9 tp -131.18 132.56 44.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -174.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 3.8 mm? -116.58 150.16 38.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.14 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.56 -37.03 82.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.066 0.546 . . . . 0.0 110.131 -177.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -64.32 -31.73 73.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 12.0 mm100 -76.43 -17.64 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.862 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 95.8 mt -76.1 137.25 40.01 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.257 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -159.09 150.94 17.07 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 176.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 83.2 Cg_endo -79.56 -166.4 0.41 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.304 2.669 . . . . 0.0 111.563 175.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -74.12 91.71 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.249 0.547 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -99.09 12.86 34.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.691 178.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.38 -39.44 90.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.832 -177.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.18 136.23 46.92 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? . . . . . 0 C--N 1.309 -1.161 0 CA-C-O 118.371 -0.823 . . . . 0.0 109.617 -179.164 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -60.12 146.98 94.97 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.305 2.67 . . . . 0.0 112.802 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.9 tp 55.11 68.03 0.93 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.964 0.906 . . . . 0.0 111.536 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.93 -86.68 0.14 Allowed Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.025 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t -62.74 -41.9 99.41 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.133 0.573 . . . . 0.0 110.606 -178.361 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -86.03 122.75 30.5 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -79.7 100.84 8.07 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.644 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -164.72 136.38 4.37 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.569 -170.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 41.8 t -75.85 114.66 38.99 Favored Pre-proline 0 N--CA 1.438 -1.035 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.397 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.1 -19.4 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.121 1.881 . . . . 0.0 113.224 -177.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -67.96 -44.33 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 14.4 p -100.28 -24.62 14.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.079 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 65.1 21.9 12.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.348 0.659 . . . . 0.0 110.866 -176.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.3 mmt -96.4 -70.14 0.73 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.706 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.68 -168.67 0.24 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -176.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.35 122.16 44.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -84.57 -66.38 0.9 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.685 177.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -88.29 -15.64 35.25 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.555 176.451 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.44 56.3 7.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.659 1.184 . . . . 0.0 112.297 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.4 m -80.88 116.56 25.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.251 0.548 . . . . 0.0 111.636 -175.45 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 22' ' ' THR . 26.7 tt0 -81.4 131.52 35.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.206 176.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 82.3 p -83.82 159.18 61.04 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.299 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD2' ' CD2' ' A' ' 51' ' ' LEU . 31.7 Cg_endo -61.17 -24.26 78.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.072 1.848 . . . . 0.0 111.978 178.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -76.48 -15.92 59.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.857 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 33.93 5.63 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.472 178.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -119.96 150.77 39.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -122.13 139.79 53.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' O ' HG22 ' A' ' 20' ' ' VAL . 85.5 m-85 -142.88 172.06 13.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.401 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.677 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.6 m -84.05 153.62 23.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.51 -14.07 62.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.143 0.497 . . . . 0.0 112.054 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.18 1.4 15.24 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.804 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 57.9 m -95.81 -56.44 2.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.669 172.099 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -66.81 -41.88 88.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.747 -177.47 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.435 ' HA ' HG12 ' A' ' 37' ' ' ILE . 76.5 mt -63.39 -41.58 93.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 111.915 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -77.46 -2.73 36.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.484 0.659 . . . . 0.0 109.395 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.94 -17.72 14.11 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.408 177.093 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 42' ' ' HIS . 38.2 pt -106.49 -11.73 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -175.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -95.21 -10.91 29.05 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.222 -178.144 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.7 -45.88 2.87 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.927 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.88 -76.65 0.16 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.32 158.6 31.6 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 177.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.513 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 55.1 m80 -83.56 67.48 9.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.628 0.727 . . . . 0.0 111.61 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -143.18 150.77 39.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.436 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.1 p -83.22 124.33 76.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -28.18 81.45 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.728 2.285 . . . . 0.0 113.449 -171.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -69.58 -45.45 78.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -120.17 5.56 10.78 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.052 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 57.98 33.15 22.88 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 175.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -95.57 146.21 24.63 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 177.094 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.94 120.74 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD12 HD13 ' A' ' 37' ' ' ILE . 3.3 tm? -121.76 126.75 49.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.11 -172.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.52 148.75 31.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.543 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.05 -41.04 95.52 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.639 1.176 . . . . 0.0 112.983 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -87.12 -0.61 56.95 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.363 -176.236 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -87.31 -7.86 57.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.691 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 96.0 mt -73.44 140.9 46.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.224 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -113.18 94.5 30.92 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.24 -41.96 67.93 Favored 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 122.533 2.155 . . . . 0.0 112.218 175.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -140.45 96.87 3.1 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.103 -178.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -111.59 3.39 17.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.386 0.612 . . . . 0.0 111.203 176.174 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.98 105.27 12.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 176.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -164.44 169.83 16.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.608 -176.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? . . . . . 0 N--CA 1.443 -0.817 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.854 177.161 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -55.73 -41.13 80.62 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.003 2.469 . . . . 0.0 112.451 -177.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.11 128.34 35.92 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.073 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.44 -49.15 66.97 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.047 -178.259 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -78.33 151.95 32.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.73 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -86.55 79.92 8.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.391 0.615 . . . . 0.0 111.513 -175.232 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.531 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 92.0 m-85 -111.86 15.28 20.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.554 171.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.99 147.84 28.98 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.336 -178.626 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.496 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 45.8 t -118.92 108.9 40.13 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.804 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.46 -21.52 72.13 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 122.589 2.193 . . . . 0.0 112.653 -171.6 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.49 -44.14 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.791 177.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 19.5 p -106.67 -17.9 14.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 57.08 33.52 23.46 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.112 0.965 . . . . 0.0 111.885 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -121.35 -77.02 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.328 177.339 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.6 158.47 2.75 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.774 0.43 . . . . 0.0 110.014 -179.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 96.0 mt -71.82 105.22 3.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.692 0.282 . . . . 0.0 110.853 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -70.65 -44.8 66.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 178.549 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -112.86 -16.87 12.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.644 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.0 80.72 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.97 116.47 47.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 110.326 174.407 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -81.01 136.11 35.94 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.411 -177.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -103.13 154.34 37.7 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.77 -29.35 85.56 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.051 2.501 . . . . 0.0 112.839 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.7 p -69.1 -15.59 63.47 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.51 11.41 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.172 177.821 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -114.22 155.78 25.5 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 122.571 -0.37 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -126.49 136.54 52.74 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.223 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.48 167.92 20.18 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.206 0.316 . . . . 0.0 110.814 -176.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 58.2 m -80.63 156.19 26.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.256 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.8 tttt -69.48 -12.65 61.82 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.966 -173.473 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.07 -20.56 10.94 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.156 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 98.1 m -72.1 -54.1 10.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.845 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -67.97 -39.85 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.247 -175.873 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 88.0 mt -62.73 -42.8 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.663 0.268 . . . . 0.0 111.131 -178.935 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -78.87 -0.83 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.464 0.649 . . . . 0.0 110.372 -177.123 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -103.61 -25.45 13.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.323 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -103.05 -7.32 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.452 -177.275 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -100.94 -2.84 30.82 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.625 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.7 -52.74 2.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.707 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.97 -69.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.079 0.466 . . . . 0.0 110.241 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -176.82 167.29 38.59 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 177.611 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -81.5 67.16 7.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.809 0.814 . . . . 0.0 111.616 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -148.08 157.66 43.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.339 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 50.4 t -64.9 127.22 92.48 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.44 -26.53 70.58 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.388 2.058 . . . . 0.0 112.449 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.77 -71.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.321 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -98.28 5.63 48.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -174.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 91.2 m-20 57.31 33.47 23.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.875 0.87 . . . . 0.0 113.151 173.166 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -86.44 148.58 25.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.3 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.5 mp -66.19 122.56 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 110.322 -173.716 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.24 125.74 46.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -174.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.47 152.43 18.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 177.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.68 -36.82 84.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.909 -173.253 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -71.16 -11.96 61.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.861 0.363 . . . . 0.0 111.483 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.44 -8.23 59.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.452 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 88.0 mt -76.59 79.22 3.26 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.12 0.262 . . . . 0.0 110.911 -177.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 26.1 t80 168.5 142.87 0.06 OUTLIER Pre-proline 0 C--O 1.234 0.288 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.58 162.03 40.93 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.518 2.146 . . . . 0.0 111.286 175.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.09 114.67 2.47 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.174 0.511 . . . . 0.0 111.264 -176.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -95.65 0.98 53.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.36 -178.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -61.92 -46.43 89.39 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.4 143.94 51.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.255 175.5 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.126 177.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -56.24 -45.93 34.35 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.365 2.043 . . . . 0.0 111.361 177.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 mp -138.26 -61.61 0.6 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.019 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.83 115.23 0.61 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 175.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.4 t -158.15 155.79 29.74 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 117.136 0.468 . . . . 0.0 110.543 -176.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -76.72 -7.62 55.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.554 0.693 . . . . 0.0 110.043 176.255 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -81.98 49.94 1.47 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.512 178.629 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -139.23 146.46 40.49 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.581 -176.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB2' HD23 ' A' ' 16' ' ' LEU . 40.9 t -89.78 108.05 22.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.7 Cg_exo -63.37 -20.47 70.29 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.743 2.296 . . . . 0.0 112.839 -177.527 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -66.57 -44.45 90.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.609 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.07 -20.26 14.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.7 mt 59.1 22.02 10.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.096 0.959 . . . . 0.0 112.848 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.6 mtm -98.19 -65.69 0.95 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.485 176.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.51 -169.82 0.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.254 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.472 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.5 mt -100.44 108.47 20.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.43 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 3.3 tpm_? -69.83 -42.34 73.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 43.6 mt-10 -118.29 -15.52 9.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 -177.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.93 82.17 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 57' ' ' PHE . 19.6 m -115.97 114.88 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.299 0.571 . . . . 0.0 110.661 176.496 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.56 129.49 34.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.307 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.4 p -77.96 168.21 29.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.125 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.4 -28.77 81.81 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.556 2.17 . . . . 0.0 111.731 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB2' ' OE1' ' A' ' 49' ' ' GLU . 27.6 p -84.5 -21.53 30.55 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.675 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.42 4.22 22.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.792 177.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -88.65 149.68 23.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.209 0.504 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -116.77 136.32 53.05 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.673 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.7 m-85 -139.86 170.01 16.66 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 28.3 m -83.26 147.65 27.85 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 3.5 ttpm? -69.36 -7.76 40.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -173.02 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.88 -16.62 12.68 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.708 -178.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 46.0 m -82.52 -46.28 13.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.58 -41.66 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.64 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.3 mt -63.06 -41.83 94.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 111.707 -178.205 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.66 -1.81 32.85 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.869 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 m -106.15 -20.84 13.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.433 HD11 ' HG2' ' A' ' 53' ' ' GLU . 37.7 pt -102.99 -9.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.967 -176.143 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -99.04 7.81 45.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.12 0.962 . . . . 0.0 108.533 167.58 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -114.94 -56.03 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.361 -179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.3 -70.07 0.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.163 176.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.04 172.88 40.36 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.487 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 74.4 m80 -80.4 69.12 6.8 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.707 0.765 . . . . 0.0 111.525 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 9.6 ptpp? -148.05 152.75 37.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.0 177.789 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.5 p -77.13 128.34 81.21 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.84 -22.24 69.07 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.148 1.899 . . . . 0.0 112.684 -176.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.97 -50.49 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.262 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -138.84 17.23 2.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.551 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.79 33.97 17.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.344 1.058 . . . . 0.0 113.654 170.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 56.6 mt-10 -89.12 153.06 21.26 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.712 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.4 121.82 15.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 111.302 -175.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 6.5 tt -120.6 126.27 49.85 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.131 -176.491 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.62 139.61 45.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.429 178.191 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HG2' HD11 ' A' ' 37' ' ' ILE . 77.8 mt-10 -65.46 -42.8 91.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.426 -174.018 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -69.33 -23.43 63.78 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.8 mm-40 -74.92 -14.87 60.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.482 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.05 145.65 44.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.458 ' O ' HG12 ' A' ' 20' ' ' VAL . 90.9 m-85 -83.31 127.29 69.28 Favored Pre-proline 0 C--N 1.313 -0.981 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -55.55 -40.57 84.66 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 122.541 2.161 . . . . 0.0 112.825 -178.728 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.71 -67.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.296 1.439 . . . . 0.0 111.418 -175.072 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -87.96 104.86 17.02 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.78 0.8 . . . . 0.0 109.632 174.449 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -98.15 129.8 44.93 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.099 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.12 140.82 58.91 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.29 0.567 . . . . 0.0 111.921 -174.062 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.874 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.962 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.378 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.52 148.32 78.52 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.344 2.029 . . . . 0.0 110.866 178.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.87 127.08 41.58 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.371 0.605 . . . . 0.0 110.925 -173.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.92 47.82 0.38 Allowed Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 177.662 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.9 m -82.01 158.45 23.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.353 -0.423 . . . . 0.0 110.993 -175.303 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -82.27 14.21 3.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.22 0.533 . . . . 0.0 111.826 -178.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -97.82 25.68 5.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.081 178.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -93.98 138.84 31.65 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.836 -179.032 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.3 t -93.62 111.34 52.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.13 -19.54 50.93 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.435 2.09 . . . . 0.0 113.678 -174.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.27 -44.84 83.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.8 p -103.73 -21.49 13.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.021 -174.532 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp 65.41 21.29 11.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.349 1.06 . . . . 0.0 110.617 -175.144 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.4 mmt -95.52 -75.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -179.31 162.58 1.18 Allowed 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 9' ' ' CYS . 92.5 mt -79.75 103.37 9.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.052 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -71.18 -44.94 64.48 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.656 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -112.4 -17.17 12.76 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.94 -177.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.13 73.31 0.16 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.094 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -93.59 117.57 37.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.953 175.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.28 142.0 34.98 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.04 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -108.96 168.21 8.06 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 177.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.85 -33.32 94.44 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 123.042 2.494 . . . . 0.0 113.031 -176.369 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 p -74.68 -14.55 60.76 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.961 0.41 . . . . 0.0 111.852 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.46 1.0 50.27 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.372 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -79.26 146.72 32.85 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.54 -0.388 . . . . 0.0 110.603 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -122.59 138.44 54.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.481 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 91.1 m-85 -140.91 170.13 16.32 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.186 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -81.1 159.24 24.77 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.694 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 34' ' ' ILE . 7.1 ttpm? -68.94 -11.37 60.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.438 0.637 . . . . 0.0 111.169 -176.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.94 -16.75 12.14 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.823 -179.009 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.9 m -83.91 -51.7 6.95 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.481 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 10.9 tp -69.26 -39.29 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.771 -178.082 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.1 mt -62.85 -42.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -79.53 9.51 4.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 178.011 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 m -109.6 -25.99 10.15 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.723 170.311 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.1 pt -103.96 -27.67 3.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -173.278 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -100.1 2.89 43.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.705 0.764 . . . . 0.0 108.957 175.097 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -116.05 -56.54 2.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.765 -171.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.88 -69.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.085 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.43 159.89 33.31 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.848 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -79.03 67.52 4.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.7 pttm -152.72 150.26 29.24 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.949 173.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.4 p -79.73 124.48 83.49 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.549 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.91 -28.68 75.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.929 2.42 . . . . 0.0 114.69 -168.303 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.72 -48.19 83.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.477 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -119.06 6.4 11.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 51.74 40.02 26.66 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.564 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 66.5 mm-40 -89.87 138.37 31.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.712 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.38 121.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.79 128.92 52.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.457 -173.149 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.03 150.47 27.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.487 ' HA ' HD13 ' A' ' 56' ' ' LEU . 55.0 mp0 -59.59 -37.0 77.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.896 0.379 . . . . 0.0 111.114 -174.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -65.39 -28.73 69.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 179.417 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -66.79 -21.64 66.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.848 179.539 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 53' ' ' GLU . 8.8 mp -68.59 126.69 30.48 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.441 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -89.2 163.62 33.46 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.463 -176.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.17 151.69 77.08 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.893 2.395 . . . . 0.0 110.546 176.32 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.83 138.55 47.97 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.317 0.58 . . . . 0.0 111.107 -173.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -79.04 -10.25 59.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.329 -175.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -75.03 140.93 43.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.101 0.477 . . . . 0.0 110.502 179.286 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.51 146.57 26.91 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--N 1.31 -1.147 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.069 -178.543 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.619 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.08 -42.37 23.78 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 113.177 -178.028 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.2 tp -66.74 -43.25 84.67 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.068 0.461 . . . . 0.0 110.937 177.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.6 -179.57 48.68 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 p -113.2 1.5 15.26 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 117.217 0.508 . . . . 0.0 111.689 178.538 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -78.59 138.51 38.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.561 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 95.3 m-85 73.35 12.51 4.77 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.338 1.055 . . . . 0.0 110.49 -172.004 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -120.4 127.33 52.19 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.7 t -66.32 110.19 4.41 Favored Pre-proline 0 N--CA 1.444 -0.747 0 O-C-N 123.73 0.643 . . . . 0.0 109.632 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.54 -18.14 53.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 112.339 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.03 -43.6 92.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.841 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.3 p -106.06 -17.88 14.2 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.15 26.77 12.54 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.714 0.806 . . . . 0.0 112.223 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.3 mtm -98.48 -64.99 0.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.51 175.591 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.66 -169.14 0.07 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.281 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 85.5 mt -94.99 104.51 16.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.529 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -70.82 -45.89 63.77 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.38 -176.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -110.17 -15.92 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.013 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.39 86.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.271 0.982 . . . . 0.0 112.174 -177.073 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 29.8 m -115.12 119.81 62.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.37 0.605 . . . . 0.0 111.638 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -80.33 136.0 36.32 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.75 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.479 ' HB ' HD21 ' A' ' 51' ' ' LEU . 31.2 p -98.24 159.34 30.9 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.138 176.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.93 -27.88 85.48 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.373 2.049 . . . . 0.0 112.771 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.6 p -77.61 -26.14 50.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.906 0.384 . . . . 0.0 111.41 178.683 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.52 43.11 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.436 175.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -130.77 133.58 46.12 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 88.2 mtm180 -104.99 134.35 48.24 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 120.998 0.427 . . . . 0.0 112.062 -178.234 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -135.31 -172.52 3.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.725 -176.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.5 m -89.84 151.89 21.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.143 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.91 -12.12 61.38 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 121.028 0.442 . . . . 0.0 111.853 -173.489 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.85 -18.44 12.27 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.653 -0.654 . . . . 0.0 110.713 -178.572 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.4 m -79.2 -45.94 18.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.071 0.463 . . . . 0.0 110.333 176.43 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.55 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.17 -40.49 82.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 C-N-CA 120.439 -0.505 . . . . 0.0 111.605 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.5 mt -63.15 -43.66 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -80.07 -1.64 40.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.299 0.571 . . . . 0.0 111.058 -174.036 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.2 p -106.5 -18.42 13.98 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 121.831 -0.543 . . . . 0.0 111.242 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.56 -18.47 6.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.127 -177.17 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -106.33 7.89 31.5 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.018 174.429 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -114.71 -54.3 2.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.291 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -69.47 0.61 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 0.0 109.805 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.13 159.43 32.8 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 176.518 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -77.64 67.92 3.63 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.887 0.851 . . . . 0.0 112.036 -179.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.52 150.97 35.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.219 177.573 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -76.05 129.77 79.87 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.968 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -22.54 74.39 Favored 'Trans proline' 0 N--CA 1.478 0.575 0 C-N-CA 122.97 2.447 . . . . 0.0 113.379 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.56 -72.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.208 0.528 . . . . 0.0 111.511 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -104.83 4.26 31.96 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.259 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.28 36.18 25.46 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.062 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -87.13 151.78 22.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.4 mp -66.07 119.82 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.479 HD21 ' HB ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -119.43 122.37 41.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.137 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -105.1 141.19 37.09 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.396 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.61 -39.36 94.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.261 0.553 . . . . 0.0 111.002 -175.08 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.01 -30.06 71.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.518 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -76.51 -8.01 56.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.08 -176.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 51' ' ' LEU . 96.5 mt -73.81 141.32 46.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.674 0.274 . . . . 0.0 110.836 179.175 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -151.93 148.12 21.06 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.699 178.219 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.34 146.1 97.62 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.779 2.319 . . . . 0.0 112.194 178.531 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.59 -42.88 98.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.657 177.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.01 -41.18 91.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.621 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -86.24 118.08 25.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.423 0.63 . . . . 0.0 111.912 -174.606 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.01 150.58 39.05 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.196 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--N 1.302 -1.499 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 178.699 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.681 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.99 146.78 66.09 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.597 2.198 . . . . 0.0 112.784 -177.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -100.28 117.4 34.4 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.06 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.05 -166.79 52.16 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -174.242 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.8 m -84.06 109.88 18.02 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 174.477 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -86.46 104.6 16.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.045 0.45 . . . . 0.0 110.635 -176.091 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -102.34 69.11 1.11 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.64 1.21 . . . . 0.0 110.379 175.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -143.42 129.16 19.32 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.525 -1.671 . . . . 0.0 107.546 -175.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -66.73 112.02 8.47 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 34.7 Cg_exo -61.82 -20.4 69.07 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.726 2.284 . . . . 0.0 112.432 -176.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.6 -43.93 90.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.69 178.348 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.1 p -105.55 -19.09 13.88 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.959 -176.416 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 57.16 23.12 8.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.921 0.888 . . . . 0.0 112.255 -179.327 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.5 mtm -96.0 -64.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.393 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.89 -165.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -174.594 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -103.93 125.97 50.71 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.078 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -80.18 -73.19 0.37 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.35 178.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -96.33 -16.59 21.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.05 90.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.121 0.968 . . . . 0.0 113.046 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 17.5 m -110.44 115.4 49.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.498 0.666 . . . . 0.0 111.136 175.015 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -82.56 133.49 35.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.662 176.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 39.1 p -93.11 164.99 19.48 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 30.7 Cg_endo -61.78 -26.36 79.5 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.169 1.912 . . . . 0.0 112.144 176.884 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 35.7 m -70.45 -28.33 64.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.092 0.473 . . . . 0.0 110.488 176.369 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.78 9.86 29.7 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.916 -177.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 24.3 m-70 -88.1 144.35 26.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.551 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -111.68 130.79 55.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.94 176.17 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.47 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 99.2 m-85 -132.07 172.72 12.02 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.559 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.471 ' O ' HG22 ' A' ' 33' ' ' ILE . 59.7 m -82.99 150.27 26.48 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.771 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.12 -8.63 55.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.424 0.63 . . . . 0.0 110.496 -175.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.67 -29.96 7.26 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 69.1 m -70.08 -46.06 65.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.03 175.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.482 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -68.42 -41.6 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.601 -178.406 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.7 mt -63.61 -42.33 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -77.23 -1.94 32.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.416 0.627 . . . . 0.0 110.225 -177.018 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 m -105.88 -25.41 12.15 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.772 174.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 33' ' ' ILE . 46.0 pt -103.49 -9.18 9.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.859 -176.507 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.6 ptm180 -94.18 2.13 55.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.628 0.728 . . . . 0.0 109.213 174.075 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.35 -55.08 2.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.56 -71.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.396 178.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -178.22 -179.26 48.14 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -89.55 81.22 6.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.24 0.543 . . . . 0.0 112.194 -177.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 9.5 ptpp? -170.55 144.27 2.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.734 175.216 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 p -72.02 123.8 89.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.83 -25.28 74.52 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.031 2.487 . . . . 0.0 113.554 -170.029 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.61 -46.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -175.788 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.63 6.69 8.2 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 61.16 34.21 19.0 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 177.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 69.5 mm-40 -91.17 141.23 29.03 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.908 175.064 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 50' ' ' ILE . 3.1 mp -66.57 121.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.123 0.487 . . . . 0.0 110.234 -174.153 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' H ' ' HA ' ' A' ' 43' ' ' LYS . 64.0 tp -126.85 128.75 47.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.735 -175.623 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -112.27 154.59 25.39 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.43 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -61.62 -37.08 82.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.117 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.93 -30.84 71.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.391 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 17.0 mm-40 -77.79 -9.16 58.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.239 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.62 139.5 45.52 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.669 -178.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -119.6 89.97 42.09 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 58.0 Cg_endo -69.24 141.84 48.51 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 121.917 1.744 . . . . 0.0 112.192 178.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -101.24 117.94 35.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.277 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.54 ' ND2' ' HD3' ' A' ' 63' ' ' LYS . 91.4 m-20 -81.56 86.97 6.27 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.658 0.742 . . . . 0.0 112.867 -171.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -69.27 -38.04 78.2 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.46 151.85 26.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.167 175.408 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.54 ' HD3' ' ND2' ' A' ' 60' ' ' ASN . 61.8 pttt . . . . . 0 C--N 1.307 -1.241 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.663 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.193 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.87 141.0 97.65 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.57 2.18 . . . . 0.0 112.109 -175.677 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.8 tt 51.29 84.85 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.23 1.012 . . . . 0.0 110.252 -175.58 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.52 -55.58 0.6 Allowed Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.309 -179.126 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.0 p -138.76 73.95 1.45 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.667 -0.413 . . . . 0.0 112.112 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -75.87 -33.64 59.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.551 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -85.59 67.79 10.2 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.359 1.076 . . . . 0.0 110.147 173.535 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.56 120.9 35.16 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.098 -175.357 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.539 ' HB2' HD23 ' A' ' 16' ' ' LEU . 33.8 t -77.55 116.17 55.75 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.835 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -60.97 -20.86 69.24 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.037 1.825 . . . . 0.0 112.605 -177.225 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.89 -45.05 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.618 0.247 . . . . 0.0 111.376 178.324 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 12.0 p -109.06 -22.26 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.405 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 59.23 22.9 11.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.245 1.018 . . . . 0.0 112.121 -177.386 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -95.57 -66.46 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.34 176.393 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.08 -172.46 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.883 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.4 mt -107.44 124.98 50.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.684 0.278 . . . . 0.0 110.31 175.199 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 19' ' ' ALA . 22.9 tpt180 -92.76 114.71 27.34 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.253 168.936 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 68.75 -16.21 0.22 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.594 1.158 . . . . 0.0 112.811 -179.445 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . . . 50.31 82.78 0.05 OUTLIER 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 113.329 177.161 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.2 m -97.01 116.56 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.626 0.727 . . . . 0.0 110.474 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.65 142.6 32.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.844 -179.296 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -93.17 163.65 24.35 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.628 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.91 -34.17 96.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.701 2.268 . . . . 0.0 111.935 176.6 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.06 -14.47 62.69 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.122 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.82 23.26 18.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.283 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -106.93 129.9 54.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.359 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -106.24 132.95 51.69 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.588 -173.776 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.23 167.84 19.63 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.455 -176.656 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.426 ' O ' HG22 ' A' ' 33' ' ' ILE . 85.1 m -71.62 147.82 47.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.753 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -67.88 -4.89 14.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.728 -179.33 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.97 -38.86 3.79 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.167 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.77 -46.1 80.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -66.36 -41.63 89.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.953 -173.96 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.581 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.3 mt -63.61 -43.43 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.411 . . . . 0.0 110.128 -178.534 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -79.4 -2.08 40.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.855 -176.086 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 m -106.77 -20.24 13.4 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.649 177.016 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -103.15 -24.03 4.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.226 -174.588 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.2 ptm180 -99.95 7.4 44.84 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.115 176.124 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.26 -56.69 2.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.539 -178.336 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.08 -67.64 0.8 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.527 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.05 159.12 32.3 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.093 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.406 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 75.9 m80 -86.29 64.89 8.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.584 0.707 . . . . 0.0 111.916 -176.611 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.1 ptpt -154.44 150.31 27.73 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.34 176.834 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -70.33 135.41 86.66 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.886 0.374 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.18 -23.94 75.86 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.101 2.534 . . . . 0.0 114.305 -171.698 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 m -91.39 -55.46 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.354 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -103.68 4.89 35.93 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.105 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 50.97 33.95 9.78 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.599 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 80.8 mm-40 -86.36 147.0 26.23 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.721 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.59 120.4 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 109.718 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.6 tp -120.2 130.59 54.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.223 -174.099 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.12 153.47 28.17 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.43 -36.34 83.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.43 -31.02 72.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.681 176.295 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -77.97 -8.61 58.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.683 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.81 131.05 41.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.614 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -75.2 157.58 84.89 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.181 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.68 165.02 21.95 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.126 2.551 . . . . 0.0 111.999 177.55 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -54.26 148.77 10.87 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.661 -174.664 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 29.5 t30 -60.33 -76.42 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.981 -178.467 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -160.23 133.6 6.86 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.493 -175.907 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.89 98.3 0.73 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.113 0.482 . . . . 0.0 110.134 177.9 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 tptt . . . . . 0 C--N 1.308 -1.196 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.036 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.37 -36.16 86.51 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.584 2.856 . . . . 0.0 113.092 -178.974 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.7 mt -106.45 122.7 46.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 120.942 0.401 . . . . 0.0 110.55 175.819 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.65 -7.38 42.28 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 174.087 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.9 p -85.35 -6.04 59.26 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.438 0.695 . . . . 0.0 111.067 -178.45 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -80.3 178.47 8.26 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.877 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -90.47 85.26 6.1 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.65 0.738 . . . . 0.0 111.314 -171.695 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -169.71 127.46 0.91 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.317 179.318 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 1.4 p -92.67 134.31 27.98 Favored Pre-proline 0 C--N 1.313 -0.996 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.607 -177.305 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 9' ' ' CYS . 32.3 Cg_exo -59.9 -19.85 56.94 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.869 2.379 . . . . 0.0 112.19 -178.115 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.02 -44.94 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.092 -177.173 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -120.31 -20.21 7.37 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.253 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt 60.52 27.96 17.62 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.873 0.869 . . . . 0.0 111.908 -173.499 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.1 mtm -103.16 175.34 5.51 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.092 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.22 148.37 49.94 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.505 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.1 mt -78.76 130.43 35.75 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.794 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -68.1 -60.28 2.6 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -107.52 -15.05 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -178.263 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.01 90.23 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.792 -177.494 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 116.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.684 0.754 . . . . 0.0 111.368 179.762 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -81.15 136.86 35.94 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.709 177.289 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.2 p -94.59 160.37 31.66 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.777 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -54.71 -37.52 91.6 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 112.525 178.107 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.37 -20.56 62.95 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 178.386 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.8 4.29 24.64 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.442 174.067 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.529 ' HE1' ' OD2' ' A' ' 47' ' ' ASP . 43.2 m80 -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.241 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -101.56 132.58 47.13 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.322 177.084 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 97.5 m-85 -132.71 165.39 24.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.479 179.432 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -80.97 159.52 24.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.037 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.3 tttt -76.8 -12.93 60.05 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.326 -172.043 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.91 -10.95 12.88 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 -179.383 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.5 m -85.45 -57.87 2.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.334 177.787 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -66.77 -41.04 87.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -175.909 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.634 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.9 mt -63.24 -43.49 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 111.078 -177.099 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -79.33 -1.47 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -176.751 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -104.61 -17.82 14.55 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.32 177.33 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -104.34 -30.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.923 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.1 ptm180 -96.72 2.39 51.98 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.442 178.113 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -115.9 -54.63 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.302 179.5 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.81 -69.17 0.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 0.0 110.524 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -164.8 155.14 26.37 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 176.893 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -80.04 70.41 6.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.528 0.664 . . . . 0.0 111.686 -177.296 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.94 152.21 39.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.919 178.571 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 52.3 t -74.65 122.95 88.64 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.706 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 51.7 Cg_exo -57.48 -34.25 97.7 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.241 2.627 . . . . 0.0 114.278 -172.066 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 m -83.19 -50.72 15.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -172.472 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.529 ' OD2' ' HE1' ' A' ' 26' ' ' HIS . 48.3 p-10 -104.68 5.19 33.33 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.66 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.1 32.68 20.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.721 0.808 . . . . 0.0 112.29 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -87.75 149.0 24.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.198 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.84 121.32 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.29 119.68 32.91 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.389 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.632 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -102.54 153.7 19.82 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.08 -178.671 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.41 -40.09 96.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.465 0.706 . . . . 0.0 111.532 -174.005 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -68.37 -20.8 64.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.705 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.632 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.3 mm100 -75.11 -9.95 59.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.444 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.56 138.58 46.97 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.377 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -113.31 106.87 54.23 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.993 177.433 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.89 155.95 57.16 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.64 2.227 . . . . 0.0 111.676 176.857 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -60.96 134.49 57.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.929 -179.312 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -63.21 -46.2 88.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 -175.254 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -66.11 -46.06 78.92 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.022 0.439 . . . . 0.0 111.643 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.88 87.51 4.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.387 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp . . . . . 0 C--N 1.315 -0.914 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.907 -173.654 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.245 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.07 152.43 62.46 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.815 2.344 . . . . 0.0 111.606 177.52 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.65 119.39 31.49 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.708 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.73 172.23 48.68 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -176.092 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -109.41 118.88 37.8 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.533 178.616 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -145.9 172.66 13.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.221 -179.457 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.535 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 91.0 m-85 60.67 37.64 19.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -173.984 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -121.69 133.17 54.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.9 -175.443 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.0 t -79.82 109.22 11.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.678 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.84 -19.42 65.54 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.863 2.375 . . . . 0.0 112.722 -175.265 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.93 -43.82 92.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.006 0.431 . . . . 0.0 111.26 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.38 -21.05 15.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.789 -177.018 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 65.94 20.33 11.32 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 111.633 -177.699 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -99.64 -71.03 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.088 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.33 -162.6 0.13 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -174.311 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.2 mt -106.57 125.82 51.48 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.182 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -84.47 -71.35 0.52 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.896 175.31 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -89.76 -16.23 30.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.82 178.707 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.89 77.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.252 0.621 . . . . 0.0 111.592 -176.953 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 21.1 m -92.3 116.8 34.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.042 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.31 129.89 34.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.732 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -92.27 164.9 21.25 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.338 177.631 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.58 -36.44 94.54 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 112.32 178.265 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.7 -20.49 62.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.071 -178.135 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.0 6.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.98 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -113.33 154.35 27.0 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.459 -0.436 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 81.9 mtm180 -123.47 137.56 54.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.048 0.452 . . . . 0.0 111.522 -176.321 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' O ' HG22 ' A' ' 20' ' ' VAL . 95.7 m-85 -138.91 172.93 12.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.75 -177.104 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.0 m -84.74 153.85 22.79 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.725 0.298 . . . . 0.0 110.33 175.647 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.15 -14.78 63.24 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.837 0.855 . . . . 0.0 111.886 -176.466 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.78 -13.81 12.01 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.048 -176.766 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 52.5 m -87.84 -47.91 8.24 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.078 177.772 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -68.36 -38.51 79.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.8 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.8 mt -62.67 -42.43 96.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.425 . . . . 0.0 110.561 -177.769 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 39' ' ' ASP . 29.2 tptp -77.64 -1.66 32.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.806 0.813 . . . . 0.0 109.962 -178.542 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.2 t -105.3 -21.82 13.17 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.88 -0.513 . . . . 0.0 109.982 177.009 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.5 pt -104.97 -28.06 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.391 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -96.01 -7.55 36.05 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.708 177.902 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 38.7 t70 -115.11 -40.95 3.39 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.308 -175.298 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 36' ' ' SER . . . -91.66 -72.94 0.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.969 0.414 . . . . 0.0 110.012 176.587 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.17 157.61 30.14 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.927 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -82.82 69.67 9.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.493 0.663 . . . . 0.0 111.979 -176.3 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -150.91 153.11 34.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.796 -179.781 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 p -77.34 133.56 67.81 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.039 171.793 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.07 -23.8 75.99 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 123.015 2.477 . . . . 0.0 114.244 -170.654 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -90.5 -61.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.206 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -100.91 4.22 42.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.637 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 56.33 35.23 25.49 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.046 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 71.2 mm-40 -83.5 150.67 25.85 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.782 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -66.71 121.18 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.109 0.48 . . . . 0.0 109.903 -177.719 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -126.7 129.86 49.25 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.325 -175.883 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.87 156.49 23.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.622 178.478 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 38' ' ' ARG . 54.6 mp0 -61.23 -39.05 88.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.612 0.365 . . . . 0.0 110.66 -178.894 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -74.96 -10.2 59.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 0.0 111.407 179.563 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -91.48 -7.76 49.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.026 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 96.5 mt -73.84 155.42 38.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.774 179.059 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 97.2 m-85 80.29 149.4 0.12 Allowed Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.451 1.101 . . . . 0.0 111.728 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.56 148.01 94.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.363 2.042 . . . . 0.0 109.58 173.6 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -57.89 108.67 0.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.0 0.429 . . . . 0.0 111.064 -176.454 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -149.2 133.4 17.34 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.339 176.511 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -122.39 104.58 9.5 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.738 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.09 165.7 30.03 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.128 -174.7 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? . . . . . 0 C--N 1.312 -1.062 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.268 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.469 0.851 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.418 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 39.0 Cg_exo -60.88 139.33 84.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.424 2.082 . . . . 0.0 112.44 -177.626 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.93 -43.02 89.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.496 0.665 . . . . 0.0 110.683 177.596 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.85 74.4 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -178.867 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.9 p -74.56 101.25 4.14 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -168.248 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -86.16 -5.93 59.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.832 172.644 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.78 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 88.6 t80 -63.91 -16.18 60.82 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.556 170.247 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 44.2 mt-10 -100.3 115.85 30.91 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.466 174.791 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 16.6 t -56.27 112.95 5.01 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.494 177.697 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' CYS . 32.4 Cg_exo -62.1 -20.95 71.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.7 2.267 . . . . 0.0 112.461 -173.569 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.49 -44.07 90.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.464 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -108.09 -21.25 12.87 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.647 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 56.53 30.23 16.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.824 0.849 . . . . 0.0 111.754 -175.265 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -96.29 -66.91 0.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 173.838 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -179.53 -172.65 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -176.988 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 95.5 mt -93.93 103.61 15.7 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.273 174.13 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -66.51 -43.97 83.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.904 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.549 ' HA ' ' OD1' ' A' ' 60' ' ' ASN . 76.3 mm-40 -123.0 -15.02 7.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.797 179.587 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.93 56.54 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.203 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 28' ' ' PHE . 27.3 m -76.84 116.09 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.36 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.401 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 61.0 tt0 -80.6 121.32 25.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.527 -176.438 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -88.8 160.83 43.16 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.55 -30.75 89.56 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 178.67 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -14.72 62.89 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.319 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.02 5.07 44.46 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.375 -0.916 . . . . 0.0 114.251 174.518 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.79 168.33 10.56 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.434 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.6 mtt180 -127.3 142.22 51.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 112.016 -169.784 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.471 ' O ' HG22 ' A' ' 20' ' ' VAL . 99.2 m-85 -131.42 170.23 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.769 178.583 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 53.3 m -80.19 148.19 30.98 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.555 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -68.62 -13.16 62.17 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -174.414 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.21 -17.8 12.69 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.8 m -79.59 -45.51 19.03 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.665 173.107 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -66.47 -40.95 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.832 -176.641 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.84 -42.63 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 111.006 -179.15 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -78.72 -1.9 36.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.352 0.596 . . . . 0.0 110.149 -174.737 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 m -105.32 -23.08 12.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.299 177.296 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.9 pt -104.76 -5.36 9.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.256 -177.784 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -96.82 -15.73 21.15 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.618 176.968 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -116.52 -56.09 2.32 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.145 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.28 -65.79 0.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 110.692 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.86 155.36 26.6 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -84.65 54.62 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 122.073 0.94 . . . . 0.0 109.111 -176.204 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -147.44 154.17 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.301 -175.357 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 45.3 t -61.65 123.02 75.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.112 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 50.7 Cg_exo -57.05 -35.82 99.06 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.166 2.577 . . . . 0.0 114.123 -172.042 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -82.67 -45.96 19.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.12 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -114.95 5.57 15.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.934 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 56.58 33.45 22.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.337 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -92.2 149.71 21.32 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.209 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.4 121.66 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.074 0.464 . . . . 0.0 110.589 -176.698 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 tp -126.13 127.81 46.34 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.224 -179.746 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.48 143.91 30.9 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.656 176.78 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.53 -36.59 84.27 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.303 1.041 . . . . 0.0 110.203 -175.604 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.4 -30.25 71.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.973 177.846 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -64.89 -29.11 70.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.146 0.498 . . . . 0.0 110.884 179.54 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.84 142.11 53.14 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.556 -176.7 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -65.12 143.7 98.9 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.842 -177.137 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.42 -43.48 51.32 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.956 2.437 . . . . 0.0 112.772 177.173 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -178.93 154.28 0.69 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.782 0.325 . . . . 0.0 111.049 -176.152 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' HA ' ' A' ' 18' ' ' GLU . 5.2 p-10 -116.94 -1.42 11.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.707 0.765 . . . . 0.0 109.19 168.807 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -113.28 122.63 48.01 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.623 -176.764 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.16 128.17 35.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.141 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 tttp . . . . . 0 C--O 1.25 1.113 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -176.291 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.069 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.46 150.72 75.78 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.819 2.346 . . . . 0.0 111.54 179.054 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.7 tp -67.18 104.65 1.5 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.083 0.468 . . . . 0.0 111.671 -177.221 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.86 -7.48 23.55 Favored Glycine 0 N--CA 1.44 -1.033 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 175.548 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -72.65 150.36 43.06 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.665 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' O ' ' HD2' ' A' ' 27' ' ' ARG 0.273 21.3 pttm -74.05 67.59 1.31 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.747 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.659 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 94.8 m-85 -119.57 13.77 12.59 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.688 167.095 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -119.25 137.08 53.9 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.975 -179.552 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.488 ' HB2' HD23 ' A' ' 16' ' ' LEU . 41.8 t -83.75 110.81 27.68 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -177.769 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.43 -18.81 49.65 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.069 1.846 . . . . 0.0 112.301 -176.663 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.52 -43.51 90.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 178.874 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 25.4 p -109.83 -6.41 15.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.526 -176.687 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.89 33.19 22.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.902 0.881 . . . . 0.0 111.1 -175.593 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -127.52 167.44 16.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.379 178.893 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 151.12 37.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 93.7 mt -69.89 118.35 12.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.867 0.365 . . . . 0.0 110.393 -173.416 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -69.39 -45.62 68.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.323 179.446 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -116.92 -16.54 10.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.04 87.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.135 0.897 . . . . 0.0 112.737 -178.242 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 28' ' ' PHE . 35.2 m -105.39 117.23 50.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.51 0.672 . . . . 0.0 111.476 176.204 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -73.16 132.54 43.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.137 175.155 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 61.8 p -106.29 159.04 31.16 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 178.759 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 35.9 Cg_endo -62.8 -24.41 74.52 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.88 2.386 . . . . 0.0 113.01 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.1 p -79.48 -14.66 58.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 111.203 178.483 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.61 8.36 37.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.566 175.959 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -99.23 162.05 13.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.696 0.248 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 77.5 mtt85 -124.1 137.61 54.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.916 0.389 . . . . 0.0 110.214 177.824 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 20' ' ' VAL . 90.8 m-85 -138.23 167.49 21.73 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.537 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.0 m -76.28 156.7 33.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.083 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.73 -3.97 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.139 0.495 . . . . 0.0 111.382 -170.669 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.74 -26.59 7.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.761 0.315 . . . . 0.0 110.381 178.737 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -71.86 -45.9 59.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.318 179.377 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -65.96 -38.24 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.238 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.2 mt -62.25 -42.31 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 110.386 177.987 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.84 -0.5 30.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.656 0.741 . . . . 0.0 110.452 -177.332 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -104.75 -25.33 12.71 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.915 -0.49 . . . . 0.0 109.793 177.325 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.1 pt -103.81 -15.17 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.001 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -106.78 -2.34 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.286 175.244 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.67 -50.79 2.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.733 -175.562 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.69 -68.8 0.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 -179.784 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.25 154.76 25.83 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 178.512 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -81.01 45.4 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.65 0.738 . . . . 0.0 110.927 -173.432 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -144.25 154.42 43.07 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.956 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.0 p -64.1 135.41 96.31 Favored Pre-proline 0 N--CA 1.445 -0.688 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.257 177.499 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.23 -29.61 80.58 Favored 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 122.839 2.359 . . . . 0.0 113.593 -172.599 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.86 -71.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.18 0.514 . . . . 0.0 111.697 -174.028 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -95.65 4.56 52.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.549 -173.829 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 56.93 34.17 24.43 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 169.39 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -87.45 141.96 28.23 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.624 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.5 mp -65.24 119.5 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.895 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 56' ' ' LEU . 10.2 tt -110.51 127.67 55.28 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -168.49 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.88 132.87 42.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.913 178.54 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.26 -35.43 80.4 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -173.994 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -63.56 -29.72 70.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 178.108 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -80.34 -7.86 59.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.503 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 51' ' ' LEU . 95.6 mt -70.23 125.97 28.32 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.956 177.205 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 30.2 t80 69.8 145.19 0.11 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.967 0.907 . . . . 0.0 109.789 -179.342 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 57' ' ' PHE . 33.5 Cg_endo -61.51 148.82 92.05 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.928 1.752 . . . . 0.0 111.877 178.05 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -61.36 122.28 14.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.473 -173.843 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -99.2 145.7 26.96 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.706 -179.411 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -111.57 126.57 55.14 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.797 174.73 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.13 89.99 6.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.16 0.505 . . . . 0.0 111.16 -176.063 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm . . . . . 0 C--N 1.31 -1.109 0 CA-C-O 118.503 -0.76 . . . . 0.0 108.983 175.589 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.97 144.96 96.95 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.805 2.336 . . . . 0.0 111.149 176.603 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.0 tt -75.25 127.72 33.81 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.162 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.36 -3.46 58.02 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.724 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.3 m -130.63 150.86 51.63 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.791 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.42 146.49 32.52 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.339 179.524 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.574 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 92.7 m-85 -101.11 41.65 1.17 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.487 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -123.18 124.41 42.97 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.871 -172.579 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.92 112.52 9.95 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.712 0.632 . . . . 0.0 109.689 175.864 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -63.12 -20.37 70.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.248 1.966 . . . . 0.0 112.87 -178.343 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -66.08 -44.43 91.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.2 p -105.24 -19.19 13.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.635 -177.791 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 57.0 26.7 12.22 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.791 0.836 . . . . 0.0 111.797 -176.658 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.88 -65.73 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.023 0.44 . . . . 0.0 110.469 176.689 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.3 -164.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -177.326 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 92.9 mt -103.3 113.76 27.5 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 172.512 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -63.91 -44.98 91.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 178.018 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -132.52 -7.18 3.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 178.608 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.15 92.47 0.07 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 175.623 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -117.19 111.63 35.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 110.289 171.594 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -80.94 143.43 32.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.385 178.638 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -108.82 154.68 41.66 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.272 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 55' ' ' GLN . 40.6 Cg_endo -65.37 -20.01 61.6 Favored 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 122.742 2.295 . . . . 0.0 111.463 177.448 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.4 t -73.99 -15.06 61.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.077 179.01 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.07 22.2 18.23 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.234 178.4 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -113.03 152.12 29.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.587 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -120.01 136.04 54.7 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.696 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 94.8 m-85 -136.67 172.99 12.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.092 0.472 . . . . 0.0 110.502 -177.024 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -82.01 152.0 26.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 171.05 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.0 tttt -68.87 -10.7 58.44 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -177.489 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 -12.32 12.82 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.711 -0.618 . . . . 0.0 110.205 179.325 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 70.9 m -85.92 -62.94 1.41 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.982 177.573 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.4 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.1 tp -67.79 -39.9 82.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.062 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.737 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.5 mt -63.04 -43.38 98.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 0.0 110.523 -178.504 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -79.53 0.79 28.34 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.714 0.768 . . . . 0.0 109.729 -178.561 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 t -106.38 -23.76 12.44 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.992 -0.442 . . . . 0.0 110.83 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.0 pt -103.96 -26.09 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.384 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -97.41 3.43 50.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.423 0.63 . . . . 0.0 109.773 176.553 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -116.66 -55.88 2.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.76 -72.93 0.52 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.108 179.809 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -158.46 160.46 30.98 Favored Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 178.55 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -85.42 71.08 10.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.373 0.606 . . . . 0.0 111.162 -176.242 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -152.22 150.61 30.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.764 178.023 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 9.2 p -79.9 122.03 82.84 Favored Pre-proline 0 N--CA 1.429 -1.519 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.689 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.98 -18.43 62.16 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.652 2.235 . . . . 0.0 113.274 -170.712 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.0 -48.44 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -133.53 13.77 4.1 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.621 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER 63.04 21.44 12.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 174.214 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 72.2 mm-40 -72.66 142.52 48.28 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.564 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.5 mm -66.4 121.05 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.973 0.416 . . . . 0.0 110.605 -176.39 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.1 tp -128.16 134.4 49.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.056 -177.456 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -116.89 155.27 29.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.534 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' A' ' 38' ' ' ARG . 48.8 mt-10 -62.85 -36.48 83.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.16 0.505 . . . . 0.0 110.299 179.273 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.13 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.931 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.477 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.6 mm100 -79.8 -7.69 58.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.489 -174.082 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.01 140.99 50.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.966 0.413 . . . . 0.0 110.844 179.839 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -77.17 147.26 76.21 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.116 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -55.99 139.6 84.99 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.399 2.066 . . . . 0.0 113.476 -174.481 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -83.39 147.48 27.87 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.929 -179.23 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -143.28 100.24 3.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.206 0.527 . . . . 0.0 111.697 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -151.01 106.72 3.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 173.154 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' O ' ' HD2' ' A' ' 63' ' ' LYS . . . -99.75 111.72 24.02 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -169.051 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 31.7 mmmt . . . . . 0 C--O 1.243 0.728 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.364 176.067 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.069 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.95 148.73 51.94 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.467 2.111 . . . . 0.0 111.641 177.226 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.22 97.25 7.79 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.822 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.84 -23.1 24.04 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.7 179.463 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.7 t -146.92 145.18 29.71 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.612 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.75 79.45 8.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.745 0.783 . . . . 0.0 109.272 -176.897 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.493 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 60.7 t80 -115.83 16.24 16.29 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.481 -176.018 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -102.93 135.06 45.31 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.93 -176.836 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB2' HD23 ' A' ' 16' ' ' LEU . 46.9 t -96.19 109.41 47.05 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.39 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.22 -19.47 62.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.038 1.825 . . . . 0.0 112.736 -174.438 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.61 -43.92 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.832 0.349 . . . . 0.0 111.288 178.284 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.6 p -106.51 -4.38 19.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.696 -177.131 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt 55.16 34.35 22.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.349 0.66 . . . . 0.0 111.135 -177.518 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -133.12 -174.76 3.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.368 179.286 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.17 157.38 37.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.578 HD23 ' HB2' ' A' ' 9' ' ' CYS . 95.1 mt -70.62 134.33 47.49 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -86.05 -73.45 0.45 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.783 177.64 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -93.1 -16.35 25.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 178.125 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.32 66.46 1.23 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.183 -179.29 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.5 m -85.36 117.7 30.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.135 0.493 . . . . 0.0 111.114 -179.367 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -79.55 133.38 36.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.318 -177.095 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -101.34 157.67 33.23 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.472 -178.617 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -56.84 -33.51 94.83 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.713 2.276 . . . . 0.0 112.509 178.992 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 p -69.49 -26.08 64.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.98 -178.4 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.56 51.1 0.72 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.135 -178.225 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 38.7 m80 -138.51 159.68 41.46 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 122.732 0.413 . . . . 0.0 110.909 177.582 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -126.27 135.73 51.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.169 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.436 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.6 m-85 -139.7 169.76 17.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.522 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 24.5 m -79.2 152.09 30.87 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 173.099 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.23 -13.57 62.48 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -173.877 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.08 -3.49 13.97 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.632 -178.771 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.7 m -91.55 -59.62 2.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.401 174.663 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.1 tp -68.46 -39.75 81.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.435 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.3 mt -63.13 -41.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.057 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.07 -0.97 30.08 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.555 0.693 . . . . 0.0 109.628 -178.265 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.25 -18.68 13.93 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.075 -0.391 . . . . 0.0 111.323 175.418 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -105.06 -30.08 2.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -177.118 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptm180 -98.4 4.19 48.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.554 178.999 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.56 -56.15 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.641 -179.023 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 -74.38 0.36 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 178.634 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.51 155.7 26.88 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 33.5 m80 -79.23 66.06 4.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.078 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.2 ptpp? -152.54 149.81 28.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.223 174.435 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 2.8 p -74.4 127.12 88.13 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.263 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.24 -23.81 77.76 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.282 2.655 . . . . 0.0 113.806 -171.197 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.437 HG13 ' OD1' ' A' ' 47' ' ' ASP . 4.4 p -77.1 -51.11 19.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.112 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' OD1' HG13 ' A' ' 46' ' ' VAL . 13.0 p-10 -117.59 6.4 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.1 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 59.66 35.01 22.32 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.6 mm-40 -95.41 140.13 30.72 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.978 -0.451 . . . . 0.0 110.677 176.8 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 2.4 mp -65.65 121.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.087 0.47 . . . . 0.0 110.131 -176.544 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -122.73 134.59 54.45 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.62 -176.327 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.432 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 88.9 mt -114.36 147.65 38.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.933 178.752 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.45 ' OE2' ' HB3' ' A' ' 38' ' ' ARG . 53.8 mp0 -62.75 -35.89 81.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 0.0 109.464 179.179 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -65.52 -29.77 70.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.239 -179.639 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 18.5 mm-40 -71.18 -27.79 63.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.166 0.508 . . . . 0.0 111.353 177.713 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.05 149.51 39.16 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.99 -179.236 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -61.16 133.88 92.91 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.806 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.53 -49.77 13.87 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.384 2.056 . . . . 0.0 112.752 -174.513 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.44 36.08 6.75 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.422 0.629 . . . . 0.0 112.099 -179.82 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -112.69 -70.27 0.82 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.04 -174.332 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -62.33 -46.11 90.19 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -175.085 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.17 13.21 9.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.799 -175.413 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm . . . . . 0 C--O 1.252 1.211 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.217 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -55.91 -39.51 90.7 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.281 2.654 . . . . 0.0 112.882 -179.392 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 tt -123.98 125.3 44.35 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.415 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.81 86.81 0.44 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.805 -178.867 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p -79.2 -2.23 40.03 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -175.071 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -71.17 -9.33 57.91 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.558 0.694 . . . . 0.0 110.414 173.343 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.608 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 98.0 m-85 -102.36 12.1 37.08 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.56 174.943 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -102.59 119.14 38.31 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.068 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.3 t -54.93 112.49 4.13 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.083 0.553 . . . . 0.0 110.684 179.432 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -62.21 -20.53 70.31 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.926 2.417 . . . . 0.0 113.35 -175.926 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -67.71 -44.74 85.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.336 176.229 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.45 -25.95 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.161 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 63.98 23.58 13.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.175 0.59 . . . . 0.0 111.787 -178.17 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -95.34 -66.3 0.92 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 109.64 178.913 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.69 -163.44 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -176.91 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 95.4 mt -106.23 124.81 50.16 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.812 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -79.06 -60.37 2.4 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.19 174.299 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -105.97 -14.98 15.03 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.252 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.45 90.83 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.978 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.2 117.4 52.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.035 0.445 . . . . 0.0 110.475 175.373 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -80.74 133.69 35.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.204 178.726 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.3 p -88.02 161.14 44.75 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 179.507 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.2 -29.82 88.71 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.097 2.531 . . . . 0.0 112.1 177.437 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.16 -21.2 63.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 179.52 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.84 36.67 2.34 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.813 173.825 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -149.74 167.22 27.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.352 0.576 . . . . 0.0 111.944 176.433 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -109.52 140.76 42.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.149 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.5 m-85 -132.49 167.19 20.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.962 173.249 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.577 ' O ' HG22 ' A' ' 33' ' ' ILE . 38.2 m -84.81 150.15 25.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.507 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.02 -8.83 56.11 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -172.573 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.73 -28.35 7.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.022 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -65.31 -52.96 50.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.362 0.601 . . . . 0.0 110.208 176.522 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -70.35 -40.5 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.947 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.48 -43.21 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.516 -176.749 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -78.88 -2.01 37.81 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.567 0.699 . . . . 0.0 110.359 -176.698 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 48.4 m -105.74 -18.56 14.03 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 175.683 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.7 pt -104.29 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.115 -178.267 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -95.08 -4.33 46.52 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.889 177.59 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.51 -47.49 2.73 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.398 -177.085 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 36' ' ' SER . . . -87.59 -69.69 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.03 157.71 30.3 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.534 179.047 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -87.91 18.59 4.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -176.41 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -95.92 140.83 30.12 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.005 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 53.0 t -60.79 130.85 91.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.36 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.51 -29.18 88.08 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -172.091 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.96 -55.63 5.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -103.2 4.38 36.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -173.137 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 56.6 29.5 15.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 173.898 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -79.81 145.54 32.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.462 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.36 119.5 13.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 179.012 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -125.45 131.78 52.82 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.437 -172.581 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.77 156.86 27.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -38.45 85.49 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.855 0.36 . . . . 0.0 110.952 -176.878 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -65.2 -30.51 71.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.826 178.723 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -80.15 -12.03 59.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.898 -176.068 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 33' ' ' ILE . 82.0 mt -76.65 100.39 5.35 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.024 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 84.5 t80 64.67 113.02 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -167.911 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.15 143.38 74.86 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.183 1.922 . . . . 0.0 111.849 -170.794 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -70.33 80.49 0.54 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.309 1.052 . . . . 0.0 112.988 -169.901 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -106.21 63.83 0.66 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.475 177.23 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -136.66 142.42 43.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.266 -178.288 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.54 144.73 41.77 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.145 177.594 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.31 -1.148 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.509 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.599 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.28 -29.58 80.22 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.936 2.424 . . . . 0.0 113.891 -176.802 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.6 tp -122.35 112.75 18.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.217 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.25 23.63 64.49 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.435 -0.802 . . . . 0.0 114.521 169.684 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -154.52 86.2 1.14 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.157 0.503 . . . . 0.0 110.695 -179.852 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -101.37 68.93 1.23 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.609 1.195 . . . . 0.0 111.731 179.109 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 98.3 m-85 -102.76 12.37 36.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.346 174.924 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -117.64 122.17 42.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.989 175.572 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 44.8 t -61.92 112.66 6.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.192 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -62.06 -21.32 72.21 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.569 2.18 . . . . 0.0 112.793 -174.254 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.39 -44.17 90.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.085 0.469 . . . . 0.0 111.777 179.53 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.5 p -106.06 -19.37 13.74 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.598 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 10' ' ' PRO . 98.2 mt 53.47 28.47 7.65 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -175.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -95.61 -65.5 0.97 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.259 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.66 -171.47 0.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.2 mt -97.58 109.06 21.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.28 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -70.28 -44.68 67.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.806 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 54.7 mm-40 -111.9 -16.48 13.12 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.098 -177.14 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.41 82.19 0.09 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 177.407 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.95 116.68 51.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 110.972 175.963 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -81.22 125.42 30.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.285 176.553 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -75.76 157.29 84.09 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.97 -23.69 76.08 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.375 2.05 . . . . 0.0 112.34 177.77 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 7.8 p -77.85 -20.76 52.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.617 176.876 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.76 43.53 1.42 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.024 -1.084 . . . . 0.0 114.232 174.537 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.55 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 87.3 m-70 -130.86 152.55 50.07 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.175 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -113.02 132.78 55.25 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.534 178.187 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 97.0 m-85 -138.25 167.64 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.123 -178.988 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 42.4 m -78.31 151.86 32.73 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.204 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.526 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 88.0 tttt -68.49 -13.45 62.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -171.062 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.92 -27.09 7.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.885 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.8 m -64.59 -46.79 81.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.299 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -69.43 -41.37 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.145 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 80.8 mt -63.57 -42.67 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.153 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -79.42 -0.54 33.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -177.958 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -105.29 -21.72 13.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.051 176.793 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.6 pt -104.89 -13.68 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.33 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -108.18 -1.7 20.05 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.557 175.873 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -122.23 -57.58 1.76 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.033 -179.867 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.84 -65.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.647 -178.553 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -157.09 159.2 29.48 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.546 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -79.88 -8.84 59.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.474 0.637 . . . . 0.0 110.992 -176.611 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 20.2 ptpt -81.29 149.33 29.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.121 176.591 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 51.0 t -58.8 125.97 79.0 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.751 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.92 -22.01 73.44 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.018 2.478 . . . . 0.0 113.514 -167.993 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -97.79 -48.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.443 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' CG ' ' HE2' ' A' ' 26' ' ' HIS . 53.9 p-10 -108.98 5.86 24.65 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.921 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 58.63 32.73 22.47 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 176.22 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -97.54 137.39 36.55 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.205 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' LYS . 46.6 mm -65.81 120.92 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.599 -177.458 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 37' ' ' ILE . 49.7 tp -109.7 130.22 55.53 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.99 -172.467 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.59 135.55 40.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 -176.486 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.53 -36.76 84.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.401 -179.562 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -63.58 -31.83 73.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.883 -177.342 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.7 mm-40 -71.65 -25.05 61.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 111.481 179.641 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.69 131.15 38.64 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 -175.732 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 80.7 t80 65.03 108.59 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 124.47 1.108 . . . . 0.0 112.646 176.453 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -60.58 144.96 99.58 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.556 2.171 . . . . 0.0 109.868 173.934 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -59.78 126.81 29.04 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.587 0.708 . . . . 0.0 112.199 -172.38 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -169.54 124.52 0.82 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.727 178.513 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -148.23 154.36 39.97 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.375 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.64 101.36 12.85 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.795 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 tptp . . . . . 0 C--N 1.306 -1.3 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.851 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.988 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.13 148.32 85.05 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.009 2.472 . . . . 0.0 113.514 -178.321 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.12 -45.41 92.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.536 -177.981 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.2 93.58 1.7 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.067 -176.779 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.8 m -143.17 -74.87 0.27 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 177.242 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 179.8 26.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.834 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' C ' ' HG ' ' A' ' 16' ' ' LEU . 93.2 m-85 -114.24 15.69 18.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.041 -173.374 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -107.16 119.96 40.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.222 174.141 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.55 ' HB2' HD23 ' A' ' 16' ' ' LEU . 37.1 t -71.8 114.12 25.93 Favored Pre-proline 0 C--O 1.221 -0.428 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.313 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.69 -21.27 71.73 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.583 2.189 . . . . 0.0 112.951 -176.619 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.63 -45.01 89.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.898 0.38 . . . . 0.0 111.664 179.203 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 9.6 p -105.3 -23.85 12.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.422 . . . . 0.0 111.53 -177.201 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.23 22.53 13.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.15 0.98 . . . . 0.0 111.844 -177.945 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtm -94.69 -64.69 1.04 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.043 0.449 . . . . 0.0 109.911 176.348 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.96 -175.33 0.86 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.116 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 9' ' ' CYS . 93.9 mt -96.58 116.77 29.64 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 170.442 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 20.7 tpt180 -66.18 -44.73 83.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.778 177.906 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 17' ' ' ARG . 47.4 mt-10 -132.66 -15.15 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -177.052 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.54 84.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.132 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.36 118.41 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.224 0.535 . . . . 0.0 111.009 175.208 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.406 ' OE1' ' HG3' ' A' ' 27' ' ' ARG . 7.6 tp60 -78.63 133.12 37.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.211 179.512 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -87.57 160.17 48.22 Favored Pre-proline 0 C--N 1.311 -1.1 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.483 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.53 -23.65 74.94 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.373 2.048 . . . . 0.0 112.507 179.079 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 p -80.67 -15.8 55.62 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.994 0.426 . . . . 0.0 111.551 176.191 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.59 52.3 1.32 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.162 175.218 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -135.06 141.08 46.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.727 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.406 ' HG3' ' OE1' ' A' ' 21' ' ' GLN . 90.3 mtt180 -105.63 133.47 50.32 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.686 176.242 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -135.02 169.25 17.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.744 177.184 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 61.3 m -69.36 148.81 49.15 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 171.435 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.41 -6.72 45.47 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.288 0.566 . . . . 0.0 111.356 -173.414 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.13 -34.01 5.5 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.026 -0.421 . . . . 0.0 110.263 179.332 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.1 m -65.84 -46.96 76.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.932 179.109 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.0 tp -68.89 -40.65 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.014 -177.506 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.2 mt -63.28 -43.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.961 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -80.96 4.42 19.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.008 0.433 . . . . 0.0 111.351 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -105.46 -24.67 12.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.715 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.39 -20.52 5.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.47 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.8 ptm180 -99.92 4.08 44.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.497 176.107 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -128.03 -54.51 1.29 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.018 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.15 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -179.04 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.44 144.6 11.36 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.923 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -84.19 40.62 0.78 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.736 0.779 . . . . 0.0 111.165 -171.092 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -142.63 152.86 42.92 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.119 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.23 123.58 89.14 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.731 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.59 -24.18 75.03 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.077 2.518 . . . . 0.0 114.078 -170.259 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.1 m -72.34 -49.82 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.973 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -115.49 5.74 14.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.005 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 58.76 33.68 23.23 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 175.502 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -100.23 144.5 29.17 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.351 -0.218 . . . . 0.0 110.495 179.345 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.59 121.72 15.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 -176.371 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.466 HD21 HD21 ' A' ' 56' ' ' LEU . 43.8 tp -115.33 127.78 55.66 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.275 -174.61 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.5 138.88 38.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.338 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.85 -36.85 77.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.747 0.419 . . . . 0.0 111.959 -175.133 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.78 -17.8 62.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.833 0.349 . . . . 0.0 111.571 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -81.26 -9.06 59.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.865 -177.136 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.466 HD21 HD21 ' A' ' 51' ' ' LEU . 92.4 mt -76.43 132.9 39.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.983 178.6 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -141.72 127.17 10.78 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-O 121.122 0.486 . . . . 0.0 111.805 179.321 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.14 171.19 17.31 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.106 2.537 . . . . 0.0 111.37 177.71 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.2 117.38 16.96 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.165 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -86.38 97.05 10.22 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.506 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -67.11 -38.4 85.56 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.114 -177.456 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -178.88 -51.31 0.01 OUTLIER 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.907 0.883 . . . . 0.0 109.399 176.807 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.122 -177.759 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.996 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.41 142.65 96.19 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.759 2.306 . . . . 0.0 112.425 -178.411 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tt -134.82 123.21 23.17 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.178 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.58 -144.06 3.84 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 178.951 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.5 m -69.06 132.05 46.01 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.769 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -145.92 157.11 43.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.864 0.364 . . . . 0.0 110.601 -174.488 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.438 ' CD2' HD12 ' A' ' 16' ' ' LEU . 92.9 m-85 -93.36 68.22 4.15 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.626 0.726 . . . . 0.0 111.244 178.686 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -145.47 123.79 12.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.337 177.547 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.469 ' HB2' HD23 ' A' ' 16' ' ' LEU . 5.1 t -89.92 118.13 68.67 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.28 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.76 -18.73 63.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 113.218 -176.349 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.432 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.4 mt -65.84 -44.33 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.692 0.282 . . . . 0.0 110.856 177.806 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.6 p -106.44 -26.47 11.43 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.716 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 66.3 22.93 10.82 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.142 0.977 . . . . 0.0 111.895 179.569 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -97.64 -66.85 0.88 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.316 0.579 . . . . 0.0 110.631 176.651 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.99 -161.65 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD23 ' HB2' ' A' ' 9' ' ' CYS . 90.4 mt -109.77 122.75 48.22 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.539 172.389 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 27.4 tpt180 -86.85 108.92 18.97 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.944 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 71.49 -10.39 0.82 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.155 1.382 . . . . 0.0 113.173 -179.544 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.86 83.63 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.144 0.978 . . . . 0.0 113.329 175.467 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.42 115.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.086 177.907 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -80.7 128.32 33.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.145 177.474 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -79.77 161.91 64.65 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.204 177.579 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.24 -18.95 67.3 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.5 2.133 . . . . 0.0 111.438 175.884 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.2 m -65.85 -35.43 80.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.785 174.357 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 -28.23 5.44 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.902 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -82.6 154.48 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.746 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -109.5 140.67 42.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.136 -174.946 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.43 167.81 18.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.428 176.546 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 88.3 m -73.4 146.42 45.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.28 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -69.72 -12.79 61.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.361 179.236 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.42 2.98 15.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 -177.533 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 83.5 m -105.77 -56.97 2.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.734 173.067 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -68.8 -41.85 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.28 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.0 mt -63.42 -41.68 93.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.515 0.674 . . . . 0.0 110.254 179.24 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -77.97 -0.2 26.77 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.64 -177.159 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -105.85 -22.8 12.84 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.129 -0.357 . . . . 0.0 110.71 175.93 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.4 pt -102.23 -23.4 4.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.208 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -102.81 6.15 39.09 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.754 174.345 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -114.84 -51.15 2.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.607 -178.842 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.05 -69.62 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.525 177.298 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -162.85 159.49 31.89 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.433 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -82.08 65.0 7.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -173.439 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 10.4 ptpp? -153.11 147.64 26.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.932 175.248 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.77 124.18 86.41 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.086 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.54 -26.9 81.28 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.993 2.462 . . . . 0.0 114.886 -168.488 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.14 -44.07 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.714 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -121.44 6.43 10.11 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.502 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 52.31 34.54 15.04 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.131 1.372 . . . . 0.0 113.622 177.834 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 77.0 mm-40 -88.89 142.87 27.28 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.085 178.828 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.21 120.07 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.305 0.574 . . . . 0.0 110.216 -175.3 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.8 tp -128.89 132.68 47.72 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 -177.46 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.94 152.69 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.855 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.49 -31.02 71.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.268 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -63.53 -32.81 74.38 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.051 178.167 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -68.32 -34.31 75.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.409 0.623 . . . . 0.0 109.996 178.719 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.0 mt -76.13 153.86 35.92 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.583 178.555 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -62.26 151.69 81.14 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.263 -178.36 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.16 154.64 65.96 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 122.958 2.439 . . . . 0.0 112.975 -178.443 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.65 117.19 21.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.854 -179.185 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -125.93 69.68 1.2 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.276 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.25 -45.72 92.05 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.435 179.949 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.91 159.49 42.47 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.433 -174.999 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' H ' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.741 -179.947 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.35 -40.54 66.96 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.694 2.263 . . . . 0.0 112.838 -178.685 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 tt -80.7 -45.01 17.81 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 172.489 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.28 -96.8 0.17 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -177.105 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.7 m -123.14 115.68 22.2 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 173.544 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -87.68 -16.72 33.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.457 0.646 . . . . 0.0 109.882 175.356 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.06 43.24 1.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.999 0.904 . . . . 0.0 108.94 175.658 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -100.13 134.55 42.88 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.363 -179.393 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.5 t -84.37 114.23 53.55 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.059 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.91 -21.68 73.31 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.36 2.04 . . . . 0.0 112.806 -175.323 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.79 -44.17 85.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.619 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 18.5 p -106.24 -22.15 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.54 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp 63.85 21.18 12.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 111.108 -174.907 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 30.1 mmt -95.44 -73.49 0.59 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.124 0.488 . . . . 0.0 109.792 178.778 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.09 166.88 2.96 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 9' ' ' CYS . 91.6 mt -84.19 103.65 13.57 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.232 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -83.52 -53.91 5.34 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 118.879 -1.129 . . . . 0.0 112.037 -177.348 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 9.3 mp0 -87.7 -16.56 33.96 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.595 177.318 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 43.34 73.14 0.15 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.189 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -99.65 116.31 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.369 0.604 . . . . 0.0 110.187 177.781 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 63.1 tt0 -80.08 136.53 36.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.92 179.795 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -89.95 159.46 42.77 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.092 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.15 -25.97 81.29 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 174.28 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.55 -17.62 64.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.898 177.931 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 13.84 57.46 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.804 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -109.13 143.28 38.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.844 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -109.98 139.99 44.49 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.075 0.464 . . . . 0.0 111.857 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.487 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.5 m-85 -141.0 169.68 17.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.104 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.8 m -82.81 154.05 24.9 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.352 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 41.0 ttmt -70.86 -14.37 62.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.298 0.571 . . . . 0.0 110.566 -176.59 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.97 2.62 15.86 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.186 0.517 . . . . 0.0 109.921 -178.535 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.4 m -103.06 -55.96 2.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.44 174.007 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.585 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -66.69 -43.28 90.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.641 -175.707 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.39 -41.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.229 0.538 . . . . 0.0 110.675 179.817 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -76.97 -3.83 40.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.812 -175.916 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.0 m -110.88 -23.72 10.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 176.133 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 33' ' ' ILE . 44.6 pt -103.64 -7.3 9.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.099 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -95.32 -10.11 31.11 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.252 177.451 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -116.8 -43.01 2.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.056 -177.668 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.96 -72.81 0.43 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.119 176.819 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.46 152.36 21.7 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 177.649 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 24.1 m80 -82.46 68.88 9.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.855 0.836 . . . . 0.0 111.996 -179.299 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -151.71 150.7 30.51 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.462 177.582 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.2 p -70.97 123.58 89.55 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.407 177.207 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.93 -28.07 80.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.918 2.412 . . . . 0.0 113.651 -171.615 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.49 -49.23 81.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.766 -177.758 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -127.05 6.65 6.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.417 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 60.31 35.35 20.74 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -94.53 143.18 26.63 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 174.14 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 122.18 14.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.313 0.577 . . . . 0.0 110.815 -174.003 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.1 tp -120.97 130.24 53.75 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.143 -174.436 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.57 139.18 40.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -65.35 -37.84 88.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.883 -174.058 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -68.58 -19.02 64.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 177.959 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.6 mm-40 -81.36 -8.53 59.75 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.132 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt -69.3 137.88 53.38 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.859 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HD1' ' O ' ' A' ' 21' ' ' GLN . 63.3 m-85 -66.45 133.74 94.41 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.951 179.046 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 57' ' ' PHE . 43.3 Cg_exo -59.88 144.01 99.52 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.019 2.479 . . . . 0.0 113.126 -176.781 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -91.36 -179.03 5.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.412 178.001 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -135.56 73.61 1.48 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.185 0.517 . . . . 0.0 110.743 174.101 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 18' ' ' GLU . 70.1 m-85 -120.1 -53.42 2.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.373 174.802 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.55 155.26 23.93 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.581 -179.123 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? . . . . . 0 C--N 1.308 -1.202 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.654 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.08 -40.21 87.02 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.226 2.618 . . . . 0.0 112.424 -177.374 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.1 mt -121.22 144.92 48.35 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.048 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.9 57.09 4.83 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 172.085 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 p -73.69 157.81 35.85 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.583 0.753 . . . . 0.0 112.04 -173.003 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -86.69 63.83 8.18 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.759 0.79 . . . . 0.0 111.032 -173.413 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.571 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.5 m-85 -114.09 13.23 18.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.525 173.509 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -105.86 116.74 32.46 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.512 -179.088 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.56 108.83 4.84 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.498 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.08 -19.14 51.66 Favored 'Trans proline' 0 C--O 1.226 -0.113 0 C-N-CA 122.881 2.387 . . . . 0.0 113.463 -171.113 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 95.5 mt -66.21 -43.61 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.0 111.144 178.635 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 p -99.17 -25.29 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.973 0.416 . . . . 0.0 111.042 178.692 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.1 mt 60.5 29.86 19.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 111.249 -176.349 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.6 mtm -99.09 -68.19 0.81 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 175.136 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.65 -163.24 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -176.253 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 76.6 mt -100.74 124.35 46.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.026 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -88.29 -72.28 0.54 Allowed 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.954 176.846 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.424 ' CD ' ' HG2' ' A' ' 30' ' ' LYS . 58.2 mp0 -81.13 -15.97 54.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.223 177.004 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.4 77.59 0.17 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.646 -178.281 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.12 114.03 40.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.552 0.691 . . . . 0.0 110.015 177.889 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 30.3 tt0 -80.8 135.78 36.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.928 -178.4 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -99.63 154.2 37.39 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.62 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.14 -24.69 72.91 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 122.722 2.281 . . . . 0.0 113.153 -176.229 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 p -76.21 -15.31 60.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 178.692 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.35 23.46 6.94 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.704 175.795 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -112.61 155.65 24.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.634 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -126.07 137.35 53.62 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.53 176.69 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.587 -175.761 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 8.7 m -91.61 160.43 15.4 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 170.702 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 61.2 pttt -75.88 -7.11 53.74 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.175 0.512 . . . . 0.0 110.353 -174.682 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.37 -0.85 15.24 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.152 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 49.2 m -101.94 -64.16 1.09 Allowed 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.393 175.879 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -67.32 -41.72 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.992 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 30' ' ' LYS . 82.8 mt -63.18 -42.89 98.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 110.97 -178.341 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -79.9 -3.22 47.15 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.246 0.546 . . . . 0.0 110.478 -176.933 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -106.15 -18.22 14.08 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.809 -0.557 . . . . 0.0 111.4 178.156 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 36.5 pt -102.23 -13.28 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.453 -175.051 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -104.87 0.94 28.48 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.06 174.342 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.32 -51.72 2.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 -176.032 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.79 -69.78 0.59 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.42 0.629 . . . . 0.0 109.451 174.796 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.76 163.94 35.26 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 177.682 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -80.31 72.26 7.15 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.87 0.835 . . . . 0.0 112.124 -176.709 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.0 ptpp? -144.61 150.05 36.79 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.784 176.075 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 p -83.75 123.23 76.37 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.36 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.96 -25.71 74.07 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.842 2.361 . . . . 0.0 114.109 -168.962 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.5 m -72.08 -42.96 67.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.874 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -120.27 6.43 10.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 50.93 36.55 15.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 176.303 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.6 mm-40 -96.94 153.29 17.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.345 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.53 122.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.145 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.6 118.35 35.44 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -176.368 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.36 134.82 40.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.484 179.736 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -64.89 -35.6 81.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.339 0.399 . . . . 0.0 111.74 -173.426 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -65.86 -30.65 71.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.287 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -68.1 -20.25 64.92 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.188 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.65 141.38 55.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 178.341 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 21' ' ' GLN . 22.3 m-85 -63.86 139.44 97.64 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.28 177.247 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.89 150.27 73.21 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.346 2.03 . . . . 0.0 112.276 -179.139 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -77.85 121.19 23.77 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.995 178.87 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -86.21 110.34 19.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.118 0.485 . . . . 0.0 110.861 -176.515 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -79.09 147.21 32.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.195 -179.263 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.5 158.2 41.52 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.342 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--N 1.306 -1.284 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.839 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.942 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.46 150.65 70.33 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.743 2.295 . . . . 0.0 112.319 177.859 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.8 tp -73.97 126.71 31.07 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.051 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.41 68.72 1.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.237 -0.982 . . . . 0.0 111.042 -175.485 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 p -69.31 151.16 46.55 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 111.489 -177.699 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -92.12 122.79 34.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.973 -176.198 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 52.2 69.33 0.69 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.656 0.783 . . . . 0.0 112.154 -176.875 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -146.39 128.75 15.85 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.251 179.204 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 38.7 t -70.34 114.21 24.08 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.944 0.778 . . . . 0.0 109.426 179.023 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 32.1 Cg_exo -62.7 -21.61 73.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.346 2.03 . . . . 0.0 112.553 -177.666 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.8 -44.02 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.764 0.316 . . . . 0.0 111.582 178.317 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -104.01 -22.92 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.891 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt 56.75 25.48 10.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 111.939 -176.421 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -96.4 -63.13 1.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.324 174.291 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.37 -172.72 0.31 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.786 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.4 mt -98.93 106.82 19.12 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.961 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -69.61 -43.96 71.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.138 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 67.1 mm-40 -115.38 -16.24 11.46 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 177.876 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.95 70.48 0.58 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.661 0.601 . . . . 0.0 112.329 -178.544 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 58' ' ' PRO . 26.8 m -93.27 116.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.141 0.496 . . . . 0.0 110.777 179.236 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -80.0 135.81 36.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 175.116 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -111.01 151.74 43.2 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.498 -179.791 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.449 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 50.2 Cg_exo -56.63 -37.38 97.76 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.791 2.327 . . . . 0.0 111.154 179.737 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.8 t -59.69 -31.14 69.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.907 -178.793 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.89 36.33 2.04 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.418 179.812 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.56 156.85 40.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.162 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.72 131.35 53.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.012 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.43 ' O ' HG22 ' A' ' 20' ' ' VAL . 94.5 m-85 -139.6 179.72 6.4 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.252 0.345 . . . . 0.0 110.208 -177.109 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 61.8 m -90.61 151.22 21.39 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 169.972 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 88.0 tttt -71.55 -6.8 43.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.34 0.59 . . . . 0.0 111.449 -176.121 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.48 -16.14 12.47 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.081 0.467 . . . . 0.0 109.952 -179.437 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 76.3 m -83.82 -59.28 2.47 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 175.351 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.2 tp -67.87 -41.05 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.243 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 67.0 mt -62.72 -42.97 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.658 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -78.83 -1.66 35.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.546 0.689 . . . . 0.0 109.61 -175.568 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 m -105.38 -21.08 13.3 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.651 176.158 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.7 pt -104.07 -24.34 4.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.077 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -98.9 0.49 44.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.764 177.371 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.87 -46.52 2.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.749 -177.395 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 -68.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.115 0.483 . . . . 0.0 110.794 177.202 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.49 161.98 35.66 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.31 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 66.0 m80 -86.21 76.17 9.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 117.444 0.622 . . . . 0.0 111.555 -173.886 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 22.4 pttp -154.25 144.68 22.22 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 -179.214 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.3 p -77.32 123.79 86.98 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 170.351 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.25 -24.77 76.32 Favored 'Trans proline' 0 N--CA 1.481 0.751 0 C-N-CA 123.321 2.681 . . . . 0.0 114.019 -167.251 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -66.79 -46.19 86.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.056 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.55 7.45 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.943 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.321 25.4 p30 53.77 38.12 27.83 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 178.886 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 69.1 mm-40 -86.28 142.01 28.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.382 173.336 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 48.5 mm -66.45 121.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.575 -176.941 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.68 132.39 43.9 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.402 -177.629 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HG3' ' A' ' 55' ' ' GLN . 2.7 mm? -110.58 157.99 19.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.354 177.748 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.65 -38.15 89.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.655 0.74 . . . . 0.0 109.917 -179.473 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -76.72 -6.04 50.55 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.15 -174.006 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 23' ' ' PRO . 61.7 mt-30 -89.38 -8.07 53.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 0.0 111.413 178.723 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.9 mt -73.1 146.63 45.6 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.484 -175.742 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.19 79.98 9.13 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 171.467 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HA ' HG12 ' A' ' 20' ' ' VAL . 32.0 Cg_exo -63.71 -41.57 24.1 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.606 2.871 . . . . 0.0 115.38 -175.867 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -116.32 85.68 2.35 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.875 -169.157 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -155.84 11.47 0.3 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.092 171.43 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.06 142.82 51.25 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.958 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 50.91 40.79 25.9 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.957 0.786 . . . . 0.0 112.154 173.979 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.232 -174.177 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.802 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.36 -30.85 81.23 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 123.259 2.639 . . . . 0.0 113.322 178.579 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.7 tp -118.91 130.6 55.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.505 -178.514 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.12 -150.06 18.73 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.936 177.22 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.488 ' HB3' ' HD2' ' A' ' 26' ' ' HIS . 2.7 p -114.53 104.98 12.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.407 0.622 . . . . 0.0 111.253 179.157 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 8' ' ' GLU . 63.1 tttm -97.89 163.5 12.76 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.141 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -79.3 47.92 0.84 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.785 1.278 . . . . 0.0 109.947 175.728 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 6' ' ' LYS . 35.1 tt0 -141.46 137.89 32.48 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -179.533 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -72.79 108.55 4.58 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.889 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.19 -17.5 45.16 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.528 2.152 . . . . 0.0 112.002 -174.31 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.4 mt -66.13 -43.6 92.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.61 177.527 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -104.81 -16.51 14.89 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -177.706 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 mp 57.87 22.72 8.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.928 0.891 . . . . 0.0 111.569 -176.326 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.465 ' HA ' ' CE ' ' A' ' 14' ' ' MET . 1.8 mmt -94.88 -66.89 0.88 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.529 -178.865 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.78 -169.43 0.12 Allowed 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.975 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.3 mt -97.49 109.36 22.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.898 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -65.48 -45.13 84.87 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.311 -178.823 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -132.72 -14.08 2.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.764 176.344 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.24 92.21 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.602 0.761 . . . . 0.0 112.9 178.167 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.91 117.62 49.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.163 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.31 128.22 33.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.331 -177.584 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -89.32 155.16 49.11 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.872 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.37 -29.55 89.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.504 2.136 . . . . 0.0 113.07 -173.663 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 p -76.27 -15.4 60.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.944 0.402 . . . . 0.0 111.923 178.985 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.21 42.45 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.951 174.346 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.488 ' HD2' ' HB3' ' A' ' 5' ' ' SER . 46.7 m80 -125.62 143.29 51.09 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.524 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 7.5 mpt_? -109.97 135.62 50.53 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.409 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.0 m-85 -133.81 168.08 19.39 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.8 m -75.88 156.65 34.13 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.775 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.1 tttt -68.82 -11.23 60.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.508 -174.697 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.32 -37.56 4.33 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.973 -179.101 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -62.8 -47.28 84.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.813 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -70.11 -41.61 79.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.896 -178.681 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.556 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.7 mt -63.55 -42.78 97.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.696 -178.592 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -78.01 -0.94 29.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.482 0.658 . . . . 0.0 110.02 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -105.86 -20.36 13.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.701 174.164 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.64 -21.73 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -176.577 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 12.2 ptp180 -97.57 8.01 45.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.464 171.605 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -116.2 -55.82 2.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.746 -177.94 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.87 -72.64 0.5 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.88 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.46 163.56 37.02 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.987 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.493 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 70.5 m80 -87.93 76.65 8.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.598 0.713 . . . . 0.0 111.909 -176.706 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -159.91 155.32 25.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.848 175.708 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 p -79.07 124.05 84.75 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.702 175.988 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.8 -27.21 75.15 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 122.82 2.347 . . . . 0.0 113.614 -172.851 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.91 -45.34 73.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.444 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -122.47 4.87 9.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.77 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 57.71 34.74 24.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.477 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 148.76 22.78 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.448 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.99 120.67 14.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.952 0.406 . . . . 0.0 110.594 -175.486 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 61.7 tp -121.45 127.98 51.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.154 -176.646 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.17 148.92 29.21 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.529 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.08 -37.33 87.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -175.893 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.0 -29.81 70.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.471 177.381 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.72 -15.11 62.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.076 -179.581 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.43 136.08 39.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.742 0.306 . . . . 0.0 110.729 178.65 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -151.15 144.08 16.78 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.401 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.24 142.89 68.69 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 121.865 1.71 . . . . 0.0 110.839 176.853 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -149.77 129.55 13.29 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 179.938 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -120.38 29.58 7.39 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 173.753 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 62.2 36.33 14.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.549 0.69 . . . . 0.0 109.435 -172.099 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.66 133.27 28.7 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.298 -178.289 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -179.468 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.066 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.0 147.42 95.18 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.507 2.804 . . . . 0.0 113.33 -178.82 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.38 -43.66 98.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 174.992 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.48 -134.0 52.49 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.122 -0.944 . . . . 0.0 113.33 173.674 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m -130.7 147.0 52.32 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.345 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.11 160.64 42.68 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.707 0.289 . . . . 0.0 110.43 -176.632 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.37 87.39 3.86 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 171.296 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -146.14 150.76 36.5 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.215 -173.578 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.408 ' HB2' HD23 ' A' ' 16' ' ' LEU . 38.8 t -79.79 109.84 13.55 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.712 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.79 -20.57 71.55 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.525 2.15 . . . . 0.0 112.576 -174.467 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -67.32 -44.7 87.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.684 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.3 p -103.92 -19.3 14.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.462 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp 58.42 23.19 10.34 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.693 0.797 . . . . 0.0 111.563 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.4 mtm -95.28 -64.62 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.158 178.273 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.51 -173.97 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.757 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 9' ' ' CYS . 84.8 mt -95.22 102.66 14.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 173.184 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.29 -45.06 63.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.053 -179.555 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 18.5 mm-40 -106.43 -17.45 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.815 -175.176 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 44.52 89.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.596 1.159 . . . . 0.0 114.034 -176.716 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.89 121.26 65.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 175.939 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.348 -178.811 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -110.66 151.1 42.6 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.349 174.638 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.9 -24.82 77.51 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.87 2.38 . . . . 0.0 113.634 -178.802 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.7 p -79.32 -15.47 57.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.978 177.77 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 44.8 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.304 173.621 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.47 ' HE1' ' OD2' ' A' ' 47' ' ' ASP . 16.6 m80 -133.33 149.46 51.9 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.708 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -111.45 134.85 52.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.495 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 96.9 m-85 -136.18 173.15 12.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.718 -178.725 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.7 m -86.89 151.21 23.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.124 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.525 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 65.2 tttp -68.42 -11.21 59.35 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 122.999 0.52 . . . . 0.0 111.348 -178.966 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.55 2.64 15.4 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.171 -178.994 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -105.41 -53.8 2.59 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.399 175.25 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -68.17 -38.54 79.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.923 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.09 -41.61 91.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.069 0.462 . . . . 0.0 110.126 178.326 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 32.1 mmmt -79.18 2.75 19.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -106.37 -25.46 11.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.742 173.669 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.3 pt -104.63 -5.87 9.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.387 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.0 ptm180 -124.61 3.15 8.29 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.546 171.097 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 3.9 m-20 -127.11 -42.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.149 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.41 -65.91 0.97 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.437 0.637 . . . . 0.0 110.755 -178.597 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.52 -148.52 5.42 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.579 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -139.02 31.96 2.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 171.517 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -132.5 161.03 34.79 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.086 -175.065 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.1 t -74.94 122.04 86.6 Favored Pre-proline 0 N--CA 1.43 -1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.13 -31.16 54.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.386 2.057 . . . . 0.0 113.327 -175.167 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.38 -48.57 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.007 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' OD2' ' HE1' ' A' ' 26' ' ' HIS . 48.7 p-10 -114.33 6.49 16.1 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.573 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 58.91 31.97 21.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.489 0.716 . . . . 0.0 112.439 177.106 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.76 147.17 26.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.636 178.943 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.0 122.42 16.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.129 0.49 . . . . 0.0 109.974 -178.022 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.401 HD23 HG21 ' A' ' 37' ' ' ILE . 54.5 tp -111.34 131.0 55.5 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.133 -175.114 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -97.76 138.62 34.85 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.075 -178.903 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.77 -38.64 89.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.414 -174.563 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.13 -30.13 70.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.015 0.436 . . . . 0.0 111.189 178.37 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -74.58 -7.14 52.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.57 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.6 132.02 42.33 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.013 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -134.47 137.57 28.09 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.893 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.99 139.83 89.76 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 121.8 1.667 . . . . 0.0 110.965 178.379 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.3 -45.23 81.09 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.222 0.534 . . . . 0.0 109.704 179.935 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -111.3 105.18 13.76 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.12 173.307 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -116.83 102.98 9.85 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.007 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.84 111.11 18.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.508 -174.565 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.768 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.13 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.33 42.21 1.14 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.405 2.737 . . . . 0.0 111.887 -179.521 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 7' ' ' TYR . 53.6 tp 69.87 15.13 7.93 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.971 0.908 . . . . 0.0 110.313 -179.089 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 8' ' ' GLU . . . -99.82 36.29 4.2 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.258 -177.536 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.3 m -97.73 -70.04 0.74 Allowed 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.386 -0.479 . . . . 0.0 110.422 178.122 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -92.13 -16.11 26.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.365 0.603 . . . . 0.0 110.23 175.762 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.69 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 94.6 m-85 -105.3 45.21 0.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.679 174.549 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 43.8 tt0 -102.32 141.05 35.78 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.101 177.652 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.516 ' HB2' HD23 ' A' ' 16' ' ' LEU . 39.4 t -94.88 108.37 37.43 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 173.853 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.7 -19.48 68.34 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.841 2.361 . . . . 0.0 112.862 -174.599 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.58 -44.13 90.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 178.61 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.5 p -102.79 -13.37 17.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.794 -178.351 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 mp 69.37 23.97 5.98 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.625 0.77 . . . . 0.0 110.425 -179.04 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -128.18 170.07 13.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.38 157.7 13.31 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.428 0.455 . . . . 0.0 110.899 177.853 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 86.1 mt -70.09 133.1 46.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.719 -174.859 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 12.8 tpt180 -77.98 -62.86 1.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.087 172.716 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.507 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.8 mm-40 -99.18 -18.43 17.66 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.062 -177.545 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 86.98 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.629 -175.539 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -108.8 118.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.508 0.67 . . . . 0.0 111.126 175.133 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.22 139.41 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.18 179.867 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -110.51 155.32 42.27 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.803 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.02 -20.24 63.83 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.703 2.269 . . . . 0.0 111.72 178.769 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.9 t -74.42 -19.47 60.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.876 178.253 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.72 25.98 11.17 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.979 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -113.69 154.04 27.95 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.028 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.41 ' HB3' HD11 ' A' ' 16' ' ' LEU . 77.8 mtt85 -117.99 138.43 52.19 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.665 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.7 168.29 20.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.775 0.321 . . . . 0.0 110.581 -178.689 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.598 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.8 m -86.21 148.36 25.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 169.977 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.78 -12.85 61.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.958 -171.514 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -7.92 13.41 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.352 -178.587 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -85.94 -46.39 10.6 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 170.149 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.608 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -67.78 -43.14 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.859 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.587 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.9 mt -63.46 -42.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 111.221 -177.958 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -78.76 -2.09 37.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 -175.607 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 t -106.16 -25.54 11.96 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.832 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.8 pt -103.77 -15.59 8.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.479 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.3 ptm180 -98.35 2.99 48.57 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.262 173.89 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -115.18 -52.09 2.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.068 -172.123 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.3 -68.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.223 175.671 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.74 165.73 39.1 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.099 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 62.4 m80 -87.94 80.48 7.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.837 0.827 . . . . 0.0 111.473 -177.776 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -152.7 159.51 43.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 9.7 m -67.21 127.4 93.47 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.861 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.49 -20.77 70.37 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.736 2.291 . . . . 0.0 112.516 -179.31 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.73 -61.0 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.276 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 43.2 p-10 -103.92 5.29 35.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.033 -0.417 . . . . 0.0 111.128 -174.378 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 56.28 34.55 24.25 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.542 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -90.04 145.65 24.92 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.098 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -65.86 121.58 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 0.0 110.426 -174.252 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 64.9 tp -126.89 129.12 47.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.929 -175.983 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.2 mm? -112.14 152.26 28.52 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -175.539 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.58 -36.15 82.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.302 0.573 . . . . 0.0 111.171 -177.971 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.99 -31.09 72.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.459 176.27 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.4 mm100 -78.93 -8.64 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.384 -175.735 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.84 131.75 42.67 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.667 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.73 107.43 36.76 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.866 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.88 -42.31 68.33 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.051 2.501 . . . . 0.0 113.241 -173.246 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.2 t70 68.05 -48.21 0.53 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.967 1.307 . . . . 0.0 111.413 -175.688 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -104.51 167.16 9.91 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.456 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -97.31 118.33 33.54 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.925 174.088 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.09 155.76 21.16 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.742 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.301 -1.521 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.774 178.76 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.12 156.37 62.57 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 123.372 2.715 . . . . 0.0 111.353 179.41 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.98 102.39 1.99 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.457 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.28 63.32 0.3 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 178.694 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.428 ' HB3' ' CB ' ' A' ' 8' ' ' GLU . 13.6 m -82.62 95.72 7.88 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.117 -0.541 . . . . 0.0 112.035 -170.723 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -67.43 -45.2 76.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.485 174.691 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -121.14 93.74 4.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.409 0.623 . . . . 0.0 111.158 176.451 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 44.2 tt0 -154.72 143.81 21.06 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.791 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.4 t -78.28 108.49 7.8 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.756 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 35.7 Cg_exo -64.48 -19.8 65.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.926 2.417 . . . . 0.0 112.06 -177.123 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.1 -43.86 92.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 -179.352 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.3 p -99.76 -26.0 14.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.272 179.841 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt 64.22 21.65 12.6 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.153 0.981 . . . . 0.0 111.92 179.797 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -100.52 -64.47 1.04 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.936 0.398 . . . . 0.0 111.004 177.884 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.7 -170.07 0.38 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.544 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.03 108.01 20.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.533 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.12 -45.84 75.94 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.019 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -112.45 -16.81 12.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.342 176.425 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.37 62.53 2.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.256 -175.046 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 29.1 m -83.18 118.12 30.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.39 -178.492 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -74.51 126.22 30.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.688 178.794 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.1 p -94.68 165.54 17.03 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.085 -177.27 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.83 -34.2 96.22 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.801 2.334 . . . . 0.0 112.062 177.442 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 p -76.62 -15.15 59.9 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.187 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.17 44.0 Favored Glycine 0 CA--C 1.516 0.152 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.936 179.0 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -90.97 167.15 12.62 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.054 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 92.4 mtt180 -130.55 140.24 50.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.001 179.293 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.421 ' O ' HG22 ' A' ' 20' ' ' VAL . 96.9 m-85 -138.7 -177.23 4.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.521 ' O ' HG22 ' A' ' 33' ' ' ILE . 45.6 m -91.12 152.3 20.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.371 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.77 -11.88 61.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.049 0.452 . . . . 0.0 111.131 -176.269 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.45 -10.08 13.25 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.041 -177.448 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -92.66 -56.09 3.14 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.709 177.189 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.558 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -69.03 -40.3 80.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.667 -177.167 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.594 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.0 mt -62.91 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.381 . . . . 0.0 111.851 -178.934 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.14 -3.29 41.71 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.884 0.373 . . . . 0.0 110.49 -175.44 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.9 p -108.18 -19.71 13.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 175.157 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 33' ' ' ILE . 36.4 pt -102.64 -13.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.906 -0.496 . . . . 0.0 112.183 -174.55 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.3 ptp180 -98.0 7.99 45.46 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 167.852 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.09 -54.88 2.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.685 -175.286 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.96 -72.9 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.346 0.593 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.22 167.17 39.69 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.86 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 59.8 m80 -83.38 74.27 10.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.449 0.642 . . . . 0.0 111.992 -176.338 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.7 ptpt -151.7 152.03 32.23 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.267 177.746 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 1.5 p -77.46 135.69 64.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.829 173.982 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.62 -21.88 65.09 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.502 2.134 . . . . 0.0 112.259 -179.09 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -76.43 -74.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.02 4.47 47.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -175.08 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 95.8 m-20 56.08 34.55 24.01 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 172.053 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 75.5 mm-40 -93.64 154.07 18.03 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.725 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.57 120.59 14.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.565 0.698 . . . . 0.0 109.988 -175.805 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 56' ' ' LEU . 7.8 tt -124.05 121.25 34.7 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.297 -172.341 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.51 141.35 35.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.768 0.318 . . . . 0.0 111.378 -176.453 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.51 -43.02 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.957 -175.066 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -67.29 -30.91 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.261 -177.373 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -78.85 -8.18 58.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.439 -176.953 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 51' ' ' LEU . 97.5 mt -76.82 127.31 32.52 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.684 179.407 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -135.87 127.56 17.33 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -62.43 139.52 77.12 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.437 2.091 . . . . 0.0 111.741 176.144 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -107.84 118.48 36.86 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 172.95 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 63.69 78.66 0.28 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.729 0.643 . . . . 0.0 110.302 -175.894 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -111.02 139.09 46.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.565 -174.145 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.9 139.4 46.82 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.248 179.585 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.168 0 CA-C-O 118.804 -0.617 . . . . 0.0 109.445 177.678 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.01 118.18 5.36 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.265 1.977 . . . . 0.0 112.386 -177.427 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 tm? 65.3 -52.96 0.35 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.731 1.612 . . . . 0.0 112.503 179.842 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.76 -126.25 10.61 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.689 -176.576 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -125.34 96.55 4.87 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.015 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -90.81 77.28 6.26 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.24 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.445 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 29.9 t80 -145.5 29.02 1.16 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.996 0.903 . . . . 0.0 108.73 -176.662 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -106.97 129.7 54.74 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.088 -176.242 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HB2' HD23 ' A' ' 16' ' ' LEU . 42.1 t -88.17 108.16 20.21 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.851 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.8 Cg_exo -62.73 -20.72 71.82 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.684 2.256 . . . . 0.0 113.3 -174.755 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.67 -43.74 90.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.686 178.958 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.59 -7.96 14.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.113 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt 61.73 26.46 16.09 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.503 0.721 . . . . 0.0 110.785 -177.062 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -120.08 169.16 10.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 152.9 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.744 175.481 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 77.9 mt -69.44 114.25 7.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.937 0.399 . . . . 0.0 110.003 -172.226 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -71.65 -46.56 58.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.779 -177.564 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -114.18 -17.18 11.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.464 178.485 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.45 82.68 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.872 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.43 116.72 53.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.327 0.584 . . . . 0.0 110.994 174.209 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 51.6 tt0 -82.84 133.84 35.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.891 -178.5 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -86.54 160.39 50.82 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.147 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -55.64 -37.76 94.96 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.612 2.208 . . . . 0.0 112.074 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 p -67.99 -17.23 64.37 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.649 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.41 41.44 2.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.015 174.069 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.486 ' HE1' ' OD2' ' A' ' 47' ' ' ASP . 49.7 m80 -122.49 143.76 49.5 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.193 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 21' ' ' GLN . 89.1 mtm180 -111.28 137.52 48.91 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.64 175.239 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.5 m-85 -131.65 166.36 21.62 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.428 -178.425 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.3 m -79.38 149.65 31.61 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.122 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' HD12 ' A' ' 34' ' ' ILE . 40.5 ttmt -76.22 -2.95 33.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.788 0.804 . . . . 0.0 111.455 -173.155 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.92 -24.0 9.77 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.113 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.7 m -73.35 -51.11 18.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.276 174.967 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.486 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -67.23 -39.55 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.926 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.1 mt -62.78 -41.7 93.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.625 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -78.18 -1.78 34.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.94 -176.762 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.5 m -105.86 -21.58 13.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.653 0.263 . . . . 0.0 111.178 173.828 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -102.87 -16.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.343 -175.196 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 ptm180 -99.73 1.13 43.03 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.002 175.467 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -115.49 -54.15 2.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.224 -178.0 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 -66.55 0.89 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.048 0.452 . . . . 0.0 110.48 179.013 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -172.09 161.99 33.99 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 177.218 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.615 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 47.2 m80 -83.18 83.25 7.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.776 0.798 . . . . 0.0 110.473 179.769 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.38 157.09 41.98 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.397 -176.987 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 46.3 t -80.9 122.49 82.0 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.915 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.83 -28.86 76.06 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.958 2.439 . . . . 0.0 115.055 -170.548 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.0 m -85.78 -49.93 14.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -173.095 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.486 ' OD2' ' HE1' ' A' ' 26' ' ' HIS . 42.6 p-10 -106.98 6.61 29.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.801 0.334 . . . . 0.0 111.322 -176.397 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.255 4.5 p-10 50.82 40.19 24.09 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.227 . . . . 0.0 113.736 177.826 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -80.51 149.84 29.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.799 175.064 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.09 120.84 16.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.109 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.8 tp -124.29 129.33 50.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.709 0.29 . . . . 0.0 111.138 -176.176 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.02 152.51 24.38 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -65.2 -24.19 67.29 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -174.381 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -89.57 5.48 45.4 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.75 179.162 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -84.8 -11.27 56.08 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.017 0.437 . . . . 0.0 110.168 174.063 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.43 106.62 8.16 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.397 -175.989 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -136.3 150.04 69.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.872 179.042 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.61 151.52 64.3 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.726 1.617 . . . . 0.0 108.849 167.743 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.93 123.12 16.65 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.254 0.549 . . . . 0.0 112.11 -172.425 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -72.51 142.93 48.52 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -172.247 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -158.88 -171.29 3.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 178.751 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.36 83.96 1.07 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 119.476 1.034 . . . . 0.0 109.296 171.43 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? . . . . . 0 C--O 1.257 1.459 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.683 -174.65 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.197 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.67 142.06 92.98 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.368 2.045 . . . . 0.0 110.291 175.69 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -114.73 114.58 25.81 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.346 0.593 . . . . 0.0 110.123 -178.122 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.89 -53.42 0.03 OUTLIER Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 173.995 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.3 p -87.48 99.33 11.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.623 -0.788 . . . . 0.0 108.888 169.785 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -84.68 120.77 26.77 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -177.122 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.549 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.0 m-85 -106.46 10.64 31.34 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.643 0.735 . . . . 0.0 109.553 177.267 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -96.02 122.37 38.78 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.411 177.717 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 34.7 t -68.12 115.99 34.47 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.351 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 35.8 Cg_exo -62.04 -22.49 74.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.171 1.914 . . . . 0.0 113.171 -174.653 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.78 -44.28 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.475 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 8.1 p -97.96 -16.41 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.646 -177.413 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt 54.92 27.08 8.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 109.81 -174.031 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.9 ttm -108.35 -73.96 0.67 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.699 -173.488 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.65 162.75 2.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.015 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.5 mt -77.05 104.5 7.57 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.328 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -70.65 -45.65 64.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 177.294 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 63.8 mm-40 -114.59 -16.47 11.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.948 -178.027 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 59' ' ' ASP . . . 53.58 82.67 0.08 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.949 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -111.85 117.81 56.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.244 0.545 . . . . 0.0 110.59 175.001 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 53.5 tt0 -81.34 138.33 35.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.357 -177.914 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 ' CG2' HD11 ' A' ' 51' ' ' LEU . 67.9 p -113.73 156.54 43.51 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.584 -179.011 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HG3' ' OE1' ' A' ' 55' ' ' GLN . 38.3 Cg_endo -62.98 -22.0 73.54 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.027 2.485 . . . . 0.0 113.409 -176.17 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 56.5 m -73.99 -19.25 60.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.643 177.509 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 30.56 7.18 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.169 -175.885 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.498 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 16.5 m-70 -114.0 152.13 31.38 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.078 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 88.7 mtm180 -122.64 134.34 54.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.309 171.656 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 93.0 m-85 -129.97 -177.82 4.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.289 -176.151 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.6 m -99.61 157.89 16.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.999 173.443 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.4 tttt -68.64 -13.39 62.33 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.046 0.451 . . . . 0.0 111.631 -178.209 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 1.93 16.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.863 0.84 . . . . 0.0 109.198 -178.138 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 84.0 m -103.12 -63.32 1.18 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.713 175.935 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.1 -40.63 85.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.528 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.644 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.6 mt -63.47 -42.46 96.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.953 0.406 . . . . 0.0 110.273 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.84 4.95 12.58 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.627 0.727 . . . . 0.0 110.247 -179.289 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.7 t -106.46 -26.44 11.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.738 173.418 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.9 pt -103.77 -19.47 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.968 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -101.01 8.63 42.91 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.771 0.796 . . . . 0.0 109.36 173.8 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.41 -56.61 2.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.871 -174.66 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.33 -68.93 0.77 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.947 177.322 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.1 176.09 45.9 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 178.895 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 33.5 m80 -79.11 92.66 5.05 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 117.824 0.812 . . . . 0.0 111.478 -179.806 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 18.8 ptpt -169.08 147.46 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.328 0.651 . . . . 0.0 109.526 177.733 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 125.32 71.06 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 170.197 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.01 -25.59 81.77 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.965 2.444 . . . . 0.0 114.661 -167.909 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.98 -44.74 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.099 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -121.48 5.72 10.12 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.193 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 51.21 31.07 6.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.051 1.341 . . . . 0.0 114.24 179.691 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.1 140.11 32.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.509 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 2.0 mp -66.36 120.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.278 0.561 . . . . 0.0 110.198 -176.448 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.448 HD11 ' CG2' ' A' ' 22' ' ' THR . 8.9 tt -121.78 131.99 54.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.255 -173.46 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.43 HD13 ' NE2' ' A' ' 55' ' ' GLN . 8.3 mp -111.41 153.1 26.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.445 -178.01 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -61.69 -34.43 75.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.265 0.626 . . . . 0.0 111.461 -177.671 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -74.59 -11.47 60.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.11 0.481 . . . . 0.0 111.29 -178.018 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.43 ' NE2' HD13 ' A' ' 52' ' ' LEU . 80.8 mt-30 -87.61 -10.63 50.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.841 177.9 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt -77.98 130.82 36.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 177.52 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -136.06 138.97 28.88 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.139 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -65.93 142.84 70.54 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 121.806 1.671 . . . . 0.0 111.508 -179.557 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.438 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 29.5 t70 -73.81 138.97 44.81 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.877 -177.117 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.41 -35.5 81.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -175.321 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.414 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 94.8 m-85 -66.85 -37.66 84.88 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.067 0.46 . . . . 0.0 110.012 -178.235 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.77 76.25 6.44 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.399 178.943 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 tptm . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.095 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 54.0 t -88.7 110.13 34.89 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.47 -17.86 53.92 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.848 2.365 . . . . 0.0 111.952 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.445 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -65.8 -43.99 93.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.754 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -115.0 -8.24 12.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.542 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.5 mt 56.68 34.82 25.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.845 0.858 . . . . 0.0 110.914 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -118.16 164.06 15.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.714 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.57 32.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.917 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.48 119.58 13.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.031 0.443 . . . . 0.0 111.008 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 19' ' ' ALA . 28.2 tpt180 -91.37 115.61 28.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.252 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 69.23 -16.23 0.25 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.553 1.141 . . . . 0.0 113.026 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 47.72 91.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.026 1.33 . . . . 0.0 113.569 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -101.83 116.73 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.319 0.58 . . . . 0.0 110.735 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.41 134.22 35.52 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.082 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -87.92 160.71 46.07 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.781 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.87 -17.96 62.31 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 122.39 2.06 . . . . 0.0 111.014 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.82 -21.43 63.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.411 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.91 2.08 58.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.417 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -97.54 136.39 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -102.54 135.34 44.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.98 166.61 22.31 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.9 m -65.74 150.11 49.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.06 -10.61 51.71 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.502 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.12 -38.13 3.68 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.559 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 36.6 m -61.77 -45.12 95.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.692 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -66.94 -39.34 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.577 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -62.97 -42.87 98.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.063 0.459 . . . . 0.0 110.509 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -78.61 -1.48 34.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.479 0.657 . . . . 0.0 110.374 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -105.84 -19.69 13.67 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.997 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -102.98 -26.16 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.0 ptm180 -103.02 8.55 38.87 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.795 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -115.28 -53.84 2.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.95 -66.68 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.22 0.533 . . . . 0.0 110.2 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.82 161.71 35.04 Favored Glycine 0 CA--C 1.497 -1.032 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -80.86 81.08 7.21 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 117.206 0.503 . . . . 0.0 112.197 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.2 ptpt -151.3 154.8 37.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.479 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.4 p -83.36 125.67 73.61 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.94 -27.33 84.63 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.636 2.224 . . . . 0.0 114.313 -170.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.15 -49.49 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.941 0.4 . . . . 0.0 111.864 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.91 6.39 4.29 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' HD22 ' A' ' 48' ' ' ASN . 1.0 OUTLIER 59.85 37.85 21.58 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.46 147.04 28.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.77 121.33 15.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.438 HD12 HG21 ' A' ' 37' ' ' ILE . 3.0 tm? -125.63 127.14 45.84 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.838 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.5 mm? -112.35 151.93 29.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HG3' HD11 ' A' ' 37' ' ' ILE . 2.7 mp0 -60.13 -39.44 86.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.535 0.334 . . . . 0.0 111.148 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -75.38 -15.21 60.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.772 0.32 . . . . 0.0 111.6 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.8 mm100 -83.08 -14.87 52.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 51' ' ' LEU . 93.8 mt . . . . . 0 C--O 1.24 0.557 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.02 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.2 t -86.49 107.59 14.31 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -63.16 -20.76 71.7 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.644 2.229 . . . . 0.0 113.251 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.0 -43.69 92.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.861 0.363 . . . . 0.0 111.018 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.0 p -101.15 -21.23 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.791 0.329 . . . . 0.0 111.488 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 60.27 22.35 11.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.977 0.911 . . . . 0.0 111.94 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -99.14 -71.65 0.69 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.808 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.13 -169.87 0.58 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.2 mt -97.0 107.98 20.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.764 0.316 . . . . 0.0 110.375 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 7.4 tpm_? -64.99 -49.66 69.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.695 174.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -116.11 -16.09 11.05 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.643 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.84 76.07 0.21 Allowed 'General case' 0 N--CA 1.462 0.139 0 O-C-N 123.862 0.726 . . . . 0.0 111.959 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.05 116.98 49.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.266 0.555 . . . . 0.0 110.919 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -71.8 125.89 28.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.933 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 p -89.66 158.76 44.88 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.44 -22.53 65.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.223 1.949 . . . . 0.0 113.56 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.57 -46.29 26.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.018 0.437 . . . . 0.0 110.966 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.68 48.94 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.346 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -139.92 163.17 33.37 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -124.86 137.6 54.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.08 0.467 . . . . 0.0 110.293 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.42 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.5 168.98 18.23 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.064 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 48.4 m -79.96 147.04 31.76 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -74.72 -3.58 32.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.256 0.55 . . . . 0.0 111.409 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.51 -18.57 12.38 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.957 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 43.9 m -85.07 -48.03 9.6 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.285 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.52 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.73 -42.27 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HA ' HG12 ' A' ' 37' ' ' ILE . 84.8 mt -63.48 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 111.633 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -77.25 -2.04 32.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 m -106.68 -24.21 12.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.8 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 42' ' ' HIS . 47.8 pt -105.1 -21.77 5.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -79.04 -15.45 58.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.887 -174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.16 -53.74 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.771 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.21 -65.34 0.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.562 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.43 139.65 5.49 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.866 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.545 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 71.3 m80 -79.55 67.05 5.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.698 0.761 . . . . 0.0 111.706 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -150.85 155.8 39.93 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.197 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.505 ' SG ' HD12 ' A' ' 51' ' ' LEU . 35.3 m -64.54 129.61 94.32 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.91 -21.81 56.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.989 1.793 . . . . 0.0 111.001 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.35 -74.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.553 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.14 4.52 53.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 62.5 m-80 54.61 32.99 18.21 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -88.39 155.26 19.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 50' ' ' ILE . 2.1 mp -65.73 117.39 6.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' SG ' ' A' ' 44' ' ' CYS . 7.8 tt -124.28 121.43 35.01 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.445 HD12 ' NE2' ' A' ' 55' ' ' GLN . 79.3 mt -111.36 145.22 39.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.255 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.39 -36.38 83.96 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.915 0.886 . . . . 0.0 110.466 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -64.79 -32.02 73.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.57 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.445 ' NE2' HD12 ' A' ' 52' ' ' LEU . 82.0 mt-30 -89.09 -8.64 53.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.759 174.714 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.431 -1.4 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.5 t -84.21 107.69 11.68 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.71 -18.46 47.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.423 2.082 . . . . 0.0 112.52 -174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.18 -43.58 91.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.292 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -100.53 -27.31 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.26 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.4 mt 63.89 23.09 13.25 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.778 0.831 . . . . 0.0 111.608 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.2 mtm -96.08 -71.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.497 0.665 . . . . 0.0 109.371 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.77 -158.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -98.95 104.76 16.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -68.63 -43.85 75.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.983 0.421 . . . . 0.0 110.747 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 63.2 mm-40 -119.21 -15.99 9.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.641 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.76 81.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.795 0.684 . . . . 0.0 112.278 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.42 115.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.806 0.812 . . . . 0.0 110.787 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.61 129.05 34.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.375 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -101.05 154.47 37.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -22.11 70.24 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.639 2.226 . . . . 0.0 112.094 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.06 -14.65 60.61 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.647 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.96 25.67 16.64 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.032 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -113.01 152.9 28.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -131.1 122.28 26.42 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.82 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -130.12 -169.54 2.15 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.96 0.409 . . . . 0.0 110.861 -172.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.6 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -99.54 155.38 17.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.8 172.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.0 tttt -68.13 -12.57 61.13 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.239 0.616 . . . . 0.0 111.641 -176.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.96 -24.26 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.308 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 45.5 m -76.88 -51.37 11.37 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.322 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -68.59 -41.28 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.851 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 30' ' ' LYS . 82.5 mt -63.08 -43.31 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -79.86 -1.98 41.48 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.484 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -106.45 -8.94 16.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.691 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 33' ' ' ILE . 41.3 pt -117.43 -8.18 11.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -93.96 -15.3 25.04 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.702 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -116.61 -46.71 2.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.134 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.48 -65.98 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 110.308 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.43 160.01 23.45 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.461 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 65.1 m80 -86.21 77.48 9.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.377 0.608 . . . . 0.0 111.333 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -150.39 148.95 29.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.228 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -79.52 123.7 84.17 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.61 -27.5 76.34 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 123.136 2.558 . . . . 0.0 115.097 -166.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -67.56 -46.14 83.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -119.31 4.3 11.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.286 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 56.42 33.94 23.34 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 113.211 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -87.82 150.13 23.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.29 120.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.271 0.557 . . . . 0.0 110.558 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -125.56 121.81 34.72 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.361 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.62 148.66 23.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.662 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.24 -41.57 96.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.235 0.541 . . . . 0.0 110.007 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -65.11 -29.55 70.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.562 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -73.95 -7.64 53.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.448 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.428 -1.569 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.9 t -59.91 115.64 13.77 Favored Pre-proline 0 C--N 1.317 -0.818 0 C-N-CA 123.699 0.799 . . . . 0.0 111.25 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.427 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -62.42 -20.16 69.57 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.85 2.367 . . . . 0.0 112.739 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.438 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.7 mt -67.32 -44.39 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 111.599 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -110.9 -27.54 8.77 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 62.09 23.39 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.856 0.863 . . . . 0.0 112.159 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -95.64 -65.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.875 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.96 -172.12 1.49 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.647 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 97.1 mt -108.5 122.61 47.42 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -68.67 -44.18 74.57 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.55 -11.9 2.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.14 81.71 0.18 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.129 0.49 . . . . 0.0 111.906 -175.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 116.21 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.656 0.741 . . . . 0.0 111.19 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -81.64 134.8 35.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.343 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.76 162.24 33.88 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.73 -33.11 96.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.021 2.48 . . . . 0.0 112.1 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -72.55 -15.07 61.77 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.205 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.95 34.74 5.82 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.648 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -116.47 152.93 33.05 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -124.74 121.8 35.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.21 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 81.1 m-85 -131.04 173.55 10.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.943 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.647 ' SG ' ' HA ' ' A' ' 16' ' ' LEU . 62.2 m -84.12 147.95 27.06 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.5 tttt -78.06 7.69 5.8 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.0 0.905 . . . . 0.0 110.523 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.92 -32.14 5.87 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.38 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 48.5 m -78.3 -46.07 21.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.203 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.9 tp -66.01 -41.52 89.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.249 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.551 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.0 mt -63.54 -42.51 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.365 . . . . 0.0 110.859 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.61 -1.54 34.66 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.336 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -105.64 -21.29 13.23 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.942 -0.474 . . . . 0.0 110.037 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.662 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.4 pt -103.53 -20.36 5.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.9 ptm180 -105.74 3.19 28.63 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.665 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -118.75 -55.5 2.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.15 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.8 -79.08 0.4 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -140.06 138.19 8.93 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.454 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 9.3 t-80 -80.48 53.73 1.9 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.888 0.851 . . . . 0.0 110.879 -174.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.41 157.73 43.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.109 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.67 123.65 83.96 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.46 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.85 -25.34 74.48 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.022 2.482 . . . . 0.0 114.601 -171.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.95 -49.1 77.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.62 5.81 11.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.4 34.25 24.41 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -101.08 151.05 22.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.678 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.72 121.91 16.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 121.214 0.53 . . . . 0.0 110.79 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.408 HD12 HD13 ' A' ' 37' ' ' ILE . 2.9 tm? -112.88 124.75 53.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.241 -177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -105.35 140.25 38.76 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.44 -38.16 83.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 111.155 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -72.91 -15.45 61.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.29 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.5 mm100 -84.31 -7.53 59.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.32 -0.691 0 CA-C-O 120.719 0.295 . . . . 0.0 110.383 178.704 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.0 tt0 . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 50.9 t -89.79 107.98 22.52 Favored Pre-proline 0 N--CA 1.438 -1.063 0 O-C-N 123.798 0.686 . . . . 0.0 109.376 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 31.8 Cg_exo -63.43 -18.44 64.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.479 2.786 . . . . 0.0 111.951 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.22 -43.78 91.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.049 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 p -107.9 -22.76 12.31 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 64.02 21.22 12.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.213 0.605 . . . . 0.0 112.299 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 9.4 mmt -95.81 -68.36 0.8 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.421 0.629 . . . . 0.0 109.739 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.47 -159.11 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.1 128.94 55.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -76.35 -73.29 0.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.304 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.51 -15.21 25.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.42 84.3 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.951 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.85 117.63 49.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.455 0.645 . . . . 0.0 111.033 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.68 133.53 36.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.099 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 71.9 p -88.9 162.33 38.54 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 27.7 Cg_endo -60.16 -28.82 87.74 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.478 2.118 . . . . 0.0 112.937 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.6 p -72.09 -30.57 65.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 111.152 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.1 29.74 2.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.812 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -117.75 157.56 26.32 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -125.51 139.24 53.79 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.295 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.86 171.53 14.33 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.187 0.995 . . . . 0.0 108.605 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -78.32 150.55 33.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -70.81 -8.06 49.74 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.464 0.705 . . . . 0.0 111.609 -172.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.67 -34.13 5.29 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.507 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 61.5 m -65.66 -46.48 78.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.796 0.331 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.29 -41.26 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.553 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.19 -41.95 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.427 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -78.12 -3.18 41.11 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.539 0.685 . . . . 0.0 109.673 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 m -106.95 -20.4 13.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.201 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 33' ' ' ILE . 38.5 pt -104.31 -8.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.52 -3.36 46.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -116.46 -56.02 2.33 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.341 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.09 -67.26 0.75 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.28 166.93 37.8 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 72.2 m80 -91.13 76.9 6.06 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.917 0.865 . . . . 0.0 111.651 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.75 157.53 42.12 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.83 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.5 p -77.83 132.74 67.23 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.741 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.02 -25.49 73.75 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.665 2.244 . . . . 0.0 113.749 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.36 -59.96 2.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.56 3.86 27.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.9 m120 55.26 34.03 21.91 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -78.75 151.45 32.04 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.347 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.98 121.03 15.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 7.8 tt -110.02 125.73 53.22 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.357 0.599 . . . . 0.0 110.593 -170.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.97 135.52 45.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.623 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -64.97 -38.7 91.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.924 0.392 . . . . 0.0 110.657 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -65.06 -31.5 72.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.231 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -81.53 -9.08 59.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD21 HD21 ' A' ' 51' ' ' LEU . 89.3 mt . . . . . 0 CA--C 1.508 -0.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 120.664 0.269 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.1 t -79.33 113.17 34.29 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.08 -19.91 70.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.951 2.434 . . . . 0.0 113.182 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.03 -44.62 88.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.4 p -104.13 -19.95 13.99 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 64.28 20.57 12.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.791 0.836 . . . . 0.0 111.219 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.1 mtm -102.5 -73.78 0.65 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.107 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.34 -173.24 1.42 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . 93.6 mt -97.55 107.32 19.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -68.36 -45.13 73.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.159 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.544 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 70.5 mm-40 -113.02 -16.01 12.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.299 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . . . 57.75 81.79 0.14 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.998 0.811 . . . . 0.0 113.06 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -120.08 111.99 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.781 0.8 . . . . 0.0 111.616 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -81.55 132.95 35.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.807 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 p -94.23 159.35 34.25 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.605 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.0 -39.46 90.82 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.446 2.764 . . . . 0.0 113.003 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.677 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.6 p -71.96 -15.43 62.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 35.95 3.67 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.728 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.677 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 72.3 m-70 -119.34 148.18 43.48 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.0 129.07 56.62 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.002 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -134.38 169.87 16.58 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.9 m -87.4 147.69 25.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 23.8 ttpp -78.5 -2.28 37.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.143 0.497 . . . . 0.0 111.716 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.64 -10.95 13.05 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.029 -0.419 . . . . 0.0 110.012 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.9 m -89.03 -48.21 7.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.505 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.6 -41.78 83.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.09 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.662 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.2 mt -63.5 -42.53 96.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.547 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.23 -1.5 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.45 0.643 . . . . 0.0 109.997 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.1 t -105.8 -22.78 12.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 33' ' ' ILE . 43.7 pt -102.9 -12.14 8.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 40.5 ptt85 -99.68 3.43 45.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.702 0.763 . . . . 0.0 109.306 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -116.68 -46.65 2.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.648 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.59 -66.9 0.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.256 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -175.52 167.32 39.19 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 63.0 m80 -84.33 67.18 9.74 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.895 0.855 . . . . 0.0 111.906 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -151.09 150.32 30.55 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.584 -1.189 . . . . 0.0 107.888 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.9 p -71.54 123.41 89.35 Favored Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.73 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.64 -25.21 75.19 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.644 2.229 . . . . 0.0 113.27 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.456 HG23 ' OD1' ' A' ' 47' ' ' ASP . 27.1 m -73.09 -33.0 41.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.456 ' OD1' HG23 ' A' ' 46' ' ' VAL . 15.0 p-10 -141.74 6.48 1.83 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 58.15 35.42 25.05 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.6 mm-40 -92.7 142.67 27.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -65.95 121.47 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 111.142 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.3 tp -122.68 131.78 53.96 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.513 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.629 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -106.68 150.97 25.71 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.68 -34.88 78.84 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.43 0.34 55.64 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.629 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.3 mm100 -77.72 -16.27 58.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.824 0.821 . . . . 0.0 109.344 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--N 1.314 -0.956 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.459 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.497 ' HB2' HD23 ' A' ' 16' ' ' LEU . 49.7 t -70.56 111.02 8.12 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.79 -19.73 52.84 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.195 1.93 . . . . 0.0 113.049 -172.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.15 -44.68 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.031 0.443 . . . . 0.0 111.808 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.0 p -108.14 -20.16 13.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.773 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt 69.51 22.83 6.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.279 1.032 . . . . 0.0 110.885 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -112.38 169.56 8.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.944 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 154.72 27.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.497 HD23 ' HB2' ' A' ' 9' ' ' CYS . 88.8 mt -71.08 119.17 14.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -176.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -75.46 -47.65 26.27 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.843 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 30' ' ' LYS . 50.9 mm-40 -113.85 -16.34 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.775 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.3 58.93 4.98 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.89 0.876 . . . . 0.0 112.981 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.34 115.68 27.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.442 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 27' ' ' ARG . 60.4 tt0 -81.61 135.35 35.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.897 -177.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -96.86 158.25 33.77 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.61 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.9 -23.19 74.22 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.862 2.375 . . . . 0.0 112.894 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.0 p -72.44 -28.13 62.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.91 40.72 1.05 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.491 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 59.9 m80 -127.07 160.74 30.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.674 0.273 . . . . 0.0 110.773 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 21' ' ' GLN . 31.5 mmt180 -125.6 136.59 53.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.435 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.4 m-85 -137.72 164.57 28.53 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.406 0.441 . . . . 0.0 110.012 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -85.45 157.52 20.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 87.2 tttt -68.47 -15.2 63.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -1.3 14.19 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.194 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 42.7 m -94.98 -54.2 3.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.893 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.44 -41.14 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.988 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.4 mt -63.23 -42.59 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.682 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -77.68 -1.28 30.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.385 0.612 . . . . 0.0 109.87 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -105.86 -19.98 13.58 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 122.018 -0.426 . . . . 0.0 109.958 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -103.79 -15.16 8.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.47 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -104.88 0.81 28.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.348 0.594 . . . . 0.0 110.498 173.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -116.97 -49.81 2.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.512 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.56 -66.23 0.94 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.518 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -177.86 162.16 29.68 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.33 81.68 3.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 111.176 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -173.71 155.63 2.72 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 4.9 p -76.47 126.06 86.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.275 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.96 -29.42 81.96 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.787 2.325 . . . . 0.0 114.726 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -77.16 -57.54 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -102.56 5.3 39.24 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 49.71 43.2 24.39 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 71.6 mm-40 -90.73 142.82 27.36 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.66 120.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.198 0.523 . . . . 0.0 109.876 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -124.36 130.72 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.158 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -107.64 152.51 24.21 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.87 -36.4 83.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.918 0.39 . . . . 0.0 111.551 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -69.58 -17.78 63.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.902 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.1 mm100 -68.32 -25.51 65.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.896 0.379 . . . . 0.0 111.463 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--N 1.317 -0.827 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.896 -178.644 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.56 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.4 t -72.95 114.86 34.62 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.64 -19.22 54.17 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.221 1.948 . . . . 0.0 113.875 -170.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.12 -44.78 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.245 0.545 . . . . 0.0 112.057 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 6.7 p -108.46 -17.38 14.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 63.18 46.25 4.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.696 0.76 . . . . 0.0 111.076 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.51 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 23.9 ptp -144.4 176.44 9.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.709 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.19 46.78 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.179 0.299 . . . . 0.0 111.005 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.605 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 65.8 mt -70.31 129.42 39.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.713 -174.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -71.27 -46.46 60.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -113.96 -15.2 12.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.254 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.413 ' HA ' HD13 ' A' ' 16' ' ' LEU . . . 58.26 87.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.903 0.752 . . . . 0.0 112.727 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.22 118.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.074 0.464 . . . . 0.0 111.295 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -79.76 139.31 37.32 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.12 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.471 HG21 HD11 ' A' ' 51' ' ' LEU . 41.5 p -97.69 159.41 31.08 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.73 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 29.1 Cg_endo -60.56 -25.16 80.12 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.157 2.571 . . . . 0.0 114.101 -177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.421 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.8 p -87.53 -14.76 39.42 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.495 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.44 36.3 2.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.119 -1.039 . . . . 0.0 114.483 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.421 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 79.9 m-70 -117.97 152.93 34.51 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HB3' HD11 ' A' ' 16' ' ' LEU . 84.7 mtt85 -108.57 132.98 53.32 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.29 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.5 165.2 26.06 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.156 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 35.3 m -79.13 154.27 29.47 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 167.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.27 -11.29 60.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.473 0.654 . . . . 0.0 110.707 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 2.73 15.74 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.225 0.536 . . . . 0.0 109.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 74.2 m -98.08 -56.87 2.36 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.255 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -67.95 -41.25 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.5 mt -62.61 -42.21 95.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 111.011 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -78.32 -1.39 32.98 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.526 0.679 . . . . 0.0 110.741 -177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 m -106.04 -21.76 13.05 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.965 -0.459 . . . . 0.0 111.135 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 33' ' ' ILE . 33.3 pt -104.26 -9.62 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptp180 -101.5 2.85 39.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.209 0.528 . . . . 0.0 111.101 172.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -115.91 -47.22 2.8 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.573 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -75.07 0.35 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.719 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.3 169.6 42.19 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 65.4 m80 -83.97 69.03 10.24 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.65 0.725 . . . . 0.0 112.38 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -152.04 151.23 30.87 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.431 ' HB3' HD12 ' A' ' 51' ' ' LEU . 32.0 p -83.51 146.14 49.59 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.703 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.71 -18.52 58.69 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.703 2.269 . . . . 0.0 112.526 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.74 -74.31 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -106.73 4.57 27.84 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.901 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 57.59 29.06 16.57 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -78.17 147.25 34.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.31 121.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.317 0.58 . . . . 0.0 109.846 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 22' ' ' THR . 6.8 tt -117.05 120.5 38.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.735 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.44 143.14 32.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.248 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.99 -40.57 91.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.103 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.36 -29.96 67.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.995 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -73.22 -8.61 56.56 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.432 HD21 HD21 ' A' ' 51' ' ' LEU . 96.5 mt . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 99.7 mt-10 . . . . . 0 CA--C 1.492 -1.286 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.7 t -82.62 107.31 8.74 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.677 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 41.9 Cg_exo -60.32 -21.06 65.63 Favored 'Trans proline' 0 N--CA 1.475 0.391 0 C-N-CA 122.965 2.443 . . . . 0.0 113.185 -172.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.28 -44.16 91.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.2 p -112.74 -9.11 13.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 55.56 37.05 28.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.696 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.3 mtm -121.34 168.54 11.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.625 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.5 154.79 19.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.29 123.95 22.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.614 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -69.63 -44.18 71.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.846 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -126.44 -17.14 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.962 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.81 81.7 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 m -105.83 117.51 51.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.862 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -81.59 131.78 35.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -90.16 152.43 45.97 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.11 -22.49 73.22 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.433 2.088 . . . . 0.0 112.376 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.743 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 30.9 p -79.82 -17.29 53.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.702 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.43 40.67 1.59 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.361 -0.924 . . . . 0.0 113.907 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.743 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 95.0 m-70 -133.28 161.37 34.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -128.32 137.74 52.08 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.677 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.4 m-85 -137.78 170.43 16.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.078 0.466 . . . . 0.0 111.357 -173.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 21.0 m -76.74 160.18 29.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' HD12 ' A' ' 34' ' ' ILE . 23.1 tptm -71.16 -15.35 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.707 0.289 . . . . 0.0 111.291 -171.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.33 -1.47 12.31 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.519 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 75.1 m -88.26 -65.06 1.06 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.501 ' HB ' ' CG ' ' A' ' 28' ' ' PHE . 11.1 tp -67.78 -38.89 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.2 mt -62.54 -42.84 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.96 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -78.82 -2.02 37.68 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.464 0.65 . . . . 0.0 110.5 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -105.4 -23.24 12.87 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.72 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.7 pt -102.92 -14.14 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.932 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.8 ptm180 -102.32 1.61 35.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.746 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.57 -56.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.0 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.04 -68.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.276 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -151.59 147.39 17.21 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -84.63 34.09 0.53 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.783 0.801 . . . . 0.0 111.121 -171.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -144.14 154.94 43.69 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.636 ' HB3' HD11 ' A' ' 51' ' ' LEU . 25.8 p -64.29 130.06 94.41 Favored Pre-proline 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.078 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.2 -18.94 62.4 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.442 2.094 . . . . 0.0 111.379 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.79 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.104 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -117.37 15.93 14.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 63.69 35.09 11.69 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.612 ' OE1' ' HB2' ' A' ' 24' ' ' CYS . 57.9 mt-10 -89.86 139.56 30.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 mm -66.56 122.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.099 0.476 . . . . 0.0 111.313 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 ' SG ' ' A' ' 24' ' ' CYS . 77.1 mt -112.69 128.98 56.55 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.058 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.2 133.37 50.08 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -61.42 -38.04 85.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -74.72 -13.33 60.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.507 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.62 -9.07 55.32 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.507 -0.694 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.224 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 t -76.43 112.1 19.49 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.6 Cg_exo -61.02 -19.4 62.9 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.027 2.484 . . . . 0.0 113.222 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.91 -43.98 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.45 -25.55 10.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp 66.22 23.68 10.84 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.886 0.874 . . . . 0.0 112.087 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -93.54 -67.41 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.587 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.96 -167.72 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.6 mt -98.69 106.27 18.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -68.92 -43.83 74.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 0.0 110.377 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 66.8 mm-40 -124.01 -15.16 6.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.101 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.43 83.16 0.05 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.853 0.861 . . . . 0.0 113.301 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.36 118.88 59.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 0.0 111.06 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 52.3 tt0 -80.65 128.42 33.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 51.2 p -80.93 164.69 49.54 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 25.3 Cg_endo -59.94 -28.03 86.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.551 2.168 . . . . 0.0 112.331 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.484 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.5 p -79.9 -15.69 56.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.804 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.59 45.78 2.44 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.392 -0.909 . . . . 0.0 114.325 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 89.0 m-70 -120.58 154.25 35.66 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -105.1 124.76 50.09 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 123.315 0.384 . . . . 0.0 110.325 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 92.4 m-85 -134.66 170.39 15.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.088 0.555 . . . . 0.0 110.105 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 40.0 m -85.32 150.15 24.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.474 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 62.5 tttp -68.39 -11.55 59.79 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.871 0.469 . . . . 0.0 111.136 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.18 -14.28 13.4 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.881 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.8 m -87.12 -46.57 9.66 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.896 174.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -68.17 -42.01 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.734 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.638 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.8 mt -63.5 -42.54 96.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 0.0 110.468 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.8 7.67 6.67 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.805 0.812 . . . . 0.0 110.342 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.9 t -106.83 -27.35 10.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.941 -0.475 . . . . 0.0 109.936 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 37.5 pt -104.37 -16.83 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.638 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -98.59 4.78 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -115.59 -56.56 2.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.728 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.9 -68.36 0.8 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.88 169.09 41.89 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.573 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 53.9 m80 -83.41 74.39 10.08 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.656 0.741 . . . . 0.0 111.978 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -150.88 155.28 38.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.812 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.7 t -67.72 129.04 93.51 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.94 -23.77 61.37 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.906 2.404 . . . . 0.0 114.156 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.58 -52.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -105.81 4.03 29.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.107 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 m120 56.87 31.76 20.23 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -78.71 145.79 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -66.12 122.52 17.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.272 0.558 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 60.4 tp -121.06 128.5 52.69 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.239 -171.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.29 146.5 34.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.791 0.329 . . . . 0.0 110.329 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.01 -37.37 87.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.871 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -19.49 63.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.97 0.414 . . . . 0.0 111.514 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.19 -8.0 58.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.844 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.5 mt . . . . . 0 C--N 1.322 -0.592 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.074 178.581 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -64.17 111.65 5.92 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.84 -19.45 58.75 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.061 . . . . 0.0 113.429 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.62 -44.52 89.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.014 0.435 . . . . 0.0 110.945 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -101.52 -23.65 14.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.2 mt 64.48 22.77 12.79 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 111.118 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.6 mtm -96.16 -68.33 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.933 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.33 -161.35 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.92 107.32 18.1 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 6.0 tpm_? -68.05 -44.67 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.828 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -114.92 -16.34 11.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.22 74.5 0.39 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.077 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.93 113.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.425 0.631 . . . . 0.0 110.47 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.62 142.08 32.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -101.14 159.48 29.35 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.22 -19.95 66.43 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.419 2.079 . . . . 0.0 110.979 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.1 t -75.18 -14.29 60.53 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.972 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 18.99 48.47 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.29 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -106.32 141.42 37.67 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -104.38 133.88 48.52 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -139.43 172.27 13.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.487 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 36.0 m -89.25 154.16 20.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.03 -12.91 61.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 122.922 0.489 . . . . 0.0 111.963 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.38 -13.9 12.24 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.41 -176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 44.0 m -84.64 -54.77 4.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.985 0.421 . . . . 0.0 110.689 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.16 -41.85 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -172.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.656 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.48 -43.66 98.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.789 0.328 . . . . 0.0 111.163 -175.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -81.73 1.99 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.204 0.526 . . . . 0.0 111.09 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.1 t -105.06 -22.21 13.14 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.8 pt -103.26 -25.68 3.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.656 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -98.61 3.83 47.97 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.312 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.08 -56.52 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.745 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -71.09 0.55 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.556 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.692 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -142.33 132.04 4.97 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.3 30.12 0.48 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.971 0.891 . . . . 0.0 111.39 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -142.54 153.88 43.96 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 16.8 p -63.0 124.51 83.99 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 120.859 0.362 . . . . 0.0 110.065 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.31 -22.11 73.63 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.909 2.406 . . . . 0.0 114.169 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.427 HG23 ' OD1' ' A' ' 47' ' ' ASP . 28.6 m -79.21 -51.89 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.427 ' OD1' HG23 ' A' ' 46' ' ' VAL . 11.5 p-10 -117.47 7.15 12.67 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 62.02 37.02 15.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.5 mm-40 -93.94 139.5 30.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.673 0.273 . . . . 0.0 111.303 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.78 121.91 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.631 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.3 tp -117.66 131.65 56.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.672 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.41 139.89 41.19 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.81 -38.62 82.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.418 0.449 . . . . 0.0 111.401 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -63.25 -30.15 71.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.464 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -73.81 -8.75 57.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.784 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 N--CA 1.434 -1.227 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB2' HD23 ' A' ' 16' ' ' LEU . 42.9 t -59.19 107.88 1.14 Allowed Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.753 0.658 . . . . 0.0 109.972 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.454 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.2 Cg_exo -65.51 -20.24 60.69 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.839 2.359 . . . . 0.0 112.405 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.03 -44.01 92.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.775 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -98.95 -26.78 14.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.136 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 65.5 21.17 11.79 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.192 0.997 . . . . 0.0 111.426 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.9 mtm -98.3 -67.23 0.86 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.518 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.51 -172.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 9' ' ' CYS . 88.5 mt -100.86 108.47 20.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -73.67 -45.29 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.042 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 48.8 mm-40 -104.93 -19.0 13.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.701 -175.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.43 71.58 0.27 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.224 -173.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -99.77 113.21 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.663 0.744 . . . . 0.0 109.72 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.08 135.43 35.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.815 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 p -89.7 162.37 36.29 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.01 -27.81 85.72 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.361 2.041 . . . . 0.0 112.819 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.704 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.4 p -75.8 -14.97 60.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.98 36.1 5.1 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.704 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 86.0 m-70 -117.05 151.89 35.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -117.15 135.94 53.39 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.278 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.454 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.3 m-85 -137.87 172.6 12.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.468 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.8 m -83.94 149.06 26.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 62.0 tttp -67.64 -12.82 61.31 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 120.942 0.401 . . . . 0.0 111.427 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.29 -16.79 12.89 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.435 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 47.2 m -81.59 -46.78 13.92 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.9 tp -68.95 -42.21 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.5 mt -63.25 -42.74 97.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.893 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.62 2.95 20.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.524 0.678 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -107.01 -22.77 12.55 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.05 -0.406 . . . . 0.0 111.104 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.0 pt -103.41 -19.0 6.41 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -105.22 7.97 33.8 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.656 0.741 . . . . 0.0 109.908 172.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -116.48 -56.02 2.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.373 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.63 -66.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.75 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.56 160.16 33.56 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -79.47 73.51 6.13 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.807 0.804 . . . . 0.0 111.616 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -153.36 150.73 29.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.46 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.0 129.41 86.47 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.87 -20.84 68.88 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.031 2.488 . . . . 0.0 113.649 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.414 HG23 ' OD1' ' A' ' 47' ' ' ASP . 14.9 m -82.15 -59.81 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 46' ' ' VAL . 16.2 p-10 -107.42 4.81 26.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.84 32.32 21.17 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -88.47 147.79 24.49 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.103 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 50' ' ' ILE . 3.2 mp -66.45 119.98 12.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.302 0.573 . . . . 0.0 110.297 -175.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.27 128.88 54.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.058 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.93 144.67 30.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.9 -41.55 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.752 0.821 . . . . 0.0 110.896 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -66.51 -31.28 71.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -77.22 -8.86 58.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -170.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.476 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.0 t -75.58 111.58 15.04 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 123.401 0.681 . . . . 0.0 109.621 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.5 Cg_exo -63.67 -20.44 69.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 112.903 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.93 -44.39 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.64 -23.38 13.85 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.371 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.04 22.23 7.13 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.829 0.851 . . . . 0.0 111.601 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.66 -49.77 5.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.201 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 172.7 -165.63 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.2 mt -103.56 125.65 50.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -80.08 -76.55 0.22 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.686 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -90.21 -15.32 31.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.4 84.24 0.14 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.622 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.49 116.89 50.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.291 0.567 . . . . 0.0 111.077 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -80.88 134.99 35.84 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.36 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -101.49 156.2 35.46 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.69 -22.86 74.34 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.679 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.8 p -77.23 -14.02 59.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.01 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.17 29.52 6.03 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.096 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.679 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 88.3 m-70 -112.92 148.22 35.43 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -107.59 128.59 54.67 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 88.7 m-85 -131.89 -174.74 3.51 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.4 m -99.54 159.15 15.24 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.84 0.352 . . . . 0.0 110.134 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.42 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.9 tttt -77.06 -9.94 59.05 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.566 0.747 . . . . 0.0 110.731 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.22 -6.98 13.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.165 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 85.7 m -91.26 -61.54 1.63 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.795 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -67.44 -40.91 85.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.944 -174.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.0 mt -62.89 -42.39 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 110.454 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 38.5 ttpt -79.57 1.07 27.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.721 0.772 . . . . 0.0 110.865 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -104.48 -24.77 12.99 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.5 pt -102.62 -7.05 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.7 ptm180 -99.55 2.81 45.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.033 0.444 . . . . 0.0 110.147 172.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -122.37 -56.13 1.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.072 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.35 -66.37 0.91 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.186 0.517 . . . . 0.0 110.785 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -170.65 163.96 37.15 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -85.1 73.56 10.63 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.712 0.768 . . . . 0.0 110.846 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.422 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 19.4 ptpt -149.28 151.38 34.09 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.967 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.78 123.84 90.04 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.17 -24.96 65.5 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 113.138 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.12 -57.39 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -108.13 5.7 26.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 56.74 31.77 19.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.309 1.044 . . . . 0.0 113.638 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -83.99 147.46 27.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mm -66.56 120.77 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.25 0.548 . . . . 0.0 109.615 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 43' ' ' LYS . 67.1 tp -122.46 126.27 47.55 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.965 -174.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.82 156.03 19.6 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -66.13 -35.66 81.08 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.21 0.528 . . . . 0.0 110.124 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.26 -20.76 63.93 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.019 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -82.38 -11.43 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.104 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.318 -0.762 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.279 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 45.1 tt0 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.69 0.281 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 t -83.89 111.5 33.21 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.06 -18.52 56.88 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.735 2.29 . . . . 0.0 113.708 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.45 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.789 0.328 . . . . 0.0 111.088 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.47 -20.79 14.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.921 0.391 . . . . 0.0 111.212 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.3 mt 64.03 21.34 12.56 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.294 1.037 . . . . 0.0 112.177 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.9 mtm -95.74 -66.88 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.221 0.534 . . . . 0.0 111.165 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -174.93 -173.43 0.69 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.98 125.68 36.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -79.39 -75.26 0.25 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -91.29 -16.79 26.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.91 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.24 84.74 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.038 0.935 . . . . 0.0 112.445 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -115.31 117.69 56.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.184 0.516 . . . . 0.0 110.431 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 22' ' ' THR . 52.8 tt0 -82.82 146.45 28.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.498 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 70.8 p -92.3 159.31 37.44 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -56.47 -38.43 95.36 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.74 2.294 . . . . 0.0 112.323 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -67.53 -36.71 81.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.696 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.04 48.51 0.21 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.883 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 36.0 m-70 -124.65 145.01 49.88 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.3 mtm-85 -114.25 132.4 56.15 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.205 0.526 . . . . 0.0 111.874 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.89 171.66 14.17 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.868 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.529 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.1 m -79.63 150.7 30.91 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -72.73 -9.23 58.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.347 0.594 . . . . 0.0 110.97 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.57 -14.92 12.62 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.975 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.6 m -84.69 -46.64 11.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.417 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.6 -42.09 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.943 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.1 mt -63.14 -42.35 96.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.629 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -77.43 -1.92 32.66 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.402 0.62 . . . . 0.0 109.939 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -104.99 -23.69 12.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.205 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.49 -7.3 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -97.85 0.05 45.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.546 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -139.55 -56.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.83 -65.86 0.94 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.271 0.558 . . . . 0.0 111.132 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.38 136.57 5.27 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.406 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 6.0 t-80 -83.31 52.73 2.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.527 0.68 . . . . 0.0 109.542 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -147.24 156.17 42.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.266 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.32 123.35 75.1 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.62 -24.15 69.83 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.955 2.437 . . . . 0.0 114.428 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.59 -48.66 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -118.78 5.79 11.51 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.979 -0.451 . . . . 0.0 111.653 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 57.47 33.08 22.79 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.437 0.695 . . . . 0.0 112.807 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -87.27 145.18 26.47 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.491 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.21 121.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.59 130.27 56.29 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.105 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.54 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -109.38 146.87 33.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.18 -33.51 73.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.489 0.716 . . . . 0.0 109.651 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.517 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.8 mm100 -77.67 -14.7 59.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.847 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--O 1.246 0.92 0 CA-C-O 120.744 0.306 . . . . 0.0 110.41 -177.096 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 t -92.78 113.65 60.26 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.79 -18.92 63.9 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.599 2.199 . . . . 0.0 113.575 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.2 -43.91 91.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.839 0.352 . . . . 0.0 111.181 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.9 p -101.7 -21.22 14.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.798 0.332 . . . . 0.0 111.325 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt 59.51 23.03 11.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.001 0.92 . . . . 0.0 111.907 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.8 mtm -95.32 -68.54 0.8 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.672 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.74 -165.59 0.32 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.06 124.08 47.05 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.35 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 8.8 tpt180 -78.4 -61.13 2.1 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.169 174.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 69.9 mm-40 -108.42 -15.05 14.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.338 -176.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.91 73.87 0.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.959 0.787 . . . . 0.0 112.335 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.32 116.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 110.684 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -81.2 139.95 35.22 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.004 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 p -98.46 158.67 32.19 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.7 -34.63 91.27 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.092 2.528 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -15.34 61.93 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.47 42.18 3.01 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.715 -0.755 . . . . 0.0 114.006 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -127.47 141.13 51.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.12 136.86 42.96 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.119 0.485 . . . . 0.0 111.6 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -133.68 173.3 11.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.651 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.589 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -86.03 149.63 25.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 66.0 tttm -68.51 -12.2 60.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.37 0.668 . . . . 0.0 111.606 -176.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.25 -5.62 12.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.992 0.425 . . . . 0.0 110.143 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 79.5 m -92.59 -58.68 2.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.625 175.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -65.93 -42.43 91.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.836 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.616 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.51 -43.19 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.674 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -80.34 -1.5 41.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.599 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -105.54 -20.09 13.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.9 pt -102.1 -19.83 5.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.953 -175.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.8 ptm180 -100.87 2.79 41.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.614 0.721 . . . . 0.0 110.254 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -115.96 -46.57 2.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.78 -70.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 0.0 110.466 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.54 155.27 26.35 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 62.3 m80 -80.1 68.58 6.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.963 0.887 . . . . 0.0 112.358 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.27 153.89 34.64 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.02 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.5 p -79.35 123.42 84.53 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.786 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.18 -21.41 67.6 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.142 2.562 . . . . 0.0 113.942 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.2 m -78.54 -52.55 15.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -112.03 4.85 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 57.73 35.26 25.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.456 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 62.3 mm-40 -94.51 148.26 22.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.41 121.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.35 127.43 49.77 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.013 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.6 mm? -106.28 150.34 26.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.475 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.69 -37.97 89.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.3 -27.41 67.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.818 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.6 mm100 -73.75 -8.47 56.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 -174.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.7 mt . . . . . 0 C--N 1.319 -0.75 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.171 179.393 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.434 -1.257 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.2 t -69.01 113.83 19.1 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.43 -18.19 54.51 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.192 2.595 . . . . 0.0 112.271 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.8 mt -66.62 -44.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.106 0.479 . . . . 0.0 111.134 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 p -105.24 -20.84 13.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.09 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 62.94 22.94 13.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 111.516 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -103.93 -68.12 0.86 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.67 -167.27 1.08 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.3 mt -113.98 132.29 56.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB3' ' H ' ' A' ' 30' ' ' LYS . 27.9 tpt180 -69.09 -77.42 0.08 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.1 5.6 20.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 171.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.54 80.78 0.14 Allowed 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.612 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.1 m -90.9 116.24 31.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.783 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.08 130.12 34.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.643 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.3 p -89.56 155.96 48.09 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.88 -23.14 75.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.735 2.29 . . . . 0.0 112.754 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.522 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 5.0 p -77.94 -20.14 53.31 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.4 39.93 2.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.151 -1.024 . . . . 0.0 114.142 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.522 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 88.3 m-70 -122.51 155.37 36.36 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -124.38 131.09 53.5 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -134.16 172.85 12.28 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.871 0.469 . . . . 0.0 110.891 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.433 ' O ' HG22 ' A' ' 33' ' ' ILE . 63.6 m -72.09 160.08 33.08 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.732 169.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' O ' HD12 ' A' ' 34' ' ' ILE . 89.2 tttt -82.63 -1.07 49.94 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.99 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.4 -40.07 3.48 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.319 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.7 m -62.26 -50.07 73.18 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -69.34 -42.36 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.556 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.8 mt -63.53 -43.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 111.575 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -78.0 -0.37 27.57 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.578 0.704 . . . . 0.0 109.553 -174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 t -105.25 -26.16 12.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.748 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.9 pt -104.24 -14.01 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -93.39 -6.96 45.98 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.5 174.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -115.74 -56.8 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.71 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.27 -66.1 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.986 0.422 . . . . 0.0 110.048 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.02 165.54 38.7 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -87.6 69.2 9.7 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.497 0.665 . . . . 0.0 111.759 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -147.17 154.61 41.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.228 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 29.7 m -62.14 131.74 93.59 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.75 -24.37 61.97 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.235 1.957 . . . . 0.0 111.505 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.53 -70.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.234 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -97.46 6.17 48.58 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -172.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 9.2 p30 54.33 16.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 174.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.54 151.33 45.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.3 120.47 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -120.93 122.03 39.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.514 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.67 138.91 34.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.65 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.4 -41.13 96.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.835 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -74.99 -12.7 60.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.205 0.526 . . . . 0.0 111.317 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -82.19 -10.17 59.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.246 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 C--O 1.236 0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.191 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' HD23 ' A' ' 16' ' ' LEU . 41.3 t -83.44 112.35 38.67 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.13 -20.01 65.96 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 122.42 2.08 . . . . 0.0 112.513 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.26 -44.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.532 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -119.15 -2.42 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.8 mt 53.8 27.3 6.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.093 0.957 . . . . 0.0 112.053 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.3 mtm -111.67 174.16 6.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.724 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.16 149.95 49.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.359 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 9' ' ' CYS . 89.3 mt -70.28 109.86 4.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -65.56 -46.22 80.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 57.6 mm-40 -116.49 -15.51 10.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.079 -176.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 47.81 72.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.053 0.941 . . . . 0.0 113.164 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.79 116.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.363 0.602 . . . . 0.0 110.674 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 22' ' ' THR . 9.6 tt0 -82.13 136.61 35.13 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.965 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 32.3 p -84.29 163.62 46.9 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.81 -36.47 95.37 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.694 2.262 . . . . 0.0 112.508 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.511 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 5.0 p -65.68 -21.74 66.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.812 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.5 38.07 3.83 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.102 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -115.54 143.06 45.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.01 130.28 53.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.746 0.307 . . . . 0.0 111.267 -173.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -139.65 162.83 34.15 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.641 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.63 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 47.1 m -78.39 147.8 33.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.3 tttt -68.83 -10.25 55.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -174.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 -13.29 13.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.63 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.5 m -85.64 -45.16 11.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.694 173.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -65.58 -39.98 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.75 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.86 -41.38 92.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.164 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.08 -2.25 33.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.355 0.598 . . . . 0.0 109.944 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 m -105.68 -21.3 13.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.0 pt -103.12 -8.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.559 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.54 -2.27 45.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.085 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -116.78 -55.51 2.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.073 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.63 -64.79 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.42 -175.08 41.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -80.42 80.77 6.8 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.546 0.689 . . . . 0.0 111.596 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.0 ptpt -148.53 153.29 38.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.556 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 49' ' ' GLU . 4.6 p -76.78 136.01 67.36 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 165.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.98 -20.3 69.05 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 122.848 2.365 . . . . 0.0 114.167 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 47' ' ' ASP . 3.8 m -92.89 -71.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.481 ' H ' HG23 ' A' ' 46' ' ' VAL . 12.8 p-10 -96.14 5.27 51.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.827 0.451 . . . . 0.0 112.052 -174.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.33 0.3 OUTLIER 44.19 56.67 4.71 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.098 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 17.5 pt-20 -94.58 163.52 13.35 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.54 115.33 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 109.504 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.1 tp -115.63 130.08 56.73 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.182 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.456 HD23 HE21 ' A' ' 55' ' ' GLN . 3.9 mm? -113.97 149.4 35.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.307 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.97 -35.84 75.87 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.529 0.518 . . . . 0.0 110.193 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -63.8 -31.28 72.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.776 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.456 HE21 HD23 ' A' ' 52' ' ' LEU . 46.7 mt-30 -78.43 -7.59 57.55 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.318 -0.777 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.21 176.774 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.95 108.01 11.2 Favored Pre-proline 0 N--CA 1.436 -1.136 0 O-C-N 123.657 0.598 . . . . 0.0 109.764 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HG3' HG13 ' A' ' 46' ' ' VAL . 58.5 Cg_endo -69.64 -17.86 37.87 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.948 2.432 . . . . 0.0 111.789 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.77 -43.77 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.1 p -99.72 -20.19 16.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.99 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 61.87 21.76 12.52 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.729 0.811 . . . . 0.0 111.883 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.68 -71.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.704 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.22 -166.49 0.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.16 105.04 17.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -70.47 -57.01 5.25 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 63.8 mm-40 -103.42 -16.41 15.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.006 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.55 61.51 3.16 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -93.04 118.23 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.188 0.518 . . . . 0.0 111.374 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 65.3 tt0 -75.51 134.44 40.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.947 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -99.96 159.17 30.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.766 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.89 -23.77 68.24 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.749 2.299 . . . . 0.0 113.113 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -73.11 -28.61 62.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.379 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.64 38.75 1.16 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -133.28 162.02 32.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 80.2 mtp180 -127.98 140.12 52.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -136.13 173.9 11.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.1 m -84.91 148.23 26.35 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 87.9 tttt -79.33 -3.58 46.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 110.324 -174.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.61 -12.55 13.41 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.6 m -94.09 -54.22 3.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.777 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -66.03 -38.57 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.9 mt -62.8 -42.99 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.663 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.95 -2.52 40.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.611 0.719 . . . . 0.0 110.48 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -105.43 -16.47 14.72 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.965 -0.459 . . . . 0.0 110.618 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.661 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -104.09 -24.18 4.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.559 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -97.42 1.04 48.77 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.813 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -116.4 -56.02 2.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.564 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.26 -66.71 0.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.467 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.1 159.1 32.0 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 64.0 m80 -85.45 75.64 10.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.285 0.543 . . . . 0.0 110.871 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -153.76 155.19 35.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.498 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.1 p -80.71 130.91 62.35 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -31.55 85.61 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.782 2.321 . . . . 0.0 114.775 -172.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 10' ' ' PRO . 16.0 m -78.87 -53.28 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -106.05 3.5 28.26 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 m120 52.82 40.18 30.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.15 146.22 24.02 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 mm -66.65 120.58 14.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.373 0.606 . . . . 0.0 109.909 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.6 tp -124.42 118.05 25.81 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.801 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.565 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -96.05 161.42 13.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.91 -37.39 87.48 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.806 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.89 -24.02 64.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 111.247 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.565 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.7 mm100 -76.38 -10.78 59.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.665 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.32 -0.689 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.168 177.882 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 42.5 tt0 . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 51.3 t -87.63 108.74 21.8 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 37.3 Cg_exo -61.54 -20.61 69.32 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.478 2.119 . . . . 0.0 111.677 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.462 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.24 -43.47 91.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.034 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.0 m -88.89 -27.49 20.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.182 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 56.78 35.21 25.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.073 0.939 . . . . 0.0 108.693 -165.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -139.48 171.28 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.309 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.66 152.48 22.36 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.546 0.529 . . . . 0.0 111.608 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.0 mt -70.85 139.51 50.87 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.997 -177.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -79.12 -72.3 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.289 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.47 -15.96 20.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.649 0.261 . . . . 0.0 110.911 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.71 102.47 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.957 0.903 . . . . 0.0 113.274 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.8 m -117.15 118.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.411 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 60.6 tt0 -80.41 135.31 36.14 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.768 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -95.77 152.57 39.16 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -26.52 83.27 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.902 2.401 . . . . 0.0 113.823 -173.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -79.72 -19.36 49.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.72 48.48 0.68 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.649 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -133.33 152.11 51.91 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 65.2 mtt180 -121.44 136.3 54.97 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.982 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.67 170.0 16.48 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 39.0 m -78.92 153.29 30.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.96 -12.68 61.2 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.77 -31.56 6.1 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.224 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 28.0 m -62.98 -44.61 95.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.543 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -64.73 -41.12 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.0 mt -63.48 -43.51 98.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.836 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.77 -2.8 44.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.872 0.368 . . . . 0.0 110.539 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.0 t -106.92 -22.8 12.57 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.797 0.332 . . . . 0.0 110.635 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 33' ' ' ILE . 45.7 pt -101.78 -7.91 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.061 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -101.98 6.66 41.32 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.586 167.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.52 -54.89 2.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.186 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -66.11 0.94 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.137 0.494 . . . . 0.0 109.809 176.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.65 166.83 38.84 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 49.9 m80 -79.73 77.4 6.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.164 0.982 . . . . 0.0 110.83 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.1 ptpt -152.25 149.79 29.09 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.625 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.573 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 2.2 m -68.01 130.54 92.63 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.6 -34.02 94.5 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.262 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.76 -54.95 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.573 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 31.4 p-10 -104.19 4.29 33.81 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.719 -0.613 . . . . 0.0 112.07 -174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 54.96 32.23 17.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.799 0.84 . . . . 0.0 112.739 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 73.7 mm-40 -92.91 142.82 26.88 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.83 120.38 11.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 CA-C-O 121.597 0.713 . . . . 0.0 110.373 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.8 tp -117.14 129.25 55.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.316 -175.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.8 mm? -98.21 148.74 23.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.59 -37.24 86.07 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.328 0.393 . . . . 0.0 111.882 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -68.37 -19.74 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.534 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 14.1 mm-40 -77.24 -6.62 53.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.199 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.434 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 39.8 t -78.25 113.83 37.19 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.98 -20.96 64.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.481 2.121 . . . . 0.0 112.895 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.86 -44.34 85.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.094 0.473 . . . . 0.0 111.874 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 20.7 p -101.85 -13.22 17.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.166 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mp 54.09 23.37 4.07 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.996 0.918 . . . . 0.0 111.742 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.7 mtm -100.03 -70.98 0.72 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.687 0.279 . . . . 0.0 111.676 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.89 165.25 5.16 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.6 109.92 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -70.42 -46.12 64.54 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.895 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -115.35 -17.9 11.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.06 81.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.798 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.71 117.37 42.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.601 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -80.83 140.96 35.13 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.195 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -96.9 156.77 36.07 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 74.9 Cg_exo -54.53 -37.59 90.27 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.966 2.444 . . . . 0.0 112.594 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -64.9 -18.33 65.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.903 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.87 4.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.471 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -120.35 152.32 38.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -123.07 138.27 54.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.349 0.595 . . . . 0.0 112.439 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -137.3 169.26 18.08 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.329 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HB2' ' HG ' ' A' ' 32' ' ' CYS . 82.3 m -76.47 151.4 36.47 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.228 171.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.52 -5.78 31.38 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.04 0.447 . . . . 0.0 112.107 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.85 -34.13 5.55 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.93 -0.481 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.59 ' HG ' ' HB2' ' A' ' 29' ' ' CYS . 58.5 m -64.29 -44.8 90.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.015 0.436 . . . . 0.0 110.608 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.515 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.1 tp -65.53 -39.91 86.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.169 -176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -63.02 -42.35 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.039 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -78.12 -2.3 36.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.785 0.326 . . . . 0.0 110.422 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -105.35 -25.62 12.32 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.003 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.8 pt -103.81 -10.29 9.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.71 -174.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.5 ptm180 -93.47 -14.04 27.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.487 176.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -131.72 -56.33 1.0 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.138 -172.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.02 -66.2 0.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.87 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.06 137.32 5.11 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -85.23 43.44 1.01 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.854 0.835 . . . . 0.0 110.244 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -148.05 155.11 41.11 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 12.0 p -75.04 127.03 87.46 Favored Pre-proline 0 C--N 1.318 -0.778 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.192 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.7 -25.27 68.76 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.917 2.411 . . . . 0.0 113.557 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.52 -49.33 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -131.87 12.21 4.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.99 35.32 21.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 73.3 mm-40 -85.03 143.5 28.87 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.322 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.81 120.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.7 tp -121.03 126.6 50.3 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.555 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -110.43 148.01 32.88 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.02 -28.82 69.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.689 0.757 . . . . 0.0 109.835 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.96 -30.65 71.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.438 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.555 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.4 mm100 -80.16 -16.37 55.02 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.363 -175.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.239 0.506 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.35 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.241 0.636 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 19.6 p -91.55 134.15 29.88 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.573 175.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.55 -17.52 58.71 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.929 2.419 . . . . 0.0 113.131 -174.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.8 -45.03 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -106.89 -20.08 13.44 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.53 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.25 23.0 6.68 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.843 0.857 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -97.45 -66.61 0.89 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.202 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.72 -172.62 0.9 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -105.12 105.36 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.22 174.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -69.91 -44.15 70.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.709 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -125.41 -15.16 6.24 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.633 -175.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HB1' ' HD3' ' A' ' 27' ' ' ARG . . . 49.6 56.24 8.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 30.3 m -77.48 118.22 23.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -75.9 133.32 40.56 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.643 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -106.1 162.58 19.26 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.264 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.23 -36.64 99.07 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.294 2.663 . . . . 0.0 112.46 178.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.0 -25.94 64.76 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.932 0.396 . . . . 0.0 111.602 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.31 29.01 4.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.038 177.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -112.58 157.65 20.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 94.8 mtt-85 -124.74 140.48 52.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 110.238 174.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.45 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 88.3 m-85 -134.49 165.56 24.9 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.015 -176.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.5 m -73.84 152.66 40.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 171.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' O ' HD12 ' A' ' 34' ' ' ILE . 57.7 tttp -68.87 -13.23 62.3 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 121.296 0.569 . . . . 0.0 110.778 -174.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.86 -1.22 13.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.218 0.533 . . . . 0.0 110.387 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 89.3 m -90.72 -64.02 1.19 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.421 176.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.28 -40.94 83.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.8 mt -63.09 -42.15 95.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 110.336 -178.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.9 tptp -78.7 -1.64 35.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.673 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.1 m -106.9 -19.77 13.53 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.381 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.1 pt -102.99 -31.63 2.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.488 -174.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.6 ptm180 -99.13 4.31 46.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.232 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -115.72 -55.08 2.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.842 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.27 -71.77 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.433 . . . . 0.0 110.184 178.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.24 152.75 23.6 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -79.23 71.58 5.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.434 0.635 . . . . 0.0 112.105 -175.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.3 ptpt -153.36 152.29 30.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.609 178.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 m -64.76 124.77 87.29 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 170.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.51 -27.32 70.04 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 121.702 1.601 . . . . 0.0 112.067 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.72 -54.79 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.11 4.97 29.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 54.43 33.91 19.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.3 mm-40 -96.75 141.41 30.0 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.02 121.18 13.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 -176.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.53 132.82 44.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.818 -173.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.455 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -116.43 157.67 24.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.59 -37.41 78.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 109.774 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -65.12 -29.55 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.7 mm100 -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.147 -177.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.795 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.6 tt0 . . . . . 0 N--CA 1.442 -0.85 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 t -75.44 108.07 5.13 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 53.6 Cg_endo -68.23 -17.79 44.96 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.922 2.415 . . . . 0.0 111.983 -177.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.16 -43.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.232 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.92 -13.81 15.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 0.0 111.339 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.65 21.44 5.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 112.011 -177.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -99.83 -69.81 0.75 Allowed 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.45 -167.36 0.2 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.9 mt -94.41 107.07 19.05 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -69.74 -43.83 71.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 64.9 mm-40 -122.61 -14.66 7.71 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.617 -175.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.87 56.44 6.66 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.517 0.727 . . . . 0.0 112.424 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.2 m -83.51 116.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.461 0.648 . . . . 0.0 110.708 178.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -78.78 134.25 37.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.873 -176.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 157.53 36.89 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.76 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.38 -40.28 83.65 Favored 'Trans proline' 0 C--N 1.364 1.342 0 C-N-CA 122.587 2.191 . . . . 0.0 113.323 -177.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 -14.88 61.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.43 36.87 2.97 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.144 173.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -117.26 157.74 25.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.3 mtt180 -123.22 140.38 53.08 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.423 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 98.2 m-85 -132.13 173.07 11.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.263 -177.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.7 m -85.05 148.74 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 38.9 ttpt -73.69 -10.94 60.2 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.351 0.596 . . . . 0.0 111.346 -172.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.49 -4.53 12.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.019 0.438 . . . . 0.0 109.958 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 88.2 m -90.02 -60.78 1.84 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 174.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -67.1 -40.68 85.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.599 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.4 mt -62.71 -43.03 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.917 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -79.99 1.46 27.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.802 0.811 . . . . 0.0 110.169 -177.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 t -105.44 -24.8 12.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.876 175.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 49.2 pt -103.23 -22.67 4.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -99.26 4.56 46.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.456 174.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -119.37 -57.23 2.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.466 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.95 -68.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.892 0.377 . . . . 0.0 111.598 -177.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -146.03 140.12 8.65 Favored Glycine 0 CA--C 1.502 -0.756 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.483 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 3.7 t-160 -83.32 52.25 2.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.458 0.647 . . . . 0.0 110.488 -172.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -155.32 160.96 41.15 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.672 -174.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.615 ' HB3' HD11 ' A' ' 51' ' ' LEU . 2.6 p -79.16 130.47 69.26 Favored Pre-proline 0 C--N 1.318 -0.764 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.441 173.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.08 -21.05 72.68 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.209 2.606 . . . . 0.0 113.666 -173.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 47' ' ' ASP . 4.0 m -72.58 -70.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 46' ' ' VAL . 46.4 p-10 -103.13 5.56 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.16 33.0 21.1 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 113.179 173.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -83.48 139.99 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.13 121.36 16.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.493 . . . . 0.0 110.476 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 44' ' ' CYS . 83.0 mt -109.58 132.37 54.2 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.314 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 71.4 mt -108.68 143.41 37.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -61.17 -36.13 79.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.17 0.509 . . . . 0.0 110.266 -179.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -65.05 -31.71 73.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.089 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -86.14 -13.21 47.81 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.041 -176.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 85.4 mt . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.87 109.75 4.38 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.8 -19.91 69.8 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.9 2.4 . . . . 0.0 113.407 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.03 -43.97 92.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 121.139 0.495 . . . . 0.0 110.989 179.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.2 p -104.49 -21.4 13.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.791 -177.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.1 mt 59.03 29.37 18.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.703 0.801 . . . . 0.0 111.719 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.8 mtm -98.68 -66.87 0.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.174 0.512 . . . . 0.0 110.528 176.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.52 -172.03 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -91.09 105.81 18.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -69.28 -45.2 70.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.928 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.442 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 71.1 mm-40 -116.3 -15.82 10.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -178.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 88.66 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -117.24 117.59 55.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.243 0.544 . . . . 0.0 110.353 171.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -80.56 139.32 36.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.114 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 p -109.39 158.95 33.15 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.75 -27.0 82.25 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.907 2.405 . . . . 0.0 111.576 176.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.36 -24.96 67.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.262 178.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.89 8.17 57.13 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.892 -174.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -92.87 154.0 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -124.36 139.42 53.92 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.197 173.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.52 168.87 18.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.625 -174.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 49.9 m -79.12 151.72 31.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 169.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 34' ' ' ILE . 86.9 tttt -78.36 8.6 4.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.721 0.772 . . . . 0.0 111.289 -173.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.64 -38.91 3.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 38.7 m -66.39 -50.06 64.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.069 -178.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -69.12 -40.24 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.071 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.636 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.9 mt -62.94 -42.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.718 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -78.92 0.59 26.77 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.097 -177.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -105.37 -23.85 12.77 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.789 176.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.4 pt -103.92 -22.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -104.13 6.17 35.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.798 175.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.47 -53.0 2.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 178.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.73 -71.15 0.52 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.917 0.389 . . . . 0.0 110.362 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.57 161.61 35.33 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -80.32 75.55 7.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.721 0.772 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.8 ptpt -151.95 148.85 28.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.729 177.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.0 p -72.37 126.09 91.12 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.99 -22.73 73.96 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 122.326 2.018 . . . . 0.0 112.585 -175.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.18 -50.71 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -135.9 11.79 3.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.44 35.51 9.5 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 173.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 53.6 mt-10 -83.85 145.47 28.62 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -66.5 113.7 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.241 0.543 . . . . 0.0 110.25 -176.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.9 tp -126.23 123.18 37.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.987 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.568 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.1 mm? -97.61 160.39 14.35 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.11 -38.61 91.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -176.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.01 -17.65 63.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 178.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.568 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.2 mm100 -76.3 -8.99 58.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.895 -178.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.919 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.433 -1.295 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.28 109.61 22.62 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.31 -17.66 54.37 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.805 2.337 . . . . 0.0 112.657 -175.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -65.92 -43.83 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.866 0.365 . . . . 0.0 110.987 177.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.7 p -105.39 -15.63 14.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mp 57.87 22.67 8.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.889 0.876 . . . . 0.0 111.433 -176.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 8.1 mmt -95.03 -66.51 0.91 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.501 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.59 -166.61 0.06 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.69 117.58 34.35 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -67.63 -44.85 77.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 179.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -134.96 -15.03 2.04 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 67.59 88.86 0.11 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.353 1.061 . . . . 0.0 112.847 179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.0 m -106.24 117.1 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.174 0.511 . . . . 0.0 111.033 175.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -80.37 132.12 35.72 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.93 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 p -95.86 156.15 37.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.31 -29.63 86.36 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.569 2.18 . . . . 0.0 112.767 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.26 -22.91 51.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.659 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.7 51.56 0.65 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.213 -0.994 . . . . 0.0 114.013 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -131.47 161.39 32.63 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 68.9 mtt180 -127.74 136.38 51.45 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 171.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.09 -179.1 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.188 -176.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.561 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.5 m -86.7 152.94 22.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 170.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 34' ' ' ILE . 35.9 ttpt -78.65 -1.97 36.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.617 0.723 . . . . 0.0 111.021 -174.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.41 -19.26 10.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 177.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.3 m -82.86 -57.8 3.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.331 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -67.76 -41.08 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.911 -175.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 81.5 mt -62.9 -42.85 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 111.544 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -78.61 -2.72 40.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.23 0.538 . . . . 0.0 109.647 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -105.97 -21.99 13.01 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 176.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 33' ' ' ILE . 46.3 pt -103.25 -15.56 7.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.175 -177.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.4 ptm180 -99.87 2.27 43.68 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.03 175.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -116.28 -55.76 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.994 -178.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.55 -67.03 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.287 0.565 . . . . 0.0 109.773 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.48 159.68 31.43 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -81.72 72.41 8.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -156.38 148.15 22.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.124 173.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.82 124.47 89.62 Favored Pre-proline 0 N--CA 1.436 -1.14 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.831 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.1 -24.52 76.57 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.092 2.528 . . . . 0.0 113.739 -170.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.7 m -68.87 -47.47 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -119.79 5.58 10.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 m120 58.71 33.56 23.16 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.451 0.701 . . . . 0.0 112.642 177.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -95.78 144.36 26.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.6 mm -66.11 120.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.122 0.487 . . . . 0.0 110.343 -173.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.9 tp -131.18 132.56 44.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -174.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 3.8 mm? -116.58 150.16 38.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.56 -37.03 82.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.066 0.546 . . . . 0.0 110.131 -177.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -64.32 -31.73 73.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 12.0 mm100 -76.43 -17.64 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.862 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 95.8 mt . . . . . 0 C--N 1.316 -0.876 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.257 178.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 41.8 t -75.85 114.66 38.99 Favored Pre-proline 0 N--CA 1.438 -1.035 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.1 -19.4 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.121 1.881 . . . . 0.0 113.224 -177.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -67.96 -44.33 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 14.4 p -100.28 -24.62 14.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.079 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 65.1 21.9 12.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.348 0.659 . . . . 0.0 110.866 -176.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.3 mmt -96.4 -70.14 0.73 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.706 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.68 -168.67 0.24 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -176.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.35 122.16 44.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -84.57 -66.38 0.9 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.685 177.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -88.29 -15.64 35.25 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.555 176.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.44 56.3 7.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.659 1.184 . . . . 0.0 112.297 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.4 m -80.88 116.56 25.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.251 0.548 . . . . 0.0 111.636 -175.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 22' ' ' THR . 26.7 tt0 -81.4 131.52 35.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.206 176.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 82.3 p -83.82 159.18 61.04 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD2' ' CD2' ' A' ' 51' ' ' LEU . 31.7 Cg_endo -61.17 -24.26 78.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.072 1.848 . . . . 0.0 111.978 178.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -76.48 -15.92 59.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.857 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 33.93 5.63 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.472 178.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -119.96 150.77 39.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -122.13 139.79 53.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' O ' HG22 ' A' ' 20' ' ' VAL . 85.5 m-85 -142.88 172.06 13.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.677 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.6 m -84.05 153.62 23.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.51 -14.07 62.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.143 0.497 . . . . 0.0 112.054 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.18 1.4 15.24 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.804 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 57.9 m -95.81 -56.44 2.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.669 172.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -66.81 -41.88 88.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.747 -177.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.435 ' HA ' HG12 ' A' ' 37' ' ' ILE . 76.5 mt -63.39 -41.58 93.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 111.915 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -77.46 -2.73 36.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.484 0.659 . . . . 0.0 109.395 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.94 -17.72 14.11 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.408 177.093 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 42' ' ' HIS . 38.2 pt -106.49 -11.73 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -175.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -95.21 -10.91 29.05 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.222 -178.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.7 -45.88 2.87 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.927 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.88 -76.65 0.16 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.32 158.6 31.6 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 177.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.513 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 55.1 m80 -83.56 67.48 9.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.628 0.727 . . . . 0.0 111.61 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -143.18 150.77 39.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.436 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.1 p -83.22 124.33 76.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -28.18 81.45 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.728 2.285 . . . . 0.0 113.449 -171.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -69.58 -45.45 78.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -120.17 5.56 10.78 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 57.98 33.15 22.88 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 175.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -95.57 146.21 24.63 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 177.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.94 120.74 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD12 HD13 ' A' ' 37' ' ' ILE . 3.3 tm? -121.76 126.75 49.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.11 -172.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.52 148.75 31.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.543 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.05 -41.04 95.52 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.639 1.176 . . . . 0.0 112.983 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -87.12 -0.61 56.95 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.363 -176.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -87.31 -7.86 57.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.691 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 96.0 mt . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.224 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.096 0 CA-C-O 120.937 0.399 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.496 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 45.8 t -118.92 108.9 40.13 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.46 -21.52 72.13 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 122.589 2.193 . . . . 0.0 112.653 -171.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.49 -44.14 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.791 177.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 19.5 p -106.67 -17.9 14.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 57.08 33.52 23.46 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.112 0.965 . . . . 0.0 111.885 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -121.35 -77.02 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.328 177.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.6 158.47 2.75 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.774 0.43 . . . . 0.0 110.014 -179.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.0 mt -71.82 105.22 3.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.692 0.282 . . . . 0.0 110.853 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -70.65 -44.8 66.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 178.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -112.86 -16.87 12.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.644 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.0 80.72 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.97 116.47 47.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 110.326 174.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -81.01 136.11 35.94 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.411 -177.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -103.13 154.34 37.7 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.77 -29.35 85.56 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.051 2.501 . . . . 0.0 112.839 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.7 p -69.1 -15.59 63.47 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.51 11.41 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.172 177.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -114.22 155.78 25.5 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 122.571 -0.37 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -126.49 136.54 52.74 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.48 167.92 20.18 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.206 0.316 . . . . 0.0 110.814 -176.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 58.2 m -80.63 156.19 26.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.256 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.8 tttt -69.48 -12.65 61.82 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.966 -173.473 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.07 -20.56 10.94 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.156 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 98.1 m -72.1 -54.1 10.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.845 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -67.97 -39.85 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.247 -175.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 88.0 mt -62.73 -42.8 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.663 0.268 . . . . 0.0 111.131 -178.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -78.87 -0.83 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.464 0.649 . . . . 0.0 110.372 -177.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -103.61 -25.45 13.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.323 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -103.05 -7.32 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.452 -177.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -100.94 -2.84 30.82 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.7 -52.74 2.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.707 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.97 -69.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.079 0.466 . . . . 0.0 110.241 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -176.82 167.29 38.59 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 177.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -81.5 67.16 7.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.809 0.814 . . . . 0.0 111.616 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -148.08 157.66 43.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.339 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 50.4 t -64.9 127.22 92.48 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.44 -26.53 70.58 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.388 2.058 . . . . 0.0 112.449 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.77 -71.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -98.28 5.63 48.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -174.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 12.6 m120 57.31 33.47 23.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.875 0.87 . . . . 0.0 113.151 173.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -86.44 148.58 25.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.5 mp -66.19 122.56 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 110.322 -173.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.24 125.74 46.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -174.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.47 152.43 18.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 177.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.68 -36.82 84.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.909 -173.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -71.16 -11.96 61.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.861 0.363 . . . . 0.0 111.483 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.44 -8.23 59.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.452 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt . . . . . 0 C--O 1.238 0.45 0 O-C-N 123.12 0.262 . . . . 0.0 110.911 -177.669 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB2' HD23 ' A' ' 16' ' ' LEU . 40.9 t -89.78 108.05 22.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.7 Cg_exo -63.37 -20.47 70.29 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.743 2.296 . . . . 0.0 112.839 -177.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -66.57 -44.45 90.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.609 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.07 -20.26 14.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.7 mt 59.1 22.02 10.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.096 0.959 . . . . 0.0 112.848 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.6 mtm -98.19 -65.69 0.95 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.485 176.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.51 -169.82 0.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.472 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.5 mt -100.44 108.47 20.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.43 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 3.3 tpm_? -69.83 -42.34 73.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 43.6 mt-10 -118.29 -15.52 9.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 -177.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.93 82.17 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 28' ' ' PHE . 19.6 m -115.97 114.88 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.299 0.571 . . . . 0.0 110.661 176.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.56 129.49 34.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.307 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.4 p -77.96 168.21 29.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.125 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.4 -28.77 81.81 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.556 2.17 . . . . 0.0 111.731 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB2' ' OE1' ' A' ' 49' ' ' GLU . 27.6 p -84.5 -21.53 30.55 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.675 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.42 4.22 22.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.792 177.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -88.65 149.68 23.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.209 0.504 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -116.77 136.32 53.05 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.673 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.7 m-85 -139.86 170.01 16.66 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 28.3 m -83.26 147.65 27.85 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 3.5 ttpm? -69.36 -7.76 40.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -173.02 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.88 -16.62 12.68 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.708 -178.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 46.0 m -82.52 -46.28 13.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.58 -41.66 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.3 mt -63.06 -41.83 94.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 111.707 -178.205 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.66 -1.81 32.85 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.869 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 m -106.15 -20.84 13.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.433 HD11 ' HG2' ' A' ' 53' ' ' GLU . 37.7 pt -102.99 -9.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.967 -176.143 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -99.04 7.81 45.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.12 0.962 . . . . 0.0 108.533 167.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -114.94 -56.03 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.361 -179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.3 -70.07 0.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.163 176.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.04 172.88 40.36 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.487 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 74.4 m80 -80.4 69.12 6.8 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.707 0.765 . . . . 0.0 111.525 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 9.6 ptpp? -148.05 152.75 37.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.0 177.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.5 p -77.13 128.34 81.21 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.84 -22.24 69.07 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.148 1.899 . . . . 0.0 112.684 -176.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.97 -50.49 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -138.84 17.23 2.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.79 33.97 17.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.344 1.058 . . . . 0.0 113.654 170.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 56.6 mt-10 -89.12 153.06 21.26 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.712 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.4 121.82 15.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 111.302 -175.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 6.5 tt -120.6 126.27 49.85 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.131 -176.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.62 139.61 45.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.429 178.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HG2' HD11 ' A' ' 37' ' ' ILE . 77.8 mt-10 -65.46 -42.8 91.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.426 -174.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -69.33 -23.43 63.78 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.8 mm-40 -74.92 -14.87 60.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.482 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.67 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 N--CA 1.445 -0.707 0 CA-C-O 120.764 0.316 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.3 t -93.62 111.34 52.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.13 -19.54 50.93 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.435 2.09 . . . . 0.0 113.678 -174.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.27 -44.84 83.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.8 p -103.73 -21.49 13.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.021 -174.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp 65.41 21.29 11.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.349 1.06 . . . . 0.0 110.617 -175.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.4 mmt -95.52 -75.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -179.31 162.58 1.18 Allowed 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 9' ' ' CYS . 92.5 mt -79.75 103.37 9.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -71.18 -44.94 64.48 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.656 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -112.4 -17.17 12.76 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.94 -177.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.13 73.31 0.16 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -93.59 117.57 37.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.953 175.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.28 142.0 34.98 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.04 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -108.96 168.21 8.06 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 177.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.85 -33.32 94.44 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 123.042 2.494 . . . . 0.0 113.031 -176.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 p -74.68 -14.55 60.76 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.961 0.41 . . . . 0.0 111.852 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.46 1.0 50.27 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.372 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -79.26 146.72 32.85 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.54 -0.388 . . . . 0.0 110.603 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -122.59 138.44 54.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.481 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 91.1 m-85 -140.91 170.13 16.32 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.186 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -81.1 159.24 24.77 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 34' ' ' ILE . 7.1 ttpm? -68.94 -11.37 60.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.438 0.637 . . . . 0.0 111.169 -176.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.94 -16.75 12.14 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.823 -179.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.9 m -83.91 -51.7 6.95 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.481 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 10.9 tp -69.26 -39.29 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.771 -178.082 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.1 mt -62.85 -42.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -79.53 9.51 4.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 178.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 m -109.6 -25.99 10.15 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.723 170.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.1 pt -103.96 -27.67 3.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -173.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -100.1 2.89 43.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.705 0.764 . . . . 0.0 108.957 175.097 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -116.05 -56.54 2.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.765 -171.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.88 -69.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.085 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.43 159.89 33.31 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.848 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -79.03 67.52 4.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.7 pttm -152.72 150.26 29.24 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.949 173.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.4 p -79.73 124.48 83.49 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.549 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.91 -28.68 75.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.929 2.42 . . . . 0.0 114.69 -168.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.72 -48.19 83.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -119.06 6.4 11.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 51.74 40.02 26.66 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.564 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 66.5 mm-40 -89.87 138.37 31.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.38 121.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.79 128.92 52.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.457 -173.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.03 150.47 27.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.487 ' HA ' HD13 ' A' ' 56' ' ' LEU . 55.0 mp0 -59.59 -37.0 77.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.896 0.379 . . . . 0.0 111.114 -174.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -65.39 -28.73 69.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 179.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -66.79 -21.64 66.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.848 179.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 53' ' ' GLU . 8.8 mp . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.44 -0.961 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.7 t -66.32 110.19 4.41 Favored Pre-proline 0 N--CA 1.444 -0.747 0 O-C-N 123.73 0.643 . . . . 0.0 109.632 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.54 -18.14 53.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 112.339 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.03 -43.6 92.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.841 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.3 p -106.06 -17.88 14.2 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.15 26.77 12.54 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.714 0.806 . . . . 0.0 112.223 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.3 mtm -98.48 -64.99 0.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.51 175.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.66 -169.14 0.07 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -94.99 104.51 16.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -70.82 -45.89 63.77 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.38 -176.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -110.17 -15.92 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.013 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.39 86.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.271 0.982 . . . . 0.0 112.174 -177.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 29.8 m -115.12 119.81 62.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.37 0.605 . . . . 0.0 111.638 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -80.33 136.0 36.32 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.75 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.479 ' HB ' HD21 ' A' ' 51' ' ' LEU . 31.2 p -98.24 159.34 30.9 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.138 176.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.93 -27.88 85.48 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.373 2.049 . . . . 0.0 112.771 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.63 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 6.6 p -77.61 -26.14 50.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.906 0.384 . . . . 0.0 111.41 178.683 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.52 43.11 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.436 175.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.63 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 57.1 m-70 -130.77 133.58 46.12 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 88.2 mtm180 -104.99 134.35 48.24 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 120.998 0.427 . . . . 0.0 112.062 -178.234 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -135.31 -172.52 3.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.725 -176.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.5 m -89.84 151.89 21.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.143 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.91 -12.12 61.38 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 121.028 0.442 . . . . 0.0 111.853 -173.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.85 -18.44 12.27 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.653 -0.654 . . . . 0.0 110.713 -178.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.4 m -79.2 -45.94 18.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.071 0.463 . . . . 0.0 110.333 176.43 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.55 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.17 -40.49 82.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 C-N-CA 120.439 -0.505 . . . . 0.0 111.605 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.5 mt -63.15 -43.66 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -80.07 -1.64 40.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.299 0.571 . . . . 0.0 111.058 -174.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.2 p -106.5 -18.42 13.98 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 121.831 -0.543 . . . . 0.0 111.242 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.56 -18.47 6.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.127 -177.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -106.33 7.89 31.5 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.018 174.429 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -114.71 -54.3 2.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.291 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -69.47 0.61 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 0.0 109.805 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.13 159.43 32.8 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 176.518 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -77.64 67.92 3.63 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.887 0.851 . . . . 0.0 112.036 -179.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.52 150.97 35.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.219 177.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -76.05 129.77 79.87 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.968 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -22.54 74.39 Favored 'Trans proline' 0 N--CA 1.478 0.575 0 C-N-CA 122.97 2.447 . . . . 0.0 113.379 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.56 -72.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.208 0.528 . . . . 0.0 111.511 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -104.83 4.26 31.96 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.28 36.18 25.46 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -87.13 151.78 22.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.4 mp -66.07 119.82 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.479 HD21 ' HB ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -119.43 122.37 41.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.137 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -105.1 141.19 37.09 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.61 -39.36 94.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.261 0.553 . . . . 0.0 111.002 -175.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.01 -30.06 71.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.518 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -76.51 -8.01 56.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.08 -176.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 51' ' ' LEU . 96.5 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.674 0.274 . . . . 0.0 110.836 179.175 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -66.73 112.02 8.47 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 34.7 Cg_exo -61.82 -20.4 69.07 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.726 2.284 . . . . 0.0 112.432 -176.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.6 -43.93 90.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.69 178.348 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.1 p -105.55 -19.09 13.88 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.959 -176.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 57.16 23.12 8.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.921 0.888 . . . . 0.0 112.255 -179.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.5 mtm -96.0 -64.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.393 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.89 -165.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -174.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -103.93 125.97 50.71 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -80.18 -73.19 0.37 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.35 178.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -96.33 -16.59 21.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.05 90.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.121 0.968 . . . . 0.0 113.046 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m -110.44 115.4 49.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.498 0.666 . . . . 0.0 111.136 175.015 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -82.56 133.49 35.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.662 176.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 39.1 p -93.11 164.99 19.48 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 30.7 Cg_endo -61.78 -26.36 79.5 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.169 1.912 . . . . 0.0 112.144 176.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 35.7 m -70.45 -28.33 64.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.092 0.473 . . . . 0.0 110.488 176.369 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.78 9.86 29.7 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.916 -177.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 24.3 m-70 -88.1 144.35 26.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -111.68 130.79 55.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.94 176.17 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.47 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 99.2 m-85 -132.07 172.72 12.02 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.559 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.471 ' O ' HG22 ' A' ' 33' ' ' ILE . 59.7 m -82.99 150.27 26.48 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.12 -8.63 55.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.424 0.63 . . . . 0.0 110.496 -175.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.67 -29.96 7.26 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 69.1 m -70.08 -46.06 65.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.03 175.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.482 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -68.42 -41.6 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.601 -178.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.7 mt -63.61 -42.33 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -77.23 -1.94 32.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.416 0.627 . . . . 0.0 110.225 -177.018 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 m -105.88 -25.41 12.15 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.772 174.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 33' ' ' ILE . 46.0 pt -103.49 -9.18 9.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.859 -176.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.6 ptm180 -94.18 2.13 55.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.628 0.728 . . . . 0.0 109.213 174.075 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.35 -55.08 2.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.56 -71.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.396 178.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -178.22 -179.26 48.14 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -89.55 81.22 6.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.24 0.543 . . . . 0.0 112.194 -177.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 9.5 ptpp? -170.55 144.27 2.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.734 175.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 p -72.02 123.8 89.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.83 -25.28 74.52 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.031 2.487 . . . . 0.0 113.554 -170.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.61 -46.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -175.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.63 6.69 8.2 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.16 34.21 19.0 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 177.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.431 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 69.5 mm-40 -91.17 141.23 29.03 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.908 175.064 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 50' ' ' ILE . 3.1 mp -66.57 121.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.123 0.487 . . . . 0.0 110.234 -174.153 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.406 ' H ' ' HA ' ' A' ' 43' ' ' LYS . 64.0 tp -126.85 128.75 47.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.735 -175.623 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -112.27 154.59 25.39 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.43 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -61.62 -37.08 82.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.117 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.93 -30.84 71.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.391 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 17.0 mm-40 -77.79 -9.16 58.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.239 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.669 -178.985 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.539 ' HB2' HD23 ' A' ' 16' ' ' LEU . 33.8 t -77.55 116.17 55.75 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.835 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -60.97 -20.86 69.24 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.037 1.825 . . . . 0.0 112.605 -177.225 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.89 -45.05 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.618 0.247 . . . . 0.0 111.376 178.324 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 12.0 p -109.06 -22.26 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.405 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 59.23 22.9 11.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.245 1.018 . . . . 0.0 112.121 -177.386 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -95.57 -66.46 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.34 176.393 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.08 -172.46 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.4 mt -107.44 124.98 50.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.684 0.278 . . . . 0.0 110.31 175.199 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 19' ' ' ALA . 22.9 tpt180 -92.76 114.71 27.34 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.253 168.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 68.75 -16.21 0.22 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.594 1.158 . . . . 0.0 112.811 -179.445 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 50.31 82.78 0.05 OUTLIER 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 113.329 177.161 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.2 m -97.01 116.56 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.626 0.727 . . . . 0.0 110.474 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.65 142.6 32.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.844 -179.296 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -93.17 163.65 24.35 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.628 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.91 -34.17 96.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.701 2.268 . . . . 0.0 111.935 176.6 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.06 -14.47 62.69 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.122 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.82 23.26 18.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.283 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -106.93 129.9 54.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.359 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -106.24 132.95 51.69 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.588 -173.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.23 167.84 19.63 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.455 -176.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.426 ' O ' HG22 ' A' ' 33' ' ' ILE . 85.1 m -71.62 147.82 47.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.753 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -67.88 -4.89 14.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.728 -179.33 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.97 -38.86 3.79 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.167 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.77 -46.1 80.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -66.36 -41.63 89.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.953 -173.96 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.581 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.3 mt -63.61 -43.43 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.411 . . . . 0.0 110.128 -178.534 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -79.4 -2.08 40.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.855 -176.086 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 m -106.77 -20.24 13.4 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.649 177.016 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -103.15 -24.03 4.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.226 -174.588 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.2 ptm180 -99.95 7.4 44.84 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.115 176.124 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.26 -56.69 2.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.539 -178.336 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.08 -67.64 0.8 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.527 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.05 159.12 32.3 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.093 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.406 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 75.9 m80 -86.29 64.89 8.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.584 0.707 . . . . 0.0 111.916 -176.611 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.1 ptpt -154.44 150.31 27.73 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.34 176.834 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -70.33 135.41 86.66 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.886 0.374 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.18 -23.94 75.86 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.101 2.534 . . . . 0.0 114.305 -171.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 m -91.39 -55.46 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.354 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -103.68 4.89 35.93 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.105 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 50.97 33.95 9.78 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.599 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 80.8 mm-40 -86.36 147.0 26.23 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.721 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.59 120.4 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 109.718 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.6 tp -120.2 130.59 54.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.223 -174.099 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.12 153.47 28.17 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.43 -36.34 83.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.43 -31.02 72.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.681 176.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -77.97 -8.61 58.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--N 1.322 -0.625 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.614 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 1.4 p -92.67 134.31 27.98 Favored Pre-proline 0 C--N 1.313 -0.996 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.607 -177.305 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 9' ' ' CYS . 32.3 Cg_exo -59.9 -19.85 56.94 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.869 2.379 . . . . 0.0 112.19 -178.115 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.02 -44.94 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.092 -177.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -120.31 -20.21 7.37 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.253 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt 60.52 27.96 17.62 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.873 0.869 . . . . 0.0 111.908 -173.499 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.1 mtm -103.16 175.34 5.51 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.092 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.22 148.37 49.94 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.505 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.1 mt -78.76 130.43 35.75 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -68.1 -60.28 2.6 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -107.52 -15.05 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -178.263 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.01 90.23 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.792 -177.494 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 116.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.684 0.754 . . . . 0.0 111.368 179.762 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -81.15 136.86 35.94 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.709 177.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.2 p -94.59 160.37 31.66 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -54.71 -37.52 91.6 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 112.525 178.107 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.586 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.0 OUTLIER -70.37 -20.56 62.95 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 178.386 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.8 4.29 24.64 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.442 174.067 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.586 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 77.8 m-70 -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.241 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -101.56 132.58 47.13 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.322 177.084 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 97.5 m-85 -132.71 165.39 24.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.479 179.432 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.612 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -80.97 159.52 24.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.037 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.3 tttt -76.8 -12.93 60.05 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.326 -172.043 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.91 -10.95 12.88 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 -179.383 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.5 m -85.45 -57.87 2.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.334 177.787 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -66.77 -41.04 87.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -175.909 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.634 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.9 mt -63.24 -43.49 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 111.078 -177.099 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -79.33 -1.47 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -176.751 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -104.61 -17.82 14.55 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.32 177.33 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -104.34 -30.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.923 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.1 ptm180 -96.72 2.39 51.98 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.442 178.113 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -115.9 -54.63 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.302 179.5 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.81 -69.17 0.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 0.0 110.524 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -164.8 155.14 26.37 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 176.893 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -80.04 70.41 6.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.528 0.664 . . . . 0.0 111.686 -177.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.94 152.21 39.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.919 178.571 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 52.3 t -74.65 122.95 88.64 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.706 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 51.7 Cg_exo -57.48 -34.25 97.7 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.241 2.627 . . . . 0.0 114.278 -172.066 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 m -83.19 -50.72 15.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -172.472 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -104.68 5.19 33.33 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.66 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.1 32.68 20.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.721 0.808 . . . . 0.0 112.29 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -87.75 149.0 24.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.198 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.84 121.32 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.29 119.68 32.91 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.389 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.632 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -102.54 153.7 19.82 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.08 -178.671 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.41 -40.09 96.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.465 0.706 . . . . 0.0 111.532 -174.005 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -68.37 -20.8 64.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.632 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.3 mm100 -75.11 -9.95 59.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.444 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 C--N 1.324 -0.502 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.377 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 . . . . . 0 N--CA 1.438 -1.035 0 CA-C-O 120.997 0.427 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.0 t -79.82 109.22 11.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.84 -19.42 65.54 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.863 2.375 . . . . 0.0 112.722 -175.265 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.93 -43.82 92.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.006 0.431 . . . . 0.0 111.26 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.38 -21.05 15.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.789 -177.018 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 65.94 20.33 11.32 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 111.633 -177.699 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -99.64 -71.03 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.088 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.33 -162.6 0.13 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -174.311 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.2 mt -106.57 125.82 51.48 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.182 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -84.47 -71.35 0.52 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.896 175.31 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -89.76 -16.23 30.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.82 178.707 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.89 77.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.252 0.621 . . . . 0.0 111.592 -176.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 21.1 m -92.3 116.8 34.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.042 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.31 129.89 34.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.732 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -92.27 164.9 21.25 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.338 177.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.58 -36.44 94.54 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 112.32 178.265 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.7 -20.49 62.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.071 -178.135 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.0 6.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.98 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -113.33 154.35 27.0 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.459 -0.436 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 81.9 mtm180 -123.47 137.56 54.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.048 0.452 . . . . 0.0 111.522 -176.321 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' O ' HG22 ' A' ' 20' ' ' VAL . 95.7 m-85 -138.91 172.93 12.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.75 -177.104 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.0 m -84.74 153.85 22.79 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.725 0.298 . . . . 0.0 110.33 175.647 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.15 -14.78 63.24 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.837 0.855 . . . . 0.0 111.886 -176.466 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.78 -13.81 12.01 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.048 -176.766 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 52.5 m -87.84 -47.91 8.24 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.078 177.772 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -68.36 -38.51 79.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.8 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.8 mt -62.67 -42.43 96.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.425 . . . . 0.0 110.561 -177.769 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 39' ' ' ASP . 29.2 tptp -77.64 -1.66 32.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.806 0.813 . . . . 0.0 109.962 -178.542 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.2 t -105.3 -21.82 13.17 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.88 -0.513 . . . . 0.0 109.982 177.009 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.5 pt -104.97 -28.06 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.391 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -96.01 -7.55 36.05 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.708 177.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 38.7 t70 -115.11 -40.95 3.39 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.308 -175.298 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 36' ' ' SER . . . -91.66 -72.94 0.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.969 0.414 . . . . 0.0 110.012 176.587 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.17 157.61 30.14 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -82.82 69.67 9.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.493 0.663 . . . . 0.0 111.979 -176.3 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -150.91 153.11 34.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.796 -179.781 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 p -77.34 133.56 67.81 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.039 171.793 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.07 -23.8 75.99 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 123.015 2.477 . . . . 0.0 114.244 -170.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -90.5 -61.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.206 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -100.91 4.22 42.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.637 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.33 35.23 25.49 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.046 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 71.2 mm-40 -83.5 150.67 25.85 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -66.71 121.18 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.109 0.48 . . . . 0.0 109.903 -177.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -126.7 129.86 49.25 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.325 -175.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.87 156.49 23.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.622 178.478 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 38' ' ' ARG . 54.6 mp0 -61.23 -39.05 88.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.612 0.365 . . . . 0.0 110.66 -178.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -74.96 -10.2 59.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 0.0 111.407 179.563 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -91.48 -7.76 49.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.026 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.774 179.059 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 44.2 mt-10 . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 16.6 t -56.27 112.95 5.01 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.494 177.697 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' CYS . 32.4 Cg_exo -62.1 -20.95 71.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.7 2.267 . . . . 0.0 112.461 -173.569 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.49 -44.07 90.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.464 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -108.09 -21.25 12.87 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.647 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 56.53 30.23 16.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.824 0.849 . . . . 0.0 111.754 -175.265 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -96.29 -66.91 0.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 173.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -179.53 -172.65 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -176.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.5 mt -93.93 103.61 15.7 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.273 174.13 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -66.51 -43.97 83.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.904 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -123.0 -15.02 7.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.797 179.587 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.93 56.54 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.203 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 28' ' ' PHE . 27.3 m -76.84 116.09 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.36 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.401 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 61.0 tt0 -80.6 121.32 25.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.527 -176.438 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -88.8 160.83 43.16 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.55 -30.75 89.56 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 178.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -14.72 62.89 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.319 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.02 5.07 44.46 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.375 -0.916 . . . . 0.0 114.251 174.518 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.79 168.33 10.56 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.434 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.6 mtt180 -127.3 142.22 51.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 112.016 -169.784 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.471 ' O ' HG22 ' A' ' 20' ' ' VAL . 99.2 m-85 -131.42 170.23 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.769 178.583 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 53.3 m -80.19 148.19 30.98 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.555 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -68.62 -13.16 62.17 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -174.414 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.21 -17.8 12.69 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.8 m -79.59 -45.51 19.03 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.665 173.107 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -66.47 -40.95 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.832 -176.641 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.84 -42.63 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 111.006 -179.15 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -78.72 -1.9 36.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.352 0.596 . . . . 0.0 110.149 -174.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 m -105.32 -23.08 12.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.299 177.296 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.9 pt -104.76 -5.36 9.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.256 -177.784 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -96.82 -15.73 21.15 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.618 176.968 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -116.52 -56.09 2.32 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.145 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.28 -65.79 0.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 110.692 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.86 155.36 26.6 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -84.65 54.62 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 122.073 0.94 . . . . 0.0 109.111 -176.204 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -147.44 154.17 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.301 -175.357 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 45.3 t -61.65 123.02 75.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.112 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 50.7 Cg_exo -57.05 -35.82 99.06 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.166 2.577 . . . . 0.0 114.123 -172.042 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -82.67 -45.96 19.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.12 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -114.95 5.57 15.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 56.58 33.45 22.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.337 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -92.2 149.71 21.32 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.209 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.4 121.66 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.074 0.464 . . . . 0.0 110.589 -176.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 tp -126.13 127.81 46.34 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.224 -179.746 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.48 143.91 30.9 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.656 176.78 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.53 -36.59 84.27 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.303 1.041 . . . . 0.0 110.203 -175.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.4 -30.25 71.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.973 177.846 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -64.89 -29.11 70.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.146 0.498 . . . . 0.0 110.884 179.54 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.556 -176.7 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.488 ' HB2' HD23 ' A' ' 16' ' ' LEU . 41.8 t -83.75 110.81 27.68 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -177.769 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.43 -18.81 49.65 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.069 1.846 . . . . 0.0 112.301 -176.663 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.52 -43.51 90.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 178.874 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 25.4 p -109.83 -6.41 15.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.526 -176.687 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.89 33.19 22.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.902 0.881 . . . . 0.0 111.1 -175.593 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -127.52 167.44 16.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.379 178.893 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 151.12 37.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 9' ' ' CYS . 93.7 mt -69.89 118.35 12.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.867 0.365 . . . . 0.0 110.393 -173.416 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -69.39 -45.62 68.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.323 179.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -116.92 -16.54 10.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.04 87.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.135 0.897 . . . . 0.0 112.737 -178.242 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 28' ' ' PHE . 35.2 m -105.39 117.23 50.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.51 0.672 . . . . 0.0 111.476 176.204 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -73.16 132.54 43.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.137 175.155 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 61.8 p -106.29 159.04 31.16 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 178.759 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 35.9 Cg_endo -62.8 -24.41 74.52 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.88 2.386 . . . . 0.0 113.01 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.1 p -79.48 -14.66 58.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 111.203 178.483 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.61 8.36 37.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.566 175.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -99.23 162.05 13.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.696 0.248 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -124.1 137.61 54.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.916 0.389 . . . . 0.0 110.214 177.824 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 20' ' ' VAL . 90.8 m-85 -138.23 167.49 21.73 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.546 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.0 m -76.28 156.7 33.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.083 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.73 -3.97 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.139 0.495 . . . . 0.0 111.382 -170.669 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.74 -26.59 7.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.761 0.315 . . . . 0.0 110.381 178.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -71.86 -45.9 59.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.318 179.377 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -65.96 -38.24 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.238 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.2 mt -62.25 -42.31 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 110.386 177.987 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.84 -0.5 30.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.656 0.741 . . . . 0.0 110.452 -177.332 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -104.75 -25.33 12.71 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.915 -0.49 . . . . 0.0 109.793 177.325 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.1 pt -103.81 -15.17 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.001 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -106.78 -2.34 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.286 175.244 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.67 -50.79 2.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.733 -175.562 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.69 -68.8 0.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 -179.784 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.25 154.76 25.83 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 178.512 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -81.01 45.4 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.65 0.738 . . . . 0.0 110.927 -173.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -144.25 154.42 43.07 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.956 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.0 p -64.1 135.41 96.31 Favored Pre-proline 0 N--CA 1.445 -0.688 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.257 177.499 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.23 -29.61 80.58 Favored 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 122.839 2.359 . . . . 0.0 113.593 -172.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.86 -71.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.18 0.514 . . . . 0.0 111.697 -174.028 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -95.65 4.56 52.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.549 -173.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.93 34.17 24.43 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 169.39 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -87.45 141.96 28.23 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.624 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.5 mp -65.24 119.5 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.895 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 56' ' ' LEU . 10.2 tt -110.51 127.67 55.28 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -168.49 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.503 ' HB2' HE21 ' A' ' 55' ' ' GLN . 3.8 mm? -96.88 132.87 42.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.913 178.54 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.26 -35.43 80.4 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -173.994 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -63.56 -29.72 70.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 178.108 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.503 HE21 ' HB2' ' A' ' 52' ' ' LEU . 50.2 mt-30 -80.34 -7.86 59.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.503 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 51' ' ' LEU . 95.6 mt . . . . . 0 C--O 1.237 0.426 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.956 177.205 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.92 112.52 9.95 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.712 0.632 . . . . 0.0 109.689 175.864 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -63.12 -20.37 70.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.248 1.966 . . . . 0.0 112.87 -178.343 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -66.08 -44.43 91.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.2 p -105.24 -19.19 13.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.635 -177.791 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 57.0 26.7 12.22 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.791 0.836 . . . . 0.0 111.797 -176.658 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.88 -65.73 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.023 0.44 . . . . 0.0 110.469 176.689 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.3 -164.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -177.326 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.9 mt -103.3 113.76 27.5 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 172.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -63.91 -44.98 91.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 178.018 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -132.52 -7.18 3.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 178.608 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.15 92.47 0.07 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 175.623 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -117.19 111.63 35.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 110.289 171.594 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -80.94 143.43 32.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.385 178.638 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -108.82 154.68 41.66 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.272 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 55' ' ' GLN . 40.6 Cg_endo -65.37 -20.01 61.6 Favored 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 122.742 2.295 . . . . 0.0 111.463 177.448 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.4 t -73.99 -15.06 61.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.077 179.01 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.07 22.2 18.23 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.234 178.4 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -113.03 152.12 29.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.587 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -120.01 136.04 54.7 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.696 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 94.8 m-85 -136.67 172.99 12.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.092 0.472 . . . . 0.0 110.502 -177.024 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -82.01 152.0 26.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 171.05 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.0 tttt -68.87 -10.7 58.44 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -177.489 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 -12.32 12.82 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.711 -0.618 . . . . 0.0 110.205 179.325 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 70.9 m -85.92 -62.94 1.41 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.982 177.573 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.4 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.1 tp -67.79 -39.9 82.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.062 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.737 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.5 mt -63.04 -43.38 98.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 0.0 110.523 -178.504 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -79.53 0.79 28.34 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.714 0.768 . . . . 0.0 109.729 -178.561 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 t -106.38 -23.76 12.44 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.992 -0.442 . . . . 0.0 110.83 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.0 pt -103.96 -26.09 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.384 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -97.41 3.43 50.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.423 0.63 . . . . 0.0 109.773 176.553 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -116.66 -55.88 2.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.76 -72.93 0.52 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.108 179.809 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -158.46 160.46 30.98 Favored Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 178.55 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -85.42 71.08 10.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.373 0.606 . . . . 0.0 111.162 -176.242 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -152.22 150.61 30.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.764 178.023 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 9.2 p -79.9 122.03 82.84 Favored Pre-proline 0 N--CA 1.429 -1.519 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.689 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.98 -18.43 62.16 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.652 2.235 . . . . 0.0 113.274 -170.712 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.0 -48.44 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -133.53 13.77 4.1 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.621 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER 63.04 21.44 12.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 174.214 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 72.2 mm-40 -72.66 142.52 48.28 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.564 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.5 mm -66.4 121.05 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.973 0.416 . . . . 0.0 110.605 -176.39 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.1 tp -128.16 134.4 49.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.056 -177.456 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -116.89 155.27 29.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.534 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' A' ' 38' ' ' ARG . 48.8 mt-10 -62.85 -36.48 83.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.16 0.505 . . . . 0.0 110.299 179.273 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.13 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.931 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.477 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.6 mm100 -79.8 -7.69 58.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.489 -174.082 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 120.966 0.413 . . . . 0.0 110.844 179.839 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.445 -0.693 0 CA-C-O 120.956 0.408 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB2' HD23 ' A' ' 16' ' ' LEU . 46.9 t -96.19 109.41 47.05 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.39 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.22 -19.47 62.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.038 1.825 . . . . 0.0 112.736 -174.438 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.61 -43.92 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.832 0.349 . . . . 0.0 111.288 178.284 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.6 p -106.51 -4.38 19.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.696 -177.131 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt 55.16 34.35 22.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.349 0.66 . . . . 0.0 111.135 -177.518 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -133.12 -174.76 3.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.368 179.286 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.17 157.38 37.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.578 HD23 ' HB2' ' A' ' 9' ' ' CYS . 95.1 mt -70.62 134.33 47.49 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -86.05 -73.45 0.45 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.783 177.64 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -93.1 -16.35 25.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 178.125 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.32 66.46 1.23 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.183 -179.29 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.5 m -85.36 117.7 30.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.135 0.493 . . . . 0.0 111.114 -179.367 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -79.55 133.38 36.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.318 -177.095 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -101.34 157.67 33.23 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.472 -178.617 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -56.84 -33.51 94.83 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.713 2.276 . . . . 0.0 112.509 178.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 p -69.49 -26.08 64.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.98 -178.4 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.56 51.1 0.72 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.135 -178.225 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 38.7 m80 -138.51 159.68 41.46 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 122.732 0.413 . . . . 0.0 110.909 177.582 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -126.27 135.73 51.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.169 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.436 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.6 m-85 -139.7 169.76 17.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.522 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 24.5 m -79.2 152.09 30.87 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 173.099 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.23 -13.57 62.48 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -173.877 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.08 -3.49 13.97 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.632 -178.771 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.7 m -91.55 -59.62 2.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.401 174.663 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.1 tp -68.46 -39.75 81.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.435 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.3 mt -63.13 -41.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.057 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.07 -0.97 30.08 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.555 0.693 . . . . 0.0 109.628 -178.265 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.25 -18.68 13.93 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.075 -0.391 . . . . 0.0 111.323 175.418 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -105.06 -30.08 2.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -177.118 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptm180 -98.4 4.19 48.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.554 178.999 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.56 -56.15 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.641 -179.023 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 -74.38 0.36 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 178.634 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.51 155.7 26.88 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 33.5 m80 -79.23 66.06 4.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.078 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.2 ptpp? -152.54 149.81 28.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.223 174.435 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 2.8 p -74.4 127.12 88.13 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.263 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.24 -23.81 77.76 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.282 2.655 . . . . 0.0 113.806 -171.197 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.437 HG13 ' OD1' ' A' ' 47' ' ' ASP . 4.4 p -77.1 -51.11 19.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.112 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' OD1' HG13 ' A' ' 46' ' ' VAL . 13.0 p-10 -117.59 6.4 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.1 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 59.66 35.01 22.32 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.6 mm-40 -95.41 140.13 30.72 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.978 -0.451 . . . . 0.0 110.677 176.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 2.4 mp -65.65 121.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.087 0.47 . . . . 0.0 110.131 -176.544 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -122.73 134.59 54.45 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.62 -176.327 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.432 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 88.9 mt -114.36 147.65 38.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.933 178.752 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.45 ' OE2' ' HB3' ' A' ' 38' ' ' ARG . 53.8 mp0 -62.75 -35.89 81.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 0.0 109.464 179.179 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -65.52 -29.77 70.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.239 -179.639 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 18.5 mm-40 -71.18 -27.79 63.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.166 0.508 . . . . 0.0 111.353 177.713 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.99 -179.236 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.3 t -54.93 112.49 4.13 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.083 0.553 . . . . 0.0 110.684 179.432 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -62.21 -20.53 70.31 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.926 2.417 . . . . 0.0 113.35 -175.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -67.71 -44.74 85.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.336 176.229 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.45 -25.95 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.161 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 63.98 23.58 13.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.175 0.59 . . . . 0.0 111.787 -178.17 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -95.34 -66.3 0.92 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 109.64 178.913 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.69 -163.44 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -176.91 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.23 124.81 50.16 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.812 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -79.06 -60.37 2.4 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.19 174.299 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -105.97 -14.98 15.03 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.252 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.45 90.83 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.2 117.4 52.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.035 0.445 . . . . 0.0 110.475 175.373 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -80.74 133.69 35.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.204 178.726 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.3 p -88.02 161.14 44.75 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 179.507 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.2 -29.82 88.71 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.097 2.531 . . . . 0.0 112.1 177.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.16 -21.2 63.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 179.52 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.84 36.67 2.34 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.813 173.825 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -149.74 167.22 27.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.352 0.576 . . . . 0.0 111.944 176.433 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -109.52 140.76 42.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.149 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.5 m-85 -132.49 167.19 20.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.962 173.249 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.577 ' O ' HG22 ' A' ' 33' ' ' ILE . 38.2 m -84.81 150.15 25.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.507 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.02 -8.83 56.11 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -172.573 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.73 -28.35 7.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.022 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -65.31 -52.96 50.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.362 0.601 . . . . 0.0 110.208 176.522 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -70.35 -40.5 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.947 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.48 -43.21 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.516 -176.749 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -78.88 -2.01 37.81 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.567 0.699 . . . . 0.0 110.359 -176.698 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 48.4 m -105.74 -18.56 14.03 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 175.683 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.7 pt -104.29 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.115 -178.267 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -95.08 -4.33 46.52 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.889 177.59 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.51 -47.49 2.73 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.398 -177.085 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 36' ' ' SER . . . -87.59 -69.69 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.03 157.71 30.3 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.534 179.047 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -87.91 18.59 4.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -176.41 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -95.92 140.83 30.12 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.005 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 53.0 t -60.79 130.85 91.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.36 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.51 -29.18 88.08 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -172.091 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.96 -55.63 5.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -103.2 4.38 36.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -173.137 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.6 29.5 15.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 173.898 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -79.81 145.54 32.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.462 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.36 119.5 13.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 179.012 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -125.45 131.78 52.82 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.437 -172.581 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.77 156.86 27.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -38.45 85.49 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.855 0.36 . . . . 0.0 110.952 -176.878 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -65.2 -30.51 71.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.826 178.723 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -80.15 -12.03 59.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.898 -176.068 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 33' ' ' ILE . 82.0 mt . . . . . 0 C--O 1.245 0.853 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.024 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 44.8 t -61.92 112.66 6.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.192 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -62.06 -21.32 72.21 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.569 2.18 . . . . 0.0 112.793 -174.254 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.39 -44.17 90.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.085 0.469 . . . . 0.0 111.777 179.53 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.5 p -106.06 -19.37 13.74 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.598 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 10' ' ' PRO . 98.2 mt 53.47 28.47 7.65 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -175.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -95.61 -65.5 0.97 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.259 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.66 -171.47 0.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.58 109.06 21.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.28 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -70.28 -44.68 67.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.806 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 54.7 mm-40 -111.9 -16.48 13.12 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.098 -177.14 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.41 82.19 0.09 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 177.407 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.95 116.68 51.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 110.972 175.963 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.22 125.42 30.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.285 176.553 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -75.76 157.29 84.09 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.97 -23.69 76.08 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.375 2.05 . . . . 0.0 112.34 177.77 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 7.8 p -77.85 -20.76 52.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.617 176.876 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.76 43.53 1.42 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.024 -1.084 . . . . 0.0 114.232 174.537 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.55 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 87.3 m-70 -130.86 152.55 50.07 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.175 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -113.02 132.78 55.25 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.534 178.187 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 97.0 m-85 -138.25 167.64 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.123 -178.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 42.4 m -78.31 151.86 32.73 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.204 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.526 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 88.0 tttt -68.49 -13.45 62.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -171.062 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.92 -27.09 7.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.885 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.8 m -64.59 -46.79 81.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.299 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -69.43 -41.37 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.145 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 80.8 mt -63.57 -42.67 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.153 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -79.42 -0.54 33.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -177.958 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -105.29 -21.72 13.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.051 176.793 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.6 pt -104.89 -13.68 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.33 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -108.18 -1.7 20.05 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.557 175.873 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -122.23 -57.58 1.76 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.033 -179.867 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.84 -65.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.647 -178.553 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -157.09 159.2 29.48 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.546 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -79.88 -8.84 59.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.474 0.637 . . . . 0.0 110.992 -176.611 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 20.2 ptpt -81.29 149.33 29.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.121 176.591 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 51.0 t -58.8 125.97 79.0 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.92 -22.01 73.44 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.018 2.478 . . . . 0.0 113.514 -167.993 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -97.79 -48.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.443 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -108.98 5.86 24.65 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.921 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 58.63 32.73 22.47 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 176.22 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -97.54 137.39 36.55 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.205 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' LYS . 46.6 mm -65.81 120.92 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.599 -177.458 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 37' ' ' ILE . 49.7 tp -109.7 130.22 55.53 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.99 -172.467 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.59 135.55 40.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 -176.486 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.53 -36.76 84.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.401 -179.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -63.58 -31.83 73.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.883 -177.342 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.7 mm-40 -71.65 -25.05 61.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 111.481 179.641 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 C--N 1.317 -0.808 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 -175.732 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.55 ' HB2' HD23 ' A' ' 16' ' ' LEU . 37.1 t -71.8 114.12 25.93 Favored Pre-proline 0 C--O 1.221 -0.428 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.313 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.69 -21.27 71.73 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.583 2.189 . . . . 0.0 112.951 -176.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.63 -45.01 89.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.898 0.38 . . . . 0.0 111.664 179.203 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 9.6 p -105.3 -23.85 12.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.422 . . . . 0.0 111.53 -177.201 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.23 22.53 13.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.15 0.98 . . . . 0.0 111.844 -177.945 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtm -94.69 -64.69 1.04 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.043 0.449 . . . . 0.0 109.911 176.348 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.96 -175.33 0.86 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.116 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 9' ' ' CYS . 93.9 mt -96.58 116.77 29.64 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 170.442 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 20.7 tpt180 -66.18 -44.73 83.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.778 177.906 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 17' ' ' ARG . 47.4 mt-10 -132.66 -15.15 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -177.052 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.54 84.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.132 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.36 118.41 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.224 0.535 . . . . 0.0 111.009 175.208 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.406 ' OE1' ' HG3' ' A' ' 27' ' ' ARG . 7.6 tp60 -78.63 133.12 37.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.211 179.512 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -87.57 160.17 48.22 Favored Pre-proline 0 C--N 1.311 -1.1 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.483 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.53 -23.65 74.94 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.373 2.048 . . . . 0.0 112.507 179.079 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.523 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -80.67 -15.8 55.62 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.994 0.426 . . . . 0.0 111.551 176.191 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.59 52.3 1.32 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.162 175.218 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.523 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 38.9 m-70 -135.06 141.08 46.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.727 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.406 ' HG3' ' OE1' ' A' ' 21' ' ' GLN . 90.3 mtt180 -105.63 133.47 50.32 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.686 176.242 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -135.02 169.25 17.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.744 177.184 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 61.3 m -69.36 148.81 49.15 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 171.435 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.41 -6.72 45.47 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.288 0.566 . . . . 0.0 111.356 -173.414 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.13 -34.01 5.5 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.026 -0.421 . . . . 0.0 110.263 179.332 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.1 m -65.84 -46.96 76.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.932 179.109 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.0 tp -68.89 -40.65 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.014 -177.506 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.2 mt -63.28 -43.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.961 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -80.96 4.42 19.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.008 0.433 . . . . 0.0 111.351 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -105.46 -24.67 12.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.715 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.39 -20.52 5.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.47 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.8 ptm180 -99.92 4.08 44.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.497 176.107 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -128.03 -54.51 1.29 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.018 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.15 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -179.04 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.44 144.6 11.36 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.923 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -84.19 40.62 0.78 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.736 0.779 . . . . 0.0 111.165 -171.092 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -142.63 152.86 42.92 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.119 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.23 123.58 89.14 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.731 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.59 -24.18 75.03 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.077 2.518 . . . . 0.0 114.078 -170.259 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.1 m -72.34 -49.82 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.973 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -115.49 5.74 14.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.005 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 58.76 33.68 23.23 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 175.502 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -100.23 144.5 29.17 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.351 -0.218 . . . . 0.0 110.495 179.345 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.59 121.72 15.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 -176.371 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.466 HD21 HD21 ' A' ' 56' ' ' LEU . 43.8 tp -115.33 127.78 55.66 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.275 -174.61 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.5 138.88 38.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.338 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.85 -36.85 77.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.747 0.419 . . . . 0.0 111.959 -175.133 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -71.78 -17.8 62.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.833 0.349 . . . . 0.0 111.571 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -81.26 -9.06 59.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.865 -177.136 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.466 HD21 HD21 ' A' ' 51' ' ' LEU . 92.4 mt . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.983 178.6 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.469 ' HB2' HD23 ' A' ' 16' ' ' LEU . 5.1 t -89.92 118.13 68.67 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.28 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.76 -18.73 63.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 113.218 -176.349 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.432 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.4 mt -65.84 -44.33 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.692 0.282 . . . . 0.0 110.856 177.806 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.6 p -106.44 -26.47 11.43 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.716 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 66.3 22.93 10.82 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.142 0.977 . . . . 0.0 111.895 179.569 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -97.64 -66.85 0.88 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.316 0.579 . . . . 0.0 110.631 176.651 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.99 -161.65 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD23 ' HB2' ' A' ' 9' ' ' CYS . 90.4 mt -109.77 122.75 48.22 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.539 172.389 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 27.4 tpt180 -86.85 108.92 18.97 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.944 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 71.49 -10.39 0.82 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.155 1.382 . . . . 0.0 113.173 -179.544 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.86 83.63 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.144 0.978 . . . . 0.0 113.329 175.467 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.42 115.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.086 177.907 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -80.7 128.32 33.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.145 177.474 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -79.77 161.91 64.65 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.204 177.579 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.24 -18.95 67.3 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.5 2.133 . . . . 0.0 111.438 175.884 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.2 m -65.85 -35.43 80.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.785 174.357 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 -28.23 5.44 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.902 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -82.6 154.48 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.746 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -109.5 140.67 42.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.136 -174.946 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.43 167.81 18.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.428 176.546 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 88.3 m -73.4 146.42 45.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.28 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -69.72 -12.79 61.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.361 179.236 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.42 2.98 15.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 -177.533 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 83.5 m -105.77 -56.97 2.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.734 173.067 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -68.8 -41.85 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.28 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.0 mt -63.42 -41.68 93.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.515 0.674 . . . . 0.0 110.254 179.24 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -77.97 -0.2 26.77 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.64 -177.159 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -105.85 -22.8 12.84 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.129 -0.357 . . . . 0.0 110.71 175.93 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.4 pt -102.23 -23.4 4.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.208 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -102.81 6.15 39.09 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.754 174.345 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -114.84 -51.15 2.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.607 -178.842 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.05 -69.62 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.525 177.298 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -162.85 159.49 31.89 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.433 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -82.08 65.0 7.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -173.439 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 10.4 ptpp? -153.11 147.64 26.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.932 175.248 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.77 124.18 86.41 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.086 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.54 -26.9 81.28 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.993 2.462 . . . . 0.0 114.886 -168.488 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.14 -44.07 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.714 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -121.44 6.43 10.11 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.502 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 52.31 34.54 15.04 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.131 1.372 . . . . 0.0 113.622 177.834 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 77.0 mm-40 -88.89 142.87 27.28 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.085 178.828 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.21 120.07 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.305 0.574 . . . . 0.0 110.216 -175.3 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.8 tp -128.89 132.68 47.72 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 -177.46 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.94 152.69 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.855 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.49 -31.02 71.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.268 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -63.53 -32.81 74.38 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.051 178.167 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -68.32 -34.31 75.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.409 0.623 . . . . 0.0 109.996 178.719 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.437 -1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.583 178.555 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.433 -1.297 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.5 t -84.37 114.23 53.55 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.059 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.91 -21.68 73.31 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.36 2.04 . . . . 0.0 112.806 -175.323 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.79 -44.17 85.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.619 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 18.5 p -106.24 -22.15 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.54 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp 63.85 21.18 12.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 111.108 -174.907 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 30.1 mmt -95.44 -73.49 0.59 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.124 0.488 . . . . 0.0 109.792 178.778 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.09 166.88 2.96 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 9' ' ' CYS . 91.6 mt -84.19 103.65 13.57 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.232 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -83.52 -53.91 5.34 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 118.879 -1.129 . . . . 0.0 112.037 -177.348 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 9.3 mp0 -87.7 -16.56 33.96 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.595 177.318 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 43.34 73.14 0.15 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.189 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -99.65 116.31 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.369 0.604 . . . . 0.0 110.187 177.781 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -80.08 136.53 36.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.92 179.795 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -89.95 159.46 42.77 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.092 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.15 -25.97 81.29 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 174.28 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.55 -17.62 64.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.898 177.931 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 13.84 57.46 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.804 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -109.13 143.28 38.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.844 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -109.98 139.99 44.49 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.075 0.464 . . . . 0.0 111.857 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.487 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.5 m-85 -141.0 169.68 17.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.104 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.638 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.8 m -82.81 154.05 24.9 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.352 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 41.0 ttmt -70.86 -14.37 62.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.298 0.571 . . . . 0.0 110.566 -176.59 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.97 2.62 15.86 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.186 0.517 . . . . 0.0 109.921 -178.535 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.4 m -103.06 -55.96 2.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.44 174.007 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.585 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -66.69 -43.28 90.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.641 -175.707 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.39 -41.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.229 0.538 . . . . 0.0 110.675 179.817 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -76.97 -3.83 40.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.812 -175.916 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.0 m -110.88 -23.72 10.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 176.133 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 33' ' ' ILE . 44.6 pt -103.64 -7.3 9.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.099 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -95.32 -10.11 31.11 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.252 177.451 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -116.8 -43.01 2.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.056 -177.668 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.96 -72.81 0.43 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.119 176.819 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.46 152.36 21.7 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 177.649 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 24.1 m80 -82.46 68.88 9.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.855 0.836 . . . . 0.0 111.996 -179.299 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -151.71 150.7 30.51 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.462 177.582 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.2 p -70.97 123.58 89.55 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.407 177.207 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.93 -28.07 80.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.918 2.412 . . . . 0.0 113.651 -171.615 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.49 -49.23 81.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.766 -177.758 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -127.05 6.65 6.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.417 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 60.31 35.35 20.74 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -94.53 143.18 26.63 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 174.14 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 122.18 14.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.313 0.577 . . . . 0.0 110.815 -174.003 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.1 tp -120.97 130.24 53.75 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.143 -174.436 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.57 139.18 40.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -65.35 -37.84 88.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.883 -174.058 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -68.58 -19.02 64.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 177.959 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.6 mm-40 -81.36 -8.53 59.75 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.132 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.242 0.702 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.859 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 N--CA 1.432 -1.364 0 CA-C-O 120.74 0.305 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.56 108.83 4.84 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.498 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.08 -19.14 51.66 Favored 'Trans proline' 0 C--O 1.226 -0.113 0 C-N-CA 122.881 2.387 . . . . 0.0 113.463 -171.113 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 95.5 mt -66.21 -43.61 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.0 111.144 178.635 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 p -99.17 -25.29 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.973 0.416 . . . . 0.0 111.042 178.692 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.1 mt 60.5 29.86 19.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 111.249 -176.349 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.6 mtm -99.09 -68.19 0.81 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 175.136 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.65 -163.24 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -176.253 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.74 124.35 46.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.026 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -88.29 -72.28 0.54 Allowed 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.954 176.846 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.424 ' CD ' ' HG2' ' A' ' 30' ' ' LYS . 58.2 mp0 -81.13 -15.97 54.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.223 177.004 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.4 77.59 0.17 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.646 -178.281 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.12 114.03 40.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.552 0.691 . . . . 0.0 110.015 177.889 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -80.8 135.78 36.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.928 -178.4 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -99.63 154.2 37.39 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.62 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.14 -24.69 72.91 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 122.722 2.281 . . . . 0.0 113.153 -176.229 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.687 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.5 p -76.21 -15.31 60.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 178.692 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.35 23.46 6.94 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.704 175.795 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.687 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 81.4 m-70 -112.61 155.65 24.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.634 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -126.07 137.35 53.62 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.53 176.69 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.587 -175.761 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 8.7 m -91.61 160.43 15.4 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 170.702 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 61.2 pttt -75.88 -7.11 53.74 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.175 0.512 . . . . 0.0 110.353 -174.682 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.37 -0.85 15.24 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.152 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 49.2 m -101.94 -64.16 1.09 Allowed 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.393 175.879 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -67.32 -41.72 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.992 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 30' ' ' LYS . 82.8 mt -63.18 -42.89 98.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 110.97 -178.341 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -79.9 -3.22 47.15 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.246 0.546 . . . . 0.0 110.478 -176.933 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -106.15 -18.22 14.08 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.809 -0.557 . . . . 0.0 111.4 178.156 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 36.5 pt -102.23 -13.28 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.453 -175.051 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -104.87 0.94 28.48 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.06 174.342 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.32 -51.72 2.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 -176.032 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.79 -69.78 0.59 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.42 0.629 . . . . 0.0 109.451 174.796 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.76 163.94 35.26 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 177.682 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -80.31 72.26 7.15 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.87 0.835 . . . . 0.0 112.124 -176.709 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.0 ptpp? -144.61 150.05 36.79 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.784 176.075 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 p -83.75 123.23 76.37 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.36 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.96 -25.71 74.07 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.842 2.361 . . . . 0.0 114.109 -168.962 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.5 m -72.08 -42.96 67.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.874 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -120.27 6.43 10.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 50.93 36.55 15.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 176.303 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.6 mm-40 -96.94 153.29 17.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.345 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.53 122.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.145 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.6 118.35 35.44 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -176.368 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.594 ' HB2' HE21 ' A' ' 55' ' ' GLN . 2.9 mm? -98.36 134.82 40.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.484 179.736 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -64.89 -35.6 81.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.339 0.399 . . . . 0.0 111.74 -173.426 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -65.86 -30.65 71.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.287 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.594 HE21 ' HB2' ' A' ' 52' ' ' LEU . 48.7 mt-30 -68.1 -20.25 64.92 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.188 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 178.341 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 . . . . . 0 N--CA 1.442 -0.83 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 38.7 t -70.34 114.21 24.08 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.944 0.778 . . . . 0.0 109.426 179.023 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 32.1 Cg_exo -62.7 -21.61 73.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.346 2.03 . . . . 0.0 112.553 -177.666 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.8 -44.02 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.764 0.316 . . . . 0.0 111.582 178.317 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -104.01 -22.92 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.891 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt 56.75 25.48 10.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 111.939 -176.421 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -96.4 -63.13 1.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.324 174.291 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.37 -172.72 0.31 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.786 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.4 mt -98.93 106.82 19.12 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.961 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -69.61 -43.96 71.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.138 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 67.1 mm-40 -115.38 -16.24 11.46 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 177.876 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.95 70.48 0.58 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.661 0.601 . . . . 0.0 112.329 -178.544 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 28' ' ' PHE . 26.8 m -93.27 116.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.141 0.496 . . . . 0.0 110.777 179.236 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -80.0 135.81 36.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 175.116 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -111.01 151.74 43.2 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.498 -179.791 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.449 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 50.2 Cg_exo -56.63 -37.38 97.76 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.791 2.327 . . . . 0.0 111.154 179.737 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.8 t -59.69 -31.14 69.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.907 -178.793 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.89 36.33 2.04 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.418 179.812 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.56 156.85 40.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.162 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.72 131.35 53.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.012 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.43 ' O ' HG22 ' A' ' 20' ' ' VAL . 94.5 m-85 -139.6 179.72 6.4 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.252 0.345 . . . . 0.0 110.208 -177.109 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.519 ' HB2' ' HG ' ' A' ' 32' ' ' CYS . 61.8 m -90.61 151.22 21.39 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 169.972 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 88.0 tttt -71.55 -6.8 43.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.34 0.59 . . . . 0.0 111.449 -176.121 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.48 -16.14 12.47 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.081 0.467 . . . . 0.0 109.952 -179.437 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.519 ' HG ' ' HB2' ' A' ' 29' ' ' CYS . 76.3 m -83.82 -59.28 2.47 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 175.351 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.2 tp -67.87 -41.05 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.243 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 67.0 mt -62.72 -42.97 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.658 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -78.83 -1.66 35.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.546 0.689 . . . . 0.0 109.61 -175.568 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 m -105.38 -21.08 13.3 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.651 176.158 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.7 pt -104.07 -24.34 4.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.077 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -98.9 0.49 44.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.764 177.371 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.87 -46.52 2.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.749 -177.395 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 -68.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.115 0.483 . . . . 0.0 110.794 177.202 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.49 161.98 35.66 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.31 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 66.0 m80 -86.21 76.17 9.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 117.444 0.622 . . . . 0.0 111.555 -173.886 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 22.4 pttp -154.25 144.68 22.22 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 -179.214 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.3 p -77.32 123.79 86.98 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 170.351 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.25 -24.77 76.32 Favored 'Trans proline' 0 N--CA 1.481 0.751 0 C-N-CA 123.321 2.681 . . . . 0.0 114.019 -167.251 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -66.79 -46.19 86.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.056 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.55 7.45 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.943 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.321 0.2 OUTLIER 53.77 38.12 27.83 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 178.886 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 69.1 mm-40 -86.28 142.01 28.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.382 173.336 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 48.5 mm -66.45 121.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.575 -176.941 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.68 132.39 43.9 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.402 -177.629 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HG3' ' A' ' 55' ' ' GLN . 2.7 mm? -110.58 157.99 19.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.354 177.748 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.65 -38.15 89.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.655 0.74 . . . . 0.0 109.917 -179.473 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -76.72 -6.04 50.55 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.15 -174.006 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 23' ' ' PRO . 61.7 mt-30 -89.38 -8.07 53.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 0.0 111.413 178.723 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.484 -175.742 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.416 -2.127 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -72.79 108.55 4.58 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.889 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.19 -17.5 45.16 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.528 2.152 . . . . 0.0 112.002 -174.31 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.4 mt -66.13 -43.6 92.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.61 177.527 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -104.81 -16.51 14.89 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -177.706 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 mp 57.87 22.72 8.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.928 0.891 . . . . 0.0 111.569 -176.326 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.465 ' HA ' ' CE ' ' A' ' 14' ' ' MET . 1.8 mmt -94.88 -66.89 0.88 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.529 -178.865 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.78 -169.43 0.12 Allowed 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.975 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.3 mt -97.49 109.36 22.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.898 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -65.48 -45.13 84.87 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.311 -178.823 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -132.72 -14.08 2.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.764 176.344 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.24 92.21 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.602 0.761 . . . . 0.0 112.9 178.167 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.91 117.62 49.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.163 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.31 128.22 33.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.331 -177.584 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -89.32 155.16 49.11 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.872 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.37 -29.55 89.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.504 2.136 . . . . 0.0 113.07 -173.663 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.607 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -76.27 -15.4 60.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.944 0.402 . . . . 0.0 111.923 178.985 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.21 42.45 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.951 174.346 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.607 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 75.3 m-70 -125.62 143.29 51.09 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.524 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 7.5 mpt_? -109.97 135.62 50.53 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.409 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.0 m-85 -133.81 168.08 19.39 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.8 m -75.88 156.65 34.13 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.775 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.1 tttt -68.82 -11.23 60.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.508 -174.697 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.32 -37.56 4.33 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.973 -179.101 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -62.8 -47.28 84.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.813 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -70.11 -41.61 79.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.896 -178.681 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.556 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.7 mt -63.55 -42.78 97.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.696 -178.592 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -78.01 -0.94 29.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.482 0.658 . . . . 0.0 110.02 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -105.86 -20.36 13.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.701 174.164 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.64 -21.73 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -176.577 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 12.2 ptp180 -97.57 8.01 45.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.464 171.605 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -116.2 -55.82 2.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.746 -177.94 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.87 -72.64 0.5 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.88 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.46 163.56 37.02 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.987 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.493 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 70.5 m80 -87.93 76.65 8.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.598 0.713 . . . . 0.0 111.909 -176.706 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -159.91 155.32 25.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.848 175.708 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 p -79.07 124.05 84.75 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.702 175.988 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.8 -27.21 75.15 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 122.82 2.347 . . . . 0.0 113.614 -172.851 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.91 -45.34 73.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.444 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -122.47 4.87 9.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.77 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 57.71 34.74 24.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.477 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 148.76 22.78 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.448 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.99 120.67 14.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.952 0.406 . . . . 0.0 110.594 -175.486 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 61.7 tp -121.45 127.98 51.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.154 -176.646 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.17 148.92 29.21 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.529 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.08 -37.33 87.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -175.893 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.0 -29.81 70.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.471 177.381 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.72 -15.11 62.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.076 -179.581 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.742 0.306 . . . . 0.0 110.729 178.65 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.408 ' HB2' HD23 ' A' ' 16' ' ' LEU . 38.8 t -79.79 109.84 13.55 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.712 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.79 -20.57 71.55 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.525 2.15 . . . . 0.0 112.576 -174.467 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -67.32 -44.7 87.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.684 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.3 p -103.92 -19.3 14.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.462 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp 58.42 23.19 10.34 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.693 0.797 . . . . 0.0 111.563 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.4 mtm -95.28 -64.62 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.158 178.273 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.51 -173.97 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.757 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 9' ' ' CYS . 84.8 mt -95.22 102.66 14.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 173.184 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.29 -45.06 63.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.053 -179.555 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 18.5 mm-40 -106.43 -17.45 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.815 -175.176 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 44.52 89.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.596 1.159 . . . . 0.0 114.034 -176.716 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.89 121.26 65.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 175.939 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.348 -178.811 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -110.66 151.1 42.6 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.349 174.638 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.9 -24.82 77.51 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.87 2.38 . . . . 0.0 113.634 -178.802 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.45 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.7 p -79.32 -15.47 57.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.978 177.77 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 44.8 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.304 173.621 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.45 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 23.8 m-70 -133.33 149.46 51.9 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.708 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -111.45 134.85 52.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.495 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 96.9 m-85 -136.18 173.15 12.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.718 -178.725 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.7 m -86.89 151.21 23.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.124 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.525 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 65.2 tttp -68.42 -11.21 59.35 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 122.999 0.52 . . . . 0.0 111.348 -178.966 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.55 2.64 15.4 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.171 -178.994 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -105.41 -53.8 2.59 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.399 175.25 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -68.17 -38.54 79.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.923 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.09 -41.61 91.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.069 0.462 . . . . 0.0 110.126 178.326 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 32.1 mmmt -79.18 2.75 19.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -106.37 -25.46 11.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.742 173.669 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.3 pt -104.63 -5.87 9.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.387 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.0 ptm180 -124.61 3.15 8.29 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.546 171.097 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 3.9 m-20 -127.11 -42.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.149 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.41 -65.91 0.97 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.437 0.637 . . . . 0.0 110.755 -178.597 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.52 -148.52 5.42 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.579 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -139.02 31.96 2.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 171.517 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -132.5 161.03 34.79 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.086 -175.065 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.1 t -74.94 122.04 86.6 Favored Pre-proline 0 N--CA 1.43 -1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.13 -31.16 54.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.386 2.057 . . . . 0.0 113.327 -175.167 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.38 -48.57 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.007 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -114.33 6.49 16.1 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.573 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 58.91 31.97 21.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.489 0.716 . . . . 0.0 112.439 177.106 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.76 147.17 26.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.636 178.943 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.0 122.42 16.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.129 0.49 . . . . 0.0 109.974 -178.022 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.401 HD23 HG21 ' A' ' 37' ' ' ILE . 54.5 tp -111.34 131.0 55.5 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.133 -175.114 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -97.76 138.62 34.85 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.075 -178.903 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.77 -38.64 89.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.414 -174.563 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.13 -30.13 70.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.015 0.436 . . . . 0.0 111.189 178.37 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -74.58 -7.14 52.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.57 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.013 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.516 ' HB2' HD23 ' A' ' 16' ' ' LEU . 39.4 t -94.88 108.37 37.43 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 173.853 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.7 -19.48 68.34 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.841 2.361 . . . . 0.0 112.862 -174.599 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.58 -44.13 90.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 178.61 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.5 p -102.79 -13.37 17.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.794 -178.351 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 mp 69.37 23.97 5.98 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.625 0.77 . . . . 0.0 110.425 -179.04 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -128.18 170.07 13.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.38 157.7 13.31 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.428 0.455 . . . . 0.0 110.899 177.853 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 9' ' ' CYS . 86.1 mt -70.09 133.1 46.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.719 -174.859 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 12.8 tpt180 -77.98 -62.86 1.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.087 172.716 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.507 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.8 mm-40 -99.18 -18.43 17.66 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.062 -177.545 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 86.98 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.629 -175.539 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -108.8 118.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.508 0.67 . . . . 0.0 111.126 175.133 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.22 139.41 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.18 179.867 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -110.51 155.32 42.27 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.803 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.02 -20.24 63.83 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.703 2.269 . . . . 0.0 111.72 178.769 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.9 t -74.42 -19.47 60.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.876 178.253 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.72 25.98 11.17 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.979 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -113.69 154.04 27.95 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.028 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.41 ' HB3' HD11 ' A' ' 16' ' ' LEU . 77.8 mtt85 -117.99 138.43 52.19 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.665 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.7 168.29 20.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.775 0.321 . . . . 0.0 110.581 -178.689 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.612 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.8 m -86.21 148.36 25.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 169.977 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.78 -12.85 61.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.958 -171.514 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -7.92 13.41 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.352 -178.587 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -85.94 -46.39 10.6 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 170.149 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.608 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -67.78 -43.14 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.859 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.587 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.9 mt -63.46 -42.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 111.221 -177.958 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -78.76 -2.09 37.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 -175.607 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 t -106.16 -25.54 11.96 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.832 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.8 pt -103.77 -15.59 8.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.479 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.3 ptm180 -98.35 2.99 48.57 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.262 173.89 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -115.18 -52.09 2.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.068 -172.123 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.3 -68.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.223 175.671 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.74 165.73 39.1 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.099 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 62.4 m80 -87.94 80.48 7.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.837 0.827 . . . . 0.0 111.473 -177.776 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -152.7 159.51 43.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 9.7 m -67.21 127.4 93.47 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.861 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.49 -20.77 70.37 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.736 2.291 . . . . 0.0 112.516 -179.31 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.73 -61.0 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.276 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 43.2 p-10 -103.92 5.29 35.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.033 -0.417 . . . . 0.0 111.128 -174.378 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 56.28 34.55 24.25 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.542 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -90.04 145.65 24.92 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.098 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -65.86 121.58 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 0.0 110.426 -174.252 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 64.9 tp -126.89 129.12 47.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.929 -175.983 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.2 mm? -112.14 152.26 28.52 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -175.539 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.58 -36.15 82.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.302 0.573 . . . . 0.0 111.171 -177.971 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.99 -31.09 72.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.459 176.27 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.4 mm100 -78.93 -8.64 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.384 -175.735 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.238 0.456 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.667 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 44.2 tt0 . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.4 t -78.28 108.49 7.8 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.756 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 35.7 Cg_exo -64.48 -19.8 65.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.926 2.417 . . . . 0.0 112.06 -177.123 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.1 -43.86 92.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 -179.352 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.3 p -99.76 -26.0 14.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.272 179.841 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt 64.22 21.65 12.6 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.153 0.981 . . . . 0.0 111.92 179.797 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -100.52 -64.47 1.04 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.936 0.398 . . . . 0.0 111.004 177.884 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.7 -170.07 0.38 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.544 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.03 108.01 20.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.533 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.12 -45.84 75.94 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.019 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -112.45 -16.81 12.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.342 176.425 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.37 62.53 2.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.256 -175.046 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 29.1 m -83.18 118.12 30.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.39 -178.492 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -74.51 126.22 30.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.688 178.794 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.1 p -94.68 165.54 17.03 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.085 -177.27 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.83 -34.2 96.22 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.801 2.334 . . . . 0.0 112.062 177.442 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 p -76.62 -15.15 59.9 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.187 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.17 44.0 Favored Glycine 0 CA--C 1.516 0.152 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.936 179.0 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -90.97 167.15 12.62 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.054 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 92.4 mtt180 -130.55 140.24 50.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.001 179.293 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.421 ' O ' HG22 ' A' ' 20' ' ' VAL . 96.9 m-85 -138.7 -177.23 4.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.521 ' O ' HG22 ' A' ' 33' ' ' ILE . 45.6 m -91.12 152.3 20.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.371 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.77 -11.88 61.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.049 0.452 . . . . 0.0 111.131 -176.269 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.45 -10.08 13.25 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.041 -177.448 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -92.66 -56.09 3.14 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.709 177.189 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.558 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -69.03 -40.3 80.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.667 -177.167 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.594 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.0 mt -62.91 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.381 . . . . 0.0 111.851 -178.934 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.14 -3.29 41.71 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.884 0.373 . . . . 0.0 110.49 -175.44 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.9 p -108.18 -19.71 13.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 175.157 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 33' ' ' ILE . 36.4 pt -102.64 -13.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.906 -0.496 . . . . 0.0 112.183 -174.55 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.3 ptp180 -98.0 7.99 45.46 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 167.852 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.09 -54.88 2.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.685 -175.286 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.96 -72.9 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.346 0.593 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.22 167.17 39.69 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.86 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 59.8 m80 -83.38 74.27 10.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.449 0.642 . . . . 0.0 111.992 -176.338 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.7 ptpt -151.7 152.03 32.23 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.267 177.746 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 1.5 p -77.46 135.69 64.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.829 173.982 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.62 -21.88 65.09 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.502 2.134 . . . . 0.0 112.259 -179.09 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -76.43 -74.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.02 4.47 47.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -175.08 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 11.8 m120 56.08 34.55 24.01 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 172.053 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 75.5 mm-40 -93.64 154.07 18.03 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.725 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.57 120.59 14.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.565 0.698 . . . . 0.0 109.988 -175.805 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 56' ' ' LEU . 7.8 tt -124.05 121.25 34.7 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.297 -172.341 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.51 141.35 35.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.768 0.318 . . . . 0.0 111.378 -176.453 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.51 -43.02 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.957 -175.066 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -67.29 -30.91 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.261 -177.373 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -78.85 -8.18 58.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.439 -176.953 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 51' ' ' LEU . 97.5 mt . . . . . 0 C--N 1.315 -0.915 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.684 179.407 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 120.703 0.287 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HB2' HD23 ' A' ' 16' ' ' LEU . 42.1 t -88.17 108.16 20.21 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.851 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.8 Cg_exo -62.73 -20.72 71.82 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.684 2.256 . . . . 0.0 113.3 -174.755 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.67 -43.74 90.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.686 178.958 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.59 -7.96 14.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.113 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt 61.73 26.46 16.09 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.503 0.721 . . . . 0.0 110.785 -177.062 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -120.08 169.16 10.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 152.9 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.744 175.481 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 9' ' ' CYS . 77.9 mt -69.44 114.25 7.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.937 0.399 . . . . 0.0 110.003 -172.226 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -71.65 -46.56 58.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.779 -177.564 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -114.18 -17.18 11.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.464 178.485 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.45 82.68 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.872 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.43 116.72 53.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.327 0.584 . . . . 0.0 110.994 174.209 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 51.6 tt0 -82.84 133.84 35.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.891 -178.5 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -86.54 160.39 50.82 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.147 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -55.64 -37.76 94.96 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.612 2.208 . . . . 0.0 112.074 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.556 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -67.99 -17.23 64.37 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.649 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.41 41.44 2.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.015 174.069 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.556 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 76.7 m-70 -122.49 143.76 49.5 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.193 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 21' ' ' GLN . 89.1 mtm180 -111.28 137.52 48.91 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.64 175.239 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.5 m-85 -131.65 166.36 21.62 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.428 -178.425 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.626 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.3 m -79.38 149.65 31.61 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.122 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' HD12 ' A' ' 34' ' ' ILE . 40.5 ttmt -76.22 -2.95 33.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.788 0.804 . . . . 0.0 111.455 -173.155 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.92 -24.0 9.77 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.113 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.7 m -73.35 -51.11 18.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.276 174.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.486 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -67.23 -39.55 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.926 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.1 mt -62.78 -41.7 93.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.625 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -78.18 -1.78 34.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.94 -176.762 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.5 m -105.86 -21.58 13.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.653 0.263 . . . . 0.0 111.178 173.828 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -102.87 -16.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.343 -175.196 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 ptm180 -99.73 1.13 43.03 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.002 175.467 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -115.49 -54.15 2.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.224 -178.0 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 -66.55 0.89 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.048 0.452 . . . . 0.0 110.48 179.013 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -172.09 161.99 33.99 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 177.218 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.615 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 47.2 m80 -83.18 83.25 7.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.776 0.798 . . . . 0.0 110.473 179.769 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.38 157.09 41.98 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.397 -176.987 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 46.3 t -80.9 122.49 82.0 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.915 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.83 -28.86 76.06 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.958 2.439 . . . . 0.0 115.055 -170.548 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.0 m -85.78 -49.93 14.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -173.095 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -106.98 6.61 29.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.801 0.334 . . . . 0.0 111.322 -176.397 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.255 4.5 p-10 50.82 40.19 24.09 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.227 . . . . 0.0 113.736 177.826 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -80.51 149.84 29.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.799 175.064 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.09 120.84 16.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.109 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.8 tp -124.29 129.33 50.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.709 0.29 . . . . 0.0 111.138 -176.176 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.02 152.51 24.38 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -65.2 -24.19 67.29 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -174.381 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -89.57 5.48 45.4 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.75 179.162 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -84.8 -11.27 56.08 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.017 0.437 . . . . 0.0 110.168 174.063 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.397 -175.989 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 N--CA 1.428 -1.533 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 34.7 t -68.12 115.99 34.47 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.351 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 35.8 Cg_exo -62.04 -22.49 74.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.171 1.914 . . . . 0.0 113.171 -174.653 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.78 -44.28 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.475 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 8.1 p -97.96 -16.41 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.646 -177.413 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt 54.92 27.08 8.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 109.81 -174.031 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.9 ttm -108.35 -73.96 0.67 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.699 -173.488 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.65 162.75 2.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.015 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.05 104.5 7.57 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.328 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -70.65 -45.65 64.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 177.294 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 63.8 mm-40 -114.59 -16.47 11.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.948 -178.027 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.58 82.67 0.08 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.949 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -111.85 117.81 56.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.244 0.545 . . . . 0.0 110.59 175.001 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 53.5 tt0 -81.34 138.33 35.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.357 -177.914 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.448 ' CG2' HD11 ' A' ' 51' ' ' LEU . 67.9 p -113.73 156.54 43.51 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.584 -179.011 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HG3' ' OE1' ' A' ' 55' ' ' GLN . 38.3 Cg_endo -62.98 -22.0 73.54 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.027 2.485 . . . . 0.0 113.409 -176.17 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 56.5 m -73.99 -19.25 60.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.643 177.509 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 30.56 7.18 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.169 -175.885 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.498 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 16.5 m-70 -114.0 152.13 31.38 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.078 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 88.7 mtm180 -122.64 134.34 54.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.309 171.656 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 93.0 m-85 -129.97 -177.82 4.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.289 -176.151 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.6 m -99.61 157.89 16.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.999 173.443 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.4 tttt -68.64 -13.39 62.33 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.046 0.451 . . . . 0.0 111.631 -178.209 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 1.93 16.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.863 0.84 . . . . 0.0 109.198 -178.138 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 84.0 m -103.12 -63.32 1.18 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.713 175.935 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.1 -40.63 85.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.528 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.644 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.6 mt -63.47 -42.46 96.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.953 0.406 . . . . 0.0 110.273 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.84 4.95 12.58 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.627 0.727 . . . . 0.0 110.247 -179.289 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.7 t -106.46 -26.44 11.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.738 173.418 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.9 pt -103.77 -19.47 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.968 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -101.01 8.63 42.91 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.771 0.796 . . . . 0.0 109.36 173.8 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.41 -56.61 2.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.871 -174.66 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.33 -68.93 0.77 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.947 177.322 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.1 176.09 45.9 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 178.895 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 33.5 m80 -79.11 92.66 5.05 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 117.824 0.812 . . . . 0.0 111.478 -179.806 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 18.8 ptpt -169.08 147.46 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.328 0.651 . . . . 0.0 109.526 177.733 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 125.32 71.06 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 170.197 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.01 -25.59 81.77 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.965 2.444 . . . . 0.0 114.661 -167.909 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.98 -44.74 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.099 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -121.48 5.72 10.12 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.193 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 51.21 31.07 6.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.051 1.341 . . . . 0.0 114.24 179.691 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.1 140.11 32.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.509 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 2.0 mp -66.36 120.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.278 0.561 . . . . 0.0 110.198 -176.448 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.448 HD11 ' CG2' ' A' ' 22' ' ' THR . 8.9 tt -121.78 131.99 54.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.255 -173.46 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.43 HD13 ' NE2' ' A' ' 55' ' ' GLN . 8.3 mp -111.41 153.1 26.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.445 -178.01 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -61.69 -34.43 75.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.265 0.626 . . . . 0.0 111.461 -177.671 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -74.59 -11.47 60.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.11 0.481 . . . . 0.0 111.29 -178.018 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.43 ' NE2' HD13 ' A' ' 52' ' ' LEU . 80.8 mt-30 -87.61 -10.63 50.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.841 177.9 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 177.52 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.188 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -60.44 143.76 99.48 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.389 2.059 . . . . 0.0 111.129 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.52 123.89 46.3 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.84 81.75 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.275 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.7 m -76.25 141.45 41.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.848 0.356 . . . . 0.0 111.457 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.35 102.34 5.92 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 48.7 76.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.56 0.695 . . . . 0.0 110.88 -170.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -134.46 149.7 50.76 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.741 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 54.0 t -88.7 110.13 34.89 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.47 -17.86 53.92 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.848 2.365 . . . . 0.0 111.952 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.445 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -65.8 -43.99 93.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.754 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.6 p -115.0 -8.24 12.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.542 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.5 mt 56.68 34.82 25.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.845 0.858 . . . . 0.0 110.914 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.7 mtm -118.16 164.06 15.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.714 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.57 32.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.917 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.48 119.58 13.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.031 0.443 . . . . 0.0 111.008 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 19' ' ' ALA . 28.2 tpt180 -91.37 115.61 28.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.252 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 69.23 -16.23 0.25 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.553 1.141 . . . . 0.0 113.026 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . 47.72 91.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.026 1.33 . . . . 0.0 113.569 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -101.83 116.73 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.319 0.58 . . . . 0.0 110.735 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.41 134.22 35.52 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.082 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -87.92 160.71 46.07 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.781 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.87 -17.96 62.31 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 122.39 2.06 . . . . 0.0 111.014 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.82 -21.43 63.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.411 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.91 2.08 58.41 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.417 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -97.54 136.39 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -102.54 135.34 44.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.98 166.61 22.31 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.9 m -65.74 150.11 49.05 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.06 -10.61 51.71 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.502 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.12 -38.13 3.68 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.559 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 36.6 m -61.77 -45.12 95.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.692 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -66.94 -39.34 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.577 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -62.97 -42.87 98.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.063 0.459 . . . . 0.0 110.509 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -78.61 -1.48 34.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.479 0.657 . . . . 0.0 110.374 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -105.84 -19.69 13.67 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.997 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -102.98 -26.16 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.0 ptm180 -103.02 8.55 38.87 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.795 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -115.28 -53.84 2.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.95 -66.68 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.22 0.533 . . . . 0.0 110.2 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.82 161.71 35.04 Favored Glycine 0 CA--C 1.497 -1.032 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -80.86 81.08 7.21 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 117.206 0.503 . . . . 0.0 112.197 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.2 ptpt -151.3 154.8 37.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.479 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.4 p -83.36 125.67 73.61 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.94 -27.33 84.63 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.636 2.224 . . . . 0.0 114.313 -170.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.15 -49.49 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.941 0.4 . . . . 0.0 111.864 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.91 6.39 4.29 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' HD22 ' A' ' 48' ' ' ASN . 1.0 OUTLIER 59.85 37.85 21.58 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 174.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.46 147.04 28.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.77 121.33 15.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.438 HD12 HG21 ' A' ' 37' ' ' ILE . 3.0 tm? -125.63 127.14 45.84 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.838 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.5 mm? -112.35 151.93 29.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HG3' HD11 ' A' ' 37' ' ' ILE . 2.7 mp0 -60.13 -39.44 86.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.535 0.334 . . . . 0.0 111.148 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -75.38 -15.21 60.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.772 0.32 . . . . 0.0 111.6 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.8 mm100 -83.08 -14.87 52.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 51' ' ' LEU . 93.8 mt -76.06 133.85 40.22 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.02 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -130.97 124.89 20.92 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.325 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.59 136.53 74.68 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 121.928 1.752 . . . . 0.0 110.367 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.73 136.67 41.77 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.305 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.24 104.08 16.69 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.675 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -97.51 8.59 44.35 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.566 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.44 2.62 47.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.395 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.607 ' O ' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.3 150.56 42.03 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.71 2.273 . . . . 0.0 111.855 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.67 -47.1 85.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.668 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 53.47 -127.84 37.66 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.22 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -136.36 120.69 18.0 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -126.52 174.24 8.8 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.917 0.389 . . . . 0.0 111.319 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.626 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 98.4 m-85 -106.54 29.48 6.86 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.938 0.875 . . . . 0.0 110.211 -174.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -96.48 136.7 36.62 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.897 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.2 t -86.49 107.59 14.31 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 168.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -63.16 -20.76 71.7 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.644 2.229 . . . . 0.0 113.251 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.0 -43.69 92.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.861 0.363 . . . . 0.0 111.018 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.0 p -101.15 -21.23 15.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.791 0.329 . . . . 0.0 111.488 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 60.27 22.35 11.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.977 0.911 . . . . 0.0 111.94 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -99.14 -71.65 0.69 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.808 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.13 -169.87 0.58 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 98.2 mt -97.0 107.98 20.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.764 0.316 . . . . 0.0 110.375 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 7.4 tpm_? -64.99 -49.66 69.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.695 174.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -116.11 -16.09 11.05 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.643 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.84 76.07 0.21 Allowed 'General case' 0 N--CA 1.462 0.139 0 O-C-N 123.862 0.726 . . . . 0.0 111.959 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.05 116.98 49.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.266 0.555 . . . . 0.0 110.919 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -71.8 125.89 28.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.933 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 p -89.66 158.76 44.88 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.44 -22.53 65.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.223 1.949 . . . . 0.0 113.56 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.57 -46.29 26.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.018 0.437 . . . . 0.0 110.966 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.68 48.94 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.346 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -139.92 163.17 33.37 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -124.86 137.6 54.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.08 0.467 . . . . 0.0 110.293 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.42 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.5 168.98 18.23 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.064 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 48.4 m -79.96 147.04 31.76 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' HD3' ' HB3' ' A' ' 59' ' ' ASP . 63.6 tttm -74.72 -3.58 32.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.256 0.55 . . . . 0.0 111.409 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.51 -18.57 12.38 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.957 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 43.9 m -85.07 -48.03 9.6 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.285 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.52 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.73 -42.27 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HA ' HG12 ' A' ' 37' ' ' ILE . 84.8 mt -63.48 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 111.633 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -77.25 -2.04 32.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 m -106.68 -24.21 12.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.8 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 42' ' ' HIS . 47.8 pt -105.1 -21.77 5.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -79.04 -15.45 58.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.887 -174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.16 -53.74 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.771 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.21 -65.34 0.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.562 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.43 139.65 5.49 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.866 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.545 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 71.3 m80 -79.55 67.05 5.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.698 0.761 . . . . 0.0 111.706 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -150.85 155.8 39.93 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.197 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.505 ' SG ' HD12 ' A' ' 51' ' ' LEU . 35.3 m -64.54 129.61 94.32 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.91 -21.81 56.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.989 1.793 . . . . 0.0 111.001 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.35 -74.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.553 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.14 4.52 53.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 62.5 m-80 54.61 32.99 18.21 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -88.39 155.26 19.79 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 50' ' ' ILE . 2.1 mp -65.73 117.39 6.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' SG ' ' A' ' 44' ' ' CYS . 7.8 tt -124.28 121.43 35.01 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.445 HD12 ' NE2' ' A' ' 55' ' ' GLN . 79.3 mt -111.36 145.22 39.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.255 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.39 -36.38 83.96 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.915 0.886 . . . . 0.0 110.466 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -64.79 -32.02 73.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.57 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' NE2' HD12 ' A' ' 52' ' ' LEU . 82.0 mt-30 -89.09 -8.64 53.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.41 141.16 41.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.759 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 98.4 m-85 -72.71 144.85 86.37 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.639 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 48.8 Cg_exo -60.21 146.04 97.22 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 122.767 2.311 . . . . 0.0 111.392 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.486 ' HB3' ' HD3' ' A' ' 30' ' ' LYS . 2.6 p30 -86.09 -176.12 5.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.282 0.563 . . . . 0.0 112.153 -175.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -102.3 14.35 32.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.791 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -140.73 150.2 43.13 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.937 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.72 -33.91 21.37 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.447 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 5.0 ttpm? . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.527 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -63.05 148.02 93.81 Favored 'Trans proline' 0 CA--C 1.515 -0.457 0 C-N-CA 123.211 2.607 . . . . 0.0 111.512 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -84.35 128.58 34.66 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.7 -154.72 32.81 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.941 -175.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.7 m -72.95 146.65 45.89 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.698 0.285 . . . . 0.0 110.83 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' A' ' 8' ' ' GLU . 62.5 tttp -86.69 125.51 33.92 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.441 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 97.0 m-85 -109.11 12.76 24.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.894 0.854 . . . . 0.0 110.253 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.5 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 42.1 tt0 -105.39 124.23 49.19 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.829 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.5 t -84.21 107.69 11.68 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.71 -18.46 47.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.423 2.082 . . . . 0.0 112.52 -174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.18 -43.58 91.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.292 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -100.53 -27.31 13.48 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.26 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.4 mt 63.89 23.09 13.25 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.778 0.831 . . . . 0.0 111.608 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.2 mtm -96.08 -71.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.497 0.665 . . . . 0.0 109.371 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.77 -158.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 91.7 mt -98.95 104.76 16.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -68.63 -43.85 75.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.983 0.421 . . . . 0.0 110.747 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 63.2 mm-40 -119.21 -15.99 9.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.641 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.76 81.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.795 0.684 . . . . 0.0 112.278 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.42 115.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.806 0.812 . . . . 0.0 110.787 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.61 129.05 34.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.375 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -101.05 154.47 37.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -22.11 70.24 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.639 2.226 . . . . 0.0 112.094 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.06 -14.65 60.61 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.647 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.96 25.67 16.64 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.032 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -113.01 152.9 28.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -131.1 122.28 26.42 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.82 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -130.12 -169.54 2.15 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.96 0.409 . . . . 0.0 110.861 -172.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.6 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -99.54 155.38 17.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.8 172.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.0 tttt -68.13 -12.57 61.13 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.239 0.616 . . . . 0.0 111.641 -176.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.96 -24.26 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.308 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 45.5 m -76.88 -51.37 11.37 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.322 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -68.59 -41.28 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.851 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 30' ' ' LYS . 82.5 mt -63.08 -43.31 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -79.86 -1.98 41.48 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.484 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -106.45 -8.94 16.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.691 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 33' ' ' ILE . 41.3 pt -117.43 -8.18 11.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -93.96 -15.3 25.04 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.702 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -116.61 -46.71 2.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.134 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.48 -65.98 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 110.308 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.43 160.01 23.45 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.461 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 65.1 m80 -86.21 77.48 9.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.377 0.608 . . . . 0.0 111.333 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -150.39 148.95 29.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.228 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -79.52 123.7 84.17 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.61 -27.5 76.34 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 123.136 2.558 . . . . 0.0 115.097 -166.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -67.56 -46.14 83.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -119.31 4.3 11.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.286 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 56.42 33.94 23.34 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 113.211 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -87.82 150.13 23.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.29 120.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.271 0.557 . . . . 0.0 110.558 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -125.56 121.81 34.72 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.361 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.62 148.66 23.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.662 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.24 -41.57 96.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.235 0.541 . . . . 0.0 110.007 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -65.11 -29.55 70.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.562 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -73.95 -7.64 53.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.48 136.04 52.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -119.15 148.39 44.92 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.53 150.36 87.86 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.251 1.967 . . . . 0.0 109.538 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.13 122.23 11.24 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -95.58 5.3 51.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -62.1 -46.42 89.14 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 119.896 -0.721 . . . . 0.0 109.226 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.61 129.08 50.62 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 tptm . . . . . 0 C--N 1.305 -1.363 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.739 -172.154 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.12 143.34 99.55 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.581 2.188 . . . . 0.0 110.548 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp 71.55 -48.92 0.68 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.302 1.041 . . . . 0.0 111.15 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.33 -168.08 41.2 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.2 m -100.38 87.1 3.32 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.277 0.561 . . . . 0.0 110.559 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' HG2' ' CD2' ' A' ' 7' ' ' TYR . 8.2 ttpm? -111.16 130.68 55.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.431 ' CD2' ' HG2' ' A' ' 6' ' ' LYS . 75.1 m-85 60.2 24.22 13.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.219 1.009 . . . . 0.0 110.327 -171.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -138.26 124.96 20.91 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 113.852 -1.522 . . . . 0.0 106.947 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.9 t -59.91 115.64 13.77 Favored Pre-proline 0 C--N 1.317 -0.818 0 C-N-CA 123.699 0.799 . . . . 0.0 111.25 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.427 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -62.42 -20.16 69.57 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.85 2.367 . . . . 0.0 112.739 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.438 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.7 mt -67.32 -44.39 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 111.599 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -110.9 -27.54 8.77 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 62.09 23.39 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.856 0.863 . . . . 0.0 112.159 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -95.64 -65.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.875 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.96 -172.12 1.49 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.647 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 97.1 mt -108.5 122.61 47.42 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -68.67 -44.18 74.57 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.55 -11.9 2.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.14 81.71 0.18 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.129 0.49 . . . . 0.0 111.906 -175.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.75 116.21 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.656 0.741 . . . . 0.0 111.19 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -81.64 134.8 35.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.343 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.76 162.24 33.88 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.73 -33.11 96.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.021 2.48 . . . . 0.0 112.1 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -72.55 -15.07 61.77 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.205 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.95 34.74 5.82 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.648 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -116.47 152.93 33.05 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -124.74 121.8 35.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.21 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 81.1 m-85 -131.04 173.55 10.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.943 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.647 ' SG ' ' HA ' ' A' ' 16' ' ' LEU . 62.2 m -84.12 147.95 27.06 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.5 tttt -78.06 7.69 5.8 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.0 0.905 . . . . 0.0 110.523 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.92 -32.14 5.87 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.38 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 48.5 m -78.3 -46.07 21.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.203 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.9 tp -66.01 -41.52 89.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.249 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.551 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.0 mt -63.54 -42.51 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.365 . . . . 0.0 110.859 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.61 -1.54 34.66 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.336 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 t -105.64 -21.29 13.23 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.942 -0.474 . . . . 0.0 110.037 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.662 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.4 pt -103.53 -20.36 5.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.9 ptm180 -105.74 3.19 28.63 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.665 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -118.75 -55.5 2.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.15 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.8 -79.08 0.4 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.86 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -140.06 138.19 8.93 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.454 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 9.3 t-80 -80.48 53.73 1.9 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.888 0.851 . . . . 0.0 110.879 -174.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.41 157.73 43.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.109 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.67 123.65 83.96 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.46 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.85 -25.34 74.48 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.022 2.482 . . . . 0.0 114.601 -171.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.95 -49.1 77.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.62 5.81 11.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.4 34.25 24.41 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -101.08 151.05 22.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.678 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.72 121.91 16.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-O 121.214 0.53 . . . . 0.0 110.79 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD12 HD13 ' A' ' 37' ' ' ILE . 2.9 tm? -112.88 124.75 53.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.241 -177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -105.35 140.25 38.76 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.44 -38.16 83.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 111.155 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -72.91 -15.45 61.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.29 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.5 mm100 -84.31 -7.53 59.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.86 137.99 55.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.719 0.295 . . . . 0.0 110.383 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -118.98 104.21 46.9 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.982 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.39 143.36 99.47 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.562 2.175 . . . . 0.0 111.302 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -113.72 144.74 42.44 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.962 0.411 . . . . 0.0 110.22 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.4 p30 -95.54 5.85 50.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.849 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.17 -47.29 86.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.692 0.282 . . . . 0.0 110.877 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.6 152.47 34.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 111.824 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm . . . . . 0 C--O 1.244 0.791 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.609 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.45 -28.81 71.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.942 2.428 . . . . 0.0 113.349 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.8 mt -113.08 134.43 54.54 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.7 106.69 1.88 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -93.6 115.41 27.89 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -170.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -66.74 -38.21 86.2 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 167.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -88.59 88.13 7.5 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.0 tt0 -150.97 142.92 23.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 50.9 t -89.79 107.98 22.52 Favored Pre-proline 0 N--CA 1.438 -1.063 0 O-C-N 123.798 0.686 . . . . 0.0 109.376 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 31.8 Cg_exo -63.43 -18.44 64.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.479 2.786 . . . . 0.0 111.951 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.22 -43.78 91.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.049 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.1 p -107.9 -22.76 12.31 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 64.02 21.22 12.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.213 0.605 . . . . 0.0 112.299 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 9.4 mmt -95.81 -68.36 0.8 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.421 0.629 . . . . 0.0 109.739 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.47 -159.11 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.1 128.94 55.12 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -76.35 -73.29 0.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.304 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.51 -15.21 25.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.42 84.3 0.13 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.951 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.85 117.63 49.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.455 0.645 . . . . 0.0 111.033 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.68 133.53 36.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.099 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 71.9 p -88.9 162.33 38.54 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 27.7 Cg_endo -60.16 -28.82 87.74 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.478 2.118 . . . . 0.0 112.937 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.6 p -72.09 -30.57 65.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 111.152 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.1 29.74 2.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.812 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -117.75 157.56 26.32 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -125.51 139.24 53.79 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.295 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 97.1 m-85 -135.86 171.53 14.33 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.187 0.995 . . . . 0.0 108.605 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -78.32 150.55 33.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -70.81 -8.06 49.74 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.464 0.705 . . . . 0.0 111.609 -172.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.67 -34.13 5.29 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.507 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 61.5 m -65.66 -46.48 78.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.796 0.331 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.29 -41.26 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.553 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.19 -41.95 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.427 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -78.12 -3.18 41.11 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.539 0.685 . . . . 0.0 109.673 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 m -106.95 -20.4 13.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.201 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 33' ' ' ILE . 38.5 pt -104.31 -8.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.52 -3.36 46.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -116.46 -56.02 2.33 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.341 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.09 -67.26 0.75 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.28 166.93 37.8 Favored Glycine 0 CA--C 1.495 -1.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 72.2 m80 -91.13 76.9 6.06 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.917 0.865 . . . . 0.0 111.651 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.75 157.53 42.12 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.83 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.5 p -77.83 132.74 67.23 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.741 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.02 -25.49 73.75 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.665 2.244 . . . . 0.0 113.749 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.36 -59.96 2.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -106.56 3.86 27.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.9 m120 55.26 34.03 21.91 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -78.75 151.45 32.04 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.347 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.98 121.03 15.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 7.8 tt -110.02 125.73 53.22 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.357 0.599 . . . . 0.0 110.593 -170.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.97 135.52 45.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.623 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -64.97 -38.7 91.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.924 0.392 . . . . 0.0 110.657 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -65.06 -31.5 72.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.231 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -81.53 -9.08 59.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD21 HD21 ' A' ' 51' ' ' LEU . 89.3 mt -69.88 116.62 10.46 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.5 t80 68.35 121.18 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.361 0 O-C-N 124.163 0.914 . . . . 0.0 109.449 -172.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.04 133.26 56.99 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 121.982 1.788 . . . . 0.0 110.971 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.43 112.86 22.6 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.829 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -98.06 140.82 31.82 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -60.24 -45.36 93.49 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 123.466 0.479 . . . . 0.0 111.16 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.46 111.88 23.62 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.967 0.413 . . . . 0.0 110.509 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.2 tptp . . . . . 0 C--N 1.308 -1.231 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.38 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.05 141.27 88.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.607 2.204 . . . . 0.0 110.992 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.5 tp -64.18 -45.27 89.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.001 0.429 . . . . 0.0 110.684 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.84 -159.37 46.24 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.7 m -79.79 153.49 29.13 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -80.61 83.24 6.44 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.31 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.757 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 92.5 m-85 -122.47 28.47 7.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.295 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -104.81 125.81 51.25 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.863 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.1 t -79.33 113.17 34.29 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.08 -19.91 70.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.951 2.434 . . . . 0.0 113.182 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.03 -44.62 88.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.4 p -104.13 -19.95 13.99 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 64.28 20.57 12.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.791 0.836 . . . . 0.0 111.219 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.1 mtm -102.5 -73.78 0.65 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.107 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.34 -173.24 1.42 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 93.6 mt -97.55 107.32 19.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -68.36 -45.13 73.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.159 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.544 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 70.5 mm-40 -113.02 -16.01 12.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.299 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . . . 57.75 81.79 0.14 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.998 0.811 . . . . 0.0 113.06 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -120.08 111.99 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.781 0.8 . . . . 0.0 111.616 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -81.55 132.95 35.33 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.807 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 p -94.23 159.35 34.25 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.605 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.0 -39.46 90.82 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 123.446 2.764 . . . . 0.0 113.003 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.677 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.6 p -71.96 -15.43 62.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 35.95 3.67 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.728 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.677 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 72.3 m-70 -119.34 148.18 43.48 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.0 129.07 56.62 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.002 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -134.38 169.87 16.58 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.9 m -87.4 147.69 25.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 23.8 ttpp -78.5 -2.28 37.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.143 0.497 . . . . 0.0 111.716 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.64 -10.95 13.05 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.029 -0.419 . . . . 0.0 110.012 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.9 m -89.03 -48.21 7.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.505 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.6 -41.78 83.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.09 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.662 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.2 mt -63.5 -42.53 96.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.547 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -78.23 -1.5 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.45 0.643 . . . . 0.0 109.997 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.1 t -105.8 -22.78 12.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 33' ' ' ILE . 43.7 pt -102.9 -12.14 8.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 40.5 ptt85 -99.68 3.43 45.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.702 0.763 . . . . 0.0 109.306 169.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -116.68 -46.65 2.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.648 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.59 -66.9 0.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.07 0.462 . . . . 0.0 110.256 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -175.52 167.32 39.19 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 63.0 m80 -84.33 67.18 9.74 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.895 0.855 . . . . 0.0 111.906 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -151.09 150.32 30.55 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.584 -1.189 . . . . 0.0 107.888 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.9 p -71.54 123.41 89.35 Favored Pre-proline 0 C--N 1.312 -1.053 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.73 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.64 -25.21 75.19 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 122.644 2.229 . . . . 0.0 113.27 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.456 HG23 ' OD1' ' A' ' 47' ' ' ASP . 27.1 m -73.09 -33.0 41.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.456 ' OD1' HG23 ' A' ' 46' ' ' VAL . 15.0 p-10 -141.74 6.48 1.83 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 58.15 35.42 25.05 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.6 mm-40 -92.7 142.67 27.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -65.95 121.47 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 111.142 -175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.3 tp -122.68 131.78 53.96 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.513 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.629 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -106.68 150.97 25.71 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.68 -34.88 78.84 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.43 0.34 55.64 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.629 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.3 mm100 -77.72 -16.27 58.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.824 0.821 . . . . 0.0 109.344 172.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.31 161.02 29.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.459 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 58' ' ' PRO 0.254 19.4 p90 66.01 135.43 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 125.908 1.683 . . . . 0.0 115.069 172.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 57' ' ' PHE . 34.1 Cg_exo -63.39 141.16 80.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.098 1.865 . . . . 0.0 109.628 170.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 61' ' ' PHE . 4.3 p-10 -78.68 153.89 30.59 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 75.33 -22.29 0.27 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.49 0.716 . . . . 0.0 111.043 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.422 ' H ' ' C ' ' A' ' 59' ' ' ASP . 91.5 t80 -61.07 -47.52 85.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.58 0.752 . . . . 0.0 111.666 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.88 78.46 1.12 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.715 0.769 . . . . 0.0 109.564 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? . . . . . 0 C--N 1.301 -1.537 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -177.199 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.841 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.61 147.31 76.06 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.388 2.059 . . . . 0.0 111.962 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 tt -112.41 123.22 49.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.89 -46.5 0.02 OUTLIER Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.371 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.3 m -95.74 37.34 1.22 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.184 0.516 . . . . 0.0 109.863 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -79.45 111.15 15.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.05 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 93.8 m-85 -113.87 10.31 17.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.641 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -101.3 120.3 40.05 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.504 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.497 ' HB2' HD23 ' A' ' 16' ' ' LEU . 49.7 t -70.56 111.02 8.12 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.79 -19.73 52.84 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.195 1.93 . . . . 0.0 113.049 -172.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.15 -44.68 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.031 0.443 . . . . 0.0 111.808 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.0 p -108.14 -20.16 13.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.773 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.5 mt 69.51 22.83 6.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.279 1.032 . . . . 0.0 110.885 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -112.38 169.56 8.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.944 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 154.72 27.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 88.8 mt -71.08 119.17 14.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -176.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -75.46 -47.65 26.27 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.843 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 30' ' ' LYS . 50.9 mm-40 -113.85 -16.34 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.775 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.3 58.93 4.98 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.89 0.876 . . . . 0.0 112.981 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.34 115.68 27.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.442 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 27' ' ' ARG . 60.4 tt0 -81.61 135.35 35.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.897 -177.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -96.86 158.25 33.77 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.61 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.9 -23.19 74.22 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.862 2.375 . . . . 0.0 112.894 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.0 p -72.44 -28.13 62.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.91 40.72 1.05 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.491 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 59.9 m80 -127.07 160.74 30.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.674 0.273 . . . . 0.0 110.773 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 21' ' ' GLN . 31.5 mmt180 -125.6 136.59 53.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.435 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.4 m-85 -137.72 164.57 28.53 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.406 0.441 . . . . 0.0 110.012 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 19.1 m -85.45 157.52 20.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 87.2 tttt -68.47 -15.2 63.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -1.3 14.19 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.194 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 42.7 m -94.98 -54.2 3.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.893 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.44 -41.14 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.988 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.4 mt -63.23 -42.59 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.682 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -77.68 -1.28 30.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.385 0.612 . . . . 0.0 109.87 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -105.86 -19.98 13.58 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 122.018 -0.426 . . . . 0.0 109.958 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -103.79 -15.16 8.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.47 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -104.88 0.81 28.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.348 0.594 . . . . 0.0 110.498 173.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -116.97 -49.81 2.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.512 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.56 -66.23 0.94 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.518 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -177.86 162.16 29.68 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -76.33 81.68 3.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.305 0.574 . . . . 0.0 111.176 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -173.71 155.63 2.72 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 4.9 p -76.47 126.06 86.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.275 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.96 -29.42 81.96 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.787 2.325 . . . . 0.0 114.726 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -77.16 -57.54 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -102.56 5.3 39.24 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 49.71 43.2 24.39 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 71.6 mm-40 -90.73 142.82 27.36 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.66 120.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.198 0.523 . . . . 0.0 109.876 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -124.36 130.72 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.158 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -107.64 152.51 24.21 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.87 -36.4 83.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.918 0.39 . . . . 0.0 111.551 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -69.58 -17.78 63.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.902 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.1 mm100 -68.32 -25.51 65.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.896 0.379 . . . . 0.0 111.463 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.67 148.68 47.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.896 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -60.83 158.98 29.28 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -60.02 146.92 94.89 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.796 2.331 . . . . 0.0 110.873 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -78.1 112.07 14.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.728 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -65.41 -41.12 93.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.502 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -111.76 106.95 15.87 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.115 0.483 . . . . 0.0 111.162 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.12 102.96 8.66 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.584 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 tttm . . . . . 0 C--N 1.312 -1.03 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.295 -177.477 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.89 144.49 99.58 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.661 2.241 . . . . 0.0 111.867 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.6 tp -111.47 112.94 25.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.22 -55.01 3.59 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.2 m -153.03 165.45 35.56 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -111.56 152.86 27.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.236 0.541 . . . . 0.0 111.222 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.478 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 97.3 m-85 -108.23 19.85 19.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.861 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -101.36 127.13 48.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.46 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 42.4 t -72.95 114.86 34.62 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.64 -19.22 54.17 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.221 1.948 . . . . 0.0 113.875 -170.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.12 -44.78 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.245 0.545 . . . . 0.0 112.057 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 6.7 p -108.46 -17.38 14.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 63.18 46.25 4.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.696 0.76 . . . . 0.0 111.076 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.51 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 23.9 ptp -144.4 176.44 9.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.709 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.19 46.78 Favored 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.179 0.299 . . . . 0.0 111.005 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.605 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 65.8 mt -70.31 129.42 39.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.713 -174.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -71.27 -46.46 60.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -113.96 -15.2 12.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.254 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.413 ' HA ' HD13 ' A' ' 16' ' ' LEU . . . 58.26 87.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.903 0.752 . . . . 0.0 112.727 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.22 118.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.074 0.464 . . . . 0.0 111.295 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.421 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 37.1 tt0 -79.76 139.31 37.32 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.12 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.471 HG21 HD11 ' A' ' 51' ' ' LEU . 41.5 p -97.69 159.41 31.08 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.73 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 29.1 Cg_endo -60.56 -25.16 80.12 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.157 2.571 . . . . 0.0 114.101 -177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.421 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.8 p -87.53 -14.76 39.42 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.495 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.44 36.3 2.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.119 -1.039 . . . . 0.0 114.483 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.421 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 79.9 m-70 -117.97 152.93 34.51 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HB3' HD11 ' A' ' 16' ' ' LEU . 84.7 mtt85 -108.57 132.98 53.32 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.29 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.5 165.2 26.06 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.156 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 35.3 m -79.13 154.27 29.47 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 167.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.27 -11.29 60.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.473 0.654 . . . . 0.0 110.707 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 2.73 15.74 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.225 0.536 . . . . 0.0 109.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 74.2 m -98.08 -56.87 2.36 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.255 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -67.95 -41.25 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.5 mt -62.61 -42.21 95.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 111.011 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -78.32 -1.39 32.98 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.526 0.679 . . . . 0.0 110.741 -177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 m -106.04 -21.76 13.05 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.965 -0.459 . . . . 0.0 111.135 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 33' ' ' ILE . 33.3 pt -104.26 -9.62 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptp180 -101.5 2.85 39.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.209 0.528 . . . . 0.0 111.101 172.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -115.91 -47.22 2.8 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.573 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -75.07 0.35 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.719 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.3 169.6 42.19 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 65.4 m80 -83.97 69.03 10.24 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.65 0.725 . . . . 0.0 112.38 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -152.04 151.23 30.87 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.431 ' HB3' HD12 ' A' ' 51' ' ' LEU . 32.0 p -83.51 146.14 49.59 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.703 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.71 -18.52 58.69 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.703 2.269 . . . . 0.0 112.526 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.74 -74.31 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -106.73 4.57 27.84 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.901 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 57.59 29.06 16.57 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -78.17 147.25 34.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.31 121.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.317 0.58 . . . . 0.0 109.846 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 22' ' ' THR . 6.8 tt -117.05 120.5 38.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.735 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.44 143.14 32.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.248 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.99 -40.57 91.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.103 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.36 -29.96 67.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.995 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -73.22 -8.61 56.56 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.432 HD21 HD21 ' A' ' 51' ' ' LEU . 96.5 mt -65.17 137.87 57.9 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.421 ' HD1' ' O ' ' A' ' 21' ' ' GLN . 50.8 m-85 -62.94 134.61 95.76 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -61.11 142.2 96.25 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 C-N-CA 122.686 2.257 . . . . 0.0 114.376 -160.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -119.8 109.87 16.1 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.135 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -103.49 134.31 47.06 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.095 0.474 . . . . 0.0 110.789 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -151.78 160.62 43.51 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.32 110.81 9.72 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 120.963 0.411 . . . . 0.0 110.432 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.106 -178.516 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.113 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.41 150.8 64.78 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 123.003 2.469 . . . . 0.0 112.536 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.8 tt -109.26 125.26 52.09 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.0 -143.45 7.69 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.805 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 p -65.23 -33.77 76.77 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.507 0.723 . . . . 0.0 112.546 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -70.28 133.44 47.01 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -92.2 126.64 37.37 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.23 0.538 . . . . 0.0 111.29 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 99.7 mt-10 -131.74 157.13 44.62 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.7 t -82.62 107.31 8.74 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.677 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 41.9 Cg_exo -60.32 -21.06 65.63 Favored 'Trans proline' 0 N--CA 1.475 0.391 0 C-N-CA 122.965 2.443 . . . . 0.0 113.185 -172.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -66.28 -44.16 91.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.2 p -112.74 -9.11 13.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 55.56 37.05 28.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.331 1.052 . . . . 0.0 111.696 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.3 mtm -121.34 168.54 11.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.625 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.5 154.79 19.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.29 123.95 22.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.614 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -69.63 -44.18 71.16 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.846 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -126.44 -17.14 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.962 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.81 81.7 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 m -105.83 117.51 51.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.862 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -81.59 131.78 35.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -90.16 152.43 45.97 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.11 -22.49 73.22 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.433 2.088 . . . . 0.0 112.376 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.743 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 30.9 p -79.82 -17.29 53.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.702 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.43 40.67 1.59 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.361 -0.924 . . . . 0.0 113.907 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.743 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 95.0 m-70 -133.28 161.37 34.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -128.32 137.74 52.08 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.677 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 97.4 m-85 -137.78 170.43 16.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.078 0.466 . . . . 0.0 111.357 -173.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 21.0 m -76.74 160.18 29.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' HD12 ' A' ' 34' ' ' ILE . 23.1 tptm -71.16 -15.35 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.707 0.289 . . . . 0.0 111.291 -171.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.33 -1.47 12.31 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.519 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 75.1 m -88.26 -65.06 1.06 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.501 ' HB ' ' CG ' ' A' ' 28' ' ' PHE . 11.1 tp -67.78 -38.89 81.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.2 mt -62.54 -42.84 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.96 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -78.82 -2.02 37.68 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.464 0.65 . . . . 0.0 110.5 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -105.4 -23.24 12.87 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.72 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.7 pt -102.92 -14.14 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.932 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.8 ptm180 -102.32 1.61 35.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.746 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.57 -56.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.0 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.04 -68.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.276 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -151.59 147.39 17.21 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -84.63 34.09 0.53 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.783 0.801 . . . . 0.0 111.121 -171.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -144.14 154.94 43.69 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.636 ' HB3' HD11 ' A' ' 51' ' ' LEU . 25.8 p -64.29 130.06 94.41 Favored Pre-proline 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.078 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.2 -18.94 62.4 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.442 2.094 . . . . 0.0 111.379 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.79 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.104 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -117.37 15.93 14.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 63.69 35.09 11.69 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.612 ' OE1' ' HB2' ' A' ' 24' ' ' CYS . 57.9 mt-10 -89.86 139.56 30.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 mm -66.56 122.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.099 0.476 . . . . 0.0 111.313 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 ' SG ' ' A' ' 24' ' ' CYS . 77.1 mt -112.69 128.98 56.55 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.058 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -105.2 133.37 50.08 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -61.42 -38.04 85.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -74.72 -13.33 60.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.507 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.62 -9.07 55.32 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.2 mt -73.32 136.13 44.44 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -80.78 121.54 81.15 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.85 155.55 68.74 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.347 2.032 . . . . 0.0 111.705 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -47.54 104.46 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.226 0.954 . . . . 0.0 111.78 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -101.32 -17.6 16.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.183 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -86.29 131.03 34.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.273 0.558 . . . . 0.0 111.222 -172.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.82 138.77 35.48 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.994 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.6 pttt . . . . . 0 C--N 1.298 -1.656 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.76 -176.962 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.719 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.51 158.78 43.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.847 2.365 . . . . 0.0 111.373 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.53 127.25 45.6 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.35 -123.07 2.54 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -132.48 145.78 51.43 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 6' ' ' LYS . 25.9 tptp -92.74 -7.51 46.42 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 171.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 95.1 m-85 -83.69 38.22 0.62 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.692 170.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -122.98 128.15 49.82 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.244 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 t -76.43 112.1 19.49 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.6 Cg_exo -61.02 -19.4 62.9 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.027 2.484 . . . . 0.0 113.222 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.91 -43.98 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.45 -25.55 10.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp 66.22 23.68 10.84 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.886 0.874 . . . . 0.0 112.087 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -93.54 -67.41 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.587 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.96 -167.72 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 93.6 mt -98.69 106.27 18.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -68.92 -43.83 74.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 0.0 110.377 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 66.8 mm-40 -124.01 -15.16 6.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.101 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.43 83.16 0.05 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.853 0.861 . . . . 0.0 113.301 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.36 118.88 59.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 0.0 111.06 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 52.3 tt0 -80.65 128.42 33.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 51.2 p -80.93 164.69 49.54 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 25.3 Cg_endo -59.94 -28.03 86.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.551 2.168 . . . . 0.0 112.331 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.484 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.5 p -79.9 -15.69 56.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.804 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.59 45.78 2.44 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.392 -0.909 . . . . 0.0 114.325 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 89.0 m-70 -120.58 154.25 35.66 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -105.1 124.76 50.09 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 123.315 0.384 . . . . 0.0 110.325 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 92.4 m-85 -134.66 170.39 15.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.088 0.555 . . . . 0.0 110.105 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 40.0 m -85.32 150.15 24.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.474 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 62.5 tttp -68.39 -11.55 59.79 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.871 0.469 . . . . 0.0 111.136 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.18 -14.28 13.4 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.881 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.8 m -87.12 -46.57 9.66 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.896 174.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -68.17 -42.01 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.734 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.638 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.8 mt -63.5 -42.54 96.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 0.0 110.468 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.8 7.67 6.67 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.805 0.812 . . . . 0.0 110.342 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.9 t -106.83 -27.35 10.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.941 -0.475 . . . . 0.0 109.936 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 37.5 pt -104.37 -16.83 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.638 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -98.59 4.78 48.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -115.59 -56.56 2.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.728 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.9 -68.36 0.8 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.88 169.09 41.89 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.573 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 53.9 m80 -83.41 74.39 10.08 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.656 0.741 . . . . 0.0 111.978 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -150.88 155.28 38.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.812 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.7 t -67.72 129.04 93.51 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.94 -23.77 61.37 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.906 2.404 . . . . 0.0 114.156 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.58 -52.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -105.81 4.03 29.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.107 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 m120 56.87 31.76 20.23 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -78.71 145.79 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -66.12 122.52 17.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.272 0.558 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 60.4 tp -121.06 128.5 52.69 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.239 -171.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.29 146.5 34.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.791 0.329 . . . . 0.0 110.329 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.01 -37.37 87.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.871 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -19.49 63.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.97 0.414 . . . . 0.0 111.514 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.19 -8.0 58.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.844 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.5 mt -76.3 124.32 27.32 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.074 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.4 160.97 64.76 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.56 150.28 86.08 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 122.66 2.24 . . . . 0.0 110.636 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -51.81 134.87 30.57 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -75.69 94.43 3.24 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -166.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.17 -2.87 20.44 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 164.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.42 136.35 47.66 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.167 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? . . . . . 0 C--N 1.298 -1.664 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.405 179.578 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.904 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.85 144.44 96.76 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 122.675 2.25 . . . . 0.0 110.911 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.85 125.84 29.66 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.897 0.38 . . . . 0.0 110.393 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.45 -17.47 59.22 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.963 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.8 m -102.85 108.84 20.2 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.882 0.372 . . . . 0.0 110.179 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -146.81 150.64 35.69 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.774 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.704 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 95.6 m-85 -110.49 15.26 22.24 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.031 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.96 112.15 20.93 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.764 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -64.17 111.65 5.92 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.84 -19.45 58.75 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.061 . . . . 0.0 113.429 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.62 -44.52 89.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.014 0.435 . . . . 0.0 110.945 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -101.52 -23.65 14.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.2 mt 64.48 22.77 12.79 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 111.118 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.6 mtm -96.16 -68.33 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.933 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.33 -161.35 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 95.3 mt -102.92 107.32 18.1 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 6.0 tpm_? -68.05 -44.67 75.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.828 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -114.92 -16.34 11.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.183 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.22 74.5 0.39 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.077 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 20.7 m -104.93 113.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.425 0.631 . . . . 0.0 110.47 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.62 142.08 32.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.7 p -101.14 159.48 29.35 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.22 -19.95 66.43 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.419 2.079 . . . . 0.0 110.979 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.1 t -75.18 -14.29 60.53 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.972 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 18.99 48.47 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.29 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -106.32 141.42 37.67 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -104.38 133.88 48.52 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -139.43 172.27 13.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.487 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 36.0 m -89.25 154.16 20.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -68.03 -12.91 61.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 122.922 0.489 . . . . 0.0 111.963 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.38 -13.9 12.24 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.41 -176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 44.0 m -84.64 -54.77 4.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.985 0.421 . . . . 0.0 110.689 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.16 -41.85 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -172.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.656 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.48 -43.66 98.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.789 0.328 . . . . 0.0 111.163 -175.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -81.73 1.99 31.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.204 0.526 . . . . 0.0 111.09 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.1 t -105.06 -22.21 13.14 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.8 pt -103.26 -25.68 3.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.656 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -98.61 3.83 47.97 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.312 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.08 -56.52 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.745 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -71.09 0.55 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.556 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.692 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -142.33 132.04 4.97 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.3 30.12 0.48 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.971 0.891 . . . . 0.0 111.39 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -142.54 153.88 43.96 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 16.8 p -63.0 124.51 83.99 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-O 120.859 0.362 . . . . 0.0 110.065 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.31 -22.11 73.63 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.909 2.406 . . . . 0.0 114.169 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.427 HG23 ' OD1' ' A' ' 47' ' ' ASP . 28.6 m -79.21 -51.89 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.427 ' OD1' HG23 ' A' ' 46' ' ' VAL . 11.5 p-10 -117.47 7.15 12.67 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 62.02 37.02 15.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 68.5 mm-40 -93.94 139.5 30.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.673 0.273 . . . . 0.0 111.303 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.78 121.91 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.631 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.3 tp -117.66 131.65 56.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.672 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.41 139.89 41.19 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.81 -38.62 82.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.418 0.449 . . . . 0.0 111.401 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -63.25 -30.15 71.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.464 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -73.81 -8.75 57.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.42 124.56 25.41 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -131.43 122.44 18.93 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 46.2 Cg_exo -60.14 126.25 19.7 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 121.754 1.636 . . . . 0.0 111.844 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.01 -34.32 61.92 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -73.94 112.79 10.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.232 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -79.18 152.24 30.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.684 0.278 . . . . 0.0 111.368 -172.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.16 99.09 3.29 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.796 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 C--N 1.308 -1.2 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.6 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.42 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -60.81 145.4 99.04 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.663 2.242 . . . . 0.0 111.719 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.94 127.57 32.17 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.834 0.35 . . . . 0.0 110.336 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.65 -157.66 53.57 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.949 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.7 p -79.63 151.19 30.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.792 0.33 . . . . 0.0 110.553 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HG3' ' H ' ' A' ' 8' ' ' GLU . 18.0 tppt? -107.57 130.76 54.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.876 0.369 . . . . 0.0 110.292 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.427 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.3 m-85 -108.69 14.58 24.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.654 0.74 . . . . 0.0 111.057 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 43.9 tt0 -123.28 119.44 30.16 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.901 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB2' HD23 ' A' ' 16' ' ' LEU . 42.9 t -59.19 107.88 1.14 Allowed Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.753 0.658 . . . . 0.0 109.972 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.454 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 38.2 Cg_exo -65.51 -20.24 60.69 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.839 2.359 . . . . 0.0 112.405 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.03 -44.01 92.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.775 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -98.95 -26.78 14.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.136 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 65.5 21.17 11.79 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.192 0.997 . . . . 0.0 111.426 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.9 mtm -98.3 -67.23 0.86 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.077 0.465 . . . . 0.0 110.518 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.51 -172.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 9' ' ' CYS . 88.5 mt -100.86 108.47 20.26 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -73.67 -45.29 53.42 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.042 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 48.8 mm-40 -104.93 -19.0 13.99 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.701 -175.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.43 71.58 0.27 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.224 -173.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -99.77 113.21 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.663 0.744 . . . . 0.0 109.72 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.08 135.43 35.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.815 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 p -89.7 162.37 36.29 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.01 -27.81 85.72 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.361 2.041 . . . . 0.0 112.819 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.704 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.4 p -75.8 -14.97 60.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.98 36.1 5.1 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.704 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 86.0 m-70 -117.05 151.89 35.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -117.15 135.94 53.39 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.278 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.454 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.3 m-85 -137.87 172.6 12.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.468 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.8 m -83.94 149.06 26.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 62.0 tttp -67.64 -12.82 61.31 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 120.942 0.401 . . . . 0.0 111.427 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.29 -16.79 12.89 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.435 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 47.2 m -81.59 -46.78 13.92 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.9 tp -68.95 -42.21 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.5 mt -63.25 -42.74 97.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.893 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.62 2.95 20.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.524 0.678 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -107.01 -22.77 12.55 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.05 -0.406 . . . . 0.0 111.104 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.0 pt -103.41 -19.0 6.41 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -105.22 7.97 33.8 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.656 0.741 . . . . 0.0 109.908 172.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -116.48 -56.02 2.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.373 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.63 -66.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.75 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.56 160.16 33.56 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -79.47 73.51 6.13 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.807 0.804 . . . . 0.0 111.616 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -153.36 150.73 29.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.46 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -73.0 129.41 86.47 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.87 -20.84 68.88 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.031 2.488 . . . . 0.0 113.649 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.414 HG23 ' OD1' ' A' ' 47' ' ' ASP . 14.9 m -82.15 -59.81 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 46' ' ' VAL . 16.2 p-10 -107.42 4.81 26.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.84 32.32 21.17 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -88.47 147.79 24.49 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.103 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 50' ' ' ILE . 3.2 mp -66.45 119.98 12.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.302 0.573 . . . . 0.0 110.297 -175.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.27 128.88 54.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.058 -173.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.93 144.67 30.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.9 -41.55 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.752 0.821 . . . . 0.0 110.896 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -66.51 -31.28 71.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -77.22 -8.86 58.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -170.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.47 135.0 52.4 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -76.04 155.38 84.57 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.9 148.76 87.33 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 123.15 2.567 . . . . 0.0 112.227 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -58.33 106.91 0.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.947 0.879 . . . . 0.0 112.131 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -69.36 -40.29 77.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.24 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -77.68 137.58 38.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.327 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.82 139.86 56.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 ttmm . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.597 -174.082 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.012 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.63 -30.96 93.67 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.145 2.563 . . . . 0.0 112.404 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.5 tp -110.73 131.93 54.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.776 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.45 -111.6 1.71 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.9 p -77.41 139.92 39.79 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -126.97 144.5 50.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 111.92 -174.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.4 m-85 -109.74 18.19 20.47 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 172.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -126.46 144.5 50.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.902 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.0 t -75.58 111.58 15.04 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 123.401 0.681 . . . . 0.0 109.621 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.5 Cg_exo -63.67 -20.44 69.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.569 2.179 . . . . 0.0 112.903 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.93 -44.39 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.64 -23.38 13.85 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.371 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.04 22.23 7.13 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.829 0.851 . . . . 0.0 111.601 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.66 -49.77 5.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.201 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 172.7 -165.63 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.2 mt -103.56 125.65 50.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -80.08 -76.55 0.22 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.686 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -90.21 -15.32 31.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.4 84.24 0.14 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.622 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.545 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 32.8 m -105.49 116.89 50.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.291 0.567 . . . . 0.0 111.077 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -80.88 134.99 35.84 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.36 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -101.49 156.2 35.46 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.69 -22.86 74.34 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.679 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.8 p -77.23 -14.02 59.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.01 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.17 29.52 6.03 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.096 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.679 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 88.3 m-70 -112.92 148.22 35.43 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -107.59 128.59 54.67 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 88.7 m-85 -131.89 -174.74 3.51 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.4 m -99.54 159.15 15.24 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.84 0.352 . . . . 0.0 110.134 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.42 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.9 tttt -77.06 -9.94 59.05 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.566 0.747 . . . . 0.0 110.731 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.22 -6.98 13.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.165 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 85.7 m -91.26 -61.54 1.63 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.795 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -67.44 -40.91 85.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.944 -174.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.0 mt -62.89 -42.39 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 110.454 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 38.5 ttpt -79.57 1.07 27.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.721 0.772 . . . . 0.0 110.865 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -104.48 -24.77 12.99 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.5 pt -102.62 -7.05 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.7 ptm180 -99.55 2.81 45.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.033 0.444 . . . . 0.0 110.147 172.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -122.37 -56.13 1.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.072 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.35 -66.37 0.91 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.186 0.517 . . . . 0.0 110.785 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -170.65 163.96 37.15 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -85.1 73.56 10.63 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.712 0.768 . . . . 0.0 110.846 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 19.4 ptpt -149.28 151.38 34.09 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.967 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.78 123.84 90.04 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.17 -24.96 65.5 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 113.138 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.12 -57.39 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -108.13 5.7 26.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 56.74 31.77 19.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.309 1.044 . . . . 0.0 113.638 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -83.99 147.46 27.43 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mm -66.56 120.77 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.25 0.548 . . . . 0.0 109.615 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 43' ' ' LYS . 67.1 tp -122.46 126.27 47.55 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.965 -174.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.82 156.03 19.6 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -66.13 -35.66 81.08 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.21 0.528 . . . . 0.0 110.124 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -69.26 -20.76 63.93 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.019 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -82.38 -11.43 58.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.104 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.59 143.59 44.33 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.545 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 93.1 m-85 72.54 156.34 0.16 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 123.938 0.895 . . . . 0.0 109.119 -173.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.56 138.15 81.94 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.36 1.373 . . . . 0.0 110.016 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -86.77 1.73 51.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.164 0.507 . . . . 0.0 111.735 -171.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -79.26 -12.66 59.95 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.7 t80 55.17 79.49 0.15 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.971 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.479 ' C ' ' HD2' ' A' ' 63' ' ' LYS . . . -139.55 131.54 27.82 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' HD2' ' C ' ' A' ' 62' ' ' ALA . 3.7 mptp? . . . . . 0 C--N 1.305 -1.328 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.019 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.88 118.64 5.53 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 121.931 1.754 . . . . 0.0 110.689 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.9 tt 46.89 85.53 0.02 OUTLIER 'General case' 0 C--O 1.246 0.9 0 O-C-N 124.358 1.036 . . . . 0.0 109.61 -170.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.1 67.58 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.926 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 m -131.75 156.04 46.64 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -66.28 125.24 24.97 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.25 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 50.27 78.27 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.652 0.781 . . . . 0.0 112.139 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 45.1 tt0 -129.72 131.12 46.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.202 -174.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 t -83.89 111.5 33.21 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.06 -18.52 56.88 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.735 2.29 . . . . 0.0 113.708 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.45 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.789 0.328 . . . . 0.0 111.088 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.47 -20.79 14.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.921 0.391 . . . . 0.0 111.212 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.3 mt 64.03 21.34 12.56 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.294 1.037 . . . . 0.0 112.177 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.9 mtm -95.74 -66.88 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.221 0.534 . . . . 0.0 111.165 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -174.93 -173.43 0.69 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.98 125.68 36.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -79.39 -75.26 0.25 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 56.1 mp0 -91.29 -16.79 26.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.91 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.24 84.74 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.038 0.935 . . . . 0.0 112.445 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -115.31 117.69 56.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.184 0.516 . . . . 0.0 110.431 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 22' ' ' THR . 52.8 tt0 -82.82 146.45 28.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.498 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 70.8 p -92.3 159.31 37.44 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -56.47 -38.43 95.36 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.74 2.294 . . . . 0.0 112.323 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -67.53 -36.71 81.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.696 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.04 48.51 0.21 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.883 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 36.0 m-70 -124.65 145.01 49.88 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.3 mtm-85 -114.25 132.4 56.15 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.205 0.526 . . . . 0.0 111.874 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.89 171.66 14.17 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.868 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.525 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.1 m -79.63 150.7 30.91 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -72.73 -9.23 58.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.347 0.594 . . . . 0.0 110.97 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.57 -14.92 12.62 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.975 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.6 m -84.69 -46.64 11.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.417 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.6 -42.09 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.943 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.1 mt -63.14 -42.35 96.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.629 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -77.43 -1.92 32.66 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.402 0.62 . . . . 0.0 109.939 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -104.99 -23.69 12.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.205 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.49 -7.3 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -97.85 0.05 45.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.546 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -139.55 -56.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.83 -65.86 0.94 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.271 0.558 . . . . 0.0 111.132 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.38 136.57 5.27 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.406 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 6.0 t-80 -83.31 52.73 2.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.527 0.68 . . . . 0.0 109.542 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -147.24 156.17 42.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.266 -174.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.32 123.35 75.1 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.62 -24.15 69.83 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.955 2.437 . . . . 0.0 114.428 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.59 -48.66 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -118.78 5.79 11.51 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.979 -0.451 . . . . 0.0 111.653 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 57.47 33.08 22.79 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.437 0.695 . . . . 0.0 112.807 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -87.27 145.18 26.47 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.491 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.21 121.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.59 130.27 56.29 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.105 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.54 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 5.7 mp -109.38 146.87 33.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.18 -33.51 73.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.489 0.716 . . . . 0.0 109.651 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.517 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.8 mm100 -77.67 -14.7 59.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.847 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.55 137.56 48.16 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 120.744 0.306 . . . . 0.0 110.41 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -71.9 163.13 69.27 Favored Pre-proline 0 C--O 1.246 0.918 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.285 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -60.55 145.67 98.37 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.441 2.094 . . . . 0.0 111.552 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 18' ' ' GLU . 6.6 p-10 -70.38 148.62 48.2 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.962 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -91.86 -8.52 46.25 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.097 0.475 . . . . 0.0 110.778 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -64.85 -47.15 78.95 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.129 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.09 100.18 12.46 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.961 0.41 . . . . 0.0 111.348 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 N--CA 1.44 -0.945 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.868 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.67 151.03 63.6 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.585 2.19 . . . . 0.0 111.721 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.69 115.16 27.42 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.54 -51.15 0.58 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.8 m -133.35 149.41 51.88 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.707 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -88.62 -4.43 58.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 117.92 -1.512 . . . . 0.0 110.663 177.421 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -75.84 78.76 2.76 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 166.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.04 128.5 22.78 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.941 -170.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 t -92.78 113.65 60.26 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.79 -18.92 63.9 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.599 2.199 . . . . 0.0 113.575 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.2 -43.91 91.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.839 0.352 . . . . 0.0 111.181 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.9 p -101.7 -21.22 14.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.798 0.332 . . . . 0.0 111.325 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt 59.51 23.03 11.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.001 0.92 . . . . 0.0 111.907 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.8 mtm -95.32 -68.54 0.8 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.672 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.74 -165.59 0.32 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.06 124.08 47.05 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.35 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 8.8 tpt180 -78.4 -61.13 2.1 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.169 174.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 69.9 mm-40 -108.42 -15.05 14.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.338 -176.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.91 73.87 0.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.959 0.787 . . . . 0.0 112.335 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.32 116.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.538 0.685 . . . . 0.0 110.684 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -81.2 139.95 35.22 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.004 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 p -98.46 158.67 32.19 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.7 -34.63 91.27 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.092 2.528 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -15.34 61.93 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.47 42.18 3.01 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.715 -0.755 . . . . 0.0 114.006 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -127.47 141.13 51.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.12 136.86 42.96 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.119 0.485 . . . . 0.0 111.6 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -133.68 173.3 11.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.651 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.589 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.4 m -86.03 149.63 25.03 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 66.0 tttm -68.51 -12.2 60.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.37 0.668 . . . . 0.0 111.606 -176.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.25 -5.62 12.99 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.992 0.425 . . . . 0.0 110.143 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 79.5 m -92.59 -58.68 2.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.625 175.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -65.93 -42.43 91.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.836 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.616 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.1 mt -63.51 -43.19 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.674 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -80.34 -1.5 41.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.599 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -105.54 -20.09 13.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.9 pt -102.1 -19.83 5.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.953 -175.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.8 ptm180 -100.87 2.79 41.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.614 0.721 . . . . 0.0 110.254 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -115.96 -46.57 2.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.78 -70.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 0.0 110.466 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.54 155.27 26.35 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 62.3 m80 -80.1 68.58 6.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.963 0.887 . . . . 0.0 112.358 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.27 153.89 34.64 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.02 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.5 p -79.35 123.42 84.53 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.786 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.18 -21.41 67.6 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.142 2.562 . . . . 0.0 113.942 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.2 m -78.54 -52.55 15.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -112.03 4.85 18.35 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 57.73 35.26 25.39 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.456 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 62.3 mm-40 -94.51 148.26 22.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.41 121.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.35 127.43 49.77 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.013 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.6 mm? -106.28 150.34 26.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.475 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.69 -37.97 89.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.3 -27.41 67.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.818 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.6 mm100 -73.75 -8.47 56.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 -174.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.7 mt -70.01 137.69 51.57 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.171 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.74 120.18 42.94 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.166 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.01 158.02 58.01 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.434 2.089 . . . . 0.0 111.663 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.426 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 5.8 p-10 -79.71 12.14 2.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.922 0.391 . . . . 0.0 110.412 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -65.99 -0.86 2.59 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.681 1.192 . . . . 0.0 112.945 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.426 ' CE2' ' HA ' ' A' ' 59' ' ' ASP . 43.5 p90 -63.09 -26.76 68.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.665 0.745 . . . . 0.0 109.47 170.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.79 135.86 48.16 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 CA-C-O 117.995 -1.002 . . . . 0.0 108.524 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.566 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.29 145.44 43.46 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 121.857 1.705 . . . . 0.0 111.917 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.52 -44.06 92.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.0 -163.49 54.6 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.919 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.6 m -126.87 154.64 44.13 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 65.5 2.65 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -175.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.8 m-85 -111.58 17.63 19.82 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 170.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -116.9 131.66 56.9 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 113.481 -1.691 . . . . 0.0 108.882 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.2 t -69.01 113.83 19.1 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.43 -18.19 54.51 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.192 2.595 . . . . 0.0 112.271 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.8 mt -66.62 -44.39 89.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.106 0.479 . . . . 0.0 111.134 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 p -105.24 -20.84 13.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.09 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp 62.94 22.94 13.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 111.516 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -103.93 -68.12 0.86 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.67 -167.27 1.08 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 98.3 mt -113.98 132.29 56.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB3' ' H ' ' A' ' 30' ' ' LYS . 27.9 tpt180 -69.09 -77.42 0.08 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.1 5.6 20.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 171.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 56.54 80.78 0.14 Allowed 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.612 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.1 m -90.9 116.24 31.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.783 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.08 130.12 34.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.643 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.3 p -89.56 155.96 48.09 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.88 -23.14 75.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.735 2.29 . . . . 0.0 112.754 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.522 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 5.0 p -77.94 -20.14 53.31 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.4 39.93 2.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.151 -1.024 . . . . 0.0 114.142 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.522 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 88.3 m-70 -122.51 155.37 36.36 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -124.38 131.09 53.5 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.21 177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -134.16 172.85 12.28 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.871 0.469 . . . . 0.0 110.891 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.433 ' O ' HG22 ' A' ' 33' ' ' ILE . 63.6 m -72.09 160.08 33.08 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.732 169.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' O ' HD12 ' A' ' 34' ' ' ILE . 89.2 tttt -82.63 -1.07 49.94 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.99 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.4 -40.07 3.48 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.319 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.7 m -62.26 -50.07 73.18 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -69.34 -42.36 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.556 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.8 mt -63.53 -43.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 111.575 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -78.0 -0.37 27.57 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.578 0.704 . . . . 0.0 109.553 -174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 t -105.25 -26.16 12.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.748 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.9 pt -104.24 -14.01 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -93.39 -6.96 45.98 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.5 174.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -115.74 -56.8 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.71 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.27 -66.1 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.986 0.422 . . . . 0.0 110.048 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.02 165.54 38.7 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -87.6 69.2 9.7 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.497 0.665 . . . . 0.0 111.759 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -147.17 154.61 41.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.228 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 29.7 m -62.14 131.74 93.59 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.75 -24.37 61.97 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.235 1.957 . . . . 0.0 111.505 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.53 -70.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.234 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -97.46 6.17 48.58 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -172.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 9.2 p30 54.33 16.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 174.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.54 151.33 45.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.3 120.47 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -120.93 122.03 39.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.514 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.67 138.91 34.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.65 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.4 -41.13 96.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.835 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -74.99 -12.7 60.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.205 0.526 . . . . 0.0 111.317 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -82.19 -10.17 59.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.246 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.35 130.98 38.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -137.86 135.02 18.41 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 32.0 Cg_exo -61.74 141.04 89.19 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.205 1.936 . . . . 0.0 112.441 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.59 -38.78 87.75 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.53 0.732 . . . . 0.0 110.027 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -103.99 -176.7 3.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.087 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -142.61 157.13 45.01 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.983 0.42 . . . . 0.0 111.177 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.87 146.24 37.24 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.164 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -56.14 -39.87 88.49 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.051 2.5 . . . . 0.0 111.776 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.4 tp -103.88 129.21 51.36 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.89 101.72 0.57 Allowed Glycine 0 N--CA 1.445 -0.763 0 O-C-N 123.618 0.574 . . . . 0.0 112.319 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -150.79 153.69 35.93 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -113.63 86.57 2.42 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.936 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 86.3 m-85 -110.1 13.85 23.09 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.469 173.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -94.9 126.67 40.38 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.364 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' HD23 ' A' ' 16' ' ' LEU . 41.3 t -83.44 112.35 38.67 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.13 -20.01 65.96 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 122.42 2.08 . . . . 0.0 112.513 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.26 -44.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.532 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -119.15 -2.42 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.8 mt 53.8 27.3 6.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.093 0.957 . . . . 0.0 112.053 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 73.3 mtm -111.67 174.16 6.0 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.724 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 7' ' ' TYR . . . -67.16 149.95 49.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.359 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 9' ' ' CYS . 89.3 mt -70.28 109.86 4.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -65.56 -46.22 80.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 57.6 mm-40 -116.49 -15.51 10.88 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.079 -176.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 47.81 72.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.053 0.941 . . . . 0.0 113.164 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.79 116.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.363 0.602 . . . . 0.0 110.674 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 22' ' ' THR . 9.6 tt0 -82.13 136.61 35.13 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.965 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 32.3 p -84.29 163.62 46.9 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.81 -36.47 95.37 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.694 2.262 . . . . 0.0 112.508 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.511 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 5.0 p -65.68 -21.74 66.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.812 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.5 38.07 3.83 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.102 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -115.54 143.06 45.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.01 130.28 53.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.746 0.307 . . . . 0.0 111.267 -173.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -139.65 162.83 34.15 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.641 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.63 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 47.1 m -78.39 147.8 33.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.3 tttt -68.83 -10.25 55.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -174.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 -13.29 13.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.63 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.5 m -85.64 -45.16 11.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.694 173.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -65.58 -39.98 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.75 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.86 -41.38 92.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.164 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.08 -2.25 33.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.355 0.598 . . . . 0.0 109.944 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 m -105.68 -21.3 13.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.0 pt -103.12 -8.64 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.559 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.54 -2.27 45.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.085 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -116.78 -55.51 2.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.073 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.63 -64.79 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.42 -175.08 41.25 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -80.42 80.77 6.8 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.546 0.689 . . . . 0.0 111.596 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 20.0 ptpt -148.53 153.29 38.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.556 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 49' ' ' GLU . 4.6 p -76.78 136.01 67.36 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 165.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.98 -20.3 69.05 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 122.848 2.365 . . . . 0.0 114.167 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 47' ' ' ASP . 3.8 m -92.89 -71.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.481 ' H ' HG23 ' A' ' 46' ' ' VAL . 12.8 p-10 -96.14 5.27 51.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.827 0.451 . . . . 0.0 112.052 -174.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.33 0.3 OUTLIER 44.19 56.67 4.71 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.098 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 17.5 pt-20 -94.58 163.52 13.35 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.54 115.33 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 109.504 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.1 tp -115.63 130.08 56.73 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.182 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.456 HD23 HE21 ' A' ' 55' ' ' GLN . 3.9 mm? -113.97 149.4 35.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.307 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.97 -35.84 75.87 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.529 0.518 . . . . 0.0 110.193 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -63.8 -31.28 72.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.776 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.456 HE21 HD23 ' A' ' 52' ' ' LEU . 46.7 mt-30 -78.43 -7.59 57.55 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.45 128.73 36.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.21 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -144.72 124.02 7.03 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 120.963 0.411 . . . . 0.0 111.396 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.09 145.58 44.77 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.839 1.693 . . . . 0.0 111.133 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.76 -35.36 79.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.089 0.471 . . . . 0.0 109.732 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -96.03 103.11 14.98 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 172.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.92 120.28 17.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.051 0.453 . . . . 0.0 110.894 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.51 154.05 36.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.226 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.828 175.336 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.002 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.96 147.7 94.64 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.462 2.775 . . . . 0.0 112.812 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 57.77 91.28 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.431 1.092 . . . . 0.0 112.896 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.05 106.59 0.27 Allowed Glycine 0 N--CA 1.431 -1.645 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.512 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.9 m -79.61 -7.16 58.35 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.186 0.517 . . . . 0.0 110.727 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -66.86 149.63 50.32 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -97.05 120.04 36.66 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -139.94 135.68 33.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.95 108.01 11.2 Favored Pre-proline 0 N--CA 1.436 -1.136 0 O-C-N 123.657 0.598 . . . . 0.0 109.764 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HG3' HG13 ' A' ' 46' ' ' VAL . 58.5 Cg_endo -69.64 -17.86 37.87 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.948 2.432 . . . . 0.0 111.789 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.77 -43.77 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.1 p -99.72 -20.19 16.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.99 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 61.87 21.76 12.52 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.729 0.811 . . . . 0.0 111.883 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.68 -71.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.704 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.22 -166.49 0.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.16 105.04 17.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -70.47 -57.01 5.25 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 63.8 mm-40 -103.42 -16.41 15.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.006 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.55 61.51 3.16 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -93.04 118.23 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.188 0.518 . . . . 0.0 111.374 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 65.3 tt0 -75.51 134.44 40.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.947 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -99.96 159.17 30.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.766 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.89 -23.77 68.24 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.749 2.299 . . . . 0.0 113.113 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -73.11 -28.61 62.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.379 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.64 38.75 1.16 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -133.28 162.02 32.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 80.2 mtp180 -127.98 140.12 52.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -136.13 173.9 11.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 20.1 m -84.91 148.23 26.35 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 87.9 tttt -79.33 -3.58 46.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.593 0.711 . . . . 0.0 110.324 -174.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.61 -12.55 13.41 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.6 m -94.09 -54.22 3.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.777 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -66.03 -38.57 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 86.9 mt -62.8 -42.99 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.663 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.95 -2.52 40.45 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.611 0.719 . . . . 0.0 110.48 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -105.43 -16.47 14.72 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.965 -0.459 . . . . 0.0 110.618 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.661 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -104.09 -24.18 4.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.559 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -97.42 1.04 48.77 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.813 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -116.4 -56.02 2.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.564 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.26 -66.71 0.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.467 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -169.1 159.1 32.0 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 64.0 m80 -85.45 75.64 10.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.285 0.543 . . . . 0.0 110.871 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -153.76 155.19 35.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.498 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 3.1 p -80.71 130.91 62.35 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -31.55 85.61 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.782 2.321 . . . . 0.0 114.775 -172.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 10' ' ' PRO . 16.0 m -78.87 -53.28 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -106.05 3.5 28.26 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 m120 52.82 40.18 30.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.15 146.22 24.02 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 mm -66.65 120.58 14.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.373 0.606 . . . . 0.0 109.909 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.6 tp -124.42 118.05 25.81 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.801 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.565 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -96.05 161.42 13.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.91 -37.39 87.48 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.806 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.89 -24.02 64.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 111.247 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.565 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.7 mm100 -76.38 -10.78 59.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.665 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.37 147.47 46.22 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.168 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -55.13 115.23 8.6 Favored Pre-proline 0 C--O 1.237 0.438 0 O-C-N 123.775 0.672 . . . . 0.0 110.332 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.81 143.68 46.42 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.111 1.874 . . . . 0.0 111.759 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -97.81 115.21 27.59 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -62.85 -44.33 96.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -157.13 129.23 7.25 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.5 103.09 4.71 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.246 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.952 -176.401 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.938 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.99 -30.63 83.51 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.669 2.246 . . . . 0.0 112.114 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.1 tp -133.89 91.97 2.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.935 0.398 . . . . 0.0 109.985 173.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.7 -163.39 36.58 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.5 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 72.0 m -130.72 78.94 1.87 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -113.83 129.86 56.54 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.41 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 53.4 m-85 60.97 20.57 10.93 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.45 0.469 . . . . 0.0 111.066 -169.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 42.5 tt0 -124.78 140.89 52.51 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 51.3 t -87.63 108.74 21.8 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 37.3 Cg_exo -61.54 -20.61 69.32 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.478 2.119 . . . . 0.0 111.677 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.462 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 96.5 mt -66.24 -43.47 91.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.034 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.0 m -88.89 -27.49 20.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.182 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.9 mt 56.78 35.21 25.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.073 0.939 . . . . 0.0 108.693 -165.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -139.48 171.28 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.309 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.66 152.48 22.36 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.546 0.529 . . . . 0.0 111.608 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.0 mt -70.85 139.51 50.87 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.997 -177.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -79.12 -72.3 0.4 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.289 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.47 -15.96 20.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.649 0.261 . . . . 0.0 110.911 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.71 102.47 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.957 0.903 . . . . 0.0 113.274 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.8 m -117.15 118.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.411 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 60.6 tt0 -80.41 135.31 36.14 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.768 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -95.77 152.57 39.16 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -26.52 83.27 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.902 2.401 . . . . 0.0 113.823 -173.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 p -79.72 -19.36 49.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.72 48.48 0.68 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.649 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -133.33 152.11 51.91 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 65.2 mtt180 -121.44 136.3 54.97 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.982 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.67 170.0 16.48 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 39.0 m -78.92 153.29 30.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.96 -12.68 61.2 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.77 -31.56 6.1 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.224 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 28.0 m -62.98 -44.61 95.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.588 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.543 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -64.73 -41.12 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.0 mt -63.48 -43.51 98.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.836 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.77 -2.8 44.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.872 0.368 . . . . 0.0 110.539 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.0 t -106.92 -22.8 12.57 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.797 0.332 . . . . 0.0 110.635 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 33' ' ' ILE . 45.7 pt -101.78 -7.91 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.061 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -101.98 6.66 41.32 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.586 167.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.52 -54.89 2.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.186 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -66.11 0.94 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.137 0.494 . . . . 0.0 109.809 176.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -174.65 166.83 38.84 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 49.9 m80 -79.73 77.4 6.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 118.164 0.982 . . . . 0.0 110.83 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.1 ptpt -152.25 149.79 29.09 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.625 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.573 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 2.2 m -68.01 130.54 92.63 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.6 -34.02 94.5 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.262 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.76 -54.95 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.573 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 31.4 p-10 -104.19 4.29 33.81 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.719 -0.613 . . . . 0.0 112.07 -174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 54.96 32.23 17.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.799 0.84 . . . . 0.0 112.739 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 73.7 mm-40 -92.91 142.82 26.88 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.83 120.38 11.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 CA-C-O 121.597 0.713 . . . . 0.0 110.373 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.8 tp -117.14 129.25 55.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.316 -175.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.8 mm? -98.21 148.74 23.3 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.59 -37.24 86.07 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 123.328 0.393 . . . . 0.0 111.882 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -68.37 -19.74 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.534 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 14.1 mm-40 -77.24 -6.62 53.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.23 131.66 45.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -128.61 129.02 23.53 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.492 ' HD2' ' CE1' ' A' ' 61' ' ' PHE . 72.4 Cg_endo -74.35 165.71 31.18 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 122.517 2.145 . . . . 0.0 110.298 165.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.31 -42.25 95.19 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.573 0.702 . . . . 0.0 110.323 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -128.35 137.97 52.16 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.492 ' CE1' ' HD2' ' A' ' 58' ' ' PRO . 94.0 m-85 -88.15 104.02 16.3 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.884 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.98 119.02 25.83 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.572 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.253 1.256 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.18 -176.171 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.027 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.3 139.93 85.67 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.652 2.234 . . . . 0.0 111.578 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.61 -43.53 89.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.635 0.731 . . . . 0.0 110.465 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.21 -89.27 0.15 Allowed Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.5 t -129.66 136.27 49.51 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.135 0.493 . . . . 0.0 110.309 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -145.58 153.59 41.23 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -79.61 81.84 5.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.869 0.842 . . . . 0.0 109.793 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -158.59 139.07 12.55 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.151 -174.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.434 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 39.8 t -78.25 113.83 37.19 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.98 -20.96 64.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.481 2.121 . . . . 0.0 112.895 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.86 -44.34 85.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.094 0.473 . . . . 0.0 111.874 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 20.7 p -101.85 -13.22 17.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.166 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mp 54.09 23.37 4.07 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.996 0.918 . . . . 0.0 111.742 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.7 mtm -100.03 -70.98 0.72 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.687 0.279 . . . . 0.0 111.676 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.89 165.25 5.16 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.6 109.92 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -70.42 -46.12 64.54 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.895 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -115.35 -17.9 11.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.03 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.478 ' HB3' ' H ' ' A' ' 61' ' ' PHE . . . 56.06 81.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.798 -174.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.71 117.37 42.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.601 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.424 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 53.0 tt0 -80.83 140.96 35.13 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.195 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -96.9 156.77 36.07 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 74.9 Cg_exo -54.53 -37.59 90.27 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.966 2.444 . . . . 0.0 112.594 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -64.9 -18.33 65.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.017 0.437 . . . . 0.0 111.903 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.87 4.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.471 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -120.35 152.32 38.02 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -123.07 138.27 54.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.349 0.595 . . . . 0.0 112.439 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -137.3 169.26 18.08 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.329 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.3 m -76.47 151.4 36.47 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.228 171.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.52 -5.78 31.38 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.04 0.447 . . . . 0.0 112.107 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.85 -34.13 5.55 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.93 -0.481 . . . . 0.0 110.279 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.5 m -64.29 -44.8 90.53 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.015 0.436 . . . . 0.0 110.608 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.515 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.1 tp -65.53 -39.91 86.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.169 -176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.2 mt -63.02 -42.35 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.039 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -78.12 -2.3 36.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.785 0.326 . . . . 0.0 110.422 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -105.35 -25.62 12.32 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.003 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.8 pt -103.81 -10.29 9.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.71 -174.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.5 ptm180 -93.47 -14.04 27.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.487 176.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -131.72 -56.33 1.0 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.138 -172.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.02 -66.2 0.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.898 0.38 . . . . 0.0 110.87 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.06 137.32 5.11 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -85.23 43.44 1.01 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.854 0.835 . . . . 0.0 110.244 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -148.05 155.11 41.11 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 12.0 p -75.04 127.03 87.46 Favored Pre-proline 0 C--N 1.318 -0.778 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.192 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.7 -25.27 68.76 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.917 2.411 . . . . 0.0 113.557 -172.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.52 -49.33 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -131.87 12.21 4.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.99 35.32 21.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 73.3 mm-40 -85.03 143.5 28.87 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.322 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -66.81 120.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.7 tp -121.03 126.6 50.3 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.722 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.555 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 1.9 mm? -110.43 148.01 32.88 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.02 -28.82 69.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.689 0.757 . . . . 0.0 109.835 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.96 -30.65 71.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.438 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.555 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.4 mm100 -80.16 -16.37 55.02 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.363 -175.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.4 mt -69.28 131.99 45.75 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' HD2' ' O ' ' A' ' 21' ' ' GLN . 97.0 m-85 -85.19 153.3 59.45 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.48 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.26 153.48 77.89 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.005 2.47 . . . . 0.0 111.953 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -36.19 102.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.031 1.332 . . . . 0.0 113.738 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 21' ' ' GLN . 8.5 m120 -67.22 -45.38 76.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.986 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.478 ' H ' ' HB3' ' A' ' 19' ' ' ALA . 98.6 m-85 -141.49 100.47 3.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.955 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.94 125.61 41.83 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.345 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--N 1.303 -1.421 0 CA-C-O 118.404 -0.808 . . . . 0.0 109.172 -177.476 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.854 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -60.82 144.48 99.56 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 122.869 2.38 . . . . 0.0 112.023 178.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.43 133.69 49.04 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.1 123.28 31.96 Favored Glycine 0 N--CA 1.444 -0.812 0 O-C-N 123.784 0.678 . . . . 0.0 111.726 -178.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 m -127.97 157.5 40.43 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -177.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -65.26 -32.8 74.65 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.437 -177.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.431 ' C ' ' HG ' ' A' ' 16' ' ' LEU . 91.9 m-85 -80.67 61.16 4.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.245 0.545 . . . . 0.0 110.413 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -146.9 122.58 10.51 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.142 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 19.6 p -91.55 134.15 29.88 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.573 175.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.55 -17.52 58.71 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.929 2.419 . . . . 0.0 113.131 -174.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.8 -45.03 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -106.89 -20.08 13.44 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.53 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.25 23.0 6.68 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.843 0.857 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.0 mtm -97.45 -66.61 0.89 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.202 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.72 -172.62 0.9 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.431 ' HG ' ' C ' ' A' ' 7' ' ' TYR . 91.7 mt -105.12 105.36 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.22 174.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -69.91 -44.15 70.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.709 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -125.41 -15.16 6.24 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.633 -175.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HB1' ' HD3' ' A' ' 27' ' ' ARG . . . 49.6 56.24 8.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 30.3 m -77.48 118.22 23.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -75.9 133.32 40.56 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.643 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -106.1 162.58 19.26 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.264 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.23 -36.64 99.07 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 123.294 2.663 . . . . 0.0 112.46 178.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.0 -25.94 64.76 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.932 0.396 . . . . 0.0 111.602 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.31 29.01 4.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.038 177.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -112.58 157.65 20.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 94.8 mtt-85 -124.74 140.48 52.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 110.238 174.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.45 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 88.3 m-85 -134.49 165.56 24.9 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.015 -176.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.5 m -73.84 152.66 40.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 171.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' O ' HD12 ' A' ' 34' ' ' ILE . 57.7 tttp -68.87 -13.23 62.3 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 121.296 0.569 . . . . 0.0 110.778 -174.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.86 -1.22 13.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.218 0.533 . . . . 0.0 110.387 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 89.3 m -90.72 -64.02 1.19 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.421 176.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -68.28 -40.94 83.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.8 mt -63.09 -42.15 95.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 110.336 -178.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.9 tptp -78.7 -1.64 35.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.673 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.1 m -106.9 -19.77 13.53 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.381 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.1 pt -102.99 -31.63 2.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.488 -174.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.6 ptm180 -99.13 4.31 46.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.232 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -115.72 -55.08 2.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.842 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.27 -71.77 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.433 . . . . 0.0 110.184 178.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.24 152.75 23.6 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -79.23 71.58 5.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.434 0.635 . . . . 0.0 112.105 -175.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.3 ptpt -153.36 152.29 30.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.609 178.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.7 m -64.76 124.77 87.29 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 170.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.51 -27.32 70.04 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 121.702 1.601 . . . . 0.0 112.067 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.72 -54.79 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.11 4.97 29.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 54.43 33.91 19.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.3 mm-40 -96.75 141.41 30.0 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.02 121.18 13.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 -176.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.53 132.82 44.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.818 -173.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.455 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -116.43 157.67 24.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.59 -37.41 78.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 109.774 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -65.12 -29.55 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.7 mm100 -77.43 -13.94 59.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.147 -177.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.9 mt -76.14 136.32 39.81 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -73.04 148.01 88.75 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.08 145.78 96.39 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 C-N-CA 122.256 1.97 . . . . 0.0 112.08 -172.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -77.24 90.27 3.72 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 122.002 0.906 . . . . 0.0 109.947 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -143.9 138.22 28.41 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.456 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.06 101.13 8.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.21 0.529 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.81 131.25 42.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.805 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? . . . . . 0 C--N 1.311 -1.096 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.277 178.098 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.13 140.58 78.94 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.312 2.008 . . . . 0.0 111.342 178.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 44.3 64.63 1.25 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 112.673 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.69 117.41 1.79 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.327 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -83.7 96.93 8.86 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.708 0.766 . . . . 0.0 110.69 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -113.1 115.84 28.94 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 55.2 30.57 14.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.037 0.922 . . . . 0.0 109.993 -171.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 43.6 tt0 -127.09 130.72 50.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.217 -1.356 . . . . 0.0 107.382 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 t -75.44 108.07 5.13 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 53.6 Cg_endo -68.23 -17.79 44.96 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.922 2.415 . . . . 0.0 111.983 -177.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.16 -43.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.232 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.3 p -105.92 -13.81 15.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 0.0 111.339 -178.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.65 21.44 5.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 112.011 -177.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -99.83 -69.81 0.75 Allowed 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.45 -167.36 0.2 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.9 mt -94.41 107.07 19.05 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -69.74 -43.83 71.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 64.9 mm-40 -122.61 -14.66 7.71 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.617 -175.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.87 56.44 6.66 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.517 0.727 . . . . 0.0 112.424 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.2 m -83.51 116.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.461 0.648 . . . . 0.0 110.708 178.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -78.78 134.25 37.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.873 -176.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 157.53 36.89 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.76 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.38 -40.28 83.65 Favored 'Trans proline' 0 C--N 1.364 1.342 0 C-N-CA 122.587 2.191 . . . . 0.0 113.323 -177.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 -14.88 61.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.43 36.87 2.97 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.144 173.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -117.26 157.74 25.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.3 mtt180 -123.22 140.38 53.08 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.423 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 98.2 m-85 -132.13 173.07 11.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.263 -177.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.7 m -85.05 148.74 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 38.9 ttpt -73.69 -10.94 60.2 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.351 0.596 . . . . 0.0 111.346 -172.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.49 -4.53 12.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.019 0.438 . . . . 0.0 109.958 177.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 88.2 m -90.02 -60.78 1.84 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 174.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.0 tp -67.1 -40.68 85.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.599 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.4 mt -62.71 -43.03 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.917 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -79.99 1.46 27.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.802 0.811 . . . . 0.0 110.169 -177.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 t -105.44 -24.8 12.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.876 175.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 49.2 pt -103.23 -22.67 4.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -99.26 4.56 46.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.456 174.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -119.37 -57.23 2.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.466 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.95 -68.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.892 0.377 . . . . 0.0 111.598 -177.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -146.03 140.12 8.65 Favored Glycine 0 CA--C 1.502 -0.756 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.483 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 3.7 t-160 -83.32 52.25 2.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.458 0.647 . . . . 0.0 110.488 -172.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -155.32 160.96 41.15 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.672 -174.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.615 ' HB3' HD11 ' A' ' 51' ' ' LEU . 2.6 p -79.16 130.47 69.26 Favored Pre-proline 0 C--N 1.318 -0.764 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.441 173.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.08 -21.05 72.68 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.209 2.606 . . . . 0.0 113.666 -173.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 47' ' ' ASP . 4.0 m -72.58 -70.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 46' ' ' VAL . 46.4 p-10 -103.13 5.56 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.16 33.0 21.1 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 113.179 173.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -83.48 139.99 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.13 121.36 16.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.493 . . . . 0.0 110.476 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 44' ' ' CYS . 83.0 mt -109.58 132.37 54.2 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.314 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 71.4 mt -108.68 143.41 37.81 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -61.17 -36.13 79.0 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.17 0.509 . . . . 0.0 110.266 -179.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -65.05 -31.71 73.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.089 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -86.14 -13.21 47.81 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.041 -176.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 85.4 mt -76.63 124.98 28.45 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 55.3 t80 68.58 141.12 0.07 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 O-C-N 124.187 0.929 . . . . 0.0 110.815 177.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.63 146.41 91.73 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.168 1.912 . . . . 0.0 111.893 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.11 113.52 9.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.593 -176.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -107.47 0.76 23.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.369 178.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -114.53 83.65 1.92 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.093 -176.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.68 -21.58 19.92 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 170.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.78 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.22 177.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -56.08 -41.45 76.78 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.871 2.381 . . . . 0.0 112.72 -178.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.9 tp -129.02 121.64 28.34 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.686 0.279 . . . . 0.0 110.803 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.39 86.04 0.97 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 175.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -137.98 149.34 46.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.031 0.443 . . . . 0.0 111.521 -172.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.639 ' HD3' ' H ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -85.37 7.17 23.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.161 176.168 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.636 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 97.2 m-85 -91.83 10.95 26.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.965 0.888 . . . . 0.0 109.196 171.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -110.1 122.7 48.21 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.607 173.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.87 109.75 4.38 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.8 -19.91 69.8 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.9 2.4 . . . . 0.0 113.407 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.03 -43.97 92.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 121.139 0.495 . . . . 0.0 110.989 179.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.2 p -104.49 -21.4 13.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.791 -177.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.1 mt 59.03 29.37 18.91 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.703 0.801 . . . . 0.0 111.719 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.8 mtm -98.68 -66.87 0.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.174 0.512 . . . . 0.0 110.528 176.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.52 -172.03 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 91.7 mt -91.09 105.81 18.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -69.28 -45.2 70.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.928 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.442 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 71.1 mm-40 -116.3 -15.82 10.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -178.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 88.66 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -117.24 117.59 55.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.243 0.544 . . . . 0.0 110.353 171.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -80.56 139.32 36.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.114 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 p -109.39 158.95 33.15 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.75 -27.0 82.25 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.907 2.405 . . . . 0.0 111.576 176.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.36 -24.96 67.38 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.262 178.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.89 8.17 57.13 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.892 -174.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -92.87 154.0 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -124.36 139.42 53.92 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.794 -0.763 . . . . 0.0 109.197 173.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.52 168.87 18.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.625 -174.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 49.9 m -79.12 151.72 31.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 169.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 34' ' ' ILE . 86.9 tttt -78.36 8.6 4.82 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.721 0.772 . . . . 0.0 111.289 -173.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.64 -38.91 3.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 38.7 m -66.39 -50.06 64.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.069 -178.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -69.12 -40.24 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.071 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.636 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.9 mt -62.94 -42.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.718 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -78.92 0.59 26.77 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.097 -177.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 m -105.37 -23.85 12.77 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.789 176.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.4 pt -103.92 -22.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -104.13 6.17 35.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.798 175.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.47 -53.0 2.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 178.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.73 -71.15 0.52 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.917 0.389 . . . . 0.0 110.362 177.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.57 161.61 35.33 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -80.32 75.55 7.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.721 0.772 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.8 ptpt -151.95 148.85 28.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.729 177.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.0 p -72.37 126.09 91.12 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.99 -22.73 73.96 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 122.326 2.018 . . . . 0.0 112.585 -175.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.18 -50.71 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -135.9 11.79 3.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.44 35.51 9.5 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 173.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 53.6 mt-10 -83.85 145.47 28.62 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -66.5 113.7 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-O 121.241 0.543 . . . . 0.0 110.25 -176.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.9 tp -126.23 123.18 37.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.987 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.568 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.1 mm? -97.61 160.39 14.35 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.11 -38.61 91.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -176.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.01 -17.65 63.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 178.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.568 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 16.2 mm100 -76.3 -8.99 58.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.895 -178.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.7 mt -75.15 126.96 32.1 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -100.2 132.92 21.91 Favored Pre-proline 0 C--N 1.311 -1.098 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.55 153.11 65.52 Favored 'Trans proline' 0 C--N 1.327 -0.595 0 C-N-CA 122.429 2.086 . . . . 0.0 111.088 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -56.01 137.54 50.81 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.243 0.339 . . . . 0.0 110.405 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -99.26 -17.1 18.26 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.419 -175.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -62.21 -47.17 85.63 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 120.938 0.399 . . . . 0.0 110.592 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.12 134.86 40.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.232 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? . . . . . 0 C--N 1.311 -1.103 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.106 -177.589 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.329 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -56.93 -40.81 81.43 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.574 2.183 . . . . 0.0 110.612 177.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.1 tp -143.9 139.8 29.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.82 106.65 0.93 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 172.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.7 m -93.51 119.47 32.62 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 120.901 0.382 . . . . 0.0 111.447 -168.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -67.46 -33.7 75.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.95 176.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -79.51 65.61 4.73 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.867 0.841 . . . . 0.0 110.059 177.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -137.09 146.13 44.75 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.217 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.28 109.61 22.62 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.31 -17.66 54.37 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.805 2.337 . . . . 0.0 112.657 -175.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -65.92 -43.83 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.866 0.365 . . . . 0.0 110.987 177.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.7 p -105.39 -15.63 14.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mp 57.87 22.67 8.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.889 0.876 . . . . 0.0 111.433 -176.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 8.1 mmt -95.03 -66.51 0.91 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.501 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.59 -166.61 0.06 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.69 117.58 34.35 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -67.63 -44.85 77.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 179.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -134.96 -15.03 2.04 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 67.59 88.86 0.11 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.353 1.061 . . . . 0.0 112.847 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.0 m -106.24 117.1 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.174 0.511 . . . . 0.0 111.033 175.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -80.37 132.12 35.72 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.93 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.9 p -95.86 156.15 37.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.31 -29.63 86.36 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.569 2.18 . . . . 0.0 112.767 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.26 -22.91 51.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.659 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.7 51.56 0.65 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.213 -0.994 . . . . 0.0 114.013 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -131.47 161.39 32.63 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 68.9 mtt180 -127.74 136.38 51.45 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 171.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.09 -179.1 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.188 -176.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.5 m -86.7 152.94 22.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 170.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 34' ' ' ILE . 35.9 ttpt -78.65 -1.97 36.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.617 0.723 . . . . 0.0 111.021 -174.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.41 -19.26 10.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 177.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 51.3 m -82.86 -57.8 3.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.331 178.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -67.76 -41.08 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.911 -175.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 81.5 mt -62.9 -42.85 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 111.544 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -78.61 -2.72 40.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.23 0.538 . . . . 0.0 109.647 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -105.97 -21.99 13.01 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 176.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 33' ' ' ILE . 46.3 pt -103.25 -15.56 7.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.175 -177.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.4 ptm180 -99.87 2.27 43.68 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.03 175.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -116.28 -55.76 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.994 -178.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.55 -67.03 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.287 0.565 . . . . 0.0 109.773 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -171.48 159.68 31.43 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -81.72 72.41 8.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -176.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -156.38 148.15 22.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.124 173.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.82 124.47 89.62 Favored Pre-proline 0 N--CA 1.436 -1.14 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.831 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.1 -24.52 76.57 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.092 2.528 . . . . 0.0 113.739 -170.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.7 m -68.87 -47.47 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -119.79 5.58 10.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 m120 58.71 33.56 23.16 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.451 0.701 . . . . 0.0 112.642 177.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -95.78 144.36 26.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.6 mm -66.11 120.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.122 0.487 . . . . 0.0 110.343 -173.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.9 tp -131.18 132.56 44.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -174.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 3.8 mm? -116.58 150.16 38.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.56 -37.03 82.34 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.066 0.546 . . . . 0.0 110.131 -177.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -64.32 -31.73 73.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 12.0 mm100 -76.43 -17.64 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.862 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 95.8 mt -76.1 137.25 40.01 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.257 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -159.09 150.94 17.07 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 176.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 83.2 Cg_endo -79.56 -166.4 0.41 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.304 2.669 . . . . 0.0 111.563 175.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -74.12 91.71 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.249 0.547 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -99.09 12.86 34.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.691 178.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.38 -39.44 90.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.832 -177.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.18 136.23 46.92 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? . . . . . 0 C--N 1.309 -1.161 0 CA-C-O 118.371 -0.823 . . . . 0.0 109.617 -179.164 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -60.12 146.98 94.97 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.305 2.67 . . . . 0.0 112.802 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.9 tp 55.11 68.03 0.93 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.964 0.906 . . . . 0.0 111.536 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.93 -86.68 0.14 Allowed Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.025 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t -62.74 -41.9 99.41 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.133 0.573 . . . . 0.0 110.606 -178.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -86.03 122.75 30.5 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -79.7 100.84 8.07 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -164.72 136.38 4.37 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.569 -170.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 41.8 t -75.85 114.66 38.99 Favored Pre-proline 0 N--CA 1.438 -1.035 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.1 -19.4 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.121 1.881 . . . . 0.0 113.224 -177.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -67.96 -44.33 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 14.4 p -100.28 -24.62 14.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.079 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp 65.1 21.9 12.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.348 0.659 . . . . 0.0 110.866 -176.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.3 mmt -96.4 -70.14 0.73 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.706 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.68 -168.67 0.24 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -176.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.35 122.16 44.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -84.57 -66.38 0.9 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.685 177.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -88.29 -15.64 35.25 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.555 176.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.44 56.3 7.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.659 1.184 . . . . 0.0 112.297 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.4 m -80.88 116.56 25.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.251 0.548 . . . . 0.0 111.636 -175.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 22' ' ' THR . 26.7 tt0 -81.4 131.52 35.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.206 176.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 21' ' ' GLN . 82.3 p -83.82 159.18 61.04 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD2' ' CD2' ' A' ' 51' ' ' LEU . 31.7 Cg_endo -61.17 -24.26 78.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.072 1.848 . . . . 0.0 111.978 178.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -76.48 -15.92 59.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.857 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 33.93 5.63 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.472 178.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -119.96 150.77 39.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -122.13 139.79 53.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' O ' HG22 ' A' ' 20' ' ' VAL . 85.5 m-85 -142.88 172.06 13.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.677 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.6 m -84.05 153.62 23.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.51 -14.07 62.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.143 0.497 . . . . 0.0 112.054 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.18 1.4 15.24 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.804 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 57.9 m -95.81 -56.44 2.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.669 172.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.5 tp -66.81 -41.88 88.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.747 -177.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.435 ' HA ' HG12 ' A' ' 37' ' ' ILE . 76.5 mt -63.39 -41.58 93.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 111.915 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -77.46 -2.73 36.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.484 0.659 . . . . 0.0 109.395 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.94 -17.72 14.11 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.408 177.093 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 42' ' ' HIS . 38.2 pt -106.49 -11.73 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -175.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -95.21 -10.91 29.05 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.222 -178.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.7 -45.88 2.87 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.927 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.88 -76.65 0.16 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.32 158.6 31.6 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 177.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.513 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 55.1 m80 -83.56 67.48 9.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.628 0.727 . . . . 0.0 111.61 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -143.18 150.77 39.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.436 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.1 p -83.22 124.33 76.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.79 -28.18 81.45 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.728 2.285 . . . . 0.0 113.449 -171.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -69.58 -45.45 78.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -120.17 5.56 10.78 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 57.98 33.15 22.88 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 175.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -95.57 146.21 24.63 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 177.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.94 120.74 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD12 HD13 ' A' ' 37' ' ' ILE . 3.3 tm? -121.76 126.75 49.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.11 -172.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.52 148.75 31.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.543 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.05 -41.04 95.52 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.639 1.176 . . . . 0.0 112.983 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -87.12 -0.61 56.95 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.363 -176.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -87.31 -7.86 57.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.691 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 96.0 mt -73.44 140.9 46.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.224 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -113.18 94.5 30.92 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.24 -41.96 67.93 Favored 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 122.533 2.155 . . . . 0.0 112.218 175.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -140.45 96.87 3.1 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.103 -178.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -111.59 3.39 17.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.386 0.612 . . . . 0.0 111.203 176.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.98 105.27 12.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 176.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -164.44 169.83 16.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.608 -176.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? . . . . . 0 N--CA 1.443 -0.817 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.854 177.161 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -55.73 -41.13 80.62 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.003 2.469 . . . . 0.0 112.451 -177.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.11 128.34 35.92 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.073 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.44 -49.15 66.97 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.047 -178.259 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -78.33 151.95 32.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -86.55 79.92 8.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.391 0.615 . . . . 0.0 111.513 -175.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.531 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 92.0 m-85 -111.86 15.28 20.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.554 171.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.99 147.84 28.98 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.336 -178.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.496 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 45.8 t -118.92 108.9 40.13 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.46 -21.52 72.13 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 122.589 2.193 . . . . 0.0 112.653 -171.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.49 -44.14 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.791 177.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 19.5 p -106.67 -17.9 14.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt 57.08 33.52 23.46 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.112 0.965 . . . . 0.0 111.885 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -121.35 -77.02 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.328 177.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.6 158.47 2.75 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.774 0.43 . . . . 0.0 110.014 -179.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 96.0 mt -71.82 105.22 3.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.692 0.282 . . . . 0.0 110.853 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -70.65 -44.8 66.38 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 178.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -112.86 -16.87 12.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.644 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.0 80.72 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.97 116.47 47.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 110.326 174.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -81.01 136.11 35.94 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.411 -177.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -103.13 154.34 37.7 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.77 -29.35 85.56 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.051 2.501 . . . . 0.0 112.839 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.7 p -69.1 -15.59 63.47 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.51 11.41 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.172 177.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -114.22 155.78 25.5 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 122.571 -0.37 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -126.49 136.54 52.74 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.48 167.92 20.18 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.206 0.316 . . . . 0.0 110.814 -176.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 58.2 m -80.63 156.19 26.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.256 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.8 tttt -69.48 -12.65 61.82 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.966 -173.473 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.07 -20.56 10.94 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.156 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 98.1 m -72.1 -54.1 10.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.845 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -67.97 -39.85 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.247 -175.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 88.0 mt -62.73 -42.8 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.663 0.268 . . . . 0.0 111.131 -178.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -78.87 -0.83 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.464 0.649 . . . . 0.0 110.372 -177.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -103.61 -25.45 13.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.323 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.0 pt -103.05 -7.32 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.452 -177.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.6 ptm180 -100.94 -2.84 30.82 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.7 -52.74 2.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.707 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.97 -69.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.079 0.466 . . . . 0.0 110.241 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -176.82 167.29 38.59 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 177.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -81.5 67.16 7.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.809 0.814 . . . . 0.0 111.616 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -148.08 157.66 43.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.339 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 50.4 t -64.9 127.22 92.48 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.44 -26.53 70.58 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.388 2.058 . . . . 0.0 112.449 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.77 -71.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -98.28 5.63 48.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -174.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 12.6 m120 57.31 33.47 23.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.875 0.87 . . . . 0.0 113.151 173.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -86.44 148.58 25.49 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.5 mp -66.19 122.56 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 110.322 -173.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.4 tp -122.24 125.74 46.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -174.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.47 152.43 18.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 177.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.68 -36.82 84.73 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.909 -173.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -71.16 -11.96 61.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.861 0.363 . . . . 0.0 111.483 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.44 -8.23 59.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.452 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 88.0 mt -76.59 79.22 3.26 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.12 0.262 . . . . 0.0 110.911 -177.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 26.1 t80 168.5 142.87 0.06 OUTLIER Pre-proline 0 C--O 1.234 0.288 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.58 162.03 40.93 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.518 2.146 . . . . 0.0 111.286 175.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.09 114.67 2.47 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.174 0.511 . . . . 0.0 111.264 -176.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -95.65 0.98 53.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.36 -178.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -61.92 -46.43 89.39 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.4 143.94 51.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.255 175.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.126 177.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -56.24 -45.93 34.35 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.365 2.043 . . . . 0.0 111.361 177.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 mp -138.26 -61.61 0.6 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.83 115.23 0.61 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 175.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.4 t -158.15 155.79 29.74 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 117.136 0.468 . . . . 0.0 110.543 -176.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -76.72 -7.62 55.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.554 0.693 . . . . 0.0 110.043 176.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -81.98 49.94 1.47 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.512 178.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -139.23 146.46 40.49 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.581 -176.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB2' HD23 ' A' ' 16' ' ' LEU . 40.9 t -89.78 108.05 22.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.7 Cg_exo -63.37 -20.47 70.29 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.743 2.296 . . . . 0.0 112.839 -177.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -66.57 -44.45 90.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.609 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 p -102.07 -20.26 14.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.7 mt 59.1 22.02 10.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.096 0.959 . . . . 0.0 112.848 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.6 mtm -98.19 -65.69 0.95 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.485 176.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.51 -169.82 0.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.472 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.5 mt -100.44 108.47 20.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.43 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 3.3 tpm_? -69.83 -42.34 73.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 43.6 mt-10 -118.29 -15.52 9.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 -177.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.93 82.17 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 57' ' ' PHE . 19.6 m -115.97 114.88 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.299 0.571 . . . . 0.0 110.661 176.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.56 129.49 34.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.307 176.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.4 p -77.96 168.21 29.48 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.125 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.4 -28.77 81.81 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.556 2.17 . . . . 0.0 111.731 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB2' ' OE1' ' A' ' 49' ' ' GLU . 27.6 p -84.5 -21.53 30.55 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.675 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.42 4.22 22.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.792 177.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -88.65 149.68 23.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.209 0.504 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -116.77 136.32 53.05 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.673 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.7 m-85 -139.86 170.01 16.66 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 28.3 m -83.26 147.65 27.85 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 3.5 ttpm? -69.36 -7.76 40.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -173.02 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.88 -16.62 12.68 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.708 -178.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 46.0 m -82.52 -46.28 13.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 174.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -68.58 -41.66 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 91.3 mt -63.06 -41.83 94.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.0 111.707 -178.205 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -77.66 -1.81 32.85 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.869 -177.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 m -106.15 -20.84 13.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.433 HD11 ' HG2' ' A' ' 53' ' ' GLU . 37.7 pt -102.99 -9.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.967 -176.143 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.1 ptm180 -99.04 7.81 45.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.12 0.962 . . . . 0.0 108.533 167.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -114.94 -56.03 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.361 -179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.3 -70.07 0.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.163 176.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.04 172.88 40.36 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.487 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 74.4 m80 -80.4 69.12 6.8 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.707 0.765 . . . . 0.0 111.525 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 9.6 ptpp? -148.05 152.75 37.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.0 177.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 25.5 p -77.13 128.34 81.21 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.84 -22.24 69.07 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.148 1.899 . . . . 0.0 112.684 -176.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.97 -50.49 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -177.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -138.84 17.23 2.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.79 33.97 17.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.344 1.058 . . . . 0.0 113.654 170.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 56.6 mt-10 -89.12 153.06 21.26 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.712 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.4 121.82 15.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 111.302 -175.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 6.5 tt -120.6 126.27 49.85 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.131 -176.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.62 139.61 45.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.429 178.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HG2' HD11 ' A' ' 37' ' ' ILE . 77.8 mt-10 -65.46 -42.8 91.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.426 -174.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -69.33 -23.43 63.78 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.8 mm-40 -74.92 -14.87 60.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.482 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.05 145.65 44.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.458 ' O ' HG12 ' A' ' 20' ' ' VAL . 90.9 m-85 -83.31 127.29 69.28 Favored Pre-proline 0 C--N 1.313 -0.981 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -55.55 -40.57 84.66 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 122.541 2.161 . . . . 0.0 112.825 -178.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.71 -67.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.296 1.439 . . . . 0.0 111.418 -175.072 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -87.96 104.86 17.02 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.78 0.8 . . . . 0.0 109.632 174.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -98.15 129.8 44.93 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.099 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.12 140.82 58.91 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.29 0.567 . . . . 0.0 111.921 -174.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.874 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.962 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.378 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.52 148.32 78.52 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.344 2.029 . . . . 0.0 110.866 178.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.87 127.08 41.58 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.371 0.605 . . . . 0.0 110.925 -173.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.92 47.82 0.38 Allowed Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 177.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.9 m -82.01 158.45 23.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.353 -0.423 . . . . 0.0 110.993 -175.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -82.27 14.21 3.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.22 0.533 . . . . 0.0 111.826 -178.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -97.82 25.68 5.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.081 178.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -93.98 138.84 31.65 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.836 -179.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.3 t -93.62 111.34 52.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.13 -19.54 50.93 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.435 2.09 . . . . 0.0 113.678 -174.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.27 -44.84 83.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.8 p -103.73 -21.49 13.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.021 -174.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp 65.41 21.29 11.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.349 1.06 . . . . 0.0 110.617 -175.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.4 mmt -95.52 -75.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -179.31 162.58 1.18 Allowed 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 9' ' ' CYS . 92.5 mt -79.75 103.37 9.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -71.18 -44.94 64.48 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.656 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -112.4 -17.17 12.76 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.94 -177.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 45.13 73.31 0.16 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 m -93.59 117.57 37.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.953 175.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.28 142.0 34.98 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.04 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -108.96 168.21 8.06 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 177.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.85 -33.32 94.44 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 123.042 2.494 . . . . 0.0 113.031 -176.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 p -74.68 -14.55 60.76 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.961 0.41 . . . . 0.0 111.852 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.46 1.0 50.27 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.372 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -79.26 146.72 32.85 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.54 -0.388 . . . . 0.0 110.603 178.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -122.59 138.44 54.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.481 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 91.1 m-85 -140.91 170.13 16.32 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.186 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -81.1 159.24 24.77 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 34' ' ' ILE . 7.1 ttpm? -68.94 -11.37 60.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.438 0.637 . . . . 0.0 111.169 -176.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.94 -16.75 12.14 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.823 -179.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.9 m -83.91 -51.7 6.95 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.481 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 10.9 tp -69.26 -39.29 78.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.771 -178.082 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 85.1 mt -62.85 -42.5 96.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -79.53 9.51 4.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 178.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 m -109.6 -25.99 10.15 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.723 170.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.1 pt -103.96 -27.67 3.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -173.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.2 ptm180 -100.1 2.89 43.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.705 0.764 . . . . 0.0 108.957 175.097 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -116.05 -56.54 2.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.765 -171.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.88 -69.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.085 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.43 159.89 33.31 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.848 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -79.03 67.52 4.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.7 pttm -152.72 150.26 29.24 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.949 173.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.4 p -79.73 124.48 83.49 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.549 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.91 -28.68 75.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.929 2.42 . . . . 0.0 114.69 -168.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.72 -48.19 83.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -119.06 6.4 11.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 51.74 40.02 26.66 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.564 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 66.5 mm-40 -89.87 138.37 31.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.38 121.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -121.79 128.92 52.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.457 -173.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.03 150.47 27.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.487 ' HA ' HD13 ' A' ' 56' ' ' LEU . 55.0 mp0 -59.59 -37.0 77.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.896 0.379 . . . . 0.0 111.114 -174.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -65.39 -28.73 69.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 179.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -66.79 -21.64 66.04 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.848 179.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 53' ' ' GLU . 8.8 mp -68.59 126.69 30.48 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -89.2 163.62 33.46 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.463 -176.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.17 151.69 77.08 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.893 2.395 . . . . 0.0 110.546 176.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.83 138.55 47.97 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.317 0.58 . . . . 0.0 111.107 -173.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.04 -10.25 59.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.329 -175.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -75.03 140.93 43.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.101 0.477 . . . . 0.0 110.502 179.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.51 146.57 26.91 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--N 1.31 -1.147 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.069 -178.543 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.619 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.08 -42.37 23.78 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 113.177 -178.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.2 tp -66.74 -43.25 84.67 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.068 0.461 . . . . 0.0 110.937 177.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.6 -179.57 48.68 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 p -113.2 1.5 15.26 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 117.217 0.508 . . . . 0.0 111.689 178.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -78.59 138.51 38.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.561 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 95.3 m-85 73.35 12.51 4.77 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.338 1.055 . . . . 0.0 110.49 -172.004 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -120.4 127.33 52.19 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.7 t -66.32 110.19 4.41 Favored Pre-proline 0 N--CA 1.444 -0.747 0 O-C-N 123.73 0.643 . . . . 0.0 109.632 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.54 -18.14 53.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 112.339 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.03 -43.6 92.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.841 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.3 p -106.06 -17.88 14.2 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.15 26.77 12.54 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.714 0.806 . . . . 0.0 112.223 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.3 mtm -98.48 -64.99 0.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.51 175.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.66 -169.14 0.07 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 85.5 mt -94.99 104.51 16.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.6 tpt85 -70.82 -45.89 63.77 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.38 -176.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -110.17 -15.92 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.013 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.39 86.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.271 0.982 . . . . 0.0 112.174 -177.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 29.8 m -115.12 119.81 62.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.37 0.605 . . . . 0.0 111.638 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -80.33 136.0 36.32 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.75 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.479 ' HB ' HD21 ' A' ' 51' ' ' LEU . 31.2 p -98.24 159.34 30.9 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.138 176.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.93 -27.88 85.48 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.373 2.049 . . . . 0.0 112.771 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.63 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 6.6 p -77.61 -26.14 50.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.906 0.384 . . . . 0.0 111.41 178.683 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.52 43.11 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.436 175.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.63 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 57.1 m-70 -130.77 133.58 46.12 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 88.2 mtm180 -104.99 134.35 48.24 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 120.998 0.427 . . . . 0.0 112.062 -178.234 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -135.31 -172.52 3.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.725 -176.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 37.5 m -89.84 151.89 21.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.143 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.91 -12.12 61.38 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 121.028 0.442 . . . . 0.0 111.853 -173.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.85 -18.44 12.27 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.653 -0.654 . . . . 0.0 110.713 -178.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.4 m -79.2 -45.94 18.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.071 0.463 . . . . 0.0 110.333 176.43 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.55 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.7 tp -68.17 -40.49 82.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 C-N-CA 120.439 -0.505 . . . . 0.0 111.605 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.5 mt -63.15 -43.66 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -80.07 -1.64 40.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.299 0.571 . . . . 0.0 111.058 -174.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.2 p -106.5 -18.42 13.98 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 121.831 -0.543 . . . . 0.0 111.242 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.56 -18.47 6.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.127 -177.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -106.33 7.89 31.5 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.018 174.429 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -114.71 -54.3 2.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.291 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -69.47 0.61 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 0.0 109.805 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -167.13 159.43 32.8 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 176.518 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -77.64 67.92 3.63 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.887 0.851 . . . . 0.0 112.036 -179.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.52 150.97 35.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.219 177.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -76.05 129.77 79.87 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.968 177.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -22.54 74.39 Favored 'Trans proline' 0 N--CA 1.478 0.575 0 C-N-CA 122.97 2.447 . . . . 0.0 113.379 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.56 -72.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.208 0.528 . . . . 0.0 111.511 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -104.83 4.26 31.96 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.28 36.18 25.46 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -87.13 151.78 22.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.4 mp -66.07 119.82 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.479 HD21 ' HB ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -119.43 122.37 41.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.137 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -105.1 141.19 37.09 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.61 -39.36 94.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.261 0.553 . . . . 0.0 111.002 -175.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.01 -30.06 71.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.518 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -76.51 -8.01 56.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.08 -176.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 51' ' ' LEU . 96.5 mt -73.81 141.32 46.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.674 0.274 . . . . 0.0 110.836 179.175 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -151.93 148.12 21.06 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.699 178.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.34 146.1 97.62 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.779 2.319 . . . . 0.0 112.194 178.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.59 -42.88 98.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.657 177.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.01 -41.18 91.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.621 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -86.24 118.08 25.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.423 0.63 . . . . 0.0 111.912 -174.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.01 150.58 39.05 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.196 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--N 1.302 -1.499 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 178.699 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.681 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.99 146.78 66.09 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.597 2.198 . . . . 0.0 112.784 -177.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -100.28 117.4 34.4 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.06 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.05 -166.79 52.16 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -174.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.8 m -84.06 109.88 18.02 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 174.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -86.46 104.6 16.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.045 0.45 . . . . 0.0 110.635 -176.091 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -102.34 69.11 1.11 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.64 1.21 . . . . 0.0 110.379 175.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -143.42 129.16 19.32 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.525 -1.671 . . . . 0.0 107.546 -175.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -66.73 112.02 8.47 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 34.7 Cg_exo -61.82 -20.4 69.07 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.726 2.284 . . . . 0.0 112.432 -176.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.6 -43.93 90.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.69 178.348 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.1 p -105.55 -19.09 13.88 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.959 -176.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.5 mt 57.16 23.12 8.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.921 0.888 . . . . 0.0 112.255 -179.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.5 mtm -96.0 -64.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.393 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.89 -165.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -174.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -103.93 125.97 50.71 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -80.18 -73.19 0.37 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.35 178.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -96.33 -16.59 21.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.05 90.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.121 0.968 . . . . 0.0 113.046 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 17.5 m -110.44 115.4 49.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.498 0.666 . . . . 0.0 111.136 175.015 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -82.56 133.49 35.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.662 176.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 39.1 p -93.11 164.99 19.48 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 30.7 Cg_endo -61.78 -26.36 79.5 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.169 1.912 . . . . 0.0 112.144 176.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 35.7 m -70.45 -28.33 64.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.092 0.473 . . . . 0.0 110.488 176.369 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.78 9.86 29.7 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.916 -177.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 24.3 m-70 -88.1 144.35 26.54 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -111.68 130.79 55.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.94 176.17 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.47 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 99.2 m-85 -132.07 172.72 12.02 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.559 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.471 ' O ' HG22 ' A' ' 33' ' ' ILE . 59.7 m -82.99 150.27 26.48 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.12 -8.63 55.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.424 0.63 . . . . 0.0 110.496 -175.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.67 -29.96 7.26 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 69.1 m -70.08 -46.06 65.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.03 175.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.482 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.0 tp -68.42 -41.6 83.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.601 -178.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.7 mt -63.61 -42.33 95.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -77.23 -1.94 32.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.416 0.627 . . . . 0.0 110.225 -177.018 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 m -105.88 -25.41 12.15 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.772 174.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 33' ' ' ILE . 46.0 pt -103.49 -9.18 9.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.859 -176.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.6 ptm180 -94.18 2.13 55.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.628 0.728 . . . . 0.0 109.213 174.075 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.35 -55.08 2.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.56 -71.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.396 178.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -178.22 -179.26 48.14 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -89.55 81.22 6.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.24 0.543 . . . . 0.0 112.194 -177.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 9.5 ptpp? -170.55 144.27 2.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.734 175.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.8 p -72.02 123.8 89.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.83 -25.28 74.52 Favored 'Trans proline' 0 N--CA 1.473 0.276 0 C-N-CA 123.031 2.487 . . . . 0.0 113.554 -170.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.61 -46.66 82.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -175.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -124.63 6.69 8.2 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.16 34.21 19.0 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 177.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 69.5 mm-40 -91.17 141.23 29.03 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.908 175.064 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 50' ' ' ILE . 3.1 mp -66.57 121.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.123 0.487 . . . . 0.0 110.234 -174.153 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' H ' ' HA ' ' A' ' 43' ' ' LYS . 64.0 tp -126.85 128.75 47.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.735 -175.623 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.7 mm? -112.27 154.59 25.39 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.43 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -61.62 -37.08 82.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.117 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.93 -30.84 71.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.391 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 17.0 mm-40 -77.79 -9.16 58.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.239 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.62 139.5 45.52 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.669 -178.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -119.6 89.97 42.09 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 58.0 Cg_endo -69.24 141.84 48.51 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 121.917 1.744 . . . . 0.0 112.192 178.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -101.24 117.94 35.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.407 ' HA ' HD22 ' A' ' 60' ' ' ASN . 12.7 m120 -81.56 86.97 6.27 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.658 0.742 . . . . 0.0 112.867 -171.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -69.27 -38.04 78.2 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.46 151.85 26.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.167 175.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.8 pttt . . . . . 0 C--N 1.307 -1.241 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.663 179.238 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.193 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.87 141.0 97.65 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.57 2.18 . . . . 0.0 112.109 -175.677 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.8 tt 51.29 84.85 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.23 1.012 . . . . 0.0 110.252 -175.58 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.52 -55.58 0.6 Allowed Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.309 -179.126 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.0 p -138.76 73.95 1.45 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.667 -0.413 . . . . 0.0 112.112 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -75.87 -33.64 59.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.551 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -85.59 67.79 10.2 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.359 1.076 . . . . 0.0 110.147 173.535 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.56 120.9 35.16 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.098 -175.357 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.539 ' HB2' HD23 ' A' ' 16' ' ' LEU . 33.8 t -77.55 116.17 55.75 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 173.835 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -60.97 -20.86 69.24 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.037 1.825 . . . . 0.0 112.605 -177.225 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.89 -45.05 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.618 0.247 . . . . 0.0 111.376 178.324 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 12.0 p -109.06 -22.26 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.405 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.1 mt 59.23 22.9 11.2 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.245 1.018 . . . . 0.0 112.121 -177.386 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.9 mtm -95.57 -66.46 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.34 176.393 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.08 -172.46 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -178.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.4 mt -107.44 124.98 50.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.684 0.278 . . . . 0.0 110.31 175.199 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 19' ' ' ALA . 22.9 tpt180 -92.76 114.71 27.34 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.253 168.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 68.75 -16.21 0.22 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.594 1.158 . . . . 0.0 112.811 -179.445 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . . . 50.31 82.78 0.05 OUTLIER 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 113.329 177.161 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.2 m -97.01 116.56 39.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.626 0.727 . . . . 0.0 110.474 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.65 142.6 32.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.844 -179.296 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -93.17 163.65 24.35 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.628 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.91 -34.17 96.6 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.701 2.268 . . . . 0.0 111.935 176.6 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.06 -14.47 62.69 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.122 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.82 23.26 18.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.283 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -106.93 129.9 54.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.359 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -106.24 132.95 51.69 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.588 -173.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.23 167.84 19.63 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.455 -176.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.426 ' O ' HG22 ' A' ' 33' ' ' ILE . 85.1 m -71.62 147.82 47.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.753 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -67.88 -4.89 14.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.728 -179.33 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.97 -38.86 3.79 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.167 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.77 -46.1 80.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -66.36 -41.63 89.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.953 -173.96 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.581 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 95.3 mt -63.61 -43.43 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.411 . . . . 0.0 110.128 -178.534 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -79.4 -2.08 40.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.855 -176.086 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 m -106.77 -20.24 13.4 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.649 177.016 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -103.15 -24.03 4.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.226 -174.588 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.2 ptm180 -99.95 7.4 44.84 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.115 176.124 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -115.26 -56.69 2.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.539 -178.336 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.08 -67.64 0.8 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.527 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.05 159.12 32.3 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.093 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.406 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 75.9 m80 -86.29 64.89 8.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.584 0.707 . . . . 0.0 111.916 -176.611 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.1 ptpt -154.44 150.31 27.73 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.34 176.834 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 p -70.33 135.41 86.66 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.886 0.374 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.18 -23.94 75.86 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.101 2.534 . . . . 0.0 114.305 -171.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 m -91.39 -55.46 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.354 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -103.68 4.89 35.93 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.105 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 50.97 33.95 9.78 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.599 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 80.8 mm-40 -86.36 147.0 26.23 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.721 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.59 120.4 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 109.718 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 54.6 tp -120.2 130.59 54.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.223 -174.099 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.12 153.47 28.17 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.43 -36.34 83.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -64.43 -31.02 72.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.681 176.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -77.97 -8.61 58.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.81 131.05 41.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.614 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -75.2 157.58 84.89 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.181 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.68 165.02 21.95 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.126 2.551 . . . . 0.0 111.999 177.55 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -54.26 148.77 10.87 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.661 -174.664 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 29.5 t30 -60.33 -76.42 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.981 -178.467 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -160.23 133.6 6.86 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.493 -175.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.89 98.3 0.73 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.113 0.482 . . . . 0.0 110.134 177.9 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 tptt . . . . . 0 C--N 1.308 -1.196 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.036 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.37 -36.16 86.51 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.584 2.856 . . . . 0.0 113.092 -178.974 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.7 mt -106.45 122.7 46.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 120.942 0.401 . . . . 0.0 110.55 175.819 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.65 -7.38 42.28 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 174.087 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.9 p -85.35 -6.04 59.26 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.438 0.695 . . . . 0.0 111.067 -178.45 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -80.3 178.47 8.26 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.877 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -90.47 85.26 6.1 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.65 0.738 . . . . 0.0 111.314 -171.695 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -169.71 127.46 0.91 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.317 179.318 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . 1.4 p -92.67 134.31 27.98 Favored Pre-proline 0 C--N 1.313 -0.996 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.607 -177.305 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 9' ' ' CYS . 32.3 Cg_exo -59.9 -19.85 56.94 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.869 2.379 . . . . 0.0 112.19 -178.115 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.02 -44.94 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.092 -177.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -120.31 -20.21 7.37 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.253 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt 60.52 27.96 17.62 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.873 0.869 . . . . 0.0 111.908 -173.499 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.1 mtm -103.16 175.34 5.51 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.092 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.22 148.37 49.94 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.505 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.1 mt -78.76 130.43 35.75 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -68.1 -60.28 2.6 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -107.52 -15.05 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -178.263 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.01 90.23 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.792 -177.494 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 116.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.684 0.754 . . . . 0.0 111.368 179.762 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -81.15 136.86 35.94 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.709 177.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.2 p -94.59 160.37 31.66 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -54.71 -37.52 91.6 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 112.525 178.107 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.586 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.0 OUTLIER -70.37 -20.56 62.95 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 178.386 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.8 4.29 24.64 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.442 174.067 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.586 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 77.8 m-70 -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.241 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -101.56 132.58 47.13 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.322 177.084 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 97.5 m-85 -132.71 165.39 24.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.479 179.432 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 38.3 m -80.97 159.52 24.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.037 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.3 tttt -76.8 -12.93 60.05 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.326 -172.043 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.91 -10.95 12.88 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 -179.383 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.5 m -85.45 -57.87 2.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.334 177.787 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -66.77 -41.04 87.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -175.909 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.634 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 90.9 mt -63.24 -43.49 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 111.078 -177.099 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -79.33 -1.47 37.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -176.751 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -104.61 -17.82 14.55 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.32 177.33 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 41.5 pt -104.34 -30.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.923 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.1 ptm180 -96.72 2.39 51.98 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.442 178.113 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -115.9 -54.63 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.302 179.5 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.81 -69.17 0.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 0.0 110.524 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -164.8 155.14 26.37 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 176.893 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -80.04 70.41 6.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.528 0.664 . . . . 0.0 111.686 -177.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.94 152.21 39.85 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.919 178.571 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 52.3 t -74.65 122.95 88.64 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.706 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 51.7 Cg_exo -57.48 -34.25 97.7 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.241 2.627 . . . . 0.0 114.278 -172.066 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 m -83.19 -50.72 15.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -172.472 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -104.68 5.19 33.33 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.66 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.1 32.68 20.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.721 0.808 . . . . 0.0 112.29 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -87.75 149.0 24.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.198 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.84 121.32 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.29 119.68 32.91 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.389 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.632 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -102.54 153.7 19.82 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.08 -178.671 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.41 -40.09 96.26 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.465 0.706 . . . . 0.0 111.532 -174.005 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -68.37 -20.8 64.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.632 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.3 mm100 -75.11 -9.95 59.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.444 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.56 138.58 46.97 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.377 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -113.31 106.87 54.23 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.993 177.433 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.89 155.95 57.16 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.64 2.227 . . . . 0.0 111.676 176.857 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -60.96 134.49 57.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.929 -179.312 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -63.21 -46.2 88.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 -175.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -66.11 -46.06 78.92 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.022 0.439 . . . . 0.0 111.643 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.88 87.51 4.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.387 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp . . . . . 0 C--N 1.315 -0.914 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.907 -173.654 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.245 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.07 152.43 62.46 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.815 2.344 . . . . 0.0 111.606 177.52 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.65 119.39 31.49 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.708 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.73 172.23 48.68 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -176.092 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -109.41 118.88 37.8 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.533 178.616 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -145.9 172.66 13.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.221 -179.457 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.535 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 91.0 m-85 60.67 37.64 19.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -173.984 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -121.69 133.17 54.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.9 -175.443 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.0 t -79.82 109.22 11.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.84 -19.42 65.54 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.863 2.375 . . . . 0.0 112.722 -175.265 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.93 -43.82 92.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.006 0.431 . . . . 0.0 111.26 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.38 -21.05 15.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.789 -177.018 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp 65.94 20.33 11.32 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 111.633 -177.699 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -99.64 -71.03 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.088 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.33 -162.6 0.13 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -174.311 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.2 mt -106.57 125.82 51.48 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.182 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -84.47 -71.35 0.52 Allowed 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.896 175.31 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -89.76 -16.23 30.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.82 178.707 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.89 77.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.252 0.621 . . . . 0.0 111.592 -176.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 21.1 m -92.3 116.8 34.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.042 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.31 129.89 34.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.732 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -92.27 164.9 21.25 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.338 177.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.58 -36.44 94.54 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 112.32 178.265 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 p -70.7 -20.49 62.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.071 -178.135 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.0 6.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.98 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -113.33 154.35 27.0 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.459 -0.436 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 81.9 mtm180 -123.47 137.56 54.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.048 0.452 . . . . 0.0 111.522 -176.321 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' O ' HG22 ' A' ' 20' ' ' VAL . 95.7 m-85 -138.91 172.93 12.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.75 -177.104 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.0 m -84.74 153.85 22.79 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.725 0.298 . . . . 0.0 110.33 175.647 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.15 -14.78 63.24 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.837 0.855 . . . . 0.0 111.886 -176.466 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.78 -13.81 12.01 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.048 -176.766 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 52.5 m -87.84 -47.91 8.24 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.078 177.772 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.1 tp -68.36 -38.51 79.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.8 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 93.8 mt -62.67 -42.43 96.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.425 . . . . 0.0 110.561 -177.769 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 39' ' ' ASP . 29.2 tptp -77.64 -1.66 32.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.806 0.813 . . . . 0.0 109.962 -178.542 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.2 t -105.3 -21.82 13.17 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 121.88 -0.513 . . . . 0.0 109.982 177.009 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.5 pt -104.97 -28.06 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.391 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -96.01 -7.55 36.05 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.708 177.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 38.7 t70 -115.11 -40.95 3.39 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.308 -175.298 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 36' ' ' SER . . . -91.66 -72.94 0.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.969 0.414 . . . . 0.0 110.012 176.587 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.17 157.61 30.14 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -82.82 69.67 9.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.493 0.663 . . . . 0.0 111.979 -176.3 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -150.91 153.11 34.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.796 -179.781 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 p -77.34 133.56 67.81 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.039 171.793 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.07 -23.8 75.99 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 123.015 2.477 . . . . 0.0 114.244 -170.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -90.5 -61.46 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.206 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -100.91 4.22 42.45 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.637 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.33 35.23 25.49 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.046 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 71.2 mm-40 -83.5 150.67 25.85 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -66.71 121.18 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.109 0.48 . . . . 0.0 109.903 -177.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -126.7 129.86 49.25 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.325 -175.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.87 156.49 23.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.622 178.478 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 38' ' ' ARG . 54.6 mp0 -61.23 -39.05 88.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.612 0.365 . . . . 0.0 110.66 -178.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -74.96 -10.2 59.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 0.0 111.407 179.563 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -91.48 -7.76 49.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.026 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 96.5 mt -73.84 155.42 38.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.774 179.059 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 97.2 m-85 80.29 149.4 0.12 Allowed Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.451 1.101 . . . . 0.0 111.728 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.56 148.01 94.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.363 2.042 . . . . 0.0 109.58 173.6 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -57.89 108.67 0.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.0 0.429 . . . . 0.0 111.064 -176.454 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -149.2 133.4 17.34 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.339 176.511 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -122.39 104.58 9.5 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.738 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.09 165.7 30.03 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.128 -174.7 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? . . . . . 0 C--N 1.312 -1.062 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.268 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.469 0.851 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.418 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 39.0 Cg_exo -60.88 139.33 84.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.424 2.082 . . . . 0.0 112.44 -177.626 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.93 -43.02 89.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.496 0.665 . . . . 0.0 110.683 177.596 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.85 74.4 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -178.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.9 p -74.56 101.25 4.14 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -168.248 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -86.16 -5.93 59.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.832 172.644 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.78 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 88.6 t80 -63.91 -16.18 60.82 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.556 170.247 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 44.2 mt-10 -100.3 115.85 30.91 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.466 174.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 16.6 t -56.27 112.95 5.01 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.494 177.697 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' CYS . 32.4 Cg_exo -62.1 -20.95 71.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.7 2.267 . . . . 0.0 112.461 -173.569 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.49 -44.07 90.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.464 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -108.09 -21.25 12.87 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.647 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 56.53 30.23 16.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.824 0.849 . . . . 0.0 111.754 -175.265 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -96.29 -66.91 0.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 173.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . . . -179.53 -172.65 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -176.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 95.5 mt -93.93 103.61 15.7 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.273 174.13 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -66.51 -43.97 83.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.904 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.699 ' HA ' ' ND2' ' A' ' 60' ' ' ASN . 76.3 mm-40 -123.0 -15.02 7.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.797 179.587 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.93 56.54 7.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.203 177.203 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 28' ' ' PHE . 27.3 m -76.84 116.09 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.36 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.401 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 61.0 tt0 -80.6 121.32 25.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.527 -176.438 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -88.8 160.83 43.16 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.55 -30.75 89.56 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.892 2.395 . . . . 0.0 111.625 178.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -14.72 62.89 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.319 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.02 5.07 44.46 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.375 -0.916 . . . . 0.0 114.251 174.518 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.79 168.33 10.56 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.434 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 96.6 mtt180 -127.3 142.22 51.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 112.016 -169.784 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.471 ' O ' HG22 ' A' ' 20' ' ' VAL . 99.2 m-85 -131.42 170.23 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.769 178.583 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 53.3 m -80.19 148.19 30.98 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.555 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -68.62 -13.16 62.17 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -174.414 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.21 -17.8 12.69 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.235 -177.172 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.8 m -79.59 -45.51 19.03 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.665 173.107 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -66.47 -40.95 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.832 -176.641 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.84 -42.63 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 111.006 -179.15 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -78.72 -1.9 36.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.352 0.596 . . . . 0.0 110.149 -174.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 m -105.32 -23.08 12.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.299 177.296 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 43.9 pt -104.76 -5.36 9.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 120.509 -0.476 . . . . 0.0 112.256 -177.784 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -96.82 -15.73 21.15 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.618 176.968 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -116.52 -56.09 2.32 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.145 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.28 -65.79 0.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 110.692 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -165.86 155.36 26.6 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -84.65 54.62 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 122.073 0.94 . . . . 0.0 109.111 -176.204 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -147.44 154.17 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.301 -175.357 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 45.3 t -61.65 123.02 75.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.112 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 50.7 Cg_exo -57.05 -35.82 99.06 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.166 2.577 . . . . 0.0 114.123 -172.042 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -82.67 -45.96 19.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.12 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -114.95 5.57 15.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 56.58 33.45 22.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.337 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -92.2 149.71 21.32 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.209 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.4 121.66 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.074 0.464 . . . . 0.0 110.589 -176.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 tp -126.13 127.81 46.34 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.224 -179.746 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.48 143.91 30.9 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.656 176.78 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.53 -36.59 84.27 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.303 1.041 . . . . 0.0 110.203 -175.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.4 -30.25 71.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.973 177.846 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -64.89 -29.11 70.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.146 0.498 . . . . 0.0 110.884 179.54 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.84 142.11 53.14 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.556 -176.7 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -65.12 143.7 98.9 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.842 -177.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.42 -43.48 51.32 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.956 2.437 . . . . 0.0 112.772 177.173 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -178.93 154.28 0.69 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.782 0.325 . . . . 0.0 111.049 -176.152 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.699 ' ND2' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -116.94 -1.42 11.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.707 0.765 . . . . 0.0 109.19 168.807 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -113.28 122.63 48.01 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.623 -176.764 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.16 128.17 35.7 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.141 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 tttp . . . . . 0 C--O 1.25 1.113 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -176.291 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.069 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.46 150.72 75.78 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.819 2.346 . . . . 0.0 111.54 179.054 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.7 tp -67.18 104.65 1.5 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.083 0.468 . . . . 0.0 111.671 -177.221 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.86 -7.48 23.55 Favored Glycine 0 N--CA 1.44 -1.033 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 175.548 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -72.65 150.36 43.06 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.665 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' O ' ' HD2' ' A' ' 27' ' ' ARG 0.273 21.3 pttm -74.05 67.59 1.31 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.747 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.659 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 94.8 m-85 -119.57 13.77 12.59 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.688 167.095 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -119.25 137.08 53.9 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.975 -179.552 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.488 ' HB2' HD23 ' A' ' 16' ' ' LEU . 41.8 t -83.75 110.81 27.68 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -177.769 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.43 -18.81 49.65 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.069 1.846 . . . . 0.0 112.301 -176.663 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.52 -43.51 90.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 178.874 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 25.4 p -109.83 -6.41 15.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.526 -176.687 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.89 33.19 22.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.902 0.881 . . . . 0.0 111.1 -175.593 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.3 mtm -127.52 167.44 16.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.379 178.893 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.37 151.12 37.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 93.7 mt -69.89 118.35 12.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.867 0.365 . . . . 0.0 110.393 -173.416 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -69.39 -45.62 68.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.323 179.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -116.92 -16.54 10.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.04 87.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.135 0.897 . . . . 0.0 112.737 -178.242 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 28' ' ' PHE . 35.2 m -105.39 117.23 50.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.51 0.672 . . . . 0.0 111.476 176.204 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -73.16 132.54 43.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.137 175.155 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 23' ' ' PRO . 61.8 p -106.29 159.04 31.16 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 178.759 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 35.9 Cg_endo -62.8 -24.41 74.52 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.88 2.386 . . . . 0.0 113.01 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.1 p -79.48 -14.66 58.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 111.203 178.483 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.61 8.36 37.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.566 175.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -99.23 162.05 13.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.696 0.248 . . . . 0.0 110.811 -179.703 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 77.5 mtt85 -124.1 137.61 54.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.916 0.389 . . . . 0.0 110.214 177.824 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 20' ' ' VAL . 90.8 m-85 -138.23 167.49 21.73 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.537 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.0 m -76.28 156.7 33.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.083 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.73 -3.97 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.139 0.495 . . . . 0.0 111.382 -170.669 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.74 -26.59 7.78 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.761 0.315 . . . . 0.0 110.381 178.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -71.86 -45.9 59.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.318 179.377 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -65.96 -38.24 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.238 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.2 mt -62.25 -42.31 94.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 110.386 177.987 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.84 -0.5 30.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.656 0.741 . . . . 0.0 110.452 -177.332 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -104.75 -25.33 12.71 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.915 -0.49 . . . . 0.0 109.793 177.325 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 39.1 pt -103.81 -15.17 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.001 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.6 ptm180 -106.78 -2.34 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.286 175.244 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -116.67 -50.79 2.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.733 -175.562 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.69 -68.8 0.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 -179.784 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -159.25 154.76 25.83 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 178.512 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -81.01 45.4 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.65 0.738 . . . . 0.0 110.927 -173.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -144.25 154.42 43.07 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.956 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.0 p -64.1 135.41 96.31 Favored Pre-proline 0 N--CA 1.445 -0.688 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.257 177.499 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.23 -29.61 80.58 Favored 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 122.839 2.359 . . . . 0.0 113.593 -172.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.86 -71.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.18 0.514 . . . . 0.0 111.697 -174.028 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -95.65 4.56 52.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.549 -173.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.0 m120 56.93 34.17 24.43 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 169.39 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -87.45 141.96 28.23 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.624 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 50' ' ' ILE . 3.5 mp -65.24 119.5 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.895 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 56' ' ' LEU . 10.2 tt -110.51 127.67 55.28 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -168.49 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.503 ' HB2' HE21 ' A' ' 55' ' ' GLN . 3.8 mm? -96.88 132.87 42.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.913 178.54 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.26 -35.43 80.4 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -173.994 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -63.56 -29.72 70.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 178.108 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.503 HE21 ' HB2' ' A' ' 52' ' ' LEU . 50.2 mt-30 -80.34 -7.86 59.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.503 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 51' ' ' LEU . 95.6 mt -70.23 125.97 28.32 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.956 177.205 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' CG ' ' HD2' ' A' ' 58' ' ' PRO . 30.2 t80 69.8 145.19 0.11 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.967 0.907 . . . . 0.0 109.789 -179.342 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 57' ' ' PHE . 33.5 Cg_endo -61.51 148.82 92.05 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.928 1.752 . . . . 0.0 111.877 178.05 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -61.36 122.28 14.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.473 -173.843 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -99.2 145.7 26.96 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.706 -179.411 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -111.57 126.57 55.14 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.797 174.73 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.13 89.99 6.21 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.16 0.505 . . . . 0.0 111.16 -176.063 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm . . . . . 0 C--N 1.31 -1.109 0 CA-C-O 118.503 -0.76 . . . . 0.0 108.983 175.589 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.97 144.96 96.95 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.805 2.336 . . . . 0.0 111.149 176.603 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.0 tt -75.25 127.72 33.81 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.162 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.36 -3.46 58.02 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.724 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.3 m -130.63 150.86 51.63 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.791 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.42 146.49 32.52 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.339 179.524 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.574 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 92.7 m-85 -101.11 41.65 1.17 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.487 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -123.18 124.41 42.97 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.871 -172.579 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.92 112.52 9.95 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 123.712 0.632 . . . . 0.0 109.689 175.864 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -63.12 -20.37 70.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.248 1.966 . . . . 0.0 112.87 -178.343 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -66.08 -44.43 91.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.2 p -105.24 -19.19 13.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.635 -177.791 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 57.0 26.7 12.22 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.791 0.836 . . . . 0.0 111.797 -176.658 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -95.88 -65.73 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.023 0.44 . . . . 0.0 110.469 176.689 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.3 -164.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -177.326 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 92.9 mt -103.3 113.76 27.5 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 172.512 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -63.91 -44.98 91.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 178.018 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -132.52 -7.18 3.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 178.608 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.15 92.47 0.07 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 175.623 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -117.19 111.63 35.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 110.289 171.594 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -80.94 143.43 32.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.385 178.638 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -108.82 154.68 41.66 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.272 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 55' ' ' GLN . 40.6 Cg_endo -65.37 -20.01 61.6 Favored 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 122.742 2.295 . . . . 0.0 111.463 177.448 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.4 t -73.99 -15.06 61.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.077 179.01 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.07 22.2 18.23 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.234 178.4 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -113.03 152.12 29.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.587 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -120.01 136.04 54.7 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.696 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 94.8 m-85 -136.67 172.99 12.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.092 0.472 . . . . 0.0 110.502 -177.024 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.6 m -82.01 152.0 26.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 171.05 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.0 tttt -68.87 -10.7 58.44 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -177.489 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 -12.32 12.82 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 121.711 -0.618 . . . . 0.0 110.205 179.325 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 70.9 m -85.92 -62.94 1.41 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.982 177.573 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.4 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.1 tp -67.79 -39.9 82.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.062 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.737 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 84.5 mt -63.04 -43.38 98.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 0.0 110.523 -178.504 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -79.53 0.79 28.34 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.714 0.768 . . . . 0.0 109.729 -178.561 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 t -106.38 -23.76 12.44 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.992 -0.442 . . . . 0.0 110.83 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 46.0 pt -103.96 -26.09 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.384 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -97.41 3.43 50.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.423 0.63 . . . . 0.0 109.773 176.553 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -116.66 -55.88 2.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.76 -72.93 0.52 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.108 179.809 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -158.46 160.46 30.98 Favored Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 178.55 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -85.42 71.08 10.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.373 0.606 . . . . 0.0 111.162 -176.242 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -152.22 150.61 30.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.764 178.023 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 9.2 p -79.9 122.03 82.84 Favored Pre-proline 0 N--CA 1.429 -1.519 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.689 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.98 -18.43 62.16 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.652 2.235 . . . . 0.0 113.274 -170.712 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.0 -48.44 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -133.53 13.77 4.1 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.621 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER 63.04 21.44 12.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 174.214 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 72.2 mm-40 -72.66 142.52 48.28 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.564 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.5 mm -66.4 121.05 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.973 0.416 . . . . 0.0 110.605 -176.39 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.1 tp -128.16 134.4 49.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.056 -177.456 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.0 mm? -116.89 155.27 29.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.534 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' A' ' 38' ' ' ARG . 48.8 mt-10 -62.85 -36.48 83.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.16 0.505 . . . . 0.0 110.299 179.273 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.13 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.931 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.477 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.6 mm100 -79.8 -7.69 58.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.489 -174.082 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.01 140.99 50.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.966 0.413 . . . . 0.0 110.844 179.839 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -77.17 147.26 76.21 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.116 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -55.99 139.6 84.99 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.399 2.066 . . . . 0.0 113.476 -174.481 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -83.39 147.48 27.87 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.929 -179.23 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -143.28 100.24 3.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.206 0.527 . . . . 0.0 111.697 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -151.01 106.72 3.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 173.154 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' O ' ' HD2' ' A' ' 63' ' ' LYS . . . -99.75 111.72 24.02 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -169.051 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 31.7 mmmt . . . . . 0 C--O 1.243 0.728 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.364 176.067 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.069 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.95 148.73 51.94 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.467 2.111 . . . . 0.0 111.641 177.226 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.22 97.25 7.79 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.822 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.84 -23.1 24.04 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.7 179.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.7 t -146.92 145.18 29.71 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.612 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.75 79.45 8.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.745 0.783 . . . . 0.0 109.272 -176.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.493 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 60.7 t80 -115.83 16.24 16.29 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.481 -176.018 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -102.93 135.06 45.31 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.93 -176.836 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB2' HD23 ' A' ' 16' ' ' LEU . 46.9 t -96.19 109.41 47.05 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.39 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.22 -19.47 62.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.038 1.825 . . . . 0.0 112.736 -174.438 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.61 -43.92 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.832 0.349 . . . . 0.0 111.288 178.284 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.6 p -106.51 -4.38 19.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.696 -177.131 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt 55.16 34.35 22.46 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.349 0.66 . . . . 0.0 111.135 -177.518 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.4 mtm -133.12 -174.76 3.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.368 179.286 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.17 157.38 37.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.578 HD23 ' HB2' ' A' ' 9' ' ' CYS . 95.1 mt -70.62 134.33 47.49 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -86.05 -73.45 0.45 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.783 177.64 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -93.1 -16.35 25.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 178.125 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.32 66.46 1.23 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.183 -179.29 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.5 m -85.36 117.7 30.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.135 0.493 . . . . 0.0 111.114 -179.367 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -79.55 133.38 36.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.318 -177.095 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.8 p -101.34 157.67 33.23 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.472 -178.617 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -56.84 -33.51 94.83 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.713 2.276 . . . . 0.0 112.509 178.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 p -69.49 -26.08 64.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.98 -178.4 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.56 51.1 0.72 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.135 -178.225 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 21' ' ' GLN . 38.7 m80 -138.51 159.68 41.46 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 122.732 0.413 . . . . 0.0 110.909 177.582 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -126.27 135.73 51.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.169 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.436 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 92.6 m-85 -139.7 169.76 17.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.522 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 24.5 m -79.2 152.09 30.87 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 173.099 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.23 -13.57 62.48 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -173.877 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.08 -3.49 13.97 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.632 -178.771 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.7 m -91.55 -59.62 2.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.401 174.663 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 28' ' ' PHE . 11.1 tp -68.46 -39.75 81.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.435 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.3 mt -63.13 -41.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.057 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.07 -0.97 30.08 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.555 0.693 . . . . 0.0 109.628 -178.265 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -106.25 -18.68 13.93 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 122.075 -0.391 . . . . 0.0 111.323 175.418 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.4 pt -105.06 -30.08 2.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -177.118 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.1 ptm180 -98.4 4.19 48.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.554 178.999 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.56 -56.15 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.641 -179.023 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 -74.38 0.36 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.269 178.634 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -160.51 155.7 26.88 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 33.5 m80 -79.23 66.06 4.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.078 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.2 ptpp? -152.54 149.81 28.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.223 174.435 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 2.8 p -74.4 127.12 88.13 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.263 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.24 -23.81 77.76 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.282 2.655 . . . . 0.0 113.806 -171.197 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.437 HG13 ' OD1' ' A' ' 47' ' ' ASP . 4.4 p -77.1 -51.11 19.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.112 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' OD1' HG13 ' A' ' 46' ' ' VAL . 13.0 p-10 -117.59 6.4 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.1 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 59.66 35.01 22.32 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 74.6 mm-40 -95.41 140.13 30.72 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.978 -0.451 . . . . 0.0 110.677 176.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 2.4 mp -65.65 121.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.087 0.47 . . . . 0.0 110.131 -176.544 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -122.73 134.59 54.45 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.62 -176.327 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.432 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 88.9 mt -114.36 147.65 38.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.933 178.752 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.45 ' OE2' ' HB3' ' A' ' 38' ' ' ARG . 53.8 mp0 -62.75 -35.89 81.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 0.0 109.464 179.179 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -65.52 -29.77 70.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.239 -179.639 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 18.5 mm-40 -71.18 -27.79 63.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.166 0.508 . . . . 0.0 111.353 177.713 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.05 149.51 39.16 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.99 -179.236 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -61.16 133.88 92.91 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.806 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.53 -49.77 13.87 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.384 2.056 . . . . 0.0 112.752 -174.513 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.44 36.08 6.75 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.422 0.629 . . . . 0.0 112.099 -179.82 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -112.69 -70.27 0.82 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.04 -174.332 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -62.33 -46.11 90.19 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -175.085 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.17 13.21 9.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.799 -175.413 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm . . . . . 0 C--O 1.252 1.211 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.217 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -55.91 -39.51 90.7 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.281 2.654 . . . . 0.0 112.882 -179.392 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 tt -123.98 125.3 44.35 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.415 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.81 86.81 0.44 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.805 -178.867 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p -79.2 -2.23 40.03 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -175.071 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -71.17 -9.33 57.91 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.558 0.694 . . . . 0.0 110.414 173.343 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.608 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 98.0 m-85 -102.36 12.1 37.08 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.56 174.943 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -102.59 119.14 38.31 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.068 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.3 t -54.93 112.49 4.13 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.083 0.553 . . . . 0.0 110.684 179.432 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 32.0 Cg_exo -62.21 -20.53 70.31 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.926 2.417 . . . . 0.0 113.35 -175.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -67.71 -44.74 85.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.336 176.229 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.45 -25.95 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.161 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp 63.98 23.58 13.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.175 0.59 . . . . 0.0 111.787 -178.17 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -95.34 -66.3 0.92 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 109.64 178.913 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.69 -163.44 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -176.91 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 95.4 mt -106.23 124.81 50.16 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.812 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -79.06 -60.37 2.4 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.19 174.299 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -105.97 -14.98 15.03 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.252 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.45 90.83 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.2 117.4 52.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.035 0.445 . . . . 0.0 110.475 175.373 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -80.74 133.69 35.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.204 178.726 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.3 p -88.02 161.14 44.75 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.684 179.507 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.2 -29.82 88.71 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.097 2.531 . . . . 0.0 112.1 177.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.16 -21.2 63.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 179.52 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.84 36.67 2.34 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.813 173.825 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -149.74 167.22 27.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.352 0.576 . . . . 0.0 111.944 176.433 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -109.52 140.76 42.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -168.149 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 96.5 m-85 -132.49 167.19 20.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.962 173.249 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.577 ' O ' HG22 ' A' ' 33' ' ' ILE . 38.2 m -84.81 150.15 25.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.507 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.02 -8.83 56.11 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -172.573 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.73 -28.35 7.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.022 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -65.31 -52.96 50.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.362 0.601 . . . . 0.0 110.208 176.522 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.5 tp -70.35 -40.5 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.947 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.48 -43.21 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.516 -176.749 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -78.88 -2.01 37.81 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.567 0.699 . . . . 0.0 110.359 -176.698 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 48.4 m -105.74 -18.56 14.03 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 175.683 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.7 pt -104.29 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.115 -178.267 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 17.2 ptm180 -95.08 -4.33 46.52 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.889 177.59 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.51 -47.49 2.73 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.398 -177.085 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 36' ' ' SER . . . -87.59 -69.69 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.03 157.71 30.3 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.534 179.047 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -87.91 18.59 4.06 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -176.41 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -95.92 140.83 30.12 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.005 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 53.0 t -60.79 130.85 91.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.36 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.51 -29.18 88.08 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -172.091 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.96 -55.63 5.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -103.2 4.38 36.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -173.137 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.6 29.5 15.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 173.898 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -79.81 145.54 32.75 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.462 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.36 119.5 13.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 179.012 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -125.45 131.78 52.82 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.437 -172.581 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.77 156.86 27.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -38.45 85.49 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.855 0.36 . . . . 0.0 110.952 -176.878 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -65.2 -30.51 71.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.826 178.723 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -80.15 -12.03 59.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.898 -176.068 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 33' ' ' ILE . 82.0 mt -76.65 100.39 5.35 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.024 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 84.5 t80 64.67 113.02 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -167.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.15 143.38 74.86 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.183 1.922 . . . . 0.0 111.849 -170.794 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -70.33 80.49 0.54 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.309 1.052 . . . . 0.0 112.988 -169.901 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -106.21 63.83 0.66 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.475 177.23 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -136.66 142.42 43.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.266 -178.288 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.54 144.73 41.77 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.145 177.594 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.31 -1.148 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.509 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.599 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.28 -29.58 80.22 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.936 2.424 . . . . 0.0 113.891 -176.802 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.6 tp -122.35 112.75 18.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.217 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.25 23.63 64.49 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.435 -0.802 . . . . 0.0 114.521 169.684 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -154.52 86.2 1.14 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.157 0.503 . . . . 0.0 110.695 -179.852 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -101.37 68.93 1.23 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.609 1.195 . . . . 0.0 111.731 179.109 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 98.3 m-85 -102.76 12.37 36.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.346 174.924 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -117.64 122.17 42.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.989 175.572 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 44.8 t -61.92 112.66 6.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.192 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 31.9 Cg_exo -62.06 -21.32 72.21 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.569 2.18 . . . . 0.0 112.793 -174.254 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.39 -44.17 90.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.085 0.469 . . . . 0.0 111.777 179.53 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.5 p -106.06 -19.37 13.74 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.598 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 10' ' ' PRO . 98.2 mt 53.47 28.47 7.65 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -175.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -95.61 -65.5 0.97 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.259 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.66 -171.47 0.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.2 mt -97.58 109.06 21.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.28 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -70.28 -44.68 67.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.806 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 54.7 mm-40 -111.9 -16.48 13.12 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.098 -177.14 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.41 82.19 0.09 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 177.407 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.95 116.68 51.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 110.972 175.963 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.22 125.42 30.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.285 176.553 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -75.76 157.29 84.09 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.97 -23.69 76.08 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.375 2.05 . . . . 0.0 112.34 177.77 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 7.8 p -77.85 -20.76 52.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.617 176.876 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.76 43.53 1.42 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.024 -1.084 . . . . 0.0 114.232 174.537 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.55 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 87.3 m-70 -130.86 152.55 50.07 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.175 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -113.02 132.78 55.25 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.534 178.187 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 97.0 m-85 -138.25 167.64 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.123 -178.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 42.4 m -78.31 151.86 32.73 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.204 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.526 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 88.0 tttt -68.49 -13.45 62.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -171.062 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.92 -27.09 7.87 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.885 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 58.8 m -64.59 -46.79 81.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.299 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -69.43 -41.37 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.145 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 80.8 mt -63.57 -42.67 96.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.153 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -79.42 -0.54 33.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -177.958 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -105.29 -21.72 13.19 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.051 176.793 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.6 pt -104.89 -13.68 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.33 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -108.18 -1.7 20.05 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.557 175.873 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -122.23 -57.58 1.76 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.64 -0.424 . . . . 0.0 112.033 -179.867 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.84 -65.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.647 -178.553 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -157.09 159.2 29.48 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.546 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -79.88 -8.84 59.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.474 0.637 . . . . 0.0 110.992 -176.611 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 20.2 ptpt -81.29 149.33 29.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.121 176.591 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 51.0 t -58.8 125.97 79.0 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.92 -22.01 73.44 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.018 2.478 . . . . 0.0 113.514 -167.993 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -97.79 -48.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.443 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' CG ' ' HE2' ' A' ' 26' ' ' HIS . 53.9 p-10 -108.98 5.86 24.65 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.921 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 58.63 32.73 22.47 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 176.22 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -97.54 137.39 36.55 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.205 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' LYS . 46.6 mm -65.81 120.92 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.599 -177.458 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 37' ' ' ILE . 49.7 tp -109.7 130.22 55.53 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.99 -172.467 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.59 135.55 40.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 -176.486 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.53 -36.76 84.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.401 -179.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -63.58 -31.83 73.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.883 -177.342 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.7 mm-40 -71.65 -25.05 61.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 111.481 179.641 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.69 131.15 38.64 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 -175.732 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 80.7 t80 65.03 108.59 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 124.47 1.108 . . . . 0.0 112.646 176.453 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -60.58 144.96 99.58 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.556 2.171 . . . . 0.0 109.868 173.934 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -59.78 126.81 29.04 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.587 0.708 . . . . 0.0 112.199 -172.38 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -169.54 124.52 0.82 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.288 -1.324 . . . . 0.0 107.727 178.513 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -148.23 154.36 39.97 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.375 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.64 101.36 12.85 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.795 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 tptp . . . . . 0 C--N 1.306 -1.3 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.851 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.988 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.13 148.32 85.05 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.009 2.472 . . . . 0.0 113.514 -178.321 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.12 -45.41 92.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.536 -177.981 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.2 93.58 1.7 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.067 -176.779 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.8 m -143.17 -74.87 0.27 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 177.242 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 179.8 26.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.834 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' C ' ' HG ' ' A' ' 16' ' ' LEU . 93.2 m-85 -114.24 15.69 18.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.041 -173.374 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -107.16 119.96 40.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.222 174.141 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.55 ' HB2' HD23 ' A' ' 16' ' ' LEU . 37.1 t -71.8 114.12 25.93 Favored Pre-proline 0 C--O 1.221 -0.428 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.313 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.69 -21.27 71.73 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.583 2.189 . . . . 0.0 112.951 -176.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.63 -45.01 89.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.898 0.38 . . . . 0.0 111.664 179.203 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 9.6 p -105.3 -23.85 12.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.985 0.422 . . . . 0.0 111.53 -177.201 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.23 22.53 13.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.15 0.98 . . . . 0.0 111.844 -177.945 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.1 mtm -94.69 -64.69 1.04 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.043 0.449 . . . . 0.0 109.911 176.348 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.96 -175.33 0.86 Allowed 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.116 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 9' ' ' CYS . 93.9 mt -96.58 116.77 29.64 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 170.442 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 20.7 tpt180 -66.18 -44.73 83.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.778 177.906 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 17' ' ' ARG . 47.4 mt-10 -132.66 -15.15 2.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -177.052 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.54 84.87 0.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.132 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.36 118.41 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.224 0.535 . . . . 0.0 111.009 175.208 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.406 ' OE1' ' HG3' ' A' ' 27' ' ' ARG . 7.6 tp60 -78.63 133.12 37.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.211 179.512 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -87.57 160.17 48.22 Favored Pre-proline 0 C--N 1.311 -1.1 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.483 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.53 -23.65 74.94 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.373 2.048 . . . . 0.0 112.507 179.079 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.523 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -80.67 -15.8 55.62 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.994 0.426 . . . . 0.0 111.551 176.191 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.59 52.3 1.32 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.162 175.218 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.523 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 38.9 m-70 -135.06 141.08 46.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.727 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.406 ' HG3' ' OE1' ' A' ' 21' ' ' GLN . 90.3 mtt180 -105.63 133.47 50.32 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.686 176.242 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -135.02 169.25 17.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.744 177.184 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 61.3 m -69.36 148.81 49.15 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 171.435 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.41 -6.72 45.47 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.288 0.566 . . . . 0.0 111.356 -173.414 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.13 -34.01 5.5 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.026 -0.421 . . . . 0.0 110.263 179.332 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 59.1 m -65.84 -46.96 76.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.932 179.109 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 29' ' ' CYS . 11.0 tp -68.89 -40.65 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.014 -177.506 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.2 mt -63.28 -43.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.961 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -80.96 4.42 19.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.008 0.433 . . . . 0.0 111.351 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -105.46 -24.67 12.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.715 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.6 pt -103.39 -20.52 5.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.47 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.8 ptm180 -99.92 4.08 44.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.497 176.107 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -128.03 -54.51 1.29 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.018 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.15 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -179.04 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -154.44 144.6 11.36 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.923 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -84.19 40.62 0.78 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.736 0.779 . . . . 0.0 111.165 -171.092 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -142.63 152.86 42.92 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.119 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.23 123.58 89.14 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.731 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.59 -24.18 75.03 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.077 2.518 . . . . 0.0 114.078 -170.259 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.1 m -72.34 -49.82 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.973 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -115.49 5.74 14.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.005 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 58.76 33.68 23.23 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 175.502 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -100.23 144.5 29.17 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.351 -0.218 . . . . 0.0 110.495 179.345 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.59 121.72 15.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 -176.371 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.466 HD21 HD21 ' A' ' 56' ' ' LEU . 43.8 tp -115.33 127.78 55.66 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.275 -174.61 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.5 138.88 38.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.338 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.85 -36.85 77.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 122.747 0.419 . . . . 0.0 111.959 -175.133 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -71.78 -17.8 62.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.833 0.349 . . . . 0.0 111.571 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -81.26 -9.06 59.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.865 -177.136 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.466 HD21 HD21 ' A' ' 51' ' ' LEU . 92.4 mt -76.43 132.9 39.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.983 178.6 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -141.72 127.17 10.78 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-O 121.122 0.486 . . . . 0.0 111.805 179.321 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.14 171.19 17.31 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.106 2.537 . . . . 0.0 111.37 177.71 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.2 117.38 16.96 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.165 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -86.38 97.05 10.22 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.506 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -67.11 -38.4 85.56 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.114 -177.456 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -178.88 -51.31 0.01 OUTLIER 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.907 0.883 . . . . 0.0 109.399 176.807 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.122 -177.759 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.996 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.41 142.65 96.19 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.759 2.306 . . . . 0.0 112.425 -178.411 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tt -134.82 123.21 23.17 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.178 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.58 -144.06 3.84 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 178.951 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.5 m -69.06 132.05 46.01 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.769 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -145.92 157.11 43.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.864 0.364 . . . . 0.0 110.601 -174.488 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.438 ' CD2' HD12 ' A' ' 16' ' ' LEU . 92.9 m-85 -93.36 68.22 4.15 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.626 0.726 . . . . 0.0 111.244 178.686 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -145.47 123.79 12.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.337 177.547 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.469 ' HB2' HD23 ' A' ' 16' ' ' LEU . 5.1 t -89.92 118.13 68.67 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.28 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.76 -18.73 63.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 113.218 -176.349 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.432 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 95.4 mt -65.84 -44.33 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.692 0.282 . . . . 0.0 110.856 177.806 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.6 p -106.44 -26.47 11.43 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.716 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt 66.3 22.93 10.82 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.142 0.977 . . . . 0.0 111.895 179.569 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.5 mtm -97.64 -66.85 0.88 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.316 0.579 . . . . 0.0 110.631 176.651 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.99 -161.65 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD23 ' HB2' ' A' ' 9' ' ' CYS . 90.4 mt -109.77 122.75 48.22 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.539 172.389 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 27.4 tpt180 -86.85 108.92 18.97 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.944 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 71.49 -10.39 0.82 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.155 1.382 . . . . 0.0 113.173 -179.544 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.86 83.63 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.144 0.978 . . . . 0.0 113.329 175.467 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.42 115.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.086 177.907 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -80.7 128.32 33.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.145 177.474 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -79.77 161.91 64.65 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.204 177.579 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.24 -18.95 67.3 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.5 2.133 . . . . 0.0 111.438 175.884 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.2 m -65.85 -35.43 80.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.785 174.357 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 -28.23 5.44 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.902 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -82.6 154.48 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.746 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -109.5 140.67 42.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.136 -174.946 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.43 167.81 18.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.428 176.546 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 88.3 m -73.4 146.42 45.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.28 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -69.72 -12.79 61.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.361 179.236 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.42 2.98 15.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.497 0.665 . . . . 0.0 109.854 -177.533 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 83.5 m -105.77 -56.97 2.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.734 173.067 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 29' ' ' CYS . 10.7 tp -68.8 -41.85 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.28 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.0 mt -63.42 -41.68 93.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.515 0.674 . . . . 0.0 110.254 179.24 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -77.97 -0.2 26.77 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.64 -177.159 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.2 t -105.85 -22.8 12.84 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.129 -0.357 . . . . 0.0 110.71 175.93 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 42.4 pt -102.23 -23.4 4.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.208 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 13.9 ptm180 -102.81 6.15 39.09 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.754 174.345 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -114.84 -51.15 2.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.607 -178.842 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.05 -69.62 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.525 177.298 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -162.85 159.49 31.89 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.433 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -82.08 65.0 7.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -173.439 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 10.4 ptpp? -153.11 147.64 26.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.932 175.248 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.77 124.18 86.41 Favored Pre-proline 0 N--CA 1.441 -0.889 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.086 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.54 -26.9 81.28 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.993 2.462 . . . . 0.0 114.886 -168.488 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.14 -44.07 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.714 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -121.44 6.43 10.11 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.502 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 52.31 34.54 15.04 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.131 1.372 . . . . 0.0 113.622 177.834 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 77.0 mm-40 -88.89 142.87 27.28 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.085 178.828 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.21 120.07 12.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.305 0.574 . . . . 0.0 110.216 -175.3 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.8 tp -128.89 132.68 47.72 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.603 -177.46 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.94 152.69 34.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.855 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.49 -31.02 71.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.268 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -63.53 -32.81 74.38 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.051 178.167 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -68.32 -34.31 75.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.409 0.623 . . . . 0.0 109.996 178.719 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.0 mt -76.13 153.86 35.92 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.583 178.555 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -62.26 151.69 81.14 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.263 -178.36 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.16 154.64 65.96 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 122.958 2.439 . . . . 0.0 112.975 -178.443 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.65 117.19 21.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.854 -179.185 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -125.93 69.68 1.2 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.276 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.25 -45.72 92.05 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.435 179.949 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.91 159.49 42.47 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.433 -174.999 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' H ' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.741 -179.947 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.35 -40.54 66.96 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.694 2.263 . . . . 0.0 112.838 -178.685 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 tt -80.7 -45.01 17.81 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 172.489 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.28 -96.8 0.17 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -177.105 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.7 m -123.14 115.68 22.2 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 173.544 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -87.68 -16.72 33.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.457 0.646 . . . . 0.0 109.882 175.356 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.06 43.24 1.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.999 0.904 . . . . 0.0 108.94 175.658 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -100.13 134.55 42.88 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.363 -179.393 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 50.5 t -84.37 114.23 53.55 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.059 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.91 -21.68 73.31 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.36 2.04 . . . . 0.0 112.806 -175.323 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.79 -44.17 85.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.619 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 18.5 p -106.24 -22.15 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.54 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 mp 63.85 21.18 12.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.081 0.952 . . . . 0.0 111.108 -174.907 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 30.1 mmt -95.44 -73.49 0.59 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.124 0.488 . . . . 0.0 109.792 178.778 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.09 166.88 2.96 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 9' ' ' CYS . 91.6 mt -84.19 103.65 13.57 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.232 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -83.52 -53.91 5.34 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 118.879 -1.129 . . . . 0.0 112.037 -177.348 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 9.3 mp0 -87.7 -16.56 33.96 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.595 177.318 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 43.34 73.14 0.15 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.189 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -99.65 116.31 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.369 0.604 . . . . 0.0 110.187 177.781 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 63.1 tt0 -80.08 136.53 36.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.92 179.795 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -89.95 159.46 42.77 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.092 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.15 -25.97 81.29 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 174.28 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.55 -17.62 64.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.898 177.931 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 13.84 57.46 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.804 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -109.13 143.28 38.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.844 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -109.98 139.99 44.49 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.075 0.464 . . . . 0.0 111.857 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.487 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.5 m-85 -141.0 169.68 17.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.104 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.8 m -82.81 154.05 24.9 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.352 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 41.0 ttmt -70.86 -14.37 62.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.298 0.571 . . . . 0.0 110.566 -176.59 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.97 2.62 15.86 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.186 0.517 . . . . 0.0 109.921 -178.535 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.4 m -103.06 -55.96 2.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.44 174.007 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.585 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -66.69 -43.28 90.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.641 -175.707 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.39 -41.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.229 0.538 . . . . 0.0 110.675 179.817 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -76.97 -3.83 40.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.812 -175.916 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.0 m -110.88 -23.72 10.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 176.133 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 33' ' ' ILE . 44.6 pt -103.64 -7.3 9.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.099 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -95.32 -10.11 31.11 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.252 177.451 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -116.8 -43.01 2.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.056 -177.668 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.96 -72.81 0.43 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.119 176.819 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.46 152.36 21.7 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 177.649 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 24.1 m80 -82.46 68.88 9.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.855 0.836 . . . . 0.0 111.996 -179.299 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -151.71 150.7 30.51 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.462 177.582 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.2 p -70.97 123.58 89.55 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.407 177.207 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.93 -28.07 80.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.918 2.412 . . . . 0.0 113.651 -171.615 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.49 -49.23 81.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.766 -177.758 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -127.05 6.65 6.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.417 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 60.31 35.35 20.74 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -94.53 143.18 26.63 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 174.14 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 122.18 14.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.313 0.577 . . . . 0.0 110.815 -174.003 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.1 tp -120.97 130.24 53.75 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.143 -174.436 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.57 139.18 40.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -65.35 -37.84 88.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.883 -174.058 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -68.58 -19.02 64.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 177.959 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 12.6 mm-40 -81.36 -8.53 59.75 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.132 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.7 mt -69.3 137.88 53.38 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.859 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HD1' ' O ' ' A' ' 21' ' ' GLN . 63.3 m-85 -66.45 133.74 94.41 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.951 179.046 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 57' ' ' PHE . 43.3 Cg_exo -59.88 144.01 99.52 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.019 2.479 . . . . 0.0 113.126 -176.781 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -91.36 -179.03 5.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.412 178.001 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -135.56 73.61 1.48 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.185 0.517 . . . . 0.0 110.743 174.101 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 18' ' ' GLU . 70.1 m-85 -120.1 -53.42 2.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.373 174.802 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.55 155.26 23.93 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.581 -179.123 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? . . . . . 0 C--N 1.308 -1.202 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.654 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.08 -40.21 87.02 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.226 2.618 . . . . 0.0 112.424 -177.374 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.1 mt -121.22 144.92 48.35 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.048 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.9 57.09 4.83 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 172.085 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 p -73.69 157.81 35.85 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.583 0.753 . . . . 0.0 112.04 -173.003 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -86.69 63.83 8.18 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.759 0.79 . . . . 0.0 111.032 -173.413 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.571 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.5 m-85 -114.09 13.23 18.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.525 173.509 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -105.86 116.74 32.46 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.512 -179.088 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.56 108.83 4.84 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.498 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.08 -19.14 51.66 Favored 'Trans proline' 0 C--O 1.226 -0.113 0 C-N-CA 122.881 2.387 . . . . 0.0 113.463 -171.113 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 95.5 mt -66.21 -43.61 91.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.0 111.144 178.635 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 p -99.17 -25.29 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.973 0.416 . . . . 0.0 111.042 178.692 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.1 mt 60.5 29.86 19.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 111.249 -176.349 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 76.6 mtm -99.09 -68.19 0.81 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 175.136 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.65 -163.24 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -176.253 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 76.6 mt -100.74 124.35 46.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.026 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -88.29 -72.28 0.54 Allowed 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.954 176.846 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.424 ' CD ' ' HG2' ' A' ' 30' ' ' LYS . 58.2 mp0 -81.13 -15.97 54.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.223 177.004 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.4 77.59 0.17 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.646 -178.281 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.12 114.03 40.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.552 0.691 . . . . 0.0 110.015 177.889 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 30.3 tt0 -80.8 135.78 36.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.928 -178.4 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -99.63 154.2 37.39 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.62 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.14 -24.69 72.91 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 122.722 2.281 . . . . 0.0 113.153 -176.229 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.687 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.5 p -76.21 -15.31 60.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 178.692 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.35 23.46 6.94 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.704 175.795 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.687 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 81.4 m-70 -112.61 155.65 24.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.634 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -126.07 137.35 53.62 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.53 176.69 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.587 -175.761 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 8.7 m -91.61 160.43 15.4 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 170.702 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 61.2 pttt -75.88 -7.11 53.74 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.175 0.512 . . . . 0.0 110.353 -174.682 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.37 -0.85 15.24 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.152 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 49.2 m -101.94 -64.16 1.09 Allowed 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.393 175.879 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -67.32 -41.72 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.992 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 30' ' ' LYS . 82.8 mt -63.18 -42.89 98.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 110.97 -178.341 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -79.9 -3.22 47.15 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.246 0.546 . . . . 0.0 110.478 -176.933 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -106.15 -18.22 14.08 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.809 -0.557 . . . . 0.0 111.4 178.156 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 36.5 pt -102.23 -13.28 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.453 -175.051 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -104.87 0.94 28.48 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.06 174.342 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.32 -51.72 2.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 -176.032 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.79 -69.78 0.59 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.42 0.629 . . . . 0.0 109.451 174.796 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.76 163.94 35.26 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 177.682 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -80.31 72.26 7.15 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.87 0.835 . . . . 0.0 112.124 -176.709 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.0 ptpp? -144.61 150.05 36.79 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.784 176.075 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 p -83.75 123.23 76.37 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.36 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.96 -25.71 74.07 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.842 2.361 . . . . 0.0 114.109 -168.962 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.5 m -72.08 -42.96 67.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.874 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -120.27 6.43 10.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 50.93 36.55 15.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 176.303 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.6 mm-40 -96.94 153.29 17.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.345 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.53 122.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.145 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.6 118.35 35.44 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -176.368 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.594 ' HB2' HE21 ' A' ' 55' ' ' GLN . 2.9 mm? -98.36 134.82 40.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.484 179.736 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -64.89 -35.6 81.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.339 0.399 . . . . 0.0 111.74 -173.426 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -65.86 -30.65 71.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.287 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.594 HE21 ' HB2' ' A' ' 52' ' ' LEU . 48.7 mt-30 -68.1 -20.25 64.92 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.188 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.65 141.38 55.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 178.341 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 21' ' ' GLN . 22.3 m-85 -63.86 139.44 97.64 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.28 177.247 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.89 150.27 73.21 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.346 2.03 . . . . 0.0 112.276 -179.139 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -77.85 121.19 23.77 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.995 178.87 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -86.21 110.34 19.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.118 0.485 . . . . 0.0 110.861 -176.515 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -79.09 147.21 32.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.195 -179.263 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.5 158.2 41.52 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.342 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--N 1.306 -1.284 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.839 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.942 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.46 150.65 70.33 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.743 2.295 . . . . 0.0 112.319 177.859 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.8 tp -73.97 126.71 31.07 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.051 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.41 68.72 1.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.237 -0.982 . . . . 0.0 111.042 -175.485 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 p -69.31 151.16 46.55 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 111.489 -177.699 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -92.12 122.79 34.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.973 -176.198 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 52.2 69.33 0.69 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.656 0.783 . . . . 0.0 112.154 -176.875 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -146.39 128.75 15.85 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.251 179.204 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 38.7 t -70.34 114.21 24.08 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.944 0.778 . . . . 0.0 109.426 179.023 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 32.1 Cg_exo -62.7 -21.61 73.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.346 2.03 . . . . 0.0 112.553 -177.666 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.8 -44.02 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.764 0.316 . . . . 0.0 111.582 178.317 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.5 p -104.01 -22.92 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.891 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt 56.75 25.48 10.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 111.939 -176.421 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.8 mtm -96.4 -63.13 1.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.324 174.291 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.37 -172.72 0.31 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.786 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' A' ' 9' ' ' CYS . 96.4 mt -98.93 106.82 19.12 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.961 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -69.61 -43.96 71.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.138 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 67.1 mm-40 -115.38 -16.24 11.46 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 177.876 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.95 70.48 0.58 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.661 0.601 . . . . 0.0 112.329 -178.544 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 58' ' ' PRO . 26.8 m -93.27 116.98 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.141 0.496 . . . . 0.0 110.777 179.236 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -80.0 135.81 36.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 175.116 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -111.01 151.74 43.2 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.498 -179.791 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.449 ' CG ' ' HB3' ' A' ' 55' ' ' GLN . 50.2 Cg_exo -56.63 -37.38 97.76 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.791 2.327 . . . . 0.0 111.154 179.737 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.8 t -59.69 -31.14 69.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.907 -178.793 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.89 36.33 2.04 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.418 179.812 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.56 156.85 40.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.162 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.72 131.35 53.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.012 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.43 ' O ' HG22 ' A' ' 20' ' ' VAL . 94.5 m-85 -139.6 179.72 6.4 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.252 0.345 . . . . 0.0 110.208 -177.109 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 61.8 m -90.61 151.22 21.39 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 169.972 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 88.0 tttt -71.55 -6.8 43.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.34 0.59 . . . . 0.0 111.449 -176.121 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.48 -16.14 12.47 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.081 0.467 . . . . 0.0 109.952 -179.437 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 76.3 m -83.82 -59.28 2.47 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 175.351 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.2 tp -67.87 -41.05 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.243 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 67.0 mt -62.72 -42.97 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.658 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -78.83 -1.66 35.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.546 0.689 . . . . 0.0 109.61 -175.568 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 m -105.38 -21.08 13.3 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.651 176.158 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 44.7 pt -104.07 -24.34 4.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.077 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.1 ptm180 -98.9 0.49 44.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.764 177.371 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.87 -46.52 2.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.749 -177.395 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 -68.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.115 0.483 . . . . 0.0 110.794 177.202 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.49 161.98 35.66 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.31 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 66.0 m80 -86.21 76.17 9.77 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 117.444 0.622 . . . . 0.0 111.555 -173.886 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 22.4 pttp -154.25 144.68 22.22 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 -179.214 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 49' ' ' GLU . 1.3 p -77.32 123.79 86.98 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 170.351 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.25 -24.77 76.32 Favored 'Trans proline' 0 N--CA 1.481 0.751 0 C-N-CA 123.321 2.681 . . . . 0.0 114.019 -167.251 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -66.79 -46.19 86.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.056 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.55 7.45 5.78 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -174.943 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.321 0.2 OUTLIER 53.77 38.12 27.83 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 178.886 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 69.1 mm-40 -86.28 142.01 28.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.382 173.336 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 48.5 mm -66.45 121.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.575 -176.941 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.68 132.39 43.9 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.402 -177.629 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HG3' ' A' ' 55' ' ' GLN . 2.7 mm? -110.58 157.99 19.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.354 177.748 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.65 -38.15 89.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.655 0.74 . . . . 0.0 109.917 -179.473 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -76.72 -6.04 50.55 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.15 -174.006 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 23' ' ' PRO . 61.7 mt-30 -89.38 -8.07 53.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 0.0 111.413 178.723 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.9 mt -73.1 146.63 45.6 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.484 -175.742 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.19 79.98 9.13 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 171.467 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HA ' HG12 ' A' ' 20' ' ' VAL . 32.0 Cg_exo -63.71 -41.57 24.1 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.606 2.871 . . . . 0.0 115.38 -175.867 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -116.32 85.68 2.35 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.875 -169.157 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -155.84 11.47 0.3 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.092 171.43 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.06 142.82 51.25 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.958 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 50.91 40.79 25.9 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.957 0.786 . . . . 0.0 112.154 173.979 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.232 -174.177 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.802 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.36 -30.85 81.23 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 123.259 2.639 . . . . 0.0 113.322 178.579 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.7 tp -118.91 130.6 55.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.505 -178.514 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.12 -150.06 18.73 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.936 177.22 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 p -114.53 104.98 12.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.407 0.622 . . . . 0.0 111.253 179.157 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 8' ' ' GLU . 63.1 tttm -97.89 163.5 12.76 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.141 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -79.3 47.92 0.84 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.785 1.278 . . . . 0.0 109.947 175.728 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 6' ' ' LYS . 35.1 tt0 -141.46 137.89 32.48 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -179.533 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.5 t -72.79 108.55 4.58 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.889 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.19 -17.5 45.16 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.528 2.152 . . . . 0.0 112.002 -174.31 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.4 mt -66.13 -43.6 92.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.61 177.527 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -104.81 -16.51 14.89 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -177.706 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 mp 57.87 22.72 8.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.928 0.891 . . . . 0.0 111.569 -176.326 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.465 ' HA ' ' CE ' ' A' ' 14' ' ' MET . 1.8 mmt -94.88 -66.89 0.88 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.529 -178.865 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.78 -169.43 0.12 Allowed 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -177.975 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.3 mt -97.49 109.36 22.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.898 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -65.48 -45.13 84.87 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.311 -178.823 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -132.72 -14.08 2.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.764 176.344 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.24 92.21 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.602 0.761 . . . . 0.0 112.9 178.167 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.91 117.62 49.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.163 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.31 128.22 33.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.331 -177.584 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -89.32 155.16 49.11 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.872 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.37 -29.55 89.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.504 2.136 . . . . 0.0 113.07 -173.663 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.607 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -76.27 -15.4 60.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.944 0.402 . . . . 0.0 111.923 178.985 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.21 42.45 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.951 174.346 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.607 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 75.3 m-70 -125.62 143.29 51.09 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.524 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 7.5 mpt_? -109.97 135.62 50.53 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.409 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 97.0 m-85 -133.81 168.08 19.39 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 59.8 m -75.88 156.65 34.13 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.775 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' HD12 ' A' ' 34' ' ' ILE . 88.1 tttt -68.82 -11.23 60.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.508 -174.697 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.32 -37.56 4.33 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.973 -179.101 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -62.8 -47.28 84.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.813 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -70.11 -41.61 79.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.896 -178.681 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.556 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 87.7 mt -63.55 -42.78 97.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.696 -178.592 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -78.01 -0.94 29.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.482 0.658 . . . . 0.0 110.02 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.0 m -105.86 -20.36 13.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.701 174.164 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 33' ' ' ILE . 39.6 pt -103.64 -21.73 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -176.577 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 12.2 ptp180 -97.57 8.01 45.43 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.464 171.605 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -116.2 -55.82 2.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.746 -177.94 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.87 -72.64 0.5 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.88 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -166.46 163.56 37.02 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.987 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.493 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 70.5 m80 -87.93 76.65 8.62 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.598 0.713 . . . . 0.0 111.909 -176.706 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -159.91 155.32 25.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.848 175.708 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 p -79.07 124.05 84.75 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.702 175.988 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.8 -27.21 75.15 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 122.82 2.347 . . . . 0.0 113.614 -172.851 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.91 -45.34 73.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.444 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -122.47 4.87 9.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.77 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 57.71 34.74 24.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 175.477 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.14 148.76 22.78 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.448 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.99 120.67 14.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.952 0.406 . . . . 0.0 110.594 -175.486 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 61.7 tp -121.45 127.98 51.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.154 -176.646 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.17 148.92 29.21 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.529 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.08 -37.33 87.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 -175.893 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.0 -29.81 70.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.471 177.381 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.72 -15.11 62.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.076 -179.581 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.43 136.08 39.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.742 0.306 . . . . 0.0 110.729 178.65 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -151.15 144.08 16.78 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.401 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.24 142.89 68.69 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 121.865 1.71 . . . . 0.0 110.839 176.853 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -149.77 129.55 13.29 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 179.938 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -120.38 29.58 7.39 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 173.753 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 62.2 36.33 14.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.549 0.69 . . . . 0.0 109.435 -172.099 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.66 133.27 28.7 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.298 -178.289 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -179.468 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.066 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.0 147.42 95.18 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.507 2.804 . . . . 0.0 113.33 -178.82 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.38 -43.66 98.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 174.992 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.48 -134.0 52.49 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.122 -0.944 . . . . 0.0 113.33 173.674 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m -130.7 147.0 52.32 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.345 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.11 160.64 42.68 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.707 0.289 . . . . 0.0 110.43 -176.632 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.37 87.39 3.86 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 171.296 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -146.14 150.76 36.5 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.215 -173.578 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.408 ' HB2' HD23 ' A' ' 16' ' ' LEU . 38.8 t -79.79 109.84 13.55 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.712 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.79 -20.57 71.55 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.525 2.15 . . . . 0.0 112.576 -174.467 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.5 mt -67.32 -44.7 87.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.684 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 24.3 p -103.92 -19.3 14.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.462 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp 58.42 23.19 10.34 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.693 0.797 . . . . 0.0 111.563 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 75.4 mtm -95.28 -64.62 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.824 0.345 . . . . 0.0 110.158 178.273 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.51 -173.97 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.757 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 9' ' ' CYS . 84.8 mt -95.22 102.66 14.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 173.184 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.29 -45.06 63.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.053 -179.555 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HB2' ' H ' ' A' ' 30' ' ' LYS . 18.5 mm-40 -106.43 -17.45 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.815 -175.176 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 44.52 89.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.596 1.159 . . . . 0.0 114.034 -176.716 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.89 121.26 65.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 175.939 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.348 -178.811 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -110.66 151.1 42.6 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.349 174.638 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.9 -24.82 77.51 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.87 2.38 . . . . 0.0 113.634 -178.802 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.45 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.7 p -79.32 -15.47 57.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.978 177.77 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 44.8 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.304 173.621 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.45 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 23.8 m-70 -133.33 149.46 51.9 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.708 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -111.45 134.85 52.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.495 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 96.9 m-85 -136.18 173.15 12.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.718 -178.725 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 55.7 m -86.89 151.21 23.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.124 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.525 ' H ' ' HB2' ' A' ' 18' ' ' GLU . 65.2 tttp -68.42 -11.21 59.35 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 122.999 0.52 . . . . 0.0 111.348 -178.966 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.55 2.64 15.4 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.171 -178.994 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 60.1 m -105.41 -53.8 2.59 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.399 175.25 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.6 tp -68.17 -38.54 79.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.923 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 77.2 mt -62.09 -41.61 91.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.069 0.462 . . . . 0.0 110.126 178.326 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 32.1 mmmt -79.18 2.75 19.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -106.37 -25.46 11.9 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.742 173.669 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.3 pt -104.63 -5.87 9.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.387 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.0 ptm180 -124.61 3.15 8.29 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.546 171.097 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 3.9 m-20 -127.11 -42.67 1.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.149 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.41 -65.91 0.97 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.437 0.637 . . . . 0.0 110.755 -178.597 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.52 -148.52 5.42 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 175.579 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -139.02 31.96 2.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 171.517 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -132.5 161.03 34.79 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.086 -175.065 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.1 t -74.94 122.04 86.6 Favored Pre-proline 0 N--CA 1.43 -1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.13 -31.16 54.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.386 2.057 . . . . 0.0 113.327 -175.167 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.38 -48.57 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.007 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -114.33 6.49 16.1 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.573 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 58.91 31.97 21.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.489 0.716 . . . . 0.0 112.439 177.106 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.76 147.17 26.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.636 178.943 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.0 122.42 16.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.129 0.49 . . . . 0.0 109.974 -178.022 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.401 HD23 HG21 ' A' ' 37' ' ' ILE . 54.5 tp -111.34 131.0 55.5 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.133 -175.114 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.4 mt -97.76 138.62 34.85 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.075 -178.903 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.77 -38.64 89.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.414 -174.563 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.13 -30.13 70.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.015 0.436 . . . . 0.0 111.189 178.37 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -74.58 -7.14 52.17 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.57 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.6 132.02 42.33 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.013 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -134.47 137.57 28.09 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.893 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.99 139.83 89.76 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 121.8 1.667 . . . . 0.0 110.965 178.379 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.3 -45.23 81.09 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.222 0.534 . . . . 0.0 109.704 179.935 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -111.3 105.18 13.76 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.12 173.307 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -116.83 102.98 9.85 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.007 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.84 111.11 18.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.508 -174.565 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.768 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.13 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.33 42.21 1.14 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.405 2.737 . . . . 0.0 111.887 -179.521 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 7' ' ' TYR . 53.6 tp 69.87 15.13 7.93 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.971 0.908 . . . . 0.0 110.313 -179.089 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 8' ' ' GLU . . . -99.82 36.29 4.2 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.258 -177.536 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.3 m -97.73 -70.04 0.74 Allowed 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.386 -0.479 . . . . 0.0 110.422 178.122 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -92.13 -16.11 26.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.365 0.603 . . . . 0.0 110.23 175.762 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.69 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 94.6 m-85 -105.3 45.21 0.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.679 174.549 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 43.8 tt0 -102.32 141.05 35.78 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.101 177.652 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.516 ' HB2' HD23 ' A' ' 16' ' ' LEU . 39.4 t -94.88 108.37 37.43 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 173.853 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.7 -19.48 68.34 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.841 2.361 . . . . 0.0 112.862 -174.599 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.58 -44.13 90.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 178.61 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.5 p -102.79 -13.37 17.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.794 -178.351 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 mp 69.37 23.97 5.98 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.625 0.77 . . . . 0.0 110.425 -179.04 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.1 mtm -128.18 170.07 13.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.38 157.7 13.31 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.428 0.455 . . . . 0.0 110.899 177.853 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 86.1 mt -70.09 133.1 46.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.719 -174.859 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 12.8 tpt180 -77.98 -62.86 1.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.087 172.716 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.507 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 4.8 mm-40 -99.18 -18.43 17.66 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.062 -177.545 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.27 86.98 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.629 -175.539 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -108.8 118.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.508 0.67 . . . . 0.0 111.126 175.133 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.22 139.41 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.18 179.867 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -110.51 155.32 42.27 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.803 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.02 -20.24 63.83 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.703 2.269 . . . . 0.0 111.72 178.769 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.9 t -74.42 -19.47 60.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.876 178.253 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.72 25.98 11.17 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.979 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -113.69 154.04 27.95 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.028 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.41 ' HB3' HD11 ' A' ' 16' ' ' LEU . 77.8 mtt85 -117.99 138.43 52.19 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.665 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.7 168.29 20.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.775 0.321 . . . . 0.0 110.581 -178.689 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.598 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.8 m -86.21 148.36 25.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 169.977 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.78 -12.85 61.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.958 -171.514 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.46 -7.92 13.41 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.352 -178.587 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 55.8 m -85.94 -46.39 10.6 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 170.149 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.608 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.8 tp -67.78 -43.14 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.859 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.587 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 89.9 mt -63.46 -42.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 111.221 -177.958 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -78.76 -2.09 37.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 -175.607 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 t -106.16 -25.54 11.96 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.832 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 33' ' ' ILE . 40.8 pt -103.77 -15.59 8.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.479 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.3 ptm180 -98.35 2.99 48.57 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.262 173.89 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -115.18 -52.09 2.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.068 -172.123 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.3 -68.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.223 175.671 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -168.74 165.73 39.1 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.099 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 62.4 m80 -87.94 80.48 7.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.837 0.827 . . . . 0.0 111.473 -177.776 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -152.7 159.51 43.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.02 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 47' ' ' ASP . 9.7 m -67.21 127.4 93.47 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 172.861 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.49 -20.77 70.37 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.736 2.291 . . . . 0.0 112.516 -179.31 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.73 -61.0 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.276 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 44' ' ' CYS . 43.2 p-10 -103.92 5.29 35.56 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.033 -0.417 . . . . 0.0 111.128 -174.378 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 56.28 34.55 24.25 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.542 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -90.04 145.65 24.92 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.098 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mm -65.86 121.58 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 0.0 110.426 -174.252 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 64.9 tp -126.89 129.12 47.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.929 -175.983 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 2.2 mm? -112.14 152.26 28.52 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -175.539 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.58 -36.15 82.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.302 0.573 . . . . 0.0 111.171 -177.971 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.99 -31.09 72.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.459 176.27 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 15.4 mm100 -78.93 -8.64 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.384 -175.735 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.84 131.75 42.67 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.667 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.73 107.43 36.76 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.866 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.88 -42.31 68.33 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.051 2.501 . . . . 0.0 113.241 -173.246 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.2 t70 68.05 -48.21 0.53 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.967 1.307 . . . . 0.0 111.413 -175.688 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -104.51 167.16 9.91 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.456 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -97.31 118.33 33.54 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.925 174.088 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.09 155.76 21.16 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.742 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.301 -1.521 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.774 178.76 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.12 156.37 62.57 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 123.372 2.715 . . . . 0.0 111.353 179.41 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.98 102.39 1.99 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.457 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.28 63.32 0.3 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 178.694 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.428 ' HB3' ' CB ' ' A' ' 8' ' ' GLU . 13.6 m -82.62 95.72 7.88 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.117 -0.541 . . . . 0.0 112.035 -170.723 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -67.43 -45.2 76.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.485 174.691 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -121.14 93.74 4.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.409 0.623 . . . . 0.0 111.158 176.451 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 44.2 tt0 -154.72 143.81 21.06 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.791 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 38.4 t -78.28 108.49 7.8 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.756 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 8' ' ' GLU . 35.7 Cg_exo -64.48 -19.8 65.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.926 2.417 . . . . 0.0 112.06 -177.123 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.1 -43.86 92.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 -179.352 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.3 p -99.76 -26.0 14.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.272 179.841 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt 64.22 21.65 12.6 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.153 0.981 . . . . 0.0 111.92 179.797 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 78.2 mtm -100.52 -64.47 1.04 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.936 0.398 . . . . 0.0 111.004 177.884 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.7 -170.07 0.38 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -176.544 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.03 108.01 20.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.533 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.12 -45.84 75.94 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.019 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -112.45 -16.81 12.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.342 176.425 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.37 62.53 2.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.256 -175.046 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 29.1 m -83.18 118.12 30.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.39 -178.492 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -74.51 126.22 30.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.688 178.794 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.1 p -94.68 165.54 17.03 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.085 -177.27 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.83 -34.2 96.22 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.801 2.334 . . . . 0.0 112.062 177.442 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 p -76.62 -15.15 59.9 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.187 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.17 44.0 Favored Glycine 0 CA--C 1.516 0.152 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.936 179.0 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -90.97 167.15 12.62 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.054 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 92.4 mtt180 -130.55 140.24 50.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.001 179.293 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.421 ' O ' HG22 ' A' ' 20' ' ' VAL . 96.9 m-85 -138.7 -177.23 4.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.521 ' O ' HG22 ' A' ' 33' ' ' ILE . 45.6 m -91.12 152.3 20.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.371 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -70.77 -11.88 61.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.049 0.452 . . . . 0.0 111.131 -176.269 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.45 -10.08 13.25 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.041 -177.448 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.5 m -92.66 -56.09 3.14 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.709 177.189 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.558 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -69.03 -40.3 80.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.667 -177.167 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.594 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.0 mt -62.91 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.381 . . . . 0.0 111.851 -178.934 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.14 -3.29 41.71 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.884 0.373 . . . . 0.0 110.49 -175.44 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.9 p -108.18 -19.71 13.4 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 175.157 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 33' ' ' ILE . 36.4 pt -102.64 -13.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.906 -0.496 . . . . 0.0 112.183 -174.55 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 14.3 ptp180 -98.0 7.99 45.46 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 167.852 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.09 -54.88 2.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.685 -175.286 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.96 -72.9 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.346 0.593 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.22 167.17 39.69 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.86 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 59.8 m80 -83.38 74.27 10.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.449 0.642 . . . . 0.0 111.992 -176.338 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.7 ptpt -151.7 152.03 32.23 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.267 177.746 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 1.5 p -77.46 135.69 64.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.829 173.982 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.62 -21.88 65.09 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.502 2.134 . . . . 0.0 112.259 -179.09 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -76.43 -74.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.02 4.47 47.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -175.08 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 11.8 m120 56.08 34.55 24.01 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 172.053 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 75.5 mm-40 -93.64 154.07 18.03 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.725 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.57 120.59 14.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.565 0.698 . . . . 0.0 109.988 -175.805 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 56' ' ' LEU . 7.8 tt -124.05 121.25 34.7 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.297 -172.341 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.51 141.35 35.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.768 0.318 . . . . 0.0 111.378 -176.453 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.51 -43.02 86.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.957 -175.066 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -67.29 -30.91 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.261 -177.373 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -78.85 -8.18 58.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.439 -176.953 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 51' ' ' LEU . 97.5 mt -76.82 127.31 32.52 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.684 179.407 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -135.87 127.56 17.33 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -62.43 139.52 77.12 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.437 2.091 . . . . 0.0 111.741 176.144 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -107.84 118.48 36.86 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 172.95 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 63.69 78.66 0.28 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.729 0.643 . . . . 0.0 110.302 -175.894 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -111.02 139.09 46.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.565 -174.145 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.9 139.4 46.82 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.248 179.585 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.168 0 CA-C-O 118.804 -0.617 . . . . 0.0 109.445 177.678 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.01 118.18 5.36 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.265 1.977 . . . . 0.0 112.386 -177.427 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 tm? 65.3 -52.96 0.35 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.731 1.612 . . . . 0.0 112.503 179.842 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.76 -126.25 10.61 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.689 -176.576 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -125.34 96.55 4.87 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.015 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -90.81 77.28 6.26 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.24 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.445 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 29.9 t80 -145.5 29.02 1.16 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.996 0.903 . . . . 0.0 108.73 -176.662 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -106.97 129.7 54.74 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.088 -176.242 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HB2' HD23 ' A' ' 16' ' ' LEU . 42.1 t -88.17 108.16 20.21 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 173.851 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 28' ' ' PHE . 31.8 Cg_exo -62.73 -20.72 71.82 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.684 2.256 . . . . 0.0 113.3 -174.755 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.67 -43.74 90.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.686 178.958 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.59 -7.96 14.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.113 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt 61.73 26.46 16.09 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.503 0.721 . . . . 0.0 110.785 -177.062 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 77.3 mtm -120.08 169.16 10.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 152.9 38.09 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.744 175.481 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 77.9 mt -69.44 114.25 7.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.937 0.399 . . . . 0.0 110.003 -172.226 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -71.65 -46.56 58.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.779 -177.564 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -114.18 -17.18 11.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.464 178.485 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.45 82.68 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.872 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.43 116.72 53.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.327 0.584 . . . . 0.0 110.994 174.209 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 51.6 tt0 -82.84 133.84 35.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.891 -178.5 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -86.54 160.39 50.82 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.147 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -55.64 -37.76 94.96 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.612 2.208 . . . . 0.0 112.074 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.556 ' SG ' ' HD2' ' A' ' 26' ' ' HIS . 1.2 p -67.99 -17.23 64.37 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.649 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.41 41.44 2.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.267 -0.968 . . . . 0.0 114.015 174.069 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.556 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 76.7 m-70 -122.49 143.76 49.5 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.193 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 21' ' ' GLN . 89.1 mtm180 -111.28 137.52 48.91 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.64 175.239 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 98.5 m-85 -131.65 166.36 21.62 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.428 -178.425 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 34.3 m -79.38 149.65 31.61 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.122 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' HD12 ' A' ' 34' ' ' ILE . 40.5 ttmt -76.22 -2.95 33.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.788 0.804 . . . . 0.0 111.455 -173.155 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.92 -24.0 9.77 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.113 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 56.7 m -73.35 -51.11 18.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.276 174.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.486 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.9 tp -67.23 -39.55 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.926 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 82.1 mt -62.78 -41.7 93.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.625 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -78.18 -1.78 34.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.94 -176.762 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.5 m -105.86 -21.58 13.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.653 0.263 . . . . 0.0 111.178 173.828 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 40.9 pt -102.87 -16.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.343 -175.196 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 ptm180 -99.73 1.13 43.03 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.002 175.467 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -115.49 -54.15 2.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.224 -178.0 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 -66.55 0.89 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.048 0.452 . . . . 0.0 110.48 179.013 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -172.09 161.99 33.99 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 177.218 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.615 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 47.2 m80 -83.18 83.25 7.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.776 0.798 . . . . 0.0 110.473 179.769 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.38 157.09 41.98 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.397 -176.987 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 46.3 t -80.9 122.49 82.0 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.915 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.83 -28.86 76.06 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.958 2.439 . . . . 0.0 115.055 -170.548 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.0 m -85.78 -49.93 14.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -173.095 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -106.98 6.61 29.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.801 0.334 . . . . 0.0 111.322 -176.397 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.255 4.5 p-10 50.82 40.19 24.09 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.227 . . . . 0.0 113.736 177.826 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -80.51 149.84 29.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.799 175.064 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.09 120.84 16.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.109 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 42' ' ' HIS . 58.8 tp -124.29 129.33 50.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.709 0.29 . . . . 0.0 111.138 -176.176 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.02 152.51 24.38 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -65.2 -24.19 67.29 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -174.381 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -89.57 5.48 45.4 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.75 179.162 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -84.8 -11.27 56.08 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.017 0.437 . . . . 0.0 110.168 174.063 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.43 106.62 8.16 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.397 -175.989 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -136.3 150.04 69.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.872 179.042 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.61 151.52 64.3 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.726 1.617 . . . . 0.0 108.849 167.743 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.93 123.12 16.65 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.254 0.549 . . . . 0.0 112.11 -172.425 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -72.51 142.93 48.52 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -172.247 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -158.88 -171.29 3.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 178.751 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.36 83.96 1.07 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 119.476 1.034 . . . . 0.0 109.296 171.43 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? . . . . . 0 C--O 1.257 1.459 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.683 -174.65 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.197 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.67 142.06 92.98 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.368 2.045 . . . . 0.0 110.291 175.69 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -114.73 114.58 25.81 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.346 0.593 . . . . 0.0 110.123 -178.122 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.89 -53.42 0.03 OUTLIER Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 173.995 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.3 p -87.48 99.33 11.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.623 -0.788 . . . . 0.0 108.888 169.785 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -84.68 120.77 26.77 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -177.122 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.549 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 96.0 m-85 -106.46 10.64 31.34 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.643 0.735 . . . . 0.0 109.553 177.267 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -96.02 122.37 38.78 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.411 177.717 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 34.7 t -68.12 115.99 34.47 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.351 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 35.8 Cg_exo -62.04 -22.49 74.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.171 1.914 . . . . 0.0 113.171 -174.653 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.7 mt -68.78 -44.28 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.475 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 8.1 p -97.96 -16.41 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.646 -177.413 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt 54.92 27.08 8.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 109.81 -174.031 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.9 ttm -108.35 -73.96 0.67 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.699 -173.488 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.65 162.75 2.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.015 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 7' ' ' TYR . 97.5 mt -77.05 104.5 7.57 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.328 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -70.65 -45.65 64.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 177.294 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 30' ' ' LYS . 63.8 mm-40 -114.59 -16.47 11.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.948 -178.027 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 59' ' ' ASP . . . 53.58 82.67 0.08 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.949 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -111.85 117.81 56.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.244 0.545 . . . . 0.0 110.59 175.001 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 53.5 tt0 -81.34 138.33 35.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.357 -177.914 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 ' CG2' HD11 ' A' ' 51' ' ' LEU . 67.9 p -113.73 156.54 43.51 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.584 -179.011 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HG3' ' OE1' ' A' ' 55' ' ' GLN . 38.3 Cg_endo -62.98 -22.0 73.54 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.027 2.485 . . . . 0.0 113.409 -176.17 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 26' ' ' HIS . 56.5 m -73.99 -19.25 60.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.643 177.509 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 30.56 7.18 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.169 -175.885 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.498 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 16.5 m-70 -114.0 152.13 31.38 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.078 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 21' ' ' GLN . 88.7 mtm180 -122.64 134.34 54.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.309 171.656 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 93.0 m-85 -129.97 -177.82 4.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.289 -176.151 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 33.6 m -99.61 157.89 16.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.999 173.443 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' HB3' ' HG3' ' A' ' 18' ' ' GLU . 88.4 tttt -68.64 -13.39 62.33 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.046 0.451 . . . . 0.0 111.631 -178.209 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.59 1.93 16.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.863 0.84 . . . . 0.0 109.198 -178.138 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 84.0 m -103.12 -63.32 1.18 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.713 175.935 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.1 -40.63 85.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.528 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.644 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 83.6 mt -63.47 -42.46 96.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.953 0.406 . . . . 0.0 110.273 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.84 4.95 12.58 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.627 0.727 . . . . 0.0 110.247 -179.289 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.7 t -106.46 -26.44 11.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.738 173.418 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 45.9 pt -103.77 -19.47 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.968 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 16.9 ptm180 -101.01 8.63 42.91 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.771 0.796 . . . . 0.0 109.36 173.8 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.41 -56.61 2.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.871 -174.66 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.33 -68.93 0.77 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.947 177.322 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 37' ' ' ILE . . . -173.1 176.09 45.9 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 178.895 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 33.5 m80 -79.11 92.66 5.05 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 117.824 0.812 . . . . 0.0 111.478 -179.806 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 18.8 ptpt -169.08 147.46 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.328 0.651 . . . . 0.0 109.526 177.733 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 125.32 71.06 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 170.197 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -61.01 -25.59 81.77 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.965 2.444 . . . . 0.0 114.661 -167.909 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.98 -44.74 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.099 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -121.48 5.72 10.12 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.193 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 51.21 31.07 6.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.051 1.341 . . . . 0.0 114.24 179.691 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 68.0 mm-40 -83.1 140.11 32.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.509 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 2.0 mp -66.36 120.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.278 0.561 . . . . 0.0 110.198 -176.448 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.448 HD11 ' CG2' ' A' ' 22' ' ' THR . 8.9 tt -121.78 131.99 54.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.255 -173.46 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.43 HD13 ' NE2' ' A' ' 55' ' ' GLN . 8.3 mp -111.41 153.1 26.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.445 -178.01 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -61.69 -34.43 75.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.265 0.626 . . . . 0.0 111.461 -177.671 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -74.59 -11.47 60.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.11 0.481 . . . . 0.0 111.29 -178.018 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.43 ' NE2' HD13 ' A' ' 52' ' ' LEU . 80.8 mt-30 -87.61 -10.63 50.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.841 177.9 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.2 mt -77.98 130.82 36.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.026 177.52 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -136.06 138.97 28.88 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.139 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -65.93 142.84 70.54 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 121.806 1.671 . . . . 0.0 111.508 -179.557 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.438 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 29.5 t70 -73.81 138.97 44.81 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.877 -177.117 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.41 -35.5 81.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -175.321 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.414 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 94.8 m-85 -66.85 -37.66 84.88 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.067 0.46 . . . . 0.0 110.012 -178.235 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.77 76.25 6.44 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.399 178.943 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 tptm . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.095 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_